<SEC-DOCUMENT>0000764180-22-000091.txt : 20220728
<SEC-HEADER>0000764180-22-000091.hdr.sgml : 20220728
<ACCEPTANCE-DATETIME>20220728071202
ACCESSION NUMBER:		0000764180-22-000091
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		92
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220728
DATE AS OF CHANGE:		20220728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTRIA GROUP, INC.
		CENTRAL INDEX KEY:			0000764180
		STANDARD INDUSTRIAL CLASSIFICATION:	CIGARETTES [2111]
		IRS NUMBER:				133260245
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08940
		FILM NUMBER:		221112781

	BUSINESS ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230
		BUSINESS PHONE:		(804) 274-2200

	MAIL ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTRIA GROUP INC
		DATE OF NAME CHANGE:	20030127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIP MORRIS COMPANIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mo-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c,d:8ab1f6ba80d642c6abc401018a1063a1--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:mo="http://www.altria.com/20220630" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mo-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8xLTEtMS0xLTEyOTEwOQ_e3a8e060-130b-4538-a2ca-0b3a5f49ce78">false</ix:nonNumeric><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8yLTEtMS0xLTEyOTEwOQ_52f9be05-2f9e-4ca4-a6da-af09604c982f">2022</ix:nonNumeric><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8zLTEtMS0xLTEyOTEwOQ_c5d7ed3d-84bb-4030-92a3-d27c7f249fcc">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF80LTEtMS0xLTEyOTEwOQ_2f74205a-580a-45dc-a674-de6069d9ca3d">0000764180</ix:nonNumeric><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF81LTEtMS0xLTEyOTEwOQ_7c1596a0-94d6-45cd-a50b-26467e8021e3">12/31</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xNi9mcmFnOjQ2OGZhMmE5ZjQ4YjRjM2FiMDBlMDRmNWY2YTk4Zjk5L3RhYmxlOjNlYjczZjhkNGViMzRmZWE4N2Y0NjMxYjMwMWQzMzNlL3RhYmxlcmFuZ2U6M2ViNzNmOGQ0ZWIzNGZlYTg3ZjQ2MzFiMzAxZDMzM2VfMi0xLTEtMS0xMjkxMDk_d2401b62-ce8f-4bf2-82c8-b16944adf1ce">0.3333</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xNi9mcmFnOjQ2OGZhMmE5ZjQ4YjRjM2FiMDBlMDRmNWY2YTk4Zjk5L3RhYmxlOjNlYjczZjhkNGViMzRmZWE4N2Y0NjMxYjMwMWQzMzNlL3RhYmxlcmFuZ2U6M2ViNzNmOGQ0ZWIzNGZlYTg3ZjQ2MzFiMzAxZDMzM2VfMi0yLTEtMS0xMjkxMDk_c7c4490e-6cac-4f46-9a4b-d10151f89304">0.3333</ix:nonFraction><ix:nonFraction unitRef="court" contextRef="ib54ecad677fe41feb6b487a4b5b5f14a_I20220725" decimals="INF" name="mo:LossContingencyStateCourtsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDkvZnJhZzo3NDYzZTM4OTM2NTA0N2MyOGE1MTQ0ZTM3MWQ5OWY0ZC90ZXh0cmVnaW9uOjc0NjNlMzg5MzY1MDQ3YzI4YTUxNDRlMzcxZDk5ZjRkXzU_263f58dd-9a5f-4517-ae3c-a585b6c618bc">21</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mo-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6921171ae08e465e932c11f79502724a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab2de85898814346924624f350e5562e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b840b10f44411fb19fdc6d7a05d2f6_I20220719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i964ab02efa4447bb862d040ab72bdce7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ef8abb29b764b4c8ca775c97572d064_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idccb1b2994cd40fbbb5731c88d1d399c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b219eedfb714d8fb1b867d806c10b05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2449a2bfd124fe2ab3313d8a383b536_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48fb5645cbc4cc196e6db7c24a03af9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55831b17fc8441a290ddc1bf9c38fa94_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec91f7ffcfe043208c2fbae9bff40d21_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i195abdcdf51a4a099f84b2ae27653186_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53b0d24d8a90491486fda069a8ee99d0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f71e968f79944aea5e02c01739659a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0846deffb1664429a509a79024bf0f26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i538011103d4d4bedadad7ef6aa58ff25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43964e9db78c4442b2a6c1bae24600b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcddf93cb1114af5b696e99fca98b0b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0586e2af9dcd4681a41fbb0b0e0b0e79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5349a45275c54d33af6c9dba5397bc77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138581f0b65743e59bd88750dcecf150_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e757a9350804423a1366f4edcb70ffa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9b71519dae4e209d412a66a68839cc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9132d76bdc6b46ce939091d328d35fee_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a159b1f5b8644c382a69af99c56dcc2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4b9693299744ec9899bea6e3abb91dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i737149184ecf4228959b9dd0c167bdf5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825c93cb311e47a19c18659fc18b76d8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d52eb68d4d748e6aa0dd402d9c0d6f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6110daa1294fd39e39d73a439bd261_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i803401904f8b457e80587a15d7c74d13_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1d15baae55479686b0438960a20553_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied487a078f8f45c08115f899f30d2518_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bbd121042c745818aabb802a6d44f50_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i540c66305f294fbb945da9a41514ff51_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a8a4571fc3d4acab135fe43eef795fe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9788f29297284a1d88ff1e6c6548cad3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f65898626a94e9ea933742220b4c7d5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aa773030fca4e1f899e5ed5dd14b7d4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2233715bedd740d4a3940763dda60aa8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e5356c990d4784a27d514236852917_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69c7f39e03b4eba8436ad80b94446b0_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13871dd12543440895ab2e9a2d7be37e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i456a551753af43a3a51e3142885b59a0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac8a899318948c599bdf090d2fa77ba_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36cd43db55f34600bccfbf93673a50c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fa611f2a7f4ac18373b103852f2b2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if488a491d85b439783705940ff379d59_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a9923020f3440a85a8e77c1756d28c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1faac1f996b4486abd195c7b20753e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78dea82ae7d4b92b9519c98e6eefa7a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c85ce8790e54af78ef8a2b11e4fb9f9_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c05c358d1bb48aebde77f979670acd7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10dd4f1f71584811bc9ce1be4117dc8e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7229434de434e45a7fba1248a55d390_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i7b9574e42f5641358c71bcf9e4257b4b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i392d38c364c74d9ea72ff1e3530414b2_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60a5c0afbb434e35bbda711cca223cb1_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="director"><xbrli:measure>mo:director</xbrli:measure></xbrli:unit><xbrli:context id="ied72379ce65f44d1b138e007119e5e27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dfcd799dbb04d77a027eb24466e1b75_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591aee96bde948f381ffaaf7af7d4bdd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f889b38500d46f991a8ea1dc2bff214_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31a79b3a3b64912992fc8127b6f0253_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e2fd4010d1f4eceb5b59561d986587a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8022e2eba341430684992380ece3f792_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6943e16458bc4ca2852601e0fa80a2ae_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd81d8232428439e8af3fc2c52b75b21_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ic7724f34336b4837a6779170d66ce1e5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a65e4417b704c50af9108de96b6b9b3_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5be1411a627b4cb2955ad80477a30400_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id53917fedb1842eab0669c6ca15b2879_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantAndEquityContractPreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6bcff8fcbbc4e029d7f839b563920a1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie77e3add79c947548aa389bbcf1bc640_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0cc7b4fc994f51b95e2edb4d99dce0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7ee7b42337247669b6c69451925af0c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ce0fd62aa842c6addcbbd8362247ca_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e04bbbcf2b4dddba8b27254730fe6a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bbdf8e5b22441f4b146cdf0423fa04e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d389b0b33184827ac627cf3211504bb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6624310334664ad8b05bff9a8f611a26_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5daf1435da144756965535f298d285e2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e90128024045188206f3b663f58feb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4535f30518454d34a9ae59f849dec461_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4efe104b447e4349b4028ad89097f7aa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1baef738ae429aa8454cd5df509063_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b1ed807a4fe4443a7762e06a922c55b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ebc102806994715ad16146f4c465135_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee1450fe7da747d081507d7cea3a3f5a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i566c0e2a3879453286eaf377b9a994cc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6749d38ea74544afbe22946f715804b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie13b50de35bf49209e674bd75e9e2e9f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e9c5a285474dabbe7a8a197ec8c8a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91101d4785604fc9a749636f25538235_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2971e561fd5144678760d3bf8b1861d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22f157089c764d978e4b4467c3bb28c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i512cc5d83afb4aa79f389b6fc7d146d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd280e0972524a94a5802c10e628c014_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ef05e22327463983a5721739547724_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93682eae4e1b4cba8a7db027c701e88b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bddaa56c404c9383c99f3a0b6c9eab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ce748f70124616bdcdd3de3090c9e4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icec1267d474e4789a588d1c86899f643_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5fde125fe824d80b32071a2130ef0fe_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d6d19ffeee64ff1b5584b7c5aabb4bd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b25cddbc4ed4d17a6a79d919abc4d22_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b4810d1ceab46dfb83be9f80e3e4aab_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51fed6551e784a959a8fd96ee3dd8391_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de3b3f3b48d41c4ad4828796b656496_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2725c640d5cc48fb9a0ce5d1941b72e6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icef447b72ac047088d37bbe5edc817f9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice90d1e8bfe848d8b5e0d085479ebb80_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i806001e09fa14faaae11598091f1f498_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55511d6e0eb14ca08f381602cf9690cd_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66543092e0e046ca8c1b86aca084bfe7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96273d2e0d845948f345d07e913c368_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8779bb1a61dd4789bc38ae36caf3dafe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4009a312b9e9481c9ed1f1d8e29d8f11_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2b530e082794b12975168c91979ce08_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429b6c1211f54752a9fbc0980c7003cc_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9b9f4a38e840c984bc661555d3412d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b6d5238a8934a91b23047ee5dc570e6_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d2ec74dc3743e885b697dfef6ecf65_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e01747e65a4c47874b561f5f5591d9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9467a64aae949aa85d911d37de5f523_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32394b7c33e4adaa729d30f5b7f8492_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife875847779a4eb0971d8c1bba755f05_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54b43a0052a4188ada7399179966cb3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87386dcee92742288df164bf8606efee_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e3820406df4495e896788d13764aafd_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9f07419638445eab9c375777cf6a504_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide49c713466f480384f5feb6704320bf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6597a9719154f9bbebe60e2abbfae97_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10ee74830654452a7f2606b4d8c93b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78c606bc0ba64901873c5992d4eff20d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfc2a0eede234b6486bae3fec8149242_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8be97c192668455c8b81cd42aa504ee4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93ba44bf6fce4bd5974e74d3b133117d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f65ccbdc8ff41efb0c6806847d43860_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a8a884562fd49f18dfd6aeeb09a20a8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c63006a91f04aa0a97e0e25d1afb998_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a9924f43b44980bdeea6e55ddeab2a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6bc7e58db8428ebf31c693b4236ea7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46db2dd0967c4895b93fb83754d195c0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife349d051cc74966a11492b5681f511d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieedfff3a9a3247c9bb3467f1b57505f3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10790d601d0144df92ffc1eee752bd0d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51aba496809142e593bb1b943f268798_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9269c502f174ba7b95d543c1fe32410_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5096748718454223a3a223a6cfd489a3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie43f576a9e9d4820aedbcd69fd64f322_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd2f0a9c69f413b81668b9456672a69_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i844eb97024c84e86b793fb4669de42da_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d1c6700b304008a01681c4c742502b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28febc0f256b49e2a19127bac1eefd4f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e8b966e2d51497780ea70bf9d0c4b17_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90b9e0213b45474dab5f5de82137fd03_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad51ca79f2ce481bb8b8ba1aea9c8bfc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e492b0fc2d45a8b2e224d8465d9026_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be9a00b70904e04a6f468eec5058227_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf22930994534713a83c19ce49bde1ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie526609fec74474d87c0aa3c9e2a3ccc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904889c18dee449b9c1967209d215e07_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i834f7afe8d0b4966b98bf4be48676817_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mo:state</xbrli:measure></xbrli:unit><xbrli:context id="ib7333de9d7b44fc198078f692ff042c5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e7b37987ea44128d943580102fc338_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb300ff50687440da92f6d2d8898e254_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2611638f3f074e30be114be0592513de_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c088115b8af479895ab47b7bff4f51e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71508c07d42a42569b52bd3ebbac6370_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15710cf918bb4ad0bfe9ff7a338e1fb1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2626fb7367b400aba3c194f31411f4f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e58a9d31fd4b2b9e8753887b69b312_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80273ba6b18457cbc2b5182392c76b1_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mo:claim</xbrli:measure></xbrli:unit><xbrli:context id="i5d91ab5e046640bcbabc478601fd21b3_I20210726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc4defe52f8b46b09b0531c0541a5403_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac977efcc9484319b8cd4e82324c3fa3_I20210726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3402c70aef94f5b9ca25910ffaecba2_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87bf8ff853e2425f96934e4e9ddef164_I20210726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i470465d1a67e47cf963f96112e6bcc56_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c6153fbe7224388926901e9703fa838_I20210726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36e57c0c00746cd9d7c260932b94d8e_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb8d2231c6e42c68730b177faaedcd8_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie41710be5b8c41ee96fe3ba722416d41_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf33c42aea2a44e9a567c3723d8ddceb_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4d2c2e9803462e976b555918c63490_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mo:case</xbrli:measure></xbrli:unit><xbrli:unit id="lawsuit"><xbrli:measure>mo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i18fb1c9978ec48949a63f54f3c2ec853_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4f544b33974b84b91ca169738940e5_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057dcd83a81443d6895e291fa75e63cf_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602c7b1521144698b0e57a755cdea240_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdbc8a7fc0b140448112768ac4469793_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8405d610414876a75ffeb4cb61a3be_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90bb52ef7113414d8e3846eac30005d0_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f105d7b0a5346afb83dd5c09220d92e_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i682d73a693e04609b5d9fbeaba2fcd92_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a1559a0e1124131910366a39aff6d12_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i509864cccb2f40b98af72697cece813f_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica10ed061e3c4768a08c7c6d78a09387_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1143b32ee544e99d873d85d649da2f_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6d5b4f9824425c86ad308c5211697c_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1283cfc29e491f80a171844b65131e_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba9fd76fee584f7ca0719a4a74458197_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i368a47758f0742e6a4c03e7856369fd6_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie79e75207b814e8c961e323037e2b7ea_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e26448b3750441c87cc00de2ed31100_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic873084e522446c8862fe8e1fa9cf238_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e31195d77d48bbb3cea0dade509ea8_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0abc218a2ef4d91b7ebb3f361f67c37_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f81cf3349f04c67bca28e5eb157473e_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76f91e8dbc44f6582842261cefc0a50_D19990101-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c5245e6da544ef581a1619155446591_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a6cce22a9241bfbe34dbe658ae9cde_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada3831810b84380a34be34e3dbc1ffe_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b2ca9e1f1054d9fba499bdf41e121e9_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2baa872a94b482c8bb1018ad55264cb_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e53bc2b6de4394af0f5e9e5f1faa3a_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ac825808e1a4f3b84e8fee44f14e337_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7f18929f5e4ba98e6d6041dd284fc6_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9240c78c98394f3cb2cc1b313917c5ad_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17eebd26ab63497ab584d767938f5d8b_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-07-01</xbrli:startDate><xbrli:endDate>2006-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9927761764b40a786f566330b852304_I20080131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia60506d9acad48209c8c8dcaed0769be_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb55d0b8c2e34a54b634281cfd15e7c5_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plantiff"><xbrli:measure>mo:plantiff</xbrli:measure></xbrli:unit><xbrli:context id="ifd6affc6fc324b9da397010ae49673c8_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc9177f9baa34fbdbf6605706769f68e_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanAndSommersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4081d6a41ea492c824d20493bcf3dce_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a58875756fe4911aa25efd5db88be0b_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c068a726b53483290f0d1fd038adfcd_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6e24acdccca4adbaac072d4e4022eae_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae106d4c552a4de1b53156ad6d849934_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259df7aad9264b5a979579e9065bdd22_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3ead33c4fb46be8b5f3121b9156fae_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50edc02879964eff963fa402576e9210_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6122c7f81bc4da79b3a3ebea157c058_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fcf223c1d694ec285210be845848dc5_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9df9b90b8d244415b8523a07918dc0b2_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe894efd4be468984d251e1e5c76e61_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea6cffa455ad48dfb0c461d66ddf84e1_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if38694f1fdb142f8995d60ccb8ade4a4_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd6b27156ef4c5189f7baa650560310_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea83e832e8d04b5bb9090996f5901381_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b7a204571b434cae1afa93d9ad5f88_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7287b41052449eda9a16b7a4c0ec748_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f691b340eae41fab60e5ecfae6d3d73_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMcLauighlinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855a49b8e94a44d8845849b0b6cdafcb_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMcLauighlinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdb791827ba48ab8cd3664a2010e68d_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb9002b835be42eeb751f0eeed99f3a6_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic88503c7bdfe46aa8828a4d6ab9c1639_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f26ea5a3014b9b9729fe7e127386e6_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc8ad30209f44f13aa28826ce714e1e3_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46aef541c52b44488e878806bd18c603_I20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93894bc913ad47c68ff2b60978052595_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c72bf9fe7e94489a9a55eb6ef0170d2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494b0e99edea410eab5611b73ffe2f4b_I20090630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1eedb0c135405eb108bc5d0c630bdc_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319065433abd4969ae1ac14852b67636_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide83d291e49e4954a5a0296df977d166_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae966d42be24dd582723eae2b55cfaf_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia610c28441d14994af28fe694a231c07_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ab1a010fd441a897ef5fce3716965a_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998145dbc029488dbf42ec885813145a_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4118f17df3314a5b83ef7db05acfe8e7_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c5fce8de1e4a369b1fdaaeee2023be_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1edca63a676640e6b6829445de1c62ba_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ab3c65ee434f54b6c4e29b1fa9f142_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee45707683a643b6bbb8071e6dfc639a_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204541f308ef43d6a18a8ad65ed791a5_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ec71c620304120a35b6a786a7af7ca_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic571c755a3174b2f8b0b4330bc60eb8e_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie244b73417994d3d8fc685443c7bab67_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8c697029cb24766b6430bb454ff76d2_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61bee51f4e7549f7b26494a823b20219_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie263e9c12c0c49598ae4af4a0e29d138_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e1760e3dc3429e9de3e8b11b5e3aae_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95792785b13646e3a52dbef118639cab_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib918bb45881a41b88b31716185a5601b_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51dbba0c72e44ef8b9724d88a7e26133_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88a99b9d1e4244df95287f1de8eef4b2_D19960501-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8281813f0706492da71cbfe50a5ba129_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="manufacture"><xbrli:measure>mo:manufacture</xbrli:measure></xbrli:unit><xbrli:context id="id68e6389cd4f47489796944107883c14_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ruling"><xbrli:measure>mo:ruling</xbrli:measure></xbrli:unit><xbrli:context id="i4852a02f887c486abc8978cdda91ec14_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8536b6fab27d4581bb4d23b4348e4024_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c93e0173c414555a75af3caf5b31494_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1998-11-01</xbrli:startDate><xbrli:endDate>1998-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id640778c3952418d9eddb33bdb279309_I19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad4667992974c56b30361191a43c305_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3684944b3b7443d8a34cefbfc60a1e71_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398ddf29c5ae4d1cba9418e41e0bdc83_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156ce9dc699a4fa88302b05d0f029496_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470d9d37b2e54ca2bef0338fb55cea99_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd811b49bbac43eda9afecebc9563fdc_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id180aaaf475140e1b559d11028dd32ad_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2059686678443feb7b68e80c9cb4cb2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc032ffd1fbe41ae93ae94b0ece2a49d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i956ef150cdde441bbced0f592c3f89a2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ac9e5fa08264e408b57748a0cb725e9_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2a140870c1d49dd85a9a4cf55517c3e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de839768ad94cfab14e39ee519be5eb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia26efd9028144ce997e13ba03004b3e4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6183a39e504c4bf3875e7ca13284f323_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5dcbeb354e44d0a63d24ea3d885915_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f62b64e22cb44d0ad3a08021fc5a3eb_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3bfca6d5eb04b478cd4cce359cc1b8e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d910ce0936c4de79d300ec7d603cc96_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc172e1bfb8a4ca18d58681f22ba1e18_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01dc1495f92d44cc975d4c4d9ef6db7a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5b27f46d834849b12eed1fa7de3baa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2021NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bf50e945174e8eb4da9d6fb6259656_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6e1e56b911e47e2a8a17ad4923c4e1d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b1662c87ee4da4894098d4f121317e_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79edba75585544a1b364c3a2a5272a9a_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9908c88820c8407882fd66aaee5e71fe_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20192021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba9d82d27f974b7fb350c60b0eddb7e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1439f2cfb5bf487799a6201d4441815e_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69bc69e5749b4429a718b65ce3094b6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc810a366b774b66bbcdcf2086537c48_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f54360a45714f0c8d17beb27f673520_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaea83fd15864426afc96fc88210b860_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i346e658d67ab4443b81460637eece234_D20060801-20060831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-08-01</xbrli:startDate><xbrli:endDate>2006-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1126f30d7047cabf8a35e278d210e4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90404e480bd486abe1322ee5d399a7e_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic402594e8e0340378ab44dfc725a5202_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17131fdfa6d4b22ab39238b34d989c6_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i611c10d6dd834dab966ca0225a1eac42_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe88256c0632439c804ad259ee58ac49_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ee7e14784294b1aa50a20edf7383985_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-25</xbrli:startDate><xbrli:endDate>2022-07-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06aaddc0651c4da18fe616a4c53e7a2e_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c099a74ac94476c86a02b82115806c9_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib39dbb98e8d440f28749e4aee5911bf3_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54b8c1baf4c4086bb509612132c190e_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mo:complaint</xbrli:measure></xbrli:unit><xbrli:context id="id41b8120810c4e6d829b0b1591449c2e_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>mo:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6585b27441174f2ea5fcb1e108ef4379_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9be017d1acc2442bb23883e51a46e1d2_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae31955a3e5d46a98b6382848e87c3dc_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic49230ad8f5446c9b722373434519ae5_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b290e9d4bd4c9f8883131d3263103a_D20210701-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49fc4815acd44dd095f74bae91742f69_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d3390cbcd0491bb2a57fa5618b6c6a_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453bba98eb8743d79202cf42541d0607_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7dbe193b884cf4a3753d6b4bbf0f5f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c873e1e88d4ecaa8226421d8083196_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54ecad677fe41feb6b487a4b5b5f14a_I20220725"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="court"><xbrli:measure>mo:court</xbrli:measure></xbrli:unit><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712 id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8 id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDgy_2e26f203-4b42-43c9-b64f-2ba5662cebac">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NWVlMjdlN2RlMTU5NDc0Y2I1ZTMxOGNkNDNmMTcwMjkvdGFibGVyYW5nZTo1ZWUyN2U3ZGUxNTk0NzRjYjVlMzE4Y2Q0M2YxNzAyOV8wLTAtMS0xLTEyOTEwOQ_1145311e-6e54-448e-8e53-ecc1efd83b3c">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8zMjk4NTM0ODg1NTQ1_891deb94-a581-40da-aa1a-a5214addbc9b">June 30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.392%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6YzVmYTFlNzc1ODIyNDliYWIyNmE5ZWZjNDhlZjRkNWIvdGFibGVyYW5nZTpjNWZhMWU3NzU4MjI0OWJhYjI2YTllZmM0OGVmNGQ1Yl8wLTAtMS0xLTEyOTEwOQ_517c807f-9948-4658-80db-c92cf3bfc72a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg3_acfb9bef-e5b7-4696-a7e0-0cb56c61fb27">1-08940</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg0_fe8fe378-191e-4dea-9efd-a0ce68e06607">Altria Group, Inc.</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF8xLTAtMS0xLTEyOTEwOQ_4d7ce48d-77ca-4d05-8e25-bd8cb96abae0">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF8xLTMtMS0xLTEyOTEwOQ_e3af965b-ef8d-4701-98a5-37b0b7013dc2">13-3260245</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTAtMS0xLTEyOTEwOQ_0d6bf416-28f2-419c-b697-826b2e3b5c93">6601 West Broad Street,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTEtMS0xLTEyOTEwOQ_8909418e-f26e-4958-8dc8-4d7982158fcd">Richmond,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTItMS0xLTEyOTEwOQ_38c2c743-69ef-4627-ab43-87a5309c7062">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTMtMS0xLTEyOTEwOQ_f541c43a-776a-4e0f-8bf8-5913b313b0b1">23230</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;(<ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg4_fd354657-fa2a-4b6d-9534-866cc2ae2625">804</ix:nonNumeric>) <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDgx_1c35f58f-237f-4336-b760-89022dba7006">274-2200</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Former name, former address and former fiscal year, if changed since last report</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title of each class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbols</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTAtMS0xLTEyOTEwOQ_7be15835-0ef1-41ce-8c29-bb207a45e28b">Common Stock, $0.33 1/3 par value</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTEtMS0xLTEyOTEwOQ_dcbae44d-a54c-42d6-8df2-bbf68c7b1084">MO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTItMS0xLTEyOTEwOQ_fc9b6cb7-8568-486f-a220-61852a3bab3b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTAtMS0xLTEyOTEwOQ_1fbb6131-8899-4be6-9156-1ca3f577a6bf">1.000% Notes due 2023</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTEtMS0xLTEyOTEwOQ_3313a6bf-e3d1-480c-ab7a-efed3c43aecc">MO23A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTItMS0xLTEyOTEwOQ_c5877b4c-413d-4e93-8cba-627b6a592564">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTAtMS0xLTEyOTEwOQ_8ba09be0-fd4a-404a-b9f3-5123535589ff">1.700% Notes due 2025</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTEtMS0xLTEyOTEwOQ_e740a14c-9133-47f9-8649-4f5b31f933d3">MO25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTItMS0xLTEyOTEwOQ_1abe9698-1932-4043-990e-ebcc710f4199">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTAtMS0xLTEyOTEwOQ_3b79a2e1-9ac3-478e-9cff-2306b0d8eb1d">2.200% Notes due 2027</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTEtMS0xLTEyOTEwOQ_5c8dae32-3dcd-40cf-87db-3b265ce7f4dd">MO27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTItMS0xLTEyOTEwOQ_dba08a66-ff8c-445c-af01-cf85778739a0">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTAtMS0xLTEyOTEwOQ_05746b40-4035-4ab9-bd16-7d42322fbd92">3.125% Notes due 2031</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTEtMS0xLTEyOTEwOQ_0ccc7f24-499e-4ce7-8348-db140f76f233">MO31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTItMS0xLTEyOTEwOQ_29f6f804-6713-488b-b5d7-4c8824f47410">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg5_e3b64051-c568-4905-9bed-8140cdea8066">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; No&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg1_0bee080c-3657-49e2-8ee6-d185e4a677e8">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:21.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8wLTAtMS0xLTEyOTEwOQ_a0867130-931b-466f-9c8b-858269b61f07">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8yLTYtMS0xLTEyOTEwOQ_9ad357cc-e6fe-42bc-b093-ceba5b9e61f5">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8zLTYtMS0xLTEyOTEwOQ_620b8e5e-e758-4da5-b507-8a8ef0b0b2aa">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg2_d2845300-0da2-4c47-b7ee-899774b7f53d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At July 19, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ia7b840b10f44411fb19fdc6d7a05d2f6_I20220719" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8xOTk2_61637bb8-25da-463d-9080-fc729989b8d1">1,800,823,383</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, par value $0.33 1/3&#160;per share.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;I -</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_13">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_13"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_13">June 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_13">3</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_19">Condensed Consolidated Statements of Earnings for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_19"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_19">Six and Three Months Ended June 30, 2022 and 2021 </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_19">5</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_22">Condensed Consolidated Statements of Comprehensive Earnings for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_22"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_22">Six and Three Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_22">6</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_25">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_25"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_25">Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_25">7</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_28">Three Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_28">8</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:45pt;text-indent:-22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_31">Condensed Consolidated Statements of Cash Flows for the</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_31"><br/></a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_31">Six Months Ended June 30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_31">9</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:22.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_34">11</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_115">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_115">36</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_154">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_154">69</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_157">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_157">69</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART&#160;II -</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_160">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_160">69</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_163">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_163">70</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_166">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_166">70</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_169">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_169">72</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_172">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_172">73</a></span></div></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.  Financial Statements</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMi0yLTEtMS0xMjkxMDk_f9eef227-bfd7-412c-babe-37356544dbfe">2,567</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMi00LTEtMS0xMjkxMDk_7d6aa5bb-bc27-402a-aad8-0d7c1617516a">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMy0yLTEtMS0xMjkxMDk_2f3e091b-345e-42a8-bb64-c2d2dc6591b0">43</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMy00LTEtMS0xMjkxMDk_d5657214-9511-429b-a809-e6716e750f9b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leaf tobacco</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNS0yLTEtMS0xMjkxMDk_2fc1d591-0b77-49ae-9601-25f84d7a564c">605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNS00LTEtMS0xMjkxMDk_4eb1551c-87a2-4585-873c-6665578c9c9e">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other raw materials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNi0yLTEtMS0xMjkxMDk_556bac2c-f6f4-4bef-b5fd-2b10e6d3ea2b">183</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNi00LTEtMS0xMjkxMDk_f8a6ffb7-8b94-49ff-b90b-29c25ade3685">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNy0yLTEtMS0xMjkxMDk_9b4fdfb0-a962-436d-89de-0e6a0b1c99ee">29</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNy00LTEtMS0xMjkxMDk_3e13a994-f17d-4047-9aae-821c07a08d36">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOC0yLTEtMS0xMjkxMDk_6ea40507-4a5c-472b-8d32-18a901b50ee4">327</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOC00LTEtMS0xMjkxMDk_9b868bc2-75c7-48b8-a20f-756036dddafd">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOS0yLTEtMS0xMjkxMDk_cec3284d-1f17-48ae-808e-1cd208f15a32">1,144</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOS00LTEtMS0xMjkxMDk_a1c8cce7-78e6-4c9d-90af-8faf5ab6bc18">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTMtMi0xLTEtMTI5MTA5_b19cf88e-650b-4fa0-b9a9-21cc2ab2a29b">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTMtNC0xLTEtMTI5MTA5_d9b1a0e5-3cc3-4c08-9167-ba40432cbf7f">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTQtMi0xLTEtMTI5MTA5_093513db-72f4-42d5-ab87-d16b91199eaf">4,086</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTQtNC0xLTEtMTI5MTA5_21138333-b165-4363-928d-13c80db5891f">6,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTUtMi0xLTEtMTI5MTA5_c204d04c-e4bb-43df-92e8-aa38b955b007">4,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTUtNC0xLTEtMTI5MTA5_17f4c278-e855-47f6-a0a5-54b6e12e2e15">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTYtMi0xLTEtMTI5MTA5_3f645ae0-c37c-4fdf-995e-a7c53181847a">2,788</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTYtNC0xLTEtMTI5MTA5_99f08266-10aa-415a-959e-a9dd05680dca">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTctMi0xLTEtMTI5MTA5_ab543739-1cb4-4440-bcd7-6137e21e2530">1,557</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTctNC0xLTEtMTI5MTA5_dd607f96-74dd-4c55-a0bc-84ed14ded364">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTgtMi0xLTEtMTI5MTA5_0f7236f7-db7e-4740-a810-de2bfe8aa6bf">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTgtNC0xLTEtMTI5MTA5_00403fe4-f813-453b-ba09-ff2c150ee216">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTktMi0xLTEtMTI5MTA5_1c392bda-6239-4879-9926-b9ca4066d567">12,372</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTktNC0xLTEtMTI5MTA5_52b0e40e-3f9f-4642-8769-73176b8a55b1">12,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities ($<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MjU3NDg0NTU5NDI0NDIyNzg3MjIzMjQ0MmQ0MGE3MGVfMzg_476b6b01-f380-4418-a970-ed39560d1144">451</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MjU3NDg0NTU5NDI0NDIyNzg3MjIzMjQ0MmQ0MGE3MGVfNDU_3db21b47-a644-4c0d-a22f-5cbbd6dd8515">1,720</ix:nonFraction> million at June 30, 2022 and December 31, 2021, respectively, measured at fair value)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMi0xLTEtMTI5MTA5_61e6134b-c363-4ce9-8f89-26af0adc69da">12,590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtNC0xLTEtMTI5MTA5_ec7b66d4-2e6f-4c1f-bc26-915aa9ea0325">13,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjItMi0xLTEtMTI5MTA5_ae51c32c-d873-4256-bb66-f04928b344fa">964</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjItNC0xLTEtMTI5MTA5_3cb0c34f-dac2-4d97-9ac0-fe9dc09b696b">923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjMtMi0xLTEtMTI5MTA5_0f6d8ca4-309e-44f2-a0d0-b3a19ff2a50d">36,746</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjMtNC0xLTEtMTI5MTA5_74e3b701-2747-4b9c-9d3b-ac6e2dcbec2b">39,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMy0yLTEtMS0xMjkxMDk_02e5994c-489c-437d-8cf1-a236980ae2a5">2,634</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMy00LTEtMS0xMjkxMDk_1ced265a-cba2-4ac1-87a6-61cc3c7fd1ac">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNC0yLTEtMS0xMjkxMDk_bfc4eb30-4afb-4c32-bac9-d51db0d945eb">396</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNC00LTEtMS0xMjkxMDk_0e183a6c-4ee4-468b-b65e-c3a71525ea20">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNi0yLTEtMS0xMjkxMDk_5f592c4c-a00c-46f0-8e54-542e51637d66">708</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNi00LTEtMS0xMjkxMDk_d6d91a30-5fed-4efc-88ae-8388e6f1f215">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="mo:AccruedSettlementLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfOS0yLTEtMS0xMjkxMDk_d8d37cc7-7c52-439b-9f07-eca1f4f7607b">1,749</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="mo:AccruedSettlementLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfOS00LTEtMS0xMjkxMDk_730cc62d-2828-4dcb-a9cd-62e9b2e7e0a8">3,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTAtMi0xLTEtMTI5MTA5_6fd11651-9fbe-4d2a-b3fb-ef05a362355d">1,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTAtNC0xLTEtMTI5MTA5_37016798-46b7-4ffd-97db-706e82132bde">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTItMi0xLTEtMTI5MTA5_78daa3a2-2573-4722-8c0c-3bfe489896ea">1,630</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTItNC0xLTEtMTI5MTA5_b38812d3-64d6-4e3b-b180-469954e920a1">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTQtMi0xLTEtMTI5MTA5_7cb85763-0236-49c9-b69f-9fdc01657777">8,311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTQtNC0xLTEtMTI5MTA5_818d66d0-52cc-489c-b9af-a415b776d649">8,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTUtMi0xLTEtMTI5MTA5_aed6469a-a803-4998-aeca-31c76fcda242">25,046</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTUtNC0xLTEtMTI5MTA5_c955037c-963f-46da-af75-d8f41865f1e2">26,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTYtMi0xLTEtMTI5MTA5_aba33a4a-f5e1-46da-8ca3-2cc780572cb1">3,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTYtNC0xLTEtMTI5MTA5_4f64b40e-c160-49e6-a9a2-174dfd7bd179">3,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTctMi0xLTEtMTI5MTA5_1c9df6c2-b2a8-4712-a97a-86898c531479">197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTctNC0xLTEtMTI5MTA5_518badf4-0e7a-4257-ad26-07e79abba620">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement health care costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTgtMi0xLTEtMTI5MTA5_b889fb09-e926-4496-b223-2370d7a8634e">1,437</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTgtNC0xLTEtMTI5MTA5_420a8d72-fe71-4257-a7eb-531a45d893d6">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTktMi0xLTEtMTI5MTA5_9b259b6f-f4cb-4010-8951-f597c5278bf6">260</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTktNC0xLTEtMTI5MTA5_1b4aeb14-3e68-4b89-b7b2-1fe174884228">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjAtMi0xLTEtMTI5MTA5_03db6511-3f3b-4d50-ba9f-66fe9bbe89ad">39,149</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjAtNC0xLTEtMTI5MTA5_80d72038-6aa3-4aa4-9804-4ec750d469f5">41,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 11)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjEtMi0xLTEtMTI5MTA5_3273f8d4-8bf1-4692-beb9-8bc90670e506"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjEtNC0xLTEtMTI5MTA5_9623d958-bffe-462a-83c5-9250d9a10300"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $0.33 1/3&#160;per share</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MzQyZjdjOWE5MjkwNDU4OGJmMzY0ZDFkYjIyYmI4NWRfNTA_7e9709e7-039c-4e36-8ffa-445e5bd30cef"><ix:nonFraction unitRef="shares" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MzQyZjdjOWE5MjkwNDU4OGJmMzY0ZDFkYjIyYmI4NWRfNTA_dc4f2e6f-0d94-4141-9ea3-0b57d38f63ad">2,805,961,317</ix:nonFraction></ix:nonFraction> shares issued)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMi0xLTEtMTI5MTA5_dd513274-3b7f-4b5c-b991-1ed49a0bb9d0">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtNC0xLTEtMTI5MTA5_a7e0bec0-bfe5-49b7-b80e-3eda97aca817">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjUtMi0xLTEtMTI5MTA5_4db85094-8825-407f-9847-6d76d5815ee0">5,861</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjUtNC0xLTEtMTI5MTA5_eb4aacb7-3e0c-4831-b5e5-a9512b79e107">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings reinvested in the business</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjYtMi0xLTEtMTI5MTA5_db98b48b-e05d-4485-af7d-e3050ddfb0f8">30,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjYtNC0xLTEtMTI5MTA5_08a56b4f-ab12-4bec-9041-2a3bdea25759">30,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjctMi0xLTEtMTI5MTA5_6eb844d5-f5e0-407f-bca1-56246b21d9d7">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjctNC0xLTEtMTI5MTA5_0b5b68f3-0702-462c-838d-899ac02bb940">3,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of repurchased stock</span></div><div style="padding-left:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246ODc0MzE4YzVhNzZkNGQ4YzllYmVhNzE5MTZmYzJkN2FfMzI_ec5d504e-8021-447c-ac44-91707ed895e7">1,003,717,832</ix:nonFraction> shares at June 30, 2022 and </span></div><div style="padding-left:22.5pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246ODc0MzE4YzVhNzZkNGQ4YzllYmVhNzE5MTZmYzJkN2FfNjU_919c8220-d326-40b9-bef6-1dc451a0728b">982,785,699</ix:nonFraction> shares at December 31, 2021)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMi0xLTEtMTI5MTA5_c0eca3d9-f7c1-456b-afe6-7eca3f223078">37,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtNC0xLTEtMTI5MTA5_d197402c-6df3-444a-a3fe-d16449333073">36,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity (deficit)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjktMi0xLTEtMTI5MTA5_825bec99-300f-4ad7-b75d-b2096a1bae6e">2,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjktNC0xLTEtMTI5MTA5_0f3b5200-4d28-4062-a57d-ee82a060a1ee">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:49.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMzAtMi0xLTEtMTI5MTA5_21e57fd0-4cc6-4fa3-9c8e-1a767b670bda">36,746</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMzAtNC0xLTEtMTI5MTA5_8802f062-3d77-47e9-aecf-22f74791b109">39,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi0yLTEtMS0xMjkxMDk_6598fe6e-ea1f-4afd-a55a-cb4b3d825414">12,435</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi00LTEtMS0xMjkxMDk_0562c702-b7d9-41a6-8230-493162700964">12,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi02LTEtMS0xMzAyMDk_aa2fa493-2b09-419e-808f-7b63e0adabb3">6,543</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi04LTEtMS0xMzAxMTM_1348952e-9e62-4865-9b62-e56ce087f857">6,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy0yLTEtMS0xMjkxMDk_1f5de9fa-0239-4ca2-b8fd-0e27eac75ce3">3,154</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy00LTEtMS0xMjkxMDk_889f7764-e5f2-439b-9ba2-87f20e0894c0">3,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy02LTEtMS0xMzAyMjM_0cfe493c-1d4e-482c-910f-40593c4fafca">1,708</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy04LTEtMS0xMzAxMTk_569f5c54-d96a-4d70-beeb-1b7f590db171">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OtherCostOfOperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC0yLTEtMS0xMjkxMDk_940df0cf-3dcc-4720-b9df-6b945a910e64">2,242</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OtherCostOfOperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC00LTEtMS0xMjkxMDk_bc880fd0-fa87-420a-a4b6-b8f803daa41d">2,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OtherCostOfOperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC02LTEtMS0xMzAyMjY_168d0c4e-e96f-48e7-a62b-aab416f92e05">1,169</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OtherCostOfOperatingRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC04LTEtMS0xMzAxNTA_826a6a3b-4d82-47ce-9e20-10f39aea9c29">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS0yLTEtMS0xMjkxMDk_1b68583c-b0d2-4c7f-a371-888f36b3b123">7,039</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS00LTEtMS0xMjkxMDk_7b9d2222-b6a7-4b22-8435-a79b29e7421f">7,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS02LTEtMS0xMjkxMDk_e51ab122-ea45-46ad-a4e1-9c88013e0c63">3,666</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS04LTEtMS0xMjkxMDk_6dfb53f5-8ffc-47f6-a463-ed3ec47eacd7">3,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi0yLTEtMS0xMjkxMDk_911c0358-cbf8-4516-83d0-ec48ec81ac50">1,050</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi00LTEtMS0xMjkxMDk_5c05eb81-f058-45bb-b496-47e67e3a44ea">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi02LTEtMS0xMzAyMjk_1b3794c4-e993-4582-991f-eb9996bc66ac">561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi04LTEtMS0xMzAxNTM_b0aaf86d-d6e1-4b34-a66c-59b7924ad1bd">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy0yLTEtMS0xMjkxMDk_48728440-c08f-4e7a-a3b1-f8beae7a1fd5">5,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy00LTEtMS0xMjkxMDk_1de60849-c97f-4815-853c-4502e6372912">5,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy02LTEtMS0xMjkxMDk_4b652693-e86d-4edf-b5d0-b43502fea257">3,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy04LTEtMS0xMjkxMDk_dbf65f5d-edc9-4293-b4d5-97a6e2bd2a9b">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC0yLTEtMS0xMjkxMDk_8c0c1b7e-da6f-43c6-807c-a820bd3950f5">561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC00LTEtMS0xMjkxMDk_816d4873-fc8b-42f6-8cf3-a2b6f13e2c31">603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC02LTEtMS0xMzAyMzg_6a682dfc-c2c6-40e7-ad72-7ac3748ba0b9">280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC04LTEtMS0xMzAxNjI_93817cbe-868a-4a31-9796-41f5718466a5">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS0yLTEtMS0xNDYyNzU_0bfe1628-f141-4c8d-a26b-232adde50b92">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS00LTEtMS0xNDYyNzU_02720d3a-856f-411f-b617-8f1b1b1b3304">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS02LTEtMS0xNDYyNzU_220a44cc-df6e-4393-833a-ed41be3fffa8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS04LTEtMS0xNDYyNzU_7dff7384-0137-4c05-82ec-bdaf88d0de9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS0yLTEtMS0xMjkxMDk_9618708e-364d-4747-a4e7-43b26db252ee">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS00LTEtMS0xMjkxMDk_3e0b07bc-e905-4d1b-af99-859c1e9a32de">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS02LTEtMS0xMzAyNDE_351b5a20-ac20-4885-ba74-f067582e9cc9">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS04LTEtMS0xMzAxNjI_425df93d-bd18-43bb-8bdb-d7ea744fce15">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtMi0xLTEtMTI5MTA5_67749fec-2554-4b4a-80c2-3da94bb3ca95">1,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtNC0xLTEtMTI5MTA5_29d3edfb-a743-4d23-a953-473f4fe799ee">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtNi0xLTEtMTMwMjQ0_fa499363-0e32-4244-85fc-93480a45644b">1,263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtOC0xLTEtMTMwMTcw_a3490d89-fc01-414b-8c52-7cd710642d07">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtMi0xLTEtMTI5MTA5_124d19ec-c22a-48ac-9773-76446a5a398c">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtNC0xLTEtMTI5MTA5_534dfb72-ae4c-4ce2-bfe9-f10c8b91ae37">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtNi0xLTEtMTMwMjQ3_701a3cdb-2c25-4593-8bc7-46f8beb049c0">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtOC0xLTEtMTMwMjAy_68cf8a06-56bd-4515-a286-449a213347e5">103</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtMi0xLTEtMTI5MTA5_9e299253-b1dc-465c-8bfb-bf70caa4a3a3">4,278</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNC0xLTEtMTI5MTA5_b22bde34-054f-4093-84ae-c918fd1768c3">4,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNi0xLTEtMTI5MTA5_b63e355e-fc7c-4e29-8e68-8191b7f554fc">1,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtOC0xLTEtMTI5MTA5_f89bda50-189d-436a-933b-bb982ec231f0">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTYtMi0xLTEtMTI5MTA5_2c06d624-f8a6-4aac-b35a-891ad198534e">1,428</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTYtNC0xLTEtMTI5MTA5_95ea14fe-d1a2-495a-b27f-5de6a95f0e3a">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNi0xLTEtMTMwMjUw_85127633-40ed-4daf-9bdb-8d7916cce633">714</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtOC0xLTEtMTMwMTg4_583ed364-308e-440e-a0a1-5a68e2b4f15c">759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctMi0xLTEtMTI5MTA5_a874030b-00d3-4396-855b-eb96b708931e">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNC0xLTEtMTI5MTA5_1f7a1855-fef6-48d3-94e3-489588770bcc">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNi0xLTEtMTI5MTA5_7b4aa128-cc39-46a1-9dbe-7d1d39fa0816">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctOC0xLTEtMTI5MTA5_a3883295-5818-4023-8bbe-21b8525ba9f3">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (earnings) losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTgtMi0xLTEtMTI5MTA5_ec4f3aeb-f783-41d5-8743-c57009bb2694">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTgtNC0xLTEtMTI5MTA5_43d3db44-5ce0-472d-bb12-c5c9ea5555be">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNi0xLTEtMTMwMjUz_0854a320-d7cc-462a-a8a8-6a93dccb8a32">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctOC0xLTEtMTMwMTkx_0de95d50-6f0f-4375-b399-2f5204bfe70f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktMi0xLTEtMTI5MTA5_1b9da82b-6ac6-4586-9898-0affd1d28030">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktNC0xLTEtMTI5MTA5_89c4855b-69c5-43d2-beab-399c400f1ec7">3,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktNi0xLTEtMTI5MTA5_a08d86e0-f545-4d9a-8a7e-079eb84a2c52">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktOC0xLTEtMTI5MTA5_835cf747-d43a-48ba-9806-8628529d16b8">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted earnings per share attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItMi0xLTEtMTI5MTA5_da297e87-b856-4799-9c6e-f4a2e7ea65de"><ix:nonFraction unitRef="usdPerShare" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItMi0xLTEtMTI5MTA5_e9e53606-7021-4797-b604-574856fe57f4">1.57</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItNC0xLTEtMTI5MTA5_3eb1bebe-844f-4b3d-9e32-b7c442d33d21"><ix:nonFraction unitRef="usdPerShare" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItNC0xLTEtMTI5MTA5_e4eb38c1-c434-46f2-9162-4265a6b08950">1.93</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtNi0xLTEtMTQzODk0_ad80ea14-e761-4941-a990-8418c984f957"><ix:nonFraction unitRef="usdPerShare" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtNi0xLTEtMTQzODk0_ce030d26-8bf8-4176-a04a-c63c52102766">0.49</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtOC0xLTEtMTMwMTk1_24f601a6-203b-41b1-94f2-16fe62783233"><ix:nonFraction unitRef="usdPerShare" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtOC0xLTEtMTMwMTk1_e5e81d58-da45-4984-ae70-af4e5199a380">1.16</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi0yLTEtMS0xMjkxMDk_747d3b42-66df-455c-826c-caf12c9c1412">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi00LTEtMS0xMjkxMDk_15547dc1-3e7a-44fc-86e8-3354cdca5b0a">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi02LTEtMS0xMzk2MTE_75c21eb1-4d68-42a9-a350-41ac96567155">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi04LTEtMS0xMzAzNDE_dead28b9-ee81-4114-86f8-6114077b2b1e">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC0yLTEtMS0xMjkxMDk_4e3abae3-14c8-4409-a11b-0da81cb5ea15">31</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC00LTEtMS0xMjkxMDk_83372ca6-bb07-4135-bf2e-3f22ca2fb936">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC02LTEtMS0xMzk2MTE_ad1b9140-f76e-4771-8c02-497c8470ca64">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC04LTEtMS0xMzAzNDY_e494a941-0748-48ac-bf00-6bdff808095e">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS0yLTEtMS0xMjkxMDk_08cd4084-6c54-496c-b29c-f83bd41f5f15">643</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS00LTEtMS0xMjkxMDk_ec1c0092-11da-4238-b7f9-a82630f0dfe2">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS02LTEtMS0xMzk2MTE_4da76919-dc7d-456d-9e87-a566feedf897">565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS04LTEtMS0xMzAzNTQ_86042868-bcf9-4f83-866f-971c60cfd38f">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi0yLTEtMS0xMjkxMDk_44c557eb-2909-4d56-ace0-9e93ed88120c">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi00LTEtMS0xMjkxMDk_db6963fe-ef30-4a48-ad10-57693d5c4855">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi02LTEtMS0xMzk2MTE_160b43c8-b600-46d0-8ded-15ec4b4031d4">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi04LTEtMS0xMzAzOTA_452676ad-368e-4ff8-ad0e-644e628ed5cf">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred </span></div><div style="padding-left:51.75pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy0yLTEtMS0xMjkxMDk_d039f55e-3a1c-4d15-ae3d-f2acc71b84f3">679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy00LTEtMS0xMjkxMDk_d8058284-d570-49d7-92a4-1442a75006ca">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy02LTEtMS0xMjkxMDk_b8af9f50-7b49-4cdc-ab1e-0efb6e3ee5ad">585</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy04LTEtMS0xMjkxMDk_bd3a04ed-dee3-44ab-ad0b-ee8aef243154">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS0yLTEtMS0xMjkxMDk_ac283256-44af-4d5e-aa98-3e78dc44e05d">3,529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS00LTEtMS0xMjkxMDk_dd36b600-c5a3-4821-b33e-3e0776934bc6">4,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS02LTEtMS0xMjkxMDk_8e19d169-89a9-41a1-8307-2917a83f9394">1,476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS04LTEtMS0xMjkxMDk_cc547069-b119-4c9c-991e-06e6f838a35e">2,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (earnings) losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtMi0xLTEtMTI5MTA5_7ef00ef3-8219-4980-b888-0a4f9da9203d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtNC0xLTEtMTI5MTA5_4d9f6e19-3c3e-431e-8652-03c6fb082a42">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtNi0xLTEtMTM5NjIy_bf219729-5f4e-4521-9109-d1951eb4705d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtOC0xLTEtMTMwNDAy_c16f481d-fab6-4d5c-988d-a076b589a2be">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtMi0xLTEtMTI5MTA5_8080beb7-a488-432c-9c78-1c21375235b5">3,529</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtNC0xLTEtMTI5MTA5_5f7e893f-37c0-4c3c-8b3c-9c755222aef3">4,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtNi0xLTEtMTI5MTA5_866bc692-3b1c-4fd6-9c93-893640b68870">1,476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtOC0xLTEtMTI5MTA5_1518e1c7-fa46-4013-9c09-5b32c13c7aab">2,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">for the Six Months Ended June 30, 2022 and 2021 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ef8abb29b764b4c8ca775c97572d064_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0yLTEtMS0xMjkxMDk_b00834e0-f18e-41dc-9c92-6f294b95a4e1">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccb1b2994cd40fbbb5731c88d1d399c_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi00LTEtMS0xMjkxMDk_9e223f1b-4e60-40ee-b981-84a8f9339ece">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b219eedfb714d8fb1b867d806c10b05_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi02LTEtMS0xMjkxMDk_0417346b-f60c-4eca-a21c-6ac896fd21ce">30,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi04LTEtMS0xMjkxMDk_f4b28f98-fd2a-45e2-b25f-6b348af1bbfc">3,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2449a2bfd124fe2ab3313d8a383b536_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0xMC0xLTEtMTI5MTA5_a38530df-cf6e-435e-a913-f92f8772a4e5">36,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0xNC0xLTEtMTI5MTA5_fa86a2f4-b32c-4c5d-9faa-ad4e04fbb018">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMy02LTEtMS0xMjkxMDk_a03d0817-01f9-413c-a871-360d3b67544c">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMy0xNC0xLTEtMTI5MTA5_71b415bf-663b-4058-acae-4c0fc950690d">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNC04LTEtMS0xMjkxMDk_f61918dd-9a00-4ebb-9bcc-4df26e5316d8">679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNC0xNC0xLTEtMTI5MTA5_280d4a8c-e59e-439f-b528-6ad4f33481a0">679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48fb5645cbc4cc196e6db7c24a03af9_D20220101-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS00LTEtMS0xMjkxMDk_68f2ce89-83c2-4cef-b431-7a6d5055a6b0">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS0xMC0xLTEtMTI5MTA5_862bf842-a639-4fa6-8f17-b6ff205dcee5">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS0xNC0xLTEtMTI5MTA5_8bb3ce21-958c-49aa-8f76-43083b51f97a">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjoxMDY2MmE0ZDZhNjg0M2JkODA3MzQzZTNlYjBjZmFlY18yNzQ4Nzc5MDY5NDg2_db10a1da-147e-4418-b6ea-d6e7413282f5">1.80</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi02LTEtMS0xMjkxMDk_7c6a0351-b4dd-41c1-9691-86eee525e499">3,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi0xNC0xLTEtMTI5MTA5_dba1f45d-63d1-4606-ae2d-09738bf82436">3,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNy0xMC0xLTEtMTI5MTA5_661e1db0-56ed-44f2-ade8-a6f52bf612ef">1,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNy0xNC0xLTEtMTI5MTA5_0c359dab-2fd9-4000-b9e3-8e563072a450">1,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55831b17fc8441a290ddc1bf9c38fa94_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMi0xLTEtMTI5MTA5_ed0c83a7-6a07-49da-ad88-56a87bb7c02b">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec91f7ffcfe043208c2fbae9bff40d21_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtNC0xLTEtMTI5MTA5_6d055f15-c7c1-4d73-bf24-947e61509a3f">5,861</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i195abdcdf51a4a099f84b2ae27653186_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtNi0xLTEtMTI5MTA5_b1f26b5f-d032-47b2-a467-59dd0ac088ee">30,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtOC0xLTEtMTI5MTA5_58659e4e-32c7-445a-9929-5714d9f7775d">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0d24d8a90491486fda069a8ee99d0_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMTAtMS0xLTEyOTEwOQ_125498f9-5558-4636-a62d-b774234d3164">37,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMTQtMS0xLTEyOTEwOQ_8f0d44dc-5332-48c5-8178-d531e860d1ab">2,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71e968f79944aea5e02c01739659a7_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0yLTEtMS0xMjkxMDk_07a18e58-130a-463e-aa95-7607389a8b1e">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0846deffb1664429a509a79024bf0f26_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi00LTEtMS0xMjkxMDk_0af11e53-0501-4ef8-bfd4-2c75127892c4">5,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i538011103d4d4bedadad7ef6aa58ff25_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi02LTEtMS0xMjkxMDk_e540779c-8fca-4e53-b6a6-da5062ff4269">34,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43964e9db78c4442b2a6c1bae24600b8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi04LTEtMS0xMjkxMDk_c32f22be-95f4-4522-ad94-9ee67e5834d4">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcddf93cb1114af5b696e99fca98b0b2_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xMC0xLTEtMTI5MTA5_0db0d76a-3fef-487d-9415-59181e53a350">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586e2af9dcd4681a41fbb0b0e0b0e79_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xMi0xLTEtMTI5MTA5_1f1840c0-a51f-431b-8be3-3a15034f5301">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xNC0xLTEtMTI5MTA5_ce589341-73ef-436d-bd76-6d1ed5bd213f">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy02LTEtMS0xMjkxMDk_e4dd0dc9-a2c1-416e-b059-e5386f08a393">3,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy0xMi0xLTEtMTI5MTA5_676d6f87-b287-401c-9d79-5d207955bedc">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy0xNC0xLTEtMTI5MTA5_c793b84b-2f95-4d05-a148-8ab9e6ba9766">3,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNC04LTEtMS0xMjkxMDk_4a4e1efe-fb9b-4c12-9968-5a531b56933e">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNC0xNC0xLTEtMTI5MTA5_733bd536-9894-4aa1-9a20-615e9d411e2c">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138581f0b65743e59bd88750dcecf150_D20210101-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS00LTEtMS0xMjkxMDk_90ddfbe5-82ab-448a-80de-02c887e564b0">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS0xMC0xLTEtMTI5MTA5_5fbd8a2b-67f6-488c-a623-337ae6ed822b">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS0xNC0xLTEtMTI5MTA5_8971438e-6ff4-41e7-933f-7232d116d2a3">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjo4MmJlMDVmNWIwYjA0NTYzOTBkZmMzYjUwOWQxZWRmMF8yNzQ4Nzc5MDY5NDgz_620a5699-121e-467a-9e5e-ac491c50d9a9">1.72</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi02LTEtMS0xMjkxMDk_dc239d04-7231-4b47-8926-88da24ed1b0b">3,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi0xNC0xLTEtMTI5MTA5_82d7b0a3-fcb4-4d0a-9637-d3fcabfab97b">3,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNy0xMC0xLTEtMTI5MTA5_d2810bda-f96a-4722-ac7b-ddd53453ebaa">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNy0xNC0xLTEtMTI5MTA5_ae96eef3-7e50-445d-ad3a-f01058158b66">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i138581f0b65743e59bd88750dcecf150_D20210101-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e757a9350804423a1366f4edcb70ffa_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMi0xLTEtMTI5MTA5_d61e6946-838f-4c41-8a2d-a48a7512ef4d">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc9b71519dae4e209d412a66a68839cc_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtNC0xLTEtMTI5MTA5_654d6b77-f248-48d4-8951-41b280512ce9">5,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtNi0xLTEtMTI5MTA5_656d0f70-49b7-4a57-b868-2f7693b48f90">35,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtOC0xLTEtMTI5MTA5_d654b650-cdfc-49ab-a11f-073de6c6e344">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a159b1f5b8644c382a69af99c56dcc2_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTAtMS0xLTEyOTEwOQ_cf49de96-c47c-4157-baf3-3a88b1f61916">34,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b9693299744ec9899bea6e3abb91dd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTItMS0xLTEyOTEwOQ_6a05941a-940c-4275-9606-d0ec1603ae01">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTQtMS0xLTEyOTEwOQ_eb7b5632-a167-46f5-a3ce-4ac635436fb0">3,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10" footnoteRole="http://www.xbrl.org/2003/role/footnote">Represents the purchase of the remaining noncontrolling interests in Helix in the second quarter of 2021.</ix:footnote></span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">for the Three Months Ended June 30, 2022 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_______________________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.133%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825c93cb311e47a19c18659fc18b76d8_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0yLTEtMS0xMjkxMDk_3c98c95d-5bb4-45a9-bc86-d48649d78059">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d52eb68d4d748e6aa0dd402d9c0d6f8_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi00LTEtMS0xMjkxMDk_3e3d45d9-873e-4482-9ea6-3bf4c03b9867">5,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6110daa1294fd39e39d73a439bd261_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi02LTEtMS0xMjkxMDk_e1a4bf09-6274-4ffe-9335-06f981f76ecc">30,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi04LTEtMS0xMjkxMDk_5aca1614-f8d0-4a36-90d3-d0ef0ca6ff98">2,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i803401904f8b457e80587a15d7c74d13_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0xMC0xLTEtMTI5MTA5_ec08f59a-6d45-42e6-a3dd-f2c191fd98f9">36,569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea1d15baae55479686b0438960a20553_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0xNC0xLTEtMTI5MTA5_bc394e6c-289c-4af3-9b67-f586e9c87586">1,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMy02LTEtMS0xMjkxMDk_8399741e-15db-4a9d-b5d0-2572806a8559">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMy0xNC0xLTEtMTI5MTA5_fcb9851b-e839-4b2e-8880-1f0c78808256">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNC04LTEtMS0xMjkxMDk_81bc375d-6bbd-4113-b4dc-26262ba5f2e0">585</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNC0xNC0xLTEtMTI5MTA5_967f467a-6229-46e8-a1a8-1f76be041455">585</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied487a078f8f45c08115f899f30d2518_D20220401-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS00LTEtMS0xMjkxMDk_841cde5d-1d85-4873-b90d-2aa3daa9d172">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS0xMC0xLTEtMTI5MTA5_7401d1db-8864-4951-b334-6d4b4aae734d">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS0xNC0xLTEtMTI5MTA5_90be72e9-1159-47fe-8a32-2d310a5b9798">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjoxNDlmNjEwMWE3MDY0Nzg4ODI1ZGI1ZDVhNzIzNWY2MV8yNzQ4Nzc5MDY5NDgz_0a943b14-9765-46d2-a5b5-3c833997f401">0.90</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi02LTEtMS0xMjkxMDk_263f75e2-bc2d-41f4-9226-5a43a0c8ccf8">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi0xNC0xLTEtMTI5MTA5_d8f35b46-f128-4ce1-ab5e-d6e3ff6d86af">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNy0xMC0xLTEtMTI5MTA5_e311773d-241f-43dd-abd1-ab7ae34c4a45">507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNy0xNC0xLTEtMTI5MTA5_3e8345e3-2163-45a1-ad76-61a78f2f75bc">507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55831b17fc8441a290ddc1bf9c38fa94_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0yLTEtMS0xMjkxMDk_8ac5fe07-7a72-4a45-8f2f-0b6150055df6">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec91f7ffcfe043208c2fbae9bff40d21_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS00LTEtMS0xMjkxMDk_ea2c7b92-2655-4672-baa8-44a3a87c021a">5,861</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i195abdcdf51a4a099f84b2ae27653186_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS02LTEtMS0xMjkxMDk_1fe9e2b8-dc22-48a6-b1c5-bb89459bcff4">30,252</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS04LTEtMS0xMjkxMDk_6ee5a7f7-d5de-4fbe-9a2c-5d41435cbd97">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0d24d8a90491486fda069a8ee99d0_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0xMC0xLTEtMTI5MTA5_e66b5077-176f-41b5-ba19-6f7ab320060f">37,074</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0xNC0xLTEtMTI5MTA5_3a587562-9137-4533-8e86-b75deced5857">2,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested<br/>in the<br/>Business</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbd121042c745818aabb802a6d44f50_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0yLTEtMS0xMjkxMDk_1c9c3dba-5182-4e4b-a125-584215a193a3">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i540c66305f294fbb945da9a41514ff51_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi00LTEtMS0xMjkxMDk_01697121-09f6-496b-ad99-2ab467c96359">5,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a8a4571fc3d4acab135fe43eef795fe_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi02LTEtMS0xMjkxMDk_7ece5c2f-b186-421c-b425-97c460731812">34,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9788f29297284a1d88ff1e6c6548cad3_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi04LTEtMS0xMjkxMDk_79fb15d4-13f2-4ed1-8adf-bb8183138708">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f65898626a94e9ea933742220b4c7d5_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xMC0xLTEtMTI5MTA5_a6ef792d-e286-47e0-a0d8-e5d7560539a3">34,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aa773030fca4e1f899e5ed5dd14b7d4_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xMi0xLTEtMTI5MTA5_387f133f-7ea7-444e-b9ef-fedb287202cb">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233715bedd740d4a3940763dda60aa8_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xNC0xLTEtMTI5MTA5_9cbeb9de-b2c6-4978-9b87-f0826e50e8c5">2,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy02LTEtMS0xMjkxMDk_ec7714e7-a797-4d51-bbe4-d83536effc52">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy0xMi0xLTEtMTI5MTA5_eddee955-dabb-4bcd-9585-6f2c17e7da73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy0xNC0xLTEtMTI5MTA5_1ee7e8a4-18bb-4a69-9386-54d5f71e612c">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNC04LTEtMS0xMjkxMDk_d3a17e66-b129-40d6-b0e8-2d49c204c3d3">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNC0xNC0xLTEtMTI5MTA5_44fba74d-8198-4c00-bb91-ca167a5af460">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS00LTEtMS0xMjkxMDk_370b7384-4435-442a-80f8-fe96f6a54cf0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS0xMC0xLTEtMTI5MTA5_6fee7f6a-46c8-4ee3-a5e8-80cb63d60c47">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS0xNC0xLTEtMTI5MTA5_79306cec-f935-4e3f-8aa6-ed5959965dc7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjo2ZjEzZjI1YjE5YTk0ZjlmYmQ3NjQ5NWNkNmQxNjMxNV8yNzQ4Nzc5MDY5NDgz_461c8211-0ff4-4e96-bbfa-682515e9868f">0.86</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi02LTEtMS0xMjkxMDk_ad94ca17-e094-460d-bf3b-7f6a33aa1e1f">1,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi0xNC0xLTEtMTI5MTA5_d20dc957-7d54-4bf2-893a-8811a9b2fb84">1,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNy0xMC0xLTEtMTI5MTA5_c9e68a37-cfed-4ef8-8593-b503e38db66f">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNy0xNC0xLTEtMTI5MTA5_8c36bcff-1261-4fab-b048-35919311d753">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e757a9350804423a1366f4edcb70ffa_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0yLTEtMS0xMjkxMDk_34f18154-ea38-4b5b-a9ab-b8e44c7c12a1">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc9b71519dae4e209d412a66a68839cc_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS00LTEtMS0xMjkxMDk_8f8662fc-71c9-4247-9e5d-09c5338983e1">5,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS02LTEtMS0xMjkxMDk_e133518f-e0bf-4432-b41e-b9231d18c886">35,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS04LTEtMS0xMjkxMDk_016eed7d-90c4-44a6-9a91-40e111a719ef">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a159b1f5b8644c382a69af99c56dcc2_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xMC0xLTEtMTI5MTA5_38b9f1ff-9ed7-404c-a34f-4a9e692ce5de">34,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b9693299744ec9899bea6e3abb91dd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xMi0xLTEtMTI5MTA5_e1237cd1-be64-4621-aa9e-9fce00982c5d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xNC0xLTEtMTI5MTA5_89ecf448-02da-4ef3-8df5-d9ec5cb7836a">3,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Represents the purchase of the remaining noncontrolling interests in Helix in the second quarter of 2021.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMi0yLTEtMS0xMjkxMDk_0038383f-df90-4292-9c14-9dae1c7549a9">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMi00LTEtMS0xMjkxMDk_f224557e-8a62-478a-a664-3acb9a9526b9">3,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to operating cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNC0yLTEtMS0xMjkxMDk_8696c114-77f8-4ce9-9fe7-745efd619fa5">109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNC00LTEtMS0xMjkxMDk_ec08223d-9994-403c-9c54-d909a5103e1a">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNS0yLTEtMS0xMjkxMDk_e8e020c2-1b18-41f3-a750-46a79f5927be">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNS00LTEtMS0xMjkxMDk_2ef5aaef-2b33-4e43-bc79-d1b389fe6191">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNi0yLTEtMS0xMjkxMDk_96ccb35f-b4b4-4a7c-987d-2dc171daaf61">1,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNi00LTEtMS0xMjkxMDk_f253cdc1-1f55-4d6e-b955-522e8d936415">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from ABI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNy0yLTEtMS0xMjkxMDk_a40d0406-9390-4848-a839-6cc178c034a4">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNy00LTEtMS0xMjkxMDk_196cc1fd-2e07-4e91-bb1e-625dd8373e29">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfOS0yLTEtMS0xMjkxMDk_459e2c99-5c13-48c7-9074-f8e208774b1e">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfOS00LTEtMS0xMjkxMDk_a44ad4a5-cfee-40a4-93e4-16710769abc5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTMtMi0xLTEtMTI5MTA5_a5a79afe-cb37-454a-9341-a90412ac8023">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTMtNC0xLTEtMTI5MTA5_ffb2f673-1409-49c5-b274-9cb302ba1c3a">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash effects of changes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTYtMi0xLTEtMTI5MTA5_316fc2d9-8c66-4316-98ad-6f78254caa9e">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTYtNC0xLTEtMTI5MTA5_f6c0b84d-037a-4df0-a52f-701f219202e9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTctMi0xLTEtMTI5MTA5_6d450851-22c8-401e-92ab-3ced9e27c68d">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTctNC0xLTEtMTI5MTA5_14eacb57-ca6e-4117-8781-8f9e601d70c5">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTgtMi0xLTEtMTI5MTA5_3f3224e3-6422-4426-bd62-3407c190b3d0">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTgtNC0xLTEtMTI5MTA5_f8f2bcb2-287e-4bc1-9408-e55e3bcadf14">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTktMi0xLTEtMTI5MTA5_0afb4da1-9283-4170-ab05-923ca867ec56">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTktNC0xLTEtMTI5MTA5_17fb06cc-11f5-4a05-9f05-0184c9b94854">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjAtMi0xLTEtMTI5MTA5_b658f802-c71a-4409-ba50-67d1c351d1d0">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjAtNC0xLTEtMTI5MTA5_bb7d5a23-cedf-4586-9f7b-a6158bc3639f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued settlement charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjEtMi0xLTEtMTI5MTA5_2c69aeb8-f921-47b5-a4d9-7f8e123b217a">1,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjEtNC0xLTEtMTI5MTA5_f4e37217-005e-41f8-ab97-56999f95b9ce">1,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjItMi0xLTEtMTI5MTA5_ad3ea58d-4159-4e76-8742-504a971a0ff2">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjItNC0xLTEtMTI5MTA5_3543bc55-a4a5-4da5-aa35-e8fba3d4e377">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension provisions and postretirement, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjMtMi0xLTEtMTI5MTA5_450a09da-db2f-436a-a115-0643dab6182e">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjMtNC0xLTEtMTI5MTA5_2c6587b6-078a-48ce-9622-1810cbcc2a71">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjQtMi0xLTEtMTI5MTA5_8e35055a-ab1a-4ad8-bf89-828d747d8dd8">81</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjQtNC0xLTEtMTI5MTA5_315eb97b-dee0-4445-a9c4-8f9559b7d120">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjUtMi0xLTEtMTI5MTA5_64d9620d-b764-409b-af44-95336758c413">2,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjUtNC0xLTEtMTI5MTA5_f38d17ef-9b95-4491-8dbe-efc3b2ff5923">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjctMi0xLTEtMTI5MTA5_2621f096-9396-48e2-8866-a2250fa75f38">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjctNC0xLTEtMTI5MTA5_27010a88-cc22-4659-8302-ef25cdc9e8ed">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzEtMi0xLTEtMTI5MTA5_a41eb5d3-201e-4cae-b5fe-518c2d543520">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzEtNC0xLTEtMTI5MTA5_7914dc89-d838-447a-8c20-22d6ba983a36">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzItMi0xLTEtMTI5MTA5_79e56b69-74ed-4f62-a520-d6656bbe9e03">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzItNC0xLTEtMTI5MTA5_20fe0195-864d-4da3-b7c8-06b1f9d4e090">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNC0yLTEtMS0xMjkxMDk_7f611ff5-5080-4eaa-b43e-fdf3954dd4bf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNC00LTEtMS0xMjkxMDk_17f257e2-cccc-44fa-b74b-89406767f24e">5,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt repaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNS0yLTEtMS0xMjkxMDk_bf91ab5c-eaf7-425a-8c34-b490cc97031c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNS00LTEtMS0xMjkxMDk_f3923ad6-f47a-4486-8621-a131b021d872">6,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNi0yLTEtMS0xMjkxMDk_21a0fe6a-b178-40a2-b1fe-7ba0a2c16445">1,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNi00LTEtMS0xMjkxMDk_94603574-afad-4cef-9ea8-b562dc5ed60f">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNy0yLTEtMS0xMjkxMDk_b8ea3aa8-a0f8-4ec7-8614-988e9ee42aa0">3,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNy00LTEtMS0xMjkxMDk_4a2c27d6-b025-4817-afcf-2f2c6dbfc04b">3,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and fees related to early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTAtMi0xLTEtMTI5MTA5_53e3b305-f4bb-4b1a-9c24-d368dbb5fcc2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTAtNC0xLTEtMTI5MTA5_92987842-0b8e-4d07-9a7f-be7835a0de74">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTEtMi0xLTEtMTI5MTA5_06046864-f4f7-431d-94c1-6aa9a785f6b7">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTEtNC0xLTEtMTI5MTA5_1caf5642-651c-414a-b0b5-fb5fa1b229ad">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTItMi0xLTEtMTI5MTA5_dac788d1-3c54-470a-b451-8f0285f213cd">4,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTItNC0xLTEtMTI5MTA5_1e27ebbe-3002-4ee6-998d-c82ba925fc0a">5,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTQtMi0xLTEtMTI5MTA5_43384f97-9fa1-462f-b612-c95be72768b0">1,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTQtNC0xLTEtMTI5MTA5_5a3b362b-02d5-44e7-919e-dd9992b1e2cf">3,079</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTUtMi0xLTEtMTI5MTA5_9464acef-585a-4c72-8c93-3ecb00b97dc5">4,594</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTUtNC0xLTEtMTI5MTA5_94c9bea5-77dc-40b5-bfea-27af8df1db87">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTYtMi0xLTEtMTI5MTA5_cb375dc2-dc91-4072-a017-c9b2d8835a4c">2,632</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTYtNC0xLTEtMTI5MTA5_3c7c0b15-82ec-4e17-adc6-4f78a4dff44d">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table provides a reconciliation of cash, cash equivalents and restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to the amounts reported on Altria&#8217;s condensed consolidated balance sheets:</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjAtMi0xLTEtMTI5MTA5_e78867cb-b4dd-431d-8031-e9cf8e930d3a">2,567</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjAtNC0xLTEtMTI5MTA5_4fa7003d-5e4d-4cf0-ace4-f7c6a5b682cc">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjEtMi0xLTEtMTI5MTA5_fc5dd51f-d5a2-4332-bc5c-900fb5d8fd80">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjEtNC0xLTEtMTI5MTA5_a1fa4ac3-0b34-47fc-8874-2fc08365d9f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjItMi0xLTEtMTI5MTA5_44cf312b-ef5d-43a4-b6ed-8d9f10fd5237">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjItNC0xLTEtMTI5MTA5_569160c8-093b-44f7-b864-02097e08a893">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjQtMi0xLTEtMTI5MTA5_d7e0d766-ecf7-4474-8851-dcf04cc1d4db">2,632</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjQtNC0xLTEtMTI5MTA5_94fa8b8f-bf0a-418f-8f9e-908e9edd9216">4,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted cash consisted primarily of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;text-indent:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNA_17df1f23-311c-4a86-b883-aa1cff891d39" continuedAt="i69053a4ef5744bfa8bac1ee6ba9ca5eb" escape="true">Background and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i69053a4ef5744bfa8bac1ee6ba9ca5eb" continuedAt="i99ac2259e304488893f87eb59f990ffe"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the terms </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;) and snus products; Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which has one leveraged lease remaining.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies, and Altria Client Services LLC, which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs.  Altria&#8217;s access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At June&#160;30, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2021, UST sold its subsidiary, International Wine &amp; Spirits, which included Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), Cronos Group Inc. (&#8220;Cronos&#8221;) and JUUL Labs, Inc. (&#8220;JUUL&#8221;).  <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNQ_a3bb78a3-66a9-4990-b69e-acc912161f1c" escape="true">We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our equity investment in JUUL under the fair value option.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in equity securities, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;) authorized a $<ix:nonFraction unitRef="usd" contextRef="ie69c7f39e03b4eba8436ad80b94446b0_I20210131" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjc3OQ_4b885ea7-6235-416a-8ff6-3c6fe6a20bf6">2.0</ix:nonFraction> billion share repurchase program that it expanded to $<ix:nonFraction unitRef="usd" contextRef="ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjgyNw_3e571c77-515a-4429-a378-a7ea3337a328">3.5</ix:nonFraction> billion in October 2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;).  At June&#160;30, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i13871dd12543440895ab2e9a2d7be37e_I20220630" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjkyMQ_c87145c9-c629-4a9b-ad31-5cbf37dfd3c1">742</ix:nonFraction> million remaining in the January 2021 share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUyMA_6bb3fc81-4404-41b1-b62f-f5661493ae44" escape="true"><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share repurchase activity was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0xLTEtMS0xMjkxMDk_927f828f-3d49-472f-aa93-0964b1d07fc9">21.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0zLTEtMS0xMzI2ODI_fcd3cabe-1440-4982-9d1b-2e514f953f71">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi01LTEtMS0xMzI3MDc_650ee34d-07eb-416b-963c-5ff7a1815017">10.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0zLTEtMS0xMjkxMDk_ced89ede-6528-4fbf-8d0c-7a186071e4f8">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0xLTEtMS0xMjkxMDk_bb7cdf0a-e2d0-4bcd-82ca-d1517ee8f8b8">1,083</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0zLTEtMS0xMzI2ODI_dbe15dc9-7cfd-43d4-a544-3e81d3953d59">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy01LTEtMS0xMzI3MDc_ec107e38-cf7f-4ca9-8058-3c1b79188780">507</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0zLTEtMS0xMjkxMDk_9e8f04df-4fda-4280-a20a-2678917ea07e">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0xLTEtMS0xMjkxMDk_5a7e4da8-cd6f-44ce-84c7-8945a8e1bf57">50.53</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0zLTEtMS0xMzI2ODI_c4ed8e1e-0022-4b3c-a16e-7f1b521b0752">48.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC01LTEtMS0xMzI3MDc_b83bd564-f818-4bb9-9f7c-fe3ff6db2e11">50.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0zLTEtMS0xMjkxMDk_994e74d2-3d7b-40f6-90fa-90a6b8639dfa">49.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNw_dea98a9d-8322-49b6-b853-bf6bf966c796" escape="true">Our interim condensed consolidated financial statements are unaudited.  Our management believes that all adjustments necessary for a fair statement of the interim results presented have been reflected in our interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with our audited consolidated financial statements and related notes, which appear in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-bottom:5pt"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNg_8f61046e-323e-46e5-8182-80fb17e68690" continuedAt="i027614dd75764f15b01fc8983e16bc42" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our condensed consolidated financial statements.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><ix:continuation id="i99ac2259e304488893f87eb59f990ffe"><ix:continuation id="i027614dd75764f15b01fc8983e16bc42" continuedAt="i69bd249cc2fe4da28a5be5c8937fefc9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></ix:continuation></ix:continuation></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_40"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0Ng_4306012f-2e5d-4018-8c12-e016814ad9fd" continuedAt="i98ae730811e14501a7797ce61d4b36fc" escape="true">Revenues from Contracts with Customers</ix:nonNumeric></span></div><ix:continuation id="i98ae730811e14501a7797ce61d4b36fc"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate net revenues based on product type.  For further discussion, see Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="mo:CashDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0OA_57cd0e18-8b50-4679-a1d8-89b8db2de8a1" escape="true">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our condensed consolidated balance sheets.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record payments received in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfODc1_61705c06-e7fb-4113-8ed6-94fc47d171ac">303</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfODgy_6202e2c2-729b-4b38-b88f-767a2d3dd197">287</ix:nonFraction> million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  When cash is received in advance of product shipment, we satisfy our performance obligations within <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTAxNA_adafdb5f-9f99-4f1e-9d0c-b4b0612470b8">three days</ix:nonNumeric> of receiving payment.  At June&#160;30, 2022 and December&#160;31, 2021, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables were $<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTE5MA_58fbf559-96c6-4978-81b1-f2ab8d11a92b">43</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTE5Nw_28d46e76-89cd-4ed1-b2c5-e6144bf61c53">47</ix:nonFraction> million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  At June&#160;30, 2022 and December&#160;31, 2021, there were no expected differences between amounts recorded and subsequently received, and we did <ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTM0MQ_13067ec0-2627-4953-8159-d943456761e0"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTM0MQ_f40d9670-bda8-4339-bf41-1465e3ff161f">no</ix:nonFraction></ix:nonFraction>t record an allowance for credit losses against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0OQ_912f3b6d-cb28-4c2e-9b97-f6f27f96b71d" escape="true">We record an allowance for returned goods, which is included in other accrued liabilities on our condensed consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make price promotion payments, substantially all of which are made to our retail partners, to incent the promotion of certain product offerings in select geographic areas.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.</span></div></ix:continuation><div id="i8ab1f6ba80d642c6abc401018a1063a1_55"></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_58"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxNQ_64957583-1625-4566-b4d3-4153f906df5e" continuedAt="i7c8af43613c4427181100f1572b1df75" escape="true">Investments in Equity Securities</ix:nonNumeric></span></div><ix:continuation id="i7c8af43613c4427181100f1572b1df75" continuedAt="i706e3d577b914450b9d25966a31e4916"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:InvestmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIwOA_9eedef2f-9340-47f0-b79f-a45f9a2f18d3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.885%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMS0yLTEtMS0xMjkxMDk_d61dd46b-6966-4b1a-9c63-178adb90d1d1">11,702</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cd43db55f34600bccfbf93673a50c7_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMS00LTEtMS0xMjkxMDk_1219b232-eb2a-44a4-b8ca-cc914cbf7bfb">11,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="-6" name="mo:EquityInvestmentFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMi0yLTEtMS0xMjkxMDk_db65ff56-f58d-4683-8618-b7cc82ff5751">450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fa611f2a7f4ac18373b103852f2b2a_I20211231" decimals="-6" name="mo:EquityInvestmentFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMi00LTEtMS0xMjkxMDk_19d4e57f-9a43-4fde-8159-505ec7c5d014">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="-6" name="mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMy0yLTEtMS0xMjkxMDk_6c8187b7-68d2-462d-9851-5ce55c18cbcb">438</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a9923020f3440a85a8e77c1756d28c_I20211231" decimals="-6" name="mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMy00LTEtMS0xMjkxMDk_b862702a-5fa9-4c09-9677-074ec24d3897">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfNC0yLTEtMS0xMjkxMDk_f23ee4e7-0dae-4d34-a2f5-4768bf1edf59">12,590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfNC00LTEtMS0xMjkxMDk_25afd38f-4f1e-4cda-aae1-1820cdcd2339">13,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at June&#160;30, 2022 and December 31, 2021 consisted of our equity method investment in Cronos of $<ix:nonFraction unitRef="usd" contextRef="ic1faac1f996b4486abd195c7b20753e5_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMjI0_1d67d9fb-a97f-423e-9da4-ee2cac277aee">437</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMjMy_9492908c-a783-4974-8cbd-b7d8445ddeb8">617</ix:nonFraction> million, respectively, and also included the Cronos warrant and the Fixed-price Preemptive Rights, which are measured at fair value (collectively, &#8220;Investment in Cronos&#8221;).  See below for further discussion.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i706e3d577b914450b9d25966a31e4916" continuedAt="if938ceb771e54f1fa7acc6015532d9ba"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxNw_6a01df02-c4af-4633-aea9-dbae34bcbde6" continuedAt="i97abb497306849beaf6ccb4eca63cd21" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi0xLTEtMS0xMjkxMDk_7f8d0f16-0dad-4789-ba7d-896f7416ead0">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie78dea82ae7d4b92b9519c98e6eefa7a_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi0zLTEtMS0xMjkxMDk_63ee1775-665b-46da-b705-1437899015dc">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c85ce8790e54af78ef8a2b11e4fb9f9_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi01LTEtMS0xMjkxMDk_d18fdc1b-fb91-4e9b-a68b-162407cb7177">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c05c358d1bb48aebde77f979670acd7_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi03LTEtMS0xMjkxMDk_6ae67049-f08a-466f-8a58-d55152cfd300">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy0xLTEtMS0xMjkxMDk_417b39fe-2a81-4fe2-8400-0c0c59e6f326">186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10dd4f1f71584811bc9ce1be4117dc8e_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy0zLTEtMS0xMjkxMDk_182e853e-5bc2-4dbe-b7e3-c363e1b2219d">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy01LTEtMS0xMjkxMDk_2363f307-9027-43d2-b171-7341ea89c7b0">120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7229434de434e45a7fba1248a55d390_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy03LTEtMS0xMjkxMDk_3b844efd-a6e7-4c9a-ad3e-4618b2298a52">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC0xLTEtMS0xMjkxMDk_d469c212-bc4a-440b-8a81-69892202fa25">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC0zLTEtMS0xMjkxMDk_61f37e80-17b5-4bfb-8df2-03fd1cbe6928">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC01LTEtMS0xMjkxMDk_6f0c18df-d394-4f20-b58a-a6815de0cd75">108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC03LTEtMS0xMjkxMDk_b6e1f9de-fdf2-4061-8f3d-97ebb1587eca">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS0xLTEtMS0xMjkxMDk_2057f848-9e0d-4fa9-95c7-9f5c4e795a89">1,255</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS0zLTEtMS0xMjkxMDk_e7631422-251f-4878-a9d1-2ffdaca5dcd3">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS01LTEtMS0xMjkxMDk_0d0c9e29-8d9c-4a4e-8f0d-cb873c7069b1">1,155</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS03LTEtMS0xMjkxMDk_ee1f5835-050a-4b5b-90ab-3f9ad80e6af1">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi0xLTEtMS0xMjkxMDk_5ec68acd-b34e-4e2b-8761-cccdaca7623d">1,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi0zLTEtMS0xMjkxMDk_899b0dc1-15b6-4ebf-ac1c-2fc06c7279c1">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi01LTEtMS0xMjkxMDk_5ce3bfad-5bee-4b18-a148-9f9b23f6b645">1,263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi03LTEtMS0xMjkxMDk_dd180f19-7f9e-4644-ad75-3a8e2b0df3da">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had an approximate <ix:nonFraction unitRef="number" contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfOTAw_64be11dc-0fe1-4732-8db0-c8f6425a5304">10</ix:nonFraction>% ownership interest in ABI, consisting of <ix:nonFraction unitRef="shares" contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesOwnedRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfOTQ0_e0dd23fc-fe04-43ae-a257-f9c98dcd0080">185</ix:nonFraction> million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and <ix:nonFraction unitRef="shares" contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTAwMg_19398c22-392f-449a-859a-b7cd9d311531">12</ix:nonFraction> million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by us into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restricted Shares were subject to a <ix:nonNumeric contextRef="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630" name="mo:RestrictedSharesLockupPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxMA_05c5e21d-daf1-498e-b852-1e43b77a2bfa">five-year</ix:nonNumeric> lock-up period that ended October 10, 2021.  As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIwNQ_6aad8272-faea-4cd2-9c48-76280a26deaa" continuedAt="i581ee90be68045cdb31c1d514509a329" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the fair value of our equity investment in ABI was $<ix:nonFraction unitRef="usd" contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTg5Ng_232ad781-23ca-4aa9-a3f6-5ea332413b03">10.6</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTkxMw_989ec070-b9ad-4005-8b84-51f5876967a0">11.7</ix:nonFraction> billion), which was below its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630" decimals="-6" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk1NA_7decb96e-7baf-4b93-a56d-7f0c0501161b">1.1</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk2OQ_e763f549-64ea-4a39-a4a0-6c249904bfa4">9</ix:nonFraction>%.  The fair value of our equity investment in ABI at December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTM3NDM4OTUzNTI2MjA_e87bdd3c-1d8e-478e-88f8-f32341c0420c">11.9</ix:nonFraction> billion, which exceeded its carrying value of $<ix:nonFraction unitRef="usd" contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTM3NDM4OTUzNTI2Mjk_d866d421-5011-43f2-bde7-0c9324e088a6">11.1</ix:nonFraction> billion by approximately <ix:nonFraction unitRef="number" contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk3NQ_ec3ce60b-8862-4e90-a886-943397fccf69">7</ix:nonFraction>%.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity investment until full recovery to its carrying value in the near term.  In preparing our financial statements for the period ended June&#160;30, 2022, we have evaluated these factors, including the macroeconomic and geopolitical factors that have resulted in significant changes to certain foreign exchange rates, including the Euro to U.S. dollar exchange rate.  Additionally, ABI has delivered consistent business and earnings performance over the past several quarters demonstrating its ability to continue to execute its strategies and navigate challenges.  At June 30, 2022, we concluded that the decline in fair value of our equity investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.  At July 25, 2022, the fair value of our equity investment in ABI was below its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i392d38c364c74d9ea72ff1e3530414b2_I20220725" decimals="-6" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk5NA_a5a9e374-dda0-481f-9319-4ac0f7e70c3a">0.9</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i392d38c364c74d9ea72ff1e3530414b2_I20220725" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg5MDAwOQ_87a5e889-c6b8-4ee5-8c45-b2f2e053940f">8</ix:nonFraction>%.</span></div></ix:continuation><div id="i8ab1f6ba80d642c6abc401018a1063a1_61"></div><ix:continuation id="if938ceb771e54f1fa7acc6015532d9ba" continuedAt="ia51e1fb56808474e810ac2ad4a6b84c2"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we made an investment in JUUL for $<ix:nonFraction unitRef="usd" contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231" decimals="-8" name="mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzY_83960249-9ef1-48a1-9d7e-f0352c5b0cd5">12.8</ix:nonFraction> billion and received a <ix:nonFraction unitRef="number" contextRef="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfOTQ_8c3d3b8f-e906-4e92-a470-5654772f8a42">35</ix:nonFraction>% economic interest in JUUL through non-voting shares, which were convertible at our election into voting shares (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  At June&#160;30, 2022, we had a <ix:nonFraction unitRef="number" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDI3_546a9921-03cf-451e-940e-3994d3a47fc0">35</ix:nonFraction>% ownership interest in JUUL, consisting of <ix:nonFraction unitRef="shares" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="-6" name="mo:EquityInvestmentsFairValueOptionVotingShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDcy_84552652-a52b-4937-900a-e4a754c4e271">42</ix:nonFraction> million voting shares.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="ia51e1fb56808474e810ac2ad4a6b84c2" continuedAt="if02e212c1b63461baf41896963f10a78"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain our ownership percentage and we are subject to a standstill restriction under which we may not acquire additional JUUL shares above our <ix:nonFraction unitRef="number" contextRef="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQw_b74c8d88-051a-43e4-b794-b49f91c2f57a">35</ix:nonFraction>% interest.  Furthermore, we agreed not to sell or transfer any of our JUUL shares until December 20, 2024.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the JUUL Transaction, we entered into a services agreement with JUUL pursuant to which we agreed to provide JUUL with certain commercial services, as requested by JUUL, for an initial term of <ix:nonNumeric contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQ4OQ_a08631b0-3dc5-4023-8cfc-a6b11860de90">six years</ix:nonNumeric>.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  In conjunction with these amendments, the parties agreed that we would discontinue all services as of March 31, 2020 except regulatory affairs support for JUUL&#8217;s pursuit of its pre-market tobacco applications and/or its modified risk tobacco products applications.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  However, we have the option to be released from our non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the United States for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances), (ii) if the carrying value of our investment in JUUL is not more than <ix:nonFraction unitRef="number" contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMTkyNQ_ad2d0b9f-a86a-4ab6-bb2a-247b00a1095b">10</ix:nonFraction>% of its initial carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231" decimals="-8" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMTk2MQ_260991d1-30da-46f7-9a72-3f51dad082be">12.8</ix:nonFraction> billion or (iii) if we are no longer providing JUUL services as of December 20, 2024.  If any of the conditions described above are met and we elect to be released from our non-competition obligations, we would lose our board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least <ix:nonFraction unitRef="number" contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYxNQ_fb83a397-1947-4f75-b897-8e0b32bc047e">10</ix:nonFraction>%), preemptive rights, consent rights and certain other rights with respect to our investment in JUUL and, in addition, our JUUL shares would be converted to single vote common stock, which would result in a significant reduction in our voting power.  As discussed below, at June 30, 2022, the carrying value of our investment in JUUL was $<ix:nonFraction unitRef="usd" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYyMQ_ad850264-95f6-41ba-871c-03cb49f00da7">450</ix:nonFraction> million, which was less than <ix:nonFraction unitRef="number" contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYzOA_6bdbcd0e-0d46-429c-8d62-7ce43e34dfb7">10</ix:nonFraction>% of our initial carrying value of $<ix:nonFraction unitRef="usd" contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231" decimals="-8" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTY0NA_cb8a8bc7-e614-46fa-a8b1-05cb99fd23d9">12.8</ix:nonFraction> billion.  As a result, we currently have the option to be released from our non-competition obligations.  However, as of this filing, we have not elected to be released from our non-competition obligations.  We retain our option to be released from the non-competition obligations in accordance with our relationship agreement with JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares into voting shares.  We do not currently intend to exercise our additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#8217;s board, as described below, or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we choose to exercise our governance rights, JUUL has agreed to:</span></div><div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;&#160;&#160;&#160;&#160;restructure JUUL&#8217;s current <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzIxNw_0f5e439a-0e74-4853-b324-af9825836235">seven</ix:nonFraction>-member board of directors to a <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzI1MQ_8934dfe7-4baf-4740-9fa3-7a1f116310a9">nine</ix:nonFraction>-member board that will include independent board members.  The new structure will include: (i) <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzM0OQ_c327fa0e-7ba6-4248-80c6-249c18b44ef2">three</ix:nonFraction> independent directors (<ix:nonFraction unitRef="director" contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzM3NQ_ec0e35d8-894d-4ef5-9c41-9fe390487c7b">one</ix:nonFraction> of whom will be designated by us and <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzQxNQ_d98fa965-c67a-4d45-b442-4490c408bfa3">two</ix:nonFraction> of whom will be designated by JUUL stockholders other than us) unanimously certified as independent by a nominating committee, which will include at least <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzU3Mw_aa133ac0-4130-472c-879e-5b8d468e99ff">one</ix:nonFraction> Altria designee, (ii) <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzU5OA_d524b320-5a58-4abd-8dd1-08d49b045117">two</ix:nonFraction> directors designated by us, (iii) <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzYzNQ_50054bcd-4f9f-4603-847d-de7065ac057c">three</ix:nonFraction> directors designated by JUUL stockholders other than us and (iv) the JUUL chief executive officer; and </span></div><div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;&#160;&#160;&#160;&#160;create a litigation oversight committee, which will include <ix:nonFraction unitRef="director" contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4NDgwMw_7cc3fbab-dca4-4bde-a344-fb03da5549a2">two</ix:nonFraction> Altria designated directors (<ix:nonFraction unitRef="director" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4NDgxMA_938ea047-f8de-4cdd-bf68-fae0430fa19e">one</ix:nonFraction> of whom will chair the litigation oversight committee).  The committee will have oversight authority and review of litigation management for matters in which JUUL and we are co-defendants and have, or reasonably could have, a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#8217;s management being resolved by majority vote of JUUL&#8217;s board of directors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL pre-market tobacco applications that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products currently remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDk0NzgwMjMzNDgyOQ_70c84373-7fab-4591-92dc-50511512b4be" escape="true">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  Under this option, our condensed consolidated statements of earnings include any cash dividends received from our investment in JUUL and any changes in the estimated fair value of our investment, which is calculated quarterly.</ix:nonNumeric>  We believe the fair value option provides quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="if02e212c1b63461baf41896963f10a78" continuedAt="i12af741fbab048bf8d5d8ea7782d0c39"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i581ee90be68045cdb31c1d514509a329" continuedAt="ibb4bc36d7b2241559f204972763244ef">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the estimated fair value of our investment in JUUL, at June&#160;30, 2022 and December&#160;31, 2021, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency law; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQ4NQ_06ab1c6b-8ed1-4186-a67e-38132a5335e0" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied72379ce65f44d1b138e007119e5e27_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfMi0yLTEtMS0xMjkxMDk_2bfccbc4-1806-4810-b276-23d0c70d98d6">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dfcd799dbb04d77a027eb24466e1b75_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfMy0yLTEtMS0xMjkxMDk_80a3c114-17ca-4ec6-b111-cc7a47c7b52d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i591aee96bde948f381ffaaf7af7d4bdd_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNC0yLTEtMS0xMjkxMDk_ef17d077-eae3-44fc-9428-e622e23e09e8">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f889b38500d46f991a8ea1dc2bff214_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNS0yLTEtMS0xMjkxMDk_cee784c0-8955-4db1-a75d-83391cbef730">1,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31a79b3a3b64912992fc8127b6f0253_I20220630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNi0yLTEtMS0xMjkxMDk_68b1798c-7a2c-4ecc-bef4-c4451f7e4873">450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six and three months ended June&#160;30, 2022, we recorded non-cash, pre-tax unrealized losses of $<ix:nonFraction unitRef="usd" contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNjY3NQ_dc5f1ea1-055a-427d-b3b1-5f9c0200f3f2">1,255</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzczNg_e6cbd912-fa7f-4e98-a329-a68f11a1347d">1,155</ix:nonFraction> million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency law, and (iii) projections of higher operating expenses resulting in lower long-term operating margins.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six and three months ended June&#160;30, 2021, we recorded a non-cash, pre-tax unrealized loss of $<ix:nonFraction unitRef="usd" contextRef="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzA2OA_358a4490-a86d-4e7e-b6a7-4685e37c079d">100</ix:nonFraction> million and a non-cash, pre-tax unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestmentsFairValueOption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzEyMA_558ae0d7-469c-4456-80d1-a1cf7d70522e">100</ix:nonFraction> million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  There were no material changes to the significant assumptions used in the valuations, as described above, during the six and three months ended June&#160;30, 2021, compared to the assumptions used for the December 31, 2020 valuation.</span></div></ix:continuation><div id="i8ab1f6ba80d642c6abc401018a1063a1_64"></div><ix:continuation id="i12af741fbab048bf8d5d8ea7782d0c39" continuedAt="i6dc7f6b5d8164bf9835223a1c8ad3e7c"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had a <ix:nonFraction unitRef="number" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfNDI_5c53c0a4-0992-4717-b97e-4642b61b7169">41.4</ix:nonFraction>% ownership interest in Cronos, consisting of <ix:nonFraction unitRef="shares" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="-5" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfODk_99880aac-d887-4c71-b87e-f535f326fee6">156.6</ix:nonFraction>&#160;million shares, which we account for under the equity method of accounting.  We report our share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value and carrying value of our equity method investment in Cronos at December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk0MzE_2227ec54-88d4-481a-980d-888d41c793c1"><ix:nonFraction unitRef="usd" contextRef="i80a9923020f3440a85a8e77c1756d28c_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk0MzE_40eb2e4f-30e1-4d6f-b040-86ec8dea4d42">617</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i5e2fd4010d1f4eceb5b59561d986587a_I20220331" decimals="-6" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY1NA_8532db42-49c1-43de-a71e-1e8cdcd59f02">55</ix:nonFraction>&#160;million or approximately <ix:nonFraction unitRef="number" contextRef="i5e2fd4010d1f4eceb5b59561d986587a_I20220331" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3Mg_d2b87e17-39a8-40b0-8a64-0eeffe38962b">10</ix:nonFraction>%.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June&#160;30, 2022.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity method investment until full recovery to its carrying value in the near-term.  In preparing our financial statements for the period ended June&#160;30, 2022, we evaluated these factors and determined that there was not sufficient evidence to conclude that the impairment was temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3OQ_4d6af68a-b7a3-403c-9942-e9561584554e"><ix:nonFraction unitRef="usd" contextRef="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3OQ_bc2a455b-d75d-4f42-845a-cbd4fa79f575">107</ix:nonFraction></ix:nonFraction> million for the six and three months ended June&#160;30, 2022, which was recorded to (income) losses from equity investments in our condensed consolidated statement of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#8217;s share price and the Canadian dollar (&#8220;CAD&#8221;) to U.S. dollar exchange rate at June&#160;30, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i6dc7f6b5d8164bf9835223a1c8ad3e7c"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and the carrying value of our equity method investment in Cronos at June&#160;30, 2022.  At June&#160;30, 2022, prior to recording the impairment charge, the fair value of our equity method investment in Cronos was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk1NTQ_506a0f25-c6f6-4f3f-ae6a-b2105f89b472">20</ix:nonFraction>%.  After recording the impairment charge, the fair value and carrying value of our equity method investment in Cronos at June&#160;30, 2022 were both $<ix:nonFraction unitRef="usd" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY5NA_636c3459-7dc8-4dee-af8c-75ce6165f07d"><ix:nonFraction unitRef="usd" contextRef="if488a491d85b439783705940ff379d59_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY5NA_c33db982-140a-4f62-a67a-62e9d99b2427">437</ix:nonFraction></ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Investment in Cronos, at June&#160;30, 2022, we also owned:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i8022e2eba341430684992380ece3f792_I20220630" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTIzMQ_2c8aa7a4-a1cb-4b70-8712-08f59eef614c">16.25</ix:nonFraction> upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on our assumptions as of June&#160;30, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately <ix:nonFraction unitRef="shares" contextRef="i8022e2eba341430684992380ece3f792_I20220630" decimals="-3" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTQ0Nw_67d2e3a0-65d8-47f2-8202-98d9dabe5958">11</ix:nonFraction> million common shares of Cronos; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing us the ability to purchase an additional approximate <ix:nonFraction unitRef="number" contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630" decimals="1" name="mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTU1Mg_647f5a1a-f948-410c-8b39-b0ff3be1006b">10</ix:nonFraction>% of common shares of Cronos (approximately <ix:nonFraction unitRef="shares" contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTU5Nw_4f480901-695a-4a9a-9aec-e21788fe8032">84</ix:nonFraction> million common shares at June&#160;30, 2022) at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTY1OA_b99d1eba-eadc-4ae3-af37-3825fd09b846">19.00</ix:nonFraction>, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $<ix:nonFraction unitRef="cad" contextRef="icd81d8232428439e8af3fc2c52b75b21_D20220101-20220630" decimals="-8" name="mo:EquityMethodInvestmentAggregateExercisePrice" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTgwOQ_2a52bd4d-d30d-447a-afd3-271b993a700b">1.6</ix:nonFraction> billion and CAD $<ix:nonFraction unitRef="cad" contextRef="ic7724f34336b4837a6779170d66ce1e5_D20220101-20220630" decimals="-8" name="mo:EquityMethodInvestmentAggregateExercisePrice" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTgyMA_2ace92d5-ffa8-4554-9ddf-ee2786b83326">0.2</ix:nonFraction> billion, respectively (approximately U.S. dollar $<ix:nonFraction unitRef="usd" contextRef="i4a65e4417b704c50af9108de96b6b9b3_D20220725-20220725" decimals="-8" name="mo:EquityMethodInvestmentAggregateExercisePrice" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTg2NA_72354826-e6ee-49a0-9366-ce0412f052c0">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5be1411a627b4cb2955ad80477a30400_D20220725-20220725" decimals="-8" name="mo:EquityMethodInvestmentAggregateExercisePrice" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTg3MQ_44b4f7cb-a39b-4311-a7a4-086644c8ceb1">0.1</ix:nonFraction> billion, respectively, based on the CAD to U.S. dollar exchange rate on July 25, 2022).  At June&#160;30, 2022, upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, we would own approximately <ix:nonFraction unitRef="number" contextRef="id53917fedb1842eab0669c6ca15b2879_D20220101-20220630" decimals="2" name="mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjEwOA_225d2c84-9997-4a28-84de-226a9e6f1e6e">52</ix:nonFraction>% of the outstanding common shares of Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibb4bc36d7b2241559f204972763244ef" continuedAt="ied8995ba16fe48a1b5237de86f5b477a">The Fixed-price Preemptive Rights and Cronos warrant are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy).  We elect to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on our condensed consolidated balance sheets in investments in equity securities.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied8995ba16fe48a1b5237de86f5b477a">We record in our condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occu</ix:continuation>r.</span></div><ix:continuation id="i97abb497306849beaf6ccb4eca63cd21"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded non-cash, pre-tax unrealized (gains) losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6bcff8fcbbc4e029d7f839b563920a1_D20220101-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi0xLTEtMS0xMjkxMDk_78b86630-9742-4be9-99d2-435561c6184a">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie77e3add79c947548aa389bbcf1bc640_D20210101-20210630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi0zLTEtMS0xMjkxMDk_02ef07d8-6749-43a5-9c3c-cb01bfc177bf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0cc7b4fc994f51b95e2edb4d99dce0_D20220401-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi01LTEtMS0xMjkxMDk_38597835-f5b5-43a2-97bd-087ca779a5e8">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7ee7b42337247669b6c69451925af0c_D20210401-20210630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi03LTEtMS0xMjkxMDk_a65534f8-26a0-4f7c-a7e9-357993cabb34">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ce0fd62aa842c6addcbbd8362247ca_D20220101-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy0xLTEtMS0xMjkxMDk_ee5eb239-8d7c-4858-b599-1a439f003b7d">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23e04bbbcf2b4dddba8b27254730fe6a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy0zLTEtMS0xMjkxMDk_2b0d1c37-63f7-496c-9c69-472108f6dfde">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bbdf8e5b22441f4b146cdf0423fa04e_D20220401-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy01LTEtMS0xMjkxMDk_c5b3e501-004e-4aae-9ce3-d54b3ad18cea">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d389b0b33184827ac627cf3211504bb_D20210401-20210630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy03LTEtMS0xMjkxMDk_dac3912e-9d29-4341-ba8a-0e1e6bc283a0">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC0xLTEtMS0xMjkxMDk_f352b7b9-31b8-4e81-8588-4a9d1d9153c0">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC0zLTEtMS0xMjkxMDk_75a07cda-c5b5-4059-96df-3c60dbd191f0">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC01LTEtMS0xMzU4Mzc_0e3f8a96-de14-4558-8357-80e804623916">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC03LTEtMS0xMzU4NTA_d6369bb0-4079-42f2-8c7c-6476d2296f91">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_67"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjg0MQ_1805a55f-dd22-415d-8528-c5ca5f205212" continuedAt="ic78fec5c3c924b07a107b324395abd09" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="ic78fec5c3c924b07a107b324395abd09" continuedAt="i8b1787d50b414a878f4b430270ade839"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of our investment in ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured and, at June&#160;30, 2022 and December&#160;31, 2021, we had no outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i8b1787d50b414a878f4b430270ade839"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjgzNg_08c631b7-998b-4e54-861e-84268e627fe5" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of our total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMS0xLTEtMS0xMjkxMDk_efe2de83-0788-4ddb-8063-81f210feafa9">27,680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMS0zLTEtMS0xMjkxMDk_e9f1039e-0d95-4831-8e8c-b385d7c2ff05">28,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMi0xLTEtMS0xMjkxMDk_336605fa-c1a0-4402-9f21-d549dad07d29">23,956</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMi0zLTEtMS0xMjkxMDk_89b7ea3b-7ab0-488e-9b35-93748e817011">30,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt above:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNC0xLTEtMS0xMzQwMzE_84c50e26-7996-4feb-b98f-5e9d79b00ed4">4,444</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6624310334664ad8b05bff9a8f611a26_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNC0zLTEtMS0xMzQwMjU_5873d175-b101-4d81-b555-38f6a26ade77">4,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNS0xLTEtMS0xMzQwNDc_8b712013-f115-414a-b46c-91809c2f39e4">4,150</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6624310334664ad8b05bff9a8f611a26_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNS0zLTEtMS0xMzQwMjg_edc1e333-c96e-4d01-8cae-6563342a7740">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the carrying value of our long-term debt was primarily driven by changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during the first six months of 2022.  The decrease in the fair value of our long-term debt was primarily driven by increases in interest rates.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjgzOA_eb7d91cd-35bb-426f-b5cd-8d0b83935762" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0yLTEtMS0xMjkxMDk_4846ab8e-57fd-421c-b3a4-81259687436f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy00LTEtMS0xMjkxMDk_174b00f5-aecd-46cb-aad5-528968f5246a">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy02LTEtMS0xMjkxMDk_640852e9-1f38-4bf3-ad9b-2c49b08b4fe5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy04LTEtMS0xMjkxMDk_154f6313-9b55-4d83-b8f2-5599cfe421cd">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daf1435da144756965535f298d285e2_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xMC0xLTEtMTI5MTA5_8e00abab-68af-4ffc-84d4-717950be9ad3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xMi0xLTEtMTI5MTA5_f3de4623-2ab5-48e9-b276-ca3421e8f190">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5daf1435da144756965535f298d285e2_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xNC0xLTEtMTI5MTA5_a7f2dddb-a567-4643-8b6d-461f68c8577a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xNi0xLTEtMTI5MTA5_6bf724b9-ac50-4748-bcc1-be76691b4e66">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0yLTEtMS0xMjkxMDk_d79ce4bb-4efb-4974-8c6a-8b66054e8990">375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC00LTEtMS0xMjkxMDk_f7be5fde-0f9a-4f39-947d-57f9235cfee3">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC02LTEtMS0xMjkxMDk_3d96a74a-4573-4b43-a06e-c12697a25e06">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC04LTEtMS0xMjkxMDk_d685f4e4-c46b-45f3-85fc-4716f93fa090">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xMC0xLTEtMTI5MTA5_4d03c9c5-3c66-4bfd-911b-375e0ae32145">247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xMi0xLTEtMTI5MTA5_1d6c6345-e689-4b95-a9c8-3b5993b0dae7">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xNC0xLTEtMTI5MTA5_f5718f87-989f-4c64-bf26-a00f36bfe369">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xNi0xLTEtMTI5MTA5_d7818027-e189-4c44-9837-f40499ddf075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0yLTEtMS0xMjkxMDk_8f8de403-942d-48cc-96bc-9045049de2af">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS00LTEtMS0xMjkxMDk_5c9b917a-7fa8-496d-a584-7b9bd6b2bf00">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS02LTEtMS0xMjkxMDk_1f93e08e-5567-4c63-adf8-1f140047a008">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS04LTEtMS0xMjkxMDk_cd02507f-0a90-4f65-8a3f-96a531b5126d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xMC0xLTEtMTI5MTA5_62a2d7ee-9952-4b3f-ac63-7c415d6e7833">247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xMi0xLTEtMTI5MTA5_e5c02cca-1497-4fde-b162-be24ff070d19">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xNC0xLTEtMTI5MTA5_c94a5a14-d029-488a-8342-659772c54e67">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xNi0xLTEtMTI5MTA5_232f2d13-8bda-4827-b43a-7e8c50c2c630">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfNDk0NzgwMjMyODA5NQ_7173824b-94c4-46ef-b570-c9a6f67af1ff" escape="true">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our condensed consolidated statements of earnings based on an amortization approach.</ix:nonNumeric></span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_73"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfMTAxNg_f4e5cc7e-9de0-43f5-9caa-21d9e2a256d5" continuedAt="i8ca71480da514d789417917a353c0822" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i8ca71480da514d789417917a353c0822" continuedAt="idbfbdf7c238e4fd49b05041a75927895"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfMTAxMw_2859ace5-4eaf-4fd0-b505-38342ec9c73c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xLTEtMS0xMjkxMDk_66f6177c-3f5a-4e25-85cf-34d267fbe64f">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0zLTEtMS0xMjkxMDk_166beba8-ddb1-41fa-bfe6-df1a0d947d2a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy01LTEtMS0xMjkxMDk_4cf9b706-f092-4a78-8e8f-b6c4b652637f">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy03LTEtMS0xMjkxMDk_adc36226-7526-4883-9aa1-a0842293c328">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy05LTEtMS0xMzExMjA_8927bd29-9e72-4095-b5b9-c973724a1390">17</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xMS0xLTEtMTMxMTA2_a7a8b0f3-dbf6-4dbe-8fcf-9084914ba91c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xMy0xLTEtMTMxMTU1_bec11a59-20d7-4b7e-9409-fde6e834c33f">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xNS0xLTEtMTMxMTY5_481b4213-367e-40ac-91a4-5588626e2851">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xLTEtMS0xMjkxMDk_df1cd856-b3eb-4d67-895a-76810de86150">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0zLTEtMS0xMjkxMDk_8c6289b0-e337-4ac0-8f28-191b0263f8a4">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC01LTEtMS0xMjkxMDk_04a2e4b4-efa8-4389-9cf7-3191644dffd3">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC03LTEtMS0xMjkxMDk_5b1ce26d-f63d-4634-b79c-52051b16f472">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC05LTEtMS0xMzExMjA_c66923e5-239f-40cc-824b-605dc294d4dc">52</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xMS0xLTEtMTMxMTA2_83b4018c-2e73-40d9-94d9-004cf7723597">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xMy0xLTEtMTMxMTU1_e136deee-31dd-43cc-b790-dc793a8b4ca1">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xNS0xLTEtMTMxMTY5_c49874e4-9467-4f79-8ac3-e89645d19036">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xLTEtMS0xMjkxMDk_f40725a7-d289-42b3-bdd8-b0fdeb3f732d">247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0zLTEtMS0xMjkxMDk_3e5aaa44-1a7a-48ec-83c3-cf805805879f">262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS01LTEtMS0xMjkxMDk_da0539d7-e9cd-4325-94fc-038a7c8268b4">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS03LTEtMS0xMjkxMDk_2fc5f069-9978-48e9-8e20-a4b62b82de0f">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS05LTEtMS0xMzExMjA_9cbb1009-00eb-4fa6-b446-c97d5b5522e3">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xMS0xLTEtMTMxMTA2_1a362bd3-c984-43d3-b8f8-3764fd145742">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xMy0xLTEtMTMxMTU1_d7663412-5cb8-418d-aae6-86b24f273af0">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xNS0xLTEtMTMxMTY5_3955dfc7-23cd-4980-a17b-eb154716fc77">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xLTEtMS0xMjkxMDk_020aee24-aaab-4d54-852e-b5e883387023">48</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0zLTEtMS0xMjkxMDk_0d2a44cb-69f5-4441-8c12-eefbe601e9d1">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy01LTEtMS0xMjkxMDk_e371d1af-3500-4082-b5e0-11c8e0ddca1e">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy03LTEtMS0xMjkxMDk_dc8bb513-ceea-415f-a5fe-5c5075347def">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy05LTEtMS0xMzExMzU_b03e3fd3-58a8-4c67-9bc0-2e6b4c06093a">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xMS0xLTEtMTMxMTEz_2e83ccea-8c64-477f-89a8-5924f5eb74d5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xMy0xLTEtMTMxMTYy_4c1298c1-3942-423c-bcde-50a3f7b0975d">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xNS0xLTEtMTMxMTc4_2f9bdc0f-69db-4f3f-add5-6c78fb66c450">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xLTEtMS0xMjkxMDk_ef5e0f46-b60a-4cbe-b4ae-598c713371bd">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0zLTEtMS0xMjkxMDk_9dde1d46-83eb-46f0-b23f-c08b24e1dcfa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC01LTEtMS0xMjkxMDk_4f98a4f5-311c-4f8e-af01-cdaddfaa45d3">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC03LTEtMS0xMjkxMDk_3f8bb7bd-0acc-452e-b48e-acca13432e57">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC05LTEtMS0xMzExMzU_4b1c25df-1465-44ea-93fb-ef1ab2ee66d8">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xMS0xLTEtMTMxMTEz_ed0129a7-bb38-4ec2-bae4-c56fa4139f6d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xMy0xLTEtMTMxMTYy_9df72546-ae1d-47de-88ac-b820917f5cc1">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xNS0xLTEtMTMxMTc4_ef3737d9-0809-4e37-b60f-8f73df215f81">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMS0xLTEtMTI5MTA5_5ac0c400-7930-4eef-ab5c-46a4e6a4acc0">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMy0xLTEtMTI5MTA5_ad5928fb-3c61-49e2-97db-e8d59b324c14">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtNS0xLTEtMTI5MTA5_e2ce5f75-3ade-4ff3-b12e-db82a0e6819a">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtNy0xLTEtMTI5MTA5_abc15039-a52e-4a49-9de2-4fa6f715c430">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtOS0xLTEtMTI5MTA5_6bb87320-c0cb-4eac-9886-0a9075daba40">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTEtMS0xLTEyOTEwOQ_8e24d6b6-7c13-4824-8c08-9223d224ca1f">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTMtMS0xLTEyOTEwOQ_e561dae4-ad5d-4f7d-a53a-51071cb1ea93">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTUtMS0xLTEyOTEwOQ_3dc231d9-908e-4e3a-ad60-f9782d15c7d1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="idbfbdf7c238e4fd49b05041a75927895"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make contributions to our pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  We made employer contributions of $<ix:nonFraction unitRef="usd" contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNDIy_3729cac5-484b-4dc2-8f5b-c13e9df5a0ff">8</ix:nonFraction> million to our pension plans and did <ix:nonFraction unitRef="usd" contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630" decimals="INF" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNDU0_ce905594-a7b1-48e4-bbc9-84b574dd2829">no</ix:nonFraction>t make any contributions to our postretirement plans during the six months ended June 30, 2022.  Currently, we anticipate making additional employer contributions of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i4535f30518454d34a9ae59f849dec461_I20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTg3NQ_6bdff4e9-a082-4861-a0b7-44655b8faf0d">25</ix:nonFraction> million to our pension plan and $<ix:nonFraction unitRef="usd" contextRef="i4efe104b447e4349b4028ad89097f7aa_I20220630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTk1OA_0a603446-9603-479b-b8a9-bd49115d8cf9">30</ix:nonFraction> million to our postretirement plans in 2022.  However, the foregoing estimates of 2022 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan amendments to our postretirement plans for the year ended December 31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $<ix:nonFraction unitRef="usd" contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTE4Mg_90f26a72-96cf-4099-8afc-c7b910c23f64">432</ix:nonFraction> million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_76"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RleHRyZWdpb246ZmZhMDM2MmEyMTI1NDBjNDg0MmUzOWY3YmExZDZmMjBfMTEw_98cef055-3750-4b78-ac7c-6ffac13d5368" continuedAt="i19068fa2f42e4172a1446ff2f8b5e864" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i19068fa2f42e4172a1446ff2f8b5e864"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RleHRyZWdpb246ZmZhMDM2MmEyMTI1NDBjNDg0MmUzOWY3YmExZDZmMjBfMTMw_8c9ad253-baa9-43b6-8b71-6acf5930cab9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi0yLTEtMS0xMjkxMDk_e809c68b-0d9b-4b06-b411-4692730f623f">2,850</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi00LTEtMS0xMjkxMDk_5ba08567-a9c7-4b59-973d-371ebddedf2c">3,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi02LTEtMS0xMzEwMjg_4014b8ae-dbb9-43cb-bc73-6e4a7570d226">891</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi04LTEtMS0xMzEwMjA_4f32e54a-91e1-4c8c-91a1-31b34e01f169">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy0yLTEtMS0xMjkxMDk_ab10907b-8525-4afa-923f-5f3dc7df667a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy00LTEtMS0xMjkxMDk_4fc82dbd-748a-4665-9971-77d63c672285">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy02LTEtMS0xMzEwMjg_28c063f0-0f60-4441-bc1d-264cbd6a7291">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy04LTEtMS0xMzEwMjA_a26bdba8-fba0-43fd-a82f-0d5e4162384c">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC0yLTEtMS0xMjkxMDk_6cb18ef9-097a-4977-9385-ab0b03d758cf"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC0yLTEtMS0xMjkxMDk_6dbe8825-8fd3-4c67-9ae3-dbfeb2305d0c">2,844</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC00LTEtMS0xMjkxMDk_3cd31bd7-f926-46cf-9aab-b06283c81afd"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC00LTEtMS0xMjkxMDk_af81933c-9d1e-4ed8-bb61-30aa444c28eb">3,567</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC02LTEtMS0xMjkxMDk_5fc3a25d-cec9-4666-a8ff-bb3d44a4afeb"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC02LTEtMS0xMjkxMDk_af443e1d-2522-4b70-b937-1b75069d9ee6">889</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC04LTEtMS0xMjkxMDk_e994b46d-90e2-4a43-9af1-17109bcb7567"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC04LTEtMS0xMjkxMDk_fcc05ea4-7892-46b5-9d56-7e10c0155714">2,146</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC0yLTEtMS0xMjkxMDk_05541967-ed32-4265-8610-57b1fe2c3a7e"><ix:nonFraction unitRef="shares" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC0yLTEtMS0xMjkxMDk_46a92b9d-cbfc-4426-9c48-01791c5a8363">1,813</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC00LTEtMS0xMjkxMDk_125b923e-ee02-423c-8330-bef09a0f2cf8"><ix:nonFraction unitRef="shares" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC00LTEtMS0xMjkxMDk_e2f31f91-a928-43d5-a84b-9d685dcacb34">1,853</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC02LTEtMS0xMzEwNDM_7c4cae34-51ad-4017-b971-2a16a3d3ad38"><ix:nonFraction unitRef="shares" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC02LTEtMS0xMzEwNDM_c2efb872-80ef-4a9f-b5f3-3f19c4238dfe">1,809</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC04LTEtMS0xMzEwMzE_4d860d8d-f8c1-4d01-869f-3763ab2cdb37"><ix:nonFraction unitRef="shares" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC04LTEtMS0xMzEwMzE_cbb99522-8ecf-4d1b-9ebb-7986bae1b5f6">1,849</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i8ab1f6ba80d642c6abc401018a1063a1_79"></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RleHRyZWdpb246ODdiMWE3ODFlNTU3NDc2OTkxNzIxOThmMDJlODdiZjlfNDI5_0efb38e5-d393-444b-a556-65d5d1fdb679" continuedAt="i1b73777a0d43419387db2ff88dcf46b2" escape="true">Other Comprehensive Earnings/Losses</ix:nonNumeric></span></div><ix:continuation id="i1b73777a0d43419387db2ff88dcf46b2" continuedAt="i7106e61949af4be1be3687bdcab722f4"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RleHRyZWdpb246ODdiMWE3ODFlNTU3NDc2OTkxNzIxOThmMDJlODdiZjlfNDE0_99e35399-39c5-47a9-b90f-6d6b64fd16af" continuedAt="i8b89743d4f3e4f4ab95def8958b6e62c" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b1baef738ae429aa8454cd5df509063_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi0yLTEtMS0xMjkxMDk_edff70d1-8307-435f-9611-1cc95e391970">1,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b1ed807a4fe4443a7762e06a922c55b_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi00LTEtMS0xMjkxMDk_6e116bde-a4e1-4143-bf36-2c1951bae669">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebc102806994715ad16146f4c465135_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi02LTEtMS0xMjkxMDk_25f05285-bce6-493a-8bb8-260939ac872d">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi04LTEtMS0xMjkxMDk_71e36b28-191d-45a0-965a-387f07d6c0ee">3,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC0yLTEtMS0xMjkxMDk_231dcafc-1495-47a5-94ec-e040b73a764b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC00LTEtMS0xMjkxMDk_9cd5285f-888c-4369-8b1d-fd6940cbd5cd">884</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC02LTEtMS0xMjkxMDk_3ec07156-5975-4c6c-81aa-81b5191a1cd0">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC04LTEtMS0xMjkxMDk_ab30179b-c9c9-49ed-9763-cc475e11aef0">889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS0yLTEtMS0xMjkxMDk_bc1706d8-959e-4e24-9268-19f2f54207c1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS00LTEtMS0xMjkxMDk_78126e89-4866-4cd4-b7f5-088310e2d250">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS02LTEtMS0xMjkxMDk_d68c1853-fbd8-49fa-8ee9-4d728627ba1a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS04LTEtMS0xMjkxMDk_6e48e1f3-92b3-402c-a446-19ac382c525b">195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi0yLTEtMS0xMjkxMDk_f00fa9f2-5fb7-415b-bbd4-76facb011096">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi00LTEtMS0xMjkxMDk_059df55d-ea03-4dc1-8168-c65157182be9">689</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi02LTEtMS0xMjkxMDk_821043b6-5170-4900-8d3a-cb26bf32169a">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi04LTEtMS0xMjkxMDk_fbd6b137-322b-460b-8e55-88f061a4c7cf">694</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC0yLTEtMS0xMjkxMDk_aa504d97-c6d0-4c84-83b0-2b74124d228a">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC00LTEtMS0xMjkxMDk_41acb34b-dd86-4321-a3e3-8eb336c1beea">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC02LTEtMS0xMjkxMDk_7ccf3436-b6c9-490b-bab0-f0717294c73d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC04LTEtMS0xMjkxMDk_e3765a8c-f661-4652-a158-f0cef3536c4b">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS0yLTEtMS0xMjkxMDk_fead3952-b97b-4f60-908d-6cecb0ee888f">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS00LTEtMS0xMjkxMDk_d73e2c38-498b-458c-9da6-14d1a2c044da">12</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS02LTEtMS0xMjkxMDk_4e8e4cf3-1476-4a3d-bfe5-ed67435a6d0e">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS04LTEtMS0xMjkxMDk_e79f47da-2d1a-467f-9c1b-c060036a31c8">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtMi0xLTEtMTI5MTA5_abfc6c36-5c0c-4fa4-b6fe-6919908d2547">31</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtNC0xLTEtMTI5MTA5_70cfbfdd-0c21-49c2-ab8b-693e9737b5b4">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtNi0xLTEtMTI5MTA5_72ea0feb-df40-4bbb-b071-c446160f0de9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtOC0xLTEtMTI5MTA5_4f558a54-f9d1-44cb-9cac-605290ee1b11">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItMi0xLTEtMTI5MTA5_b0006bdd-7f1f-4d42-9a47-da76c8351ab4">31</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItNC0xLTEtMTI5MTA5_f4dce6aa-7000-48d5-97a4-1ef38523f249">643</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItNi0xLTEtMTI5MTA5_6c10ede0-fde7-4f2b-8f76-0537884d7c44">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItOC0xLTEtMTI5MTA5_2fd48bdd-9bfb-409c-a1eb-e7266e4ebc05">679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee1450fe7da747d081507d7cea3a3f5a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtMi0xLTEtMTI5MTA5_7191d2d1-5387-4397-8717-afa81e9939e9">1,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtNC0xLTEtMTI5MTA5_477c325d-e012-4c98-ae70-4abf6af241be">869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566c0e2a3879453286eaf377b9a994cc_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtNi0xLTEtMTI5MTA5_0467e230-01f5-4a5c-b55c-bc9e39df72ce">73</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtOC0xLTEtMTI5MTA5_4a683ce1-5f39-4b14-b3aa-06b9b9072dd5">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_82"></div><div style="text-align:center"><ix:continuation id="i7106e61949af4be1be3687bdcab722f4" continuedAt="i90227b6d5dc14ba5b8fcf5b457d64db8"><ix:continuation id="i8b89743d4f3e4f4ab95def8958b6e62c" continuedAt="i16b895e6b629468dad8238e0bd022769"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6749d38ea74544afbe22946f715804b5_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi0yLTEtMS0xMjkxMDk_a988428c-4061-466a-94cb-6e7a372010a1">1,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie13b50de35bf49209e674bd75e9e2e9f_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi00LTEtMS0xMjkxMDk_e4458947-8605-4e1c-be8f-2836a79b4b87">1,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e9c5a285474dabbe7a8a197ec8c8a1_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi02LTEtMS0xMjkxMDk_fc97d450-427f-4bf9-8695-99b207c22ba1">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi04LTEtMS0xMjkxMDk_20bb3abd-5121-4687-8d95-1f8772cf3cbe">2,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC0yLTEtMS0xMjkxMDk_8f844411-d4b5-4ec0-b24e-65850b98e872">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC00LTEtMS0xMjkxMDk_59baf23c-ead1-44a3-96b8-1890796f8d0a">746</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC02LTEtMS0xMjkxMDk_1fce9dea-66fb-48a9-a358-1d46ccdb195c">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC04LTEtMS0xMjkxMDk_fd0687e3-8b8c-46d1-9880-4532246c7bf6">750</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS0yLTEtMS0xMjkxMDk_1f61bb00-7733-4627-808a-555fe9fd15e7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS00LTEtMS0xMjkxMDk_18394f3b-3d69-4efb-9563-e61aa813388d">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS02LTEtMS0xMjkxMDk_be63496e-1c1d-4daa-9b7d-ee94d1c87dbf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS04LTEtMS0xMjkxMDk_49ea9bd6-2e8b-4c42-b18c-c2a828afd1ed">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi0yLTEtMS0xMjkxMDk_f1c8a0bf-2606-4d95-ac3b-26b51d0d67d0">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi00LTEtMS0xMjkxMDk_32e400ab-cd0e-427a-ad52-b8e758ada8c4">583</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi02LTEtMS0xMjkxMDk_22781cd3-9bc6-49b4-bc48-7cc98e763dc9">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi04LTEtMS0xMjkxMDk_68e22a98-2e21-49b6-bc5a-885305db84c5">587</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC0yLTEtMS0xMjkxMDk_e64aed0e-c01f-40c0-a0d1-287049b3c37e">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC00LTEtMS0xMjkxMDk_63ec287d-0edd-4f57-80d6-65f75b8d06e8">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC02LTEtMS0xMjkxMDk_c8bc0bb6-c89f-4637-9cde-b1354887a00d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC04LTEtMS0xMjkxMDk_194eba94-96ca-472a-93ad-1fd36b5d1959">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS0yLTEtMS0xMjkxMDk_29842832-4849-457e-830a-dfc57d081c7f">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS00LTEtMS0xMjkxMDk_604648eb-cb23-45b5-a873-0bc8801f2bbd">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS02LTEtMS0xMjkxMDk_367e7613-63d1-4e0d-988c-23d10630bc8a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS04LTEtMS0xMjkxMDk_ea326dbc-8cf5-412b-a993-5dfc762b1051">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtMi0xLTEtMTI5MTA5_33151525-29cb-4f78-b339-35ceb05db44e">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtNC0xLTEtMTI5MTA5_89aebae3-458e-46df-9851-033df870363c">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtNi0xLTEtMTI5MTA5_4d7b763a-8dca-4b6a-8e96-2ca631eeb6ac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtOC0xLTEtMTI5MTA5_c7c74718-050f-4f85-9446-746140630cc0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItMi0xLTEtMTI5MTA5_6f97a428-2d4f-4590-a552-7ff09533908a">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItNC0xLTEtMTI5MTA5_6152cc5a-f828-49d2-8cd9-c8166b39715a">565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItNi0xLTEtMTI5MTA5_c5ec471f-739a-47b1-8284-c3401043775f">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItOC0xLTEtMTI5MTA5_fb84bd23-ba21-485c-9b5d-99fe41dff753">585</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee1450fe7da747d081507d7cea3a3f5a_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtMi0xLTEtMTI5MTA5_7c99ef32-3576-41c9-ad01-4a899e1a68fd">1,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtNC0xLTEtMTI5MTA5_2040d5a3-eafa-4740-9c65-7c4539453b4a">869</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566c0e2a3879453286eaf377b9a994cc_I20220630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtNi0xLTEtMTI5MTA5_3553b627-b0a1-4a94-bb20-c6cc42de2c56">73</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtOC0xLTEtMTI5MTA5_dcf6957a-8469-4691-a14f-f05c6b50b8c7">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_85"></div><div style="text-align:center"><ix:continuation id="i90227b6d5dc14ba5b8fcf5b457d64db8" continuedAt="i43df733574c44e0cab941d9997bc361f"><ix:continuation id="i16b895e6b629468dad8238e0bd022769" continuedAt="i6ce15e0bfc58434aa5e98f70bcf9985f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.939%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2971e561fd5144678760d3bf8b1861d2_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi0yLTEtMS0xMjkxMDk_2aca5b44-146c-4975-90be-afb029509336">2,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22f157089c764d978e4b4467c3bb28c6_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi00LTEtMS0xMjkxMDk_08d95986-921e-4dde-bb21-94d1a039e6b0">1,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i512cc5d83afb4aa79f389b6fc7d146d5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi02LTEtMS0xMjkxMDk_f2dfad1f-4904-4b28-8085-4327614eaa8f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43964e9db78c4442b2a6c1bae24600b8_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi04LTEtMS0xMjkxMDk_b0485fb7-63d5-4d63-94aa-4a3a963b1c6f">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC0yLTEtMS0xMjkxMDk_d9306d74-e3c4-4896-be60-dc2b085f2587">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC00LTEtMS0xMjkxMDk_45bf3ce5-a487-4147-98dc-d44e6e5745d0">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC02LTEtMS0xMjkxMDk_1544eaa9-befa-4051-bbde-4df07477410a">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC04LTEtMS0xMjkxMDk_2e43a5f0-aac1-48ee-b900-dfc61b04ecb6">931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS0yLTEtMS0xMjkxMDk_3a6d21e1-9910-4674-900b-f215d356b905">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS00LTEtMS0xMjkxMDk_de7dae4e-780e-4a31-9df6-916a182fd218">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS02LTEtMS0xMjkxMDk_adc3ec8e-1648-4d00-a26a-8393a4e12a6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS04LTEtMS0xMjkxMDk_a0a61e32-4f66-47a6-a1a5-7ad2322bae7f">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi0yLTEtMS0xMjkxMDk_e3b9a5fa-db6c-42e6-8261-b9a5dfbf9f2f">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi00LTEtMS0xMjkxMDk_effe297f-b9ea-45e0-a460-326cbadbb443">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi02LTEtMS0xMjkxMDk_14a5ab4a-90c8-4b1b-b87e-4bc9b8821f89">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi04LTEtMS0xMjkxMDk_2c8aa587-ba98-4dd8-8009-e2dbdb029065">719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC0yLTEtMS0xMjkxMDk_8553cf7f-b563-46cb-b6ca-44b531f14e5c">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC00LTEtMS0xMjkxMDk_295225e7-f309-4743-9b80-1b4e5b74db31">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC02LTEtMS0xMjkxMDk_9089ad6f-4770-45db-b3df-b4ad193f5e08">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC04LTEtMS0xMjkxMDk_7ad49184-1e74-46b9-b8cc-63ab0739446c">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS0yLTEtMS0xMjkxMDk_a83a331c-f5aa-47bf-87c8-0b6c5cccca96">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS00LTEtMS0xMjkxMDk_980699cb-6d91-4c6a-b7c8-db6a7028556d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS02LTEtMS0xMjkxMDk_46f2668d-660f-41c8-b2ea-b24bb185454e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS04LTEtMS0xMjkxMDk_2d42dfb2-ee77-4a4d-ab8e-482cce76b905">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtMi0xLTEtMTI5MTA5_a8e5b4a6-da74-4b24-af26-06697e03ef37">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtNC0xLTEtMTI5MTA5_a6b4ffda-585f-4fd3-b730-f6404d3889a5">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtNi0xLTEtMTI5MTA5_d6f2ceba-98e3-40b7-ae60-1c76b23613b0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtOC0xLTEtMTI5MTA5_16dd9862-1fb9-4e75-8bb7-a32901165431">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItMi0xLTEtMTI5MTA5_767a78d9-bb3b-4aea-b257-cbf18fc5f682">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItNC0xLTEtMTI5MTA5_135fd01f-82b6-4dbb-b12e-95027d6e9355">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItNi0xLTEtMTI5MTA5_a4a9172f-70cb-40f2-bd37-958142845a3b">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItOC0xLTEtMTI5MTA5_e7dc952c-dea9-41f5-b7ee-8ceb79d9ead4">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd280e0972524a94a5802c10e628c014_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtMi0xLTEtMTI5MTA5_c385d334-8b34-4920-9f31-cd5e8b59a133">2,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ef05e22327463983a5721739547724_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtNC0xLTEtMTI5MTA5_e1ed6a09-c10f-43f9-9710-bb343cfbad7a">1,604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtNi0xLTEtMTI5MTA5_7bf2e011-1fb6-47f2-ba5f-f1aa33f2dfdd">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtOC0xLTEtMTI5MTA5_1499912b-5d85-4d7a-aefb-0f83a9cdf20e">3,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i43df733574c44e0cab941d9997bc361f" continuedAt="i6eebecd98d514e26a04ff4d3958a0a95"><ix:continuation id="i6ce15e0bfc58434aa5e98f70bcf9985f"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93682eae4e1b4cba8a7db027c701e88b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi0yLTEtMS0xMjkxMDk_646f9f65-efca-4faa-8654-9a51c799d631">2,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42bddaa56c404c9383c99f3a0b6c9eab_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi00LTEtMS0xMjkxMDk_fab92e0c-4cd3-48a5-9a2a-46f2a92df155">1,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ce748f70124616bdcdd3de3090c9e4_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi02LTEtMS0xMjkxMDk_171067cf-b261-40f6-9b60-9e4ad525f17a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9788f29297284a1d88ff1e6c6548cad3_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi04LTEtMS0xMjkxMDk_b99a8634-bbe9-42cb-8ae5-2ceef3c18a3c">3,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC0yLTEtMS0xMjkxMDk_b27d8f8a-d43d-41eb-914d-27a69f45c969">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC00LTEtMS0xMjkxMDk_6c3d5832-5f94-4529-b75f-0efd2e920e43">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC02LTEtMS0xMjkxMDk_8d9537f8-1985-49a2-b5a8-7c9d05122d7f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC04LTEtMS0xMjkxMDk_50fe6a24-e526-4a8d-9a1c-96eb60e332e8">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS0yLTEtMS0xMjkxMDk_18a75051-aa52-4015-8c3c-2e101980cfd3">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS00LTEtMS0xMjkxMDk_51ab6b49-14c0-4a80-afdf-3b1c21b5c4e9">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS02LTEtMS0xMjkxMDk_6d9ec10b-afc0-4ece-a9ad-33710d38ca58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS04LTEtMS0xMjkxMDk_ce56dde4-2ce8-4c3c-9754-6838319e90af">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi0yLTEtMS0xMjkxMDk_02aa1ff9-26a0-4c41-af56-2e2501027a78">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi00LTEtMS0xMjkxMDk_519f8f15-f22c-42c9-b6c8-e5f5f89bbe16">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi02LTEtMS0xMjkxMDk_b649ebbe-e8cb-4aa0-b98d-52985f0b47e3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi04LTEtMS0xMjkxMDk_a657a0dc-72b3-44b0-aa8b-9910ac82509e">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC0yLTEtMS0xMjkxMDk_d940f5a6-4990-407a-9e2b-bb81faa35df8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC00LTEtMS0xMjkxMDk_75c0f977-42c9-4555-a027-2ff8c4ce1139">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC02LTEtMS0xMjkxMDk_6c9688f6-531c-4171-a2ed-b29d38c108dc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC04LTEtMS0xMjkxMDk_1d1d001e-8106-444e-8572-47aa74044964">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS0yLTEtMS0xMjkxMDk_e194f004-29d0-49f3-8613-dd0a46f8c867">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS00LTEtMS0xMjkxMDk_6dbd5d78-29d5-4ae2-b98d-0025b1d23b90">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS02LTEtMS0xMjkxMDk_2cbbcd26-6cf0-4331-b4c2-f0d992b9b671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS04LTEtMS0xMjkxMDk_ca48ade5-1409-41dc-b08d-03500ca5554e">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtMi0xLTEtMTI5MTA5_71c0936c-271e-4b95-8189-d1e92dd58a67">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtNC0xLTEtMTI5MTA5_50c3a290-8540-46a8-ba58-e5b21082e902">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtNi0xLTEtMTI5MTA5_41518cd1-8bcf-4bfb-bb44-c64d6c0a29e6">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtOC0xLTEtMTI5MTA5_98ea53ab-bf74-4e4d-8239-3e5ebbfb0880">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItMi0xLTEtMTI5MTA5_cf224ce9-7473-4c6f-86e0-7e71ffe662d9">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItNC0xLTEtMTI5MTA5_3115d69b-f017-4056-aac1-63ec9f0bfb03">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItNi0xLTEtMTI5MTA5_3beb7376-d6d3-425f-8c0b-b31fd59955bc">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItOC0xLTEtMTI5MTA5_3b3f8ddd-8db1-4bee-80b7-8257693302b0">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd280e0972524a94a5802c10e628c014_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtMi0xLTEtMTI5MTA5_3c19cc4c-bab5-40e2-a347-612627a2a15a">2,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1ef05e22327463983a5721739547724_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtNC0xLTEtMTI5MTA5_41c0b69b-c5d8-41d5-8119-c90dcc51f25a">1,604</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtNi0xLTEtMTI5MTA5_64e866ea-8c5a-409b-9964-4dca9654ae96">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtOC0xLTEtMTI5MTA5_245aaae0-59d1-4e34-b389-8a6015b7344d">3,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our investment in ABI.  For further discussion of designated net investment hedges, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div></ix:continuation></ix:continuation><div id="i8ab1f6ba80d642c6abc401018a1063a1_91"></div><ix:continuation id="i6eebecd98d514e26a04ff4d3958a0a95"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RleHRyZWdpb246ZTA0MjExM2IyYzEzNDc4ZjhhYTk4Y2EzNzYzZDdlYzBfNDAx_0dce4e0e-cbcc-488f-8f35-b10cbe48555b" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fde125fe824d80b32071a2130ef0fe_D20220101-20220630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy0yLTEtMS0xMjkxMDk_ce0d7065-1f46-479f-a386-c17e458a8a43">61</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6d19ffeee64ff1b5584b7c5aabb4bd_D20210101-20210630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy00LTEtMS0xMjkxMDk_10aca4ba-9690-4f20-9035-4588775fd7d9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b25cddbc4ed4d17a6a79d919abc4d22_D20220401-20220630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy02LTEtMS0xMzI4NDc_fe20c8aa-c4fb-4d56-87a6-5fe4778ef99a">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4810d1ceab46dfb83be9f80e3e4aab_D20210401-20210630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy04LTEtMS0xMzI1NjM_f7678d61-fd54-4ca5-9c95-8bbb81fa7f18">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51fed6551e784a959a8fd96ee3dd8391_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC0yLTEtMS0xMjkxMDk_6034da20-79a4-4d42-953a-a6ff0c1009c9">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de3b3f3b48d41c4ad4828796b656496_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC00LTEtMS0xMjkxMDk_660470d3-7cde-4bd9-9f46-dd4360f4dbee">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2725c640d5cc48fb9a0ce5d1941b72e6_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC02LTEtMS0xMzI4NDk_854f30a5-f42a-48ef-9735-c01445cd0996">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icef447b72ac047088d37bbe5edc817f9_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC04LTEtMS0xMzI1NjM_1011c071-eeed-4512-8b49-85fc92bbb303">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice90d1e8bfe848d8b5e0d085479ebb80_D20220101-20220630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS0yLTEtMS0xMjkxMDk_6462da0d-9493-4b5f-af05-882535498dff">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i806001e09fa14faaae11598091f1f498_D20210101-20210630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS00LTEtMS0xMjkxMDk_4543b3ea-c482-46be-a3b5-e9a668e05ce7">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55511d6e0eb14ca08f381602cf9690cd_D20220401-20220630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS02LTEtMS0xMjkxMDk_b9e5526c-a896-4e8c-a117-9697ea666503">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66543092e0e046ca8c1b86aca084bfe7_D20210401-20210630" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS04LTEtMS0xMjkxMDk_5a86b993-e60d-43e1-988f-dca1f871f98f">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib96273d2e0d845948f345d07e913c368_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi0yLTEtMS0xMjkxMDk_03ca648d-c736-47d1-a0e3-6e0a6fde450b">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8779bb1a61dd4789bc38ae36caf3dafe_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi00LTEtMS0xMjkxMDk_d22ff1b8-af23-4b06-9d71-093e42b6acd1">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4009a312b9e9481c9ed1f1d8e29d8f11_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi02LTEtMS0xMzI4NTM_5167ca1d-0860-4e74-9b37-14452a4c4d8c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2b530e082794b12975168c91979ce08_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi04LTEtMS0xMzI1NjY_9a56654b-5c11-4657-a4c8-bb399d52241b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i429b6c1211f54752a9fbc0980c7003cc_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy0yLTEtMS0xMjkxMDk_87a40793-9886-43df-b309-fe08bc67ebdc">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9b9f4a38e840c984bc661555d3412d_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy00LTEtMS0xMjkxMDk_2c71ff7a-384a-4e48-bacf-47b8f5444953">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b6d5238a8934a91b23047ee5dc570e6_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy02LTEtMS0xMjkxMDk_86177a2e-7784-4ca6-be5c-0c980b47ea76">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d2ec74dc3743e885b697dfef6ecf65_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy04LTEtMS0xMzI1NzQ_c701faa8-6682-4322-a6a5-af4032501722">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e01747e65a4c47874b561f5f5591d9_D20220101-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC0yLTEtMS0xMjkxMDk_c3ff0ff6-0617-48d2-9ab5-f63106fa4204">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9467a64aae949aa85d911d37de5f523_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC00LTEtMS0xMjkxMDk_6faa218a-71e2-4177-8839-ef2aa2b7a4b4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic32394b7c33e4adaa729d30f5b7f8492_D20220401-20220630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC02LTEtMS0xMjkxMDk_5c5819ca-bc9a-4694-b473-cbcef77f87d4">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife875847779a4eb0971d8c1bba755f05_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC04LTEtMS0xMjkxMDk_6c453547-5721-4844-b10f-407241af0bec">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further details, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_94"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjkxOA_0cb0a772-3c74-490f-8de3-80ed3e2e5031" continuedAt="i46a1b25ec6c04805b13cd5600e3b1239" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="i46a1b25ec6c04805b13cd5600e3b1239" continuedAt="i255fb74b35d840da8d5cdf4b58ac27b6"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constitute our reportable segments of smokeable products and oral tobacco products at June&#160;30, 2022.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker (&#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i255fb74b35d840da8d5cdf4b58ac27b6" continuedAt="i435174d92d114cfabd1d1d0eb7e99fcf"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjkwOA_1712d3e2-a15c-4345-811b-0891a3267979" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy0yLTEtMS0xMjkxMDk_d87c716e-0031-4f85-9d19-c3f05bec9392">11,138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy00LTEtMS0xMjkxMDk_a03d22f9-6c92-4412-8831-62e8561ea6fa">11,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy02LTEtMS0xMzM0NDQ_f4656f73-ab72-400a-8c39-15e13adabf32">5,873</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54b43a0052a4188ada7399179966cb3_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy04LTEtMS0xMzM0NDQ_89283c30-a5fe-457d-b42f-ef388645907f">6,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87386dcee92742288df164bf8606efee_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC0yLTEtMS0xMjkxMDk_84d13989-6838-4831-ae31-88af7afd68a4">1,278</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC00LTEtMS0xMjkxMDk_e581c3c0-0b7b-4751-94b2-91547b664e5c">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3820406df4495e896788d13764aafd_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC02LTEtMS0xMzM0NTA_c1cd6138-61cd-4fe6-87e3-f1d4d1363da8">665</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f07419638445eab9c375777cf6a504_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC04LTEtMS0xMzM0NTA_ef944956-4336-4f19-b183-3aea676ee173">693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS0yLTEtMS0xMjkxMDk_ce2d6ddd-7b51-4aac-946e-23d649b65359">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide49c713466f480384f5feb6704320bf_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS00LTEtMS0xMjkxMDk_5cac7ab2-a4c2-4cef-a875-14f5fc55fbdf">317</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS02LTEtMS0xMzM0NTY_7ed84fdb-e190-428d-97ee-b11e2bcb7280">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS04LTEtMS0xMzM0NTY_133ddb28-bf17-49b9-8b76-38941f58d02c">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi0yLTEtMS0xMjkxMDk_413a4022-f655-4790-b41b-1c382fd9def5">19</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi00LTEtMS0xMjkxMDk_d0b23348-8c49-4adf-b3fd-ac6c216f7243">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi02LTEtMS0xMzM0Njc_c39ad909-75b7-4887-80b9-a08f4f4aad97">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi04LTEtMS0xMzM0NjM_fc9ed766-8718-4dcb-99f9-2187822d615f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy0yLTEtMS0xMjkxMDk_af0f1cf4-11ab-454e-bb3a-85dcd8ebcc09">12,435</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy00LTEtMS0xMjkxMDk_8643b4bc-498c-4a55-8a61-09d054b2054d">12,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy02LTEtMS0xMjkxMDk_28c554f7-3e9c-4a14-bec5-df1d44dba386">6,543</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy04LTEtMS0xMjkxMDk_3897c0e2-baaa-43c1-bb25-2097e6c67460">6,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtMi0xLTEtMTI5MTA5_535740f8-ed9f-4a1e-8ba2-31fc5e6d46f5">5,321</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtNC0xLTEtMTI5MTA5_e4cc5f0a-de9f-4187-8a49-16e8a28a3ceb">5,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtNi0xLTEtMTMzNDQ3_3c63523d-5ad5-49fb-ae4b-fef5ad28adfe">2,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54b43a0052a4188ada7399179966cb3_D20210401-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtOC0xLTEtMTMzNDQ3_802ac820-7d08-455d-b342-588a6f361b0b">2,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87386dcee92742288df164bf8606efee_D20220101-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtMi0xLTEtMTI5MTA5_9d7e9060-0db5-465b-af5e-c36cc1d3eb8e">837</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtNC0xLTEtMTI5MTA5_42391841-e366-42a4-8ab7-58fea23abec6">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3820406df4495e896788d13764aafd_D20220401-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtNi0xLTEtMTMzNDUz_bc8dadf0-9a9a-4ed1-9458-90dffb5f735f">430</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9f07419638445eab9c375777cf6a504_D20210401-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtOC0xLTEtMTMzNDUz_b2d940d3-85de-4ec7-be16-c4d835391d98">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItMi0xLTEtMTI5MTA5_248af0b6-72af-4a78-ad16-c51010b933b6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide49c713466f480384f5feb6704320bf_D20210101-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItNC0xLTEtMTI5MTA5_28fe0759-9087-4238-8a51-dd8a960d0ade">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItNi0xLTEtMTMzNDU5_16dd6b17-7ad3-4bb5-8987-375280c406e9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630" decimals="-6" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItOC0xLTEtMTMzNDU5_c7b18017-c0a8-47c4-bf6e-61fc5361516d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtMi0xLTEtMTI5MTA5_2d4d6fa4-ac74-45a3-94c1-734ce4221350">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtNC0xLTEtMTI5MTA5_6bb5fe0e-5a55-4f51-aab9-cd685c16dc0f">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtNi0xLTEtMTMzNDc1_89872a75-1be4-41f6-af9e-5b159d10c906">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630" decimals="-6" sign="-" name="mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtOC0xLTEtMTMzNDcy_36186a45-6a6f-49b4-8d43-b2ecbddde120">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6597a9719154f9bbebe60e2abbfae97_D20220101-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtMi0xLTEtMTI5MTA5_173192ad-2a76-4cf1-bf47-197a036f769e">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia10ee74830654452a7f2606b4d8c93b7_D20210101-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtNC0xLTEtMTI5MTA5_a6f5dda7-2107-4c86-bbd2-a0277b9e1949">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78c606bc0ba64901873c5992d4eff20d_D20220401-20220630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtNi0xLTEtMTMzNDkw_0fb8a5e6-741d-43d1-85f0-084c739db4bc">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfc2a0eede234b6486bae3fec8149242_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtOC0xLTEtMTMzNDgy_47527d96-5a13-4cc0-9cd2-1668aa01caf5">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8be97c192668455c8b81cd42aa504ee4_D20220101-20220630" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtMi0xLTEtMTI5MTA5_3e5c0a11-33ac-4807-97e8-6c807d4393b4">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93ba44bf6fce4bd5974e74d3b133117d_D20210101-20210630" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtNC0xLTEtMTI5MTA5_b855744d-4b9c-4585-8464-5848a357472e">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f65ccbdc8ff41efb0c6806847d43860_D20220401-20220630" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtNi0xLTEtMTMzNDkw_24284b9d-2db1-4fb2-a01e-7fca5c1b3569">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a8a884562fd49f18dfd6aeeb09a20a8_D20210401-20210630" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtOC0xLTEtMTMzNDgy_3e8ab264-d3b4-4920-9ec9-ae7ad153dcae">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctMi0xLTEtMTI5MTA5_8c8d6abc-b827-4c83-b435-4603d5611878">5,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctNC0xLTEtMTI5MTA5_d42f9e53-03c2-42fc-8430-309b85951cc2">5,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctNi0xLTEtMTI5MTA5_2c125ffb-e64e-452c-aa9f-6d5323c5ac47">3,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctOC0xLTEtMTI5MTA5_20c19c89-6704-4bc8-9919-c50931e1d03d">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtMi0xLTEtMTI5MTA5_8c0c1b7e-da6f-43c6-807c-a820bd3950f5">561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtNC0xLTEtMTI5MTA5_816d4873-fc8b-42f6-8cf3-a2b6f13e2c31">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtNi0xLTEtMTMzNTIw_6a682dfc-c2c6-40e7-ad72-7ac3748ba0b9">280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtOC0xLTEtMTMzNTAw_93817cbe-868a-4a31-9796-41f5718466a5">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktMi0xLTEtMTQ2MjYz_0ffe0f35-9836-4e62-8bfa-90e7e72c82e7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNC0xLTEtMTQ2MjYz_02720d3a-856f-411f-b617-8f1b1b1b3304">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNi0xLTEtMTQ2MjYz_220a44cc-df6e-4393-833a-ed41be3fffa8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktOC0xLTEtMTQ2MjYz_7dff7384-0137-4c05-82ec-bdaf88d0de9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktMi0xLTEtMTI5MTA5_9618708e-364d-4747-a4e7-43b26db252ee">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNC0xLTEtMTI5MTA5_3e0b07bc-e905-4d1b-af99-859c1e9a32de">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNi0xLTEtMTMzNTE3_351b5a20-ac20-4885-ba74-f067582e9cc9">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktOC0xLTEtMTMzNDk3_425df93d-bd18-43bb-8bdb-d7ea744fce15">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtMi0xLTEtMTI5MTA5_67749fec-2554-4b4a-80c2-3da94bb3ca95">1,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtNC0xLTEtMTI5MTA5_29d3edfb-a743-4d23-a953-473f4fe799ee">126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtNi0xLTEtMTMzNTE0_fa499363-0e32-4244-85fc-93480a45644b">1,263</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtOC0xLTEtMTMzNTAz_a3490d89-fc01-414b-8c52-7cd710642d07">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtMi0xLTEtMTI5MTA5_124d19ec-c22a-48ac-9773-76446a5a398c">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtNC0xLTEtMTI5MTA5_534dfb72-ae4c-4ce2-bfe9-f10c8b91ae37">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtNi0xLTEtMTMzNTEx_701a3cdb-2c25-4593-8bc7-46f8beb049c0">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtOC0xLTEtMTMzNTA2_68cf8a06-56bd-4515-a286-449a213347e5">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtMi0xLTEtMTI5MTA5_7f178b03-3721-4eee-ba61-c14444db5686">4,278</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtNC0xLTEtMTI5MTA5_05057912-aa81-49c6-9af6-1790e9227211">4,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtNi0xLTEtMTI5MTA5_29fbfd61-d5c5-4e1a-9a22-2a072c728159">1,605</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtOC0xLTEtMTI5MTA5_60c1b6c0-f4c4-409e-99eb-2eb122bdea31">2,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for our reportable segments was affected by the following:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax income for NPM adjustment items of $<ix:nonFraction unitRef="usd" contextRef="i0c63006a91f04aa0a97e0e25d1afb998_D20220101-20220630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfNTQ5NzU1ODE0NDI4Mw_7eb39f5e-c96a-474f-85ee-71bf18529e2d">60</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6a9924f43b44980bdeea6e55ddeab2a_D20210101-20210630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMTYzMw_0efbc9dc-4672-4f65-af47-5bc2480004eb">32</ix:nonFraction> million for the six months ended June 30, 2022 and 2021, respectively, in our smokeable products segment.  We recorded these items in cost of sales in our condensed consolidated statements of earnings.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="mo:ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfNDk0NzgwMjMyOTgxNg_561fe959-3648-4bc0-97e7-b733e425efc3" continuedAt="i1ead34b076de44f793e122799ae35afb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:</span></ix:nonNumeric></div><div style="margin-bottom:5pt"><ix:continuation id="i1ead34b076de44f793e122799ae35afb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6bc7e58db8428ebf31c693b4236ea7_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi0yLTEtMS0xMzM0MzU_89e2f2bc-1b9c-4723-a511-3ab17dc85e00">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46db2dd0967c4895b93fb83754d195c0_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi00LTEtMS0xMzM0MjM_5d4b3409-ffe4-4d1d-877a-8403274e0774">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife349d051cc74966a11492b5681f511d_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi02LTEtMS0xMzM0Mzg_e780031c-f797-4966-af6a-8fc1161aa7b6">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieedfff3a9a3247c9bb3467f1b57505f3_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi04LTEtMS0xMzM0Mjg_53cb31bd-d018-4e25-908a-d6bc44aeac21">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10790d601d0144df92ffc1eee752bd0d_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy0yLTEtMS0xNDU3NTM_3b74cb5c-fe6b-4cd6-afaf-aa640e6a99ce">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51aba496809142e593bb1b943f268798_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy00LTEtMS0xNDk3NjQ_449cb735-2261-4c64-af58-74df3b9c77e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9269c502f174ba7b95d543c1fe32410_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy02LTEtMS0xNDU3Mzg_7608a63d-08a7-4e1e-87d0-ea7d5916f35c">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5096748718454223a3a223a6cfd489a3_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy04LTEtMS0xNDk3NjQ_b9674177-a563-46ca-925b-916d4ab227f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43f576a9e9d4820aedbcd69fd64f322_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy0yLTEtMS0xNDExNDc_bb15d91b-b5a9-4387-bfe1-4641034b50c4">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd2f0a9c69f413b81668b9456672a69_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy00LTEtMS0xNDExNzI_f16ec07b-d91e-40b0-9b0b-ee5c4a97e1dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844eb97024c84e86b793fb4669de42da_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy02LTEtMS0xNDExNTA_0a1e59a5-b79e-4a7b-87e8-db627607b204">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d1c6700b304008a01681c4c742502b_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy04LTEtMS0xNDExNTg_f88fd4f3-1180-47f9-bfec-a384ca1d4980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28febc0f256b49e2a19127bac1eefd4f_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC0yLTEtMS0xNDEyNjg_4f859c54-7a43-4c99-b1e2-4cbc0b2bae27">58</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8b966e2d51497780ea70bf9d0c4b17_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC00LTEtMS0xNDEyODc_aec4721e-afe3-42f3-9a64-820e2bd3b51a">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b9e0213b45474dab5f5de82137fd03_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC02LTEtMS0xNDEyOTA_daaeb7ab-3817-4b85-bf5a-83beedbadc69">46</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad51ca79f2ce481bb8b8ba1aea9c8bfc_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC04LTEtMS0xNDEyOTI_a387515e-4de8-47c2-93cb-8131e52b445f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts shown in the table above for the smokeable products segment in marketing, administration and research costs in our condensed consolidated statements of earnings.  For further discussion, see Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><ix:continuation id="i435174d92d114cfabd1d1d0eb7e99fcf"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Acquisition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjYwMw_71a095e1-74cb-4ec5-9b54-86f193e3adb1">37</ix:nonFraction> million for the six months ended June 30, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  We included these costs in marketing, administration and research costs in our condensed consolidated statements of earnings.</span></ix:continuation></div><div style="margin-bottom:5pt;text-indent:18pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_100"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NjE_aff4a8d4-ea88-4920-9c1a-b89d82444c28" continuedAt="i150702cd828f441895e9fa64663881e7" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="i150702cd828f441895e9fa64663881e7"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, we had <ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzg0_63746755-a066-43f8-ada4-da379e7c0d64"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzg0_d1348cbf-3760-40d2-8718-24949792e8a9">no</ix:nonFraction></ix:nonFraction> short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a senior unsecured <ix:nonNumeric contextRef="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NjI_dd2b0eab-0d4e-4391-91f1-5a610906338e">5-year</ix:nonNumeric> revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;) that provides for borrowings up to an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i37e492b0fc2d45a8b2e224d8465d9026_I20220630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI3Nw_868bd5b1-bc9e-4e8d-964e-e439b60c71d7">3.0</ix:nonFraction> billion.  The Credit Agreement, which is used for general corporate purposes, expires on August 1, 2024 and includes an option, subject to certain conditions, for us to extend the expiration date for an additional <ix:nonNumeric contextRef="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630" name="mo:DebtInstrumentExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NzE_a3ad044a-db57-45ef-989e-ce69f8b402fa">one-year</ix:nonNumeric> period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i37e492b0fc2d45a8b2e224d8465d9026_I20220630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzYxNw_4300039c-5cca-4da1-883e-d436877288ab">3.0</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage for borrowings under the Credit Agreement at June&#160;30, 2022 was <ix:nonFraction unitRef="number" contextRef="i2be9a00b70904e04a6f468eec5058227_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzEyNzE_ac3b57da-6a2d-4a7b-9151-1022d53e94d0">1.0</ix:nonFraction>% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than <ix:nonFraction unitRef="number" contextRef="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630" decimals="INF" name="mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzE2Mzg_89619ecd-6968-45ce-9266-17caec0ed92d">4.0</ix:nonFraction> to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At June&#160;30, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was <ix:nonFraction unitRef="number" contextRef="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630" decimals="INF" name="mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzE4NjU_47fa1485-f794-49ce-8b60-92d95d6a1ab1">10.7</ix:nonFraction> to 1.0.  At June&#160;30, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of our total long-term debt at June&#160;30, 2022 and December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzIyODE_ea76f50d-31b6-46bc-aec6-feb384e0e92f">27.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-8" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzIyODg_9f0a4650-a541-42e5-9f96-86f4588d8f29">28.0</ix:nonFraction> billion, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we issued long-term senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="icf22930994534713a83c19ce49bde1ba_I20210331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI0MjA_545e0bc2-1678-4274-85ab-17bf680bfeea">5.5</ix:nonFraction> billion.  We used the net proceeds from these notes (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ie526609fec74474d87c0aa3c9e2a3ccc_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI4MTQ_c8df8528-377f-4d0b-8324-e016419395a6">4,042</ix:nonFraction> million and also redeemed all of our outstanding <ix:nonFraction unitRef="number" contextRef="i904889c18dee449b9c1967209d215e07_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI4NTg_ad407d47-02b2-41ea-835d-c60ce84e7897">3.490</ix:nonFraction>% notes due 2022 in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i834f7afe8d0b4966b98bf4be48676817_D20210101-20210331" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI5MTI_0927ad92-07a7-4f0a-ad00-26096ef17de5">1.0</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMwNjY_2cd6b382-8515-42ab-becc-ff6d8746f5c9">649</ix:nonFraction> million, which included premiums and fees of $<ix:nonFraction unitRef="usd" contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMxMDY_98121317-84fe-43ec-a3f7-4b24ef398e2a">623</ix:nonFraction> million and the write-off of unamortized debt discounts and debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMxODQ_a2ad702f-e8ea-4a66-9df4-a2cf3401ca03">26</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, accrued interest on long-term debt of $<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMyNDA_196e37cd-195a-4345-a908-50bb3e92e227">376</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMyNDc_9d132283-69bd-4f0e-b4cc-5a7994c01489">429</ix:nonFraction> million, respectively, was included in other accrued liabilities on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzM_fa504991-a4d6-4c6e-bcff-d3f4cdc0ba0d" continuedAt="i2e1d1876b9584d53a7ddc69e00b8adb9" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i2e1d1876b9584d53a7ddc69e00b8adb9"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="mo:SummaryOfIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzk_6cd482a8-c6bf-4925-8f8d-c7b545dabd91" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings before income taxes, provision for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItMi0xLTEtMTI5MTA5_8224f05a-ed16-4593-95a0-4b98e7ce446e">4,278</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItNC0xLTEtMTI5MTA5_ba07c82d-a32f-4b4f-a5a5-6b19c0649bc6">4,846</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItNi0xLTEtMTI5MTA5_9b84b99f-4ab8-46bb-9e26-8f87cf079d0a">1,605</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItOC0xLTEtMTI5MTA5_70715f55-957c-46db-9d56-7d43094fb14e">2,909</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtMi0xLTEtMTI5MTA5_0c425ed0-c984-47f1-9f85-ede49cd008eb">1,428</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtNC0xLTEtMTI5MTA5_2608f084-62bb-40a2-a29c-a3b67586e15a">1,275</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtNi0xLTEtMTI5MTA5_3e395f76-864a-42a0-88bd-c8cea8a8bbc8">714</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtOC0xLTEtMTI5MTA5_192222bd-95b0-43d9-8a4b-db62db2e7d94">759</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtMi0xLTEtMTI5MTA5_a68e5621-5044-4a56-a8a4-fcbfbd21c7d8">33.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtNC0xLTEtMTI5MTA5_54d525e5-f8e1-4719-9dca-c2a70acce0dd">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtNi0xLTEtMTI5MTA5_0ce85e72-a4c7-4fbc-87ce-378d1282f29f">44.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtOC0xLTEtMTI5MTA5_97ea0f41-e552-41e1-9a96-70c4d2e36d99">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the six and three months ended June 30, 2022 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the six months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances recorded against deferred tax assets related to our investment in JUUL and our Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the three months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to our Investment in Cronos, partially offset by a valuation allowance release related to the increase in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the changes in the estimated fair value of our investment in JUUL and our Investment in Cronos, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzQ_74e6b06a-013d-4800-9af1-8ca81567de42" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended June&#160;30, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzEtMi0xLTEtMTI5MTA5_5749352c-85b4-4211-a5da-456afb6b1819">3,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzItMi0xLTEtMTI5MTA5_ed49876c-40cd-4bbc-a4d2-efdcd654f214">368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzMtMi0xLTEtMTI5MTA5_fb95a0df-f251-4a75-87b7-a2ce34eb23e5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" sign="-" name="mo:ValuationAllowanceForeignCurrencyTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzQtMi0xLTEtMTI5MTA5_7cb4620d-e174-4fca-80cd-30fff500710c">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzUtMi0xLTEtMTI5MTA5_e64a1bec-1dd1-472e-a36a-f33030f5b5eb">3,456</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzQ5NDc4MDIzMjc2MDU_b2e516a6-c6fc-4a2f-a8fd-e433707f3a4e" escape="true">We determine the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized.  In reaching this determination, we consider all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in valuation allowances for the six months ended June 30, 2022 were due primarily to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The cumulative valuation allowance at June&#160;30, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL and our Investment in Cronos.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_106"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0ODk2_ac816430-a14f-4b40-8c84-6982dacc6894" continuedAt="ic85dc5b0b4e8448d8e798d09718c0b18" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="ic85dc5b0b4e8448d8e798d09718c0b18" continuedAt="ie6e212e558c84469aeb819ee985531e4"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="ie6e212e558c84469aeb819ee985531e4" continuedAt="i6eb3d51f6b5c4a0ca475dee2e26fe98b"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that <ix:nonFraction unitRef="state" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="INF" name="mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIzNTE_fe9181e7-e9b4-4b25-9f30-eb2a811d9d70">47</ix:nonFraction> states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record provisions in our condensed consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in our condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation) and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0OTAy_bf453cad-6b6e-4463-a481-4beb11280752" continuedAt="if912375d90564815a7dc18036db081a6" escape="true">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</ix:nonNumeric></span></div><ix:continuation id="if912375d90564815a7dc18036db081a6" continuedAt="id1893b474b084494bb24f713cedefca3"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItMS0xLTEtMTI5MTA5_4d98a9f2-67d9-405a-b078-281d5a33f52b">91</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItMy0xLTEtMTI5MTA5_822b8f9c-c566-48ac-a9a6-3d1f1c825e97">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1d15baae55479686b0438960a20553_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItNS0xLTEtMTI5MTA5_20026b41-3370-44ad-a4dd-2d53f81660ce">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2233715bedd740d4a3940763dda60aa8_I20210331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItNy0xLTEtMTI5MTA5_ffead1dd-f538-49fe-b24b-f5389e6aa640">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7333de9d7b44fc198078f692ff042c5_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtMS0xLTEtMTI5MTA5_6aaf957b-fa45-4e53-b741-89cccb703b88">57</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64e7b37987ea44128d943580102fc338_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtMy0xLTEtMTI5MTA5_d71464d9-af0c-4406-839c-e63ed6216a51">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb300ff50687440da92f6d2d8898e254_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtNS0xLTEtMTI5MTA5_0fcfa823-0648-46bd-95bb-0c0e1e09260e">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2611638f3f074e30be114be0592513de_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtNy0xLTEtMTI5MTA5_9a2d29e6-0f96-40bf-96c7-5c4aac7b451f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c088115b8af479895ab47b7bff4f51e_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtMS0xLTEtMTI5MTA5_b00d83c0-9bd3-44dd-b340-0832fea57bc3">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71508c07d42a42569b52bd3ebbac6370_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtMy0xLTEtMTI5MTA5_e09e9c7f-1f24-4eca-9c87-e30729d5890e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15710cf918bb4ad0bfe9ff7a338e1fb1_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtNS0xLTEtMTI5MTA5_2d136667-88d3-4e55-b12c-20343bb8b573">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2626fb7367b400aba3c194f31411f4f_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtNy0xLTEtMTI5MTA5_db4b4d7c-8a1f-4c61-a8a4-b7fa3704227f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktMS0xLTEtMTI5MTA5_ff74b9c6-eb53-4ff0-b037-61efc80f1323">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktMy0xLTEtMTI5MTA5_44340fba-6315-42d8-9a09-72fcc0be26ba">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktNS0xLTEtMTI5MTA5_550e637b-0972-4a17-ae16-7a456d7a6eb0">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktNy0xLTEtMTI5MTA5_1a135640-68b6-475c-9856-3f33a2fd801d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTEtMS0xLTEyOTEwOQ_0935c2ad-c786-4b3e-84c0-b235e2a7a277">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTMtMS0xLTEyOTEwOQ_d990ea02-1259-4057-819e-aea1e6ba8007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTUtMS0xLTEyOTEwOQ_9232a3ee-5c7d-4ae0-b7a2-883902c8bccc">25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTctMS0xLTEyOTEwOQ_de4a08be-e3e7-4e1c-97c0-c1a041ce4250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our condensed consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU5NzU_9fb1b016-42d0-4240-9880-1ce6d8f50538">929</ix:nonFraction> million and interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630" decimals="-6" name="us-gaap:LitigationSettlementInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMTQ_04b67683-0c12-4fbf-ad4d-716763d0d624">228</ix:nonFraction> million as of June 30, 2022.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxNTE_ddb4fb19-9581-47f0-8a05-4fefec6ba399">421</ix:nonFraction> million and related interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630" decimals="-6" name="us-gaap:LitigationSettlementInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxOTg_9023c3cf-feee-4376-a791-119f3c70c20f">57</ix:nonFraction> million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i6eb3d51f6b5c4a0ca475dee2e26fe98b" continuedAt="ib01dd1e12e3f4af5a1277c85f20ae0ba"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of July 25, 2022, PM USA has posted appeal bonds totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ib0e58a9d31fd4b2b9e8753887b69b312_I20220725" decimals="-6" name="mo:LitigationEscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzOTM_1d42f9eb-cf2d-4bd1-b06f-73382ae7d9a5">50</ix:nonFraction> million, which have been collateralized with restricted cash that are included in assets on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><ix:continuation id="id1893b474b084494bb24f713cedefca3" continuedAt="ifb4f9be98dc645ed8672fbec3e87e967"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 25, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 26, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="if80273ba6b18457cbc2b5182392c76b1_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzEtMS0xLTEtMTI5MTA5_dc8376b0-dcc3-43b3-b185-68770b83f6d4">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i5d91ab5e046640bcbabc478601fd21b3_I20210726" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzEtMy0xLTEtMTI5MTA5_58d0737f-b8d4-4180-b214-c90b8bd09659">169</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ifc4defe52f8b46b09b0531c0541a5403_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzItMS0xLTEtMTI5MTA5_35794465-cc3b-4828-8ab5-5b0a40d6f7ca">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="iac977efcc9484319b8cd4e82324c3fa3_I20210726" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzItMy0xLTEtMTI5MTA5_53703694-9e07-46a6-aa0c-f997629929bc">1</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzMtMS0xLTEtMTI5MTA5_25291631-3a97-4a40-9c83-74424e3821cb">4,030</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i87bf8ff853e2425f96934e4e9ddef164_I20210726" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzMtMy0xLTEtMTI5MTA5_caef98e2-432f-4f5b-b6cc-fbc1e75a37ec">2,626</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzQtMS0xLTEtMTI5MTA5_6be9e32e-a1d7-4960-9d72-95a18328cf26">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i0c6153fbe7224388926901e9703fa838_I20210726" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzQtMy0xLTEtMTI5MTA5_95f07e77-7cd1-4706-9a2e-abd6d7e7b173">3</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of July 25, 2022, <ix:nonFraction unitRef="claim" contextRef="ib36e57c0c00746cd9d7c260932b94d8e_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc0NTE_00b4330e-4de1-4e56-a3a5-e8b4850931b8">16</ix:nonFraction> cases filed in Illinois, <ix:nonFraction unitRef="claim" contextRef="i8eb8d2231c6e42c68730b177faaedcd8_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc0Nzk_a313d96d-2e7d-4adf-a59c-aa69841560bf">18</ix:nonFraction> cases filed in New Mexico, <ix:nonFraction unitRef="claim" contextRef="ie41710be5b8c41ee96fe3ba722416d41_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc1MDk_e7dd526d-1a3e-4956-952d-2b3053c5f9e3">36</ix:nonFraction> cases filed in Massachusetts and <ix:nonFraction unitRef="claim" contextRef="icf33c42aea2a44e9a567c3723d8ddceb_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc1NDU_8a98435f-0b5a-4d72-bf6d-4ea0fb0fbaef">58</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include <ix:nonFraction unitRef="case" contextRef="i5a4d2c2e9803462e976b555918c63490_D20220725-20220725" decimals="INF" name="mo:LossContingencyNumberOfCases" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc4ODQ_36f6dbab-2e5b-4a54-920d-f4c05831cc61">1,396</ix:nonFraction> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, <ix:nonFraction unitRef="lawsuit" contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2MDA_79225e69-93dd-45ea-b501-de44b2da9ed0">58</ix:nonFraction> class action lawsuits, <ix:nonFraction unitRef="claim" contextRef="i18fb1c9978ec48949a63f54f3c2ec853_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2MjY_ac5086c3-790a-499e-8c87-d13e43219b74">2,957</ix:nonFraction> individual lawsuits and <ix:nonFraction unitRef="claim" contextRef="iec4f544b33974b84b91ca169738940e5_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2NTM_f42de754-d70f-4ec6-b0ac-01648906771c">1,015</ix:nonFraction> &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The <ix:nonFraction unitRef="lawsuit" contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg4OTA_79225e69-93dd-45ea-b501-de44b2da9ed0">58</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="claim" contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg5MjM_1437cb7a-9d6e-4b78-b6be-f729f53dcf98">32</ix:nonFraction> cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, <ix:nonFraction unitRef="case" contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725" decimals="INF" name="mo:LossContingencyNumberOfInactiveCases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzkyMjU_46f3e8f2-7ec8-4fa2-a487-6b4327385fbc">one</ix:nonFraction> inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and <ix:nonFraction unitRef="case" contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725" decimals="INF" name="mo:LossContingencyNumberOfInactiveClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzkzNjU_50670a25-cd1e-4e6a-8c3c-d6a45992e80c">two</ix:nonFraction> inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, (i) Altria is named as a defendant in <ix:nonFraction unitRef="claim" contextRef="i057dcd83a81443d6895e291fa75e63cf_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk2OTY_973ea5b2-b535-4ded-9125-13004c6ff53c">three</ix:nonFraction> e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in <ix:nonFraction unitRef="claim" contextRef="i602c7b1521144698b0e57a755cdea240_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk3NzY_06441e91-a6f1-4d58-aa3c-4fc9f39310a0">10</ix:nonFraction> health care cost recovery actions in Canada, <ix:nonFraction unitRef="claim" contextRef="ifdbc8a7fc0b140448112768ac4469793_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk4MjQ_6c677aa2-27cf-4a33-88e0-efccb5046ebb">eight</ix:nonFraction> of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in <ix:nonFraction unitRef="claim" contextRef="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk5MjQ_7965dc43-128d-4c4c-8eb0-8fac528ebaa1">seven</ix:nonFraction> smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement (defined below) between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, <ix:nonFraction unitRef="case" contextRef="iff8405d610414876a75ffeb4cb61a3be_I20220725" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwMzEw_0fa67d25-bea8-4348-8a8d-12dd80806497">six</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, <ix:nonFraction unitRef="case" contextRef="i90bb52ef7113414d8e3846eac30005d0_I20220725" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTAxMDk_8e69e7c5-1b74-448c-9694-ec30f10d2697">two</ix:nonFraction> individual smoking and health cases and <ix:nonFraction unitRef="case" contextRef="i9f105d7b0a5346afb83dd5c09220d92e_I20220725" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTA5NDI_7df957c0-c887-4b20-815a-c0deeb9214a1">no</ix:nonFraction> e-vapor cases are set for trial through September 30, 2022.  Trial dates are subject to change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwNzY1_60d05815-a3cb-4444-b9c3-f24d02feb2de">70</ix:nonFraction> tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwODkw_bc4f74a1-4fed-4bb2-897c-feb216b219e9">45</ix:nonFraction> of the <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTAw_60d05815-a3cb-4444-b9c3-f24d02feb2de">70</ix:nonFraction> cases.  These <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTE3_bc4f74a1-4fed-4bb2-897c-feb216b219e9">45</ix:nonFraction> cases were tried in Alaska (<ix:nonFraction unitRef="case" contextRef="i682d73a693e04609b5d9fbeaba2fcd92_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTQ4_7ef03fa6-3fec-4ad4-8dc7-91af93d194d6">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="i6a1559a0e1124131910366a39aff6d12_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTY1_9c7c5f0d-617a-4e42-8042-b617281e2b24">7</ix:nonFraction>), Connecticut (<ix:nonFraction unitRef="case" contextRef="i509864cccb2f40b98af72697cece813f_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTgz_a8e2e311-369b-483b-869b-ceba0e45a71c">1</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="ica10ed061e3c4768a08c7c6d78a09387_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTk3_8da049d2-297f-4e11-a370-497ff84b6cdc">10</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="i4b1143b32ee544e99d873d85d649da2f_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDEz_574c4f23-7784-4c20-b0f0-d05fd035ae68">1</ix:nonFraction>), Massachusetts (<ix:nonFraction unitRef="case" contextRef="i7f6d5b4f9824425c86ad308c5211697c_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDMz_25a8a46c-c193-424f-8484-5332406aedd6">5</ix:nonFraction>), Mississippi (<ix:nonFraction unitRef="case" contextRef="ica1283cfc29e491f80a171844b65131e_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDUx_028b9a3d-7b08-4720-8db7-558b96c5d52a">1</ix:nonFraction>), Missouri (<ix:nonFraction unitRef="case" contextRef="iba9fd76fee584f7ca0719a4a74458197_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDY2_ea49240b-390b-4f77-8318-e95abedfd993">4</ix:nonFraction>), New Hampshire (<ix:nonFraction unitRef="case" contextRef="i368a47758f0742e6a4c03e7856369fd6_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDg2_fb7a65af-1b94-4895-89ce-7e89ce98b20c">1</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ie79e75207b814e8c961e323037e2b7ea_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTAz_23af87d1-b6b2-4cbe-b862-c498a833e33a">1</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i2e26448b3750441c87cc00de2ed31100_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTE4_57712b95-afe4-4bfa-8d04-def924b68bf7">5</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="ic873084e522446c8862fe8e1fa9cf238_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTI5_b0be9873-7a8c-471a-b072-830952d4600e">2</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="ib0e31195d77d48bbb3cea0dade509ea8_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTQ4_dc9dae70-7c3b-47e8-b428-d0258e45c337">1</ix:nonFraction>), Rhode Island (<ix:nonFraction unitRef="case" contextRef="ic0abc218a2ef4d91b7ebb3f361f67c37_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTY3_5f107b44-0fd3-45d1-9d94-0dcdeb156496">1</ix:nonFraction>), Tennessee (<ix:nonFraction unitRef="case" contextRef="i3f81cf3349f04c67bca28e5eb157473e_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTgz_1edf0392-d637-4974-bea9-24606601b2cb">2</ix:nonFraction>) and West Virginia (<ix:nonFraction unitRef="case" contextRef="id76f91e8dbc44f6582842261cefc0a50_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMjA2_298f633f-aff0-4d66-8451-96fb9539a05d">2</ix:nonFraction>).  One case in Massachusetts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Main</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMzY2_3f3c51eb-079e-44b6-9fbe-073bb1eb7ebc">25</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, <ix:nonFraction unitRef="case" contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725" decimals="INF" name="mo:LossContingencyClaimsResolvedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExNDQ5_ee66e123-c7b3-4ca9-8bb1-89fe0a3bbacd">23</ix:nonFraction> have reached final resolution.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of July 25, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="ib01dd1e12e3f4af5a1277c85f20ae0ba" continuedAt="iea9a14f160eb43159c42475c305e970f"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i0c5245e6da544ef581a1619155446591_I20200229" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzMzUz_c029abb6-5388-4a66-81d7-5f30c360e777">11</ix:nonFraction> million in compensatory damages.  There was <ix:nonFraction unitRef="usd" contextRef="i0c5245e6da544ef581a1619155446591_I20200229" decimals="INF" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzMzky_cbd33692-2ded-4598-968f-d9792c493466">no</ix:nonFraction> claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#8217;s motion for discretionary review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="ie0a6cce22a9241bfbe34dbe658ae9cde_I20190930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzOTg4_48c204e7-b6a5-4d96-a9ea-08198affc697">10</ix:nonFraction> million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $<ix:nonFraction unitRef="usd" contextRef="iada3831810b84380a34be34e3dbc1ffe_I20200531" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0MTM3_47d78340-13bc-4d3b-b4d9-022ba9f6711c">30</ix:nonFraction> million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i8b2ca9e1f1054d9fba499bdf41e121e9_I20210228" decimals="-5" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0MjUy_2b56c155-8855-4c71-91cc-e4a40b90281b">2.3</ix:nonFraction> million.  In July 2021, following denial of PM USA&#8217;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $<ix:nonFraction unitRef="usd" contextRef="id2baa872a94b482c8bb1018ad55264cb_I20190831" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0NTUx_6990b978-5168-4ad8-8175-09c53a83d8f4">11</ix:nonFraction> million in compensatory damages and $<ix:nonFraction unitRef="usd" contextRef="id2baa872a94b482c8bb1018ad55264cb_I20190831" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0NTgy_fd2b4ef9-ee86-44b8-b7c8-e595010d3b00">10</ix:nonFraction> million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $<ix:nonFraction unitRef="usd" contextRef="i94e53bc2b6de4394af0f5e9e5f1faa3a_D20210901-20210930" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0ODIx_049c3026-d084-4e1b-857d-db73d03f6af0">21</ix:nonFraction> million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $<ix:nonFraction unitRef="usd" contextRef="i5ac825808e1a4f3b84e8fee44f14e337_D20210701-20210930" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0OTE2_8f9e25ba-9829-48be-b638-76870d1e2aef">27.1</ix:nonFraction> million in the third quarter of 2021 and paid $<ix:nonFraction unitRef="usd" contextRef="i8c7f18929f5e4ba98e6d6041dd284fc6_D20211201-20211231" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0OTU3_ce841752-779c-4075-ac8d-e9a84ddd08a9">30.3</ix:nonFraction> million (including the judgment and interest) in December 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i9240c78c98394f3cb2cc1b313917c5ad_I20000731" decimals="-9" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2MDUw_670b795d-3021-4a2e-b359-6755d9cfd224">145</ix:nonFraction> billion against various defendants, including $<ix:nonFraction unitRef="usd" contextRef="i17eebd26ab63497ab584d767938f5d8b_I20000731" decimals="-9" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2MDkx_9e9f3434-6dcf-40f8-849d-e2eb33cb2f06">74</ix:nonFraction> billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within <ix:nonNumeric contextRef="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2NjU0_0caabcfe-4494-490f-a2bf-ac57f152e1ab">one year</ix:nonNumeric> of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within <ix:nonNumeric contextRef="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2ODIy_0ce6d524-d436-4815-ae48-e79ac7dcd477">one year</ix:nonNumeric> of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately <ix:nonFraction unitRef="claim" contextRef="if9927761764b40a786f566330b852304_I20080131" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NTUw_0f228f98-4b26-4047-92fb-5584b62480df">9,300</ix:nonFraction> federal and state claims were pending.  As of July 25, 2022, approximately <ix:nonFraction unitRef="claim" contextRef="ia60506d9acad48209c8c8dcaed0769be_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NjI5_d96bff0e-b0ff-4d71-908f-524e6b29868c">727</ix:nonFraction> state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately <ix:nonFraction unitRef="plantiff" contextRef="ieb55d0b8c2e34a54b634281cfd15e7c5_D20220725-20220725" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NzQ5_923f5bbe-d343-4e12-a9c8-354cefa15647">911</ix:nonFraction> state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="iea9a14f160eb43159c42475c305e970f" continuedAt="i9526ebf9df454a6da7f969177f278422"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are estimates.  While the 2015 federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of July 25, 2022, <ix:nonFraction unitRef="claim" contextRef="ifd6affc6fc324b9da397010ae49673c8_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MDQ3_477aa0cb-29a2-4a56-8fb7-c922a4959391">one</ix:nonFraction> case was pending against PM USA in federal court representing the only case excluded from that agreement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, <ix:nonFraction unitRef="case" contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MjA1_953c2df7-0b3e-4253-be21-59a51745f8e8">139</ix:nonFraction> federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  <ix:nonFraction unitRef="case" contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MzM4_d700455d-ac14-41fc-bbcb-99ed380d379b">Seventy-six</ix:nonFraction> verdicts were returned in favor of plaintiffs, and <ix:nonFraction unitRef="case" contextRef="iff8405d610414876a75ffeb4cb61a3be_I20220725" decimals="INF" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5Mzkx_56af8618-c867-42cc-96ec-ed66550389c6">eight</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frogel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In <ix:nonFraction unitRef="case" contextRef="ibc9177f9baa34fbdbf6605706769f68e_I20220725" decimals="INF" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDk5MTI_2f726066-12ab-4a4f-bd96-382751293375">two</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kaplan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the punitive damages awards were vacated on appeal and remanded for new trials.  In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the trial court granted PM USA&#8217;s motion for summary judgment, and plaintiff has appealed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5NTky_fe7e3fde-b309-4315-9fb9-5f2dfcdd2494">Fifty-five</ix:nonFraction> verdicts were returned in favor of PM USA, of which <ix:nonFraction unitRef="case" contextRef="ic4081d6a41ea492c824d20493bcf3dce_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5NjQ3_22c488c5-6252-4060-85b9-d5b677c9a2b7">45</ix:nonFraction> were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of July 25, 2022.  The jury in one case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  <ix:nonFraction unitRef="case" contextRef="i2a58875756fe4911aa25efd5db88be0b_D20220725-20220725" decimals="INF" name="mo:LossContingencyVerdictReversedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMDkx_faee46e4-047f-44a5-b0e9-2180dc441774">Four</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in <ix:nonFraction unitRef="case" contextRef="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725" decimals="INF" name="mo:LossContingencyZeroDamagesVerdicts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMjM0_756dc30f-9d6f-49ab-b1ae-75e68c0b9c82">two</ix:nonFraction> cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned <ix:nonFraction unitRef="usd" contextRef="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMjcx_f135ba68-cdc0-4ed0-b420-2dbb096db718">zero</ix:nonFraction> damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Juries in <ix:nonFraction unitRef="case" contextRef="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725" decimals="INF" name="mo:LossContingencyZeroDamagesVerdictModified" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMzIy_af575575-9fe2-4dfa-8cbc-e58b8bcfb551">two</ix:nonFraction> other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding <ix:nonFraction unitRef="usd" contextRef="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNDAy_c2388a87-de2a-44d8-af57-ddc4d2c4c118">no</ix:nonFraction> damages, but the trial court in each case decided to award plaintiffs damages.  <ix:nonFraction unitRef="case" contextRef="i2c068a726b53483290f0d1fd038adfcd_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNDg1_af23eed1-b4f8-4f5b-ad0e-a0d2d467272f">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  <ix:nonFraction unitRef="case" contextRef="ib6e24acdccca4adbaac072d4e4022eae_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNzQw_1ae35608-af50-4beb-8517-6e1f59212e2a">Three</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The verdicts in the retrials in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) were reversed upon appeal and remanded for new trials.  <ix:nonFraction unitRef="case" contextRef="iae106d4c552a4de1b53156ad6d849934_D20220725-20220725" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIxMDY1_062bdead-48d4-42ca-9d0e-089fb30dd462">Two</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of July 25, 2022 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><ix:continuation id="ifb4f9be98dc645ed8672fbec3e87e967" continuedAt="i9fed238b615648f0872812d9a90fcccf"><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i259df7aad9264b5a979579e9065bdd22_I20220430" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246ZDA5Nzk4MzNkY2JhNGM2MTk3YjgzMzBhMWQyMDBjYjFfNA_2d4f0ab6-d200-490c-b19e-fb57267bc963">3</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7b3ead33c4fb46be8b5f3121b9156fae_I20220430" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246NDIyNWU3YjJkMDhkNGM4Yjk1MWNlZGJiNDdlOTYyNWVfNA_c273deb4-71a3-4035-9d32-5c503f3ead24">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defendants&#8217; and PM USA&#8217;s post-trial motions pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i50edc02879964eff963fa402576e9210_I20210930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzItNC0xLTEtMTI5MTA5L3RleHRyZWdpb246MTZiZDk2NjExMzgwNDg3NTliZDZiZjY3YjFlNjlhNWZfNA_97653c37-8859-4841-a09f-e254417385f2">15</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie6122c7f81bc4da79b3a3ebea157c058_I20210930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzItNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZGI3Yzc0NTA1ZjhkNDI5OWE1NTc5ODFhNGMwODNjZjBfNA_07f8ab34-a0e9-43bd-8ce0-97d2804c3df1">28</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4fcf223c1d694ec285210be845848dc5_I20210531" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzMtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246OGVjMDZiYzJlZmFjNGM4NmJlNTE1NWU3Y2VjYWRkM2RfNA_79abf100-c0f5-463d-926c-fee68c966f66">6</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9df9b90b8d244415b8523a07918dc0b2_I20200229" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzQtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246MTM1ODdhOGNmNDU5NDg1Y2EzZTlmZjhlYzA4ZmQxMzhfNA_01094322-5c63-48bf-a10d-5afd1ec2ae3a">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icbe894efd4be468984d251e1e5c76e61_I20200229" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzQtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZTIwNjIzYjJkNGNlNDlhOTkzNzJkMzQzODQxYTlhZjhfNA_9b4aa1ba-47c0-482e-82d8-07bc79524d18">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="iea6cffa455ad48dfb0c461d66ddf84e1_I20190331" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246N2I0NWYyMGJkYjE4NDA4YWJjZjExMWZiZWE5ZTcxMjJfNQ_48053163-b5b8-49a7-a0e9-588ba467e286">1</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="if38694f1fdb142f8995d60ccb8ade4a4_I20190331" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246N2I0NWYyMGJkYjE4NDA4YWJjZjExMWZiZWE5ZTcxMjJfMTA_a761e222-1c08-4034-b5db-6dded017ab50">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if38694f1fdb142f8995d60ccb8ade4a4_I20190331" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZjA1YjRhMjExYThmNGUzNjhlMWZmOGY5MjRiY2U4NWRfNA_ad64ddb6-137d-4d0d-acf2-19e8ac089d08">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ifcd6b27156ef4c5189f7baa650560310_I20190228" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzExLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmRlNTNkZTcwMWU1NDQ4NzhhZmFjZGMxYzUyYTg5NWFjXzQ_712eca3a-189c-4c2e-8677-84c03fe10ebf">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iea83e832e8d04b5bb9090996f5901381_I20190228" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzExLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjhiZjU5YjA3OGM0ZDRiYWU5ZDRlOWE4ZmUzYTk4ZmMwXzQ_ca221a82-5b4e-438b-b767-fbb7369f9fb4">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia0b7a204571b434cae1afa93d9ad5f88_I20180930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEyLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmNkZmViM2EyZjdlZDQ4YTI4YTk5ZDQ4MmVhZTg0OGJjXzQ_0f3e3e3f-b5c1-449a-8585-304292804e2b">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib7287b41052449eda9a16b7a4c0ec748_I20180930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEyLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjM2M2RhNmRkNmMzNTRjMjM4ZmI2MTJiYWQ0YzliNGY1XzQ_31d6f04b-a2e9-4aff-aead-43620f8aaaca">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0f691b340eae41fab60e5ecfae6d3d73_I20180731" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEzLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmRlZDE5Mzg0MWY3ZjRjMWM5NTUzOWIzMDFmNjk4M2ZhXzQ_82982ddb-6227-4af5-8b75-7bbcf7766a96">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i855a49b8e94a44d8845849b0b6cdafcb_I20180731" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEzLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjU3YzYyMDhiMjc3MjQ3NjJiZTRiOTdlM2ZjZTY3MzVjXzQ_016f319f-7efa-4d82-97ec-154ce22d9f45">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i9526ebf9df454a6da7f969177f278422" continuedAt="i076ec9e0edec4dd3b11013d52954fadb"><ix:continuation id="i9fed238b615648f0872812d9a90fcccf"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i0bdb791827ba48ab8cd3664a2010e68d_I20171130" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE0LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmY1MTZkMjIyZWMzNTRmOWY4ODkwOTEyOWM3YzIxZDY4XzU_5f47d810-794e-4436-ab1b-fb00e5d77e41">1</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icb9002b835be42eeb751f0eeed99f3a6_I20171130" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE0LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmY1MjA1Y2VhODY4NjRhODU5OTIzMWMwODg2NDgwMGZjXzQ_2bf3ad84-8f03-40cd-b590-babcee9ae600">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic88503c7bdfe46aa8828a4d6ab9c1639_I20150930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmFhMGNkOWIzNTJmMzQxMTBiZTYxNTRkMTEzNDJiNTc3XzQ_c47bfcf6-5141-46b2-9804-3629f6bcc136">5</ix:nonFraction>&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$<ix:nonFraction unitRef="usd" contextRef="i57f26ea5a3014b9b9729fe7e127386e6_I20150930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmFhMGNkOWIzNTJmMzQxMTBiZTYxNTRkMTEzNDJiNTc3XzEw_8eb7716b-8d2f-409a-ad64-8b7595feaa7c">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i57f26ea5a3014b9b9729fe7e127386e6_I20150930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmE3ZDNlN2ZjNWFjODQ5OTdhNGQ3NGQ5MDE2ZDcxNmI0XzQ_4df6a8aa-9fa8-4016-b3f1-a475f72692ef">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idc8ad30209f44f13aa28826ce714e1e3_I20150131" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjE1MzRmZGI1NTVmYzQ3ODQ5NDZkYWFjZTM5Y2ZjOTJiXzI3NDg3NzkwNjk1NTY_e9d719e9-b4f1-4a0f-b05b-69faa57afea2">8</ix:nonFraction> million</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i46aef541c52b44488e878806bd18c603_I20150131" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjE1MzRmZGI1NTVmYzQ3ODQ5NDZkYWFjZTM5Y2ZjOTJiXzI3NDg3NzkwNjk1NTE_d6404cc1-eeef-4bbc-90e1-655e5b8df8db">5</ix:nonFraction> million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i46aef541c52b44488e878806bd18c603_I20150131" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjA3MWE1NWQ1ZDUwOTQ5NmFhMDJhMGM1ZDMwNTc5MTVlXzQ_dbedf5d8-4583-4b7b-b010-9922f0af259d">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">U.S. Court of Appeals for the Eleventh Circuit vacated the punitive damages award and reduced the compensatory damages to $<ix:nonFraction unitRef="usd" contextRef="i93894bc913ad47c68ff2b60978052595_I20220630" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTYtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmQyYzEwNmUwNmZkMzQ1YWE5MTAwN2IxZDZhNWU0MTc3XzI3NDg3NzkwNjk2Nzc_a9444093-a693-445e-b025-d2da809a93e0">5</ix:nonFraction> million based on plaintiff&#8217;s comparative fault. </span></div></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which is discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9c72bf9fe7e94489a9a55eb6ef0170d2_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpkNTU2OTFiOTAyZjI0NWMxODYwMTcxZjkxYjZjMDEwMi90YWJsZXJhbmdlOmQ1NTY5MWI5MDJmMjQ1YzE4NjAxNzFmOTFiNmMwMTAyXzE1LTUtMS0xLTEzOTMwNQ_396c528d-5c31-470e-8a12-f47509d28b12">2</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr></table></div></ix:continuation><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appellate decisions in the following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that in order for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings, described above in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Plaintiffs filed a motion seeking rehearing on the proper remedy for cases in which the court&#8217;s jury instructions did not comply with the Florida Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In May 2022, the Florida Supreme Court denied plaintiffs&#8217; motion for rehearing.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $<ix:nonFraction unitRef="usd" contextRef="i494b0e99edea410eab5611b73ffe2f4b_I20090630" decimals="INF" name="mo:MaximumBondForAllDefendants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI0MzEz_fbb5e348-f477-4c63-8798-dd0544187c90">200</ix:nonFraction> million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in <ix:nonFraction unitRef="case" contextRef="i9a1eedb0c135405eb108bc5d0c630bdc_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NTk4_1198c6ad-85ae-4138-a0b8-9568cbeb3115">61</ix:nonFraction> smoking and health class actions involving PM USA in Arkansas (<ix:nonFraction unitRef="case" contextRef="i319065433abd4969ae1ac14852b67636_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NjY0_90913822-2f2b-48ab-88d9-b8c1111b702e">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="ide83d291e49e4954a5a0296df977d166_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Njgx_61b86f9e-0211-4fb0-8f8d-16f0fbba4c7e">1</ix:nonFraction>), Delaware (<ix:nonFraction unitRef="case" contextRef="i0ae966d42be24dd582723eae2b55cfaf_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Njk2_621b3aa2-ba79-46aa-a1f7-7c61ac9d3bb0">1</ix:nonFraction>), the District of Columbia (<ix:nonFraction unitRef="case" contextRef="ia610c28441d14994af28fe694a231c07_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzI3_c9636094-f5be-4d67-a2f8-472c3d50ac83">2</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i30ab1a010fd441a897ef5fce3716965a_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzQx_d350bf8b-fe5b-4c2d-b84c-dfd51b43acc7">2</ix:nonFraction>), Illinois (<ix:nonFraction unitRef="case" contextRef="i998145dbc029488dbf42ec885813145a_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzU2_b3fb5508-1e66-4fa7-8ea3-5373a1ac9c76">3</ix:nonFraction>), Iowa (<ix:nonFraction unitRef="case" contextRef="i4118f17df3314a5b83ef7db05acfe8e7_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzY3_b1092801-2f72-4dad-95d2-03969e106fc1">1</ix:nonFraction>), Kansas (<ix:nonFraction unitRef="case" contextRef="i19c5fce8de1e4a369b1fdaaeee2023be_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Nzgw_9caa025c-a320-4d36-80ac-318a718f09aa">1</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="i1edca63a676640e6b6829445de1c62ba_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Nzk2_ba7f783b-1d8d-45e0-aa8e-29ecceef4bc0">1</ix:nonFraction>), Maryland (<ix:nonFraction unitRef="case" contextRef="i55ab3c65ee434f54b6c4e29b1fa9f142_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODEx_4000eb60-06c0-454e-a4e0-1eb9a04c5739">1</ix:nonFraction>), Michigan (<ix:nonFraction unitRef="case" contextRef="iee45707683a643b6bbb8071e6dfc639a_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODI2_7cfc9597-7a3e-4198-b118-a3179c011048">1</ix:nonFraction>), Minnesota (<ix:nonFraction unitRef="case" contextRef="i204541f308ef43d6a18a8ad65ed791a5_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODQy_00785f7b-7443-4c51-b50a-56a18585732d">1</ix:nonFraction>), Nevada (<ix:nonFraction unitRef="case" contextRef="i15ec71c620304120a35b6a786a7af7ca_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODU1_888ed7d4-c5a4-43d9-8f25-ebbcfe1d1aad">29</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ic571c755a3174b2f8b0b4330bc60eb8e_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODcy_9e656f4e-e826-458e-9284-bcc767e6f243">6</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="ie244b73417994d3d8fc685443c7bab67_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODg3_e8c977c3-bace-4e08-9a0d-2d7f7b129e05">2</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="ie8c697029cb24766b6430bb454ff76d2_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODk4_f17c1e24-7824-4277-a99c-5ec5f7a908ce">1</ix:nonFraction>), Oklahoma (<ix:nonFraction unitRef="case" contextRef="i61bee51f4e7549f7b26494a823b20219_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTEz_8e6c65c2-1b59-41e7-93cc-b92481c28774">1</ix:nonFraction>), Oregon (<ix:nonFraction unitRef="case" contextRef="ie263e9c12c0c49598ae4af4a0e29d138_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTI2_53ecf793-6870-4425-bb88-12bd87b019fc">1</ix:nonFraction>), </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i076ec9e0edec4dd3b11013d52954fadb" continuedAt="i1e08289f1e7c48749256c541e259f1a2"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pennsylvania (<ix:nonFraction unitRef="case" contextRef="i21e1760e3dc3429e9de3e8b11b5e3aae_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTQ1_15939c4f-af97-4da9-b06c-f72af634bdca">1</ix:nonFraction>), Puerto Rico (<ix:nonFraction unitRef="case" contextRef="i95792785b13646e3a52dbef118639cab_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTYz_34927662-2c49-4cc5-b8f0-ee905a1da150">1</ix:nonFraction>), South Carolina (<ix:nonFraction unitRef="case" contextRef="ib918bb45881a41b88b31716185a5601b_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTg0_6a6fffcd-cfa5-4262-aead-af462b680448">1</ix:nonFraction>), Texas (<ix:nonFraction unitRef="case" contextRef="i51dbba0c72e44ef8b9724d88a7e26133_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTk2_b07df914-741f-4bfa-97fe-46a400feffc3">1</ix:nonFraction>)&#160;and Wisconsin (<ix:nonFraction unitRef="case" contextRef="i88a99b9d1e4244df95287f1de8eef4b2_D19960501-20220630" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2MDE1_c6e0d96c-eac2-45dc-b47b-a42920830e3e">1</ix:nonFraction>).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in <ix:nonFraction unitRef="claim" contextRef="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2MzE1_7965dc43-128d-4c4c-8eb0-8fac528ebaa1">seven</ix:nonFraction> class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (<ix:nonFraction unitRef="claim" contextRef="i8281813f0706492da71cbfe50a5ba129_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2NDc5_3f35374f-c091-4c36-9b47-7a9f9bb67207">two</ix:nonFraction> separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of <ix:nonFraction unitRef="manufacture" contextRef="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331" decimals="INF" name="mo:LossContingencyNumberofManufacturers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2OTcx_7d50b5ee-b3ef-49fb-ad88-6d73b3bcb672">three</ix:nonFraction> Canadian tobacco manufacturers (<ix:nonFraction unitRef="manufacture" contextRef="id68e6389cd4f47489796944107883c14_I20190331" decimals="INF" name="mo:LossContingencyNumberofManufacturers" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MDA2_0d063de7-edd0-4c4c-9364-f326474de3e6">no</ix:nonFraction>ne of which is related to us) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding <ix:nonFraction unitRef="ruling" contextRef="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331" decimals="INF" name="mo:LossContingencyVerdictsUpheld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MjY4_5afcd888-bbaf-4215-98c1-519612bc05af">two</ix:nonFraction> smoking and health class action verdicts against those companies totaling approximately CAD $<ix:nonFraction unitRef="cad" contextRef="i4852a02f887c486abc8978cdda91ec14_D20190301-20190331" decimals="-9" name="mo:AmountAwardedtoOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MzYz_df565ad3-0a18-4a8d-b511-1c53269d7ec4">13</ix:nonFraction> billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (<ix:nonFraction unitRef="claim" contextRef="i8536b6fab27d4581bb4d23b4348e4024_I20220630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI4OTM2_b2fe396e-12d1-4bb1-a4f1-5c45fcab0582">10</ix:nonFraction> cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving <ix:nonFraction unitRef="manufacture" contextRef="i2c93e0173c414555a75af3caf5b31494_I20220630" decimals="INF" name="mo:LossContingencyNumberofManufacturers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI5ODE3_79771dee-a87c-41f6-aa63-37b2beab47af">three</ix:nonFraction> tobacco manufacturers (none of which are affiliated with us) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#8220;MSA&#8221;) with <ix:nonFraction unitRef="state" contextRef="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMwNDU1_e8831999-097c-4777-ac33-81d087abc5b0">46</ix:nonFraction> states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $<ix:nonFraction unitRef="usd" contextRef="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130" decimals="-8" name="mo:LitigationSettlementAnnualPaymentAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMxMDY0_e7cf658e-f438-4aa8-8c78-4e1782480013">9.4</ix:nonFraction> billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $<ix:nonFraction unitRef="usd" contextRef="id640778c3952418d9eddb33bdb279309_I19981130" decimals="INF" name="mo:LitigationSettlementAnnualLegalFeesPayableMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMxMjc2_cd25b412-8248-4b3f-80cd-deb95d4e9548">500</ix:nonFraction> million; these quarterly payments are expected to end in 2024.  For the three months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i7ad4667992974c56b30361191a43c305_D20220401-20220630" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNjM_8c1f6841-e44e-4ac1-9783-33f19415af2e">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3684944b3b7443d8a34cefbfc60a1e71_D20210401-20210630" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNDc_eb160e0c-5761-448c-b708-4d951aef9948">1.2</ix:nonFraction> billion, respectively.  For the six months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i398ddf29c5ae4d1cba9418e41e0bdc83_D20220101-20220630" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNzY_fe717129-8601-47d1-b38d-8af4b1ed8f74">1.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i156ce9dc699a4fa88302b05d0f029496_D20210101-20210630" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNzI_81bd3a41-57da-4c93-8b0a-96c72cf61803">2.1</ix:nonFraction> billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i1e08289f1e7c48749256c541e259f1a2" continuedAt="ieb8bd3a428de40bf9399cc65d205e0fa"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $<ix:nonFraction unitRef="usd" contextRef="i470d9d37b2e54ca2bef0338fb55cea99_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMTk3_76de4783-981f-4cb1-8605-2ede3fa0a5ef">388</ix:nonFraction> million for 2004; $<ix:nonFraction unitRef="usd" contextRef="idd811b49bbac43eda9afecebc9563fdc_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjEw_b8cc0dd2-e599-4bb6-b615-fbe284631f8c">181</ix:nonFraction> million for 2005; $<ix:nonFraction unitRef="usd" contextRef="id180aaaf475140e1b559d11028dd32ad_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjIz_1893c6cc-36a2-495c-a1bd-998d7b7247af">154</ix:nonFraction> million for 2006; $<ix:nonFraction unitRef="usd" contextRef="if2059686678443feb7b68e80c9cb4cb2_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjM2_5939b294-d6df-44d3-a6fa-fb457c1b6b57">185</ix:nonFraction> million for 2007; $<ix:nonFraction unitRef="usd" contextRef="ibc032ffd1fbe41ae93ae94b0ece2a49d_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjQ5_0aedc1b7-6ac5-464f-bc4a-7b91912c1cd0">250</ix:nonFraction> million for 2008; $<ix:nonFraction unitRef="usd" contextRef="i956ef150cdde441bbced0f592c3f89a2_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjYy_27f43dbe-1e90-45da-90ac-b73e56a2bc08">211</ix:nonFraction> million for 2009; $<ix:nonFraction unitRef="usd" contextRef="i4ac9e5fa08264e408b57748a0cb725e9_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjc1_2f790ec7-2c25-4cb3-a27a-ccc60255cf1d">218</ix:nonFraction> million for 2010; $<ix:nonFraction unitRef="usd" contextRef="ic2a140870c1d49dd85a9a4cf55517c3e_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjg4_9a9ee49a-aeb0-484d-801e-5222a7c0cd69">166</ix:nonFraction> million for 2011; $<ix:nonFraction unitRef="usd" contextRef="i4de839768ad94cfab14e39ee519be5eb_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzAx_b52e76f5-2890-4134-8619-d1ef5013307f">214</ix:nonFraction> million for 2012; $<ix:nonFraction unitRef="usd" contextRef="ia26efd9028144ce997e13ba03004b3e4_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzE0_533a19cb-c2ce-4970-87f1-a89aa555c7fd">224</ix:nonFraction> million for 2013; $<ix:nonFraction unitRef="usd" contextRef="i6183a39e504c4bf3875e7ca13284f323_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzI3_7ad6a31a-430b-40ed-8492-2ac57b21d0db">258</ix:nonFraction> million for 2014; $<ix:nonFraction unitRef="usd" contextRef="iae5dcbeb354e44d0a63d24ea3d885915_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzQw_4ff34ff8-382f-4b7b-8f1b-2e0fc42b1f24">313</ix:nonFraction> million for 2015; $<ix:nonFraction unitRef="usd" contextRef="i0f62b64e22cb44d0ad3a08021fc5a3eb_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzUz_7c32350a-4758-4ee8-8bc2-b94b69ed6010">292</ix:nonFraction> million for 2016; $<ix:nonFraction unitRef="usd" contextRef="id3bfca6d5eb04b478cd4cce359cc1b8e_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzY2_9c02f6e4-1f92-4785-9a74-76c9e914e095">285</ix:nonFraction> million for 2017; $<ix:nonFraction unitRef="usd" contextRef="i6d910ce0936c4de79d300ec7d603cc96_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzc5_b558d703-8152-4695-875c-9215fd1b7723">318</ix:nonFraction> million for 2018; $<ix:nonFraction unitRef="usd" contextRef="idc172e1bfb8a4ca18d58681f22ba1e18_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzky_2129d557-324d-4351-a867-3d86b2ec2dcb">415</ix:nonFraction> million for 2019; $<ix:nonFraction unitRef="usd" contextRef="i01dc1495f92d44cc975d4c4d9ef6db7a_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyNDA1_b85added-625c-4b8b-8d9c-648206063bcc">573</ix:nonFraction> million for 2020; and $<ix:nonFraction unitRef="usd" contextRef="i3d5b27f46d834849b12eed1fa7de3baa_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyNDIy_864b5e22-d921-4131-bfaf-209a137b777c">635</ix:nonFraction> million for 2021.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of <ix:nonFraction unitRef="state" contextRef="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyOTg3_e2ad2e9a-5ab6-49ab-8f52-a964cd9fdeee">36</ix:nonFraction> MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with <ix:nonFraction unitRef="state" contextRef="ia2bf50e945174e8eb4da9d6fb6259656_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMDg3_e79cd743-3721-4766-8310-694dcf395278">35</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMDk3_8c615c1e-c6e0-46ff-b76e-49862e84a534">36</ix:nonFraction> states, and through 2024 with <ix:nonFraction unitRef="state" contextRef="if6e1e56b911e47e2a8a17ad4923c4e1d_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMTMw_a7924a97-15ae-4bbd-b575-6c89e2f58ef1">one</ix:nonFraction> state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to <ix:nonFraction unitRef="state" contextRef="i87b1662c87ee4da4894098d4f121317e_D20220301-20220331" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzE4_f8e69409-ef2e-41b8-abfa-3f2b99ed4a83">37</ix:nonFraction>.  As a result, PM USA will receive approximately $<ix:nonFraction unitRef="usd" contextRef="i79edba75585544a1b364c3a2a5272a9a_D20220301-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzcw_846a936e-4195-4937-a8ad-62d83cdc478a">80</ix:nonFraction> million for 2004-2021 ($<ix:nonFraction unitRef="usd" contextRef="i9908c88820c8407882fd66aaee5e71fe_D20220301-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzg4_7fd68556-d69e-4b38-bc83-4a0ebf15942d">20</ix:nonFraction> million of which relates to the 2019-2021 &#8220;transition years&#8221;).  In connection with this development for Illinois, PM USA recorded $<ix:nonFraction unitRef="usd" contextRef="iba9d82d27f974b7fb350c60b0eddb7e9_D20220101-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNTEz_030a2622-22dc-483d-8242-865932a0034f">80</ix:nonFraction> million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state settlement, PM USA has received $<ix:nonFraction unitRef="usd" contextRef="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630" decimals="-7" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNjM5_4e6b80df-8a38-4f31-93ec-0f87e42f5702">1.15</ix:nonFraction> billion and expects to receive approximately $<ix:nonFraction unitRef="usd" contextRef="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630" decimals="-6" name="mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNjc5_1bb08801-059f-4883-9462-c230162958e1">410</ix:nonFraction> million in credits to offset PM USA&#8217;s MSA payments through 2036.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $<ix:nonFraction unitRef="usd" contextRef="i1439f2cfb5bf487799a6201d4441815e_D20150101-20151231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzOTQz_b73fd8f0-be9b-4f22-9a03-53719d2aaee0">435</ix:nonFraction> million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $<ix:nonFraction unitRef="usd" contextRef="i69bc69e5749b4429a718b65ce3094b6f_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0MzE1_9899e51a-2b3c-4b7b-902b-e9c1c3af5c09">4</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesWithConcludedHearings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NDI3_ee51c5b4-72dc-43c1-a4a1-24a85e1bb942">nine</ix:nonFraction> states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for <ix:nonFraction unitRef="state" contextRef="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231" decimals="INF" name="mo:LossContingencyNumberOfStatesWithConcludedHearings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NzU4_847dbcad-ba81-4e6c-8f1d-70cf41f34b3e">nine</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NzY4_be85a368-8051-47b8-a454-962bd2ce70b6">10</ix:nonFraction> states concluded by the end of 2020.  In September 2021, the arbitration panels issued decisions finding that <ix:nonFraction unitRef="state" contextRef="icc810a366b774b66bbcdcf2086537c48_D20210901-20210930" decimals="INF" name="mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0ODgx_8e91a58f-19e4-4b15-a51c-e4ffb872741f">two</ix:nonFraction> states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining <ix:nonFraction unitRef="state" contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1MTA2_50b4f22e-9e12-467b-b47f-4dd845a0326f">seven</ix:nonFraction> states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state concluded in March 2022; however, a decision has not yet been issued.  The two states determined by the arbitration panel to be non-diligent have filed motions in applicable state courts and with the arbitration panels challenging these determinations and several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $<ix:nonFraction unitRef="usd" contextRef="i4f54360a45714f0c8d17beb27f673520_D20210701-20210930" decimals="-6" name="mo:LossContingencyReductionToCostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1Njg0_2cd72c16-19b5-485e-8df9-8ddf65463124">21</ix:nonFraction> million as a reduction in cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $<ix:nonFraction unitRef="usd" contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1ODkz_c8fcf617-9ca1-4d46-a81f-3f85ca17d231">23</ix:nonFraction> million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="iaaea83fd15864426afc96fc88210b860_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MDUx_6c0dc89f-2e6f-492b-9ef1-7eda23982fa2">nine</ix:nonFraction> states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses <ix:nonNumeric contextRef="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0ODk3_880fe98e-1de9-4b03-8862-1ff3a5908abe">three years</ix:nonNumeric>, 2005-2007, for <ix:nonFraction unitRef="state" contextRef="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MjUz_45dd30df-1099-4a3d-8ee9-690c10d22fd6">eight</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="iaaea83fd15864426afc96fc88210b860_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MjYz_159517d9-c3ed-4708-9e1a-c694e25f2e75">nine</ix:nonFraction> states, and <ix:nonNumeric contextRef="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0OTAx_8c0eb87f-3e8b-40d2-83d9-f2bd86dd5290">one year</ix:nonNumeric>, 2005, for <ix:nonFraction unitRef="state" contextRef="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2Mjk4_3a83b4c5-d071-47ca-8fc5-ce991f4e715c">one</ix:nonFraction> state.  As of July 25, 2022, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="ieb8bd3a428de40bf9399cc65d205e0fa" continuedAt="i4746ae8c8c894135a87aa045c028613b"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enforce have now been resolved either through settlement or exhaustion of appeals.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#8217;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $<ix:nonFraction unitRef="usd" contextRef="iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM4NjA3_1221e5bf-9d06-4f81-bf5e-062d09f70138">32</ix:nonFraction> million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings for the first quarter of 2021 as a reduction in cost of sales.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of <ix:nonNumeric contextRef="i346e658d67ab4443b81460637eece234_D20060801-20060831" name="mo:FederalTradeCommissionDisclosurePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQyMTkx_6e047c27-1646-4763-9d1f-159864a023f0">10</ix:nonNumeric> years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i4746ae8c8c894135a87aa045c028613b" continuedAt="i3b4a637e4d834a018b22dc538f160339"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, we recorded provisions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i5a1126f30d7047cabf8a35e278d210e4_D20190101-20191231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_050b50f1-2b15-4b65-bc6c-3fb1f42ccd65"><ix:nonFraction unitRef="usd" contextRef="ie90404e480bd486abe1322ee5d399a7e_D20140101-20141231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_648ca754-c29e-422d-aa85-d03c34b1980d"><ix:nonFraction unitRef="usd" contextRef="ic402594e8e0340378ab44dfc725a5202_D20190101-20191231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_65ca27ea-afd0-40ba-9a3c-f9cd94163c3c"><ix:nonFraction unitRef="usd" contextRef="ic17131fdfa6d4b22ab39238b34d989c6_D20140101-20141231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_a87fc328-2a30-4b57-97a9-72bad7cd5e43">36</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million for the estimated costs of implementing the corrective communications remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  A hearing for the district court to consider and approve any settlement and consent decree proposed by the parties is set for July 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, we filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, we are defendants in <ix:nonFraction unitRef="claim" contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0NDcw_82d0c0d3-1682-4bab-bc0d-9c7958e556e3">58</ix:nonFraction> class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The <ix:nonFraction unitRef="claim" contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0ODU2_5512f943-cfbd-4aff-ac65-26b5ea49ef21">58</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="claim" contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0ODg5_aebddeb1-35c2-495c-94d2-d10c6704bd0a">32</ix:nonFraction> cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  <ix:nonFraction unitRef="claim" contextRef="i611c10d6dd834dab966ca0225a1eac42_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MDgw_815feaf5-fa8f-4739-8adc-556f1ac73d75">Three</ix:nonFraction> of the class action lawsuits are pending in Canada.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including <ix:nonFraction unitRef="claim" contextRef="i18fb1c9978ec48949a63f54f3c2ec853_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MjM0_f7010e5f-f871-4c16-b499-469dc70699c7">2,957</ix:nonFraction> individual lawsuits and <ix:nonFraction unitRef="claim" contextRef="iec4f544b33974b84b91ca169738940e5_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MjYx_0012472e-fd6e-495b-9e71-8742b22e1f84">1,015</ix:nonFraction> &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#8217; motion to certify a nationwide class based on state law claims against JUUL and RICO claims against Altria and other defendants.  Altria and the other defendants have filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court has set trial dates for <ix:nonFraction unitRef="case" contextRef="ibe88256c0632439c804ad259ee58ac49_I20220630" decimals="INF" name="mo:LossContingencyNumberOfCasesWithSetTrialDates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTAxMTk_42887e93-280e-42ea-9856-fe34ea29e838">five</ix:nonFraction> cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for November 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="lawsuit" contextRef="i7ee7e14784294b1aa50a20edf7383985_I20220630" decimals="INF" name="mo:NumberOfThirdPartyLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3MTk1_83fd260d-41c5-4c64-b358-6230b3009ed3">Three</ix:nonFraction> of the &#8220;third party&#8221; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss each of these three lawsuits and the motions were denied in February 2022, May 2021 and June 2021, respectively.  However, in the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#8217;s claims, the trial court did dismiss plaintiff&#8217;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  JUUL is also named in other attorneys general lawsuits in which we </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i3b4a637e4d834a018b22dc538f160339" continuedAt="i97f6ca046cab478881ba1cdd3304eee6"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are not currently named.  As of July 25, 2022, JUUL settled <ix:nonFraction unitRef="claim" contextRef="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725" decimals="INF" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3ODY0_c805f434-93d6-4dd8-a495-5cefe0d37d56">four</ix:nonFraction> such lawsuits by, in each case, agreeing to a monetary payment (on average approximately $<ix:nonFraction unitRef="usd" contextRef="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725" decimals="INF" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3OTU2_0bf31075-6dce-4946-a634-7c8f8394c340">20</ix:nonFraction> million) and to certain restrictions on its sales and marketing activities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the IQOS electronic device and HeatSticks in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#8217; claims against the other defendants have been stayed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA, Altria Client Services LLC and Philip Morris Products S.A. filed counterclaims against plaintiffs alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In June 2022, PM USA and Altria Client Services LLC reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#8220;ITC&#8221;), but the remedies sought included a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  <ix:nonFraction unitRef="usd" contextRef="i06aaddc0651c4da18fe616a4c53e7a2e_D20200401-20200430" decimals="INF" name="mo:LossContingencyDamagesRecoverableValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ5NTEz_b6956dba-4a5b-42c8-9bec-4c85ce700f0e">No</ix:nonFraction> damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#8217; motion to stay the orders pending the conclusion of the appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#8217;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our <ix:nonFraction unitRef="number" contextRef="i3c099a74ac94476c86a02b82115806c9_I20200430" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUwOTI3_1e428697-8878-4fde-bf9a-9e42c45a410c">35</ix:nonFraction>% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#8217;s decision to the FTC.  Oral argument with respect to the appeal is currently scheduled for September 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of July 25, 2022, <ix:nonFraction unitRef="lawsuit" contextRef="ib39dbb98e8d440f28749e4aee5911bf3_I20220725" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUyMjkx_1f33ad87-0533-4da3-814d-4fbdb9d19a2f">17</ix:nonFraction> putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into <ix:nonFraction unitRef="complaint" contextRef="id54b8c1baf4c4086bb509612132c190e_I20201130" decimals="INF" name="mo:LossContingencyNumberOfComplaints" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUyNzUy_7f816804-0fd8-47e7-8830-9f552136a9b7">three</ix:nonFraction> complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#8217; claims against JUUL be sent to arbitration pursuant to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i97f6ca046cab478881ba1cdd3304eee6" continuedAt="i7211502b0f934f3786c95b8eb97beca1"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an arbitration provision in JUUL&#8217;s online purchase agreement.  The court granted plaintiffs&#8217; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in <ix:nonFraction unitRef="claim" contextRef="id41b8120810c4e6d829b0b1591449c2e_D20220201-20220228" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU0MjM4_11362d02-9dc4-4157-a17a-ef31acd20cb7">four</ix:nonFraction> new plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  We do not currently intend to exercise our additional governance rights obtained upon conversion, including the right to elect directors to JUUL&#8217;s board or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October and December 2019, <ix:nonFraction unitRef="shareholder" contextRef="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU0NzU3_79d61fc4-c636-41a2-9551-d31f4fb435d4">two</ix:nonFraction> purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the <ix:nonFraction unitRef="shareholder" contextRef="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU1MTQ1_79d61fc4-c636-41a2-9551-d31f4fb435d4">two</ix:nonFraction> lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2MTU4_6ba5adb8-e152-44f3-94a4-d0e75fc27a1e">90</ix:nonFraction> million, which amount includes attorneys&#8217; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court preliminarily approved the settlement in December 2021 and granted final approval in March 2022.  We recorded pre-tax provisions totaling $<ix:nonFraction unitRef="usd" contextRef="i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2NTQy_958b40ff-ac93-40c5-8fbf-cd88aa5206e9">90</ix:nonFraction> million in 2021 and, in January 2022, paid $<ix:nonFraction unitRef="usd" contextRef="i6585b27441174f2ea5fcb1e108ef4379_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2NTgw_30b71fe7-c75b-42ed-9568-4b5e241b08f6">90</ix:nonFraction> million to plaintiffs&#8217; escrow account.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, <ix:nonFraction unitRef="shareholder" contextRef="i9be017d1acc2442bb23883e51a46e1d2_D20200801-20200831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2Njcx_49e105b3-c0ad-4952-b8c4-2981b7199ce5">two</ix:nonFraction> purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  <ix:nonFraction unitRef="shareholder" contextRef="iae31955a3e5d46a98b6382848e87c3dc_D20201001-20210331" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU3MzUw_5d9e3acc-f75e-48ea-85c4-b7596b38b06c">Three</ix:nonFraction> additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="ic49230ad8f5446c9b722373434519ae5_D20210401-20210430" decimals="INF" name="mo:LossContingencyNumberOfPendingCasesConsolidated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4MDY1_012a2fb8-7898-4604-9ea4-abe323d888dd">five</ix:nonFraction> cases pending in the Eastern District of Virginia into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shareholder" contextRef="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4MTc3_480af928-3567-4de4-8caf-dceb5180bf8a">Six</ix:nonFraction> derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, the court consolidated <ix:nonFraction unitRef="claim" contextRef="id4b290e9d4bd4c9f8883131d3263103a_D20210701-20220131" decimals="INF" name="mo:LossContingencyNumberOfPendingCasesConsolidated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4ODk1_f5ce8ef6-9bbb-45fc-a1ae-04e1db4318ee">five</ix:nonFraction> of these <ix:nonFraction unitRef="shareholder" contextRef="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4OTA3_43d8b78e-928c-4042-b659-6136f6ffc682">six</ix:nonFraction> state derivative cases into a single consolidated case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and other parties to the federal and state derivative actions have reached an agreement in principle to resolve these actions through the execution of a memorandum of understanding.  The parties are in the process of negotiating formal settlement documentation.  The derivative settlement will be subject to court approval.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in <ix:nonFraction unitRef="case" contextRef="i49fc4815acd44dd095f74bae91742f69_I20220725" decimals="INF" name="mo:LossContingencyClaimsNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU5OTY4_9e409350-acce-412c-9eee-e20bdd00c5e5">23</ix:nonFraction> &#8220;Lights&#8221; cases have refused to certify class actions, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><ix:continuation id="i7211502b0f934f3786c95b8eb97beca1"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of July 25, 2022, <ix:nonFraction unitRef="claim" contextRef="i49fc4815acd44dd095f74bae91742f69_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMTc0_7f395757-c96e-40f6-a682-5e630d39c6d3">two</ix:nonFraction> &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state courts.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, <ix:nonFraction unitRef="claim" contextRef="i44d3390cbcd0491bb2a57fa5618b6c6a_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMjk0_2ecbc880-e20f-44e5-848e-6d795747b674">one</ix:nonFraction> smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of July 25, 2022, there is <ix:nonFraction unitRef="claim" contextRef="i453bba98eb8743d79202cf42541d0607_I20220725" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxMzQ2_c62d8a7c-cd1e-4971-94ca-a30e68c49495">no</ix:nonFraction> such case pending against UST and/or its tobacco subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our condensed consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At June&#160;30, 2022, we (i) had $<ix:nonFraction unitRef="usd" contextRef="i8f7dbe193b884cf4a3753d6b4bbf0f5f_I20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzMjY0_d2e91972-ba1e-4fc5-8a4b-898d56f55762">46</ix:nonFraction> million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $<ix:nonFraction unitRef="usd" contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzNDMw_2195b684-a48e-495b-87ca-bcaeba957d73">19</ix:nonFraction> million for surety bonds recorded on our condensed consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our condensed consolidated balance sheet at June&#160;30, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $<ix:nonFraction unitRef="usd" contextRef="i70c873e1e88d4ecaa8226421d8083196_I20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0Nzc0_eed85b9f-e278-4ecb-b34a-df2cfe882a23">3.0</ix:nonFraction> billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 9. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ebt.</span></div></ix:continuation><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMTIvZnJhZzpjZDk5ZWVkODRmNDM0ZTlkYjI3YzA4MDFiMGYyM2Q5ZS90ZXh0cmVnaW9uOmNkOTllZWQ4NGY0MzRlOWRiMjdjMDgwMWIwZjIzZDllXzE3Mg_43ac2fe2-6321-4dd6-b264-dcbd85e752ec" continuedAt="id8c62e038e4c41e888e525ac93a1fefa" escape="true">New Accounting Guidance Not Yet Adopted</ix:nonNumeric></span></div><ix:continuation id="id8c62e038e4c41e888e525ac93a1fefa"><ix:nonNumeric contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMTIvZnJhZzpjZDk5ZWVkODRmNDM0ZTlkYjI3YzA4MDFiMGYyM2Q5ZS90ZXh0cmVnaW9uOmNkOTllZWQ4NGY0MzRlOWRiMjdjMDgwMWIwZjIzZDllXzE4OQ_d599d52b-ad3c-4c1e-8548-8a285e2ea1a6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:</span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i69bd249cc2fe4da28a5be5c8937fefc9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_115"></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_118"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in this Quarterly Report on Form 10-Q (&#8220;Form 10-Q&#8221;), the terms </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) section, we refer to the following &#8220;adjusted&#8221; financial measures: adjusted operating companies income (loss) (&#8220;OCI&#8221;); adjusted OCI margins; adjusted net earnings attributable to Altria; adjusted diluted earnings per share attributable to Altria; and adjusted effective tax rates.  These adjusted financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (&#8220;GAAP&#8221;) and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.  For a further description of these non-GAAP financial measures, see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_121"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+.  Our Vision by 2030 is to responsibly lead the transition of adult smokers to a smoke-free future (&#8220;Vision&#8221;).  We are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moving Beyond Smoking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, our businesses and society.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products.  In combustibles, we own Philip Morris USA Inc. (&#8220;PM USA&#8221;), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (&#8220;Middleton&#8221;), a leading U.S. cigar manufacturer.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), the leading global moist smokeless tobacco (&#8220;MST&#8221;) manufacturer, and Helix Innovations LLC (&#8220;Helix&#8221;), a rapidly growing manufacturer of oral nicotine pouches.  We also enhance our smoke-free product portfolio with exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and an equity investment in JUUL Labs, Inc. (&#8220;JUUL&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we own equity investments in Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), the world&#8217;s largest brewer, and Cronos Group Inc. (&#8220;Cronos&#8221;), a leading Canadian cannabinoid company.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The brand portfolios of our tobacco operating companies include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Black &amp; Mild</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Trademarks and service marks related to Altria referenced in this Form 10-Q are the property of Altria or our subsidiaries or are used with permission.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends and Developments</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this MD&amp;A section, we discuss factors that have impacted our business as of the date of this Form 10-Q.  In addition, we are aware of certain trends and developments that could, individually or in the aggregate, have a material impact on our business, including the value of our equity investments, in the future.  In this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends and Developments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section, we focus on the potential </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effects on our business resulting from the recent rise in the rate of inflation, the continuing effects of the COVID-19 pandemic, the Russian invasion of Ukraine and recent regulatory actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor the evolving macroeconomic and geopolitical landscape.  High rates of inflation continued in the second quarter of 2022, driven by increasing global energy, commodity and food prices, which were further exacerbated by other factors, including supply and demand imbalances, labor shortages and the Russian invasion of Ukraine.  High inflation, high gas prices, rising interest rates, the COVID-19 pandemic and the end of federal government stimulus could impact our business by negatively impacting adult tobacco consumers&#8217; disposable income and future purchasing behavior.  We expect fluctuations in discount product share for cigarettes and MST products as price sensitive adult tobacco consumers react to their economic conditions.  We continue to monitor the effect of these dynamics on adult tobacco consumers and their purchasing behaviors, including overall tobacco product expenditures, mix between premium and discount brand purchases and adoption of smoke-free products.  Increases in inflation also have a direct and adverse impact on our Master Settlement Agreement (&#8220;MSA&#8221;) expense and other direct and indirect costs.  We expect inflation to continue at increased levels in 2022, and the extent of any effects on adult tobacco consumer purchasing behavior depends in part on the magnitude and duration of such increase.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on evolving trends in the tobacco industry and the impacts to our business from increased inflation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volatility in domestic and global economies and disruptions in the supply and distribution chains continued in the second quarter of 2022, resulting from several factors, including the on-going impacts of the COVID-19 pandemic and the Russian invasion of Ukraine.  While our operating companies focus on the manufacture and sale of tobacco products in the United States and have little direct exposure to Russia and Ukraine, we have experienced negative effects on the cost and availability of certain raw materials and component parts for our products.  We continue to work to mitigate the potential negative impacts of these macroeconomic and geopolitical dynamics on our businesses through, among other actions, proactive engagement with current and potential suppliers and distributors, the development of alternative sourcing strategies, long-term supply contracts, evolution of our safety, health and environmental protocols at our facilities and prudent oversight of our liquidity.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the supply chain and other impacts of the macroeconomic and geopolitical environment on our business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco companies are subject to broad and evolving regulatory and legislative frameworks that could have a material impact on our business.  For example, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) has stated its intention to issue proposed product standards regarding menthol in cigarettes and characterizing flavors in cigars in the near future and, in June 2022, the Biden Administration published plans for future potential regulatory actions that include the FDA&#8217;s plans to develop a proposed product standard that would establish a maximum nicotine level for cigarettes and certain other combusted tobacco products.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on the nature, scope and potential impacts of regulatory and legislative developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FDA issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL pre-market tobacco applications (&#8220;PMTA&#8221;) that warrant additional agency review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products currently remain on the market.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment - FSPTCA and FDA Regulation - FDA Regulatory Actions - Electronic Nicotine Delivery System Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the MDOs.  We considered, among other factors, the impact of the FDA&#8217;s actions in conducting our quarterly quantitative valuation of our investment in JUUL at June 30, 2022.  As a result, we recorded a non-cash, pre-tax unrealized loss of $1.2 billion for the three months ended June 30, 2022.  We will continue to monitor developments with the FDA&#8217;s additional review, among other factors, in our quarterly quantitative valuations of JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ABI&#8217;s business also continues to be impacted by macroeconomic and geopolitical factors.  ABI has been impacted by supply chain constraints across certain markets, foreign exchange rate fluctuations, inflation and commodity cost headwinds.  ABI has a joint venture with exposure to Russia and Ukraine, which it fully impaired in the first quarter of 2022 and has announced plans to sell.  Additionally, the macroeconomic and geopolitical factors have contributed to significant changes in certain foreign exchange rates, including the Euro to U.S. dollar exchange rate, resulting in the fair value of our investment in ABI declining below its carrying value by $1.1 billion at June 30, 2022, which we concluded was temporary.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements in Part I, Item 1. Financial Statements of this Form 10-Q (&#8220;Item 1&#8221;) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our equity investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor the increased risk of cyber attacks as a result of the Russian invasion of Ukraine.  We have implemented heightened cybersecurity monitoring of our systems and those of our critical suppliers designed to address the evolving threat landscape.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the reduction in the fair value of our equity investment in JUUL has had a material adverse effect on our financial results, to date, we have not experienced any material adverse effects on our business or our ability to achieve our Vision as a result of the trends and developments discussed above.  As the trends and developments discussed above evolve and new ones emerge, we will continue to evaluate the potential impacts on our business and our Vision.</span></div><div style="margin-bottom:5pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations for the Six Months Ended June 30, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in net earnings attributable to Altria and diluted earnings per share (&#8220;EPS&#8221;) attributable to Altria for the six months ended June 30, 2022, from the six months ended June 30, 2021, were due primarily to the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the six months ended June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 JUUL changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Income tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2021 special items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 NPM Adjustment Items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 JUUL changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.09)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Income tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2022 special items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.81)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the six months ended June 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported Net Earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported Net Earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Fewer Shares Outstanding:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fewer shares outstanding were due to shares we repurchased under our share repurchase program.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Operations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $61 million in operations (which excludes the impact of special items shown in the table above) was due primarily to higher OCI and lower interest and other debt expense, net.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations for the Three Months Ended June 30, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in net earnings attributable to Altria and diluted EPS attributable to Altria for the three months ended June 30, 2022, from the three months ended June 30, 2021, were due primarily to the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 JUUL changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Income tax items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2021 special items</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 JUUL changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Income tax items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2022 special items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.77)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the three months ended June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported Net Earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported Net Earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(57.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted Net Earnings and Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.81pt">Fewer Shares Outstanding:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fewer shares outstanding were due to shares we repurchased under our share repurchase program.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Forecasted Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our 2022 full-year adjusted diluted EPS to be in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% over our 2021 full-year adjusted diluted EPS of $4.61, as shown in the first table below.  While the 2022 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic.  We will continue to monitor conditions related to (i) the economy, including the impact of increased inflation, rising interest rates and global supply chain disruptions, (ii) the impact of current and future COVID-19 variants and mitigation strategies, (iii) adult tobacco consumer dynamics, including tobacco usage occasions, available disposable income, purchasing patterns and adoption of smoke-free products, (iv) regulatory and legislative developments and (v) the impacts of the Russian invasion of Ukraine.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2022 full-year adjusted diluted EPS guidance range includes planned investments in support of our Vision, such as (i) enhancement of our digital consumer engagement system, (ii) increased smoke-free product research, development and regulatory preparation expenses and (iii) marketplace activities in support of our smoke-free products.  The guidance range also includes anticipated inflationary increases in MSA expenses and direct and indirect materials costs and our current expectation that PM USA will not have access to the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system in 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of 2021 Reported Diluted EPS to 2021 Adjusted Diluted EPS</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following (income) expense items are excluded from our 2022 forecasted adjusted diluted EPS growth rate:</span></div><div style="margin-bottom:5pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Income) Expense Excluded from 2022 Forecasted Adjusted Diluted EPS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of certain income and expense items excluded from the forecasted results above, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our full-year adjusted diluted EPS forecast excludes the impact of certain income and expense items, including those items noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, that our management believes are not part of underlying operations.  Our management cannot estimate on a forward-looking basis the impact of these items on our reported diluted EPS because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable.  As a result, we do not provide a corresponding GAAP measure for, or reconciliation to, our adjusted diluted EPS forecast.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_124"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we report our financial results in accordance with GAAP, our management reviews OCI, which is defined as operating income before general corporate expenses and amortization of intangibles, to evaluate the performance of, and allocate resources to, our segments.  Our management also reviews certain financial results, including OCI, OCI margins, net earnings attributable to Altria and diluted EPS, on an adjusted basis, which excludes certain income and expense items that our management believes are not part of underlying operations.  These items may include, for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition-related and disposition-related costs, equity investment-related special items (including any changes in fair value of our equity investment recorded using the fair value option and any changes in the fair value of related warrants and preemptive rights), certain income tax items, charges associated with tobacco and health and certain other litigation items, and resolutions of certain non-participating manufacturer (&#8220;NPM&#8221;) adjustment disputes under the MSA (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221;).  Our management does not view any of these special items to be part of our underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results.  Our management also reviews income tax rates on an adjusted basis.  Our adjusted effective tax rate may exclude certain income tax items from our reported effective tax rate.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management believes that adjusted financial measures provide useful additional insight into underlying business trends and results, and provide a more meaningful comparison of year-over-year results.  Our management uses adjusted financial measures and regularly provides these to our chief operating decision maker (&#8220;CODM&#8221;) for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.  These adjusted financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.  Except as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Forecasted Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, when we provide a non-GAAP measure in this Form 10-Q, we also provide a reconciliation of that non-GAAP financial measure to the most directly comparable GAAP financial measure.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:10pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Discussion and Analysis</span></div><div style="margin-bottom:5pt;margin-top:10pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, our equity investment in ABI consisted of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The fair value of our equity investment in ABI is based on: (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI at December 31, 2021 and March 31, 2022 was $11.9 billion for both periods, which exceeded its carrying value of $11.1 billion and $11.3 billion by approximately 7% and 5%, respectively.  In the second quarter of 2022, the fair value of our equity investment in ABI declined and at June 30, 2022 was below its carrying value by $1.1 billion or approximately 9%.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity investment until full recovery to its carrying value in the near-term.  In preparing our financial statements for the period ended June 30, 2022, we evaluated these factors, including the macroeconomic and geopolitical factors that have resulted in significant changes in certain foreign exchange rates.  We determined that the primary driver of the decline in fair value below the carrying value, which began during the second quarter of 2022, was the significant changes in foreign exchange rates, including the Euro to U.S. dollar exchange rate, and not a decline in ABI&#8217;s Euro-based share price.  From the time that we recorded the non-cash pre-tax impairment charge of $6.2 billion in the third quarter of 2021, ABI&#8217;s Euro-based share price has increased 5% as of June 30, 2022.  Additionally, ABI has delivered consistent business and earnings performance over the past several quarters demonstrating its ability to continue to execute its strategies and navigate challenges.  We concluded at June 30, 2022 that the decline in fair value of our equity investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.  We continue to have confidence in ABI&#8217;s (i) long-term strategies, (ii) premium global brands, (iii) experienced management team and (iv) capability to successfully navigate its near-term challenges.  At July 25, 2022, the fair value of our equity investment in ABI was below its carrying value by $0.9 billion or approximately 8%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to monitor our equity investment in ABI.  If we were to conclude that the decline in fair value was other than temporary, we would determine and recognize, in the period identified, the impairment of our equity investment, which could result in a material adverse effect on our consolidated financial position or earnings.</span></div><div style="margin-bottom:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2022, the estimated fair value of our investment in JUUL was $450 million, as compared with $1.6 billion at March 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FDA issued MDOs to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products currently remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the estimated fair value of our investment in JUUL at June 30, 2022 was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products, which are currently marketed in the United States that have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency law, and (iii) projections of higher operating expenses resulting in lower long-term operating margins.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of our investment in JUUL in the second quarter of 2022, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the: (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency law; (iii) risk created by the number and types of legal cases </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our discounted cash flow analyses were based on assumptions that our management considered reasonable and were based on the best available information at the time that the analyses were developed, there is significant judgment used in determining future cash flows.  If the following factors, in isolation, significantly deviate from current expectations, we believe that they have the potential to materially impact our significant assumptions of the likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates, thus potentially materially decrease our valuation of our investment in JUUL:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">unfavorable regulatory and legislative developments at the international, federal, state and local levels such as (i) final determination by the FDA on the JUUL MDOs, which are now under additional administrative review (which could result in the removal of products from the U.S. market) or (ii) FDA denying future tobacco product applications for JUUL&#8217;s flavored e-vapor products, which are currently not permitted in the market without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">JUUL&#8217;s inability to maintain adequate liquidity necessary to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency law;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a successful challenge by the U.S. Federal Trade Commission (&#8220;FTC&#8221;) in its administrative complaint against Altria and JUUL, discussed further in Note 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our condensed consolidated financial statements in Item 1 (&#8220;Note 11&#8221;);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">unfavorable financial and market performance, including substantial changes in competitive dynamics; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">delay in timing of international expansion plans.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the following factors, in isolation, significantly deviate from current expectations, we believe that they have the potential to materially impact our significant assumptions of the likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates, thus potentially materially increase our valuation of our investment in JUUL: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable regulatory and legislative developments at the international, federal, state and local levels such as FDA authorization of (i) existing JUUL products that have received MDOs from the FDA and that are now under additional administrative review or (ii) future tobacco product applications for JUUL&#8217;s flavored e-vapor products, which are currently not permitted in the market without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.78pt">JUUL&#8217;s ability to maintain adequate financing to fund projected cash needs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable developments related to litigation; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable financial and market performance, including substantial changes in competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our management believes that the recorded value of our investment in JUUL at June 30, 2022 represents our best estimate of the fair value of the investment, JUUL&#8217;s actual performance in the short term or long term could be significantly different from forecasted performance due to changes in the factors noted above.  Additionally, the value of our investment in JUUL could be significantly impacted by changes in the discount rate, which could be caused by numerous factors, including changes in market inputs, as well as risks specific to JUUL, including the outcome of the FDA&#8217;s additional review of the JUUL PMTAs that have received MDOs and favorable or unfavorable developments related to JUUL&#8217;s liquidity and litigation environment.</span></div><div style="margin-bottom:5pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value and carrying value of our equity method investment in Cronos at December 31, 2021 was $617 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $55 million or approximately 10%.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June 30, 2022.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity method investment until full recovery to its carrying value in the near-term.  In preparing our financial statements for the period ended June 30, 2022, we evaluated these factors and determined that there was not sufficient evidence to conclude that the impairment was temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $107 million for the six and three months ended June 30, 2022, which was recorded in (income) losses from equity investments in our condensed consolidated statement of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#8217;s share price and the Canadian dollar to U.S. dollar exchange rate at June 30, 2022 and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">carrying value of our equity method investment in Cronos at June 30, 2022.  At June 30, 2022, prior to recording the impairment charge, the fair value of our equity method investment in Cronos was less than its carrying value by approximately 20%.  After recording the impairment charge, the fair value and carrying value of our equity method investment in Cronos at June 30, 2022 were both $437 million.  We will continue to assess the fair value of our equity method investment in Cronos to determine if any decline in fair value below its carrying value is other than temporary.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in ABI, JUUL and Cronos, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements in Item 1 (&#8220;Note 3&#8221;).</span></div><div style="margin-bottom:2pt"><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consolidated Operating Results</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,543</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excise Taxes on Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,181</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,137</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,242</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,169</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements in Item 1 (&#8220;Note 8&#8221;), our CODM reviews OCI to evaluate the performance of, and allocate resources to, our segments.  Our management believes it is appropriate to disclose this measure to help investors analyze the business performance and trends of our business segments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the six months ended June 30:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,428</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">167</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted for Special Items</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,768</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,439</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,329</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted for Special Items</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,267&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the three months ended June 30:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">714</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted for Special Items</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,034</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">752</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.26</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">litigation items </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted for Special Items</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following special items affected the comparability of statements of earnings amounts for the six and three months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">NPM Adjustment Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NPM Adjustment Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 8, respectively.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Asset Impairment, Exit, Implementation, Acquisition and Disposition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of acquisition-related costs in our oral tobacco products segment for the six months ended June 30, 2021, see Note 8.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Tobacco and Health and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of tobacco and health and certain other litigation items and a breakdown of these costs by segment, see Note 11 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health and Certain Other Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 8, respectively.</span></div><div style="margin-bottom:2pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">JUUL Changes in Fair Value: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded non-cash, pre-tax unrealized (income) losses from equity investments in our condensed consolidated statements of earnings as a result of changes in the estimated fair value of our investment in JUUL consisting of the following:</span></div><div style="margin-bottom:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:42.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded corresponding adjustments to the JUUL tax valuation allowance in 2022 and 2021.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 3.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.11pt">ABI-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax losses of $53&#160;million from our equity investment in ABI for the six months ended June 30, 2022, consisting primarily of ABI&#8217;s non-cash impairment charge related to its investment in a joint venture with direct exposure to Russia and Ukraine, partially offset by net mark-to-market gains on certain ABI financial instruments associated with its share commitments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax losses of $112&#160;million from our equity investment in ABI for the three months ended June 30, 2022, consisting primarily of ABI&#8217;s non-cash impairment charge related to its investment in a joint venture with direct exposure to Russia and Ukraine.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax income of $89&#160;million from our equity investment in ABI for the six months ended June 30, 2021, consisting primarily of ABI&#8217;s completion of the issuance of a minority stake in its U.S.-based metal container operations and net mark-to-market gains on certain ABI financial instruments associated with its share commitments, partially offset by charges associated with early bond terminations by ABI.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax charges of $39&#160;million from our equity investment in ABI for the three months ended June 30, 2021, consisting primarily of charges associated with early bond terminations by ABI.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts include our respective share of the amounts recorded by ABI and additional adjustments related to (i) conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Cronos-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax (income) expense consisting of the following:</span></div><div style="margin-top:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.531%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Cronos-related special items - (income) expense</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts are related to the non-cash change in the fair value of the warrant and certain anti-dilution protections (the &#8220;Fixed-price Preemptive Rights&#8221;) acquired in the Cronos transaction.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Amounts include our share of special items recorded by Cronos and additional adjustments, if required under the equity method of accounting, related to our investment in Cronos including the $107 million non-cash, pre-tax impairment of our investment in Cronos in the second quarter of 2022.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded corresponding adjustments to the Cronos tax valuation allowance in 2022 and 2021 relating to the special items.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 3.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Loss on Early Extinguishment of Debt:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax losses of $649&#160;million for the for the six months ended June 30, 2021, as a result of the completion of debt tender offers and redemption for certain of our long-term senior unsecured notes as discussed in Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our condensed consolidated financial statements in Item 1 (&#8220;Note 9&#8221;).</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2022 Compared with Six Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $537 million (4.1%), due primarily to the sale of our wine business in October 2021 and lower net revenues in the smokeable products and oral tobacco products segments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $336 million (9.6%), due primarily to lower shipment volume in our smokeable products segment and the sale of our wine business, partially offset by higher per unit settlement charges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $236 million (9.5%), due primarily to lower shipment volume in our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs decreased $78 million (6.9%), due primarily to the sale of our wine business, acquisition-related costs in 2021 in our oral tobacco products segment and lower spending associated with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, partially offset by higher costs in our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased $113 million (1.9%), due primarily to higher operating results in our smokeable products segment, partially offset by the sale of our wine business and lower operating results in our oral tobacco products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other debt expense, net decreased $42 million (7.0%), due primarily to lower interest costs as a result of debt maturities and refinancing activities in 2021 and lower interest costs on our Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from equity investments decreased $1,355 million (100%+), due primarily to non-cash, unrealized losses resulting from the changes in the estimated fair value of our investment in JUUL in 2022 and lower income from our equity investment in ABI, which included a negative impact from special items.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rate increased 7.1 percentage points to 33.4%.  For further discussion, see Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our condensed consolidated financial statements in Item 1 (&#8220;Note 10&#8221;). </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings attributable to Altria of $2,850 million decreased $723 million (20.2%), due primarily to unfavorable results from our equity investments, partially offset by the loss on early extinguishment of debt in 2021, higher operating income and lower interest and other debt expense, net.  Reported basic and diluted EPS attributable to Altria of $1.57 each decreased by 18.7%, due to lower reported net earnings attributable to Altria, partially offset by fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $4,329 million increased $60 million (1.4%), due primarily to higher OCI and lower interest and other debt expense, net.  Adjusted diluted EPS attributable to Altria of $2.38 increased by 3.5%, due to fewer shares outstanding and higher adjusted net earnings attributable to Altria.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2022 Compared with Three Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $393 million (5.7%), due primarily to lower net revenues in the smokeable products segment, the sale of our wine business in October 2021 and lower net revenues in the oral tobacco products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $174 million (9.2%), due primarily to lower shipment volume in our smokeable products segment and the sale of our wine business, partially offset by higher per unit settlement charges and higher manufacturing costs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $153 million (11.6%), due primarily to lower shipment volume in our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs increased $15 million (2.7%), due primarily to higher costs in our smokeable products segment (including higher tobacco and health and certain other litigation items), partially offset by the sale of our wine business and lower spending associated with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income decreased $81 million (2.5%), due primarily to lower operating results in our oral tobacco and smokeable products segments and the sale of our wine business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other debt expense, net decreased $15 million (5.1%), due primarily to lower interest costs on our Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro and debt maturities in 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from equity investments decreased $1,338 million (100.0%+), due primarily to non-cash, unrealized losses resulting from the change in the estimated fair value of our investment in JUUL in 2022 and lower income from our equity investment in ABI, primarily due to special items.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rate increased 18.4 percentage points to 44.5%.  For further discussion, see Note 10. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings attributable to Altria of $891 million decreased $1,258 million (58.5%), due primarily to unfavorable results from our equity investments and lower operating income, partially offset by the loss on Cronos-related instruments in 2021.  Reported basic and diluted EPS attributable to Altria of $0.49, each decreased by 57.8%, due to lower reported net earnings attributable to Altria, partially offset by fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $2,282 million decreased $4 million (0.2%).  Adjusted diluted EPS attributable to Altria of $1.26 increased by 2.4%, due to fewer shares outstanding.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_130"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results by Business Segment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco Space</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States tobacco industry faces a number of business and legal challenges that have adversely affected and may adversely affect our business and our consolidated results of operations, cash flows or financial position or our ability to achieve our Vision.  These challenges, some of which are discussed in more detail in Note 11 and in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2021 (&#8220;2021 Form 10-K&#8221;), include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">pending and threatened litigation and bonding requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions and requirements imposed by the Family Smoking Prevention and Tobacco Control Act (the &#8220;FSPTCA&#8221;), and restrictions and requirements (and related enforcement actions) that have been, and in the future will be, imposed by the FDA;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">actual and proposed excise tax increases, as well as changes in tax structures and tax stamping requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">bans and restrictions on tobacco use imposed by governmental entities and private establishments and employers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other federal, state and local government actions, including:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions on the sale of certain tobacco products, the sale of tobacco products by certain retail establishments, the sale of tobacco products with characterizing flavors and the sale of tobacco products in certain package sizes;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">additional restrictions on the advertising and promotion of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other actual and proposed tobacco-related legislation and regulation; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">governmental investigations;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reductions in cigarette and MST products consumption levels due to growth of innovative tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">increased efforts by tobacco control advocates and other private sector entities (including retail establishments) to further restrict the availability and use of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">changes in adult tobacco consumer purchase behavior, which is influenced by various factors such as macroeconomic conditions (including inflation), excise taxes and price gap relationships, may result in adult tobacco consumers switching to discount products or other lower-priced tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the highly competitive nature of all tobacco categories, including competitive disadvantages related to cigarette price increases attributable to the settlement of certain litigation and the proliferation of innovative tobacco products, such as e-vapor and oral nicotine pouch products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">illicit trade in tobacco products; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">potential adverse changes in prices, availability and quality of tobacco, other raw materials and component parts, including as a result of changes in macroeconomic and geopolitical conditions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to and in connection with the foregoing, evolving adult tobacco consumer preferences continue to impact the tobacco industry.  We believe that a significant number of adult tobacco consumers switch among tobacco categories, use multiple forms of tobacco products and try innovative tobacco products, such as e-vapor products and oral nicotine pouches.  Adult smokers continue to transition from cigarettes to exclusive use of smoke-free tobacco product alternatives, which aligns with our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work to meet these evolving adult tobacco consumer preferences over time by developing, manufacturing, marketing and distributing products both within and outside the United States through innovation and other growth strategies (including, where appropriate, arrangements with, or investments in, third parties).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past two years, the legislative and regulatory activities discussed below negatively impacted growth in the e-vapor category.  Despite the challenges these activities have created and continue to create in the marketplace, the e-vapor category experienced moderate growth in 2021 and remains competitive in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oral nicotine pouch retail share of the total oral tobacco category grew significantly over the prior year from 13.6% for the six months ended June 30, 2021 to 20.1% for the six months ended June 30, 2022.  The oral nicotine pouch category continues to be increasingly competitive.  In addition, oral nicotine pouch growth has primarily sourced from cigarette and smokeless tobacco consumers.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are monitoring the sale and distribution of synthetic nicotine products, including in the form of e-vapor products and oral nicotine pouches.  As a result of recent amendments to the U.S. Food, Drug and Cosmetic Act, synthetic nicotine products are now subject to FDA regulatory oversight, as discussed further below.  We believe FDA regulatory actions, which may be subject to legal challenges, will further impact the competitive environment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the innovative tobacco product categories will continue to be dynamic due to competition, adult tobacco consumer exploration of a variety of tobacco product options, adult tobacco consumer perceptions of the relative risks of smoke-free products compared to cigarettes, FDA determinations on product applications and legislative actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022, we estimate that, when adjusted for trade inventory movements and other factors, domestic cigarette industry volume declined by 7.5%.  We expect 2022 cigarette industry volume trends to continue to be most influenced by (i) disposable income, purchasing patterns and adoption of smoke-free products, (ii) macroeconomic conditions (including increased inflation and gasoline prices, partially offset by low unemployment and wage inflation), (iii) cross-category movement, (iv) the potential impact of COVID-19 variants and (v) regulatory and legislative (including excise tax) developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic conditions (including a high inflationary environment) can also impact adult tobacco consumer purchasing behavior.  For example, economic downturns have coincided with adult tobacco consumers modifying purchase behavior at retail, potentially reducing the amount of their regular brand purchases or selecting discount products and other lower priced tobacco brands.  Beginning in January 2022, the Omicron variant of COVID-19 impacted consumer purchasing behavior, resulting in a short-term decrease in retail trips and tobacco sales volume.  In addition, gas prices increased due in part to the Russian invasion of Ukraine.  Increases in inflation as a result of macroeconomic and geopolitical conditions put pressure on discretionary income as the Consumer Price Index reached a 40 year high in the six months ended June 30, 2022.  These economic headwinds were partially offset by positive wage inflation, increases in federal tax refund payments, and low unemployment in comparison to the six months ended June 30, 2021.  We believe that adult tobacco consumers adapted their purchasing patterns across a variety of goods and services to compensate for the pressures on disposable income.  We expect </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fluctuations in discount product share for cigarettes and MST products as price sensitive adult tobacco consumers react to their economic conditions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FSPTCA and FDA Regulation</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">The Regulatory Framework:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA, its implementing regulations and its 2016 deeming regulations establish broad FDA regulatory authority over all tobacco products and, among other provisions:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on the advertising, promotion, sale and distribution of tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Tobacco Marketing Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">establish pre-market review pathways for new and modified tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibit any express or implied claims that a tobacco product is or may be less harmful than other tobacco products without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">authorize the FDA to impose tobacco product standards that are appropriate for the protection of the public health; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">equip the FDA with a variety of investigatory and enforcement tools, including the authority to inspect product manufacturing and other facilities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA also bans descriptors such as &#8220;light,&#8221; &#8220;low&#8221; or &#8220;mild&#8221; when used as descriptors of modified risk, unless expressly authorized by the FDA.  In connection with a 2016 lawsuit initiated by Middleton, the U.S. Department of Justice, on behalf of the FDA, informed Middleton that the FDA does not intend to bring an enforcement action against Middleton for the use of the term &#8220;mild&#8221; in the trademark &#8220;Black &amp; Mild.&#8221;  Consequently, Middleton dismissed its lawsuit without prejudice.  If the FDA were to change its position at some later date, Middleton would have the opportunity to bring another lawsuit.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the U.S. Congress expanded the statutory definition of tobacco products to include products containing nicotine derived from any source, including synthetic nicotine.  We advocated for FDA regulatory oversight of synthetic nicotine products.  The amendment became effective in April 2022.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional information on the effects of the statutory change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Final Tobacco Marketing Rule: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the FSPTCA, in March 2010, the FDA promulgated a wide range of advertising and promotion restrictions for cigarettes and smokeless tobacco </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products (the &#8220;Final Tobacco Marketing Rule&#8221;).  The May 2016 deeming regulations amended the Final Tobacco Marketing Rule to expand specific provisions to all tobacco products, including cigars, pipe tobacco and e-vapor and oral nicotine products containing tobacco-derived nicotine or other tobacco derivatives.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Final Tobacco Marketing Rule, as amended, among other things:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restricts the use of non-tobacco trade and brand names on cigarettes and smokeless tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits sampling of all tobacco products except that sampling of smokeless tobacco products is permitted in qualified adult-only facilities;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits the sale or distribution of items such as hats and tee shirts with cigarette or smokeless tobacco brands or logos;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits cigarettes and smokeless tobacco brand name sponsorship of any athletic, musical, artistic or other social or cultural event, or any entry or team in any event; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">requires the development by the FDA of graphic warnings for cigarettes, establishes warning requirements for other tobacco products, and gives the FDA the authority to require new warnings for any type of tobacco product (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain limitations arising from legal challenges, the Final Tobacco Marketing Rule took effect in June 2010 for cigarettes and smokeless tobacco products, in August 2016 for all other tobacco products, including e-vapor and oral nicotine pouch products containing tobacco-derived nicotine, and in April 2022 for tobacco products, including e-vapor and oral nicotine pouch products, that contain synthetic nicotine.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Rulemaking and Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FDA issues proposed regulations and guidance, which may be issued in draft or final form, generally involve public comment and may include scientific review.  The FDA also may request comments on broad topics through an Advanced Notice of Proposed Rulemaking (&#8220;ANPRM&#8221;).  We actively engage with the FDA to develop and implement the FSPTCA&#8217;s regulatory framework, including submission of comments to various FDA policies and proposals and participation in public hearings and engagement sessions.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">&#8220;Smokeless tobacco,&#8221; as used in this section of this Form 10-Q, refers to smokeless tobacco products first regulated by the FDA in 2009, including MST.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">It excludes oral nicotine pouches, which were first regulated by the FDA in 2016.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s implementation of the FSPTCA and related regulations and guidance also may have an impact on enforcement efforts by states, territories and localities of their laws and regulations as well as of the State Settlement Agreements discussed below (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).&#160; Such enforcement efforts may adversely affect our ability to market and sell regulated tobacco products in those states, territories and localities and impact the value of our investment in JUUL.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the FDA announced a &#8220;Comprehensive Plan for Tobacco and Nicotine Regulation&#8221; (&#8220;Comprehensive Plan&#8221;) designed to strike a balance between regulation and encouraging the development of innovative tobacco products that may be less risky than cigarettes.  Since then, the FDA has issued additional information about its Comprehensive Plan in response to concerns associated with the rise in the use of e-vapor products by youth and the potential youth appeal of flavored tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).  As part of the Comprehensive Plan, the FDA:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">issued ANPRMs relating to potential product standards for nicotine in cigarettes, flavors in all tobacco products (including menthol in cigarettes and characterizing flavors in all cigars) and, for e-vapor products, to protect against known public health risks such as concerns about youth exposure to liquid nicotine;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">took actions to restrict youth access to e-vapor products; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reconsidered the processes used by the FDA to review certain reports and new product applications.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA permits the sale of tobacco products on the market as of February 15, 2007 and not subsequently modified (&#8220;Grandfathered Products&#8221;) and new or modified products authorized through the PMTA, Substantial Equivalence (&#8220;SE&#8221;) or SE Exemption pathways.  Subsequent FDA rules also provide a Supplemental PMTA pathway designed to increase the efficiency of submission and review for modified versions of previously authorized products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA pre-market authorization enforcement policy varies based on product type and date of availability in the market, specifically:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Grandfathered Products are exempt from the pre-market authorization requirement;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">cigarette and smokeless tobacco products that were modified or first introduced into the market between February 15, 2007 and March 22, 2011 are generally considered &#8220;Provisional Products&#8221; for which SE reports were required to be filed by March 22, 2011.  These reports must demonstrate that the product has the same characteristics as a product on the market as of February 15, 2007 or to a product previously determined to be substantially equivalent, or has different characteristics but does not raise different questions of public health; </span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco products that were first regulated by the FDA in 2016, including cigars, e-vapor products and oral nicotine pouches that are not Grandfathered Products, are generally products for which either an SE report or PMTA needed to be filed by September 9, 2020; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco products containing nicotine from any source other than tobacco (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, synthetic nicotine) that were on the market between March 15, 2022 and April 14, 2022 and are not Grandfathered Products are generally products for which a manufacturer must have filed a PMTA by May 14, 2022.  A manufacturer was permitted to keep such a product on the market until July 13, 2022 provided that a PMTA was filed by May 14, 2022.  Thereafter, unless the FDA granted the product a marketing order, the product is unlawful and subject to the FDA&#8217;s enforcement discretion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Modifications to currently marketed products, including modifications that result from, for example, changes to the quantity of tobacco product(s) in a package, a manufacturer being unable to acquire ingredients or a supplier being unable to maintain the consistency required in ingredients, could trigger the FDA&#8217;s pre-market or SE review processes.  Through these processes, a manufacturer could receive (i) a &#8220;not substantially equivalent&#8221; determination, (ii) a denial of a PMTA or (iii) a marketing order withdrawal by the FDA on one or more products, which would require the removal of the product or products from the market.  In addition, new scientific data continues to be developed relating to innovative tobacco products, which could impact FDA&#8217;s determination as to whether a product is, or continues to be, appropriate for the protection of public health and could, therefore, result in the removal of one or more products from the market.  Any such actions affecting our or JUUL&#8217;s products could have a material adverse impact on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most cigarette and smokeless tobacco products currently marketed by PM USA and USSTC are &#8220;Provisional Products.&#8221;  PM USA and USSTC timely submitted SE reports for these Provisional Products and have received SE determinations on certain Provisional Products.  Those products that were found by the FDA to be not substantially equivalent (certain smokeless tobacco products) had been discontinued for business reasons prior to the FDA&#8217;s determinations; therefore, those determinations did not impact business results.  PM USA and USSTC have other Provisional Products that continue to be subject to the FDA&#8217;s pre-market review process.  In the meantime, they can continue marketing these products unless the FDA determines that a specific Provisional Product is not substantially equivalent.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA has communicated that it will not review a certain subset of Provisional Product SE reports and that the products that are the subject of those reports can continue to be legally marketed without further FDA review.  PM USA and USSTC have Provisional Products included in this subset of products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe PM USA&#8217;s and USSTC&#8217;s current Provisional Products meet the statutory requirements of the FSPTCA, we cannot predict how the FDA will ultimately apply law, regulation and guidance to their various SE reports.  Should PM USA or USSTC receive unfavorable determinations on any SE reports currently pending with the FDA, we believe PM USA and USSTC can replace the vast majority of these product volumes with other FDA authorized products or with Grandfathered Products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cigarette and smokeless tobacco products introduced into the market or modified after March 22, 2011 are &#8220;Non-Provisional Products&#8221; and must receive a marketing order from the FDA prior to being offered for sale.  Marketing orders for Non-Provisional Products may be obtained by filing an SE report, PMTA or using another pre-market pathway established by the FDA.  PM USA and USSTC may not be able to obtain a marketing order for non-provisional products because the FDA may determine that any such product does not meet the statutory requirements for approval.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Manufacturers of products first regulated by the FDA in 2016, including cigars, oral nicotine pouches and e-vapor products, that were on the market as of August 8, 2016 and not subsequently modified must have filed an SE report or PMTA by the filing deadline of September 9, 2020 in order for their products to remain on the market.  These products can remain on the market during FDA review through court-allowed, case-by-case discretion, so long as the report or application was timely filed with the FDA.  Due to the large number of applications received by September 9, 2020, the FDA did not complete its review of all submitted applications by September 9, 2021.  In May 2022, the FDA represented that it had resolved more than 99% of the timely applications it had received, with most resulting in marketing denial orders (&#8220;MDOs&#8221;).  A number of the marketing denial orders are subject to litigation challenges initiated by the affected manufacturers.  For those products still under FDA review, it is uncertain when and for how long the FDA may permit continued marketing and sale of those products pursuant to its case-by-case discretion.  For products (new or modified) not on the market as of August 8, 2016, manufacturers must file an SE report or PMTA and receive FDA authorization prior to marketing and selling the product.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helix submitted PMTAs for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;on!&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches in May 2020.  As of July 25, 2022, the FDA has not issued marketing order decisions for any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products.  JUUL submitted PMTAs for its e-vapor device and the related tobacco and menthol flavors in July 2020.  In June 2022, the FDA issued MDOs to JUUL for all of JUUL&#8217;s products currently marketed in the United States.  These MDOs are currently stayed.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Electronic Nicotine Delivery System Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further discussion.  In addition, as of July 25, 2022, Middleton has received market orders or exemptions that cover over 99% of its cigar product volume.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, we entered into a series of agreements with Philip Morris International Inc. (&#8220;PMI&#8221;), including an agreement that grants us an exclusive right to commercialize certain of PMI&#8217;s heated tobacco products in the United States, subject to FDA authorization of the applicable products.  PMI submitted a PMTA and a modified risk tobacco product (&#8220;MRTP&#8221;) application with the FDA for its electronically heated tobacco products comprising the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices heat, but do not burn tobacco.  In April 2019, the FDA authorized the PMTA for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in July 2020, the FDA authorized the marketing of this system as an MRTP with a reduced exposure claim.  In December 2020, the FDA authorized the PMTA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3, an updated version of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, and in March 2022 authorized the marketing of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3 device as an MRTP with the same reduced exposure claim.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, in connection with a patent dispute, the U.S. International Trade Commission (&#8220;ITC&#8221;) issued a cease and desist order, effective as of November 29, 2021, banning (i) the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and infringing components into the United States and (ii) the sale, marketing and distribution of such imported products in the United States.  As a result, PM USA removed the products from the marketplace.  For a further discussion of the ITC decision, see Note 11.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2021, the FDA authorized the marketing and sale of four of USSTC&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine products, including Green Mint and Blue Mint varieties, representing the first flavored product authorizations issued by the FDA for newly deemed innovative products.  These products are not currently marketed or sold.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Market Surveillance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Manufacturers that receive product authorizations through the PMTA process must adhere to the FDA post-market record keeping and reporting requirements, as detailed in market orders and in the final PMTA rule that went into effect in November 2021.  This includes notification of all marketing activities.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is subject to this post-market surveillance requirement.  The FDA may amend requirements of a market order or withdraw the market order based on this information if, among other reasons, it determines that the continued marketing of the products is no longer appropriate for the protection of the public health.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Adverse FDA Determinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: FDA review time frames have varied.  It is therefore difficult to predict the duration of FDA reviews of SE reports or PMTAs.  Failure of manufacturers to submit applications by the applicable deadline, an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unfavorable determination on an application, the withdrawal by the FDA of a prior marketing order or other changes in FDA regulatory requirements could result in the removal of products from the market.  These manufacturers would have the option of marketing products that have received FDA pre-market authorization or Grandfathered Products.  A &#8220;not substantially equivalent&#8221; determination, a denial of a PMTA or a marketing order withdrawal by the FDA on one or more products (which would require the removal of the product or products from the market) could have a material adverse impact on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).  Also, adverse FDA determinations on innovative tobacco products could impede our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA Regulatory Actions</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FDA issued a final rule requiring 11 textual warnings accompanied by color graphics depicting certain negative health consequences of smoking on cigarette packaging and advertising.  The final rule is currently set to become effective on July 8, 2023.  PM USA and other cigarette manufacturers have filed lawsuits challenging the final rule on substantive and procedural grounds.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the preamble to the final rule, the FDA stated that it would not exempt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a heated tobacco product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, as part of the rulemaking, but would consider the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> marketing order, and other marketing orders, on a case-by-case basis.  To date, the FDA has not taken any action to exempt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from the graphic health warnings requirements.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.78pt">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA announced regulatory actions in September 2018 to address underage access and use of e-vapor products.  We have engaged with the FDA on this topic and have reaffirmed to the FDA our ongoing and long-standing commitment to preventing underage use.  For example, during 2019, we advocated raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels to further address underage use, which is now federal law.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for further discussion.  In addition, through our retailer incentive program, stores representing over 70% of PM USA&#8217;s cigarette volume have implemented point-of-sale age validation technology.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the FDA issued final guidance in April 2020, stating that it intends to prioritize enforcement action against certain product categories, including cartridge-based, flavored e-vapor products and products targeted to minors.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:33.08pt">Electronic Nicotine Delivery System Products:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2022, the FDA issued MDOs to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  JUUL filed a petition for review of the MDOs with the U.S. Court of Appeals for the D.C. Circuit.  JUUL subsequently moved the D.C. Circuit for a temporary administrative stay of the MDOs, which the court granted to provide sufficient opportunity for the court to consider JUUL&#8217;s emergency motion for a stay pending the court&#8217;s consideration of JUUL&#8217;s challenge to the MDOs.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products currently remain on the market.  The proceedings in the U.S. Court of Appeals for the D.C. Circuit are being held in abeyance pending completion of the FDA&#8217;s additional review, and JUUL has withdrawn its motion for an emergency stay with respect to the MDOs, without prejudice to refiling at a later date.  In light of these developments, the D.C. Circuit dissolved the administrative stay it had previously granted and directed the parties to file motions to govern further proceedings within 14 days of FDA&#8217;s completion of its additional review process.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">As of July 25, 2022, many manufacturers of flavored e-vapor products received MDOs for failure to provide sufficiently strong product-specific scientific evidence to demonstrate that the benefit of their products to adult smokers overcomes the risk that their products pose to youth.  The FDA has communicated in these MDOs that vapor products with non-tobacco flavors present unique questions relevant to the FDA&#8217;s &#8220;Appropriate for the Protection of Public Health&#8221; standard and that successful applications require strong, product-specific evidence.  A number of these manufacturers are appealing the MDOs for their products.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Potential Product Standards</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Nicotine in Cigarettes and Other Combustible Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the FDA issued an ANPRM seeking comments on the potential public health benefits and any possible adverse effects of lowering nicotine in combustible cigarettes to non-addictive or minimally addictive levels.  Among other issues, the FDA sought comments on (i) whether smokers would compensate by smoking more cigarettes to obtain the same level of nicotine as with their current product and (ii) whether the proposed rule would create an illicit trade of cigarettes containing nicotine at levels higher than a non-addictive threshold that may be established by the FDA.  The FDA also sought comments on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whether a nicotine product standard should apply to other combustible tobacco products, including cigars.  In June 2022, the Biden Administration published its Spring 2022 Unified Regulatory Agenda, which includes the FDA&#8217;s plans to propose, by May 2023, a product standard that would establish a maximum nicotine level in cigarettes and other combustible tobacco products.  Any proposed product standard would proceed through the rulemaking process, which will take multiple years to complete. </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Flavors in Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the FDA issued two proposed product standards: (i) banning menthol in cigarettes and (ii) banning all characterizing flavors (including menthol) in cigars.  We plan to engage with the FDA through the rulemaking process, including by submitting comments during the notice-and-comment period.  We believe the rulemaking process will take multiple years to complete.  The FDA could propose an additional product standard for flavors in innovative tobacco products, including e-vapor products and oral nicotine products.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">N-nitrosonornicotine (&#8220;NNN&#8221;) in Smokeless Tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FDA proposed a product standard for NNN levels in finished smokeless tobacco products.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">If any one or more of the foregoing potential product standards were to become final and was appealed and upheld in the courts, it could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including, an adverse effect on the carrying value of our assets such as our cigar trademarks or our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Good Manufacturing Practices: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA requires that the FDA promulgate good manufacturing practice regulations (referred to by the FDA as &#8220;Requirements for Tobacco Product Manufacturing Practice&#8221;) for tobacco product manufacturers, but does not specify a timeframe for such regulations.  Compliance with any such regulations could result in increased costs, which could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including an adverse effect on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Impact on Our Business; Compliance Costs and User Fees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA regulatory actions under the FSPTCA could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position in various ways.  For example, actions by the FDA could:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impact the consumer acceptability of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">delay, discontinue or prevent the sale or distribution of existing, new or modified tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">limit adult tobacco consumer choices;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on communications with adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">create a competitive advantage or disadvantage for certain tobacco companies;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional manufacturing, labeling or packaging requirements;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional restrictions at retail;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">result in increased illicit trade in tobacco products; and/or</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">otherwise significantly increase the cost of doing business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with FDA regulatory requirements, even inadvertently, and FDA enforcement actions also could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including an adverse effect on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA imposes user fees on cigarette, cigarette tobacco, smokeless tobacco, cigar and pipe tobacco manufacturers and importers to pay for the cost of regulation and other matters.  The FSPTCA does not impose user fees on e-vapor or oral nicotine pouch manufacturers.  The cost of the FDA user fee is allocated&#160;first among tobacco product categories subject to FDA user fees and then among manufacturers and importers within each respective category based on their relative market shares, all as prescribed by the FSPTCA and FDA regulations.  Payments for user fees are adjusted for several factors, including market share and industry volume.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of our FDA user fee payments.  In addition, compliance with the FSPTCA&#8217;s regulatory requirements has resulted, and will continue to result, in additional costs.  The amount of additional compliance and related costs has not been material in any given quarter or year to date period but could become material, either individually or in the aggregate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investigation and Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has a number of investigatory and enforcement tools available to it, including document requests and other required information submissions, facility inspections, facility closures, examinations and investigations, injunction proceedings, monetary penalties, product withdrawal and recall orders, and product seizures.  Investigations or enforcement actions could result in significant costs or otherwise have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including an adverse effect on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excise Taxes</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco products are subject to substantial excise taxes in the United States.  Significant increases in tobacco-related taxes or fees have been proposed or enacted (including with respect to e-vapor products) and are likely to continue to be proposed or enacted at the federal, state and local levels within the United States.  The frequency and magnitude of excise tax increases can be influenced by various factors, including the composition of executive and legislative bodies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the U.S. Congress considered legislation that would have significantly increased the federal excise tax for all tobacco products and created a new tax for e-vapor products and other products containing nicotine that are not currently subject to a tobacco federal excise tax (&#8220;novel tobacco products&#8221;).  The U.S. House of Representatives removed the proposal to increase the federal excise tax on tobacco products currently subject to the tax from the legislation it was considering, but retained the proposed nicotine tax for novel tobacco products.  The U.S. Senate debated the legislation and removed the nicotine tax for novel tobacco products; however, as of July 25, 2022, the legislation is still pending before the Senate and could be subject to further tax related amendments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local cigarette excise taxes have increased substantially over the past two decades, far outpacing the rate of inflation.  Between the end of 1998 and July 25, 2022, the weighted-average state cigarette excise tax increased from $0.36 to $1.89 per pack.  As of July 25, 2022, no state has enacted new legislation increasing cigarette excise taxes in 2022, but various increases are under consideration or have been proposed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of states currently tax MST using an ad valorem method, which is calculated as a percentage of the price of the product, typically the wholesale price.  This ad valorem method results in more tax being paid on premium products than is paid on lower-priced products of equal weight.  We support legislation to convert ad valorem taxes on MST to a weight-based methodology because, unlike the ad valorem tax, a weight-based tax subjects cans of equal weight to the same tax.  As of July 25, 2022, the federal government, 23 states, Puerto Rico, Philadelphia, Pennsylvania and Cook County, Illinois have adopted a weight-based tax methodology for MST.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of states and localities also are imposing excise taxes on e-vapor and oral nicotine pouches.  As of July 25, 2022, 30 states, the District of Columbia, Puerto Rico and a number of cities and counties have enacted legislation to tax e-vapor products.  These taxes are calculated in varying ways and may differ based on the e-vapor product form.  Similarly, 12 states and the District of Columbia have enacted legislation to tax oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax increases are expected to continue to have an adverse impact on sales of our products through lower consumption levels and the potential shift in adult tobacco consumer purchases from premium to non-premium or discount cigarettes, to lower taxed tobacco products, or to counterfeit and contraband products.  Lower sales volume and reported share performance of our products could have a material adverse effect on our consolidated financial position or earnings.  In addition, substantial excise tax increases on e-vapor and oral nicotine products, may negatively impact adult smokers&#8217; transition to these products, which could adversely affect our ability to achieve our Vision and could have an adverse effect on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Treaty on Tobacco Control</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The World Health Organization&#8217;s Framework Convention on Tobacco Control (the &#8220;FCTC&#8221;) entered into force in February&#160;2005.  As of July 25, 2022, 181 countries, as well as the European Union, have become parties to the FCTC.  While the United States is a signatory of the FCTC, it is not currently a party to the agreement, as the agreement has not been submitted to, or ratified by, the U.S. Senate.  The FCTC is the first international public health treaty and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation.  The treaty recommends (and in certain instances, requires) signatory nations to enact legislation that would address various tobacco-related issues.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of proposals currently under consideration by the governing body of the FCTC, some of which call for substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products.  It is not possible to predict the outcome of these proposals or the impact of any FCTC actions on legislation or regulation in the United States, either indirectly or as a result of the United States becoming a party to the FCTC, or whether or how these actions might indirectly influence FDA regulation and enforcement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Settlement Agreements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 11, during 1997 and 1998, PM USA and other major domestic cigarette manufacturers entered into the State Settlement Agreements.  These settlements require participating manufacturers to make substantial annual payments, which are adjusted for several factors, including inflation, operating income, market share and industry volume.  Increases in inflation can increase our financial liability under the State Settlement Agreements.  The State Settlement Agreements&#8217; inflation calculations require us to apply the higher of 3% or the U.S. Bureau of Labor Statistics&#8217; Consumer Price Index for All Urban Consumers (&#8220;CPI-U&#8221;) percentage rate as published in January of each year.  As of December 2021, the inflation calculation was approximately 7% based on the latest CPI-U data; however, the increase in the annual payments did not have a material </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact on our financial position.  We believe that inflation will continue at increased levels in 2022, but do not expect the corresponding increase in annual payments to result in a material financial impact.  However, we will continue to monitor the impact of increased inflation on the macroeconomic environment and our businesses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the impact of the State Settlement Agreements on us, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Liquidity and Capital Resources - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below and Note 11.  The State Settlement Agreements also place numerous requirements and restrictions on participating manufacturers&#8217; business operations, including prohibitions and restrictions on the advertising and marketing of cigarettes and smokeless tobacco products.  Among these are prohibitions of outdoor and transit brand advertising, payments for product placement and free sampling (except in adult-only facilities).  The State Settlement Agreements also place restrictions on the use of brand name sponsorships and brand name non-tobacco products and prohibitions on targeting youth and the use of cartoon characters.  In addition, the State Settlement Agreements require companies to affirm corporate principles directed at reducing underage use of cigarettes; impose requirements regarding lobbying activities; limit the industry&#8217;s ability to challenge certain tobacco control and underage use laws; and provide for the dissolution of certain tobacco-related organizations and place restrictions on the establishment of any replacement organizations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, USSTC entered into the Smokeless Tobacco Master Settlement Agreement (the &#8220;STMSA&#8221;) with the attorneys general of various states and United States territories to resolve the remaining health care cost reimbursement cases initiated against USSTC.  The STMSA required USSTC to adopt various marketing and advertising restrictions.  USSTC is the only smokeless tobacco manufacturer to sign the STMSA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other International, Federal, State and Local Regulation and Governmental and Private Activity</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">International, Federal, State and Local Regulation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various states and localities have enacted or proposed legislation that imposes restrictions on tobacco products (including cigarettes, smokeless tobacco, cigars, e-vapor products and oral nicotine pouches), such as legislation that (i) prohibits the sale of all tobacco products or certain tobacco categories, such as e-vapor, (ii) prohibits the sale of tobacco products with characterizing flavors, such as menthol cigarettes and flavored e-vapor products, (iii) requires the disclosure of health information separate from or in addition to federally mandated health warnings and (iv) restricts commercial speech or imposes additional restrictions on the marketing or sale of tobacco products.  The legislation varies in terms of the type of tobacco products, the conditions under which such products are or would be restricted or prohibited, and exceptions to the restrictions or prohibitions.  For example, a number of proposals involving characterizing flavors would prohibit smokeless tobacco products with characterizing flavors without providing an exception for mint- or wintergreen-flavored products.  As of July 25, 2022, multiple states and localities are considering legislation to ban flavors in one or more tobacco products, and six states (California, Massachusetts, New Jersey, Utah, New York and Illinois) and the District of Columbia have passed such legislation.  Some of these states, such as New York, Utah and Illinois, exempt certain products that have received FDA market authorization through the PMTA pathway.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislation in California bans the sale of most tobacco products with characterizing flavors, including menthol, mint and wintergreen.  Following enactment of the flavor ban in August 2020, several registered California voters filed a referendum against the legislation.  In January 2021 the requisite number of registered California voters signed a petition to place the question of whether the legislation should be affirmed or overturned on the next statewide general election ballot, which will likely take place in November 2022, unless a special statewide election is called earlier.  As a result, the implementation of the legislation is delayed until after a vote on the referendum occurs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Massachusetts passed legislation capping the amount of nicotine in e-vapor products.  Similar legislation is pending in three other states.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restrictions on e-vapor and oral nicotine pouch products also have been instituted or proposed internationally.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have challenged and will continue to challenge certain federal, state and local legislation and other governmental action, including through litigation.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).  Such action also could negatively impact adult smokers&#8217; transition to these products, which could adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a number of states and localities proposed and enacted legislation to increase the minimum age to purchase all tobacco products, including e-vapor products, in December 2019, the federal government passed legislation increasing the minimum age to purchase all tobacco products, including e-vapor products, to 21 nationwide.  As of July 25, 2022, 41 states, the District of Columbia and Puerto Rico have enacted laws increasing the legal age to purchase tobacco products to 21.  Although an increase in the minimum age to purchase tobacco products may have a negative impact on our sales volume, as discussed above under </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we support raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels, reflecting our longstanding commitment to combat underage tobacco use.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Health Effects of Tobacco Products, Including E-vapor Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reports with respect to the health effects of smoking have been publicized for many years, including various reports by the U.S. Surgeon General.  In 2019, there were public health advisories concerning vaping-related lung injuries and deaths and there have been health concerns raised about potential increased risks associated with COVID-19 among smokers and vapers.  We believe that the public should be guided by the messages of the U.S. Surgeon General and public health authorities worldwide in making decisions concerning the use of tobacco products, including e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most jurisdictions within the United States have restricted smoking in public places and some have restricted vaping in public places.  Some public health groups have called for, and various jurisdictions have adopted or proposed, bans on smoking and vaping in outdoor places, in private apartments and in cars transporting children.  It is not possible to predict the results of ongoing scientific research or the types of future scientific research into the health risks of tobacco exposure and the impact of such research on legislation and regulation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Other Legislation or Governmental Initiatives: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the actions discussed above, other regulatory initiatives affecting the tobacco industry have been adopted or are being considered at the federal level and in a number of state and local jurisdictions.  For example, in recent years, legislation has been introduced or enacted at the state or local level to subject tobacco products to various reporting requirements and performance standards; establish educational campaigns relating to tobacco consumption or tobacco control programs or provide additional funding for governmental tobacco control activities; restrict the sale of tobacco products in certain retail establishments and the sale of tobacco products in certain package sizes; prohibit the sale of tobacco products based on environmental concerns; impose responsibility on manufacturers for the disposal, recycling or other treatment of post-consumer goods such as plastic packaging; require tax stamping of smokeless tobacco products; require the use of state tax stamps using data encryption technology; and further restrict the sale, marketing and advertising of cigarettes and other tobacco products.  Such legislation may be subject to constitutional or other challenges on various grounds, which may or may not be successful.  In addition, if the COVID-19 pandemic resurges, state and local governments may reimpose additional health and safety requirements for all businesses, which could result in the potential temporary closure of certain businesses and/or facilities.  It is possible that tobacco manufacturing and other facilities and the facilities of our and JUUL&#8217;s suppliers, our and JUUL&#8217;s suppliers&#8217; suppliers and our and JUUL&#8217;s trade partners could be subject to additional government-mandated temporary closures and restrictions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented (and, if challenged, upheld) relating to the manufacturing, design, packaging, marketing, advertising, sale or use of tobacco products, or the tobacco industry generally.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Governmental Investigations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are subject to governmental investigations on a range of matters.&#160; For example: (i) the FTC issued a Civil Investigative Demand (&#8220;CID&#8221;) to us while conducting its antitrust review of our investment in JUUL seeking information regarding, among other things, our role in the resignation of JUUL&#8217;s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee (see Note 11 for a description of the FTC&#8217;s administrative complaint against us and JUUL); (ii) the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) commenced an investigation relating to our acquisition, disclosures and accounting</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls in connection with the JUUL investment; and (iii) the New York State Office of the Attorney General and the Commonwealth of Massachusetts Office of the Attorney General, separately, issued independent subpoenas to us seeking documents relating to our investment in and provision of services to JUUL.  Additionally, JUUL is currently under investigation by various federal and state agencies, including the SEC, the FDA and the FTC, and state attorneys general.&#160; Such investigations vary in scope but at least some appear to include JUUL&#8217;s marketing practices, particularly as such practices relate to youth, and we may be asked in the context of those investigations to provide information concerning our investment in JUUL or relating to our marketing of Nu Mark LLC e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Sector Activity on Tobacco Products</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of retailers, including national chains, have discontinued the sale of all tobacco products and others have discontinued the sale of e-vapor products.  Reasons for the discontinuation include change in corporate policy and, with respect to e-vapor products, include reported illnesses and the uncertain regulatory environment.  It is possible that if this private sector activity becomes more widespread it could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Illicit Trade in Tobacco Products</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Illicit trade in tobacco products can have an adverse impact on our business and JUUL&#8217;s business.  Illicit trade can take many forms, including the sale of counterfeit tobacco products; the sale of tobacco products in the United States that are intended for sale outside the country; the sale of untaxed tobacco products over the Internet and by other means designed to avoid the collection of applicable taxes; and diversion into one taxing jurisdiction of tobacco products intended for sale in another.  Counterfeit tobacco products, for example, are manufactured by unknown third parties in unregulated environments.  Counterfeit versions of our and JUUL&#8217;s products can negatively affect adult tobacco consumer experiences with and opinions of those brands.  Illicit trade in tobacco products also harms law-abiding wholesalers and retailers by depriving them of lawful sales and undermines the significant investment we have made in legitimate distribution channels.  Moreover, illicit trade in tobacco products results in federal, state and local governments losing tax revenues.  Losses in tax revenues can cause such governments to take various actions, including increasing excise taxes, imposing legislative or regulatory requirements, or asserting claims against manufacturers of tobacco products or members of the trade channels through which such tobacco products are distributed and sold, each of which may have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position, including an adverse impact on the value of our investment in JUUL (due to the impact on JUUL&#8217;s business).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We communicate with wholesale and retail trade members regarding illicit trade in tobacco products and how we can help prevent such activities, enforce wholesale and retail trade programs and policies that address illicit trade in tobacco products and, when necessary, litigate to protect our trademarks.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Price, Availability and Quality of Tobacco, Other Raw Materials, Ingredients and Component Parts</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shifts in crops (such as those driven by economic conditions and adverse weather patterns), government restrictions and mandated prices, production control programs, economic trade sanctions, import duties and tariffs, international trade disruptions, inflation, geopolitical instability, climate and environmental changes and disruptions due to man-made or natural disasters may increase the cost or reduce the supply or quality&#160;of tobacco, other raw materials, ingredients or component parts used to manufacture our products.  Any significant change in such factors could restrict our ability to continue manufacturing and marketing existing products or impact adult consumer product acceptability and have a material adverse effect on our&#160;profitability and business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with other agricultural commodities, tobacco price, quality&#160;and availability can be influenced by variations in weather patterns, including those caused by climate change, and macroeconomic conditions and imbalances in supply and demand, among other factors.  For varieties of tobacco only available in limited geographies, government-mandated prices and production control programs, political instability or government prohibitions on the import or export of tobacco in certain countries pose additional risks to price, availability and quality.  The unavailability or unacceptability of any particular variety of tobacco leaf necessary to manufacture our products could impair our ability to continue marketing existing products or impact adult tobacco consumer product acceptability.  In addition, as consumer demand increases for smoke-free products and decreases for combustible products, the volume of tobacco leaf required for production may decrease.  The reduced demand for tobacco leaf may result in the reduced supply and availability of domestic tobacco as growers divert resources to other crops, which could result in increased costs to us.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current macroeconomic conditions and geopolitical instability (including historically high inflation, higher than normal gas prices, labor shortages, the continued impact of the COVID-19 pandemic and the Russian invasion of Ukraine) are causing worldwide disruptions and delays to supply chains and commercial markets, which limit access to, and increase the cost of, raw materials, ingredients and component parts (for example, tobacco leaf and resins and aluminum used in our packaging).  We are implementing various strategies to help secure sufficient supplies of raw materials, ingredients and component parts for production.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, government taxes, restrictions and prohibitions on the sale and use of certain products may limit access to, and increase the costs of, raw materials and component parts and, potentially, impede our ability to sell certain of our products.  For example, additional taxes on the use of certain single-use plastics have been proposed by the U.S. Congress, which, if passed, could increase the costs of, and impair our ability to, source certain materials used in the packaging for our products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work to mitigate these risks by maintaining inventory levels of certain tobacco varieties that cover several years, purchasing raw materials, ingredients and component parts from disperse geographic regions throughout the world and entering into long-term contracts with some of our tobacco growers.  To date, the impact on us of changes in the price, availability and quality of tobacco, other raw materials, ingredients and component parts has not been material.  However, the effects of the current macroeconomic and geopolitical conditions on prices, availability and quality of such items may continue, which could have a material adverse effect on our business and our consolidated results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL may experience similar impacts to its business due to the factors discussed above.  Any such changes could have an adverse impact on the value of our investment in JUUL.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Sales</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we are subject to many influences that can impact the timing of sales to customers, including the timing of holidays and other annual or special events, the timing of promotions, customer incentive programs and customer inventory programs, as well as the actual or speculated timing of pricing actions and tax-driven price increases.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_133"></div><div style="padding-right:9pt;text-align:justify"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_136"></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smokeable Products Segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for our smokeable products segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,138</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,873</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,181)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,402)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,137)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,281)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,957</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,898</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,736</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,769</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,321</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,762</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,311</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,159</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 pp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 pp</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 pp</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 pp</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended June&#160;30, 2022 Compared with Six Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $162 million (1.4%), due primarily to lower shipment volume ($1,161 million), partially offset by higher pricing ($981 million), which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI increased $173 million (3.4%), due primarily to higher pricing, which includes lower promotional investments, and higher NPM Adjustment Items ($28 million), partially offset by lower shipment volume ($706 million), higher costs ($72&#160;million) and higher per unit settlement charges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $152 million (2.9%), due primarily to higher pricing, which includes lower promotional investments, partially offset by lower shipment volume, higher costs and higher per unit settlement charges.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended June&#160;30, 2022 Compared with Three Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $177 million (2.9%), due primarily to lower shipment volume ($757 million), partially offset by higher pricing ($570 million), which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $14 million (0.5%), due primarily to lower shipment volume ($460 million), higher costs ($59&#160;million), higher per unit settlement charges and higher tobacco and health and certain other litigation items ($30 million), partially offset by higher pricing, which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $16 million (0.6%), due primarily to higher pricing, which includes lower promotional investments, partially offset by lower shipment volume, higher costs and higher per unit settlement charges.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our smokeable products segment&#8217;s shipment volume performance:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(sticks in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,325</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,035</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,017</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,847</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,457</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,126</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigars:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Black &amp; Mild</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigars</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smokeable products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,993</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,256&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,942</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,762&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Cigarettes shipment volume includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; Other premium brands, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Virginia Slims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Parliament, Benson &amp; Hedges and Nat&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; and Discount brands, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M, Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cigarettes retail share performance:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Retail share results for cigarettes are based on data from IRI/Management Science Associates, Inc., a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes.  For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers through the Store Tracking Analytical Reporting System (&#8220;STARS&#8221;).  This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets.  It is IRI&#8217;s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended June&#160;30, 2022 Compared with the Six Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased 8.9%, driven primarily by the industry&#8217;s decline rate and retail share losses (both of which were impacted by macroeconomic pressures on adult tobacco consumers&#8217; disposable income) and trade inventory movements, partially offset by other factors.  When adjusted for trade inventory movements and other factors, our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased by an estimated 9%.  When adjusted for trade inventory movements and other factors, total estimated domestic cigarette industry volume decreased by an estimated 7.5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 93.4% and 92.8% of our smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the six months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our smokeable products segment&#8217;s reported cigar shipment volume decreased 7.4%, driven by trade inventory movements, macroeconomic pressures on adult tobacco consumers&#8217; disposable income and other factors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retail share of the total cigarette category decreased 0.4 share points to 42.6%, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarette industry discount retail share increased 1.2 share point to 26.4%, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended June&#160;30, 2022 Compared with Three Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased 11.1%, driven primarily by the industry&#8217;s decline rate and retail share losses (both of which were impacted by macroeconomic pressures on adult tobacco consumers&#8217; disposable income) and trade inventory movements, partially offset by other factors.  When adjusted for trade inventory movements, our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased by an estimated 10%.  When adjusted for trade inventory movements and other factors, total estimated domestic cigarette industry volume decreased by an estimated 8.5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 93.5% and 92.8% of our smokeable products segment&#8217;s reported domestic cigarettes shipment volume for the three months ended June&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our smokeable products segment&#8217;s reported cigar shipment volume decreased 5.0%, driven by macroeconomic pressures on adult tobacco consumers&#8217; disposable income, trade inventory movements and other factors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retail share of the total cigarette category decreased 0.4 share points to 42.7%, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retail share increased 0.1 share point from the first quarter of 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarette industry discount retail share increased 1.3 share points to 26.4%, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income.  Total cigarette industry discount category retail shares was unchanged from the first quarter of 2022.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding the cigarette industry discount retail share dynamics in 2022 and the economic conditions, including a high inflationary environment, that impact adult tobacco consumer purchasing behavior, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment - Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA and Middleton executed the following pricing and promotional allowance actions during 2022 and 2021:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective May 22, 2022, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.17 per five-pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective April 24, 2022, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro, L&amp;M, Basic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.15 per pack.  PM USA also increased the list price of all its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 9, 2022, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.13 per five-pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective December 12, 2021, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro, L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.15 per pack.  In addition, PM USA increased the list price of all of its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective August 15, 2021, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro, L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chesterfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.14 per pack.  In addition, PM USA increased the list price of all of its other cigarette brands by $0.17 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 24, 2021, PM USA increased the list price on all of its cigarette brands by $0.14 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 10, 2021, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.07 per five-pack.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 17, 2022, PM USA increased the list price on all of its cigarette brands by $0.15 per pack.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oral Tobacco Products Segment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins, and provides a reconciliation of reported OCI to adjusted OCI for our oral tobacco products segment:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,278</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">665</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(32)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,217</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">633</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 7pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2) pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)  pp</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1) pp</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)  pp</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended June&#160;30, 2022 Compared with Six Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $41 million (3.1%), due primarily to lower shipment volume and a higher percentage of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on! </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment volume relative to MST versus 2021 (&#8220;volume/mix&#8221; - $66 million), partially offset by higher pricing ($29 million), which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $27 million (3.1%), due primarily to lower volume/mix ($69 million) and higher costs ($19 million), partially offset by acquisition-related costs in 2021 ($37 million) and higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI decreased $64 million (7.1%), due primarily to lower volume/mix and higher costs, partially offset by higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended June&#160;30, 2022 Compared with Three Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $28 million (4.0%), due primarily to lower volume/mix ($44 million), partially offset by higher pricing ($19 million), which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported and adjusted OCI decreased $42 million (8.9%), due primarily to lower volume/mix and higher costs ($13 million), partially offset by higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our oral tobacco products segment&#8217;s shipment volume performance:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(cans and packs in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">238.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">123.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">402.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">208.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Oral tobacco products shipment volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to our oral tobacco products segment.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our oral tobacco products segment&#8217;s retail share performance (excluding international volume):</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage Point Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Our oral tobacco products segment&#8217;s retail share results exclude international volume, which is currently not material.  Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold.  Oral tobacco products is defined by IRI as MST, snus and oral nicotine pouches.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.  Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share.  It is IRI&#8217;s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Six Months Ended June&#160;30, 2022 Compared with the Six Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s reported domestic shipment volume decreased 3.2%, driven primarily by trade inventory movements, retail share losses and the industry&#8217;s decline rate, partially offset by other factors.  The retail share losses and industry&#8217;s decline rate were impacted by macroeconomic pressures on adult tobacco consumers&#8217; disposable income.  When adjusted for trade inventory movements, our oral tobacco products segment&#8217;s reported domestic shipment volume decreased by an estimated 1%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total oral tobacco products category industry volume decreased by an estimated 0.5% over the six months ended June&#160;30, 2022, driven by macroeconomic pressures on adult tobacco consumers&#8217; disposable income and other factors, partially offset by growth in oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s retail share was 46.8%, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> continued to be the leading oral tobacco brand with a retail share of 27.6%.  Retail share losses in our oral tobacco products segment were due primarily to macroeconomic pressures on adult tobacco consumers&#8217; disposable income for MST products, partially offset by the growth of oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total U.S. oral tobacco category share for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> nicotine pouches grew to 4.5%, an increase of 2.7 percentage points.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three Months Ended June&#160;30, 2022 Compared with Three Months Ended June&#160;30, 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s reported domestic shipment volume decreased 4.4%, driven primarily by retail share losses, trade inventory movements and the industry&#8217;s decline rate, partially offset by other factors.  The retail share losses and industry&#8217;s decline rate were impacted by macroeconomic pressures on adult tobacco consumers&#8217; disposable income.  When adjusted for trade inventory movements, our oral tobacco products segment&#8217;s reported domestic shipment volume decreased by an estimated 2.5%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s retail share decreased 0.2 percentage points from the prior quarter to 46.7%, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continued to be the leading oral tobacco brand with a retail share of 27.2%.  Share losses in our oral tobacco products segment were due primarily to macroeconomic pressures on adult tobacco consumers&#8217; disposable income resulted in share declines for MST products, partially offset by the growth of oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total U.S. oral tobacco category share for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> nicotine pouches grew to 4.9%, an increase of 2.9 percentage points, driven by increased adoption of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, increased brand awareness and higher levels of investment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC executed the following pricing actions during 2022 and 2021:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective May 24, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.09 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 22, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 26, 2021, USSTC increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.  In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.17 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 29, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.46 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.05 per can.  In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $1.65 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective March 2, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.16 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.08 per can.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 26, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">popular price products by $0.13 per can.  USSTC also decreased the list price on select </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.11 per can.  In addition, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.09 per can and increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_145"></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company that is primarily dependent on the capital resources of our subsidiaries to satisfy our liquidity requirements.  Our access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans.  At June&#160;30, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.  In addition, we receive cash dividends on our interest in ABI and will continue to do so as long as ABI pays dividends.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had $2.6 billion of cash and cash equivalents.  In addition to having access to the operating cash flows of our wholly owned subsidiaries, our capital resources include access to credit markets in the form of commercial paper, availability under our $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;), which we use for general corporate purposes, and access to credit markets through the issuance of long-term senior unsecured notes.  For additional information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Markets and Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to funding current operations, we primarily use our net cash from operating activities for payment of dividends, share repurchases under our share repurchase programs, repayment of debt, acquisitions of or investments in businesses and assets, and capital expenditures.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash and cash equivalents balance, along with our future cash flows from operations, capacity for borrowings under the Credit Agreement and access to credit markets, provide sufficient liquidity to meet the needs of our business operations and to satisfy our projected cash requirements for the next 12 months and the foreseeable future.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Markets and Other Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our cost and terms of financing and our access to commercial paper markets may be impacted by applicable credit ratings.  The impact of credit ratings on the cost of borrowings under the Credit Agreement is discussed in Note 9.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the credit ratings and outlook for our indebtedness by major credit rating agencies were:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;P-2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;A3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;A-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fitch Ratings Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;F2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Stable</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Lines </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- From time to time, we have short-term borrowing needs to meet our working capital requirements arising from the timing of annual MSA payments, quarterly income tax payments and quarterly dividend payments, and generally use our commercial paper program to meet those needs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion, and we were in compliance with the covenants in the Credit Agreement.  We expect to continue to meet the covenants in the Credit Agreement.  We monitor the credit quality of our bank group and are not aware of any potential non-performing credit provider in that group.  For further discussion on short-term borrowings, see Note 9.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA guarantees any commercial paper that we issue and our borrowings under the Credit Agreement.  For further discussion, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below and Note 9.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At June&#160;30, 2022 and December&#160;31, 2021, our total debt was $27.7 billion and $28.0 billion, respectively.  We expect to retire $1.1 billion of long-term senior unsecured notes due in August 2022 with available cash.  For further details on long-term debt, see Note 9.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed in Note 11, we had unused letters of credit obtained in the ordinary course of business and guarantees (including third-party guarantees) outstanding at June&#160;30, 2022.  From time to time, we also issue lines of credit to affiliated entities.  In addition, as discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in Note 9, PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under the Credit Agreement and amounts outstanding under the commercial paper program.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed in Note 11, PM USA has entered into State Settlement Agreements with the states and territories of the United States that call for certain payments.  In addition, PM USA, Middleton and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA.  For further discussion of the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the MSA, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 11.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current agreements, estimated market share, estimated annual industry volume decline rates and inflation rates, the estimated amounts that we may charge to cost of sales for payments related to State Settlement Agreements and FDA user fees are $4.3 billion on average for the next three years.  These amounts exclude the potential impact of any NPM Adjustment Items.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amounts due under the State Settlement Agreements charged to cost of sales in each year are generally paid in April of the following year.  The amounts charged to cost of sales for FDA user fees are generally paid in the quarter in which the fees are incurred.  We paid approximately $3.7 billion and $3.8 billion for the six months ended June&#160;30, 2022 and 2021, respectively, in connection with the State Settlement Agreements and FDA user fees, primarily all of which was paid in the second quarter of each period.  We recorded $2.1 billion and $2.2 billion of charges to cost of sales for the six months ended June&#160;30, 2022 and 2021, respectively, and $1.1 billion and $1.2 billion of charges to cost of sales for the three months ended June&#160;30, 2022 and 2021, respectively, in connection with the State Settlement Agreements and FDA user fees.  As previously stated, the payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including volume, operating income, inflation and certain contingent events and, in general, are allocated based on each manufacturer&#8217;s market share.  The future payment amounts discussed above are estimates, and actual payment amounts will differ to the extent underlying assumptions differ from actual future results.  For further discussion on the potential impact of inflation on future payments, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-Related Deposits and Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - With respect to certain adverse verdicts currently on appeal, to obtain stays of judgments pending appeals, as of June&#160;30, 2022, PM USA had posted appeal bonds totaling $50 million, which have been collateralized with restricted cash that is included in assets on our condensed consolidated balance sheet.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty, and an adverse outcome or settlement of litigation could have a material adverse effect on our consolidated financial position, cash flows or results of operations in a particular fiscal quarter or fiscal year, as more fully disclosed in Note 11.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity and Dividends</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first six months of 2022 and 2021, we paid dividends of $3,279 million and $3,196 million, respectively, an increase of 2.6%, reflecting a higher dividend rate, partially offset by fewer shares outstanding as a result of shares we repurchased under our share repurchase program.  Our current annualized dividend rate is $3.60 per share.  We maintain our long-term objective of a dividend payout ratio target of approximately 80% of our adjusted diluted EPS.  Future dividend payments remain subject to the discretion of our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our share repurchase program, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our condensed consolidated financial statements in Item 1 and Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds of this Form 10-Q.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Review</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Operating Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first six months of 2022, net cash provided by operating activities was $2,561 million compared with $2,679 million during the first six months of 2021.  This decrease was due primarily to higher litigation payments and the sale of our wine business in October 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a working capital deficit at June&#160;30, 2022 and December&#160;31, 2021.  Our management believes that we have the ability to fund working capital deficits with cash provided by operating activities, borrowings under the Credit Agreement and access to credit markets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Investing Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first six months of 2022, net cash used in investing activities was $150 million compared with $9 million during the first six months of 2021.  This increase was due primarily to the purchase of certain intellectual property and higher capital expenditures.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Financing Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first six months of 2022, net cash used in financing activities was $4,373 million compared with $5,749 million during the first six months of 2021.  This decrease was due primarily to the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.5 billion in full of our senior secured notes at scheduled maturity in May 2021; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">2021 debt tender offers and redemption transactions, which included proceeds of $5.5 billion from the issuance of long-term senior unsecured notes used to repurchase and redeem $5.0 billion of our senior unsecured notes and payment of $0.6 billion for the premiums and fees;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher repurchases of common stock in 2022; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher dividends paid in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Guidance Not Yet Adopted</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our condensed consolidated financial statements in Item 1 for a discussion of issued accounting guidance applicable to, but not yet adopted by, us.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for a discussion of contingencies.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_148"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable provisions of federal bankruptcy law or comparable provisions of state fraudulent transfer law, the Guarantees could be voided, or claims in respect of the Guarantees could be subordinated to the debts of the Guarantor, if, among other things, the Guarantor, at the time it incurred the Obligations evidenced by the Guarantees:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">received less than reasonably equivalent value or fair consideration therefor; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">either:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was insolvent or rendered insolvent by reason of such occurrence;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was engaged in a business or transaction for which the assets of the Guarantor constituted unreasonably small capital; or</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under such circumstances, the payment of amounts by the Guarantor pursuant to the Guarantees could be voided and required to be returned to the Guarantor, or to a fund for the benefit of the Guarantor, as the case may be.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of insolvency for purposes of the foregoing considerations will vary depending upon the law applied in any proceeding with respect to the foregoing.  Generally, however, the Guarantor would be considered insolvent if:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the sum of its debts, including contingent liabilities, was greater than the saleable value of its assets, all at a fair valuation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">it could not pay its debts as they become due.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the Guarantees are voided as a fraudulent conveyance or held unenforceable for any other reason, the holders of the guaranteed debt obligations would not have any claim against the Guarantor and would be creditors solely of the Parent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of the Guarantor under the Guarantees are limited to the maximum amount as will not result in the Guarantor&#8217;s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees.  For this purpose, &#8220;Bankruptcy Law&#8221; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantor will be unconditionally released and discharged from the Obligations upon the earliest to occur of:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Guarantor consolidates with or merges into the Parent or any successor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Parent or any successor consolidates with or merges into the Guarantor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the payment in full of the Obligations pertaining to such Guarantees; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the rating of the Parent&#8217;s long-term senior unsecured debt by S&amp;P of A or higher.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the debt (&#8220;Non-Guarantor Subsidiaries&#8221;) are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include summarized financial information for the Parent and the Guarantor.  Transactions between the Parent and the Guarantor (including investment and intercompany balances as well as equity earnings) have been eliminated.  The Parent&#8217;s and the Guarantor&#8217;s intercompany balances with Non-Guarantor Subsidiaries have been presented separately.  This summarized financial information is not intended to present the financial position or results of operations of the Parent or the Guarantor in accordance with GAAP.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,705</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">823</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,830</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,742</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,734</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,985&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,734</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,284</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,811</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,147</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">981</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statements of Earnings (Losses)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.393%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,620</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,674</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(239)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,719</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2022, net earnings (losses) include $114 million of intercompany interest income from non-guarantor subsidiaries.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_151"></div><div style="margin-bottom:5pt;margin-top:10pt;padding-right:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Factors That May Affect Future Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking and Cautionary Statements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-Q contains statements concerning our expectations, plans, objectives, future financial performance and other statements that are not historical facts.  You can identify these forward-looking statements by use of words such as &#8220;strategy,&#8221; &#8220;expects,&#8221; &#8220;continues,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;will,&#8221; &#8220;estimates,&#8221; &#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;goals,&#8221; &#8220;objectives,&#8221; &#8220;guidance,&#8221; &#8220;targets&#8221; and other words of similar meaning.  You can also identify them by the fact that they do not relate strictly to historical or current facts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans, estimates and assumptions.  Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate.  Should known or unknown risks or uncertainties materialize, or should underlying estimates or assumptions prove inaccurate, actual results could differ materially from those anticipated, estimated or projected.  You should bear this in mind as you consider forward-looking statements and whether to invest in or remain invested in our securities.  In connection with the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes, including with respect to our ability to achieve our Vision, to differ materially from those contained in, or implied by, any forward-looking statements we made.  Any such statement is qualified by reference to the following cautionary statements.  We elaborate on these important factors and the risks we face throughout this Form 10-Q, particularly in the &#8220;Executive Summary&#8221; and &#8220;Business Environment&#8221; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections preceding our discussion of the operating results of our segments above, and in our publicly filed reports, including our 2021 Form 10-K.  These factors and risks include the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">unfavorable litigation outcomes, including risks associated with adverse jury and judicial determinations, courts and arbitrators reaching conclusions at variance with our or any of our investees&#8217; understanding of applicable law, bonding requirements in the jurisdictions that do not limit the dollar amount of appeal bonds, and certain challenges to bond cap statutes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">government (including the FDA) and private sector actions that impact adult tobacco consumer acceptability of, or access to, tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">tobacco product taxation, including lower tobacco product consumption levels and potential shifts in adult tobacco consumer purchases as a result of federal, state and local excise tax increases, and excise taxes on e-vapor and oral nicotine products and the impact on adult tobacco consumers&#8217; transition to lower priced tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">unfavorable outcomes of any government investigations of us or our investees;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">a successful challenge to our tax positions, an increase to the corporate income tax rate or other changes to federal or state tax laws;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our and our investees&#8217; international business operations, including failure to prevent violations of various United States and foreign laws and regulations such as foreign privacy laws and laws prohibiting bribery and corruption;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks associated with health epidemics and pandemics, including the COVID-19 pandemic and similar outbreaks, such as their impact on our and our investees&#8217; ability to continue manufacturing and distributing products (directly or indirectly due to their impact on suppliers, distributors and distribution chain service providers) and their impact on macroeconomic conditions and, in turn, adult tobacco consumer purchasing behavior; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the failure of our and our investees&#8217; efforts to compete effectively in their respective markets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the growth of the e-vapor category and other innovative tobacco products, including oral nicotine pouches, contributing to reductions in cigarette and MST consumption levels and sales volume;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our ability to promote brand equity successfully; anticipate and respond to evolving adult tobacco consumer preferences; develop, manufacture, market and distribute products that appeal to adult tobacco consumers; promote productivity; and protect or enhance margins through cost savings and price increases;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our unsuccessful commercialization of innovative products or processes, including innovative tobacco products that may reduce the health risks associated with cigarettes and other traditional tobacco products, and that appeal to adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">changes, including in macroeconomic and geopolitical conditions (including inflation), that result in shifts in adult tobacco consumer disposable income and purchasing behavior, including choosing lower-priced and discount brands;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of changes in macroeconomic, climate and geopolitical conditions, including the Russian invasion of Ukraine;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks, including FDA regulatory risks, related to our and our investees&#8217; reliance on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers, and the risk of an extended disruption at a facility of, or of service by, a supplier, distributor or distribution chain service provider of our tobacco subsidiaries or our investees;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">required or voluntary product recalls or prohibition on the marketing or sale of our or any of our investees&#8217; products as a result of various circumstances such as FDA or other regulatory action or product contamination;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the failure of our information systems or the information systems of key suppliers or service providers to function as intended, or cyber attacks or security breaches;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to attract and retain the best talent due to the impact of decreasing social acceptance of tobacco usage, tobacco control actions and other factors, including current labor market dynamics;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">impairment losses as a result of the write down of intangible assets, including goodwill;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the adverse effect of acquisitions, investments, dispositions or other events on our credit rating;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to acquire attractive businesses or make attractive investments on favorable terms, or at all, or to realize the anticipated benefits from an acquisition or investment and our inability to dispose of businesses or investments on favorable terms or at all;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to disruption and uncertainty in the credit and capital markets, including risk of losing access to these markets, which may adversely affect our earnings or dividend rate or both;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">our inability to attract and retain investors due to the impact of decreasing social acceptance of tobacco usage or unfavorable environmental, social and governance ratings; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risk that any challenge to our investment in JUUL, if successful, could result in a broad range of resolutions, including divestiture of the investment or rescission of the transaction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks generally related to our investments in JUUL and Cronos, including our inability to realize the expected benefits of our investments in the expected time frames, or at all, due to the risks encountered by our investees in their businesses, such as operational, competitive, compliance, litigation and reputational risks, and legislative and regulatory risks at the international, federal, state and local levels; and changes in the fair value of our investment in JUUL and impairment of our investment in Cronos;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our inability to acquire a controlling interest in JUUL as a result of standstill restrictions or to control the material decisions of JUUL, restrictions on our ability to sell or otherwise transfer our shares of JUUL until December 20, 2024, and non-competition restrictions for the same time period subject to certain exceptions;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks associated with our investment in ABI, including effects of the COVID-19 pandemic, foreign currency exchange rates and macroeconomic and geopolitical conditions, including the Russian invasion of Ukraine, on ABI&#8217;s business and the impact on our earnings from, and carrying value of, our investment in ABI;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks related to our ownership percentage in ABI decreasing below certain levels, including additional tax liabilities, a reduction in the number of directors that we have the right to have appointed to the ABI board of directors and our potential inability to use the equity method of accounting for our investment in ABI;  </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risk of a successful challenge to the tax treatment of our equity investment in ABI; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt">the risks, including criminal, civil or tax liability, related to our or Cronos&#8217;s failure to comply with applicable laws, including cannabis laws.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should understand that it is not possible to predict or identify all factors and risks.  Consequently, you should not consider the foregoing list to be complete.  We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_154"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 3.  Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, all of which is fixed-rate debt, is subject to fluctuations resulting primarily from changes in market interest rates.  The following table provides the fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates at June&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in billions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in fair value from a 1% increase in market interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value from a 1% decrease in market interest rates</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate, or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s and S&amp;P.  The applicable percentage for borrowings under the Credit Agreement at June&#160;30, 2022 was 1.0%  based on our long-term senior unsecured debt ratings on that date.  At June&#160;30, 2022 and December&#160;31, 2021, we had no borrowings under the Credit Agreement.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_157"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 4.  Controls and Procedures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, with the participation of our management, including Altria&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Form 10-Q.  Based upon that evaluation, Altria&#8217;s Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_160"></div><div style="margin-bottom:5pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Part II &#8211; OTHER INFORMATION</span></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.  Legal Proceedings</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for a discussion of legal proceedings pending against us.  See also Exhibits 99.1 and 99.2 to this Form 10-Q.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_163"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Risk Factors appears in Part I, Item 1A. Risk Factors of our 2021 Form 10-K.  Except as set forth below, there have been no material changes to the risk factors previously disclosed in our 2021 Form 10-K.  We elaborate on these and other risks we face throughout this Form 10-Q, particularly in the &#8220;Business Environment&#8221; section preceding our discussion of our operating results above in Part 1, Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Our Investments</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The expected benefits of the JUUL transaction may not materialize in the expected manner or timeframe or at all.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected benefits of the JUUL transaction may not materialize in the expected manner or timeframe or at all, including due to the risks encountered by JUUL in its business, such as operational, competitive, regulatory and legislative risks at the international, federal, state and local levels, including actions by the FDA; adverse publicity due to underage use of e-vapor products and other factors; changes in JUUL&#8217;s relationships with employees, customers, suppliers, lenders and other third parties; potential disruptions to JUUL&#8217;s management or current or future plans and operations; adverse changes with respect to JUUL&#8217;s ability to satisfy its obligations under its debt arrangements and maintain adequate financing to fund its projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency law; or developments with respect to domestic or international litigation or investigations.  JUUL and Altria and/or one or more of our subsidiaries, including PM USA, are named as defendants in various individual and class action lawsuits, including independent lawsuits initiated by certain state attorneys general.  JUUL also is named in a significant number of additional individual and class action lawsuits to which neither Altria nor any of our subsidiaries is a party.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing our financial statements for prior periods, we performed valuations of our investment in JUUL as a result of impairment indicators, determined that our investment in JUUL was impaired and recorded non-cash impairment charges in those periods totaling $11.2 billion.  Since the time we recorded those impairments, we have elected to account for our equity method investment in JUUL under the fair value option.  Under this option, we make various judgments, estimates and assumptions, including with respect to sales volume, operating margins, discount rates and perpetual growth rates, to estimate the fair value of our investment in JUUL, which is calculated quarterly.  In June 2022, the FDA issued JUUL MDOs for all of JUUL&#8217;s products currently marketed in the United States.  Although the MDOs are stayed on a temporary basis, the possibility of JUUL&#8217;s products being removed from the U.S. market and the likelihood and extent of JUUL being able to maintain adequate financing to fund projected cash needs negatively impacted the estimated fair value of our investment for the quarter ended June 30, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA ultimately denies JUUL authorization to market its products in the United States, or if the outcomes in connection with any of the other risks or circumstances discussed above deviate significantly from then-current expectations, such outcomes could materially impact the judgments, estimates and assumptions we make in connection with our quarterly estimate of the fair value of our investment in JUUL.  Accordingly, negative developments with respect to the risks or circumstances discussed above could adversely impact the fair value of our investment in JUUL, create volatility in our consolidated financial position or earnings, adversely impact our ability to recognize the expected benefits of the JUUL transaction in the expected timeframe or at all and adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the carrying value of our investment in Cronos exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired, which would result in impairment losses and could have a material adverse effect on our consolidated financial position or earnings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing our financial statements for the year ended December 31, 2021, we concluded that our equity method investment in Cronos declined below its carrying value and that there was not sufficient evidence to conclude that the impairment was temporary.  In preparing our financial statements for the period ended June 30, 2022, we concluded that our equity method investment in Cronos had declined further and that there was not  sufficient evidence to conclude that the impairment was temporary.  As a result, we recorded non-cash, pre-tax impairment charges of $205 million and $107 million to (income) losses from equity investments in our consolidated statement of earnings (losses) for the year ended December 31, 2021 and the quarter ended June 30, 2022, respectively.  If Cronos is unable to successfully execute its business plans and strategies and the fair value of our investment in Cronos continues to decrease, it could result in additional impairment losses, which could have a material adverse effect on our consolidated financial position or earnings.</span></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_166"></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October 2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;), which we expect to complete by December 31, 2022.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share repurchase activity for each of the three months in the period ended June 30, 2022, was as follows:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1-30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,406,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,406,063</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,118,821,253</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1-31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,728,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53.37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,727,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">973,237,881</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1-30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,927,146</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.89</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,925,697</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">742,277,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,062,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,059,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The total number of shares purchased includes (a) shares purchased under the January 2021 share repurchase program and (b) shares withheld in an amount equal to the statutory withholding taxes for vested stock-based awards previously granted to eligible employees (which totaled 1,309 in May and 1,449 in June).</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8ab1f6ba80d642c6abc401018a1063a1_10">Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="padding-left:45pt;padding-right:15.75pt;text-align:justify;text-indent:-42.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000074/exhibit221q22020.htm">Guarantor Subsidiary of the Registrant.  Incorporated by reference to Altria&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2020 (File No. 1-08940).</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q22022-quarter.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q22022-quarter.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q22022-quarter.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q22022-quarter.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q22022-quarter.htm">Certain Litigation Matters.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:15.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit992q22022-quarter.htm">Trial Schedule for Certain Cases.</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt;padding-left:40.5pt;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxonomy Extension Presentation Linkbase.</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></div></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i8ab1f6ba80d642c6abc401018a1063a1_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Signature</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALTRIA GROUP, INC.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="padding-right:24.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ SALVATORE MANCUSO</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salvatore Mancuso</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 28, 2022</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q22022-quarter.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icca06852b1af486bb1493bbb3b691f97_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:32.62pt;padding-right:32.62pt;text-align:center;text-indent:-29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William F. Gifford, Jr., certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  July 28, 2022</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Gifford, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q22022-quarter.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i696b8c1ba1c04f4484c15d5a3313e90e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Salvatore Mancuso, certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Altria Group, Inc.&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:58.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  July 28, 2022</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salvatore Mancuso</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></div><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q22022-quarter.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia62a3e06874e4542bbd3f5725e324a59_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, William F. Gifford, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">William F. Gifford, Jr.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">July 28, 2022</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322q22022-quarter.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icbf7efdccaed4b3dbeabecdd57894fa0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Salvatore Mancuso, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salvatore Mancuso</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President and</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">July 28, 2022</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>exhibit991q22022-quarter.htm
<DESCRIPTION>CERTAIN LITIGATION MATTERS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3e0f507041a44d10b591c28dfefee509_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN LITIGATION MATTERS</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Altria Group, Inc.&#8217;s (&#8220;Altria&#8221;) condensed consolidated financial statements in Part I, Item 1 of the Quarterly Report on Form 10-Q to which this Exhibit 99.1 is attached (&#8220;Note 11&#8221;), there are legal proceedings covering a wide range of matters pending or threatened in various United States and foreign jurisdictions against Altria, its subsidiaries, including Philip Morris USA Inc. (&#8220;PM USA&#8221;), and their respective indemnitees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act, claims for contribution and claims of competitors, shareholders or distributors.  Claims related to tobacco products generally fall within the following categories&#58; (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs, (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and&#47;or disgorgement of profits, (iv) class action suits alleging that the use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law fraud or statutory fraud, unjust enrichment, breach of warranty, or violations of the Racketeer Influenced and Corrupt Organizations Act, (v) class action suits involving e-vapor products and (vi) international cases.  The following lists certain of the pending claims against Altria and PM USA included in these and other categories.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SMOKING AND HEALTH LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the consolidated individual smoking and health cases as well as smoking and health class actions pending against PM USA and, in some cases, Altria and&#47;or its other subsidiaries and affiliates, as of July 25, 2022.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of smoking and health class actions pending in Canada.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Flight Attendant Litigation</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The settlement agreement entered into in 1997 in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin, et al. v. Philip Morris Companies Inc., et al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was brought by flight attendants seeking damages for personal injuries allegedly caused by environmental tobacco smoke, allowed members of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  See Note 11 for a discussion of this litigation.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Class Actions</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle, et al. v. R.J. Reynolds Tobacco Co., et al., Circuit Court, Eleventh Judicial Circuit, Dade County, Florida, filed May 5, 1994.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11 for a discussion of this case (which has concluded) and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny litigation.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Young, et al. v. The American Tobacco Company, et al., Civil District Court, Orleans Parish, Louisiana, filed November 12, 1997.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTH CARE COST RECOVERY LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists a health care cost recovery action pending against PM USA and Altria as of July 25, 2022.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of international health care cost recovery actions.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Department of Justice Case</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The United States of America v. Philip Morris Incorporated, et al., United States District Court, District of Columbia, filed September 22, 1999</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIGHTS&#47;ULTRA LIGHTS&#8221; CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the &#8220;Lights&#47;Ultra Lights&#8221; class actions pending against Altria and&#47;or its various subsidiaries and others as of July 25, 2022.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moore, et al. v. Philip Morris Incorporated, et al., Circuit Court, Marshall County, West Virginia, filed September 17, 2001.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virden v. Altria Group, Inc., et al., Circuit Court, Hancock County, West Virginia, filed March 28, 2003.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CLASS ACTION LAWSUITS INVOLVING E-VAPOR PRODUCTS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists class action lawsuits relating to e-vapor products that are pending against Altria and&#47;or its various subsidiaries and others as of July 25, 2022.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NesSmith, et al. v. JUUL Labs Inc., et al., United States District Court, Middle District of Florida, filed April 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peavy (formerly Swearingen), et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed May 31, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R.E., et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of West Virginia, filed August 13, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M.D., et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Mississippi, filed August 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oberhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed September 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hochhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of New York, filed October 1, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emidy et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Tennessee, filed October 2, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County, Maryland, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Maryland, filed October 11, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">King County, Washington, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 16, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Rochester, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed November 6, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jefferson County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of Mississippi, filed December 5, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ledbetter, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed December 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Escambia County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Florida, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unified School District No. 320, Pottawatomie County, KS, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">School Board of Miami-Dade County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The School Board of Broward County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frederick County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imani, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Oregon, filed December 20, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cooper, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Texas, filed January 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Reilly, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed January 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gabbard, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of Kentucky, filed February 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peoria Public Schools v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County Public Schools, MD. v. JUUL Labs, Inc. et al., United States District Court, Northern District of California, filed December 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, Individually And On Behalf Of Others Similarly Situated, On Behalf Of D.L.J. v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shayla Aceti, individually and on behalf of others similarly situated v. Juul Labs Inc et al., United States District Court, Northern District of California, filed March 30, 2021. </font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Timothy Critzer, individually and on behalf of others similarly situated v. Juul Labs Inc.., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Robert Dyer, On Behalf Of His Son, B.D., individually and on behalf of others similarly situated v. Juul Labs Inc., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joan Eubanks, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bruce Gibson, on behalf of his son, K.G., individually and others similarly situated v.  Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jenika Ingram, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shirley Moses on behalf of her daughter, K.S.C., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Katherine Dentler, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vickie Perry, On Behalf Of Her Daughter LP, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jessica Pierre, individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; Altria Group Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lacretia Pulce, On Behalf Of Her Daughter, K.P., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charles Tippe, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, on behalf of her son. D.L., individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; et al., United States District Court, Northern District of California, filed April 1, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tonya Williams-Walker, On Behalf Of Her Son, M.W., and on behalf of others similarly situated v. Juul Labs Inc.et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randi Lines, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, On Behalf Of His Son, M.R.J., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erin Puente, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shannon Kinnard, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John Hollis, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wolfgang and Suzanne Ziegenhagen on behalf of their son, H.Z. individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janis Kelly on behalf of her son, C.J.W., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coleman Holniker, individually and On Behalf of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Addison Altizer, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nicholas Vogel, on behalf of his son, E.V., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed May 13, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pike County School Corp. Metropolitan School District Of Wabash County, Individually &#38; On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed April 18, 2022.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Altria Client Services, LLC, et al., United States District Court, Eastern District of Virginia, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Tobacco Heating Articles and Components Thereof, United States International Trade Commission, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthier Choices Management Corp. v. Philip Morris USA Inc., et al., United States District Court, Northern District of Georgia, filed December 4, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANTITRUST LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Altria Group, Inc., et al., United States of America Before the Federal Trade Commission, filed April 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reece, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 7, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blomquist, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Martinez, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 14, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deadwyler, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 20, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licari, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flannery, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 27, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Walsh, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 8, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redfield, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carlson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">B&#38;C Retail, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sofijon, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noor Baig, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Somerset Party Store, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 18, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 25, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McGhee, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irwindale Fuel Station, Inc. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 15, 2020.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER DERIVATIVE LAWSUITS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sandys, et al. v. Willard, et al., United States District Court, Northern District of California, filed August 7, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lorca, et al. v. Gifford, et al., United States District Court, Northern District of California, filed August 27, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen, et al. v. Willard, et al., Circuit Court for Henrico County, Virginia, filed September 14, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gilbert, et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed October 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hamilton et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed January 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randolph et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed March 28, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Braunstein et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed May 18, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lopez et al. v. Casteen et al., Circuit Court for Henrico County, Virginia, filed June 16, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Merritts et al. v. Casteen et al., Circuit Court for Albemarle County, Virginia, filed July 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dalton et al. v. W. Hildebrandt Surgner et al., Circuit Court for Henrico County, Virginia, filed August 17, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCollum et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed August 26, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists cases pending against Altria and&#47;or its subsidiaries in foreign jurisdictions as of July 25, 2022.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canada</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Donnell, et. al. v. JUUL Labs, Canada, Ltd., et al., Ontario, Ontario Superior Court, filed April 17, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  E-vapor class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Salvatore, et al. v. JUUL Labs Canada, Ltd., et al., Quebec, District of Montreal Superior Court, filed June 12, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stephens, et al. v. JUUL Labs, Inc., et al., British Columbia, Canada Supreme Court, filed October 1, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of New Brunswick v. Rothmans, Inc., et al., Court of Queen&#8217;s Bench of New Brunswick Judicial District of Fredericton, Canada, filed March 13, 2008.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dorion v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed on or about June 17, 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Semple v. Canadian Tobacco Manufacturers&#8217; Council, et al., Supreme Court of Nova Scotia, Canada, filed on or about June 18, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kunta v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed on an unknown date in June 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adams v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench for Saskatchewan, Judicial Centre of Regina, Canada, filed on or about July 10, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Superior Court of Justice of Ontario, Canada, filed on or about September 30, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, Trial Division, Canada, filed February 8, 2011</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Quebec v. Imperial Tobacco Canada Limited, et al., Superior Court of Quebec, Montreal District, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in the Right of Manitoba v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed May 31, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Saskatchewan v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Saskatchewan, Judicial Centre of Saskatoon, Canada, filed on June 8, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in the Right of the Province of Prince Edward Island v. Rothmans, Benson &#38; Hedges, Inc., et al., Supreme Court of Prince Edward Island, filed on September 10, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Nova Scotia v. Benson &#38; Hedges, Inc., et al., Supreme Court of Nova Scotia, filed on January 2, 2015.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jacklin v. Canadian Tobacco Manufacturers&#8217; Council et al., Ontario Superior Court of Justice, Case No. 5379412, Ontario, Canada, filed on or about June 27, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  See Note 11 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>exhibit992q22022-quarter.htm
<DESCRIPTION>TRIAL SCHEDULE FOR CERTAIN CASES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia4761bdce6854f1685357f3d571b5829_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRIAL SCHEDULE FOR CERTAIN CASES </font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a schedule, as of July 25, 2022, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through September 30, 2022. </font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td></tr></table></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, there are no </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in trial.</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Individual Smoking&#160;&#38; Health </font></div><div style="margin-bottom:5pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, there are no non-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases in trial.</font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>mo-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mo="http://www.altria.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.altria.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.altria.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEarnings" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveEarnings" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Background and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationPolicies" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Background and Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationTables" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables">
        <link:definition>2303301 - Disclosure - Background and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationNarrativeDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails">
        <link:definition>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationShareRepurchaseTableDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails">
        <link:definition>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomers" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers">
        <link:definition>2106102 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomersNarrativeDetails" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails">
        <link:definition>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecurities" roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities">
        <link:definition>2108103 - Disclosure - Investments in Equity Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesTables" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables">
        <link:definition>2309302 - Disclosure - Investments in Equity Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
        <link:definition>2410404 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
        <link:definition>2411405 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
        <link:definition>2412406 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
        <link:definition>2413407 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
        <link:definition>2414408 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
        <link:definition>2415409 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails">
        <link:definition>2416410 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.altria.com/role/FinancialInstruments">
        <link:definition>2117104 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.altria.com/role/FinancialInstrumentsTables">
        <link:definition>2318303 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAggregateFairValueandCarryingValueDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails">
        <link:definition>2419411 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2420412 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.altria.com/role/BenefitPlans">
        <link:definition>2121105 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.altria.com/role/BenefitPlansTables">
        <link:definition>2322304 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
        <link:definition>2423413 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails">
        <link:definition>2424414 - Disclosure - Benefit Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShare" roleURI="http://www.altria.com/role/EarningsperShare">
        <link:definition>2125106 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareTables" roleURI="http://www.altria.com/role/EarningsperShareTables">
        <link:definition>2326305 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareBasicandDilutedEarningsPerShareDetails" roleURI="http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails">
        <link:definition>2427415 - Disclosure - Earnings per Share (Basic and Diluted Earnings Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLosses" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses">
        <link:definition>2128107 - Disclosure - Other Comprehensive Earnings/Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesTables" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables">
        <link:definition>2329306 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>2430416 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesReclassificationsDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails">
        <link:definition>2431417 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.altria.com/role/SegmentReporting">
        <link:definition>2132108 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.altria.com/role/SegmentReportingTables">
        <link:definition>2333307 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSegmentDataScheduleDetails" roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails">
        <link:definition>2434418 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2435419 - Disclosure - Segment Reporting (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails">
        <link:definition>2436420 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.altria.com/role/Debt">
        <link:definition>2137109 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.altria.com/role/DebtNarrativeDetails">
        <link:definition>2438421 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.altria.com/role/IncomeTaxes">
        <link:definition>2139110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesupdateTables" roleURI="http://www.altria.com/role/IncomeTaxesupdateTables">
        <link:definition>2340308 - Disclosure - Income Taxes update (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofIncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails">
        <link:definition>2441422 - Disclosure - Income Taxes - Summary of Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesDetails">
        <link:definition>2442423 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.altria.com/role/Contingencies">
        <link:definition>2143111 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesTables" roleURI="http://www.altria.com/role/ContingenciesTables">
        <link:definition>2344309 - Disclosure - Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGeneralInformationDetails" roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails">
        <link:definition>2445424 - Disclosure - Contingencies (General Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
        <link:definition>2446425 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesScheduleofPendingCasesDetails" roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails">
        <link:definition>2447426 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
        <link:definition>2448427 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNonEngleProgenyLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails">
        <link:definition>2449428 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
        <link:definition>2450429 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
        <link:definition>2451430 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFloridaBondStatuteDetails" roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails">
        <link:definition>2452431 - Disclosure - Contingencies (Florida Bond Statute) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherSmokingandHealthClassActionsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails">
        <link:definition>2453432 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesHealthCareCostRecoveryLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails">
        <link:definition>2454433 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNPMAdjustmentDisputesDetails" roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails">
        <link:definition>2455434 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
        <link:definition>2456435 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFederalGovernmentsLawsuitDetails" roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails">
        <link:definition>2457436 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEvaporProductLitigationandIQOSLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails">
        <link:definition>2458437 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
        <link:definition>2459438 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesLightsUltraLightsCasesDetails" roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails">
        <link:definition>2460439 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesUSTLitigationsNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails">
        <link:definition>2461440 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
        <link:definition>2462441 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdopted" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted">
        <link:definition>2163112 - Disclosure - New Accounting Guidance Not Yet Adopted</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingGuidanceNotYetAdoptedTables" roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables">
        <link:definition>2364310 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mo_SummaryOfIncomeTaxesTableTextBlock" abstract="false" name="SummaryOfIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_LitigationSettlementEstimateofPossibleGain" abstract="false" name="LitigationSettlementEstimateofPossibleGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdicts" abstract="false" name="LossContingencyZeroDamagesVerdicts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedUnfavorableNumber" abstract="false" name="LossContingencyClaimsDecidedUnfavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyClassActionLawsuit" abstract="false" name="LossContingencyClassActionLawsuit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesCooperMember" abstract="true" name="EngleProgenyCasesCooperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityInvestmentFairValueOption" abstract="false" name="EquityInvestmentFairValueOption" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LightsMember" abstract="true" name="LightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CashDiscountsPolicyTextBlock" abstract="false" name="CashDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2017NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EvaporLitigationMember" abstract="true" name="EvaporLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigation" abstract="false" name="LossContingencyNumberofStateswithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesPollariMember" abstract="true" name="EngleProgenyCasesPollariMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_LossContingencyPunitiveDamagesAwardedValue" abstract="false" name="LossContingencyPunitiveDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ETSSmokingandHealthCaseFlightAttendantsMember" abstract="true" name="ETSSmokingandHealthCaseFlightAttendantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AltriaGroupMember" abstract="true" name="AltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" abstract="false" name="LossContingencyNumberOfStatesNotSettledArbitrationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveClassActionLawsuits" abstract="false" name="LossContingencyNumberOfInactiveClassActionLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_InterestExpenseRelatedToLitigationMember" abstract="true" name="InterestExpenseRelatedToLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesReiderandBanksMember" abstract="true" name="EngleProgenyCasesReiderandBanksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IncomeLossFromEquityInvestments" abstract="false" name="IncomeLossFromEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PendingIndividualLawsuitsMember" abstract="true" name="PendingIndividualLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesFederalMember" abstract="true" name="EngleProgenyCasesFederalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_JUULMember" abstract="true" name="JUULMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" abstract="false" name="LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_ClassActionLawsuitMember" abstract="true" name="ClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NumberOfThirdPartyLawsuits" abstract="false" name="NumberOfThirdPartyLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_OtherTabaccoRelatedCasesMember" abstract="true" name="OtherTabaccoRelatedCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20192021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SmokeableProductsSegmentMember" abstract="true" name="SmokeableProductsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2019NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" abstract="false" name="PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CommonStock1.700NotesDue2025Member" abstract="true" name="CommonStock1.700NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_RevolvingCreditFacilityDueAugust2024Member" abstract="true" name="RevolvingCreditFacilityDueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityContractWarrantMember" abstract="true" name="EquityContractWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationCasesResultsMember" abstract="true" name="LitigationCasesResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2014NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMcCallMember" abstract="true" name="EngleProgenyCasesMcCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyStateCourtsNumber" abstract="false" name="LossContingencyStateCourtsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2018NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedCommon" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedCommon" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_WineSegmentMember" abstract="true" name="WineSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedRestricted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_PhilipMorrisUSAMember" abstract="true" name="PhilipMorrisUSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodAxis" abstract="true" name="ArbitrationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyVerdictsUpheld" abstract="false" name="LossContingencyVerdictsUpheld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" abstract="true" name="NonParticipatingManufacturerArbitrationPanelDecisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" abstract="false" name="LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityMethodInvestmentAggregateExercisePrice" abstract="false" name="EquityMethodInvestmentAggregateExercisePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CommonStock1.000NotesDue2023Member" abstract="true" name="CommonStock1.000NotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InvestmentsLineItems" abstract="true" name="InvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" abstract="false" name="ValuationAllowanceForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_InventoryRawMaterialsPlantMaterialNetofReserves" abstract="false" name="InventoryRawMaterialsPlantMaterialNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtAbstract" abstract="true" name="ForeignCurrencyDenominatedDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyNumberofCasesSetforTrial" abstract="false" name="LossContingencyNumberofCasesSetforTrial" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyUnfavorableVerdictsPendingReversed" abstract="false" name="LossContingencyUnfavorableVerdictsPendingReversed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseLaramieMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseLaramieMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdictModified" abstract="false" name="LossContingencyZeroDamagesVerdictModified" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesHollimanMember" abstract="true" name="EngleProgenyCasesHollimanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherDisputesUndertheStateSettlementAgreementsMember" abstract="true" name="OtherDisputesUndertheStateSettlementAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_TobaccoandHealthJudgmentMember" abstract="true" name="TobaccoandHealthJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsResolvedNumber" abstract="false" name="LossContingencyClaimsResolvedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" abstract="true" name="NonEngleProgenySmokingAndHealthCasePrincipeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStock3.125NotesDue2031Member" abstract="true" name="CommonStock3.125NotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodDomain" abstract="true" name="ArbitrationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanAndSommersMember" abstract="true" name="EngleProgenyCasesKaplanAndSommersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MarketingAdministrationandResearchCosts" abstract="false" name="MarketingAdministrationandResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2011NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesLippMember" abstract="true" name="EngleProgenyCasesLippMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" abstract="false" name="ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CommonStock0.3313ParValueMember" abstract="true" name="CommonStock0.3313ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesWeingartandHancockMember" abstract="true" name="EngleProgenyCasesWeingartandHancockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IndividualSmokingAndHealthCasesMember" abstract="true" name="IndividualSmokingAndHealthCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesCuddiheeMember" abstract="true" name="EngleProgenyCasesCuddiheeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentPercentageofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_LossContingencyNumberOfPendingCasesConsolidated" abstract="false" name="LossContingencyNumberOfPendingCasesConsolidated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_IQOSMember" abstract="true" name="IQOSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_InterestAndOtherDebtExpenseNetMember" abstract="true" name="InterestAndOtherDebtExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ABInBevMember" abstract="true" name="ABInBevMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentNumberofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2008NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2010NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PeriodOneMember" abstract="true" name="PeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentsFairValueOptionMember" abstract="true" name="EquityMethodInvestmentsFairValueOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesWithConcludedHearings" abstract="false" name="LossContingencyNumberOfStatesWithConcludedHearings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesStateMember" abstract="true" name="EngleProgenyCasesStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesD.BrownMember" abstract="true" name="EngleProgenyCasesD.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceRollforwardRollForward" abstract="true" name="ValuationAllowanceRollforwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_FederalTradeCommissionDisclosurePeriod" abstract="false" name="FederalTradeCommissionDisclosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2015NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_TobaccoandHealthLitigationCasesMember" abstract="true" name="TobaccoandHealthLitigationCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGarciaMember" abstract="true" name="EngleProgenyCasesGarciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DebtInstrumentExtensionTerm" abstract="false" name="DebtInstrumentExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingClassActionLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsMember" abstract="true" name="HealthCareCostRecoveryActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesDuignanMember" abstract="true" name="EngleProgenyCasesDuignanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" abstract="false" name="ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" abstract="false" name="DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityInvestmentsFairValueOptionVotingShares" abstract="false" name="EquityInvestmentsFairValueOptionVotingShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_LossContingencyVerdictReversedNumber" abstract="false" name="LossContingencyVerdictReversedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesFreemanMember" abstract="true" name="EngleProgenyCasesFreemanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions20052007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedValue" abstract="false" name="LossContingencyCompensatoryDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCases" abstract="false" name="LossContingencyNumberOfCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPricePerShareIfExercised" abstract="false" name="EquityMethodInvestmentPricePerShareIfExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_OtherInventoryRawMaterialsNetofReserves" abstract="false" name="OtherInventoryRawMaterialsNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PeriodTwoMember" abstract="true" name="PeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesWithSetTrialDates" abstract="false" name="LossContingencyNumberOfCasesWithSetTrialDates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenyCasesMember" abstract="true" name="NonEngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2021NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedFavorableNumber" abstract="false" name="LossContingencyClaimsDecidedFavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveCases" abstract="false" name="LossContingencyNumberOfInactiveCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" abstract="false" name="AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PhilipMorrisUSAandAltriaGroupMember" abstract="true" name="PhilipMorrisUSAandAltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMember" abstract="true" name="EngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2006NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_January2021ShareRepurchaseProgramMember" abstract="true" name="January2021ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsNotCertifiedNumber" abstract="false" name="LossContingencyClaimsNotCertifiedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" abstract="false" name="LossContingencyNumberofStateswithSettledLitigationSettlementOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationEscrowDeposit" abstract="false" name="LitigationEscrowDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGreeneMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGreeneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesSchertzerMember" abstract="true" name="EngleProgenyCasesSchertzerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettled" abstract="false" name="LossContingencyNumberOfStatesNotSettled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_AccruedSettlementLiabilityCurrent" abstract="false" name="AccruedSettlementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CanadianTobaccoManufacturersMember" abstract="true" name="CanadianTobaccoManufacturersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesR.DouglasMember" abstract="true" name="EngleProgenyCasesR.DouglasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" abstract="false" name="EquityMethodInvestmentWarrantExercisedOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EngleProgenyCasesChadwellMember" abstract="true" name="EngleProgenyCasesChadwellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualLegalFeesPayableMaximum" abstract="false" name="LitigationSettlementAnnualLegalFeesPayableMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_FederalGovernmentsLawsuitMember" abstract="true" name="FederalGovernmentsLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetDecreaseInAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" abstract="true" name="EquityContractWarrantAndEquityContractPreemptiveRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" abstract="false" name="OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanMcLauighlinMember" abstract="true" name="EngleProgenyCasesKaplanMcLauighlinMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InvestmentsTable" abstract="true" name="InvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" abstract="true" name="PendingLawsuitsFiledByStateOrLocalGovernmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" abstract="true" name="HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_BritishColumbiaSaskatchewanMember" abstract="true" name="BritishColumbiaSaskatchewanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OralTobaccoSegmentMember" abstract="true" name="OralTobaccoSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2009NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" abstract="false" name="DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_AmountAwardedtoOtherParty" abstract="false" name="AmountAwardedtoOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2004NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IncreaseDecreaseInSettlementPayable" abstract="false" name="IncreaseDecreaseInSettlementPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USTLitigationMember" abstract="true" name="USTLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotes3490PercentDue2022Member" abstract="true" name="USDDenominatedNotes3490PercentDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStock2.200NotesDue2027Member" abstract="true" name="CommonStock2.200NotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityContractPreemptiveRIghtsMember" abstract="true" name="EquityContractPreemptiveRIghtsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2013NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesMember" abstract="true" name="USDDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" abstract="true" name="AccumulatedEquityMethodInvestmentsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" abstract="false" name="EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ImplementationofCorrectiveCommunicationsMember" abstract="true" name="ImplementationofCorrectiveCommunicationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PendingClassActionLawsuitMember" abstract="true" name="PendingClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MaximumBondForAllDefendants" abstract="false" name="MaximumBondForAllDefendants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_IncomeLossFromEquityInvestmentsFairValueOption" abstract="false" name="IncomeLossFromEquityInvestmentsFairValueOption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfComplaints" abstract="false" name="LossContingencyNumberOfComplaints" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyDamagesRecoverableValue" abstract="false" name="LossContingencyDamagesRecoverableValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2012NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" abstract="true" name="EngleProgenyCasesPearsonDCohenCollarChaconMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyReductionToCostOfSales" abstract="false" name="LossContingencyReductionToCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_RestrictedSharesLockupPeriod" abstract="false" name="RestrictedSharesLockupPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerRintoulandDuignamMember" abstract="true" name="EngleProgenyCasesGlogerRintoulandDuignamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClassNotCertifiedNumber" abstract="false" name="LossContingencyClassNotCertifiedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" abstract="false" name="LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_NpmAdjustmentToCostOfSalesMember" abstract="true" name="NpmAdjustmentToCostOfSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecided" abstract="false" name="LossContingencyClaimsDecided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" abstract="false" name="LossContingencyNumberofStatesThatCapBondorRequireNoBond" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualPaymentAmount" abstract="false" name="LitigationSettlementAnnualPaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" abstract="false" name="LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2005NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2020NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SmokingAndHealthClassActionsMember" abstract="true" name="SmokingAndHealthClassActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>mo-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9ab50c01-3c6e-4d92-b5f4-0df25389b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:to="loc_us-gaap_TreasuryStockValue_9ab50c01-3c6e-4d92-b5f4-0df25389b5c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2382d5c-71d8-49f4-950f-10ee661eb000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:to="loc_us-gaap_CommonStockValue_d2382d5c-71d8-49f4-950f-10ee661eb000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_57efcccb-a7ab-4c5a-8878-c877bfccba22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_57efcccb-a7ab-4c5a-8878-c877bfccba22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f2f73ff3-e7f7-4cf5-b8e1-668202e77b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f2f73ff3-e7f7-4cf5-b8e1-668202e77b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f5e6ad33-6c2b-4080-8f10-3c04d2b8f400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1843a4e-7776-4d93-bf95-9149466a1115" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f5e6ad33-6c2b-4080-8f10-3c04d2b8f400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_df35b30b-e284-4674-91d4-d211ec4303c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ce1f1d6f-077b-4065-9d1c-8b61d817390d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_df35b30b-e284-4674-91d4-d211ec4303c1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ce1f1d6f-077b-4065-9d1c-8b61d817390d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2102ab79-aedb-4e84-b9c1-df5914e41e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_df35b30b-e284-4674-91d4-d211ec4303c1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2102ab79-aedb-4e84-b9c1-df5914e41e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_845ff785-2d32-4e7c-b3e5-f737eff2bbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_LiabilitiesCurrent_845ff785-2d32-4e7c-b3e5-f737eff2bbf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_eb2c4434-9aef-4340-95b5-8c1b89120159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_eb2c4434-9aef-4340-95b5-8c1b89120159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_79b76fda-edd4-442c-afa5-f996ff195d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_79b76fda-edd4-442c-afa5-f996ff195d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_c11c0d2b-219e-40aa-abf8-e4c78dabdcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_c11c0d2b-219e-40aa-abf8-e4c78dabdcaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_146f47c8-9a0e-4871-8226-b2b64e5a504e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_146f47c8-9a0e-4871-8226-b2b64e5a504e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_989e985d-f598-4c8b-b608-15f2982266ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_871ad7d7-4dcb-49e8-bc3f-080e5759d4cc" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_989e985d-f598-4c8b-b608-15f2982266ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_56db0682-08b7-47fc-83e2-e1f8744d1907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_AssetsCurrent_56db0682-08b7-47fc-83e2-e1f8744d1907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2d366143-71f1-4533-9498-4612b19cff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2d366143-71f1-4533-9498-4612b19cff1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b0afc2b8-5d28-49f4-8c53-7189dceb552d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_Goodwill_b0afc2b8-5d28-49f4-8c53-7189dceb552d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_13d9f407-a689-4b50-ac5b-61562ddd301f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_13d9f407-a689-4b50-ac5b-61562ddd301f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_aa310452-d38e-4802-966b-f41b62acec6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_Investments_aa310452-d38e-4802-966b-f41b62acec6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7b0688b8-7f53-45d9-bff3-413fc9e95fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ed0060df-6c40-4b43-83da-70e12e7ed75d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7b0688b8-7f53-45d9-bff3-413fc9e95fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b69faf87-38ec-4b51-ab96-284cf7f96445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_6b1a985c-778b-4fe2-b6c1-81760a22c7c6" xlink:href="mo-20220630.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b69faf87-38ec-4b51-ab96-284cf7f96445" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_6b1a985c-778b-4fe2-b6c1-81760a22c7c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_10cb48b7-6009-4843-b6df-9ff18994c5ca" xlink:href="mo-20220630.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b69faf87-38ec-4b51-ab96-284cf7f96445" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_10cb48b7-6009-4843-b6df-9ff18994c5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_305b75f1-6c73-441d-ad23-284b931fc0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b69faf87-38ec-4b51-ab96-284cf7f96445" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_305b75f1-6c73-441d-ad23-284b931fc0c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c0126fda-8e70-418f-a7ab-5603ddf543b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b69faf87-38ec-4b51-ab96-284cf7f96445" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c0126fda-8e70-418f-a7ab-5603ddf543b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a9ab9f20-0486-4335-ad6f-172b220a7c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_us-gaap_LongTermDebtCurrent_a9ab9f20-0486-4335-ad6f-172b220a7c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_bceaa503-61f4-4155-a963-406b26b66d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_us-gaap_AccountsPayableCurrent_bceaa503-61f4-4155-a963-406b26b66d30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_6c8892d6-2a5a-464e-9094-af238e0ce2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_6c8892d6-2a5a-464e-9094-af238e0ce2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_3945b22e-94da-4c61-80a3-86928123962a" xlink:href="mo-20220630.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_3945b22e-94da-4c61-80a3-86928123962a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8e1317bb-dcb1-4571-a8a2-2953d162faad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8e1317bb-dcb1-4571-a8a2-2953d162faad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_bcae07a8-0242-439f-9693-3c6385468309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0e5c9b83-b655-4987-b2f1-e7aff9ae4a52" xlink:to="loc_us-gaap_DividendsPayableCurrent_bcae07a8-0242-439f-9693-3c6385468309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b894f967-b223-4c36-8c37-658b60cd0791" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9ade8486-e011-4665-b41e-f62cc3c6859e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b894f967-b223-4c36-8c37-658b60cd0791" xlink:to="loc_us-gaap_Liabilities_9ade8486-e011-4665-b41e-f62cc3c6859e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_08f5f928-0662-44aa-b7ea-21aa1f4574b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b894f967-b223-4c36-8c37-658b60cd0791" xlink:to="loc_us-gaap_CommitmentsAndContingencies_08f5f928-0662-44aa-b7ea-21aa1f4574b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cc14055e-86cd-468c-ad8b-2ad86973bd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b894f967-b223-4c36-8c37-658b60cd0791" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cc14055e-86cd-468c-ad8b-2ad86973bd37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c3ca141b-a39a-48c8-aeae-a4d8b1af78aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c39a90dd-3b14-4983-9af2-81dfacb9320f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3ca141b-a39a-48c8-aeae-a4d8b1af78aa" xlink:to="loc_us-gaap_InventoryNet_c39a90dd-3b14-4983-9af2-81dfacb9320f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1be127da-ccbf-46ba-99d9-e6e565d981e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3ca141b-a39a-48c8-aeae-a4d8b1af78aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1be127da-ccbf-46ba-99d9-e6e565d981e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7989fa52-1ca8-4534-b21b-1e5503f16977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3ca141b-a39a-48c8-aeae-a4d8b1af78aa" xlink:to="loc_us-gaap_OtherAssetsCurrent_7989fa52-1ca8-4534-b21b-1e5503f16977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_a5b6dd48-b351-4980-9e1d-d60db978dd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c3ca141b-a39a-48c8-aeae-a4d8b1af78aa" xlink:to="loc_us-gaap_ReceivablesNetCurrent_a5b6dd48-b351-4980-9e1d-d60db978dd9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b10605e1-21d8-4359-a886-772ca80938da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_b10605e1-21d8-4359-a886-772ca80938da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c8d27b67-7702-41f6-a9eb-68dffeac0766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c8d27b67-7702-41f6-a9eb-68dffeac0766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9a9acf2b-b15a-4b4a-b2ee-d1e26a10bad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9a9acf2b-b15a-4b4a-b2ee-d1e26a10bad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e75f0d11-eafa-401d-a89b-2427cc9e358e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_us-gaap_OperatingIncomeLoss_e75f0d11-eafa-401d-a89b-2427cc9e358e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_40c6e18b-f1e3-4dcd-9b22-e4d722c6c85f" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_mo_IncomeLossFromEquityInvestments_40c6e18b-f1e3-4dcd-9b22-e4d722c6c85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_be0cd5fd-597b-43db-afd3-986ed3836bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_80eb7caa-a879-48de-96ce-a7b16b7dad5c" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_be0cd5fd-597b-43db-afd3-986ed3836bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d62fec05-b285-4e53-b435-dbc24ab0db23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2da71014-af76-420d-be3c-a6c65eee9d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d62fec05-b285-4e53-b435-dbc24ab0db23" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2da71014-af76-420d-be3c-a6c65eee9d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cb1d6d96-eabc-4776-845c-edf6d1fac6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d62fec05-b285-4e53-b435-dbc24ab0db23" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cb1d6d96-eabc-4776-845c-edf6d1fac6a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4cb8a67a-adbd-45ec-8a47-c41853081202" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_830c2714-0990-487f-b72f-bde4ca7886e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4cb8a67a-adbd-45ec-8a47-c41853081202" xlink:to="loc_us-gaap_GrossProfit_830c2714-0990-487f-b72f-bde4ca7886e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_8e701e81-4273-47ad-8cd0-23a97eac3db9" xlink:href="mo-20220630.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4cb8a67a-adbd-45ec-8a47-c41853081202" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_8e701e81-4273-47ad-8cd0-23a97eac3db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_65bc9278-24c0-4521-96fc-12b6a2617681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1efce52f-4007-4410-a701-17bd240739e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_65bc9278-24c0-4521-96fc-12b6a2617681" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1efce52f-4007-4410-a701-17bd240739e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e44885b3-e1c0-4f90-9c9f-3388440b2bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_65bc9278-24c0-4521-96fc-12b6a2617681" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e44885b3-e1c0-4f90-9c9f-3388440b2bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_2d2ec133-48b3-4c56-b5d4-b5d8f4873f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_65bc9278-24c0-4521-96fc-12b6a2617681" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_2d2ec133-48b3-4c56-b5d4-b5d8f4873f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57b15c9f-435d-4048-a42c-05edba7f93c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_efef1812-9720-4a66-91a0-0dc8ab70b044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_57b15c9f-435d-4048-a42c-05edba7f93c5" xlink:to="loc_us-gaap_ProfitLoss_efef1812-9720-4a66-91a0-0dc8ab70b044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8452dddc-51bc-4d9f-980e-2dd758fc4951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_57b15c9f-435d-4048-a42c-05edba7f93c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8452dddc-51bc-4d9f-980e-2dd758fc4951" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c255c5e4-7045-4319-84ff-6b37ab01534f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd501a3a-c345-4cc9-8cf1-41c29470735a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c255c5e4-7045-4319-84ff-6b37ab01534f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fd501a3a-c345-4cc9-8cf1-41c29470735a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f4bf27fb-b914-4ce2-b779-2105aab79334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c255c5e4-7045-4319-84ff-6b37ab01534f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f4bf27fb-b914-4ce2-b779-2105aab79334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9da71fc6-d396-49de-a7e2-b34d1db67a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_65812f15-d53d-4ebd-acb0-d959fdb47dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9da71fc6-d396-49de-a7e2-b34d1db67a57" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_65812f15-d53d-4ebd-acb0-d959fdb47dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_ed2f2b22-14fc-4c4b-bf36-2ce41cfd5cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9da71fc6-d396-49de-a7e2-b34d1db67a57" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_ed2f2b22-14fc-4c4b-bf36-2ce41cfd5cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_acb14c2f-56c1-4d06-bdfc-edd7aa76329f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9da71fc6-d396-49de-a7e2-b34d1db67a57" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_acb14c2f-56c1-4d06-bdfc-edd7aa76329f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e0c3bc85-90f6-4ef0-a150-2f58e848936e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9b3826aa-b9af-4cb9-bc86-d7f676c6ca3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e0c3bc85-90f6-4ef0-a150-2f58e848936e" xlink:to="loc_us-gaap_ProfitLoss_9b3826aa-b9af-4cb9-bc86-d7f676c6ca3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d531262b-bed4-4f94-99f4-305fe67d7316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e0c3bc85-90f6-4ef0-a150-2f58e848936e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d531262b-bed4-4f94-99f4-305fe67d7316" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4f816055-2ab5-4c56-b49a-948a1585825c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a190e6b-1f8e-4a5b-bf74-1fa12153cddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4f816055-2ab5-4c56-b49a-948a1585825c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a190e6b-1f8e-4a5b-bf74-1fa12153cddf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ea7519d-2940-4c56-9cd9-af706d093707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4f816055-2ab5-4c56-b49a-948a1585825c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6ea7519d-2940-4c56-9cd9-af706d093707" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_80aa3625-8674-4daa-b6c8-9c2951b63cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4f816055-2ab5-4c56-b49a-948a1585825c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_80aa3625-8674-4daa-b6c8-9c2951b63cf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_4fb7bbb3-73d1-43f1-b6c4-7c8a230ca193" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_mo_IncomeLossFromEquityInvestments_4fb7bbb3-73d1-43f1-b6c4-7c8a230ca193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e5c3c658-4c1f-466c-9a79-048b3825d9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e5c3c658-4c1f-466c-9a79-048b3825d9bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_cea766ec-d50b-4884-851d-ae01cf499b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_cea766ec-d50b-4884-851d-ae01cf499b66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a2027c10-2580-4908-8901-0d9704224e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a2027c10-2580-4908-8901-0d9704224e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_bba0d2b8-5e18-474e-8e07-28027d6041cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_bba0d2b8-5e18-474e-8e07-28027d6041cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e80afd3b-5c47-44d7-9a4f-33b2518d4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e80afd3b-5c47-44d7-9a4f-33b2518d4caa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_b54a83c7-8f45-4a20-a1c6-acd0020519dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_b54a83c7-8f45-4a20-a1c6-acd0020519dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_267e60da-f071-4ada-a241-ce73dcc53ed0" xlink:href="mo-20220630.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_267e60da-f071-4ada-a241-ce73dcc53ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_9e05cd79-4ec9-4ad9-b1dd-3799309f47dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_9e05cd79-4ec9-4ad9-b1dd-3799309f47dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ae4730d0-e0e8-47ab-b271-80173dc23901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_ProfitLoss_ae4730d0-e0e8-47ab-b271-80173dc23901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_0ae44873-f710-407a-b257-80be8d2164ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_0ae44873-f710-407a-b257-80be8d2164ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a09cd768-fd32-436e-9470-58fa7a93298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a09cd768-fd32-436e-9470-58fa7a93298b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0aae87e6-be97-403b-9fdb-a47a4d3edbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0aae87e6-be97-403b-9fdb-a47a4d3edbdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d56d950e-e092-4182-8482-6b7e68d93906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d56d950e-e092-4182-8482-6b7e68d93906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c6dfa8fe-41e8-4d39-9f1c-731f53c2f95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c6dfa8fe-41e8-4d39-9f1c-731f53c2f95f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_6cad797d-0778-46b0-9dc1-24726a62310b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3632ac07-1f52-4cb6-b6bf-90d2d7ebd0ef" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_6cad797d-0778-46b0-9dc1-24726a62310b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ceafe1a-ef55-4845-b81c-4cf128c894af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_647074d5-3be1-4464-8700-ffdbc60c9af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ceafe1a-ef55-4845-b81c-4cf128c894af" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_647074d5-3be1-4464-8700-ffdbc60c9af6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_b7c4ee24-41a0-4a11-9523-d92ef8f05b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ceafe1a-ef55-4845-b81c-4cf128c894af" xlink:to="loc_us-gaap_RestrictedCashCurrent_b7c4ee24-41a0-4a11-9523-d92ef8f05b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_8212d65b-8b27-4399-8281-54cc894d21d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ceafe1a-ef55-4845-b81c-4cf128c894af" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_8212d65b-8b27-4399-8281-54cc894d21d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b368536a-4fd1-4825-a071-ae8ad0a91760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b368536a-4fd1-4825-a071-ae8ad0a91760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9bee441d-8b42-4142-b8a6-48c701769361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9bee441d-8b42-4142-b8a6-48c701769361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7e813a5b-28e0-4d81-a799-500b17ef1402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7e813a5b-28e0-4d81-a799-500b17ef1402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5826e62b-3312-436b-bd51-5adee2ebf6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5826e62b-3312-436b-bd51-5adee2ebf6b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c939c9d9-70a8-40c8-b508-5bd443b6206f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c939c9d9-70a8-40c8-b508-5bd443b6206f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_fe25a368-be00-4f92-842f-41023c7f21ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4bb777c5-f129-4ed0-b774-6f98c087b53f" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_fe25a368-be00-4f92-842f-41023c7f21ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_246b6e2f-bd43-44b3-b51d-a5af0314fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9d59bdc9-a6df-4181-a6ee-4a2314bf605b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_246b6e2f-bd43-44b3-b51d-a5af0314fe24" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9d59bdc9-a6df-4181-a6ee-4a2314bf605b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_46e54ab0-e536-4dcc-8e66-ec05384866e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_246b6e2f-bd43-44b3-b51d-a5af0314fe24" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_46e54ab0-e536-4dcc-8e66-ec05384866e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_3f33620f-7542-4c71-b998-9008e496c121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_aef0a3c3-b706-4e78-b434-e626238a7dfa" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_3f33620f-7542-4c71-b998-9008e496c121" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_aef0a3c3-b706-4e78-b434-e626238a7dfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6549ea29-18ef-49ed-8641-ab0b36d8bb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_3f33620f-7542-4c71-b998-9008e496c121" xlink:to="loc_us-gaap_EquityMethodInvestments_6549ea29-18ef-49ed-8641-ab0b36d8bb53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_ad1ead3c-7345-4191-b0ab-2440a97c355d" xlink:href="mo-20220630.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_3f33620f-7542-4c71-b998-9008e496c121" xlink:to="loc_mo_EquityInvestmentFairValueOption_ad1ead3c-7345-4191-b0ab-2440a97c355d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_fec18e83-0557-439e-be81-cf197a82c3a5" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f344cfce-e067-4417-a6a4-e2e99736d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_fec18e83-0557-439e-be81-cf197a82c3a5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f344cfce-e067-4417-a6a4-e2e99736d5fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_6051acef-cafb-4c2f-bef9-607c558c16a2" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_fec18e83-0557-439e-be81-cf197a82c3a5" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_6051acef-cafb-4c2f-bef9-607c558c16a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_6521e49c-1cc6-45d3-a043-681609db8ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_6521e49c-1cc6-45d3-a043-681609db8ad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_12cc8c8d-db17-4e96-b710-36755e5767f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_12cc8c8d-db17-4e96-b710-36755e5767f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6ee9d726-de31-4f2f-8ba6-71c8e5d42aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_6ee9d726-de31-4f2f-8ba6-71c8e5d42aa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_973c77d4-b4c7-4663-890e-e0b1af964758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_973c77d4-b4c7-4663-890e-e0b1af964758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_0182056b-f569-4cd4-85ed-04162d03bdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a5713d8d-8011-4828-9733-269ac5d16a96" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_0182056b-f569-4cd4-85ed-04162d03bdb4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#EarningsperShareBasicandDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2a004216-2ea3-4aad-b99a-d15cad495aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_b7fa129f-9c9f-44f8-bd8e-8931c7cd727a" xlink:href="mo-20220630.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2a004216-2ea3-4aad-b99a-d15cad495aa6" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_b7fa129f-9c9f-44f8-bd8e-8931c7cd727a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fbcffa12-5c28-4a41-bf4b-466a32b67934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2a004216-2ea3-4aad-b99a-d15cad495aa6" xlink:to="loc_us-gaap_NetIncomeLoss_fbcffa12-5c28-4a41-bf4b-466a32b67934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b21fc2a-2e45-489a-bd50-35115a25d483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fda0afe9-3886-457e-a512-9a09125b057a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b21fc2a-2e45-489a-bd50-35115a25d483" xlink:to="loc_us-gaap_NetIncomeLoss_fda0afe9-3886-457e-a512-9a09125b057a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_8558bb6e-3663-466e-83b4-7e2ff80b5351" xlink:href="mo-20220630.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0b21fc2a-2e45-489a-bd50-35115a25d483" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_8558bb6e-3663-466e-83b4-7e2ff80b5351" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3779093-7651-46a8-a58d-1ca869ea7dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b06d566a-2895-4218-8a79-b4f229f76518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3779093-7651-46a8-a58d-1ca869ea7dab" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b06d566a-2895-4218-8a79-b4f229f76518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e3538843-596a-4996-9ef7-700ddb2e4709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b3779093-7651-46a8-a58d-1ca869ea7dab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e3538843-596a-4996-9ef7-700ddb2e4709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_adbb7265-f022-4382-8934-924514185f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_185bdcc5-479c-4216-8163-923537736dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_adbb7265-f022-4382-8934-924514185f0b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_185bdcc5-479c-4216-8163-923537736dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e4798f1e-93e0-431f-bcc2-da7dc461f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_adbb7265-f022-4382-8934-924514185f0b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e4798f1e-93e0-431f-bcc2-da7dc461f5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ce7fba00-face-4d50-97cd-d9db97956e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_539f5f14-db27-433e-84c8-5931a90eec5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ce7fba00-face-4d50-97cd-d9db97956e7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_539f5f14-db27-433e-84c8-5931a90eec5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_08838cc2-59ec-48a5-b910-18f1007f68e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ce7fba00-face-4d50-97cd-d9db97956e7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_08838cc2-59ec-48a5-b910-18f1007f68e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c553636e-2f15-4c77-a4e8-2def7957927b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_edb888b9-2d89-40b1-a564-90349ce11116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c553636e-2f15-4c77-a4e8-2def7957927b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_edb888b9-2d89-40b1-a564-90349ce11116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_f13bd542-0947-4bcd-907a-368b78026fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c553636e-2f15-4c77-a4e8-2def7957927b" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_f13bd542-0947-4bcd-907a-368b78026fe4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>mo-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20220630.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended" id="id0be780e3a8a460689c8ae7fabe56cc3_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3cbf8649-fb8e-4d46-a5bf-ee59eb481ec1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentType_3cbf8649-fb8e-4d46-a5bf-ee59eb481ec1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a6d94c54-056b-42d3-a8b8-fd8b6c87fa1d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentQuarterlyReport_a6d94c54-056b-42d3-a8b8-fd8b6c87fa1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bf7b4ad-0a85-4f62-8b7a-c41ac6b87775" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentPeriodEndDate_8bf7b4ad-0a85-4f62-8b7a-c41ac6b87775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9c36fb8a-ccc5-41f8-a0fb-27be7c1b4ef0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentTransitionReport_9c36fb8a-ccc5-41f8-a0fb-27be7c1b4ef0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_23e11e84-99ba-45f0-b7cd-1d784b6f8a7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityFileNumber_23e11e84-99ba-45f0-b7cd-1d784b6f8a7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7e0124b5-f273-4294-b2e7-b9dfe67df88e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityRegistrantName_7e0124b5-f273-4294-b2e7-b9dfe67df88e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_769ba0b0-d766-403a-802b-7d54902c78fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_769ba0b0-d766-403a-802b-7d54902c78fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8d3404b4-ea31-481d-bd5c-4487a30a210d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_8d3404b4-ea31-481d-bd5c-4487a30a210d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f530db0f-6a79-4bdc-9dfe-c6cf32e668b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressAddressLine1_f530db0f-6a79-4bdc-9dfe-c6cf32e668b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9f0633ee-954b-424a-96af-55183c3c37ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressCityOrTown_9f0633ee-954b-424a-96af-55183c3c37ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9c091e09-fd37-484d-a70a-6d2970fd480e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressStateOrProvince_9c091e09-fd37-484d-a70a-6d2970fd480e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_669fd5e2-88cd-4159-a050-2bcfacba06a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressPostalZipCode_669fd5e2-88cd-4159-a050-2bcfacba06a1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_51d5efc7-b51a-41c9-a305-d92eea0b3e9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_CityAreaCode_51d5efc7-b51a-41c9-a305-d92eea0b3e9c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3d3126cd-fb91-46d5-8b57-c4c70ba6abd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_LocalPhoneNumber_3d3126cd-fb91-46d5-8b57-c4c70ba6abd3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0c703ad2-078e-4ae3-b183-4367b4df6d22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_Security12bTitle_0c703ad2-078e-4ae3-b183-4367b4df6d22" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8f83f954-6463-4d84-9850-8aead43c1f5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_TradingSymbol_8f83f954-6463-4d84-9850-8aead43c1f5b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1ceed4cb-56c1-41f2-8826-a422b58551be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_SecurityExchangeName_1ceed4cb-56c1-41f2-8826-a422b58551be" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ea83da3a-af19-449f-b7d1-2e95a9eee203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCurrentReportingStatus_ea83da3a-af19-449f-b7d1-2e95a9eee203" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_14e3c3cb-c7e3-43a0-9175-1525c539f82b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityInteractiveDataCurrent_14e3c3cb-c7e3-43a0-9175-1525c539f82b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d6e47b4f-f928-47a7-9039-e55d22b9a03c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityFilerCategory_d6e47b4f-f928-47a7-9039-e55d22b9a03c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f707292d-eff0-438c-b6e3-5c84f1f4b066" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntitySmallBusiness_f707292d-eff0-438c-b6e3-5c84f1f4b066" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_19d16ae8-6c92-456b-a4f8-28a033e75a7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_19d16ae8-6c92-456b-a4f8-28a033e75a7a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a92b957b-1309-42b3-8d89-729208dd0696" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityShellCompany_a92b957b-1309-42b3-8d89-729208dd0696" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a097c802-3b7b-45bb-b01f-87dcdfafc77d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a097c802-3b7b-45bb-b01f-87dcdfafc77d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_77053978-0c14-4367-bf13-22aa8af7fcba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_AmendmentFlag_77053978-0c14-4367-bf13-22aa8af7fcba" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d282574f-c8a0-4a19-b4dd-9aecb42e37e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentFiscalYearFocus_d282574f-c8a0-4a19-b4dd-9aecb42e37e4" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e81a93f2-790f-43b6-9f5e-f48a4306c1df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e81a93f2-790f-43b6-9f5e-f48a4306c1df" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a99dfd7f-4447-456c-bf3c-68ea370ae81c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCentralIndexKey_a99dfd7f-4447-456c-bf3c-68ea370ae81c" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_62ee82bc-e80c-457f-a1ae-b844e4173808" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_CurrentFiscalYearEndDate_62ee82bc-e80c-457f-a1ae-b844e4173808" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_92ade357-533d-4684-9f6c-698a12d4d08b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:to="loc_us-gaap_ClassOfStockDomain_92ade357-533d-4684-9f6c-698a12d4d08b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:to="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_339fa9fc-2265-482a-a2ca-79f7db228449" xlink:href="mo-20220630.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock0.3313ParValueMember_339fa9fc-2265-482a-a2ca-79f7db228449" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_bf6348be-d4b4-4745-8dc5-bf2e26e4fcd4" xlink:href="mo-20220630.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_bf6348be-d4b4-4745-8dc5-bf2e26e4fcd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_3d8ee7ab-8988-49c7-96e5-2aa026dd6edb" xlink:href="mo-20220630.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_3d8ee7ab-8988-49c7-96e5-2aa026dd6edb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_a4064345-2ad2-4d62-9ac6-c08c12b79d98" xlink:href="mo-20220630.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_a4064345-2ad2-4d62-9ac6-c08c12b79d98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_91e7fe3f-4802-4ed6-b819-74305bab1a23" xlink:href="mo-20220630.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_91e7fe3f-4802-4ed6-b819-74305bab1a23" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="ie4d161c3f1234d2e9cf4e4d898cc45b0_CondensedConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dc1c812b-b41e-4a0a-8f12-a002900fe857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dc1c812b-b41e-4a0a-8f12-a002900fe857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9cda6952-ffb6-42b3-a8db-2e621eaa7150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9cda6952-ffb6-42b3-a8db-2e621eaa7150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfca881-db09-4bd1-80d0-e731e88e8af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfca881-db09-4bd1-80d0-e731e88e8af8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_5ab94786-5bc7-46c7-8ebf-ae5f95d13e38" xlink:href="mo-20220630.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_5ab94786-5bc7-46c7-8ebf-ae5f95d13e38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3445bf4f-eb9f-4b4a-9a40-7bed1ef7058f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_DividendsCommonStockCash_3445bf4f-eb9f-4b4a-9a40-7bed1ef7058f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e7354d3-fa6a-40c3-84cf-a9ad0752435d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e7354d3-fa6a-40c3-84cf-a9ad0752435d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_143d6c55-d394-4bdb-97fc-c8291bf76649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_StockholdersEquityOther_143d6c55-d394-4bdb-97fc-c8291bf76649" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71dd787a-4dc6-4957-9703-e913b6e1c81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:to="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_65ce082a-b088-45d3-8f3c-092e30ce5740_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:to="loc_us-gaap_EquityComponentDomain_65ce082a-b088-45d3-8f3c-092e30ce5740_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:to="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_29e91056-af6d-4677-8540-ac282bb77f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_CommonStockMember_29e91056-af6d-4677-8540-ac282bb77f7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9f39f200-d0d0-4ad1-9078-1a0c983f7e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9f39f200-d0d0-4ad1-9078-1a0c983f7e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1073ee17-c3f9-4fee-9231-234e9d436b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_RetainedEarningsMember_1073ee17-c3f9-4fee-9231-234e9d436b4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_055ced3d-d54e-4ac8-a03c-88717e28f1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_055ced3d-d54e-4ac8-a03c-88717e28f1e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_de3ed66e-48a0-4307-beaa-6b6376a5f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_TreasuryStockMember_de3ed66e-48a0-4307-beaa-6b6376a5f85d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f9841e19-53db-4c73-9aa0-42446726dfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f9841e19-53db-4c73-9aa0-42446726dfac" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended" id="ie0a990302e224e2893d3336804d964e8_BackgroundandBasisofPresentationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f8cf72f-bc4a-4ca8-8f7c-60a01394e757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f8cf72f-bc4a-4ca8-8f7c-60a01394e757" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_866f12f0-ccb1-4e9c-aeef-b1439ae0bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_866f12f0-ccb1-4e9c-aeef-b1439ae0bb3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cd7993e1-163b-4c7e-a683-87d5145e63c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cd7993e1-163b-4c7e-a683-87d5145e63c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_e937443a-39e0-45c2-9075-fe0b5ba49a74" xlink:href="mo-20220630.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_e937443a-39e0-45c2-9075-fe0b5ba49a74" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended" id="i61b73cd994d1440fa338d79376fc7849_BackgroundandBasisofPresentationShareRepurchaseTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e4fdd17c-f793-4ea7-9ba1-cedc43ff15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e4fdd17c-f793-4ea7-9ba1-cedc43ff15dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_11df1f9c-246b-4ae2-a3f4-33b57390d6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_11df1f9c-246b-4ae2-a3f4-33b57390d6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_faad617d-d9be-42c3-ac92-51dd12182675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_faad617d-d9be-42c3-ac92-51dd12182675" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e3248c90-4d6b-4885-9143-aaa28a169355_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e3248c90-4d6b-4885-9143-aaa28a169355_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_ee3dd43c-06cc-4cbb-8b9d-7975b0f55ce7" xlink:href="mo-20220630.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_ee3dd43c-06cc-4cbb-8b9d-7975b0f55ce7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended" id="i49405552b1bf4356a2721353db9331ab_InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_18b69a87-8263-4e3f-9913-3b419c55af22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_us-gaap_EquityMethodInvestments_18b69a87-8263-4e3f-9913-3b419c55af22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_f58f4d8b-482d-4606-8e10-88e995087cb0" xlink:href="mo-20220630.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_mo_EquityInvestmentFairValueOption_f58f4d8b-482d-4606-8e10-88e995087cb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_ee0a7331-2a64-4cac-8ec8-142e330a688a" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_ee0a7331-2a64-4cac-8ec8-142e330a688a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e007be95-e58a-45cf-945d-c5c5c651d4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_us-gaap_Investments_e007be95-e58a-45cf-945d-c5c5c651d4be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0e4b9f-6611-4af4-9e66-d465430cea19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6c0e4b9f-6611-4af4-9e66-d465430cea19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e493b3ed-9be6-4bac-81d6-b164c65fb1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:to="loc_us-gaap_CommonStockMember_e493b3ed-9be6-4bac-81d6-b164c65fb1ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7178e134-845d-4bf1-a784-7cdfef276d26_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7178e134-845d-4bf1-a784-7cdfef276d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_27c86c8f-ff13-4a35-b60c-c23746713b7b" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_ABInBevMember_27c86c8f-ff13-4a35-b60c-c23746713b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a764e8c6-01f9-4b3b-8607-fcbe02231dd0" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_JUULMember_a764e8c6-01f9-4b3b-8607-fcbe02231dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_26f56811-2dff-4753-93d6-6627c1f27ee9" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_CronosGroupInc.Member_26f56811-2dff-4753-93d6-6627c1f27ee9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended" id="iccaab910899d49cf9f388c9baae178f4_InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_106a655c-fef0-4e1e-be47-86ee1f5170b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_106a655c-fef0-4e1e-be47-86ee1f5170b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_e7b634b6-850c-445e-9658-2240d3c47160" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_e7b634b6-850c-445e-9658-2240d3c47160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_39babdf3-54a5-43a4-8779-bafeec513a79" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_mo_IncomeLossFromEquityInvestments_39babdf3-54a5-43a4-8779-bafeec513a79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7bddd32c-fb7e-4109-9ada-c9fa678be6eb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7bddd32c-fb7e-4109-9ada-c9fa678be6eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_f9237c59-44b9-44f0-8bfd-57158021c1fa" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_ABInBevMember_f9237c59-44b9-44f0-8bfd-57158021c1fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_c6697386-eed6-4580-b977-ebe8ecd10dd9" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_CronosGroupInc.Member_c6697386-eed6-4580-b977-ebe8ecd10dd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a3b0c9e0-0630-4d86-a66d-94fa2d6aec27" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_JUULMember_a3b0c9e0-0630-4d86-a66d-94fa2d6aec27" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended" id="i50b22c70b32744a2b1ff7a29e486ecf3_InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b26f4a0-e70e-4e30-9356-9a017158367f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b26f4a0-e70e-4e30-9356-9a017158367f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8fabd2d4-4944-4ed9-ad99-91921cb65873" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8fabd2d4-4944-4ed9-ad99-91921cb65873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_0ed38ecb-6653-413a-83ee-cdae9b3f45aa" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_0ed38ecb-6653-413a-83ee-cdae9b3f45aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod_3a813670-683a-49f5-9edd-531b88613b3e" xlink:href="mo-20220630.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_RestrictedSharesLockupPeriod_3a813670-683a-49f5-9edd-531b88613b3e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_456e2abe-da9c-4579-9791-70ad2f4cc68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_456e2abe-da9c-4579-9791-70ad2f4cc68e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_81a4f49d-9d17-4cc3-888a-4bb7b5d0fd30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestments_81a4f49d-9d17-4cc3-888a-4bb7b5d0fd30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_0fd963fd-1b4e-4b3e-8759-92360ea6240b" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_0fd963fd-1b4e-4b3e-8759-92360ea6240b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_33a9389f-d041-450f-8ba9-cf28142adb1f" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_33a9389f-d041-450f-8ba9-cf28142adb1f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04535672-5bd1-4a46-a584-a460e719dd18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_04535672-5bd1-4a46-a584-a460e719dd18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0328bae0-78f4-48d9-9186-1a723ca32c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0328bae0-78f4-48d9-9186-1a723ca32c2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4bd32638-0db8-4348-8c75-4bccc1a3d88e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4bd32638-0db8-4348-8c75-4bccc1a3d88e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c487906a-d493-4d14-9608-0ffd88629582" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:to="loc_mo_ABInBevMember_c487906a-d493-4d14-9608-0ffd88629582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_54f1fa70-5742-434d-8767-fa229d9c7d89_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:to="loc_dei_EntityDomain_54f1fa70-5742-434d-8767-fa229d9c7d89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:to="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_02034e62-ea67-4761-93c0-5ad66db8a5f9" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:to="loc_mo_ABInBevMember_02034e62-ea67-4761-93c0-5ad66db8a5f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ab2f1f7e-f4a0-480d-937f-f08c69110bda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ab2f1f7e-f4a0-480d-937f-f08c69110bda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_534f3a77-26eb-43fe-8f41-84933856ade7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:to="loc_us-gaap_SubsequentEventMember_534f3a77-26eb-43fe-8f41-84933856ade7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended" id="i9a62a4d9575d4b25afb24107c9989f69_InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_16a0bfbc-aa80-42d9-95a7-e25cdcfdf018" xlink:href="mo-20220630.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_16a0bfbc-aa80-42d9-95a7-e25cdcfdf018" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_763a6743-9f50-438d-b1ad-10e28c3373ae" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_763a6743-9f50-438d-b1ad-10e28c3373ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares_479f16bd-6800-47e1-a463-9c4da4748efa" xlink:href="mo-20220630.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquityInvestmentsFairValueOptionVotingShares_479f16bd-6800-47e1-a463-9c4da4748efa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_acc285c0-d2c9-4ac5-92ac-31f43e765006" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_acc285c0-d2c9-4ac5-92ac-31f43e765006" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_5aa9ef44-6661-4861-8091-10d101ba67bc" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_5aa9ef44-6661-4861-8091-10d101ba67bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_63df5a68-6e67-4673-8959-005dac96fb4d" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_63df5a68-6e67-4673-8959-005dac96fb4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ae2dc9-069a-4c83-b891-f508a7fddd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ae2dc9-069a-4c83-b891-f508a7fddd20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_e77dd03f-0944-4422-bc03-5f05d5b4867c" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_e77dd03f-0944-4422-bc03-5f05d5b4867c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e05d0ee9-40c4-46f6-bfdc-35f957067fb7" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e05d0ee9-40c4-46f6-bfdc-35f957067fb7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_cab74de3-634f-4f68-bf7b-6524703159eb" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_cab74de3-634f-4f68-bf7b-6524703159eb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_6fcb02d1-8532-42c2-873f-3439cf8ee418" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_6fcb02d1-8532-42c2-873f-3439cf8ee418" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_75472365-8a67-4a6f-a93e-70420409b687" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_75472365-8a67-4a6f-a93e-70420409b687" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_d4f54aee-1b19-4903-99f1-473886dfea72" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_d4f54aee-1b19-4903-99f1-473886dfea72" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_d42ee022-34de-4ea3-bd6a-9ece8836f178" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_d42ee022-34de-4ea3-bd6a-9ece8836f178" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_fcba84e6-d9d6-4ace-b1ad-5fdec9cac31b" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_fcba84e6-d9d6-4ace-b1ad-5fdec9cac31b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_71ccb569-26ca-4ec9-b0a7-f2ccfae23866" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_71ccb569-26ca-4ec9-b0a7-f2ccfae23866" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_a4005b6d-6c8c-4664-a0a9-bc2e47ab0d21" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_a4005b6d-6c8c-4664-a0a9-bc2e47ab0d21" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_36333b02-0d5f-4e23-a466-6a0c6af59267" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_36333b02-0d5f-4e23-a466-6a0c6af59267" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cb419983-e792-433f-80cb-2636e1b89f97_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cb419983-e792-433f-80cb-2636e1b89f97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_b718d678-03c4-4f58-8dc3-1ee6d10835c3" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:to="loc_mo_JUULMember_b718d678-03c4-4f58-8dc3-1ee6d10835c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended" id="ife053075508c4b7ba02d05d5b86e3bc1_InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1cf05d61-72e0-46ec-8c87-8c2f266a1512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1cf05d61-72e0-46ec-8c87-8c2f266a1512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_6e79723d-eae5-4d86-b6bd-5bcb03a129b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_6e79723d-eae5-4d86-b6bd-5bcb03a129b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_94c6ab9f-7ad4-43d8-aab1-df9973d0a346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:to="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_76869efb-dd9b-48bd-b640-f7df6c9072b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_76869efb-dd9b-48bd-b640-f7df6c9072b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember_36cf801c-ac95-46fe-a697-d48f5dd3eb13" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:to="loc_mo_EquityMethodInvestmentsFairValueOptionMember_36cf801c-ac95-46fe-a697-d48f5dd3eb13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_7c0556a6-b19f-4f4e-996a-fceca45dd7b4" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:to="loc_mo_JUULMember_7c0556a6-b19f-4f4e-996a-fceca45dd7b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended" id="i242783e069504b9ba083d7bb9e9bf14a_InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_244a7952-440e-40ff-921a-336ea6d29f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_244a7952-440e-40ff-921a-336ea6d29f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a5c1d22a-ca52-47ad-8527-491c4e6dc0d9" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a5c1d22a-ca52-47ad-8527-491c4e6dc0d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_59169767-50de-4374-b1cb-2c5afebef882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_59169767-50de-4374-b1cb-2c5afebef882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3287edd7-8cd8-432d-adce-6df9f2a9d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestments_3287edd7-8cd8-432d-adce-6df9f2a9d92a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_2e48cbd6-7814-4268-9073-7715998fa7ee" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_2e48cbd6-7814-4268-9073-7715998fa7ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_b19ff840-e84b-4faa-9d10-9629d6dcdd7f" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_b19ff840-e84b-4faa-9d10-9629d6dcdd7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_b5b0d8bb-5934-4b5f-be4b-4d9c554c962e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_b5b0d8bb-5934-4b5f-be4b-4d9c554c962e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_cfae5f2d-a72f-4b34-9efa-a7dfada3fc87" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_cfae5f2d-a72f-4b34-9efa-a7dfada3fc87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_4ada4430-d595-4387-9633-b7c23d98f1b1" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_4ada4430-d595-4387-9633-b7c23d98f1b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_552c1964-e8ce-4e33-85c1-5bc9b17e7fb8" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_552c1964-e8ce-4e33-85c1-5bc9b17e7fb8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_5ec6c8bb-eba8-4e19-b2df-0b9bf4f30330" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_5ec6c8bb-eba8-4e19-b2df-0b9bf4f30330" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_9f33c293-3fcc-433b-9dd3-5021a5367b65" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_9f33c293-3fcc-433b-9dd3-5021a5367b65" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_434eb617-d398-4a77-9e8d-42815e5bb4dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_434eb617-d398-4a77-9e8d-42815e5bb4dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2f559990-8f28-4e7a-80b8-79d0f490ddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2f559990-8f28-4e7a-80b8-79d0f490ddb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1e625451-eca8-4558-89a1-2eefa53cb79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:to="loc_us-gaap_CommonStockMember_1e625451-eca8-4558-89a1-2eefa53cb79b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4193deb4-450a-435e-874d-8ee64e8718f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4193deb4-450a-435e-874d-8ee64e8718f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_bd327508-1839-4a5b-9ee0-3298686336c7" xlink:href="mo-20220630.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_bd327508-1839-4a5b-9ee0-3298686336c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e6b1b684-0554-4587-8a12-b9b447e524f9" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractWarrantMember_e6b1b684-0554-4587-8a12-b9b447e524f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_894db4a6-a46b-43b2-b563-13e8850e49fe" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_894db4a6-a46b-43b2-b563-13e8850e49fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e0f21e55-ce42-471b-8f0b-579c3100bd41_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e0f21e55-ce42-471b-8f0b-579c3100bd41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_3de983ba-5768-4e4d-940e-b04018159279" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:to="loc_mo_CronosGroupInc.Member_3de983ba-5768-4e4d-940e-b04018159279" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_78e24403-d9b0-4705-b7a0-fff6dbf06f31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_78e24403-d9b0-4705-b7a0-fff6dbf06f31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_18176102-b6d8-4498-a2a6-24a5aacc5dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:to="loc_us-gaap_SubsequentEventMember_18176102-b6d8-4498-a2a6-24a5aacc5dea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="extended" id="i4001bbdfa8124331984e866785760be7_InvestmentsinEquitySecuritiesInvestmentinCronosDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_ddef53e2-7110-4139-bfae-d9983bdeb1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_ddef53e2-7110-4139-bfae-d9983bdeb1b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_4cb0bdf9-c059-4a0f-931a-536abb89d648" xlink:href="mo-20220630.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_4cb0bdf9-c059-4a0f-931a-536abb89d648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e06e9aa2-bae8-476b-a1aa-387cac6c9459" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:to="loc_mo_EquityContractWarrantMember_e06e9aa2-bae8-476b-a1aa-387cac6c9459" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstrumentsAggregateFairValueandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="extended" id="i4b4b123a37dd49b1931dee077794edc8_FinancialInstrumentsAggregateFairValueandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4610061c-b2de-4de7-971f-536f003fe0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_us-gaap_LongTermDebt_4610061c-b2de-4de7-971f-536f003fe0f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_a0215c6c-1e0f-49f6-8189-890927bfe56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_us-gaap_LongTermDebtFairValue_a0215c6c-1e0f-49f6-8189-890927bfe56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_19270292-c0cb-4116-a05a-9bfc5994ce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_70574089-1acf-4152-9f3f-9ea8a4412b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:to="loc_us-gaap_DebtInstrumentFairValue_70574089-1acf-4152-9f3f-9ea8a4412b10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:to="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1274b85c-967d-4903-8739-e47b6c6cd6f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1274b85c-967d-4903-8739-e47b6c6cd6f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_287820a7-5064-441e-a3b1-9a19fadfce0c" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_287820a7-5064-441e-a3b1-9a19fadfce0c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i080696be487e4054aac195e9ea8c6ff7_FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_04723a47-282c-42a1-a96f-f4254983d257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_04723a47-282c-42a1-a96f-f4254983d257" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_d2a307c7-a71e-4677-9fa5-922a6c5e6ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_d2a307c7-a71e-4677-9fa5-922a6c5e6ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_60c6276f-520a-482f-959c-91e3bb01bb98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_60c6276f-520a-482f-959c-91e3bb01bb98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8ef01c7d-b649-43da-b078-d973fca8fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8ef01c7d-b649-43da-b078-d973fca8fba4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_3f493831-a5c9-4c76-a084-9797cff297f1" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_3f493831-a5c9-4c76-a084-9797cff297f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dea24a64-070e-401a-a192-9eced902a85f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dea24a64-070e-401a-a192-9eced902a85f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1396e618-722b-4c7b-bc0f-63d5f0a5e45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1396e618-722b-4c7b-bc0f-63d5f0a5e45f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended" id="ie1d77609fc844d04bf49d6d8b10f023f_BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7e78b5c4-dddf-4212-8bd4-d0becc877d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7e78b5c4-dddf-4212-8bd4-d0becc877d41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6e771390-bec6-43f2-8c87-96c5f6362545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6e771390-bec6-43f2-8c87-96c5f6362545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0330c702-e407-4d1c-8e61-62c85a458dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0330c702-e407-4d1c-8e61-62c85a458dc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_790900f3-a653-4189-9180-b6301f92b2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_790900f3-a653-4189-9180-b6301f92b2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_82f27062-12cd-4bf7-b059-763f4165a07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_82f27062-12cd-4bf7-b059-763f4165a07a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_df657797-77b5-4212-becc-a4a92d3158f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_df657797-77b5-4212-becc-a4a92d3158f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_60c287ec-6d06-4017-8ef6-d7d682b40c58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_60c287ec-6d06-4017-8ef6-d7d682b40c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_976a9398-ccb9-406e-8a3c-b75061d6ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_976a9398-ccb9-406e-8a3c-b75061d6ebd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_58306705-6249-43c4-b543-8f4ece38014e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_58306705-6249-43c4-b543-8f4ece38014e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="ifd226744d1154f309e22d0b116974fb7_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d240c644-e546-4355-90c4-c433555b41c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d240c644-e546-4355-90c4-c433555b41c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7301c89b-a789-424e-82ff-3f67933f97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7301c89b-a789-424e-82ff-3f67933f97b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_a8a6cc08-67fb-40ab-8fdd-3336076492eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_a8a6cc08-67fb-40ab-8fdd-3336076492eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e5a0afa0-944f-4981-b6d7-46d38e48c8a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e5a0afa0-944f-4981-b6d7-46d38e48c8a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e97047cc-0dea-4293-8c87-49fbe91616c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e97047cc-0dea-4293-8c87-49fbe91616c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_fedd2f46-d4d0-4b5f-b18f-b2a454639c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_fedd2f46-d4d0-4b5f-b18f-b2a454639c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:to="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4632f960-ca6d-4b06-b872-53b9930fdf47_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:to="loc_srt_RangeMember_4632f960-ca6d-4b06-b872-53b9930fdf47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:to="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ae7167d7-7c1f-465c-9f6f-9487bb4ed393" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:to="loc_srt_MaximumMember_ae7167d7-7c1f-465c-9f6f-9487bb4ed393" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i2b39f6c69742447b9e4b6d31b42e9c08_OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdde31bf-d14a-4f55-84ba-fb60a3ba62fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdde31bf-d14a-4f55-84ba-fb60a3ba62fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4e4e55d7-ec4d-4d02-a0ca-dfe00abf6bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4e4e55d7-ec4d-4d02-a0ca-dfe00abf6bc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_787592e3-2581-455c-ab0e-a2ee742f8fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_787592e3-2581-455c-ab0e-a2ee742f8fad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ccbc7d70-fefa-4f72-b0f5-d5ed8da6217f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ccbc7d70-fefa-4f72-b0f5-d5ed8da6217f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_020b768f-b3ff-4200-a23d-5e0dfffcf987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_020b768f-b3ff-4200-a23d-5e0dfffcf987" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_89845b83-728b-4fe3-9512-e9ab0ffad9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_89845b83-728b-4fe3-9512-e9ab0ffad9b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b5a557ec-6b90-429f-b466-360a2e93f2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b5a557ec-6b90-429f-b466-360a2e93f2fd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1571c081-2913-49f0-8934-2f3991dd6012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1571c081-2913-49f0-8934-2f3991dd6012" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2867457e-6c80-4f51-97fc-7b9f8844ddc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_69a43b04-3664-4de6-917d-9c12a9ea0ffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:to="loc_us-gaap_EquityComponentDomain_69a43b04-3664-4de6-917d-9c12a9ea0ffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:to="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ae044a66-3d3e-4be8-a491-ad92e5be3105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ae044a66-3d3e-4be8-a491-ad92e5be3105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_60d194f5-974a-4cb0-a327-836d5d36cd45" xlink:href="mo-20220630.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_60d194f5-974a-4cb0-a327-836d5d36cd45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f8bf8a1-1271-4be0-b5eb-4844fc88c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f8bf8a1-1271-4be0-b5eb-4844fc88c04c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended" id="ide8be7078d564565a68ae450d3ae6498_OtherComprehensiveEarningsLossesReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_92f9fc7b-7e76-47f0-959e-2f20e3d32081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_92f9fc7b-7e76-47f0-959e-2f20e3d32081" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bfe07c09-18d1-4f2b-8cdb-2ec6d653d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bfe07c09-18d1-4f2b-8cdb-2ec6d653d4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47b562b8-7a89-4d41-87c2-c8a6e97529cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_ProfitLoss_47b562b8-7a89-4d41-87c2-c8a6e97529cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8aae16f-7a4a-4002-a6c4-936b2aec982f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:to="loc_us-gaap_EquityComponentDomain_b8aae16f-7a4a-4002-a6c4-936b2aec982f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:to="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e3fa75b7-3133-4339-9910-a792bb542348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e3fa75b7-3133-4339-9910-a792bb542348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_66256430-f22d-456c-a3a2-028345c68f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_66256430-f22d-456c-a3a2-028345c68f91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_5880d769-7bdc-4301-8fbb-1ae9d11e825e" xlink:href="mo-20220630.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_5880d769-7bdc-4301-8fbb-1ae9d11e825e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_bbda83bd-375a-4f5d-8c0b-32e0a08f95dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_bbda83bd-375a-4f5d-8c0b-32e0a08f95dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_736430c3-f45a-4dca-8b1b-da224f082cb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_736430c3-f45a-4dca-8b1b-da224f082cb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_668c9b48-12cb-4a95-8581-881abec0af97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_668c9b48-12cb-4a95-8581-881abec0af97" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended" id="ib7238da94fd44f5b889f0075a64afb64_SegmentReportingSegmentDataScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f417e7c-c246-4942-b5b3-e3b245d7e31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f417e7c-c246-4942-b5b3-e3b245d7e31d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_f378c817-f817-40f6-a5a6-98d41851bb95" xlink:href="mo-20220630.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_f378c817-f817-40f6-a5a6-98d41851bb95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_93089519-175c-488f-8af2-27eb84d7869c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_93089519-175c-488f-8af2-27eb84d7869c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2b4008a8-e6a9-4b23-a14c-bd7bf0b65369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2b4008a8-e6a9-4b23-a14c-bd7bf0b65369" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9b573135-8cd3-4ccd-9b50-188ef0671522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_OperatingIncomeLoss_9b573135-8cd3-4ccd-9b50-188ef0671522" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_c08a6921-08ae-42e9-a0b8-86ce391e0635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_c08a6921-08ae-42e9-a0b8-86ce391e0635" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc2a0804-9a45-47b0-b3a4-1a69499cd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc2a0804-9a45-47b0-b3a4-1a69499cd26b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_80d2ed79-261b-4c5a-806d-1f55cb8bcd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_80d2ed79-261b-4c5a-806d-1f55cb8bcd1f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_bbdc61fc-3aed-494a-8f3b-0cec62f3fd5f" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_mo_IncomeLossFromEquityInvestments_bbdc61fc-3aed-494a-8f3b-0cec62f3fd5f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5de8e6c7-24cc-4fb5-a204-a08763aebbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5de8e6c7-24cc-4fb5-a204-a08763aebbbd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae60f61c-5df2-466c-95f4-0189c30ac540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae60f61c-5df2-466c-95f4-0189c30ac540" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:to="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f2619025-6d8a-4598-af19-f0a1d9e3aebb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:to="loc_srt_ConsolidationItemsDomain_f2619025-6d8a-4598-af19-f0a1d9e3aebb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:to="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_30eda795-2508-45cd-b73e-6cf320cf27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_30eda795-2508-45cd-b73e-6cf320cf27bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4c4fc23e-6a7c-4bf4-9e34-7526620265c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4c4fc23e-6a7c-4bf4-9e34-7526620265c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0953b439-7757-4144-b534-d7389eb47e9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:to="loc_us-gaap_SegmentDomain_0953b439-7757-4144-b534-d7389eb47e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:to="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_cda816e5-6ae7-420c-8235-70f4648c4a29" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_SmokeableProductsSegmentMember_cda816e5-6ae7-420c-8235-70f4648c4a29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_ca26bd5c-7273-4a90-81ca-aeea07c568ee" xlink:href="mo-20220630.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_OralTobaccoSegmentMember_ca26bd5c-7273-4a90-81ca-aeea07c568ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_6029ec6f-e5af-4559-bda3-f975bde7d8db" xlink:href="mo-20220630.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_WineSegmentMember_6029ec6f-e5af-4559-bda3-f975bde7d8db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_21b1ba70-9b81-444c-a551-a75de6708e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_us-gaap_AllOtherSegmentsMember_21b1ba70-9b81-444c-a551-a75de6708e77" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="i3561cb82a6474e309d49840553cf6052_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_2dff80c2-8b16-477e-83a0-6d6639f08810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_2dff80c2-8b16-477e-83a0-6d6639f08810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d85d0088-a52c-4790-b6d3-d48764549c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d85d0088-a52c-4790-b6d3-d48764549c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd383e21-8348-4d5a-b922-84f95e214367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd383e21-8348-4d5a-b922-84f95e214367" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_84ecc2a8-d78b-485c-8f57-3af8dcfe830e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:to="loc_us-gaap_SegmentDomain_84ecc2a8-d78b-485c-8f57-3af8dcfe830e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:to="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_7b8cb0f9-3e32-4f5b-a431-987b8f980654" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:to="loc_mo_SmokeableProductsSegmentMember_7b8cb0f9-3e32-4f5b-a431-987b8f980654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_f1a14918-60f8-4ea9-8c7d-8bb04c746868" xlink:href="mo-20220630.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:to="loc_mo_OralTobaccoSegmentMember_f1a14918-60f8-4ea9-8c7d-8bb04c746868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_af428c8c-69aa-44e5-a3ea-cb92916dcef2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:to="loc_srt_ConsolidationItemsDomain_af428c8c-69aa-44e5-a3ea-cb92916dcef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:to="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dc914c87-b16b-4f11-b733-3619ea9885c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:to="loc_us-gaap_OperatingSegmentsMember_dc914c87-b16b-4f11-b733-3619ea9885c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8711c39e-6893-44e0-aa21-f33e393671c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:to="loc_srt_LitigationCaseTypeDomain_8711c39e-6893-44e0-aa21-f33e393671c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:to="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_ba05666a-6bd6-4949-b8f0-de76abf13074" xlink:href="mo-20220630.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_ba05666a-6bd6-4949-b8f0-de76abf13074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_2d67bdeb-52d3-4c98-a642-7888dfad0fb6" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_2d67bdeb-52d3-4c98-a642-7888dfad0fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1866fb79-3057-4b8a-9bf7-06bc2b1a1671_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1866fb79-3057-4b8a-9bf7-06bc2b1a1671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_ebe7d46c-f7a0-458d-b286-36ce0d2397bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:to="loc_us-gaap_OperatingIncomeLossMember_ebe7d46c-f7a0-458d-b286-36ce0d2397bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_afe42b67-6876-406a-930b-af38cc5c66d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_afe42b67-6876-406a-930b-af38cc5c66d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_0d1221f4-164b-43a9-905d-311c97ba6e4b" xlink:href="mo-20220630.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_0d1221f4-164b-43a9-905d-311c97ba6e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7dde1590-2cb7-4f97-9d91-119a67b69cb9_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:to="loc_dei_EntityDomain_7dde1590-2cb7-4f97-9d91-119a67b69cb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:to="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_03fc2966-ed5e-406d-b8ee-4dd08098e06e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:to="loc_mo_PhilipMorrisUSAMember_03fc2966-ed5e-406d-b8ee-4dd08098e06e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="extended" id="ifa0ea820e07849d7b9a801aa1b25c61f_SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d2bad346-3a95-407e-aa5e-7415720f04f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d2bad346-3a95-407e-aa5e-7415720f04f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a15074a8-fa07-42c2-914a-4d0cb38f1d95_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:to="loc_dei_EntityDomain_a15074a8-fa07-42c2-914a-4d0cb38f1d95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:to="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_881c8180-97b3-474d-a1f0-587de47083b3" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:to="loc_mo_PhilipMorrisUSAMember_881c8180-97b3-474d-a1f0-587de47083b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:to="loc_srt_LitigationCaseTypeDomain_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:to="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_0ca2a5a2-0719-403b-94b5-edfd408c4fe4" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_0ca2a5a2-0719-403b-94b5-edfd408c4fe4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_686a1286-0084-46a4-9f7c-3178445b9655_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:to="loc_srt_ConsolidationItemsDomain_686a1286-0084-46a4-9f7c-3178445b9655_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:to="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f37d6772-9166-43a9-9301-e7fd12e10bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_OperatingSegmentsMember_f37d6772-9166-43a9-9301-e7fd12e10bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_31ff3f28-ec3e-48cd-b25b-2641c4adc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_31ff3f28-ec3e-48cd-b25b-2641c4adc71c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_4078d301-2276-4897-8d53-04ef5ebd2ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_4078d301-2276-4897-8d53-04ef5ebd2ce6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e0f805a4-51de-45e0-b55c-ae1c10911dbf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:to="loc_us-gaap_SegmentDomain_e0f805a4-51de-45e0-b55c-ae1c10911dbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:to="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_e1e5b2ea-1d8a-4ce7-9b20-32be6ad056dc" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:to="loc_mo_SmokeableProductsSegmentMember_e1e5b2ea-1d8a-4ce7-9b20-32be6ad056dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bee88a4d-d4e0-496d-b686-ec25342e8b96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bee88a4d-d4e0-496d-b686-ec25342e8b96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_1e7be2a5-6bac-4eb7-a0a8-ae9ee6aa7fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:to="loc_us-gaap_OperatingIncomeLossMember_1e7be2a5-6bac-4eb7-a0a8-ae9ee6aa7fa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_90b960b6-a455-4b9f-849c-c7b8b50a22e2" xlink:href="mo-20220630.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_90b960b6-a455-4b9f-849c-c7b8b50a22e2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended" id="i41473265e0c4456da8fcbb87a79f92e2_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_94cb4bf2-b578-4a49-bbf6-f362d460dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_ShortTermBorrowings_94cb4bf2-b578-4a49-bbf6-f362d460dbc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8e1dba65-d214-4901-9b04-d56397fadb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentTerm_8e1dba65-d214-4901-9b04-d56397fadb07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_801b037d-c787-45e0-9c05-6404039416e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_801b037d-c787-45e0-9c05-6404039416e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_de5dbee5-a211-493d-8580-54c4fc8fcf83" xlink:href="mo-20220630.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentExtensionTerm_de5dbee5-a211-493d-8580-54c4fc8fcf83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a63a02ac-db12-416d-aa43-3c78176ca04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a63a02ac-db12-416d-aa43-3c78176ca04f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_eba6c565-5262-4de5-bf5b-1f7ab4080d0d" xlink:href="mo-20220630.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_eba6c565-5262-4de5-bf5b-1f7ab4080d0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_f1b2216c-28c7-4fe7-b570-eaf581277c7f" xlink:href="mo-20220630.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_f1b2216c-28c7-4fe7-b570-eaf581277c7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b5fe95a8-e3d8-4680-ad25-6f2f412b1429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_LongTermDebt_b5fe95a8-e3d8-4680-ad25-6f2f412b1429" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_df903746-0baa-4c04-8990-a7516fb201bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_df903746-0baa-4c04-8990-a7516fb201bf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f533627-5d4e-443a-be67-eae85cf17a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f533627-5d4e-443a-be67-eae85cf17a73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e46ac4d6-4aa6-4b16-a707-8be6b33a8cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e46ac4d6-4aa6-4b16-a707-8be6b33a8cd4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08cb276d-26dc-4507-b8ff-0069506e4a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08cb276d-26dc-4507-b8ff-0069506e4a03" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_301435cf-ec6a-40d9-84af-b11c50477062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_301435cf-ec6a-40d9-84af-b11c50477062" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b1d93371-fd1c-4355-b3fa-2e9743900047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b1d93371-fd1c-4355-b3fa-2e9743900047" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_9fb03c94-752e-480b-bdd7-966f45fafb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_9fb03c94-752e-480b-bdd7-966f45fafb1d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f30b1172-68b5-43f5-aac2-234e5bdfa8b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:to="loc_us-gaap_VariableRateDomain_f30b1172-68b5-43f5-aac2-234e5bdfa8b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:to="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e375455-a522-4f3c-804f-b13508368bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e375455-a522-4f3c-804f-b13508368bfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3f8f9877-5108-46f4-914a-3ed1472717bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:to="loc_us-gaap_CreditFacilityDomain_3f8f9877-5108-46f4-914a-3ed1472717bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:to="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_699d2728-c9fe-4fdf-8000-e3083cc9421e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_699d2728-c9fe-4fdf-8000-e3083cc9421e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a4512e6c-24ba-4d37-b58a-1f2044355212_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a4512e6c-24ba-4d37-b58a-1f2044355212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_98cac242-155d-47be-ba32-9dbfc7575d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:to="loc_us-gaap_LineOfCreditMember_98cac242-155d-47be-ba32-9dbfc7575d3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5cda43b9-d0e3-4b72-81b9-87f7666a54b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:to="loc_us-gaap_SeniorNotesMember_5cda43b9-d0e3-4b72-81b9-87f7666a54b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8145c1ea-a963-4493-8a74-364e565714b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8145c1ea-a963-4493-8a74-364e565714b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member_f3faf793-337b-4ed0-8671-f523a2146f30" xlink:href="mo-20220630.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2024Member_f3faf793-337b-4ed0-8671-f523a2146f30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_3c36b949-4dcd-4a91-a304-969dd7a53cf8" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_USDDenominatedNotesMember_3c36b949-4dcd-4a91-a304-969dd7a53cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_a6aded3f-08a1-4d73-9dd7-69a11daf58aa" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_a6aded3f-08a1-4d73-9dd7-69a11daf58aa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended" id="i44a810abc26f442fadb2199289a1723b_ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_3547d115-fb48-4740-9f69-c940a0631dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_3547d115-fb48-4740-9f69-c940a0631dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_20f424ef-8c3c-433a-ad81-d047f5cafe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LitigationSettlementInterest_20f424ef-8c3c-433a-ad81-d047f5cafe14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_04c64866-b2b3-44fb-811d-3831e4630019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_04c64866-b2b3-44fb-811d-3831e4630019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d1cc5560-2217-43f5-acfc-74459deb5076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d1cc5560-2217-43f5-acfc-74459deb5076" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_89f83fc6-e83b-407c-a181-a3a6fecd1b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_89f83fc6-e83b-407c-a181-a3a6fecd1b06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d7cea472-216b-45f2-8f58-8bc76f3ba220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_eb612f9f-6689-4310-9581-2c9e7ca3eb46" xlink:href="mo-20220630.xsd#mo_LitigationEscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_mo_LitigationEscrowDeposit_eb612f9f-6689-4310-9581-2c9e7ca3eb46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a143faa1-ed61-462f-89ba-259155959e9b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:to="loc_srt_LitigationCaseTypeDomain_a143faa1-ed61-462f-89ba-259155959e9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:to="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_393a4d81-d05c-4abe-b954-eeb9c91267d0" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_393a4d81-d05c-4abe-b954-eeb9c91267d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_9b1ab3d9-4643-442e-8e33-d37a8e38a348" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:to="loc_mo_EngleProgenyCasesMember_9b1ab3d9-4643-442e-8e33-d37a8e38a348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c6165ed8-2240-4e35-a840-77d6d1418efd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c6165ed8-2240-4e35-a840-77d6d1418efd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_d1940652-42ba-48a3-807f-8860257150c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:to="loc_us-gaap_AssetsMember_d1940652-42ba-48a3-807f-8860257150c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1ef189d3-5de9-4b09-a226-b0c8ea2b555a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:to="loc_us-gaap_LitigationStatusDomain_1ef189d3-5de9-4b09-a226-b0c8ea2b555a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:to="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_180fbcfd-b40c-46cd-ad71-98cebc6057b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:to="loc_us-gaap_PendingLitigationMember_180fbcfd-b40c-46cd-ad71-98cebc6057b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9b10412d-25b1-4b5c-a38d-33220e93fccc_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:to="loc_dei_EntityDomain_9b10412d-25b1-4b5c-a38d-33220e93fccc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:to="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_336516d0-13a6-4594-ac0b-8d226fdd681e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:to="loc_mo_PhilipMorrisUSAMember_336516d0-13a6-4594-ac0b-8d226fdd681e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1610e6da-7a73-47d3-b2b6-ec86eed84bf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1610e6da-7a73-47d3-b2b6-ec86eed84bf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_a9f194c9-21c4-4fcf-b1c7-f1c47e6528d6" xlink:href="mo-20220630.xsd#mo_LitigationCasesResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:to="loc_mo_LitigationCasesResultsMember_a9f194c9-21c4-4fcf-b1c7-f1c47e6528d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_fe23e1cb-05f4-4f42-b4d8-c6fb0a3552bb" xlink:href="mo-20220630.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_fe23e1cb-05f4-4f42-b4d8-c6fb0a3552bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_809caad0-8b31-45f3-9434-02bbd1c1f491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_809caad0-8b31-45f3-9434-02bbd1c1f491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f06a2df2-21aa-40e7-b258-333446477442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:to="loc_us-gaap_SubsequentEventMember_f06a2df2-21aa-40e7-b258-333446477442" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended" id="i26338322f9b147bbae01597288a9caa2_ContingenciesScheduleofPendingCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d543c03e-19c5-46db-a551-198aff2693d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d543c03e-19c5-46db-a551-198aff2693d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_e3f4f8cd-b47d-440f-848c-b90f856a79e0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfCases_e3f4f8cd-b47d-440f-848c-b90f856a79e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_27d1ce9b-a6c6-4498-8663-94d9ea8a22d7" xlink:href="mo-20220630.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyClassActionLawsuit_27d1ce9b-a6c6-4498-8663-94d9ea8a22d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_068dd297-fa61-49ca-807f-6bfb57b372dd" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_068dd297-fa61-49ca-807f-6bfb57b372dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_f2bed44d-bc8a-44d6-be22-6ac2cd0e06bf" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_f2bed44d-bc8a-44d6-be22-6ac2cd0e06bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fdf04937-a265-49f0-83e1-50e88baba804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fdf04937-a265-49f0-83e1-50e88baba804" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_a7903b02-7b9c-43a2-87d8-946dbeaa78f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_a7903b02-7b9c-43a2-87d8-946dbeaa78f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_77bac0b4-68a9-46c9-903f-b3d711d82100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_77bac0b4-68a9-46c9-903f-b3d711d82100" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1813ba0f-f613-40df-95c5-6ae85809637a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1813ba0f-f613-40df-95c5-6ae85809637a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd33f6b7-4e4d-4dd9-a1b9-26239c5089c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:to="loc_us-gaap_SubsequentEventMember_dd33f6b7-4e4d-4dd9-a1b9-26239c5089c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2b93e8b2-d1da-4933-b40c-0c3a8ae511db_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:to="loc_srt_LitigationCaseTypeDomain_2b93e8b2-d1da-4933-b40c-0c3a8ae511db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:to="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:href="mo-20220630.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_45e9d906-aad0-4bc2-9e5a-909289c0feaf" xlink:href="mo-20220630.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_45e9d906-aad0-4bc2-9e5a-909289c0feaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_18cbf163-5b05-44c0-95a3-2839c1f8db7b" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_18cbf163-5b05-44c0-95a3-2839c1f8db7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_48f8c220-d186-416a-9fb8-4ce60347b38c" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_EvaporLitigationMember_48f8c220-d186-416a-9fb8-4ce60347b38c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_a94d3c29-d5c3-4a97-8dc5-5ed98fb7c6bf" xlink:href="mo-20220630.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_a94d3c29-d5c3-4a97-8dc5-5ed98fb7c6bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_f885c8c5-f191-4e45-be8c-a87da56b27fd" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_f885c8c5-f191-4e45-be8c-a87da56b27fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_533cecb9-be51-4011-b76f-97d5f7a0a1a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:to="loc_us-gaap_LitigationStatusDomain_533cecb9-be51-4011-b76f-97d5f7a0a1a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:to="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5cc9040f-c01a-442a-bb32-60b8019c9f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_us-gaap_PendingLitigationMember_5cc9040f-c01a-442a-bb32-60b8019c9f12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_fd5a2a2b-eae9-44c9-bdbd-660ca4bc8284" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_fd5a2a2b-eae9-44c9-bdbd-660ca4bc8284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_3f3f558f-7df4-4f30-aac4-2d439109162b" xlink:href="mo-20220630.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_3f3f558f-7df4-4f30-aac4-2d439109162b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:to="loc_srt_SegmentGeographicalDomain_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:to="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_da86d156-5a89-4460-af24-9233f87ea0aa" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_IL_da86d156-5a89-4460-af24-9233f87ea0aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_bcf31ce6-0878-4705-a01e-e1119041c544" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_NM_bcf31ce6-0878-4705-a01e-e1119041c544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_de8efb22-2fa2-480a-8a9c-c5679d1a76f4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_MA_de8efb22-2fa2-480a-8a9c-c5679d1a76f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_82c38477-cb97-4913-925c-d61427411653" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_FL_82c38477-cb97-4913-925c-d61427411653" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_178b23d6-f9ca-4e58-8fae-55340a24e715_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:to="loc_us-gaap_LossContingencyNatureDomain_178b23d6-f9ca-4e58-8fae-55340a24e715_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_a772f26d-75eb-4e83-b6e9-559e0a209288" xlink:href="mo-20220630.xsd#mo_LitigationCasesResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:to="loc_mo_LitigationCasesResultsMember_a772f26d-75eb-4e83-b6e9-559e0a209288" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended" id="id5153b4f482d40189e1632da84c20579_ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_309992d9-9b2b-4177-b4ec-8c688e42e592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_309992d9-9b2b-4177-b4ec-8c688e42e592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_643e5c24-514c-49c8-b6eb-a32a2035ea32" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_643e5c24-514c-49c8-b6eb-a32a2035ea32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_23ef31f2-1770-45b3-9147-70d726066975" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecided_23ef31f2-1770-45b3-9147-70d726066975" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_b694004a-e175-4001-a2fa-a8b5241f43f3" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_b694004a-e175-4001-a2fa-a8b5241f43f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_37a328c1-98ee-4456-81ed-f3f05106ef3d" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_37a328c1-98ee-4456-81ed-f3f05106ef3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_7d106f8a-6340-46fd-83ab-d5ab16dce005" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_7d106f8a-6340-46fd-83ab-d5ab16dce005" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_8bb19007-57d8-4f9e-a60f-e762a3af098c" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_8bb19007-57d8-4f9e-a60f-e762a3af098c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fd814524-79cf-42bb-ae33-cfe63813a5d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fd814524-79cf-42bb-ae33-cfe63813a5d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0fbe8716-551a-44ba-88dd-82684d55802a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:to="loc_us-gaap_SubsequentEventMember_0fbe8716-551a-44ba-88dd-82684d55802a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7cc97bf5-db3c-418b-a1b4-b49cfba90d83_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:to="loc_dei_EntityDomain_7cc97bf5-db3c-418b-a1b4-b49cfba90d83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:to="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_676e1ebb-6234-4c1e-8a64-fb112b10a142" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:to="loc_mo_PhilipMorrisUSAMember_676e1ebb-6234-4c1e-8a64-fb112b10a142" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_3706814c-a139-4f2a-a331-0f581bbf131e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_3706814c-a139-4f2a-a331-0f581bbf131e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a01a7ae9-0250-4827-9c23-a623caca0b7f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:to="loc_srt_LitigationCaseTypeDomain_a01a7ae9-0250-4827-9c23-a623caca0b7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:to="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_04f63313-4969-42f3-afab-0d828bdd5123" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_04f63313-4969-42f3-afab-0d828bdd5123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_4beef17a-970f-4360-aa07-4daea6127292" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_4beef17a-970f-4360-aa07-4daea6127292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_83b20c4c-6820-4810-9148-1161ed49be9d" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_EngleProgenyCasesMember_83b20c4c-6820-4810-9148-1161ed49be9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_8b1d4701-bd28-4cd0-8b35-6f0cba9d57cf" xlink:href="mo-20220630.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_NonEngleProgenyCasesMember_8b1d4701-bd28-4cd0-8b35-6f0cba9d57cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_db229c03-b84d-4d21-b7bb-a6ca509aa168" xlink:href="mo-20220630.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_db229c03-b84d-4d21-b7bb-a6ca509aa168" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_06a2aec4-ef6a-4400-af12-f18d3653a3d1" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_EvaporLitigationMember_06a2aec4-ef6a-4400-af12-f18d3653a3d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:to="loc_srt_SegmentGeographicalDomain_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:to="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_bef56957-3282-479a-b526-63a1d455f328" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_country_CA_bef56957-3282-479a-b526-63a1d455f328" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_1c3d6349-4aa0-4366-b2ba-bd70ac3f02c0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_AK_1c3d6349-4aa0-4366-b2ba-bd70ac3f02c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_d36461ce-e97e-450f-bd82-e7d67db0613d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_CA_d36461ce-e97e-450f-bd82-e7d67db0613d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_1aa37e71-9422-4887-a2a3-daaf6c59354f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_CT_1aa37e71-9422-4887-a2a3-daaf6c59354f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6e6440b5-f800-410b-b03f-4c01ddb6c077" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_FL_6e6440b5-f800-410b-b03f-4c01ddb6c077" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_7f81133e-ceaa-4500-9750-f853d6b79f49" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_LA_7f81133e-ceaa-4500-9750-f853d6b79f49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_83dbaa76-689b-4ae9-9609-a58a31930f45" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MA_83dbaa76-689b-4ae9-9609-a58a31930f45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_77c89295-8e23-4c9c-a318-8e72282322ba" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MS_77c89295-8e23-4c9c-a318-8e72282322ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_e2beb550-8b82-49a3-a1ba-5479be3c7d0a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MO_e2beb550-8b82-49a3-a1ba-5479be3c7d0a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_35987657-39b2-49d4-990c-e0a4532fc527" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NH_35987657-39b2-49d4-990c-e0a4532fc527" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_77b10bcc-ff35-4ea6-a44c-3f87dfdaddf3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NJ_77b10bcc-ff35-4ea6-a44c-3f87dfdaddf3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_f46c5492-04eb-4cc7-a91a-50e74f3b23b1" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NY_f46c5492-04eb-4cc7-a91a-50e74f3b23b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_14d5287b-cc77-494e-b4c6-0e25127ed178" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_OH_14d5287b-cc77-494e-b4c6-0e25127ed178" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_0fafa7b9-768f-4e14-b992-d8b843a54311" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_PA_0fafa7b9-768f-4e14-b992-d8b843a54311" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_27b6b332-2cbd-49da-9e10-004cae4681a8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_RI_27b6b332-2cbd-49da-9e10-004cae4681a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_760edd38-31e1-4ad1-9c3d-f6180d76565e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_TN_760edd38-31e1-4ad1-9c3d-f6180d76565e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_03b89726-5972-45bd-962c-ff00f40b3530" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_WV_03b89726-5972-45bd-962c-ff00f40b3530" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended" id="iaa11dd3afa9447b8a02bfb43368ee3f1_ContingenciesNonEngleProgenyLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_82ec080b-7a25-4f8c-bb0a-f2c631020a28" xlink:href="mo-20220630.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_82ec080b-7a25-4f8c-bb0a-f2c631020a28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_c5ca7b6c-5740-48c1-b623-f831b16b0588" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_c5ca7b6c-5740-48c1-b623-f831b16b0588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_581e01a5-41a2-4ea9-80f6-78b0a5dd15f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_581e01a5-41a2-4ea9-80f6-78b0a5dd15f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_41ef76e7-eb4d-4b25-8d74-4942528b02d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_41ef76e7-eb4d-4b25-8d74-4942528b02d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:to="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:to="loc_srt_LitigationCaseTypeDomain_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:to="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_26591427-ecbd-4ec5-bcb0-f402a9d35b80" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_26591427-ecbd-4ec5-bcb0-f402a9d35b80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_c6bee0fd-4781-4b65-8a81-76e7cf4bd219" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_c6bee0fd-4781-4b65-8a81-76e7cf4bd219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_57ed86f8-a4ac-470d-b8ac-ef3772569a18" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_57ed86f8-a4ac-470d-b8ac-ef3772569a18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:to="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:to="loc_dei_EntityDomain_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:to="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_5989bb8d-2d33-487a-9079-79eea313fd6e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:to="loc_mo_PhilipMorrisUSAMember_5989bb8d-2d33-487a-9079-79eea313fd6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended" id="i8a7c716756934e6bb5ea3746fd85ede9_ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_f80ee893-daaa-42a3-ab73-54e71a341bd1" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_f80ee893-daaa-42a3-ab73-54e71a341bd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_8887760a-504b-4354-ab20-afc719400485" xlink:href="mo-20220630.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_8887760a-504b-4354-ab20-afc719400485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_64d2f059-5a18-4989-87e0-e67ccc26aafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_64d2f059-5a18-4989-87e0-e67ccc26aafa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e81be23a-67f5-466e-9085-3a250eae129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e81be23a-67f5-466e-9085-3a250eae129a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_2f9b97f3-292f-4a20-ad55-34cdeccbf603" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecided_2f9b97f3-292f-4a20-ad55-34cdeccbf603" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_61eaad92-c87d-4cd4-89cd-11296c74fb1f" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_61eaad92-c87d-4cd4-89cd-11296c74fb1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_f3237b21-63a7-4b9e-80ae-43adea50a39c" xlink:href="mo-20220630.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_f3237b21-63a7-4b9e-80ae-43adea50a39c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7409ff75-fe22-4e54-90db-8d189f290913" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7409ff75-fe22-4e54-90db-8d189f290913" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_384464d2-681a-4529-b5e0-f68cf05d6976" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_384464d2-681a-4529-b5e0-f68cf05d6976" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_dad23ca7-74f3-4914-8823-767d8f2b04df" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_dad23ca7-74f3-4914-8823-767d8f2b04df" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_dcbeeff5-32ab-41b8-a89e-b78cc6fc8c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_dcbeeff5-32ab-41b8-a89e-b78cc6fc8c9d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_3f339bc7-30c6-41af-87b7-571045a04311" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_3f339bc7-30c6-41af-87b7-571045a04311" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6616e3d3-df18-4e82-9340-5ccffb3877d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6616e3d3-df18-4e82-9340-5ccffb3877d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eacb3433-a79e-4c1b-9cad-4904776081d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:to="loc_us-gaap_SubsequentEventMember_eacb3433-a79e-4c1b-9cad-4904776081d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f22eb25d-c027-4fab-87cc-49ef618dc298_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:to="loc_srt_LitigationCaseTypeDomain_f22eb25d-c027-4fab-87cc-49ef618dc298_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:to="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_ac45d984-dcd4-4736-aa54-cb6bf846d613" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:to="loc_mo_EngleProgenyCasesStateMember_ac45d984-dcd4-4736-aa54-cb6bf846d613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_2f73c5ae-61db-470e-97e9-70992682f296" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:to="loc_mo_EngleProgenyCasesFederalMember_2f73c5ae-61db-470e-97e9-70992682f296" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_a2d83b83-c395-4664-8f3d-114dd1b8b0b0" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_a2d83b83-c395-4664-8f3d-114dd1b8b0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_3b0e9664-0cf7-45bd-9f4e-8184399cb890" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_3b0e9664-0cf7-45bd-9f4e-8184399cb890" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_d8dcaa2e-0b00-44d4-9bf7-c05cec1cd1cc" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_d8dcaa2e-0b00-44d4-9bf7-c05cec1cd1cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_e01caafd-1cad-4aea-a1ca-3dfb0d2eed28" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesPollariMember_e01caafd-1cad-4aea-a1ca-3dfb0d2eed28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_07cfdeb0-4dec-440a-b119-f33db2507f84" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_07cfdeb0-4dec-440a-b119-f33db2507f84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_3bb17ea6-dd15-426e-8d43-76aaf041af18" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_3bb17ea6-dd15-426e-8d43-76aaf041af18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember_626e1ea6-70b3-4f69-97b4-d0d5a2deb4db" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesKaplanAndSommersMember_626e1ea6-70b3-4f69-97b4-d0d5a2deb4db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:to="loc_dei_EntityDomain_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:to="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_36aec122-1548-4af0-a8d9-b85feb7e3f1c" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:to="loc_mo_PhilipMorrisUSAMember_36aec122-1548-4af0-a8d9-b85feb7e3f1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended" id="i6729d933b79a4aeb8707ce31ac35e3e8_ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_8482ed5e-b0ad-4ffc-91d1-c76ed6e79779" xlink:href="mo-20220630.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_8482ed5e-b0ad-4ffc-91d1-c76ed6e79779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_7f5fdbc3-dedd-4ae7-9f29-5e5e2c3f8aa7" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_7f5fdbc3-dedd-4ae7-9f29-5e5e2c3f8aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_31c22a1b-338d-4d41-b797-e704e45048e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_31c22a1b-338d-4d41-b797-e704e45048e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_20752d6a-8fa1-4bcc-ac39-80cca9b896cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_20752d6a-8fa1-4bcc-ac39-80cca9b896cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_64bcdf30-9226-4dff-8dba-f41116970edb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:to="loc_srt_LitigationCaseTypeDomain_64bcdf30-9226-4dff-8dba-f41116970edb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:to="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember_e81ba280-60c2-4729-8638-a8217a834322" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesSchertzerMember_e81ba280-60c2-4729-8638-a8217a834322" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_f73ebf7c-d1a0-4584-be6b-e7b8bdb4545a" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesLippMember_f73ebf7c-d1a0-4584-be6b-e7b8bdb4545a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_9fb871a3-42e1-4ab8-9c61-89d214b92029" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_9fb871a3-42e1-4ab8-9c61-89d214b92029" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_c0c5304f-8882-4938-b6d9-171bd130feb5" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_c0c5304f-8882-4938-b6d9-171bd130feb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_ed708015-c191-4bc1-b0ea-b792946d6a27" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_ed708015-c191-4bc1-b0ea-b792946d6a27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_d743b3d1-5409-4b52-995d-c040099915ff" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_d743b3d1-5409-4b52-995d-c040099915ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_16b3ff5b-1e3e-4457-be18-9e20964c5712" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_16b3ff5b-1e3e-4457-be18-9e20964c5712" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember_ba33f67e-53b2-4e5a-91fd-c9ff803e2b70" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanMcLauighlinMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember_ba33f67e-53b2-4e5a-91fd-c9ff803e2b70" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_a740e3bf-e807-4047-b41c-1ee57570b234" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_a740e3bf-e807-4047-b41c-1ee57570b234" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_68365dfc-0316-4735-90dc-923948df8bed" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesCooperMember_68365dfc-0316-4735-90dc-923948df8bed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_898d95a1-d94c-48d9-b363-4290db77c669" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_898d95a1-d94c-48d9-b363-4290db77c669" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_0d27e362-979b-4043-9e95-2e674c4f3a86" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_0d27e362-979b-4043-9e95-2e674c4f3a86" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_3db565d0-cd53-497a-bae7-4aa36b1ece8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:to="loc_us-gaap_LitigationStatusDomain_3db565d0-cd53-497a-bae7-4aa36b1ece8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:to="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c4803ed1-78a8-4781-8023-1672c99e2e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:to="loc_us-gaap_PendingLitigationMember_c4803ed1-78a8-4781-8023-1672c99e2e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_591629fa-e872-41ca-9f9b-c1e65baf29d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:to="loc_us-gaap_SettledLitigationMember_591629fa-e872-41ca-9f9b-c1e65baf29d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8b90e380-a085-4931-85aa-99b460a0fc65_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:to="loc_dei_EntityDomain_8b90e380-a085-4931-85aa-99b460a0fc65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:to="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fba16749-8ecf-4132-b172-709489348719" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:to="loc_mo_PhilipMorrisUSAMember_fba16749-8ecf-4132-b172-709489348719" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended" id="i63935f04545b4de9b6eeb063423f308d_ContingenciesFloridaBondStatuteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_92176025-249b-4431-b971-be993c0412c2" xlink:href="mo-20220630.xsd#mo_MaximumBondForAllDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:to="loc_mo_MaximumBondForAllDefendants_92176025-249b-4431-b971-be993c0412c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:to="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:to="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1661c894-4215-4ec0-bea0-5b566997e6fc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:to="loc_srt_SegmentGeographicalDomain_1661c894-4215-4ec0-bea0-5b566997e6fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:to="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_7087dacd-17d7-4f16-bff2-7a9d3d8e9e84" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:to="loc_stpr_FL_7087dacd-17d7-4f16-bff2-7a9d3d8e9e84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:to="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_51de30dd-c0bb-4452-8a6b-e49396c8a0a7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:to="loc_srt_LitigationCaseTypeDomain_51de30dd-c0bb-4452-8a6b-e49396c8a0a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:to="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_faa989d7-4f7c-4fa2-a397-d4ccd8fdd4e2" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:to="loc_mo_EngleProgenyCasesStateMember_faa989d7-4f7c-4fa2-a397-d4ccd8fdd4e2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended" id="id77f7ef889934f95a0eb82a4d89d3d80_ContingenciesOtherSmokingandHealthClassActionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_e727eb2c-d34f-4fab-b671-6a42b3f630e9" xlink:href="mo-20220630.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_e727eb2c-d34f-4fab-b671-6a42b3f630e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_794f3957-6976-4040-b71d-66a1b190ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_794f3957-6976-4040-b71d-66a1b190ad06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_b99f4e52-c950-43c9-93d5-d7729584ffb4" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyNumberofManufacturers_b99f4e52-c950-43c9-93d5-d7729584ffb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_559c05f2-e067-4522-b6e3-aa89ca96f2f0" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyVerdictsUpheld_559c05f2-e067-4522-b6e3-aa89ca96f2f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_9e0aa9b7-e861-4ce8-a000-c0db2b91b475" xlink:href="mo-20220630.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_AmountAwardedtoOtherParty_9e0aa9b7-e861-4ce8-a000-c0db2b91b475" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8052e0da-f8b4-4798-ada7-08a03b3956b9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:to="loc_srt_SegmentGeographicalDomain_8052e0da-f8b4-4798-ada7-08a03b3956b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:to="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_3a314f40-6130-40aa-86af-30138cfb1edd" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_AR_3a314f40-6130-40aa-86af-30138cfb1edd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_32b6246f-7b9a-4143-bde0-0b703d7dcad3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_CA_32b6246f-7b9a-4143-bde0-0b703d7dcad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_f520021b-8ac4-4778-b21c-c1e758cb002a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_DE_f520021b-8ac4-4778-b21c-c1e758cb002a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_c18e0185-a89b-4d3b-9bd6-82a4ebc9e27a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_DC_c18e0185-a89b-4d3b-9bd6-82a4ebc9e27a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_75c9f3e3-7504-43bb-bda6-477267f81a8d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_FL_75c9f3e3-7504-43bb-bda6-477267f81a8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b4935bfe-c5c2-41f5-93d7-aeafd71d0d37" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_IL_b4935bfe-c5c2-41f5-93d7-aeafd71d0d37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_0d83ee45-1dad-480b-ba6d-a818514663b1" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_IA_0d83ee45-1dad-480b-ba6d-a818514663b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_3ba46ac3-6b6c-4be6-a478-402b38769bde" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_KS_3ba46ac3-6b6c-4be6-a478-402b38769bde" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_2f197a9e-8439-4f2f-a8d4-402006ff11cb" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_LA_2f197a9e-8439-4f2f-a8d4-402006ff11cb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_310be9c5-f749-4fac-ae76-5bc8e18b4f0d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MD_310be9c5-f749-4fac-ae76-5bc8e18b4f0d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_1c9e85e5-41e7-4bf3-b235-236d3bbf8480" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MI_1c9e85e5-41e7-4bf3-b235-236d3bbf8480" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_284a646f-9900-45cb-9712-b7ea1457e050" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MN_284a646f-9900-45cb-9712-b7ea1457e050" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_fe4b99a6-8c52-4e04-a717-f81fb4a471c2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NV_fe4b99a6-8c52-4e04-a717-f81fb4a471c2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9597107b-eaee-4e21-94b0-204f1f54fc85" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NJ_9597107b-eaee-4e21-94b0-204f1f54fc85" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_e2c730aa-7baa-417c-ae0b-e994ddd7ceee" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NY_e2c730aa-7baa-417c-ae0b-e994ddd7ceee" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_2786029f-679d-4614-bb39-c02953bf0df5" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OH_2786029f-679d-4614-bb39-c02953bf0df5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_257870b3-2b7d-4340-a4eb-3a95af7aab3c" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OK_257870b3-2b7d-4340-a4eb-3a95af7aab3c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_9e664713-cce0-4a3e-8651-0082c5e5fc45" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OR_9e664713-cce0-4a3e-8651-0082c5e5fc45" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_9f2d126d-10f0-4c85-b869-06fd9c5893b8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_PA_9f2d126d-10f0-4c85-b869-06fd9c5893b8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_aa115e53-5617-4988-a403-c98a291916a4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_country_PR_aa115e53-5617-4988-a403-c98a291916a4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_4407d587-9081-4317-8cde-eb54b831e92f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_SC_4407d587-9081-4317-8cde-eb54b831e92f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_c4818e5f-6779-4987-a2c1-130b44e6561a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_TX_c4818e5f-6779-4987-a2c1-130b44e6561a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_8b3ef7ca-849a-44f2-a85d-2fae37134107" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_WI_8b3ef7ca-849a-44f2-a85d-2fae37134107" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_21e56f7f-d15f-494d-8af2-898f7616c36b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_country_CA_21e56f7f-d15f-494d-8af2-898f7616c36b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_37655b8d-66ea-4743-9df3-794556fd8920" xlink:href="mo-20220630.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_37655b8d-66ea-4743-9df3-794556fd8920" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_504182f8-d057-4f5d-950c-552dfaef2cde_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:to="loc_dei_EntityDomain_504182f8-d057-4f5d-950c-552dfaef2cde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:to="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b9d3cf45-b866-4442-aef4-531ba8550bb0" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_PhilipMorrisUSAMember_b9d3cf45-b866-4442-aef4-531ba8550bb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_5ca529b7-4e8d-4719-9696-6c97746c5709" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_5ca529b7-4e8d-4719-9696-6c97746c5709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_576885e1-3bf9-43a0-ae5a-784e00fccc7b" xlink:href="mo-20220630.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_576885e1-3bf9-43a0-ae5a-784e00fccc7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_314b79fc-5be3-4377-bbb8-3dbfe27a5c36" xlink:href="mo-20220630.xsd#mo_AltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_AltriaGroupMember_314b79fc-5be3-4377-bbb8-3dbfe27a5c36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4537e7d4-16fb-439f-92b6-b8427fe42d69_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:to="loc_srt_LitigationCaseTypeDomain_4537e7d4-16fb-439f-92b6-b8427fe42d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:to="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_0fcaa433-d485-4951-b44b-c16d3e8ea1f4" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_0fcaa433-d485-4951-b44b-c16d3e8ea1f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a3fecb52-7a43-4d00-a0f1-57932e4756d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a3fecb52-7a43-4d00-a0f1-57932e4756d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a2a9fd4e-3cf6-445d-9949-92459e9e9590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:to="loc_us-gaap_SubsequentEventMember_a2a9fd4e-3cf6-445d-9949-92459e9e9590" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended" id="i1b48ea4d88704ec88779b0f89b665e08_ContingenciesHealthCareCostRecoveryLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_c93fb6c1-bbc4-4b23-a911-6629b2fb40ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_c93fb6c1-bbc4-4b23-a911-6629b2fb40ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_3e7d0354-9455-44ab-918e-c19d088011ff" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LossContingencyNumberofManufacturers_3e7d0354-9455-44ab-918e-c19d088011ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_0ca02c5c-0caa-4692-baac-bf1bad849118" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_0ca02c5c-0caa-4692-baac-bf1bad849118" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_6287de01-fed2-4ee1-a0ba-7eb17bd1b7ce" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_6287de01-fed2-4ee1-a0ba-7eb17bd1b7ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_db29e034-22f6-42d2-afd7-419a9c3f7147" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_db29e034-22f6-42d2-afd7-419a9c3f7147" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7be97233-ec53-42ec-8041-3312eddd06cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7be97233-ec53-42ec-8041-3312eddd06cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5fbff160-630b-4583-9670-e05be17e6456_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:to="loc_dei_EntityDomain_5fbff160-630b-4583-9670-e05be17e6456_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:to="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_e1deb354-a19e-42b3-937b-0dc63de80b76" xlink:href="mo-20220630.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_e1deb354-a19e-42b3-937b-0dc63de80b76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2b776e6f-989d-44a1-a76d-b4e85b345f49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:to="loc_us-gaap_LitigationStatusDomain_2b776e6f-989d-44a1-a76d-b4e85b345f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:to="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_36d5a05b-a839-44a0-9965-425c66a0ef36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:to="loc_us-gaap_ThreatenedLitigationMember_36d5a05b-a839-44a0-9965-425c66a0ef36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_10ebc099-7a33-40a4-8ed8-0e6f1229f81a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:to="loc_srt_SegmentGeographicalDomain_10ebc099-7a33-40a4-8ed8-0e6f1229f81a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:to="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_a85856f1-bcf0-4aa7-9183-fc0689ec42ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:to="loc_country_CA_a85856f1-bcf0-4aa7-9183-fc0689ec42ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3f45c12f-eff5-497f-b614-3525da01c490_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:to="loc_srt_LitigationCaseTypeDomain_3f45c12f-eff5-497f-b614-3525da01c490_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:to="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_65287980-e317-46da-90ce-a566e728e06d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_65287980-e317-46da-90ce-a566e728e06d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_051bddf2-5857-4f8b-89a2-d3348fcf3101" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_051bddf2-5857-4f8b-89a2-d3348fcf3101" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended" id="ibe318017e77f414093ab0c08c9d4badf_ContingenciesNPMAdjustmentDisputesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_21397eb1-8e76-4ae3-83a0-88cd6016efc3" xlink:href="mo-20220630.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_21397eb1-8e76-4ae3-83a0-88cd6016efc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_06a140f9-383d-4a7f-8510-ce116dde2ae7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_06a140f9-383d-4a7f-8510-ce116dde2ae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_ee113d59-ff23-4448-89d1-9abf242ba5b0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_ee113d59-ff23-4448-89d1-9abf242ba5b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_32980524-698d-4432-8c89-b3e8841e5e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_32980524-698d-4432-8c89-b3e8841e5e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_12c03c62-7e70-42ce-9338-a26d82d1a5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_12c03c62-7e70-42ce-9338-a26d82d1a5b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_97ab5f67-0369-47f5-b5cf-910893c72865" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_97ab5f67-0369-47f5-b5cf-910893c72865" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_f9a7fbc4-deef-4233-abe0-9e8243fd3653" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_f9a7fbc4-deef-4233-abe0-9e8243fd3653" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_e72ab735-0813-462e-b1d9-24d8f9c058e5" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_e72ab735-0813-462e-b1d9-24d8f9c058e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_0076f199-58b1-46fa-8b71-f0f7e39026c6" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_0076f199-58b1-46fa-8b71-f0f7e39026c6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_806e474e-539c-425d-8947-5f7e7033afb7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_806e474e-539c-425d-8947-5f7e7033afb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_e58af87b-1715-4759-8f05-92045f224bb6" xlink:href="mo-20220630.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_e58af87b-1715-4759-8f05-92045f224bb6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_3dc4dc66-22e1-489b-8ecf-0a01999186d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_3dc4dc66-22e1-489b-8ecf-0a01999186d0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_77463ada-0391-4b00-9a9d-8380a5eabda6" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_77463ada-0391-4b00-9a9d-8380a5eabda6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e2f86be2-9f29-45e4-a4f8-69af1201dfa3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:to="loc_srt_SegmentGeographicalDomain_e2f86be2-9f29-45e4-a4f8-69af1201dfa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:to="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_32d915d3-378b-4529-9dd6-2a37af9063b2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_NY_32d915d3-378b-4529-9dd6-2a37af9063b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_4cb1a5a7-bd3d-4753-b8ba-dc21e3c214dc" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_MT_4cb1a5a7-bd3d-4753-b8ba-dc21e3c214dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_19f9fb44-d37d-4ff6-8330-dedd90c4cb81" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_IL_19f9fb44-d37d-4ff6-8330-dedd90c4cb81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2b59e46c-ecb3-43f4-bd15-c74ba4e67888_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:to="loc_dei_EntityDomain_2b59e46c-ecb3-43f4-bd15-c74ba4e67888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:to="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b7036655-0f6e-441e-a8a8-157874a77cb1" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:to="loc_mo_PhilipMorrisUSAMember_b7036655-0f6e-441e-a8a8-157874a77cb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7da6f4b8-f3e0-430e-ad52-62761835ad0b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:to="loc_srt_LitigationCaseTypeDomain_7da6f4b8-f3e0-430e-ad52-62761835ad0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:to="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_b2929516-3cf0-4f39-8ec5-55012c4a0bce" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_b2929516-3cf0-4f39-8ec5-55012c4a0bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_a5e8e969-9fbb-4561-9ba9-1c5d5ea6a5ff" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_a5e8e969-9fbb-4561-9ba9-1c5d5ea6a5ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_604795a9-2dcb-4bcb-a879-af517c6e2662" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_604795a9-2dcb-4bcb-a879-af517c6e2662" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_8dc07e18-0715-4495-81f5-5bdd1a5745f3" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_8dc07e18-0715-4495-81f5-5bdd1a5745f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_118f31ac-972e-401a-9294-c75fe0ae72f6" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_118f31ac-972e-401a-9294-c75fe0ae72f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_626320c1-55fd-45e9-b7ab-5bfbdc83d23a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_626320c1-55fd-45e9-b7ab-5bfbdc83d23a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_48dd357a-f65a-484a-a6e3-c20ae789b2f6" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_48dd357a-f65a-484a-a6e3-c20ae789b2f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_af9d5305-725d-4e3a-9fb6-fb82595b560d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_af9d5305-725d-4e3a-9fb6-fb82595b560d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_6cce255a-e5c8-4075-9c05-0d236892676e" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_6cce255a-e5c8-4075-9c05-0d236892676e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_2f1f240a-81d2-4e9e-a56b-a483cf3add4f" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_2f1f240a-81d2-4e9e-a56b-a483cf3add4f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_9da89a6c-25dd-4b8c-9685-4d220ef642f8" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_9da89a6c-25dd-4b8c-9685-4d220ef642f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_db8a9019-a0c1-4dc8-a5f1-1a2eada85823" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_db8a9019-a0c1-4dc8-a5f1-1a2eada85823" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_ec1586e1-f92f-4826-bc4c-80e06d72ad6b" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_ec1586e1-f92f-4826-bc4c-80e06d72ad6b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_55de34bf-f5da-463a-987b-60512989d6b7" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_55de34bf-f5da-463a-987b-60512989d6b7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_289935fb-c88e-4ebd-8cdb-f2df55b4a238" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_289935fb-c88e-4ebd-8cdb-f2df55b4a238" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_7e91eff5-dc0b-4338-bc60-c5997aec413d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_7e91eff5-dc0b-4338-bc60-c5997aec413d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_fa213793-c83d-4421-ab97-dc36a284211a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_fa213793-c83d-4421-ab97-dc36a284211a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_b514a267-f556-4e9c-8189-2f9d1dd184d2" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_b514a267-f556-4e9c-8189-2f9d1dd184d2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_9f5e5a19-6a3a-416c-b104-bd4c1a09d982" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_9f5e5a19-6a3a-416c-b104-bd4c1a09d982" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_ab54509d-cb3c-4871-ad99-501098a653f0" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_ab54509d-cb3c-4871-ad99-501098a653f0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_408b6b4b-1ba0-4c82-97f7-9831c5859a7a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_408b6b4b-1ba0-4c82-97f7-9831c5859a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_77273b45-0005-43e1-a688-2494c4332e29" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_77273b45-0005-43e1-a688-2494c4332e29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:to="loc_us-gaap_LitigationStatusDomain_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:to="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_f51b459b-9c53-4daf-831f-1a504762b02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:to="loc_us-gaap_SettledLitigationMember_f51b459b-9c53-4daf-831f-1a504762b02d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5d93b7b3-7603-4a57-a823-ccc49199dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:to="loc_us-gaap_PendingLitigationMember_5d93b7b3-7603-4a57-a823-ccc49199dd31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_078ea031-aa68-4f70-9fda-ae99b9428a0e_default" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:to="loc_mo_ArbitrationPeriodDomain_078ea031-aa68-4f70-9fda-ae99b9428a0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:to="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_d75d9642-21db-4f14-94bd-c4aaddbf730b" xlink:href="mo-20220630.xsd#mo_PeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:to="loc_mo_PeriodOneMember_d75d9642-21db-4f14-94bd-c4aaddbf730b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_95f3a3c6-ef83-4654-82a4-a66cea5f3b08" xlink:href="mo-20220630.xsd#mo_PeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:to="loc_mo_PeriodTwoMember_95f3a3c6-ef83-4654-82a4-a66cea5f3b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fa122ce0-d305-4351-a1da-31d1d934a816_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fa122ce0-d305-4351-a1da-31d1d934a816_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9b295cc9-045e-400a-bdf2-f24a96eea200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:to="loc_us-gaap_CostOfSalesMember_9b295cc9-045e-400a-bdf2-f24a96eea200" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended" id="i942db82c33544d1b92cf2d58980e4ace_ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_6a71ec22-6e2b-4efd-b95e-fbf2f01aa693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_6a71ec22-6e2b-4efd-b95e-fbf2f01aa693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:to="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:to="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_039d819d-214e-4ed4-88da-f7b7acf8762d_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:to="loc_dei_EntityDomain_039d819d-214e-4ed4-88da-f7b7acf8762d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:to="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_0188b750-b26b-4d59-8801-5b3ec5e516f9" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:to="loc_mo_PhilipMorrisUSAMember_0188b750-b26b-4d59-8801-5b3ec5e516f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:to="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:to="loc_srt_LitigationCaseTypeDomain_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:to="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_57a58a00-6f7b-4be9-aa5b-c8071d9fdebe" xlink:href="mo-20220630.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_57a58a00-6f7b-4be9-aa5b-c8071d9fdebe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended" id="i1cbf66cba67a45d288ec4488de915757_ContingenciesFederalGovernmentsLawsuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_a31a25ed-5bd9-43cc-8f75-c9ccab93b8ce" xlink:href="mo-20220630.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_a31a25ed-5bd9-43cc-8f75-c9ccab93b8ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_eba2b088-5e76-4f9b-acb3-9b7fa218315f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_eba2b088-5e76-4f9b-acb3-9b7fa218315f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:to="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:to="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_1456d034-ed90-4cdb-a7f1-57fb3e325cfa" xlink:href="mo-20220630.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_1456d034-ed90-4cdb-a7f1-57fb3e325cfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:to="loc_srt_LitigationCaseTypeDomain_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:to="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_a1ee34b2-199d-442d-8899-82d489ca8d68" xlink:href="mo-20220630.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_a1ee34b2-199d-442d-8899-82d489ca8d68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_17428c31-a877-485c-a3f3-12264fe3cf36_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:to="loc_dei_EntityDomain_17428c31-a877-485c-a3f3-12264fe3cf36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:to="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c23bfb8c-c87c-4f06-9888-ed5302559705" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:to="loc_mo_PhilipMorrisUSAMember_c23bfb8c-c87c-4f06-9888-ed5302559705" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_560baa20-9026-4d3b-8950-cf9392a03c46" xlink:href="mo-20220630.xsd#mo_AltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:to="loc_mo_AltriaGroupMember_560baa20-9026-4d3b-8950-cf9392a03c46" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEvaporProductLitigationandIQOSLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="extended" id="ib7286510b0e8430ea94fbe7a3015c3e3_ContingenciesEvaporProductLitigationandIQOSLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_b5459d6d-2e6a-486b-87e5-a061b81f419d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_b5459d6d-2e6a-486b-87e5-a061b81f419d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5c704e4e-84da-4cc0-a4c2-68f354ba4d9a" xlink:href="mo-20220630.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5c704e4e-84da-4cc0-a4c2-68f354ba4d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_3e94115e-2095-46ac-8fc6-f1b89d471ec5" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_3e94115e-2095-46ac-8fc6-f1b89d471ec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_9f5da63d-43ab-44f0-95be-f793dd6ad578" xlink:href="mo-20220630.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_9f5da63d-43ab-44f0-95be-f793dd6ad578" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_4f9eb728-3129-45da-89ef-a4a9ab861e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_4f9eb728-3129-45da-89ef-a4a9ab861e60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_f2803362-389c-459e-bc7b-55f1e535d428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_f2803362-389c-459e-bc7b-55f1e535d428" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_f67f2826-e954-4414-8239-e40dbda2ec4f" xlink:href="mo-20220630.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_f67f2826-e954-4414-8239-e40dbda2ec4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d4e855ea-d410-4726-b489-b6d48ee0646f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:to="loc_us-gaap_LitigationStatusDomain_d4e855ea-d410-4726-b489-b6d48ee0646f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:to="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_5809fbf3-d42e-4e85-834d-c1a51b84124f" xlink:href="mo-20220630.xsd#mo_ClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_ClassActionLawsuitMember_5809fbf3-d42e-4e85-834d-c1a51b84124f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_4fbe874b-15d2-49c0-bc83-792c143c55ef" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_4fbe874b-15d2-49c0-bc83-792c143c55ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_ae98f403-8286-4723-90fc-6e1f909970b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_us-gaap_SettledLitigationMember_ae98f403-8286-4723-90fc-6e1f909970b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember_2b79fd7b-1cb3-4255-a27b-b1035f6cacd7" xlink:href="mo-20220630.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_PendingClassActionLawsuitMember_2b79fd7b-1cb3-4255-a27b-b1035f6cacd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_45db4e65-db95-4b18-af10-fb949c8ff2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_us-gaap_PendingLitigationMember_45db4e65-db95-4b18-af10-fb949c8ff2ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f70c9417-166e-4649-99a6-07e253a5fa89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f70c9417-166e-4649-99a6-07e253a5fa89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e39f49ca-8c93-4e41-b1c7-c74870bbbdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:to="loc_us-gaap_SubsequentEventMember_e39f49ca-8c93-4e41-b1c7-c74870bbbdce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_38719e83-5f0b-4d1b-a2ff-997536de1751_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:to="loc_srt_LitigationCaseTypeDomain_38719e83-5f0b-4d1b-a2ff-997536de1751_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:to="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_19424b74-214a-4cdf-8e2d-e6b11c8e6370" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:to="loc_mo_EvaporLitigationMember_19424b74-214a-4cdf-8e2d-e6b11c8e6370" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_a1f890ae-4c5e-4850-89f5-472e06e0598e" xlink:href="mo-20220630.xsd#mo_IQOSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:to="loc_mo_IQOSMember_a1f890ae-4c5e-4850-89f5-472e06e0598e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53ae6c35-3236-4b7e-af70-eaf17dfa5afd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:to="loc_srt_SegmentGeographicalDomain_53ae6c35-3236-4b7e-af70-eaf17dfa5afd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:to="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_37da7b8b-9121-4811-b593-b78f947382d0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:to="loc_country_CA_37da7b8b-9121-4811-b593-b78f947382d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended" id="i56f3d5db063a4c749ff02ddf970a73d5_ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_131ace0b-f94d-4083-b830-f49efc871959" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_131ace0b-f94d-4083-b830-f49efc871959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_3a6d14d2-3248-4390-a175-cb794638ae76" xlink:href="mo-20220630.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyClassActionLawsuit_3a6d14d2-3248-4390-a175-cb794638ae76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_e27a5c69-ec47-4f3e-930d-d08c86ccdf5f" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfComplaints_e27a5c69-ec47-4f3e-930d-d08c86ccdf5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_536d8722-1448-4e99-b0b6-2d881a782088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_536d8722-1448-4e99-b0b6-2d881a782088" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_a8de4845-82d3-4a36-b8e0-8ffdc8e085b0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_a8de4845-82d3-4a36-b8e0-8ffdc8e085b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_a5b65d63-545a-483b-b8a5-3705ca268081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_a5b65d63-545a-483b-b8a5-3705ca268081" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a132739b-5f40-45e7-956d-9e264794d345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a132739b-5f40-45e7-956d-9e264794d345" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_0cd661f9-c653-47c9-a36a-29921317a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_0cd661f9-c653-47c9-a36a-29921317a89e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_5034b2cd-a47d-49bd-90ff-2bfef78e81d7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_5034b2cd-a47d-49bd-90ff-2bfef78e81d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_ef64e05b-c113-4f5a-ab31-aff3169f9089" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_ef64e05b-c113-4f5a-ab31-aff3169f9089" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b40436fc-3b44-48d9-864a-717d3e00d518_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b40436fc-3b44-48d9-864a-717d3e00d518_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e264a19-559d-46b6-987c-86df052f5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:to="loc_us-gaap_SubsequentEventMember_4e264a19-559d-46b6-987c-86df052f5d0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d0abf301-e2df-4796-a8e1-ef7721dc4f4b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d0abf301-e2df-4796-a8e1-ef7721dc4f4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_7d1bc904-3476-4a60-8165-84cfae1179cf" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:to="loc_mo_JUULMember_7d1bc904-3476-4a60-8165-84cfae1179cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended" id="i7a798ddfd52e4a3ca4df2f6cc07e9d7c_ContingenciesLightsUltraLightsCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_b971be79-221c-4cb9-a225-f866f38ea96d" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_b971be79-221c-4cb9-a225-f866f38ea96d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5919e49d-f0db-4313-9fb6-7777823468e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5919e49d-f0db-4313-9fb6-7777823468e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_a712d65c-8627-44b1-bd93-229ab64067ab" xlink:href="mo-20220630.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_mo_LossContingencyStateCourtsNumber_a712d65c-8627-44b1-bd93-229ab64067ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_01fc5aa3-e96a-431a-b108-354c3673bd2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_01fc5aa3-e96a-431a-b108-354c3673bd2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe87cf58-5284-4a8b-a029-6f8128086963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:to="loc_us-gaap_SubsequentEventMember_fe87cf58-5284-4a8b-a029-6f8128086963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_65895d00-f1cd-4581-9312-4bd19983c121_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:to="loc_srt_LitigationCaseTypeDomain_65895d00-f1cd-4581-9312-4bd19983c121_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:to="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_3952efd1-8edc-47ee-af04-24039735b4ae" xlink:href="mo-20220630.xsd#mo_LightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_LightsMember_3952efd1-8edc-47ee-af04-24039735b4ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_d5cf8277-3101-45e9-baa4-a66d3f2f2491" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_d5cf8277-3101-45e9-baa4-a66d3f2f2491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_61292039-2b13-4352-b47d-738ab9276758" xlink:href="mo-20220630.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_USTLitigationMember_61292039-2b13-4352-b47d-738ab9276758" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:to="loc_dei_EntityDomain_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:to="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_41cd671f-3e60-46c0-b440-c2b1853768c0" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:to="loc_mo_PhilipMorrisUSAMember_41cd671f-3e60-46c0-b440-c2b1853768c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended" id="i75e53ffed0b84af8a23def61247234cd_ContingenciesUSTLitigationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_1eb56bac-a941-4c93-bddf-41c9d6bb7fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_1eb56bac-a941-4c93-bddf-41c9d6bb7fd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:to="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b5579ed4-3dad-485f-92e9-d6982f4abb6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:to="loc_us-gaap_LitigationStatusDomain_b5579ed4-3dad-485f-92e9-d6982f4abb6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:to="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_c311b599-3812-4ec9-babb-6ad8542f54a2" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:to="loc_mo_PendingIndividualLawsuitsMember_c311b599-3812-4ec9-babb-6ad8542f54a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_014d4449-9712-4361-8387-07cfb8ccb3f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_014d4449-9712-4361-8387-07cfb8ccb3f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cbe29a73-536f-4f15-bfa1-0eb1e7867d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:to="loc_us-gaap_SubsequentEventMember_cbe29a73-536f-4f15-bfa1-0eb1e7867d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1f512324-77be-4827-b78c-46017e759e2f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:to="loc_srt_LitigationCaseTypeDomain_1f512324-77be-4827-b78c-46017e759e2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:to="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_e3e783ce-3d55-40de-9a5b-4f0d3f38b342" xlink:href="mo-20220630.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:to="loc_mo_USTLitigationMember_e3e783ce-3d55-40de-9a5b-4f0d3f38b342" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended" id="ief3395dc273d4966996198d8ef0b3d54_ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e9d9d0ac-c0be-40da-a1bb-f2210a76b364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e9d9d0ac-c0be-40da-a1bb-f2210a76b364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_6baaca03-4e77-40d4-9aca-12835d6f2fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_6baaca03-4e77-40d4-9aca-12835d6f2fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:to="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9dcac4c1-874b-4f4a-842d-967fe8b32775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9dcac4c1-874b-4f4a-842d-967fe8b32775" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cab5e12f-ff23-4ffe-96fd-d773694289b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cab5e12f-ff23-4ffe-96fd-d773694289b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_4397f7b9-64bb-40c2-a53d-c754aee1f66a" xlink:href="mo-20220630.xsd#mo_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:to="loc_mo_CreditAgreementMember_4397f7b9-64bb-40c2-a53d-c754aee1f66a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_89b66ed3-8ef2-4c98-b7dc-70f3361110de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:to="loc_us-gaap_CreditFacilityDomain_89b66ed3-8ef2-4c98-b7dc-70f3361110de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:to="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bced07ca-2db3-4cd9-a592-2f470f97748f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:to="loc_us-gaap_LetterOfCreditMember_bced07ca-2db3-4cd9-a592-2f470f97748f" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>mo-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_mo_InvestmentsLineItems_6be18bb9-11f5-469a-a27d-f475a58c5c93_terseLabel_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_label_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_documentation_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsLineItems" xlink:to="lab_mo_InvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_6cdffb03-34bd-4c77-bfb7-8984081c914f_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, consolidated EBITDA to interest expense ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_label_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_documentation_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:href="mo-20220630.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:to="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_3fcf5da0-50d8-49a0-82ec-37e6e0e429a8_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e154cc58-9ab2-4a25-958b-3dda04f5a491_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_785a3ab7-777a-4662-a548-15450766bf31_terseLabel_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock" xlink:href="mo-20220630.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CashDiscountsPolicyTextBlock" xlink:to="lab_mo_CashDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48d55d4f-13d7-46f2-b458-89eedae0183a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_67c2dbbc-971e-4ab1-898c-28d274067450_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3fc9e91e-941b-4c43-b017-77ccd09bcab0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b4145e3c-863a-48b5-9b88-b46e894cbe70_negatedLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_1b4d0263-44c5-4269-9231-d41e787cc4a9_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_62fe7ffa-dbf4-4ce6-ae59-f45f7cb4cd9e_terseLabel_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_label_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_documentation_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:href="mo-20220630.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:to="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_28a47e08-960b-4a56-82e4-aa380f857e6a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_4bd71850-5680-483b-8069-0b35ba1e988d_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_015206fe-54ca-4dd4-a970-cb77be46045b_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_dfbbf29f-695e-46e2-9910-9cb528bbe786_verboseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares owned (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_a474d54c-58df-4bf8-b927-87d2e770845d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_ed06342d-cf1b-4514-a6b4-9c8ed21eae54_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4e8f7ed7-1339-4c03-aa2a-450811256469_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_7acd27ef-b8d8-4920-a5f3-5e85f469d7b3_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSchertzerMember" xlink:to="lab_mo_EngleProgenyCasesSchertzerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_02001ff3-25f9-437b-8c2f-a3ea1a048638_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_label_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_documentation_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:href="mo-20220630.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:to="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_b71b7053-4090-42a6-b6c9-bbf451bec669_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases with set trial dates</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Set Trial Dates</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Set Trial Dates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:to="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_b23b3bea-dfed-43bd-8550-5faede12569e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_e07b9be3-e53b-4857-be1b-6dba5e91b116_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_641a8ffa-fda0-47bc-807d-31b5a1495920_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit line available under the agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_e4289f98-bc92-4f3c-9531-8fdbf8090c4e_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember" xlink:to="lab_mo_HealthCareCostRecoveryActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e9f69041-a9ad-440c-b817-599f2b344c28_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_39d4934f-8dba-44eb-a76f-8a20e113efd8_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f5f2a9f0-1dc0-4566-b68f-55621fe5e84e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_04df5f84-5230-4c1d-8644-d02cf55ceaf0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_704dc9df-cf69-486a-a4d6-d15228e9b736_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_40cf20d9-4ba8-4735-8640-12545a2e0df9_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_9e46f23a-ea92-4bbe-a5c1-beff5e7286e2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_d4e13b2e-177c-450b-bfa7-a23d579f539c_terseLabel_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_label_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_documentation_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:href="mo-20220630.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:to="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_c885487a-70ee-44c7-843f-f8aba3ff4f8c_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of favorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_9bc86748-e4dd-4f43-8632-4cc01ad065d6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_1f479951-453d-4104-9913-9a3220719731_terseLabel_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity securities without readily determinable fair value</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_documentation_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:href="mo-20220630.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_f958ee12-ab35-4394-b63c-a16979a2e281_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to valuation allowance charged to income tax expense</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fe977868-db01-4bce-8abb-8c6f701c17c0_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_41813e13-76f1-440d-9f45-91a4f99ef9f5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1b7804fe-0870-4fda-8eb2-4e10ffa73e49_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_e9bc0d6a-c8ba-4e06-be01-ce73e08d31f7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5e98fa5a-249c-4c7f-95bc-47e4414d31f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7bd41227-1ad5-41ac-a152-6929b5ff9605_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_9bdc4eee-fb20-4400-b146-671cf44e9074_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_70630f6b-9114-4ab4-b139-cc8f8ea8aa1c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f61313ee-9481-4f18-ada2-2374a0b6799d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_7a4f26a0-f95e-4d0b-8388-e46bbce74310_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_88afc503-9be4-420b-bd86-f2f8cd2c5c10_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_label_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_documentation_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:href="mo-20220630.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:to="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_d02229a8-d257-42a7-be33-4efc3175a9b1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4dfcf688-0c8b-4b5a-a306-1d62c919c6e2_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_400b0422-6f39-4772-aa2e-d4fb07d70588_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit (income) cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_29f333e5-c484-4c27-a811-a8fe11f34b54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_cb54598f-75dd-49da-8a56-b3f137312653_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7657d325-12d4-42b6-990d-c85db0db0507_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_fe0b6501-87bc-49b9-9fda-a918aea2bbb8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AltriaGroupMember_1acecbd2-fe72-44be-970a-3cd4d1497110_terseLabel_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_label_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group [Member]</link:label>
    <link:label id="lab_mo_AltriaGroupMember_documentation_en-US" xlink:label="lab_mo_AltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember" xlink:href="mo-20220630.xsd#mo_AltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AltriaGroupMember" xlink:to="lab_mo_AltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_41438a96-ffce-4955-abd2-aa510f05a7d6_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_a3c4c687-4dec-4f27-9535-f42c77e9996e_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, percentage of shares eligible for purchase (approximately)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fab3f20c-7883-4d91-8516-0501107c85ed_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_4ce18eee-e760-4abb-86cb-aa6c86f86cb6_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfComplaints" xlink:to="lab_mo_LossContingencyNumberOfComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_93286c43-8fa1-471b-99ae-805990829ff6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_fea02590-4b24-49ec-8278-df594ba3d20e_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_35718a59-2a7b-4168-9bdf-39780cb09141_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_7cd60614-91f4-4006-8dce-536ea897981b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesChadwellMember" xlink:to="lab_mo_EngleProgenyCasesChadwellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_fbc979cb-16f5-4c00-b129-f9011c75ab40_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WV_92844644-58eb-4959-9262-be15d2245cd1_terseLabel_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Virginia [Member]</link:label>
    <link:label id="lab_stpr_WV_label_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WV" xlink:to="lab_stpr_WV" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_765e7651-d999-49f2-accb-d788e46153dc_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_af497cf9-5e02-4e74-a55b-c79bb236191b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_7ecc845f-4164-4176-bc66-5029c948aa37_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHollimanMember" xlink:to="lab_mo_EngleProgenyCasesHollimanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_28b0b51d-70a3-4cca-accd-ed9f74b75ada_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_41735bbe-14aa-45a5-ba37-2d197ffa2f0d_terseLabel_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments, fair value option, voting shares (in shares)</link:label>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_label_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Fair Value Option, Voting Shares</link:label>
    <link:label id="lab_mo_EquityInvestmentsFairValueOptionVotingShares_documentation_en-US" xlink:label="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Fair Value Option, Voting Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:href="mo-20220630.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:to="lab_mo_EquityInvestmentsFairValueOptionVotingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_075aa029-5956-4649-b432-7bbbbef931cf_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_58403ac2-c4fd-4100-a0de-9c4d10007942_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases set for trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_label_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:to="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1b903447-3290-4345-8207-084ad395009b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_b228f7f7-c883-41ab-b4e8-d98473a5f65e_terseLabel_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of state courts</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_label_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyStateCourtsNumber" xlink:to="lab_mo_LossContingencyStateCourtsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationCasesResultsMember_4a706969-5eb0-4413-85fb-b7089422f67b_terseLabel_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health and Certain Other Litigation [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_label_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_documentation_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember" xlink:href="mo-20220630.xsd#mo_LitigationCasesResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationCasesResultsMember" xlink:to="lab_mo_LitigationCasesResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodOneMember_659a0c62-f94c-42a1-854c-d3acef836a35_terseLabel_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_mo_PeriodOneMember_label_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One [Member]</link:label>
    <link:label id="lab_mo_PeriodOneMember_documentation_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember" xlink:href="mo-20220630.xsd#mo_PeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodOneMember" xlink:to="lab_mo_PeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_0b8e7888-7d4b-4bc6-9021-1e90fa2efa75_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9f1a0b25-7429-40c7-bf84-c61ae5e0914b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7bf43bf4-147f-4951-a50f-748eaf2280f3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f766eafe-9864-486b-abce-05d3cad6314e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_fbd2f5ac-d251-4c2b-9578-ea805146ee3e_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_ad68f687-1167-4410-91cf-e8d85d3f7ee4_verboseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_fda214a6-ea09-403b-b216-4a11ae49b4b2_terseLabel_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded to other party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_label_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_documentation_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty" xlink:href="mo-20220630.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AmountAwardedtoOtherParty" xlink:to="lab_mo_AmountAwardedtoOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4fe0c728-e463-463a-be1c-3f241015bfae_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_70e9ea7e-7005-4643-aa8f-ea86673e25d7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pending claims, consolidated for pre-trial purposes</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_label_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:to="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0167b82d-b885-4bbd-b4ea-136a3e51167b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_20e6dda6-ac9c-4317-9f63-2e196dd9cc13_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_f166343a-4d22-4dc1-b757-123279d75d28_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of pending cases consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:to="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_2070a54d-b60a-4792-a7dc-72443b6ffb75_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_label_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:label id="lab_mo_ValuationAllowanceRollforwardRollForward_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance Rollforward [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward" xlink:to="lab_mo_ValuationAllowanceRollforwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_695b44b6-0765-4275-8901-405a2e83180f_terseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_label_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:to="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ef69134a-098a-45b9-a94b-c539eebd3780_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_d6020c25-d728-4ccd-a43a-520df3f6eae5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated additional employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_4a4de02c-686c-4d70-9153-31a7d3fb69f6_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesD.BrownMember" xlink:to="lab_mo_EngleProgenyCasesD.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_9b622881-5f71-4c15-b17f-b4b6dc8f5afc_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that cap bond or require no bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:to="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IQOSMember_3fcb981f-4011-4719-bed0-58e530d8ab0e_terseLabel_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS [Member]</link:label>
    <link:label id="lab_mo_IQOSMember_label_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS [Member]</link:label>
    <link:label id="lab_mo_IQOSMember_documentation_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember" xlink:href="mo-20220630.xsd#mo_IQOSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IQOSMember" xlink:to="lab_mo_IQOSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_7b738fad-5cf8-486c-b05a-2e102164278b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_55f54fa8-690c-46f9-8c79-b6e9456bf6aa_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_bc60e35a-ecd2-4b39-9300-6aac819d3f6d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of additional states extended with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_013890f2-ca7f-46ca-b809-80d5da559400_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_44b534a3-fcf5-4823-8124-5768f7578c73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in obligation, pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_19195eb7-5c7c-4070-8900-4c6290166787_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bd206668-07e5-417d-a804-f8f20abc1b4d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember_7770f8f3-78d7-42b8-917e-821212177983_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan (McLauighlin) [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanMcLauighlinMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:to="lab_mo_EngleProgenyCasesKaplanMcLauighlinMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_c71ecab9-531a-4520-906a-ae8bf1eb6760_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2169d127-015e-4d41-9286-8fd547563774_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b7b91e2-bf35-40ed-80f7-dd0d23f44df9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_7b171ece-59a1-49de-9279-4d8a56b6ba84_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_45f83cc4-085e-4c76-9227-76a236128020_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_ce5b9493-16ae-4bef-85c4-f159be8e942d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7d4a41f5-5039-4e9e-af3c-87eb98979a86_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e01ba76b-699c-4584-83bb-e2454f4e8677_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_40c85d7f-c094-42c4-9506-8d4c3d5e4693_terseLabel_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_label_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2024Member_documentation_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:href="mo-20220630.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:to="lab_mo_RevolvingCreditFacilityDueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_1d3fbbcf-b3ad-4f14-9b25-85efd34167ce_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesStateMember" xlink:to="lab_mo_EngleProgenyCasesStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_17ae62a1-c9bd-4189-ba35-2528d45ef410_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofManufacturers" xlink:to="lab_mo_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_3c740b04-31fe-4202-b8e9-d4ff0355eb42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_4c11b6bd-8d6e-43f4-867f-592e325ffa6e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_cc4e671a-269d-4792-8dff-da5686307602_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes on products</link:label>
    <link:label id="lab_us-gaap_OtherCostOfOperatingRevenue_label_en-US" xlink:label="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost of Operating Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostOfOperatingRevenue" xlink:to="lab_us-gaap_OtherCostOfOperatingRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CreditAgreementMember_92f5a73e-7bcd-4193-8dd0-f12e7d755691_terseLabel_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_label_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_documentation_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember" xlink:href="mo-20220630.xsd#mo_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CreditAgreementMember" xlink:to="lab_mo_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7ed4c7c0-a1c8-4d3a-acf3-801f9367f023_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_6d88dbd5-b7ce-4c31-9516-f06be0ce00b8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ed7ba91f-852b-4a28-a5c1-2c6056620af4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_bf32ed9f-e9e1-49ba-81b7-ea4cf9511636_terseLabel_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_label_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_documentation_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member" xlink:href="mo-20220630.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock3.125NotesDue2031Member" xlink:to="lab_mo_CommonStock3.125NotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_fc5d24ce-5d91-4f0a-bdfa-cc3f9cace50e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_35171a86-fa91-4018-9658-be6608af776e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) included in (income) losses from equity investments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_8520e1c8-49b8-43dc-b0a9-ebe768843c9f_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_935ac186-d057-4aba-acbd-544fe394e1d5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_d82c5509-e1c8-4675-a480-14b4a3ab8101_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3186eeda-cedc-4e4c-8fad-224995306cbe_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_d929ed31-ce11-421d-aa08-0820c4576dac_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JUULMember_6f90e3aa-455c-46de-b5dd-59c4c6344393_terseLabel_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_label_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_documentation_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JUULMember" xlink:to="lab_mo_JUULMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_f202605f-53d6-420d-bbc5-7b1984b0a705_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class not certified</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3c156cf3-c020-457d-825c-2a1dcf4bd377_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e737e61d-7c8e-402f-884f-40b25870e426_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_52ad1f22-5ba7-42f3-a63b-211b442cde69_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_0daa1e8e-0034-40b0-b4a1-46cd9decf7d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d707b1e6-20fa-44e7-9c6b-56029e04af40_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_95ff6071-07e2-4b96-91da-a05684774642_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, credits to offset payments</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_ece72942-6536-495d-ae05-fec988eff9f7_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount ordered to be paid from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3f56ea21-e398-4150-a361-41a4279185f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_e8266e35-11e4-42a2-b188-53f3c0d9282d_terseLabel_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_label_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_documentation_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember" xlink:href="mo-20220630.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CanadianTobaccoManufacturersMember" xlink:to="lab_mo_CanadianTobaccoManufacturersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_ad07b484-f656-4175-80b3-735022d5e667_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, contributions by employer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodDomain_4b1cf3a4-45e9-4b16-a5e0-405e77888180_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_label_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodDomain" xlink:to="lab_mo_ArbitrationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsTable_ea2b1ea8-f357-4ca4-84ec-38fdae284e39_terseLabel_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_label_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_documentation_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsTable" xlink:to="lab_mo_InvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_563ae062-9f01-4586-96f8-01d78cd42d80_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6ffdb430-8c85-42f1-b4de-a72d56196be5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_dba9e0a9-cfc1-415e-b833-22ca5b443621_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_8d1d0c39-3c9d-4b7f-a1f8-672834ce0307_terseLabel_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_label_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_documentation_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:href="mo-20220630.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:to="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c88c0f8e-f85f-40fe-8d83-a8c261bc9b6e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Planned share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_998b1e16-1af9-482c-a270-9af8e79708d7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96ec7de5-57ef-4d1d-9cde-e2437990bc67_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2ee4327a-ba15-45c6-b75b-eabceace1793_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_93afddf8-d1ae-4bad-8431-644945b7b078_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_e4b398de-5195-4a7f-962b-074db80afbeb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_3db0e112-0185-4f51-9c8a-22a91649db25_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_4b77e414-b9ad-4421-bc46-1503d2300d17_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0d19e8a6-8176-4519-b2e6-9cedb67fd50d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_0600e7db-1f1e-48ec-a4f6-04833c478232_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_d3fc86f5-7548-473d-b624-a10220905989_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AR_2b8e4537-ee72-4f07-9b02-b71e5dcfecb6_terseLabel_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkansas [Member]</link:label>
    <link:label id="lab_stpr_AR_label_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AR" xlink:to="lab_stpr_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0c397e39-9835-4bdf-9896-643001849dec_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_fb4162f3-cb85-4655-8215-a0639b9f23b0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, claims settled, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_d4cc7006-6bdb-408b-9803-83daa2590afe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AK_c9e95a5a-6e0e-411d-93e7-399032a3a49b_terseLabel_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alaska [Member]</link:label>
    <link:label id="lab_stpr_AK_label_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALASKA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AK" xlink:to="lab_stpr_AK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_46e7e4f0-d29f-467f-b8b5-c00729face55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e0ef90c4-313c-43af-9e6e-7e6d7a4d42ab_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3d426634-6ecf-4719-b993-7c842e0a9935_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_872b8983-fdd7-4469-affd-827036025d9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt, premiums and fees</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5ef76ee0-b7cf-4dc2-8dc4-73bb6e971b53_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_70e4fa82-9520-4947-88f9-459520d2d617_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9ff67a0b-4ffc-431d-a795-d3bdc503f26e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7fd4af66-fefa-4c05-bf14-b2d0444995b2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_b3e802e8-16b2-4cb4-9ac7-5e8476f6acb2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_label_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictsUpheld" xlink:to="lab_mo_LossContingencyVerdictsUpheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_174f2c60-6786-4433-8b70-1428f3a14b02_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LightsMember_8b7cd7d0-1a04-4e5d-ae3d-1a7cd987c86d_terseLabel_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_label_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_documentation_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember" xlink:href="mo-20220630.xsd#mo_LightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LightsMember" xlink:to="lab_mo_LightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_94271ee8-4ddf-434e-a620-2326f902ebad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments and Other [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_61e8ee67-4275-4a20-9faa-d63b7cc76e14_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, warrant exercised, ownership percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Warrant Exercised, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:to="lab_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c095d066-cfdd-42fa-b7c5-5552c9afab03_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_482a010e-e7a3-4b8f-9c38-4e5bb2059369_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_79063076-f391-4e9f-9439-b02deaf4301f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b132f9bc-e2fd-4691-9844-6f43507e672e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_26adac7e-a8fc-407f-acc4-54478557007d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_516138ba-121c-4bc5-a9c0-08f030d8cfbf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_e2767eae-08b3-4477-ae05-c0e9e98d8654_terseLabel_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued settlement charges</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_label_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Settlement Payable</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_documentation_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the period in Settlement payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:href="mo-20220630.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:to="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_151b5d27-f039-4123-9d1f-7da6a310d1b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c8a72b7f-4473-46ac-8eaf-25827f2537f6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_2fd93896-749c-43cf-bc25-1c1733af467f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCooperMember" xlink:to="lab_mo_EngleProgenyCasesCooperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_946d0f08-50e7-4641-ba5a-bb294a6412dd_terseLabel_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_label_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_documentation_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:href="mo-20220630.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:to="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_36ef03ac-e035-491a-903c-dc31c5358244_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares eligible for purchase (approximately) (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d572f4a1-aa90-4680-8c59-6dd8f1cd80c1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_471f207e-c3d0-4090-9bc8-4391632d0235_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_077ccf03-9b9b-4d17-9fca-2e8ded6a846b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7e772155-89ae-479d-8f5a-c8ba0cca11ca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_0b57c40d-cf3b-4dbc-8813-2c3ac93f6800_terseLabel_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_label_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_documentation_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:href="mo-20220630.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:to="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f04b86dc-45d4-4156-b9f6-43a7b68db3db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_d84457c0-6c4c-4c3f-8815-a22b5507b85a_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_25705046-cb4c-4b88-8b7f-b2b4e467711e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_181b0318-ed51-420b-a5c6-fdd009e9af4a_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_da333c34-3110-4b8d-817d-600ed5c67d2e_terseLabel_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_label_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_documentation_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:href="mo-20220630.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:to="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cada0e43-0682-4735-acbd-dff2b415a6c0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bd1b3168-2698-4357-8b84-78bf602a3133_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_2ee7cee8-a98c-4999-a23d-b74a407c5d69_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_label_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:label id="lab_mo_DebtInstrumentExtensionTerm_documentation_en-US" xlink:label="lab_mo_DebtInstrumentExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm" xlink:href="mo-20220630.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentExtensionTerm" xlink:to="lab_mo_DebtInstrumentExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_dcf8a8e5-78ad-4ffc-af59-d050fc0fb3ef_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share of shares repurchased (usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_e2876e3d-1c88-40bf-8fa3-cd0ca9fd2834_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:to="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_bf9a1005-44dd-40e7-8ce7-43cffd03de2b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_04f5dc4f-c9f7-4fc7-ae99-a25a96a33802_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1f81153b-01b2-4c18-85a0-7314cf202ba7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_03416b14-b40a-4e44-9f11-7be311aca452_terseLabel_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third party lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_label_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Third Party Lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_documentation_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Third Party Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits" xlink:href="mo-20220630.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberOfThirdPartyLawsuits" xlink:to="lab_mo_NumberOfThirdPartyLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_161cd5bd-587c-4554-9e91-24a07cb89983_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada [Member]</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_a5246027-8418-48a7-a1ad-757593f09fad_verboseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_b4a71e91-1f33-4c7a-bd9d-ce6b290b18d2_terseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-price Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_label_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_documentation_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:href="mo-20220630.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:to="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b640121f-151f-4c4e-a3e0-7c09aa4f2eec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_b57c4980-dbfe-4d94-88b8-44433df8df65_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount expected to be awarded from other party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_label_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded from Other Party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:to="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_c3122555-9d7a-40de-a05f-a6229d1fc9e5_terseLabel_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_label_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking And Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_documentation_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:href="mo-20220630.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:to="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_36164920-b37c-4170-b2e0-42eb1bf0292f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:to="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_9d660de4-4181-400d-a125-53a39a52c198_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_8f9cf338-8aa7-42db-b439-f9c3dee05f0e_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_518db78e-c367-440b-aa32-06efecd19876_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_1d66214f-a15d-45e5-be9e-f007a30ee681_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of restricted shares owned (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_9451ce7a-d225-4490-97e7-47bac81fb5cf_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_03b94461-6953-41cf-b077-65b771740fda_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0204ef34-1da6-489f-aaa8-10f1e5e39094_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_90ab76a8-9d93-41a3-ae62-9396a600c30a_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_7a5ef6de-4016-4a48-81be-cb2540eaead1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement health care costs</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Postretirement Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1afd8f84-160f-487f-bf62-a668b3835888_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_d4b5c70f-eeef-4013-966a-dfe4e56ebec7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims not certified, number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_66a2079e-d806-4c85-8f1e-d238f772deba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and fees related to early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_59c19cd6-c7de-4d40-b41f-f36b46b11f3e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished product</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a7133829-b888-4d5e-8713-5e95b75040d2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8f232e53-3ecf-4044-b49a-f37e3c4bdcea_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8dc4e006-ed80-4248-b159-249ba639e0c2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_b1945021-234c-49c8-b293-66d7de65efe2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_b6ab415c-dda1-4e8d-a143-22ac4a84de32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_edca8275-d4bf-4b19-ace2-56d7a26bfb99_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_7ca0e74b-b122-44d9-9a28-b8c7817f791a_negatedLabel_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed earnings attributable to share-based awards</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_label_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_documentation_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:href="mo-20220630.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:to="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_699dda0e-d7b1-407f-a2cd-b71bf52ca8b4_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_862ab15d-a60a-4c6d-887d-388e090babbb_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_afc1cd4d-90a6-43a1-8044-e7827aa37d27_netLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate expenses [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a54dfb06-845c-4281-b84e-d295bf4c232f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_a42ce5a5-c79b-479e-a00c-b9b121706e6f_terseLabel_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember" xlink:href="mo-20220630.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_January2021ShareRepurchaseProgramMember" xlink:to="lab_mo_January2021ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_cad54bd3-9db2-4c6a-a0d3-f409c15d34ef_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGarciaMember" xlink:to="lab_mo_EngleProgenyCasesGarciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_6b5528e2-a845-4f88-9fe5-ee3ad2fe4f41_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Repurchased Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_8a07d3ef-80b5-4f81-9e83-52529123e4e7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5010c60e-585b-474e-9da3-6385d618bd5d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_ba5f34ba-42b8-49ac-bd8a-89695deee27b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMcCallMember" xlink:to="lab_mo_EngleProgenyCasesMcCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_a157d815-efe5-4848-aa72-3670f8eb2593_terseLabel_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other raw materials</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_label_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_documentation_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:href="mo-20220630.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:to="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodAxis_e296c97a-5555-42c3-9368-1ff99e3e505a_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_label_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodAxis" xlink:to="lab_mo_ArbitrationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_c9bf0192-7713-4182-9a45-978419d86f74_terseLabel_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims with unfavorable verdicts pending/reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_label_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_documentation_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:href="mo-20220630.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:to="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCases_a4ac5dab-a780-4578-b89b-e3991f84f1c5_verboseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCases" xlink:to="lab_mo_LossContingencyNumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_a2cf70b1-982e-446c-8c95-f967981dda0c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a911c36e-a5cd-4377-aeb9-f9420b61c36d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d3edab18-6617-4f92-8a16-531c866d91fa_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash effects of changes:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_0952dcc1-55fa-411e-b996-37e70cd9fdd6_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFreemanMember" xlink:to="lab_mo_EngleProgenyCasesFreemanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_df172264-5415-4a2f-89c3-1e47f70f60ef_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Reinvested in the Business [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_51b299c2-929a-4e8c-a10e-abe319185fcb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_fa355e6e-5f48-42da-bab0-f2145310c0e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_e7b23642-f22c-4f95-a890-af09b3daf755_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) related to litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_99cccf27-5c72-40cf-a5c3-a890307b8690_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_00e2cb28-0291-4553-8123-ce35dc75ff88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0b08a0e1-65ac-46f3-b747-32cc5b2481c1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_33820d21-0b64-4d60-8963-da5268afa8d3_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_1ef3afed-7d66-4726-8409-c87f5b255496_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_0a63c22d-04e6-4fac-801b-ed3ee8b5ff5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_09871094-458e-4700-b386-11feb03f7fbe_terseLabel_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaf tobacco</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_label_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Plant Material, Net of Reserves</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_documentation_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:href="mo-20220630.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:to="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f252fa04-832a-402d-99c5-c37317795c6c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_8ade7bc8-01ca-471d-b9ff-502dd8346b18_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_add0b4d0-cff1-4c4f-aae5-37cee98db577_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_b5351c3e-fcf4-4e48-8843-6e99475b4784_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_f06d6ab4-ce87-4367-b1cb-7b49605721b6_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida [Member]</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_3fdd4fa3-d3b9-4962-b71e-b295df1a68f1_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with settled litigation including New York, subsequent expansion</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_f4fd6355-631d-46ed-a81e-177f5e2bd63c_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts reversed</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_label_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictReversedNumber" xlink:to="lab_mo_LossContingencyVerdictReversedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_c5ac3052-96b2-40b7-a10e-d7cf58d812f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_3442c5de-cf76-44e9-809e-247e02fb0aa0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6f72f651-5abd-4754-87e4-f4eb1fee5341_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_732af6b3-ca20-4286-9d2e-6e2831eb8a54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss Recognized in Net Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_d4c4083c-9f17-42bb-bd57-4bc79201c190_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of shares repurchased (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_c8b7167f-338b-4e8b-a64d-c881615512fb_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_e855c7d9-d38f-4dd5-866d-0ead74d41824_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_db1c1fee-d5e2-4622-ae0a-6d20ef1e115c_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings reinvested in the business</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_c7f567e9-abc1-467a-bfa9-7f4ca103221a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_808945c4-dd2b-439d-bcbb-7300bf24cd4d_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_29b1d2a4-95d3-473c-871c-9019a73d5479_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_61436125-de64-4604-bc83-07de9dc4f66f_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_cb3f9143-b72f-4a79-9d5f-6a8966c8b41c_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_1e627727-0db4-4042-ac2f-ac28834e0549_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_af1b094f-3520-483b-9e66-9989c5dd7e37_verboseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CT_1c8d9999-87e6-4ead-8fa2-563960d92c8b_terseLabel_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Connecticut [Member]</link:label>
    <link:label id="lab_stpr_CT_label_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONNECTICUT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CT" xlink:to="lab_stpr_CT" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6a54f4aa-981a-474a-9de1-c283dab7724c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ff9eded2-a338-4114-96ad-e97d955c7e19_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_09ce319b-6d2d-4b9a-a5cf-87523d9a3b24_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_a006e3a0-e8f0-4fd9-9378-47f142fd5fec_terseLabel_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_label_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_documentation_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember" xlink:href="mo-20220630.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherTabaccoRelatedCasesMember" xlink:to="lab_mo_OtherTabaccoRelatedCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_e60b3310-9faf-4ab3-acb9-10d9b1e7123e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_11b46975-27e0-42f1-bf00-a1ba6d42efbd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_a080d819-3c21-4e40-a41a-09a2ea3e5cf3_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California [Member]</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_e1232388-e2f7-44f2-b188-8e368237e291_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_4ede8999-812c-4ecd-af42-12a9711bb844_terseLabel_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares, lock-up period</link:label>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_label_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares, Lock-up Period</link:label>
    <link:label id="lab_mo_RestrictedSharesLockupPeriod_documentation_en-US" xlink:label="lab_mo_RestrictedSharesLockupPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares, Lock-up Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod" xlink:href="mo-20220630.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RestrictedSharesLockupPeriod" xlink:to="lab_mo_RestrictedSharesLockupPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a4f308a0-ed21-4b6d-9e81-a577504e6915_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_090c6d33-22c9-4b57-ab1f-6d81598f6947_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension provisions and postretirement, net</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_3be065f4-16d3-4e34-a370-83ae2e402587_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, service agreement term</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Service Agreement Term</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Service Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ec99b04f-09b7-43b2-9b73-821461bf5ffe_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Losses [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_e555c1ae-ed84-4ac3-9901-667e92c57dd1_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings/Losses</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_980660e9-6475-4208-908b-695e5ca1ae74_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_492663e4-196f-4eb6-ae5e-cced54ecd9b3_negatedTerseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions to valuation allowance credited to income tax benefit</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Decrease In Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_17469d69-830f-400f-aa69-e35c2cc9359a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fe159bce-dcb4-4ffe-bc84-e2b225a684c3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_e5c104bf-4cca-471b-a930-05efef1cd5c1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4859c6a5-f34c-45ae-83f6-3807f1382609_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b70c92cc-b6cb-4430-82bd-b9e94e355c6f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_256c5e2a-8eeb-44ad-9967-ad52d27a5cc3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b82d9005-4fd6-4379-b883-57ec71f771a5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_146fe99c-b443-4064-9753-d73baaf06cad_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:to="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_1c26414d-0757-4332-88cc-cbffab94050b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_c7524c4b-92cf-4245-b79b-a9c627f60078_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c4103b5e-099d-4802-8af3-c591201fb2a7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_8aceb816-598e-42da-82fa-6cc880d35e38_terseLabel_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement charges</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_label_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_documentation_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent" xlink:href="mo-20220630.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccruedSettlementLiabilityCurrent" xlink:to="lab_mo_AccruedSettlementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_3bba5af4-5888-455f-9a7d-2512ba460762_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DE_e7b31bde-0a27-4d37-81e2-9b9223cbd71d_terseLabel_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware [Member]</link:label>
    <link:label id="lab_stpr_DE_label_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DELAWARE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DE" xlink:to="lab_stpr_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_31dcbbe2-750d-4378-8ed2-3262844bbbd0_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DC_54f5e114-4b80-49d3-8f46-b3341b11eda9_terseLabel_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">District of Columbia [Member]</link:label>
    <link:label id="lab_stpr_DC_label_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISTRICT OF COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DC" xlink:to="lab_stpr_DC" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_4a356478-81e1-47ae-86b3-193ae0e22566_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, ownership percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_7c7add22-23a0-4c84-9a45-e8074f34e49d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:to="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_a53ceb61-f122-48bf-82f9-423c3f0d6ffb_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7028cf29-792d-4e26-b7b0-5a2b941f801a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to operating cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_6d114d8e-2874-4a2a-a585-e9599b2b7df0_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_286ec345-e0b2-4da8-b9f2-7fda3cf13174_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_9def02c8-6d35-4e5c-b9d6-62b837cce7f6_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_label_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member" xlink:href="mo-20220630.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.700NotesDue2025Member" xlink:to="lab_mo_CommonStock1.700NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_58843c70-14e4-4f55-bca0-c24f39f41f2b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6de1312f-52a1-458f-a791-25721966e503_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c39c175e-ac73-4d94-ad85-5d6490a7a5bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_43003917-5627-4882-9825-b754daba6008_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_d05f878a-bad8-4a9e-af4f-287adff4c7f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7e2aa71e-8e05-4b8b-9538-6d9bd82acfe9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a0468621-686f-464e-87ea-e8ab05b53bed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_bbc61dd9-6631-49cd-9f50-cd6012fa61af_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected period for satisfaction of performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_668f0ea9-b35f-41e8-981b-cdc825be7a8b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_31ef779b-2f6d-482d-abfc-136fbf263094_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3e5531c8-9c3f-4b48-b75c-d058b631f627_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_3d4e6a57-6774-44ac-93aa-83993db17fb9_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims resolved</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsResolvedNumber" xlink:to="lab_mo_LossContingencyClaimsResolvedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_53a3cd08-a976-4215-a8c3-e48261f2d616_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ba49091c-512b-4deb-8ab0-0f6b810c06df_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c21d2ad-fb33-4f76-b053-a4681b76b110_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_893442c7-34df-426a-a4e7-1ac278e19946_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodTwoMember_a3fa4d60-2565-4182-9b60-904554dbef7a_terseLabel_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_mo_PeriodTwoMember_label_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two [Member]</link:label>
    <link:label id="lab_mo_PeriodTwoMember_documentation_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember" xlink:href="mo-20220630.xsd#mo_PeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodTwoMember" xlink:to="lab_mo_PeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_398b97cc-61e3-4ed4-a825-e392c067c68b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IL_88759d56-6fda-4f14-ae33-f5662db42026_terseLabel_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Illinois [Member]</link:label>
    <link:label id="lab_stpr_IL_label_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ILLINOIS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL" xlink:to="lab_stpr_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_60d03d24-95dd-4035-a686-9ef66ecfc9ed_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_c1c01caf-4712-4ad8-b827-d1d259ffddb7_terseLabel_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_label_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_documentation_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokeableProductsSegmentMember" xlink:to="lab_mo_SmokeableProductsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_051b2d8a-4730-4bef-a438-23795118c07f_terseLabel_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_label_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_documentation_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:href="mo-20220630.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:to="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_8f60b071-d624-43b8-908d-5c649eb2cfc8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_81b2efd7-48f0-4078-9ebc-5aa8fe94d998_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b71e91de-7672-44e1-b668-b444299f0b49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_dc4c7c4a-30ef-4436-98a5-30f5d12350ec_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:to="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OralTobaccoSegmentMember_8b15ba9c-f417-4a84-aca7-d655fab3d0ed_verboseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_e99daae9-6f3e-4e9c-aef1-1af5ea4c7d41_terseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_label_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_documentation_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember" xlink:href="mo-20220630.xsd#mo_OralTobaccoSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OralTobaccoSegmentMember" xlink:to="lab_mo_OralTobaccoSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_f619c00a-79ab-416e-917f-f734ccd6f100_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_87ca6f1c-84f7-4f5c-89bf-de4c01596b8a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled, arbitration period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled, Arbitration Period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled, Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_afc52ab9-a4fc-4646-ac5e-190e23638e10_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities ($451 million and $1,720 million at June 30, 2022 and December 31, 2021, respectively, measured at fair value)</link:label>
    <link:label id="lab_us-gaap_Investments_6505bf07-71ac-435c-a0e6-4815257b0137_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_b7c6c620-c353-4f27-a55e-6ee634cc548e_netLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement interest expense (income)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementInterest" xlink:to="lab_us-gaap_LitigationSettlementInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_bb4d670b-9484-4f3a-afb6-b56774f5810a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9b34795d-c11f-4c4f-aa5e-e5a4145867a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_69245b0e-803e-4557-b8f7-94636a87b6f4_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFederalMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFederalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Federal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFederalMember" xlink:to="lab_mo_EngleProgenyCasesFederalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_5c574d48-c6b2-4458-aab7-077992cfcb9d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, period for decertified class members to file individual actions against defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_label_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_documentation_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:href="mo-20220630.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:to="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_e659342f-5d4c-4dc5-926c-d9a6788ddef0_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, administration and research costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_label_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, Administration and Research Costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts" xlink:href="mo-20220630.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationandResearchCosts" xlink:to="lab_mo_MarketingAdministrationandResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_fedb46b6-58ce-4105-941a-44d4af9cbc31_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesMember_53593d3c-67fd-4074-9ca0-a7ef681f2292_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesMember" xlink:to="lab_mo_USDDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_48901aab-47c8-472a-ad24-179bc08d9bbb_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant And Equity Contract, Preemptive Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:to="lab_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_fb62da9a-dca5-4deb-9106-a556b68e56ce_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5d996cd6-2c98-42ff-9f4a-f9b5dc6451df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_2a5ce8e3-401b-4f4f-887c-ab0d02a21a16_terseLabel_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_label_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:label id="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_documentation_en-US" xlink:label="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:href="mo-20220630.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:to="lab_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock_aa560434-74a7-4cd4-8bd4-e414d76a6960_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges</link:label>
    <link:label id="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:href="mo-20220630.xsd#mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:to="lab_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CronosGroupInc.Member_fd6be24f-dd24-40c7-a8b2-944bf49b11b3_verboseLabel_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_label_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CronosGroupInc.Member" xlink:to="lab_mo_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94821e8a-99ec-4f44-9621-b2e1aee84534_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f796b0c8-6b50-48b3-8fba-0f95fe37fac7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_04ae07e0-aa5e-4549-b770-fb748846ca6b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ee26ecd7-92b3-4bd6-b07d-3dbb01b0c80a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_de9d6b3b-5e81-412c-8444-9e737e67f2e8_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:to="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ff4887f1-1be4-40b0-aafb-7ad43983b068_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (earnings) losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_3496bb5f-c340-4fe6-88eb-d00d51ea888a_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:to="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ab1e9b46-e1a1-4a80-a79d-bf6459c92b94_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for basic EPS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6ca1952e-c67d-4d7d-83c8-a9cdbc086237_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt issued</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_c943555e-0b90-4e99-b042-7d8d015c8504_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLippMember" xlink:to="lab_mo_EngleProgenyCasesLippMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_f048eae1-29ad-4f62-8ec9-a33b46f7b839_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c8667fa6-e3d6-440c-9dbb-42f81c406d27_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b4a20f64-9ae4-4766-b62c-909469e5f109_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0bf2cd3c-e01a-420f-9ddf-622616b692d1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_42c4090c-8f5a-48a8-932a-8ba27d1eb1f8_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_24c3297a-70e9-4496-82a4-799fc45b3c34_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_ef2636d0-523f-46b3-b6c7-ac8a50fff07f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8cabf099-3613-4613-9c2d-d1dc40df0668_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_8a4e33ab-1b6d-4245-a384-def982743e7b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_76dc2376-49ca-4f25-a3ea-eb3939b38c2d_terseLabel_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_label_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_documentation_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government's Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember" xlink:href="mo-20220630.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalGovernmentsLawsuitMember" xlink:to="lab_mo_FederalGovernmentsLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_dabe897b-36a8-458b-a330-5ae6167a5071_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_65f625e8-5fea-4a72-8bf6-b887308cd195_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f7f10e6e-077f-4229-92ad-9aefffb75591_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8a3a8548-6c7d-49f2-bc43-413aac7b9c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EvaporLitigationMember_2e9829fa-bdd3-40c0-a8dc-86e653046b63_terseLabel_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_label_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_documentation_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EvaporLitigationMember" xlink:to="lab_mo_EvaporLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_69c57817-b365-4cb9-8e9b-953115c97aaf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_10bc70ec-5be1-4fe4-93ec-1322047f4555_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e46838bd-2a68-4495-89ff-50a31d0c87d4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_78d4436a-9935-4fe9-acc5-82266464fb17_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d1113c21-180d-4801-83ca-3c27bb4d5d2f_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_dda632d9-d645-419d-bd13-0c4c78b130d2_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:to="lab_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IA_cadc9320-3994-410e-90d2-b985e9bcb153_terseLabel_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iowa [Member]</link:label>
    <link:label id="lab_stpr_IA_label_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IOWA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IA" xlink:to="lab_stpr_IA" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_7bee8e19-f0c6-4187-838a-b13ad3916382_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0fd208b5-734c-42e7-9446-258c8be8729b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecided_318b6e04-7525-4e38-8e90-911939bd3fbd_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts returned</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecided" xlink:to="lab_mo_LossContingencyClaimsDecided" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2eec50d5-10d3-493b-815b-c3dfb068e923_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_7a2884f7-78a6-492d-9452-cfd4d168626d_terseLabel_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value equity investment</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_label_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_documentation_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption" xlink:href="mo-20220630.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityInvestmentFairValueOption" xlink:to="lab_mo_EquityInvestmentFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_404d73b2-90c0-4012-a3d9-d358edf8f36b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_d26e3b15-a2a1-45c3-bd82-085245337669_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency denominated debt included in long-term debt above:</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Abstract]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_41534eec-a089-4bae-9a49-22d057162907_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_c534cbba-5d33-4efa-98ec-943704170f8c_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_e848e0dd-5eed-4b98-bb9c-f2b850809d12_negatedTerseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_cb70d686-3841-4793-b367-70c63eab86a1_verboseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity investments, fair value option</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_label_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments, Fair Value Option</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption_documentation_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:to="lab_mo_IncomeLossFromEquityInvestmentsFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_77a37183-67db-406b-becc-312e86a7662e_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with concluded hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States With Concluded Hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States With Concluded Hearings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:to="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NH_0d0e4cba-0e8c-4531-9fcb-6bf2b2823e9c_terseLabel_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Hampshire [Member]</link:label>
    <link:label id="lab_stpr_NH_label_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW HAMPSHIRE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NH" xlink:to="lab_stpr_NH" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_38670d90-7c34-41aa-9aca-375ac8d777d7_terseLabel_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, reduction to cost of sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_label_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_documentation_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales" xlink:href="mo-20220630.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyReductionToCostOfSales" xlink:to="lab_mo_LossContingencyReductionToCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b6674787-880d-4ed5-8de7-60f3381b13a2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4f4683a5-7544-4f69-b62a-58662ce69e31_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_0db8f5e8-67a0-467b-84a7-14ee61b2881b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesDuignanMember" xlink:to="lab_mo_EngleProgenyCasesDuignanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_c3344aeb-83c8-4cf3-a25f-131516044c62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingencies</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_579ee735-e341-4846-b7bb-b1a4fe5f0fec_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9f56ac79-4293-4177-a165-fdd9734ff636_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_ef45b59e-d641-4aff-8b5e-94d8d15f6f33_terseLabel_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $0.33 1/3 par value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_label_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_documentation_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember" xlink:href="mo-20220630.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock0.3313ParValueMember" xlink:to="lab_mo_CommonStock0.3313ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_6e3641f7-4a5e-4b71-9eda-ecda07392a11_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_647a7902-bb12-42cb-9831-32f1998cb6de_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_bb9edbf5-4f03-4ac9-beb5-0bb9c0379213_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_ad1747ed-28c9-408b-8fdd-264c5b8e0084_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1337a0d8-a658-4931-a4d5-410600ee472b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_17969474-8266-4c85-ba06-c9d6f270e6b6_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3217a9ac-a45a-4a61-96ce-fed88e4a5b3a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_27411c1a-a0a5-4e8e-abfa-e11e3e180ab0_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts, receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_eaad9ed6-7b45-497e-9dff-5a8f5f01b8b3_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MS_2e4e7d4a-f07a-4e48-8e32-53ef63cec026_terseLabel_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mississippi [Member]</link:label>
    <link:label id="lab_stpr_MS_label_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSISSIPPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MS" xlink:to="lab_stpr_MS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a54e6ab1-5d29-4a34-948c-fd757e570059_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_69e02117-2196-45a4-b829-8999c8f90fa2_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MT_14378295-5985-4501-a018-42d0d8d7637f_terseLabel_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA [Member]</link:label>
    <link:label id="lab_stpr_MT_label_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MT" xlink:to="lab_stpr_MT" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MO_2e727263-d6a7-4a79-b9bc-6cc5232eee80_terseLabel_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Missouri [Member]</link:label>
    <link:label id="lab_stpr_MO_label_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSOURI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MO" xlink:to="lab_stpr_MO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_007aa1ae-6b62-4693-8990-9b57bace008c_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of repurchased stock (1,003,717,832 shares at June 30, 2022 and 982,785,699 shares at December 31, 2021)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b7bcb1e2-bddc-4fdc-87e3-28286581cb62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MN_af7c718e-28d4-4d71-ae57-46a31579064d_terseLabel_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minnesota [Member]</link:label>
    <link:label id="lab_stpr_MN_label_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MINNESOTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MN" xlink:to="lab_stpr_MN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_814c7d5b-19d9-49fd-b52a-b57917e2d8bd_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan contributions</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MI_d9dc455a-08c3-4637-88e2-c3a6ea356c19_terseLabel_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michigan [Member]</link:label>
    <link:label id="lab_stpr_MI_label_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MICHIGAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MI" xlink:to="lab_stpr_MI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c8bf63fc-0c33-4fe1-9fac-3f00056ef6b4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_87b8a4d9-3e6e-4605-9fa9-573ffa127f1a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b15edbea-0b8f-41fa-8527-560799178c0c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OH_2c2380b8-69a3-408c-8a17-4b87a8a15082_terseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio [Member]</link:label>
    <link:label id="lab_stpr_OH_label_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OHIO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OH" xlink:to="lab_stpr_OH" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_f62e702c-dc7c-4b6f-a143-a320c457eddf_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPollariMember" xlink:to="lab_mo_EngleProgenyCasesPollariMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ffefccfb-07f1-4878-b0d2-bfc9a5085fc0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAMember_64d56a73-9b0a-4113-a306-9ff40e953496_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PM USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAMember" xlink:to="lab_mo_PhilipMorrisUSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b161927a-ea7a-4fe4-a9ad-edab26be6edb_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ClassActionLawsuitMember_72feab36-3e2c-4106-8f69-0ad3bf0ebcd1_terseLabel_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember" xlink:href="mo-20220630.xsd#mo_ClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ClassActionLawsuitMember" xlink:to="lab_mo_ClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3fe14abc-a9ed-41b2-994f-65fb4e387f3c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_045c2a2f-0659-468b-b848-e1c23579c1c4_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_425bdac0-bf0c-4ac3-a6ef-6b32ffbc4645_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember" xlink:href="mo-20220630.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenyCasesMember" xlink:to="lab_mo_NonEngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_a29c7928-0f22-4efe-9057-f8d405d34781_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_972fc03f-f9ae-472c-b694-c2cf3206fc6e_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York [Member]</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NV_7053b123-cae6-4d86-bf7f-0930d581e1b1_terseLabel_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nevada [Member]</link:label>
    <link:label id="lab_stpr_NV_label_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEVADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NV" xlink:to="lab_stpr_NV" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3bb01b7b-0e85-4479-9103-79771fed70e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7da84a6e-ebb3-4ea5-a971-c7af2433495e_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_69993648-4c6f-4fdc-a298-793678b6a0ae_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTLitigationMember_b764d506-784f-4ea8-b1c3-a82ac99917c1_terseLabel_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_label_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_documentation_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember" xlink:href="mo-20220630.xsd#mo_USTLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTLitigationMember" xlink:to="lab_mo_USTLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_d70842bc-3f5b-4a19-9b9e-be7d3cdc3097_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Puerto Rico [Member]</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_55e4fb3a-bdb7-43b4-beaf-d21cd2d3424c_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, shares purchased, (CAD per share)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:to="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_0517458b-f0cd-468e-b0a4-a5a7451e3876_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_2882f802-846a-4b41-9c04-8092bfd4fc2c_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_1b95fd99-cf54-4178-9c4b-8aab4ffff1a3_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:to="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_864f6edf-fd65-45b2-bf38-5e344abe4d34_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NM_9cf076b8-0a75-4eba-9a09-fe988accb707_terseLabel_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Mexico [Member]</link:label>
    <link:label id="lab_stpr_NM_label_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NM" xlink:to="lab_stpr_NM" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_ad3a24d7-e84f-44d5-9840-f3d1201cf430_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey [Member]</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_44a4711f-06da-45b2-bd4a-ec416ea28fbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Periodic Benefit (Income) Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_d865bd14-e575-48d7-8247-c5fc6b8622d4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_7e8fa9c8-0dbb-4162-9019-85f5b9843e3f_terseLabel_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.200% Notes due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_label_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_documentation_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member" xlink:href="mo-20220630.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock2.200NotesDue2027Member" xlink:to="lab_mo_CommonStock2.200NotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_LA_255a09fd-8461-4cbc-9202-bbeb4991363e_terseLabel_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Louisiana [Member]</link:label>
    <link:label id="lab_stpr_LA_label_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_LA" xlink:to="lab_stpr_LA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_486c9f59-2bf3-4beb-9256-aa984f36d24e_terseLabel_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_label_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_documentation_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingIndividualLawsuitsMember" xlink:to="lab_mo_PendingIndividualLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_942da1f9-82ec-4dce-8a5d-32160105bbf5_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_label_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:href="mo-20220630.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:to="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KS_9458ee8f-f740-49de-809b-4d40e8ccc6a7_terseLabel_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kansas [Member]</link:label>
    <link:label id="lab_stpr_KS_label_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KS" xlink:to="lab_stpr_KS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_9cff0a12-dc02-4a64-99de-465b83e1a82f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of inactive cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveCases" xlink:to="lab_mo_LossContingencyNumberOfInactiveCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_7e615b73-f456-4958-b541-525d5788ac1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c5c9d302-3b40-4fde-a785-168a29a3bf56_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fdbbfe4c-3b8d-42b4-b3a7-7e3c4ac98eae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_4e8bd588-3416-486c-b10c-a9b019b2d2cd_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_135490e1-a29d-4f4d-931f-30da0fd40c44_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Equity Method Investment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:to="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_1ea44dfd-145a-435e-a0b7-058e625aca20_terseLabel_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes</link:label>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_mo_SummaryOfIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:href="mo-20220630.xsd#mo_SummaryOfIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:to="lab_mo_SummaryOfIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_6657f9bc-9b5d-465c-819c-fb3491ce2651_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from ABI</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_dae6cf09-922d-4cb4-aa49-9ecd2eaa145b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMember_5050d1b2-8588-4034-9a1f-a50b7c127f9f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMember" xlink:to="lab_mo_EngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0b35bf7d-d3c1-4859-9c77-44bba38e5b57_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MD_f4e06374-c04e-4611-81c6-8c4dd9260d38_terseLabel_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland [Member]</link:label>
    <link:label id="lab_stpr_MD_label_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARYLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MD" xlink:to="lab_stpr_MD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_5b5b6f21-dc97-4336-8c82-e375dcc52ec8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest on long-term debt</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_70b6505e-2420-4323-84a5-09b1762aff2d_verboseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts [Member]</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_96f2d75f-7614-4264-a952-42c5ed01fcd0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_310d95d0-1653-4d58-8203-285653c48948_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_140a0c5d-e780-440f-8bca-b2f814282b08_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_3f0faed9-b729-4ace-b264-c49ef0b41a27_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:to="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_ca669b18-d7d9-4c8d-a521-99ac3a5903f7_terseLabel_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia and Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_label_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_documentation_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember" xlink:href="mo-20220630.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_BritishColumbiaSaskatchewanMember" xlink:to="lab_mo_BritishColumbiaSaskatchewanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_296e72df-7502-4dd2-ae6d-d28e9b308259_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_9dbb7163-b8eb-4ffc-bd89-8ca0f2af64a4_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:to="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_93b21c13-5b79-43c5-a0ca-b572b43e17d8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_RI_733d2e15-c599-4fee-9c5f-5ca012e9ef51_terseLabel_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhode Island [Member]</link:label>
    <link:label id="lab_stpr_RI_label_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RHODE ISLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_RI" xlink:to="lab_stpr_RI" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_e38796e5-85b0-43da-91ec-1a44dbe46ae6_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_7239f12d-ff8a-4bec-8068-1d6cf66019e8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_596a67f4-5f52-47e0-bae7-d7b352b61956_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of amortized debt discounts and issuance costs, debt extinguishment</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_6e20dd04-c9ea-40d5-afa1-26c2c4f6deb2_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_01d3e8aa-4bb5-4dc3-bf52-4320b8311a11_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements attorney fees annual cap</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:to="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_307fac3f-b313-4c7c-8758-85c7cc1a3b0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_1425f39c-05bc-4e3f-9b05-07d825192535_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1c2444ec-b6cc-4c1e-8a06-20e750e2d5fc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for basic EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_87bf21c5-3028-4130-b014-af15bdce27e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_c9446923-f568-49d9-a1ca-8667e26c4cb4_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of independent board members upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_3ed53c09-7dca-4ee0-ac85-559fd21fe928_periodStartLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at beginning of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_7d906235-ed32-4a06-8699-6e01fc620692_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at end of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_6f459388-f1fc-4247-9c04-c8dbb0ce1777_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charge</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_1b78b99c-8bac-4237-94d5-08f1ef464766_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_cc75c6a6-b29e-4909-831a-b9951fc67295_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_436787aa-ab9d-4e66-8d89-48faffe9be11_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_9f958e5e-0991-4b87-a0e0-581ee5a918d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities:</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_5ec8bfa3-78d0-4769-a00f-b14518fde1d3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_8760422b-e21d-4ec7-9690-34f68a7505bf_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_label_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.000NotesDue2023Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.000NotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.000% Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member" xlink:href="mo-20220630.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.000NotesDue2023Member" xlink:to="lab_mo_CommonStock1.000NotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3de9a168-4ff3-4031-adfa-4a21335a5625_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_4868322b-78e2-4fe8-90b0-b55a0d325936_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_6b8e6100-925d-4b54-ab68-a41a8af21c05_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_4aaf38e3-85c3-4af2-a166-596bcc4f5cae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_f8f1d2f3-a1d0-41b1-9bfc-258314eee118_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option [Member]</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option [Member]</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFairValueOptionMember_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:to="lab_mo_EquityMethodInvestmentsFairValueOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_b3476cd3-9abe-4df1-9523-e312c544f75f_terseLabel_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember" xlink:href="mo-20220630.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingClassActionLawsuitMember" xlink:to="lab_mo_PendingClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_064bcd14-748b-44f6-bbad-69113ab646a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossMember" xlink:to="lab_us-gaap_OperatingIncomeLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_1a16e584-1346-4b36-94cc-64b0ede7b167_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_35c9e23d-7f30-430b-96e2-5ca20bbde4eb_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_5a448eff-49b6-43c5-a67d-1b112f6352de_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:to="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f84fa321-809a-4be4-b49c-c7e6593db811_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a101009b-804a-4a58-bb56-55b72ed87921_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_SC_fb7ab6b2-a71e-4dcc-ad11-8bdccbc99c6a_terseLabel_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Carolina [Member]</link:label>
    <link:label id="lab_stpr_SC_label_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOUTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_SC" xlink:to="lab_stpr_SC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_267143d9-3d68-4c16-bb3c-adbb463dd2bc_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_75263905-a7cf-4766-9095-9823e34b45eb_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_5f60a814-487d-409b-95d1-cab36592a062_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgments paid (approximately)</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c5ca2ceb-f82b-4349-adbd-5a33b66d7b9f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_846ebb32-0cf9-4da9-8dc3-e04d0993c428_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_082dc988-0a93-4086-89b1-64ad1efbf174_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_594505a4-8dd7-4088-93b2-c5b8debc6220_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_390d4c61-0d4e-40a8-8380-102129954ba6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_ff9bab84-aa68-4e8e-b539-3f9aa80c59fd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_6f4cf180-f6e5-4120-844e-d50bacae7bea_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_e43879d9-c808-4775-9f38-fc0367f12d67_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineSegmentMember_71ba3194-771e-4229-a94e-1250ac47d910_terseLabel_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_label_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_documentation_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember" xlink:href="mo-20220630.xsd#mo_WineSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineSegmentMember" xlink:to="lab_mo_WineSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9a1ba023-74ba-4084-8011-6fe3ee930512_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_7abe4477-4c6a-4720-a9ce-95dd73a9181e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_2bd6de4d-fe3a-49b1-9025-53e84f0e0e8a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, provision</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0a8a0466-0f5f-4ed7-ab36-2d2309eac3c4_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f93c53a6-1490-4d3c-bc48-1901af994b51_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_08390dbf-21eb-411a-a3cb-cd5f5424cccb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_PA_0861e729-b570-4dfc-9c83-a5c0426d93a8_terseLabel_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pennsylvania [Member]</link:label>
    <link:label id="lab_stpr_PA_label_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENNSYLVANIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_PA" xlink:to="lab_stpr_PA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c1ab153a-c903-4ac3-a56a-05df07e0c573_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_0361326f-29a8-4fa9-9944-d260096f2ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ca688b6b-49f1-4306-a4ac-a97b1969deac_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_abc16ba2-357f-4b07-b631-f0433c192a0a_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseLaramieMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_ba0982fc-ca05-4df6-9762-2bad9a8cb057_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_b8d053e2-8430-4e56-9b2e-a4ff03740519_terseLabel_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages recoverable, value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_label_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_documentation_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue" xlink:href="mo-20220630.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyDamagesRecoverableValue" xlink:to="lab_mo_LossContingencyDamagesRecoverableValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04cffcd6-30e6-4e00-a528-4243910d290c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_3989a3b7-1ec9-4058-b73c-6ff5b4468df6_terseLabel_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award activity</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_label_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_documentation_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:href="mo-20220630.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:to="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_3a8333b3-5f99-40b0-b318-d51bf502af8c_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OR_b1f8627f-9690-4d73-9e1e-5a90c7915d55_terseLabel_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oregon [Member]</link:label>
    <link:label id="lab_stpr_OR_label_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OREGON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OR" xlink:to="lab_stpr_OR" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_48277f66-f291-43f4-aa79-e179ae2b2282_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_f9952b96-18f5-4625-bba4-b5de7b85ed89_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, aggregate exercise price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentAggregateExercisePrice_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:to="lab_mo_EquityMethodInvestmentAggregateExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OK_dfd13c3c-1be4-4a99-8bbb-2cb392a09927_terseLabel_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma [Member]</link:label>
    <link:label id="lab_stpr_OK_label_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OK" xlink:to="lab_stpr_OK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_bf14a153-dc01-4909-91b0-221207d2bad9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for diluted EPS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4c6285d3-cfc8-4de2-b7ed-c5f8a82bf6d2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3bbbdd76-4c05-481d-953e-ba6c74a7a599_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_e3221102-6f79-40a2-bbde-def590ae7eb4_terseLabel_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_label_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_documentation_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokingAndHealthClassActionsMember" xlink:to="lab_mo_SmokingAndHealthClassActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4a55aa68-8349-423f-b8e4-244e7c73ee84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0f8a4166-3c20-4b43-bf8f-a79eb324c66b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_4f5339b8-8951-43ab-bec3-f9683bdc474f_terseLabel_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Interest Costs [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_label_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_documentation_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:href="mo-20220630.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:to="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f7dbfe3d-e2b0-4e49-96fa-992e26661cd4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_b58d1f53-e754-4780-b5e7-1524c8436d01_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing derivative lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_d8d8343f-ecd4-4320-adf1-3fb9e7b436af_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_90ba236e-da6f-4485-8b25-3561884e2364_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_44fcd7ee-9b69-4404-b7d4-6a040196dc05_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdict modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:to="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_961d404a-1158-4974-ade2-2104a89ceb7f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:to="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_52d4203f-38d7-4de4-a622-9ac0353c4475_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_a51bbad3-2a8d-413d-92a5-044f7d5b97bf_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements annual payments</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:to="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_fff10e69-ca0d-44d6-ac04-7c0f6d0d6836_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_5fb73aa4-816d-4697-b3d9-0ce9324635da_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a81846e0-5548-490d-9c12-66b9e743e864_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_61358bf1-7a96-4f86-8537-7161962d264d_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f75afedf-6272-4818-94e1-45dbbd0f3b4d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_7f093b91-cb6f-499c-a01e-ef398a529b59_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_52bf148f-f065-4d8a-85aa-ee12c79436c2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c2dc843e-c7a6-483e-9650-9f11801ef514_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_21aaad9c-3fe8-43fd-a4cc-6e3bc9e2a739_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_ab6d41d3-c59f-43f4-86cc-e7bd846c205d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f30ff117-90fb-49b6-9f94-af9fc397de88_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_c8f6c8ba-893d-4f50-9042-8582401b9f64_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_ff376f70-0352-42e4-b5b0-5800a135c2c8_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b733b0bd-2bb0-49af-91df-ad8fb80ed1f9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e058ed3c-05fc-422c-948f-408e6bd2ace7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_03aa6de2-cd5d-4bb2-badf-3b712b01dc0c_negatedTerseLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from equity investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_12e4737f-7b7e-48d3-9b4f-6f279d309f63_negatedTotalLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from equity investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_label_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_documentation_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncomeLossFromEquityInvestments" xlink:to="lab_mo_IncomeLossFromEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantMember_7086b0ca-323d-492b-a2ba-8c1274e84b3f_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_8ff59c96-6cb3-4f1f-abc9-d03092eb7ed9_verboseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantMember" xlink:to="lab_mo_EquityContractWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WI_86d67c43-ad06-42bc-b205-ecf4187756dd_terseLabel_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin [Member]</link:label>
    <link:label id="lab_stpr_WI_label_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WI" xlink:to="lab_stpr_WI" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_ef70cabb-306a-402c-8a59-b0a2e3f221a2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:href="mo-20220630.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_bd7ac1c2-454a-4792-973d-ce39fc04bedb_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:to="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_e6a365d5-e2a8-48f6-9e39-f1a6028a1e64_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unfavorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a7ad2888-529f-4892-b375-48a1e0c24525_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MaximumBondForAllDefendants_2586b3c4-c0b3-4484-84bf-6d7fc1883a8a_terseLabel_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum bond for all defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_label_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_documentation_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants" xlink:href="mo-20220630.xsd#mo_MaximumBondForAllDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MaximumBondForAllDefendants" xlink:to="lab_mo_MaximumBondForAllDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_6b08a310-4edd-41f7-b33f-442a67e23a77_terseLabel_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_label_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThreatenedLitigationMember" xlink:to="lab_us-gaap_ThreatenedLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_c71a8fa1-c113-4517-8ca7-a5d63bc456a1_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liability related to performance surety bonds</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_f42f4f0a-8bab-49e9-bb82-f6b82f374a04_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_b678c96e-dcd5-4ae1-938f-85cd97a6ff16_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2c7c173c-c126-4bf9-bbf6-f8621c961ff1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TN_de8c6ab5-ddd7-46d1-81d9-bef95999bbdc_terseLabel_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tennessee [Member]</link:label>
    <link:label id="lab_stpr_TN_label_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TN" xlink:to="lab_stpr_TN" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_aad41276-486b-4d73-85fb-4500477f2e70_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0f5e4acb-12c5-4ca8-b753-bc20b42585c5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_782c376d-3ba8-4a50-83d4-08c1eb465e0b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, class action lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_label_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_documentation_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit" xlink:href="mo-20220630.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassActionLawsuit" xlink:to="lab_mo_LossContingencyClassActionLawsuit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_d98d317d-b108-4bb8-96d1-f8864aa9de80_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_07347cb4-cc72-42cb-8fb0-789e2a1fad36_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_c51f33ca-5168-4261-853e-77ce6fda83dd_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_a6bcac99-418c-4b15-b916-703735d72467_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_490a4243-3d98-4743-a8a7-410eb49ea433_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a10151f3-abec-4851-aaf0-22b4ec3778a7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_99cafae0-26f8-40a2-96ed-f62fd61d5882_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f4347307-2ccf-4ab6-ac79-ead7e36243c6_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_80ed7cd5-423a-48dd-bad6-61b1718bdf7c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_138549f4-28a2-4c90-9e5f-c548088acda4_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ABInBevMember_27b32c18-2ab4-434e-892c-266053072091_terseLabel_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_label_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_documentation_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ABInBevMember" xlink:to="lab_mo_ABInBevMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_a93857fd-f9e3-463f-9cbe-1023cd2f68b4_terseLabel_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_label_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_documentation_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:href="mo-20220630.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:to="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_aee56638-0dbf-4f54-8bcf-61cbd74cfa72_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ffe2a5bf-5079-449d-9c4f-2888693be602_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_ac4ddcfc-040e-4096-ac8b-d76956d994a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_5d039c08-8593-4556-a069-ee724b964e66_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthJudgmentMember" xlink:to="lab_mo_TobaccoandHealthJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c0368d5b-c5ae-4054-a295-3cf11965d85c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_3f72b37e-490c-465b-ba4d-04dcebbec3a5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_8ac4ead9-6b26-4422-a482-0effa2b949eb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_a0ab296b-06de-401a-a928-de0729618f9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationEscrowDeposit_c76e1672-d599-4a4c-8e9c-bb50a09a6366_terseLabel_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security posted for appeal of judgments</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_label_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_documentation_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit" xlink:href="mo-20220630.xsd#mo_LitigationEscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationEscrowDeposit" xlink:to="lab_mo_LitigationEscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_21541766-37db-44f5-9990-176e08b38aaf_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from investments under equity method of accounting</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_cf256a79-79c5-4d71-9c56-1a1ffc9215bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from equity investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_1ae519d7-d2d7-4107-9b05-2c89bbbdf556_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fab3abdf-ad28-4fa4-9e54-f0567784f9ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d212449c-cf63-460f-bec3-1513f02c8ea5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_f6d2c098-3c61-4157-a86f-86a71274b9b4_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_40313ada-e1dc-4e3e-9f90-4d96e8b10d64_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas [Member]</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_4fe3eebe-3842-49be-b2a8-e9ecb6ec3af9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_c4203643-cb5c-4a15-b308-3dcbb24eadf6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_cf28ab7f-9353-482f-bd3b-cfd9db1fad15_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, number of board members upon share conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>mo-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3c6eed52-e93b-4118-b78e-ddd7dcd6e984,g:bac34b8e-e761-4b33-9434-9013a263883c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20220630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5b34cb44-4389-4769-b1c4-fc89bdda9828" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5b34cb44-4389-4769-b1c4-fc89bdda9828" xlink:to="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92ade357-533d-4684-9f6c-698a12d4d08b" xlink:to="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_339fa9fc-2265-482a-a2ca-79f7db228449" xlink:href="mo-20220630.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock0.3313ParValueMember_339fa9fc-2265-482a-a2ca-79f7db228449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.000NotesDue2023Member_bf6348be-d4b4-4745-8dc5-bf2e26e4fcd4" xlink:href="mo-20220630.xsd#mo_CommonStock1.000NotesDue2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock1.000NotesDue2023Member_bf6348be-d4b4-4745-8dc5-bf2e26e4fcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_3d8ee7ab-8988-49c7-96e5-2aa026dd6edb" xlink:href="mo-20220630.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_3d8ee7ab-8988-49c7-96e5-2aa026dd6edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_a4064345-2ad2-4d62-9ac6-c08c12b79d98" xlink:href="mo-20220630.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_a4064345-2ad2-4d62-9ac6-c08c12b79d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_91e7fe3f-4802-4ed6-b819-74305bab1a23" xlink:href="mo-20220630.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b2df328b-d9f3-4a9b-9625-2bf0a830a542" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_91e7fe3f-4802-4ed6-b819-74305bab1a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_efb28b75-4909-49ee-87fc-86bb660a007e" xlink:to="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3cbf8649-fb8e-4d46-a5bf-ee59eb481ec1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentType_3cbf8649-fb8e-4d46-a5bf-ee59eb481ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a6d94c54-056b-42d3-a8b8-fd8b6c87fa1d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentQuarterlyReport_a6d94c54-056b-42d3-a8b8-fd8b6c87fa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bf7b4ad-0a85-4f62-8b7a-c41ac6b87775" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentPeriodEndDate_8bf7b4ad-0a85-4f62-8b7a-c41ac6b87775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9c36fb8a-ccc5-41f8-a0fb-27be7c1b4ef0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentTransitionReport_9c36fb8a-ccc5-41f8-a0fb-27be7c1b4ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_23e11e84-99ba-45f0-b7cd-1d784b6f8a7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityFileNumber_23e11e84-99ba-45f0-b7cd-1d784b6f8a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7e0124b5-f273-4294-b2e7-b9dfe67df88e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityRegistrantName_7e0124b5-f273-4294-b2e7-b9dfe67df88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_769ba0b0-d766-403a-802b-7d54902c78fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_769ba0b0-d766-403a-802b-7d54902c78fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8d3404b4-ea31-481d-bd5c-4487a30a210d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityTaxIdentificationNumber_8d3404b4-ea31-481d-bd5c-4487a30a210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f530db0f-6a79-4bdc-9dfe-c6cf32e668b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressAddressLine1_f530db0f-6a79-4bdc-9dfe-c6cf32e668b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9f0633ee-954b-424a-96af-55183c3c37ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressCityOrTown_9f0633ee-954b-424a-96af-55183c3c37ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9c091e09-fd37-484d-a70a-6d2970fd480e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressStateOrProvince_9c091e09-fd37-484d-a70a-6d2970fd480e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_669fd5e2-88cd-4159-a050-2bcfacba06a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityAddressPostalZipCode_669fd5e2-88cd-4159-a050-2bcfacba06a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_51d5efc7-b51a-41c9-a305-d92eea0b3e9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_CityAreaCode_51d5efc7-b51a-41c9-a305-d92eea0b3e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3d3126cd-fb91-46d5-8b57-c4c70ba6abd3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_LocalPhoneNumber_3d3126cd-fb91-46d5-8b57-c4c70ba6abd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0c703ad2-078e-4ae3-b183-4367b4df6d22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_Security12bTitle_0c703ad2-078e-4ae3-b183-4367b4df6d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8f83f954-6463-4d84-9850-8aead43c1f5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_TradingSymbol_8f83f954-6463-4d84-9850-8aead43c1f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1ceed4cb-56c1-41f2-8826-a422b58551be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_SecurityExchangeName_1ceed4cb-56c1-41f2-8826-a422b58551be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ea83da3a-af19-449f-b7d1-2e95a9eee203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCurrentReportingStatus_ea83da3a-af19-449f-b7d1-2e95a9eee203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_14e3c3cb-c7e3-43a0-9175-1525c539f82b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityInteractiveDataCurrent_14e3c3cb-c7e3-43a0-9175-1525c539f82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d6e47b4f-f928-47a7-9039-e55d22b9a03c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityFilerCategory_d6e47b4f-f928-47a7-9039-e55d22b9a03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f707292d-eff0-438c-b6e3-5c84f1f4b066" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntitySmallBusiness_f707292d-eff0-438c-b6e3-5c84f1f4b066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_19d16ae8-6c92-456b-a4f8-28a033e75a7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityEmergingGrowthCompany_19d16ae8-6c92-456b-a4f8-28a033e75a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a92b957b-1309-42b3-8d89-729208dd0696" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityShellCompany_a92b957b-1309-42b3-8d89-729208dd0696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a097c802-3b7b-45bb-b01f-87dcdfafc77d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a097c802-3b7b-45bb-b01f-87dcdfafc77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_77053978-0c14-4367-bf13-22aa8af7fcba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_AmendmentFlag_77053978-0c14-4367-bf13-22aa8af7fcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d282574f-c8a0-4a19-b4dd-9aecb42e37e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentFiscalYearFocus_d282574f-c8a0-4a19-b4dd-9aecb42e37e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e81a93f2-790f-43b6-9f5e-f48a4306c1df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e81a93f2-790f-43b6-9f5e-f48a4306c1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a99dfd7f-4447-456c-bf3c-68ea370ae81c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_EntityCentralIndexKey_a99dfd7f-4447-456c-bf3c-68ea370ae81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_62ee82bc-e80c-457f-a1ae-b844e4173808" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_c0974862-5ba9-456b-8c51-6b1995172b6c" xlink:to="loc_dei_CurrentFiscalYearEndDate_62ee82bc-e80c-457f-a1ae-b844e4173808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:to="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6952ca3e-8ff3-4751-86b3-4ac279818872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6952ca3e-8ff3-4751-86b3-4ac279818872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7bec720c-c201-418d-be10-34b94099cf0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7bec720c-c201-418d-be10-34b94099cf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_64bb3e8b-f89e-4311-9ded-6e54b1d74f97" xlink:href="mo-20220630.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_64bb3e8b-f89e-4311-9ded-6e54b1d74f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_f82c21ab-8566-4fd0-b74f-8a557b2a312d" xlink:href="mo-20220630.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_f82c21ab-8566-4fd0-b74f-8a557b2a312d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e34262e7-b294-4b10-ad95-0cb6455953ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e34262e7-b294-4b10-ad95-0cb6455953ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_87a8abec-85d7-4875-8b90-58a0b266467b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_87a8abec-85d7-4875-8b90-58a0b266467b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_406a0342-8497-42c9-b902-37b43dba69b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_5f34aacf-55cb-44b8-b549-2b2ae302bd51" xlink:to="loc_us-gaap_InventoryNet_406a0342-8497-42c9-b902-37b43dba69b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_0b13156a-67a8-4365-adb4-ea49f85a72a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_OtherAssetsCurrent_0b13156a-67a8-4365-adb4-ea49f85a72a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_660c5846-6df3-4e21-aab3-3bd99202e3c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_AssetsCurrent_660c5846-6df3-4e21-aab3-3bd99202e3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2cf9bc97-a325-47b8-b183-e0e450a41b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_2cf9bc97-a325-47b8-b183-e0e450a41b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_16fa07bf-c380-4f8d-9e55-ec1a082c1b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_16fa07bf-c380-4f8d-9e55-ec1a082c1b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a351b761-107a-49e7-bc5c-564c9ba83b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a351b761-107a-49e7-bc5c-564c9ba83b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a9686597-1c62-4733-9ab0-39070a832e59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_Goodwill_a9686597-1c62-4733-9ab0-39070a832e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bee63b5b-6c5d-4dca-a6c1-c581433aa5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bee63b5b-6c5d-4dca-a6c1-c581433aa5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_bacce5da-0922-4054-b302-f3955e12a3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_Investments_bacce5da-0922-4054-b302-f3955e12a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a2b1dd55-219a-4c6e-8450-5ca97e154b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a2b1dd55-219a-4c6e-8450-5ca97e154b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_47879591-6912-49a5-80a9-a053b531499b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c49ccbf6-de2c-4d1a-ba96-86ab74d86fb5" xlink:to="loc_us-gaap_Assets_47879591-6912-49a5-80a9-a053b531499b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:to="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_4d6505d3-43de-48b8-a4a5-ddc5a6c993e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_LongTermDebtCurrent_4d6505d3-43de-48b8-a4a5-ddc5a6c993e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_03686f25-68cd-4176-a9ed-f29b1bf9345b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_AccountsPayableCurrent_03686f25-68cd-4176-a9ed-f29b1bf9345b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_d08a8a2f-19f3-4ccc-b9df-38c85383db5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_d08a8a2f-19f3-4ccc-b9df-38c85383db5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_985ad695-da7f-4c06-9060-6fb666a4e322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_d08a8a2f-19f3-4ccc-b9df-38c85383db5d" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_985ad695-da7f-4c06-9060-6fb666a4e322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_bbf45fc9-d0e0-4157-ba88-58413b3e4bfd" xlink:href="mo-20220630.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_d08a8a2f-19f3-4ccc-b9df-38c85383db5d" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_bbf45fc9-d0e0-4157-ba88-58413b3e4bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d58dd8b3-ac87-4ccc-81fb-f90af80b5054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_d08a8a2f-19f3-4ccc-b9df-38c85383db5d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d58dd8b3-ac87-4ccc-81fb-f90af80b5054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_02832475-f1d0-4db3-8117-41a30eb3a156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_DividendsPayableCurrent_02832475-f1d0-4db3-8117-41a30eb3a156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9adee0b1-1084-4741-a6e9-27375ad634a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_LiabilitiesCurrent_9adee0b1-1084-4741-a6e9-27375ad634a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_641adbc6-8e5f-44aa-ba9a-6ee3384839be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_641adbc6-8e5f-44aa-ba9a-6ee3384839be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_52870d68-cde6-432c-ad11-89389b3d81b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_52870d68-cde6-432c-ad11-89389b3d81b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0b0d721c-67c6-45a4-8bc2-9062687388fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0b0d721c-67c6-45a4-8bc2-9062687388fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_6612baa1-cb06-4228-b3b3-16df38e31507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_6612baa1-cb06-4228-b3b3-16df38e31507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d3ec8dfc-dd0c-428a-9209-c9b5d3a622ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d3ec8dfc-dd0c-428a-9209-c9b5d3a622ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_37bde2d1-f41e-4e6a-b0dc-cd55a78bb6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_313e3ab8-f929-4e1d-853a-e00db17537c0" xlink:to="loc_us-gaap_Liabilities_37bde2d1-f41e-4e6a-b0dc-cd55a78bb6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_90240afd-0c37-4609-bdca-8d6c534906a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:to="loc_us-gaap_CommitmentsAndContingencies_90240afd-0c37-4609-bdca-8d6c534906a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_24eec09a-8f44-414b-a8e0-8267faf22969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_CommonStockValue_24eec09a-8f44-414b-a8e0-8267faf22969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9b9e4c00-e39c-4b54-9f12-202b854368b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9b9e4c00-e39c-4b54-9f12-202b854368b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dc92b137-993b-42b4-8eab-4f8713261050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dc92b137-993b-42b4-8eab-4f8713261050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_addb868d-a3e5-49a3-bb90-a4c9240acee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_addb868d-a3e5-49a3-bb90-a4c9240acee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_772d5339-6a4e-49ef-9420-6c8db3d2bb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_TreasuryStockValue_772d5339-6a4e-49ef-9420-6c8db3d2bb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_19325f2d-d933-4354-9a7e-71fe017c1875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_63a44c5c-b872-42e3-b582-79ec2124fd43" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_19325f2d-d933-4354-9a7e-71fe017c1875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ffd0e19a-dad0-49ae-9636-fea2d071147f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_444286e8-d122-4b04-83cd-bf8f728da512" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ffd0e19a-dad0-49ae-9636-fea2d071147f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_190745ab-8f4a-406f-99fd-aef87921f96b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_190745ab-8f4a-406f-99fd-aef87921f96b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_fef33022-6925-4045-bbdb-81ad2dfee4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_fef33022-6925-4045-bbdb-81ad2dfee4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8a39d961-dec5-4230-b74f-a895ab0321db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8a39d961-dec5-4230-b74f-a895ab0321db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_98002d1d-2445-4ac4-881a-0e4efa3c5036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:to="loc_us-gaap_CommonStockSharesIssued_98002d1d-2445-4ac4-881a-0e4efa3c5036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_03395285-8617-44a9-8707-b1c00a8c0c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_836d7dc7-eb67-43d5-a8df-617f55c08eec" xlink:to="loc_us-gaap_TreasuryStockCommonShares_03395285-8617-44a9-8707-b1c00a8c0c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a752c3a8-fe59-46f8-8431-214be79a5924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a752c3a8-fe59-46f8-8431-214be79a5924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_765d0574-2c9a-45e4-91e0-b530ebc7480f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_765d0574-2c9a-45e4-91e0-b530ebc7480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostOfOperatingRevenue_c083528a-177a-494e-aa97-3599634ddb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_OtherCostOfOperatingRevenue_c083528a-177a-494e-aa97-3599634ddb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9ab2c3a9-55e4-404f-b9c6-bd7950b0b166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_GrossProfit_9ab2c3a9-55e4-404f-b9c6-bd7950b0b166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_a7879963-3a1c-49c4-a79e-b1ecf17414f1" xlink:href="mo-20220630.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_a7879963-3a1c-49c4-a79e-b1ecf17414f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4dbdfd1d-8fe8-46ed-b7c6-a0a21cb82647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_OperatingIncomeLoss_4dbdfd1d-8fe8-46ed-b7c6-a0a21cb82647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_db087de7-d2d6-4541-94c1-331e66eb7aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_db087de7-d2d6-4541-94c1-331e66eb7aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecc81ef5-e3ae-4fd1-a287-1cd1e9231060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ecc81ef5-e3ae-4fd1-a287-1cd1e9231060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cc4ba0ff-586e-42a3-bfce-e88450d14524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_cc4ba0ff-586e-42a3-bfce-e88450d14524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_a641ad7c-28e6-4e4b-980b-88b26ca9603c" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_mo_IncomeLossFromEquityInvestments_a641ad7c-28e6-4e4b-980b-88b26ca9603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4ae9a9dc-fe93-4e10-9e3d-f92bdea6fc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_4ae9a9dc-fe93-4e10-9e3d-f92bdea6fc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4766b030-95a8-431d-8457-85fdc799d90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4766b030-95a8-431d-8457-85fdc799d90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae7becc0-83c6-409e-b2ba-fee330f0a57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae7becc0-83c6-409e-b2ba-fee330f0a57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b8d1b127-2ef0-415d-961c-fbea23fa917b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_ProfitLoss_b8d1b127-2ef0-415d-961c-fbea23fa917b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dd3f63d-ccbe-415d-a53e-27963fd08e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5dd3f63d-ccbe-415d-a53e-27963fd08e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b02f6b2-6b9c-4f6a-9e03-c59a95a57c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_NetIncomeLoss_6b02f6b2-6b9c-4f6a-9e03-c59a95a57c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eaf7b8bd-63a0-4483-8a66-076853627572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa061b73-dc51-4c16-b17a-1548dd5bc465" xlink:to="loc_us-gaap_EarningsPerShareAbstract_eaf7b8bd-63a0-4483-8a66-076853627572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5fe45b69-cbc7-464d-b2c9-e7d96d45901f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eaf7b8bd-63a0-4483-8a66-076853627572" xlink:to="loc_us-gaap_EarningsPerShareBasic_5fe45b69-cbc7-464d-b2c9-e7d96d45901f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0dd0c60a-b4ca-4f74-b8b0-4eefa1643ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eaf7b8bd-63a0-4483-8a66-076853627572" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0dd0c60a-b4ca-4f74-b8b0-4eefa1643ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_22e66ba5-aa28-4d5e-b0f6-195e2141f028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:to="loc_us-gaap_ProfitLoss_22e66ba5-aa28-4d5e-b0f6-195e2141f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_71941bb6-ddd4-47da-9af4-5539ac40d89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_71941bb6-ddd4-47da-9af4-5539ac40d89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_a365ab5d-7a01-4b6d-af01-94c4fb3d3916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_a365ab5d-7a01-4b6d-af01-94c4fb3d3916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bed1e851-8745-4b63-9b20-06b7f812c742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bed1e851-8745-4b63-9b20-06b7f812c742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_830ca426-26f5-48d9-91ae-6c23dcdb560c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41ec686f-1e7a-4d8a-81f4-b55d5ed7f42e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_830ca426-26f5-48d9-91ae-6c23dcdb560c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8700e523-d404-4fe3-83fc-fdeee62ad322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8700e523-d404-4fe3-83fc-fdeee62ad322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7cd9e18c-9117-4e15-b236-be8727ca7ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7cd9e18c-9117-4e15-b236-be8727ca7ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_61748ddc-855c-442e-8e68-1a90231b306c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_99f39ce8-0f97-422b-9229-31b666649c94" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_61748ddc-855c-442e-8e68-1a90231b306c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4a58893-848b-4c98-8899-66865ac501e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e4a58893-848b-4c98-8899-66865ac501e3" xlink:to="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_65ce082a-b088-45d3-8f3c-092e30ce5740" xlink:to="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_29e91056-af6d-4677-8540-ac282bb77f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_CommonStockMember_29e91056-af6d-4677-8540-ac282bb77f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9f39f200-d0d0-4ad1-9078-1a0c983f7e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9f39f200-d0d0-4ad1-9078-1a0c983f7e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1073ee17-c3f9-4fee-9231-234e9d436b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_RetainedEarningsMember_1073ee17-c3f9-4fee-9231-234e9d436b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_055ced3d-d54e-4ac8-a03c-88717e28f1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_055ced3d-d54e-4ac8-a03c-88717e28f1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_de3ed66e-48a0-4307-beaa-6b6376a5f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_TreasuryStockMember_de3ed66e-48a0-4307-beaa-6b6376a5f85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f9841e19-53db-4c73-9aa0-42446726dfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_323e7c5d-0e7b-47fa-9c12-6045632af3b7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f9841e19-53db-4c73-9aa0-42446726dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1bfd2b36-4748-4cc6-8ed5-e9a8df9d0b5f" xlink:to="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_363376dc-bbeb-4a65-a59c-203fb486ed9a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dc1c812b-b41e-4a0a-8f12-a002900fe857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dc1c812b-b41e-4a0a-8f12-a002900fe857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9cda6952-ffb6-42b3-a8db-2e621eaa7150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_9cda6952-ffb6-42b3-a8db-2e621eaa7150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfca881-db09-4bd1-80d0-e731e88e8af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ddfca881-db09-4bd1-80d0-e731e88e8af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_5ab94786-5bc7-46c7-8ebf-ae5f95d13e38" xlink:href="mo-20220630.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_5ab94786-5bc7-46c7-8ebf-ae5f95d13e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_3445bf4f-eb9f-4b4a-9a40-7bed1ef7058f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_DividendsCommonStockCash_3445bf4f-eb9f-4b4a-9a40-7bed1ef7058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e7354d3-fa6a-40c3-84cf-a9ad0752435d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4e7354d3-fa6a-40c3-84cf-a9ad0752435d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_143d6c55-d394-4bdb-97fc-c8291bf76649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_StockholdersEquityOther_143d6c55-d394-4bdb-97fc-c8291bf76649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71dd787a-4dc6-4957-9703-e913b6e1c81e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b68e3d0-9970-47a2-ba66-7fd9ed906ad4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71dd787a-4dc6-4957-9703-e913b6e1c81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_610f14ce-b806-4e27-8c13-2bd240d51144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_208be31c-44aa-407c-92c0-fd72bf99e073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_610f14ce-b806-4e27-8c13-2bd240d51144" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_208be31c-44aa-407c-92c0-fd72bf99e073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8d4321e-ad73-4da1-a26a-8c286fb37c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8d4321e-ad73-4da1-a26a-8c286fb37c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_423a0e17-3cce-436e-aa00-97bab7135be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8d4321e-ad73-4da1-a26a-8c286fb37c33" xlink:to="loc_us-gaap_ProfitLoss_423a0e17-3cce-436e-aa00-97bab7135be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8d4321e-ad73-4da1-a26a-8c286fb37c33" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dcc47905-fb26-4ec4-ac33-f99f4c32a861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dcc47905-fb26-4ec4-ac33-f99f4c32a861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a33dc383-5fd1-4962-8e18-fe9b6872606d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a33dc383-5fd1-4962-8e18-fe9b6872606d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_7a67c9ad-6fe9-4d8c-952d-5bdba8ee37f1" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_mo_IncomeLossFromEquityInvestments_7a67c9ad-6fe9-4d8c-952d-5bdba8ee37f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_801b1c7e-dd13-4c9e-a82c-d79450ab9810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_801b1c7e-dd13-4c9e-a82c-d79450ab9810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6869bcc1-fd16-45eb-b5bd-0694463051fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6869bcc1-fd16-45eb-b5bd-0694463051fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a2a70387-b8d9-4f39-97d1-d64ca2809a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a2a70387-b8d9-4f39-97d1-d64ca2809a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3f2f8854-4c34-4866-be37-132673761209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_3f2f8854-4c34-4866-be37-132673761209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3ac481aa-0f95-4e47-bf01-7077df9cfa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3ac481aa-0f95-4e47-bf01-7077df9cfa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a1213e50-d682-4a62-9a6a-3f2032ed05a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a1213e50-d682-4a62-9a6a-3f2032ed05a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ff161d9b-afc8-4fa6-83f0-58eff5c6c96d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ff161d9b-afc8-4fa6-83f0-58eff5c6c96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_88c1db7a-454d-4429-9c6e-d20249aed845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_88c1db7a-454d-4429-9c6e-d20249aed845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_115a6a1c-0cdb-4ca8-ab69-b2954ef64c13" xlink:href="mo-20220630.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18a90b61-7024-4486-a260-1032f4b1211a" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_115a6a1c-0cdb-4ca8-ab69-b2954ef64c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_6f0467dc-3795-461e-91f5-9fa5096ec910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_6f0467dc-3795-461e-91f5-9fa5096ec910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_3ad6dace-6ef8-4a9a-9ea6-75f1efbe7296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_3ad6dace-6ef8-4a9a-9ea6-75f1efbe7296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dd68c94a-8732-4a6b-9bbf-1b4d3b14d741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_18e81855-4224-4145-9580-ce708545d182" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_dd68c94a-8732-4a6b-9bbf-1b4d3b14d741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ccc51ce9-589b-4a3e-97a0-bf2d5b7b0c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_e8d4321e-ad73-4da1-a26a-8c286fb37c33" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ccc51ce9-589b-4a3e-97a0-bf2d5b7b0c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_afbc081a-7f44-4bab-b548-efc5654709f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_afbc081a-7f44-4bab-b548-efc5654709f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56f3bf8f-2897-4723-99fc-6b3e5ae7bdaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_afbc081a-7f44-4bab-b548-efc5654709f6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56f3bf8f-2897-4723-99fc-6b3e5ae7bdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c3b39736-c724-4d35-93ec-678a4ddd6e06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_afbc081a-7f44-4bab-b548-efc5654709f6" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c3b39736-c724-4d35-93ec-678a4ddd6e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6da4af36-cc6d-430e-b758-856381de362d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_afbc081a-7f44-4bab-b548-efc5654709f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6da4af36-cc6d-430e-b758-856381de362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_828eccb1-210d-4550-b591-47b43fc9b270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_828eccb1-210d-4550-b591-47b43fc9b270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1322f7a3-e88f-4b76-af37-53913de71b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1322f7a3-e88f-4b76-af37-53913de71b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_333cae9d-6107-4196-9a96-1d36d07c3c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_333cae9d-6107-4196-9a96-1d36d07c3c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_06a1ac91-184b-4438-9b6f-e518ba1fa45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_06a1ac91-184b-4438-9b6f-e518ba1fa45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b984cb0-dabe-41ad-a37a-2833581540e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_4b984cb0-dabe-41ad-a37a-2833581540e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ef28505f-c34a-4f49-ad0d-8dca5f9a58d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ef28505f-c34a-4f49-ad0d-8dca5f9a58d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f25015d-2b02-4a9a-aa7f-cf7b3ebc4dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4a950b78-778e-480e-9e27-57badbe010a8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0f25015d-2b02-4a9a-aa7f-cf7b3ebc4dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_293f4506-c46a-40de-ae8f-8292a3b3bd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_293f4506-c46a-40de-ae8f-8292a3b3bd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_69d994db-6a72-4502-92e9-5b16931fa380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_293f4506-c46a-40de-ae8f-8292a3b3bd86" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_69d994db-6a72-4502-92e9-5b16931fa380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cbdc2246-0bd8-4a92-8000-648e653be943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_293f4506-c46a-40de-ae8f-8292a3b3bd86" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cbdc2246-0bd8-4a92-8000-648e653be943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19971860-3176-4039-86de-ad613a8ecd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_293f4506-c46a-40de-ae8f-8292a3b3bd86" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_19971860-3176-4039-86de-ad613a8ecd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4f84f51-3fd8-4ca0-be1b-9957c0e125a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4f84f51-3fd8-4ca0-be1b-9957c0e125a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2115721e-3b91-4666-a0a9-a6ea5a6158a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_RestrictedCashCurrent_2115721e-3b91-4666-a0a9-a6ea5a6158a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ef62bb5f-bcbd-4470-aec9-29c319afcc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ef62bb5f-bcbd-4470-aec9-29c319afcc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d185d952-7d93-4cfd-bdcd-8792439a94e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a28395c-468b-4dbe-931b-57582f00ad90" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d185d952-7d93-4cfd-bdcd-8792439a94e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefa1839-d269-4a17-8bc9-70b2e9e13f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0763deab-8a98-471b-aa84-3f1728e8cd78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefa1839-d269-4a17-8bc9-70b2e9e13f37" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0763deab-8a98-471b-aa84-3f1728e8cd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_fb1463eb-3588-4da0-a606-283b5ab7c5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_fb1463eb-3588-4da0-a606-283b5ab7c5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7656f891-37fb-417d-8cc0-5388cf0415b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7656f891-37fb-417d-8cc0-5388cf0415b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_80f2641d-0269-4cd3-a09b-5a64f99cae77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_80f2641d-0269-4cd3-a09b-5a64f99cae77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock_e4a1642f-9e66-43a6-9e8a-34ff08858939" xlink:href="mo-20220630.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_mo_CashDiscountsPolicyTextBlock_e4a1642f-9e66-43a6-9e8a-34ff08858939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e344a7c2-cf55-4284-a537-e229be7379e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e344a7c2-cf55-4284-a537-e229be7379e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_c623c9a7-22fa-456f-b615-dd62ba2fe513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_c623c9a7-22fa-456f-b615-dd62ba2fe513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_d882aea3-6f84-41ff-aea4-f30a47f17b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_d882aea3-6f84-41ff-aea4-f30a47f17b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_23788fd5-98fa-4640-a50d-c6dba8ab07ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_23788fd5-98fa-4640-a50d-c6dba8ab07ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2f178202-98ec-46a3-842f-1ef65be36b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_883b7779-f0f8-4579-bf6d-c9b015a9cb7b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_2f178202-98ec-46a3-842f-1ef65be36b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ac16efce-d488-4a48-8f8f-5399fe7a8d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_0b0b931e-93a3-4663-b782-577fb8cacfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ac16efce-d488-4a48-8f8f-5399fe7a8d30" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_0b0b931e-93a3-4663-b782-577fb8cacfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f797d222-9555-4788-9f35-8bdee20331da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f797d222-9555-4788-9f35-8bdee20331da" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cd7993e1-163b-4c7e-a683-87d5145e63c5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_e937443a-39e0-45c2-9075-fe0b5ba49a74" xlink:href="mo-20220630.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8248ec36-fcec-4915-a43f-2181bc21defc" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_e937443a-39e0-45c2-9075-fe0b5ba49a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_934d3180-e9e0-4110-a2ec-f3e68f903ce6" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f8cf72f-bc4a-4ca8-8f7c-60a01394e757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5f8cf72f-bc4a-4ca8-8f7c-60a01394e757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_866f12f0-ccb1-4e9c-aeef-b1439ae0bb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_334c650e-8bef-4f85-bae4-4b70808f6f25" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_866f12f0-ccb1-4e9c-aeef-b1439ae0bb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BackgroundandBasisofPresentationShareRepurchaseTableDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19dcbf98-d487-450b-9a93-4461bbb11e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_19dcbf98-d487-450b-9a93-4461bbb11e3f" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e3248c90-4d6b-4885-9143-aaa28a169355" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_ee3dd43c-06cc-4cbb-8b9d-7975b0f55ce7" xlink:href="mo-20220630.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1f33903d-59dd-43ca-884b-601ce0e8435c" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_ee3dd43c-06cc-4cbb-8b9d-7975b0f55ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_9bdf8702-2f80-4aef-b5ac-6bcebca71cd4" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e4fdd17c-f793-4ea7-9ba1-cedc43ff15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e4fdd17c-f793-4ea7-9ba1-cedc43ff15dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_11df1f9c-246b-4ae2-a3f4-33b57390d6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_11df1f9c-246b-4ae2-a3f4-33b57390d6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_faad617d-d9be-42c3-ac92-51dd12182675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_c8613d77-7aac-437b-ab15-df2a3540cf39" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_faad617d-d9be-42c3-ac92-51dd12182675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20220630.xsd#RevenuesfromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_043db6b4-6b87-4032-8ee8-0a0d2c99dd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ba4e8be4-08b2-4866-aff8-2b760a490fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_043db6b4-6b87-4032-8ee8-0a0d2c99dd43" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ba4e8be4-08b2-4866-aff8-2b760a490fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8465a747-fedf-4ba4-a584-94a681735913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_339606fe-84d0-48b5-ac34-dcaa02cce2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8465a747-fedf-4ba4-a584-94a681735913" xlink:to="loc_us-gaap_ContractWithCustomerLiability_339606fe-84d0-48b5-ac34-dcaa02cce2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_40d323c3-d876-47ab-bcbf-e3daac995f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8465a747-fedf-4ba4-a584-94a681735913" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_40d323c3-d876-47ab-bcbf-e3daac995f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9cd9858d-617c-4cfc-a6fa-ca577bdbfa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8465a747-fedf-4ba4-a584-94a681735913" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9cd9858d-617c-4cfc-a6fa-ca577bdbfa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_0bd2eb87-4c40-4b3b-98d2-71467e71973b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8465a747-fedf-4ba4-a584-94a681735913" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_0bd2eb87-4c40-4b3b-98d2-71467e71973b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecurities"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d75f716d-1050-4b0c-b54c-924daf665e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_7e743770-c2f2-41ee-953f-2032c7aec731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d75f716d-1050-4b0c-b54c-924daf665e44" xlink:to="loc_us-gaap_InvestmentTextBlock_7e743770-c2f2-41ee-953f-2032c7aec731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_33bf50e1-3b8d-4e21-a02d-210bdc27414a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_63c989b9-2358-4d88-bcf9-615b68ae36e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_33bf50e1-3b8d-4e21-a02d-210bdc27414a" xlink:to="loc_us-gaap_InvestmentTableTextBlock_63c989b9-2358-4d88-bcf9-615b68ae36e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_b9dcd136-ebfe-442f-9170-7f4146849e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_33bf50e1-3b8d-4e21-a02d-210bdc27414a" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_b9dcd136-ebfe-442f-9170-7f4146849e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e852b629-dd31-4f2d-a71a-e346e1f15818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_33bf50e1-3b8d-4e21-a02d-210bdc27414a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e852b629-dd31-4f2d-a71a-e346e1f15818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_782cc151-c931-4d81-af41-5b7dad26ce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_782cc151-c931-4d81-af41-5b7dad26ce0d" xlink:to="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6c0e4b9f-6611-4af4-9e66-d465430cea19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e493b3ed-9be6-4bac-81d6-b164c65fb1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b2e71b1c-5c75-4e36-8fe2-ecc23a7edf53" xlink:to="loc_us-gaap_CommonStockMember_e493b3ed-9be6-4bac-81d6-b164c65fb1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7178e134-845d-4bf1-a784-7cdfef276d26" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_27c86c8f-ff13-4a35-b60c-c23746713b7b" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_ABInBevMember_27c86c8f-ff13-4a35-b60c-c23746713b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a764e8c6-01f9-4b3b-8607-fcbe02231dd0" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_JUULMember_a764e8c6-01f9-4b3b-8607-fcbe02231dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_26f56811-2dff-4753-93d6-6627c1f27ee9" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_48e96add-7d75-4bd8-acf4-66b2a8aad270" xlink:to="loc_mo_CronosGroupInc.Member_26f56811-2dff-4753-93d6-6627c1f27ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_46de05db-2a6c-411f-9a86-c91bced3b89f" xlink:to="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_18b69a87-8263-4e3f-9913-3b419c55af22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_us-gaap_EquityMethodInvestments_18b69a87-8263-4e3f-9913-3b419c55af22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_f58f4d8b-482d-4606-8e10-88e995087cb0" xlink:href="mo-20220630.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_mo_EquityInvestmentFairValueOption_f58f4d8b-482d-4606-8e10-88e995087cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_ee0a7331-2a64-4cac-8ec8-142e330a688a" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_ee0a7331-2a64-4cac-8ec8-142e330a688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_e007be95-e58a-45cf-945d-c5c5c651d4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_c324f59b-4656-4a63-bdae-ddc9da9bb4f8" xlink:to="loc_us-gaap_Investments_e007be95-e58a-45cf-945d-c5c5c651d4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_778030a7-a76d-4370-b7c8-9e3125eee1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_778030a7-a76d-4370-b7c8-9e3125eee1ed" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bddd32c-fb7e-4109-9ada-c9fa678be6eb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_f9237c59-44b9-44f0-8bfd-57158021c1fa" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_ABInBevMember_f9237c59-44b9-44f0-8bfd-57158021c1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_c6697386-eed6-4580-b977-ebe8ecd10dd9" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_CronosGroupInc.Member_c6697386-eed6-4580-b977-ebe8ecd10dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a3b0c9e0-0630-4d86-a66d-94fa2d6aec27" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_f52510d7-5c00-4207-a7e4-92f72d6edb96" xlink:to="loc_mo_JUULMember_a3b0c9e0-0630-4d86-a66d-94fa2d6aec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f4d665b1-47d0-421a-8b1c-6c38e1a431b5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_106a655c-fef0-4e1e-be47-86ee1f5170b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_106a655c-fef0-4e1e-be47-86ee1f5170b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_e7b634b6-850c-445e-9658-2240d3c47160" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_e7b634b6-850c-445e-9658-2240d3c47160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_39babdf3-54a5-43a4-8779-bafeec513a79" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cbe74792-7e9d-4eb4-bc5d-d75338fd3242" xlink:to="loc_mo_IncomeLossFromEquityInvestments_39babdf3-54a5-43a4-8779-bafeec513a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_9c66ffbf-fc4a-4749-ba60-38c92749dfbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9c66ffbf-fc4a-4749-ba60-38c92749dfbc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_04535672-5bd1-4a46-a584-a460e719dd18" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0328bae0-78f4-48d9-9186-1a723ca32c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_34d9d6eb-6a8f-4440-9aec-5818bebef9a7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0328bae0-78f4-48d9-9186-1a723ca32c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4bd32638-0db8-4348-8c75-4bccc1a3d88e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c487906a-d493-4d14-9608-0ffd88629582" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32ba1ce3-7d11-468f-9bab-671492fe7c54" xlink:to="loc_mo_ABInBevMember_c487906a-d493-4d14-9608-0ffd88629582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_54f1fa70-5742-434d-8767-fa229d9c7d89" xlink:to="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_02034e62-ea67-4761-93c0-5ad66db8a5f9" xlink:href="mo-20220630.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_128cf949-0371-4a1e-bc32-fe2432723364" xlink:to="loc_mo_ABInBevMember_02034e62-ea67-4761-93c0-5ad66db8a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab2f1f7e-f4a0-480d-937f-f08c69110bda" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_534f3a77-26eb-43fe-8f41-84933856ade7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8a6de13f-4866-469c-88d4-4e335a73a6d2" xlink:to="loc_us-gaap_SubsequentEventMember_534f3a77-26eb-43fe-8f41-84933856ade7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d6e7f375-f301-471a-a081-7fa37035e509" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b26f4a0-e70e-4e30-9356-9a017158367f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4b26f4a0-e70e-4e30-9356-9a017158367f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8fabd2d4-4944-4ed9-ad99-91921cb65873" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8fabd2d4-4944-4ed9-ad99-91921cb65873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_0ed38ecb-6653-413a-83ee-cdae9b3f45aa" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_0ed38ecb-6653-413a-83ee-cdae9b3f45aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RestrictedSharesLockupPeriod_3a813670-683a-49f5-9edd-531b88613b3e" xlink:href="mo-20220630.xsd#mo_RestrictedSharesLockupPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_RestrictedSharesLockupPeriod_3a813670-683a-49f5-9edd-531b88613b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_456e2abe-da9c-4579-9791-70ad2f4cc68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_456e2abe-da9c-4579-9791-70ad2f4cc68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_81a4f49d-9d17-4cc3-888a-4bb7b5d0fd30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_us-gaap_EquityMethodInvestments_81a4f49d-9d17-4cc3-888a-4bb7b5d0fd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_0fd963fd-1b4e-4b3e-8759-92360ea6240b" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_0fd963fd-1b4e-4b3e-8759-92360ea6240b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_33a9389f-d041-450f-8ba9-cf28142adb1f" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_f2e9f7e3-18b1-4c29-a6b7-b0fd35a06f88" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_33a9389f-d041-450f-8ba9-cf28142adb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d8e0d383-bc17-48b5-9277-555f03686df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d8e0d383-bc17-48b5-9277-555f03686df0" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cb419983-e792-433f-80cb-2636e1b89f97" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_b718d678-03c4-4f58-8dc3-1ee6d10835c3" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_09f2bd77-676c-4681-bf33-f36a7ad8ff63" xlink:to="loc_mo_JUULMember_b718d678-03c4-4f58-8dc3-1ee6d10835c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_18e736b0-741c-409d-9f81-14e3261d4da5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_16a0bfbc-aa80-42d9-95a7-e25cdcfdf018" xlink:href="mo-20220630.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_16a0bfbc-aa80-42d9-95a7-e25cdcfdf018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_763a6743-9f50-438d-b1ad-10e28c3373ae" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_763a6743-9f50-438d-b1ad-10e28c3373ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentsFairValueOptionVotingShares_479f16bd-6800-47e1-a463-9c4da4748efa" xlink:href="mo-20220630.xsd#mo_EquityInvestmentsFairValueOptionVotingShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquityInvestmentsFairValueOptionVotingShares_479f16bd-6800-47e1-a463-9c4da4748efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_acc285c0-d2c9-4ac5-92ac-31f43e765006" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm_acc285c0-d2c9-4ac5-92ac-31f43e765006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_5aa9ef44-6661-4861-8091-10d101ba67bc" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_5aa9ef44-6661-4861-8091-10d101ba67bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_63df5a68-6e67-4673-8959-005dac96fb4d" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_63df5a68-6e67-4673-8959-005dac96fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ae2dc9-069a-4c83-b891-f508a7fddd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15ae2dc9-069a-4c83-b891-f508a7fddd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_e77dd03f-0944-4422-bc03-5f05d5b4867c" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers_e77dd03f-0944-4422-bc03-5f05d5b4867c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e05d0ee9-40c4-46f6-bfdc-35f957067fb7" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion_e05d0ee9-40c4-46f6-bfdc-35f957067fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_cab74de3-634f-4f68-bf7b-6524703159eb" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion_cab74de3-634f-4f68-bf7b-6524703159eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_6fcb02d1-8532-42c2-873f-3439cf8ee418" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion_6fcb02d1-8532-42c2-873f-3439cf8ee418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_75472365-8a67-4a6f-a93e-70420409b687" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion_75472365-8a67-4a6f-a93e-70420409b687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_d4f54aee-1b19-4903-99f1-473886dfea72" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion_d4f54aee-1b19-4903-99f1-473886dfea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_d42ee022-34de-4ea3-bd6a-9ece8836f178" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion_d42ee022-34de-4ea3-bd6a-9ece8836f178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_fcba84e6-d9d6-4ace-b1ad-5fdec9cac31b" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion_fcba84e6-d9d6-4ace-b1ad-5fdec9cac31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_71ccb569-26ca-4ec9-b0a7-f2ccfae23866" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion_71ccb569-26ca-4ec9-b0a7-f2ccfae23866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_a4005b6d-6c8c-4664-a0a9-bc2e47ab0d21" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion_a4005b6d-6c8c-4664-a0a9-bc2e47ab0d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_36333b02-0d5f-4e23-a466-6a0c6af59267" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestmentsFairValueOption"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a9662fd3-30d4-41e9-aa9c-bb75a3f3a384" xlink:to="loc_mo_IncomeLossFromEquityInvestmentsFairValueOption_36333b02-0d5f-4e23-a466-6a0c6af59267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_fd16a911-ef12-4067-94d3-ca089e82e3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_fd16a911-ef12-4067-94d3-ca089e82e3c2" xlink:to="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_76869efb-dd9b-48bd-b640-f7df6c9072b0" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFairValueOptionMember_36cf801c-ac95-46fe-a697-d48f5dd3eb13" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentsFairValueOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_de53ede9-2584-4b8d-a765-11a875a367ca" xlink:to="loc_mo_EquityMethodInvestmentsFairValueOptionMember_36cf801c-ac95-46fe-a697-d48f5dd3eb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6f4f13a6-7360-41d2-b71a-d5df8e7cbab3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_7c0556a6-b19f-4f4e-996a-fceca45dd7b4" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a5f674f5-3d46-45d1-8ce8-5c76710b127d" xlink:to="loc_mo_JUULMember_7c0556a6-b19f-4f4e-996a-fceca45dd7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_71dfca8d-b0ff-44c1-bcc1-85d80b9b28d2" xlink:to="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7c0873b6-e271-4098-b98a-2eb25fd217a7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1cf05d61-72e0-46ec-8c87-8c2f266a1512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1cf05d61-72e0-46ec-8c87-8c2f266a1512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_6e79723d-eae5-4d86-b6bd-5bcb03a129b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_6e79723d-eae5-4d86-b6bd-5bcb03a129b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_94c6ab9f-7ad4-43d8-aab1-df9973d0a346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_55541c2d-a278-4e2b-bea7-f28927e0fdce" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_94c6ab9f-7ad4-43d8-aab1-df9973d0a346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_17b72eb2-a02f-4a2d-a775-f74d2052cd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:href="mo-20220630.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_17b72eb2-a02f-4a2d-a775-f74d2052cd5b" xlink:to="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_434eb617-d398-4a77-9e8d-42815e5bb4dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_2f559990-8f28-4e7a-80b8-79d0f490ddb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c1846d0-7f4c-415a-a7ed-2b792d553a12" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_2f559990-8f28-4e7a-80b8-79d0f490ddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a32dd3c4-8b48-47c6-a0c2-c48c5c816af9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1e625451-eca8-4558-89a1-2eefa53cb79b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4b6a0d8f-bce1-4047-a750-eaae89701da8" xlink:to="loc_us-gaap_CommonStockMember_1e625451-eca8-4558-89a1-2eefa53cb79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4193deb4-450a-435e-874d-8ee64e8718f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_bd327508-1839-4a5b-9ee0-3298686336c7" xlink:href="mo-20220630.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_bd327508-1839-4a5b-9ee0-3298686336c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e6b1b684-0554-4587-8a12-b9b447e524f9" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractWarrantMember_e6b1b684-0554-4587-8a12-b9b447e524f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_894db4a6-a46b-43b2-b563-13e8850e49fe" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fd2f1624-2646-46a0-8cf4-76f3120bd43d" xlink:to="loc_mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember_894db4a6-a46b-43b2-b563-13e8850e49fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e0f21e55-ce42-471b-8f0b-579c3100bd41" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_3de983ba-5768-4e4d-940e-b04018159279" xlink:href="mo-20220630.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_8eb03cc4-3372-4c3e-8c91-b4e8c687f670" xlink:to="loc_mo_CronosGroupInc.Member_3de983ba-5768-4e4d-940e-b04018159279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_78e24403-d9b0-4705-b7a0-fff6dbf06f31" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_18176102-b6d8-4498-a2a6-24a5aacc5dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7acbf8f9-9284-4587-bb4d-269f96c055ec" xlink:to="loc_us-gaap_SubsequentEventMember_18176102-b6d8-4498-a2a6-24a5aacc5dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:href="mo-20220630.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_b722a7d2-00e5-4bf5-a12f-782e0e72690d" xlink:to="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_244a7952-440e-40ff-921a-336ea6d29f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_244a7952-440e-40ff-921a-336ea6d29f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a5c1d22a-ca52-47ad-8527-491c4e6dc0d9" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a5c1d22a-ca52-47ad-8527-491c4e6dc0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_59169767-50de-4374-b1cb-2c5afebef882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_59169767-50de-4374-b1cb-2c5afebef882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_3287edd7-8cd8-432d-adce-6df9f2a9d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquityMethodInvestments_3287edd7-8cd8-432d-adce-6df9f2a9d92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_2e48cbd6-7814-4268-9073-7715998fa7ee" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_2e48cbd6-7814-4268-9073-7715998fa7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_b19ff840-e84b-4faa-9d10-9629d6dcdd7f" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage_b19ff840-e84b-4faa-9d10-9629d6dcdd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_b5b0d8bb-5934-4b5f-be4b-4d9c554c962e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_b5b0d8bb-5934-4b5f-be4b-4d9c554c962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_cfae5f2d-a72f-4b34-9efa-a7dfada3fc87" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_cfae5f2d-a72f-4b34-9efa-a7dfada3fc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_4ada4430-d595-4387-9633-b7c23d98f1b1" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_4ada4430-d595-4387-9633-b7c23d98f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_552c1964-e8ce-4e33-85c1-5bc9b17e7fb8" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_552c1964-e8ce-4e33-85c1-5bc9b17e7fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentAggregateExercisePrice_5ec6c8bb-eba8-4e19-b2df-0b9bf4f30330" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentAggregateExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentAggregateExercisePrice_5ec6c8bb-eba8-4e19-b2df-0b9bf4f30330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_9f33c293-3fcc-433b-9dd3-5021a5367b65" xlink:href="mo-20220630.xsd#mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_4abc3db5-a8df-483b-82e2-808863a8a68e" xlink:to="loc_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage_9f33c293-3fcc-433b-9dd3-5021a5367b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6df5cdf0-0fdd-46fa-a489-40a753e8243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6df5cdf0-0fdd-46fa-a489-40a753e8243c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3fcfaa2-8efb-4077-bc0e-a2cf096b4faa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_4cb0bdf9-c059-4a0f-931a-536abb89d648" xlink:href="mo-20220630.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_4cb0bdf9-c059-4a0f-931a-536abb89d648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_e06e9aa2-bae8-476b-a1aa-387cac6c9459" xlink:href="mo-20220630.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7314c994-2092-4970-b8aa-6717f834a4c6" xlink:to="loc_mo_EquityContractWarrantMember_e06e9aa2-bae8-476b-a1aa-387cac6c9459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_a55f2839-76ac-4894-876d-3a5793998d0a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_ddef53e2-7110-4139-bfae-d9983bdeb1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_0b7417e6-9e70-4866-829c-38a37e6814aa" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_ddef53e2-7110-4139-bfae-d9983bdeb1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c253956d-7f3a-46e7-9453-69544842f434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_97624930-007a-42da-883c-1a9dfac0c25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c253956d-7f3a-46e7-9453-69544842f434" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_97624930-007a-42da-883c-1a9dfac0c25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_acaecd43-9232-4577-b315-8424d4a14ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_035b02b2-03b5-4ab7-b501-b8f6018f61b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_acaecd43-9232-4577-b315-8424d4a14ccb" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_035b02b2-03b5-4ab7-b501-b8f6018f61b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_92e093cb-fe96-4096-ac6b-3b450d79c83b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_acaecd43-9232-4577-b315-8424d4a14ccb" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_92e093cb-fe96-4096-ac6b-3b450d79c83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstrumentsAggregateFairValueandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_56007499-c933-48d4-8fb6-1a5e7b35989f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_56007499-c933-48d4-8fb6-1a5e7b35989f" xlink:to="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:to="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1274b85c-967d-4903-8739-e47b6c6cd6f9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_287820a7-5064-441e-a3b1-9a19fadfce0c" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a781cc95-b20c-4478-92e5-df06f98fef1e" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_287820a7-5064-441e-a3b1-9a19fadfce0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f0006820-fb1f-4058-a961-a9698f853a31" xlink:to="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4610061c-b2de-4de7-971f-536f003fe0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_us-gaap_LongTermDebt_4610061c-b2de-4de7-971f-536f003fe0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_a0215c6c-1e0f-49f6-8189-890927bfe56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_us-gaap_LongTermDebtFairValue_a0215c6c-1e0f-49f6-8189-890927bfe56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_247cd633-8f5a-4165-bfae-7fcd8e760d5a" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_19270292-c0cb-4116-a05a-9bfc5994ce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:to="loc_us-gaap_LongTermDebt_19270292-c0cb-4116-a05a-9bfc5994ce0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_70574089-1acf-4152-9f3f-9ea8a4412b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_22b10105-f53d-45f2-a35f-c051e4b52259" xlink:to="loc_us-gaap_DebtInstrumentFairValue_70574089-1acf-4152-9f3f-9ea8a4412b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_565dce6f-3ad4-482a-bae4-8c86304a931d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_565dce6f-3ad4-482a-bae4-8c86304a931d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_60c6276f-520a-482f-959c-91e3bb01bb98" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_8ef01c7d-b649-43da-b078-d973fca8fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_8ef01c7d-b649-43da-b078-d973fca8fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_3f493831-a5c9-4c76-a084-9797cff297f1" xlink:href="mo-20220630.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f36aa082-5572-4584-86b7-0ca28253d4cf" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_3f493831-a5c9-4c76-a084-9797cff297f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_dea24a64-070e-401a-a192-9eced902a85f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1396e618-722b-4c7b-bc0f-63d5f0a5e45f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_801031bd-e9ca-4439-aa28-569a6fafa3c2" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1396e618-722b-4c7b-bc0f-63d5f0a5e45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a1a3a25b-e658-4ec5-83e9-d69acfbd7bca" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_04723a47-282c-42a1-a96f-f4254983d257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_04723a47-282c-42a1-a96f-f4254983d257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_d2a307c7-a71e-4677-9fa5-922a6c5e6ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5c03d806-b881-4f6c-97ce-bfecaa2ae11b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_d2a307c7-a71e-4677-9fa5-922a6c5e6ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_934765b7-7066-4220-beca-2a0ddfd43573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b50b236b-8654-42a3-8b39-c0f3c2deb538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_934765b7-7066-4220-beca-2a0ddfd43573" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b50b236b-8654-42a3-8b39-c0f3c2deb538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_82a439c5-4e4b-420e-b4e7-e39e23c8d6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_9aeb4961-f0e0-41dd-9356-b1057ecf5728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_82a439c5-4e4b-420e-b4e7-e39e23c8d6ad" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_9aeb4961-f0e0-41dd-9356-b1057ecf5728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_43199b8b-d0f4-4732-8225-64184d45308d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_43199b8b-d0f4-4732-8225-64184d45308d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_60c287ec-6d06-4017-8ef6-d7d682b40c58" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_976a9398-ccb9-406e-8a3c-b75061d6ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_976a9398-ccb9-406e-8a3c-b75061d6ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_58306705-6249-43c4-b543-8f4ece38014e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_303f12c6-f806-4d07-9b73-9d35b9f34e4e" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_58306705-6249-43c4-b543-8f4ece38014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6e740ac9-4285-409f-88ea-b44c9bb0015b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7e78b5c4-dddf-4212-8bd4-d0becc877d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7e78b5c4-dddf-4212-8bd4-d0becc877d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_6e771390-bec6-43f2-8c87-96c5f6362545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_6e771390-bec6-43f2-8c87-96c5f6362545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0330c702-e407-4d1c-8e61-62c85a458dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0330c702-e407-4d1c-8e61-62c85a458dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_790900f3-a653-4189-9180-b6301f92b2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_790900f3-a653-4189-9180-b6301f92b2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_82f27062-12cd-4bf7-b059-763f4165a07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_a03ea968-d003-4b27-8c06-9fe47fb840f6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_82f27062-12cd-4bf7-b059-763f4165a07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_df657797-77b5-4212-becc-a4a92d3158f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_86a4ef4e-b0e2-4845-a42f-e4e9fe03ca23" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_df657797-77b5-4212-becc-a4a92d3158f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c0abec67-1673-4bb9-80dc-4ca2bea3d05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c0abec67-1673-4bb9-80dc-4ca2bea3d05d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e5a0afa0-944f-4981-b6d7-46d38e48c8a8" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e97047cc-0dea-4293-8c87-49fbe91616c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e97047cc-0dea-4293-8c87-49fbe91616c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_fedd2f46-d4d0-4b5f-b18f-b2a454639c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b3b038cd-ee66-4593-a5d4-1171f67191be" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_fedd2f46-d4d0-4b5f-b18f-b2a454639c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:to="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4632f960-ca6d-4b06-b872-53b9930fdf47" xlink:to="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ae7167d7-7c1f-465c-9f6f-9487bb4ed393" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fe7d1301-085a-4b4d-94c8-d4fb68d46908" xlink:to="loc_srt_MaximumMember_ae7167d7-7c1f-465c-9f6f-9487bb4ed393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_eebcd254-9e81-465b-9f6d-47fc72da8f71" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d240c644-e546-4355-90c4-c433555b41c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_d240c644-e546-4355-90c4-c433555b41c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7301c89b-a789-424e-82ff-3f67933f97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear_7301c89b-a789-424e-82ff-3f67933f97b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_a8a6cc08-67fb-40ab-8fdd-3336076492eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9142822-b669-47b4-bb0e-084430db1475" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_a8a6cc08-67fb-40ab-8fdd-3336076492eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShare" xlink:type="simple" xlink:href="mo-20220630.xsd#EarningsperShare"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6a6ededa-164f-4e5f-a381-230df883b9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ff645697-0533-46aa-b16d-202e0b6f2fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6a6ededa-164f-4e5f-a381-230df883b9c1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ff645697-0533-46aa-b16d-202e0b6f2fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareTables" xlink:type="simple" xlink:href="mo-20220630.xsd#EarningsperShareTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_feb87fd9-892c-4e03-818c-af1a89e6a307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ebbdfe5b-7036-4189-af00-637b0d5b48cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_feb87fd9-892c-4e03-818c-af1a89e6a307" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ebbdfe5b-7036-4189-af00-637b0d5b48cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#EarningsperShareBasicandDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2a3ff1f7-e772-4b39-8aed-1c7e45df5c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_us-gaap_NetIncomeLoss_2a3ff1f7-e772-4b39-8aed-1c7e45df5c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_998611bd-81c6-41ad-ac40-aae71f56c6e4" xlink:href="mo-20220630.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_998611bd-81c6-41ad-ac40-aae71f56c6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b837442-e7b2-4fcf-bb20-efbae131efaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b837442-e7b2-4fcf-bb20-efbae131efaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_179aff9b-4459-42b8-b76d-8130769baf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_179aff9b-4459-42b8-b76d-8130769baf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0d700d41-bc20-421b-9cb1-2d0a5ae8a904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0d700d41-bc20-421b-9cb1-2d0a5ae8a904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b100332-c2a8-405b-8c58-e50dc2ea22ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1c345b21-6960-4b4e-bc89-c7aa8ee1d08c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b100332-c2a8-405b-8c58-e50dc2ea22ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d6d4ad79-5961-4aea-a62b-f5161fb9fa71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_46d1da86-6cf4-4c32-923b-41cc709868d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d6d4ad79-5961-4aea-a62b-f5161fb9fa71" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_46d1da86-6cf4-4c32-923b-41cc709868d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_470db60d-4a35-4a76-9a56-f311d107270a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e451062c-268e-4746-8fc5-bc3e58a0d4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_470db60d-4a35-4a76-9a56-f311d107270a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e451062c-268e-4746-8fc5-bc3e58a0d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_14bc4c90-9d5f-4db7-95ae-be7c7df65b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_470db60d-4a35-4a76-9a56-f311d107270a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_14bc4c90-9d5f-4db7-95ae-be7c7df65b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8b14ec9e-7569-49a6-9b43-4af6506ba586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8b14ec9e-7569-49a6-9b43-4af6506ba586" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_69a43b04-3664-4de6-917d-9c12a9ea0ffa" xlink:to="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e9a7394a-d640-4443-b1cb-06bb646e5a40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ae044a66-3d3e-4be8-a491-ad92e5be3105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ae044a66-3d3e-4be8-a491-ad92e5be3105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_60d194f5-974a-4cb0-a327-836d5d36cd45" xlink:href="mo-20220630.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_60d194f5-974a-4cb0-a327-836d5d36cd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f8bf8a1-1271-4be0-b5eb-4844fc88c04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_66fb71ba-9ed6-4add-95c3-6e1f1c15d114" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3f8bf8a1-1271-4be0-b5eb-4844fc88c04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_fe760530-81ab-48f5-9da4-4865c999dcbf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_29bbb367-c5c4-4b0e-a2ab-56ddabddd2ef" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdde31bf-d14a-4f55-84ba-fb60a3ba62fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdde31bf-d14a-4f55-84ba-fb60a3ba62fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4e4e55d7-ec4d-4d02-a0ca-dfe00abf6bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4e4e55d7-ec4d-4d02-a0ca-dfe00abf6bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_787592e3-2581-455c-ab0e-a2ee742f8fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_787592e3-2581-455c-ab0e-a2ee742f8fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ccbc7d70-fefa-4f72-b0f5-d5ed8da6217f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ccbc7d70-fefa-4f72-b0f5-d5ed8da6217f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_020b768f-b3ff-4200-a23d-5e0dfffcf987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_020b768f-b3ff-4200-a23d-5e0dfffcf987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_89845b83-728b-4fe3-9512-e9ab0ffad9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_89845b83-728b-4fe3-9512-e9ab0ffad9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b5a557ec-6b90-429f-b466-360a2e93f2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b5a557ec-6b90-429f-b466-360a2e93f2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1571c081-2913-49f0-8934-2f3991dd6012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1571c081-2913-49f0-8934-2f3991dd6012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2867457e-6c80-4f51-97fc-7b9f8844ddc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_edaf95c8-1a3d-4dfb-afe3-0a8c0956af0a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2867457e-6c80-4f51-97fc-7b9f8844ddc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b2c243ab-387c-4d92-87a9-250f7af56817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b2c243ab-387c-4d92-87a9-250f7af56817" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8aae16f-7a4a-4002-a6c4-936b2aec982f" xlink:to="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e3fa75b7-3133-4339-9910-a792bb542348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_e3fa75b7-3133-4339-9910-a792bb542348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_66256430-f22d-456c-a3a2-028345c68f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_66256430-f22d-456c-a3a2-028345c68f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_5880d769-7bdc-4301-8fbb-1ae9d11e825e" xlink:href="mo-20220630.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_93e17d55-d465-4fc7-8c1f-516934ba5d28" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_5880d769-7bdc-4301-8fbb-1ae9d11e825e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_bbda83bd-375a-4f5d-8c0b-32e0a08f95dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_88098e67-7a91-4eb5-87c0-293f4c6f917b" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_bbda83bd-375a-4f5d-8c0b-32e0a08f95dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_736430c3-f45a-4dca-8b1b-da224f082cb2" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_668c9b48-12cb-4a95-8581-881abec0af97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_7611b20a-ffb6-4dcd-bb94-2c3190629566" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_668c9b48-12cb-4a95-8581-881abec0af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7aeddda4-de58-44b5-a341-d37e8ef2fa37" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_92f9fc7b-7e76-47f0-959e-2f20e3d32081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_92f9fc7b-7e76-47f0-959e-2f20e3d32081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bfe07c09-18d1-4f2b-8cdb-2ec6d653d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bfe07c09-18d1-4f2b-8cdb-2ec6d653d4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47b562b8-7a89-4d41-87c2-c8a6e97529cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_b268ee6c-6103-45d3-8480-fc975cec4455" xlink:to="loc_us-gaap_ProfitLoss_47b562b8-7a89-4d41-87c2-c8a6e97529cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ba1180e6-4c6e-4674-862d-b2ea39fd2e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9fae3ab7-1f05-4006-837d-79441c6f7c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba1180e6-4c6e-4674-862d-b2ea39fd2e83" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9fae3ab7-1f05-4006-837d-79441c6f7c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f808e711-ce90-4703-a43f-4e0667644e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_90bceaa6-3230-48b0-b4ad-61290317eb90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f808e711-ce90-4703-a43f-4e0667644e1b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_90bceaa6-3230-48b0-b4ad-61290317eb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock_21e4adb2-4587-4718-a3ce-1945cc222775" xlink:href="mo-20220630.xsd#mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f808e711-ce90-4703-a43f-4e0667644e1b" xlink:to="loc_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock_21e4adb2-4587-4718-a3ce-1945cc222775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_41325dd4-0cf2-48a6-afc0-a9e33021a685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_41325dd4-0cf2-48a6-afc0-a9e33021a685" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:to="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f2619025-6d8a-4598-af19-f0a1d9e3aebb" xlink:to="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_30eda795-2508-45cd-b73e-6cf320cf27bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_30eda795-2508-45cd-b73e-6cf320cf27bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4c4fc23e-6a7c-4bf4-9e34-7526620265c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c589904e-8c44-4ed0-b369-262faa900d90" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4c4fc23e-6a7c-4bf4-9e34-7526620265c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0953b439-7757-4144-b534-d7389eb47e9a" xlink:to="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_cda816e5-6ae7-420c-8235-70f4648c4a29" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_SmokeableProductsSegmentMember_cda816e5-6ae7-420c-8235-70f4648c4a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_ca26bd5c-7273-4a90-81ca-aeea07c568ee" xlink:href="mo-20220630.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_OralTobaccoSegmentMember_ca26bd5c-7273-4a90-81ca-aeea07c568ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_6029ec6f-e5af-4559-bda3-f975bde7d8db" xlink:href="mo-20220630.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_mo_WineSegmentMember_6029ec6f-e5af-4559-bda3-f975bde7d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_21b1ba70-9b81-444c-a551-a75de6708e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b676e97a-43be-4b96-b1dd-49f3854ead51" xlink:to="loc_us-gaap_AllOtherSegmentsMember_21b1ba70-9b81-444c-a551-a75de6708e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e20a76cb-0a07-429a-8099-fc4c6aa2f70a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f417e7c-c246-4942-b5b3-e3b245d7e31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f417e7c-c246-4942-b5b3-e3b245d7e31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_f378c817-f817-40f6-a5a6-98d41851bb95" xlink:href="mo-20220630.xsd#mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles_f378c817-f817-40f6-a5a6-98d41851bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_93089519-175c-488f-8af2-27eb84d7869c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_93089519-175c-488f-8af2-27eb84d7869c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2b4008a8-e6a9-4b23-a14c-bd7bf0b65369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2b4008a8-e6a9-4b23-a14c-bd7bf0b65369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9b573135-8cd3-4ccd-9b50-188ef0671522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_OperatingIncomeLoss_9b573135-8cd3-4ccd-9b50-188ef0671522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_c08a6921-08ae-42e9-a0b8-86ce391e0635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_c08a6921-08ae-42e9-a0b8-86ce391e0635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc2a0804-9a45-47b0-b3a4-1a69499cd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc2a0804-9a45-47b0-b3a4-1a69499cd26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_80d2ed79-261b-4c5a-806d-1f55cb8bcd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_80d2ed79-261b-4c5a-806d-1f55cb8bcd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_bbdc61fc-3aed-494a-8f3b-0cec62f3fd5f" xlink:href="mo-20220630.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_mo_IncomeLossFromEquityInvestments_bbdc61fc-3aed-494a-8f3b-0cec62f3fd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5de8e6c7-24cc-4fb5-a204-a08763aebbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5de8e6c7-24cc-4fb5-a204-a08763aebbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae60f61c-5df2-466c-95f4-0189c30ac540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_15946251-4c85-4a40-838e-5b22cfd132a3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae60f61c-5df2-466c-95f4-0189c30ac540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a0e12f0d-f4aa-465c-aa52-8c22adcc5d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a0e12f0d-f4aa-465c-aa52-8c22adcc5d88" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_84ecc2a8-d78b-485c-8f57-3af8dcfe830e" xlink:to="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_7b8cb0f9-3e32-4f5b-a431-987b8f980654" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:to="loc_mo_SmokeableProductsSegmentMember_7b8cb0f9-3e32-4f5b-a431-987b8f980654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_f1a14918-60f8-4ea9-8c7d-8bb04c746868" xlink:href="mo-20220630.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_54a52506-3af9-4020-a2c3-25100708f892" xlink:to="loc_mo_OralTobaccoSegmentMember_f1a14918-60f8-4ea9-8c7d-8bb04c746868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_af428c8c-69aa-44e5-a3ea-cb92916dcef2" xlink:to="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_dc914c87-b16b-4f11-b733-3619ea9885c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b8413eb4-1587-4a6b-aa73-09966fa36fdc" xlink:to="loc_us-gaap_OperatingSegmentsMember_dc914c87-b16b-4f11-b733-3619ea9885c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8711c39e-6893-44e0-aa21-f33e393671c3" xlink:to="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_ba05666a-6bd6-4949-b8f0-de76abf13074" xlink:href="mo-20220630.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_ba05666a-6bd6-4949-b8f0-de76abf13074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_2d67bdeb-52d3-4c98-a642-7888dfad0fb6" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_89bf439a-f608-4acd-acba-3b69a23ddaea" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_2d67bdeb-52d3-4c98-a642-7888dfad0fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1866fb79-3057-4b8a-9bf7-06bc2b1a1671" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_ebe7d46c-f7a0-458d-b286-36ce0d2397bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1bdf9c82-3c40-4df7-93ff-439c7f364349" xlink:to="loc_us-gaap_OperatingIncomeLossMember_ebe7d46c-f7a0-458d-b286-36ce0d2397bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_afe42b67-6876-406a-930b-af38cc5c66d0" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_0d1221f4-164b-43a9-905d-311c97ba6e4b" xlink:href="mo-20220630.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_e6d519f5-6ae6-4b23-b5a9-77f43f4a2ec0" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_0d1221f4-164b-43a9-905d-311c97ba6e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7dde1590-2cb7-4f97-9d91-119a67b69cb9" xlink:to="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_03fc2966-ed5e-406d-b8ee-4dd08098e06e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_966568ea-60cc-40ab-8380-01656725460c" xlink:to="loc_mo_PhilipMorrisUSAMember_03fc2966-ed5e-406d-b8ee-4dd08098e06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_41f11d77-e229-48bc-ba97-00ead4c195bf" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_2dff80c2-8b16-477e-83a0-6d6639f08810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_2dff80c2-8b16-477e-83a0-6d6639f08810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d85d0088-a52c-4790-b6d3-d48764549c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d85d0088-a52c-4790-b6d3-d48764549c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd383e21-8348-4d5a-b922-84f95e214367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1bdd8a8f-bfec-481a-93e1-743530278810" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dd383e21-8348-4d5a-b922-84f95e214367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_42546c49-371c-4fd4-920f-3179a7c5f41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_42546c49-371c-4fd4-920f-3179a7c5f41d" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a15074a8-fa07-42c2-914a-4d0cb38f1d95" xlink:to="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_881c8180-97b3-474d-a1f0-587de47083b3" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e6007b0a-3df7-489f-8407-2d6f39fb8567" xlink:to="loc_mo_PhilipMorrisUSAMember_881c8180-97b3-474d-a1f0-587de47083b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_ae22f6b9-a8dd-4bf4-a2da-1b6680d80d20" xlink:to="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_0ca2a5a2-0719-403b-94b5-edfd408c4fe4" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_998b4356-c571-4efe-a70e-fae5c83d419a" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_0ca2a5a2-0719-403b-94b5-edfd408c4fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_686a1286-0084-46a4-9f7c-3178445b9655" xlink:to="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f37d6772-9166-43a9-9301-e7fd12e10bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_OperatingSegmentsMember_f37d6772-9166-43a9-9301-e7fd12e10bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_31ff3f28-ec3e-48cd-b25b-2641c4adc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_31ff3f28-ec3e-48cd-b25b-2641c4adc71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_4078d301-2276-4897-8d53-04ef5ebd2ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_24a6166c-9141-4f28-964e-3e387d4e448f" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_4078d301-2276-4897-8d53-04ef5ebd2ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e0f805a4-51de-45e0-b55c-ae1c10911dbf" xlink:to="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_e1e5b2ea-1d8a-4ce7-9b20-32be6ad056dc" xlink:href="mo-20220630.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb61214d-645e-4f9e-aef6-53d76b2a88f4" xlink:to="loc_mo_SmokeableProductsSegmentMember_e1e5b2ea-1d8a-4ce7-9b20-32be6ad056dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_bee88a4d-d4e0-496d-b686-ec25342e8b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_1e7be2a5-6bac-4eb7-a0a8-ae9ee6aa7fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:to="loc_us-gaap_OperatingIncomeLossMember_1e7be2a5-6bac-4eb7-a0a8-ae9ee6aa7fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_90b960b6-a455-4b9f-849c-c7b8b50a22e2" xlink:href="mo-20220630.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_93124ec9-68e7-431e-9b81-40eadad8e694" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_90b960b6-a455-4b9f-849c-c7b8b50a22e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:href="mo-20220630.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_fc7d5022-6237-4473-ac0d-723d78f50766" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d2bad346-3a95-407e-aa5e-7415720f04f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bfc1fa88-ef6f-44c1-8c81-9f587ba290dc" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d2bad346-3a95-407e-aa5e-7415720f04f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Debt" xlink:type="simple" xlink:href="mo-20220630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5d48c308-cc6b-4899-a50f-52e0d0b3368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_af5f52b6-54da-455f-973c-eb90ce6258fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5d48c308-cc6b-4899-a50f-52e0d0b3368a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_af5f52b6-54da-455f-973c-eb90ce6258fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7139e250-6609-4b54-bdb7-1dd516fca384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7139e250-6609-4b54-bdb7-1dd516fca384" xlink:to="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f30b1172-68b5-43f5-aac2-234e5bdfa8b1" xlink:to="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e375455-a522-4f3c-804f-b13508368bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_06590ef3-be3a-4f57-8019-f3823c024b03" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6e375455-a522-4f3c-804f-b13508368bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3f8f9877-5108-46f4-914a-3ed1472717bf" xlink:to="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_699d2728-c9fe-4fdf-8000-e3083cc9421e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_64ece490-b1a4-42c4-a182-66735ca82c80" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_699d2728-c9fe-4fdf-8000-e3083cc9421e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a4512e6c-24ba-4d37-b58a-1f2044355212" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_98cac242-155d-47be-ba32-9dbfc7575d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:to="loc_us-gaap_LineOfCreditMember_98cac242-155d-47be-ba32-9dbfc7575d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_5cda43b9-d0e3-4b72-81b9-87f7666a54b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8e7011a2-fb68-4f40-b45d-d9c77971aff6" xlink:to="loc_us-gaap_SeniorNotesMember_5cda43b9-d0e3-4b72-81b9-87f7666a54b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8145c1ea-a963-4493-8a74-364e565714b0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2024Member_f3faf793-337b-4ed0-8671-f523a2146f30" xlink:href="mo-20220630.xsd#mo_RevolvingCreditFacilityDueAugust2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2024Member_f3faf793-337b-4ed0-8671-f523a2146f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_3c36b949-4dcd-4a91-a304-969dd7a53cf8" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_USDDenominatedNotesMember_3c36b949-4dcd-4a91-a304-969dd7a53cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_a6aded3f-08a1-4d73-9dd7-69a11daf58aa" xlink:href="mo-20220630.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf0b347d-838a-4c85-97ab-22c1cab5d88b" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_a6aded3f-08a1-4d73-9dd7-69a11daf58aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9fb3d0f9-0a75-4da0-a7bd-d2f457a30af3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_94cb4bf2-b578-4a49-bbf6-f362d460dbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_ShortTermBorrowings_94cb4bf2-b578-4a49-bbf6-f362d460dbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8e1dba65-d214-4901-9b04-d56397fadb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentTerm_8e1dba65-d214-4901-9b04-d56397fadb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_801b037d-c787-45e0-9c05-6404039416e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_801b037d-c787-45e0-9c05-6404039416e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentExtensionTerm_de5dbee5-a211-493d-8580-54c4fc8fcf83" xlink:href="mo-20220630.xsd#mo_DebtInstrumentExtensionTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentExtensionTerm_de5dbee5-a211-493d-8580-54c4fc8fcf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a63a02ac-db12-416d-aa43-3c78176ca04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a63a02ac-db12-416d-aa43-3c78176ca04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_eba6c565-5262-4de5-bf5b-1f7ab4080d0d" xlink:href="mo-20220630.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_eba6c565-5262-4de5-bf5b-1f7ab4080d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_f1b2216c-28c7-4fe7-b570-eaf581277c7f" xlink:href="mo-20220630.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_f1b2216c-28c7-4fe7-b570-eaf581277c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b5fe95a8-e3d8-4680-ad25-6f2f412b1429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_LongTermDebt_b5fe95a8-e3d8-4680-ad25-6f2f412b1429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_df903746-0baa-4c04-8990-a7516fb201bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_df903746-0baa-4c04-8990-a7516fb201bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f533627-5d4e-443a-be67-eae85cf17a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f533627-5d4e-443a-be67-eae85cf17a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e46ac4d6-4aa6-4b16-a707-8be6b33a8cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e46ac4d6-4aa6-4b16-a707-8be6b33a8cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08cb276d-26dc-4507-b8ff-0069506e4a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_08cb276d-26dc-4507-b8ff-0069506e4a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_301435cf-ec6a-40d9-84af-b11c50477062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_301435cf-ec6a-40d9-84af-b11c50477062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b1d93371-fd1c-4355-b3fa-2e9743900047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b1d93371-fd1c-4355-b3fa-2e9743900047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_9fb03c94-752e-480b-bdd7-966f45fafb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_da79dca4-d917-4a7b-b3d6-f744d762d4f2" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_9fb03c94-752e-480b-bdd7-966f45fafb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b2b5892b-d462-4125-8d29-a87b1472fc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f21942bc-179b-4d31-b975-31fb60251fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b2b5892b-d462-4125-8d29-a87b1472fc58" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f21942bc-179b-4d31-b975-31fb60251fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="simple" xlink:href="mo-20220630.xsd#IncomeTaxesupdateTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesupdateTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6d65cdde-6f92-460c-8397-ee0e4792bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SummaryOfIncomeTaxesTableTextBlock_cc103c4d-5a0d-4476-a266-479747795445" xlink:href="mo-20220630.xsd#mo_SummaryOfIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d65cdde-6f92-460c-8397-ee0e4792bf63" xlink:to="loc_mo_SummaryOfIncomeTaxesTableTextBlock_cc103c4d-5a0d-4476-a266-479747795445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_8de442e7-13be-479e-9b3b-27a953c24cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6d65cdde-6f92-460c-8397-ee0e4792bf63" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_8de442e7-13be-479e-9b3b-27a953c24cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#IncomeTaxesSummaryofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_46bcf259-0897-4145-9a4c-eff1d41b4c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33a5a34d-992e-43bc-a103-d3d7a818e993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_46bcf259-0897-4145-9a4c-eff1d41b4c50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_33a5a34d-992e-43bc-a103-d3d7a818e993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1ec79319-425b-4869-acdf-e6327623d177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_46bcf259-0897-4145-9a4c-eff1d41b4c50" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1ec79319-425b-4869-acdf-e6327623d177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1aa7d618-64aa-4b5c-b81f-a68125db1220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_46bcf259-0897-4145-9a4c-eff1d41b4c50" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1aa7d618-64aa-4b5c-b81f-a68125db1220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4695d669-d420-4270-ac61-5aa8e238c55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceRollforwardRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4695d669-d420-4270-ac61-5aa8e238c55c" xlink:to="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0441d649-6388-4eb7-a600-976159314c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0441d649-6388-4eb7-a600-976159314c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_68c3b941-f4f6-4a4a-8f26-fafd0a9d6220" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount_68c3b941-f4f6-4a4a-8f26-fafd0a9d6220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_ab2b3dc1-f5c9-4bb6-998a-1c84d8935855" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount_ab2b3dc1-f5c9-4bb6-998a-1c84d8935855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_84d676b2-75e6-48d5-a662-fc4faee3060f" xlink:href="mo-20220630.xsd#mo_ValuationAllowanceForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:to="loc_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment_84d676b2-75e6-48d5-a662-fc4faee3060f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dd469686-ff34-4caf-b112-ff18b40f4c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ValuationAllowanceRollforwardRollForward_ad7263e1-5127-43f2-823a-f812c9e8b7af" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dd469686-ff34-4caf-b112-ff18b40f4c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20220630.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_431ab437-88e6-4a00-be46-4d58ed214e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_74a82241-453d-438b-9b55-431c0dc67f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_431ab437-88e6-4a00-be46-4d58ed214e46" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_74a82241-453d-438b-9b55-431c0dc67f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b52e25c8-451a-4a59-8d49-a7c33bdf402a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f7b8644f-7dec-4606-9725-7d1820d840c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b52e25c8-451a-4a59-8d49-a7c33bdf402a" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_f7b8644f-7dec-4606-9725-7d1820d840c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesGeneralInformationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1bd7ffae-7942-4fa9-a35f-0f5414489054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_1065fad8-4707-4368-92cf-8a4a54c01ea4" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1bd7ffae-7942-4fa9-a35f-0f5414489054" xlink:to="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_1065fad8-4707-4368-92cf-8a4a54c01ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e50381a-b8bd-4942-9673-2314ca5472c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8e50381a-b8bd-4942-9673-2314ca5472c2" xlink:to="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a143faa1-ed61-462f-89ba-259155959e9b" xlink:to="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_393a4d81-d05c-4abe-b954-eeb9c91267d0" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_393a4d81-d05c-4abe-b954-eeb9c91267d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_9b1ab3d9-4643-442e-8e33-d37a8e38a348" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1761470a-b183-4e97-ac71-cc1752b5a68a" xlink:to="loc_mo_EngleProgenyCasesMember_9b1ab3d9-4643-442e-8e33-d37a8e38a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c6165ed8-2240-4e35-a840-77d6d1418efd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_d1940652-42ba-48a3-807f-8860257150c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6a3cb061-ad43-4850-9c25-19b3f0fcd124" xlink:to="loc_us-gaap_AssetsMember_d1940652-42ba-48a3-807f-8860257150c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_1ef189d3-5de9-4b09-a226-b0c8ea2b555a" xlink:to="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_180fbcfd-b40c-46cd-ad71-98cebc6057b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_320921cd-19da-4047-9c6c-5936a7b3138a" xlink:to="loc_us-gaap_PendingLitigationMember_180fbcfd-b40c-46cd-ad71-98cebc6057b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9b10412d-25b1-4b5c-a38d-33220e93fccc" xlink:to="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_336516d0-13a6-4594-ac0b-8d226fdd681e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b641bdf1-ea50-4eaa-abb0-01dab0cc9d69" xlink:to="loc_mo_PhilipMorrisUSAMember_336516d0-13a6-4594-ac0b-8d226fdd681e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1610e6da-7a73-47d3-b2b6-ec86eed84bf3" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_a9f194c9-21c4-4fcf-b1c7-f1c47e6528d6" xlink:href="mo-20220630.xsd#mo_LitigationCasesResultsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:to="loc_mo_LitigationCasesResultsMember_a9f194c9-21c4-4fcf-b1c7-f1c47e6528d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_fe23e1cb-05f4-4f42-b4d8-c6fb0a3552bb" xlink:href="mo-20220630.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9d775dc7-17cf-469c-bea9-81152d0df9a5" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_fe23e1cb-05f4-4f42-b4d8-c6fb0a3552bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_809caad0-8b31-45f3-9434-02bbd1c1f491" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f06a2df2-21aa-40e7-b258-333446477442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ca1baa06-fe19-46e5-b012-26e0aa414496" xlink:to="loc_us-gaap_SubsequentEventMember_f06a2df2-21aa-40e7-b258-333446477442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8932c0e7-f47e-4d0c-898e-f7c358c38feb" xlink:to="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_3547d115-fb48-4740-9f69-c940a0631dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_3547d115-fb48-4740-9f69-c940a0631dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_20f424ef-8c3c-433a-ad81-d047f5cafe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LitigationSettlementInterest_20f424ef-8c3c-433a-ad81-d047f5cafe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_04c64866-b2b3-44fb-811d-3831e4630019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_04c64866-b2b3-44fb-811d-3831e4630019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_d1cc5560-2217-43f5-acfc-74459deb5076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_d1cc5560-2217-43f5-acfc-74459deb5076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_89f83fc6-e83b-407c-a181-a3a6fecd1b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_89f83fc6-e83b-407c-a181-a3a6fecd1b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d7cea472-216b-45f2-8f58-8bc76f3ba220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_e6ae7f53-fb97-4e34-b60e-2c119d21ee0f" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d7cea472-216b-45f2-8f58-8bc76f3ba220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_eb612f9f-6689-4310-9581-2c9e7ca3eb46" xlink:href="mo-20220630.xsd#mo_LitigationEscrowDeposit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1784f738-ae7f-4e79-a328-8ebcd1bd6139" xlink:to="loc_mo_LitigationEscrowDeposit_eb612f9f-6689-4310-9581-2c9e7ca3eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b39b2061-5bb0-4e67-8b95-68db66e71e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b39b2061-5bb0-4e67-8b95-68db66e71e87" xlink:to="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1813ba0f-f613-40df-95c5-6ae85809637a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dd33f6b7-4e4d-4dd9-a1b9-26239c5089c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5b8e747d-0e01-4a8b-9d96-64ad063631f5" xlink:to="loc_us-gaap_SubsequentEventMember_dd33f6b7-4e4d-4dd9-a1b9-26239c5089c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2b93e8b2-d1da-4933-b40c-0c3a8ae511db" xlink:to="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:href="mo-20220630.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_45e9d906-aad0-4bc2-9e5a-909289c0feaf" xlink:href="mo-20220630.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_e7ff012d-9d2a-4e07-9e70-30f44d923b44" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_45e9d906-aad0-4bc2-9e5a-909289c0feaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_18cbf163-5b05-44c0-95a3-2839c1f8db7b" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_18cbf163-5b05-44c0-95a3-2839c1f8db7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_48f8c220-d186-416a-9fb8-4ce60347b38c" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_EvaporLitigationMember_48f8c220-d186-416a-9fb8-4ce60347b38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_a94d3c29-d5c3-4a97-8dc5-5ed98fb7c6bf" xlink:href="mo-20220630.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_a94d3c29-d5c3-4a97-8dc5-5ed98fb7c6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_f885c8c5-f191-4e45-be8c-a87da56b27fd" xlink:href="mo-20220630.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f6407599-1eec-4460-8f23-57521e6e6efd" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_f885c8c5-f191-4e45-be8c-a87da56b27fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_533cecb9-be51-4011-b76f-97d5f7a0a1a9" xlink:to="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5cc9040f-c01a-442a-bb32-60b8019c9f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_us-gaap_PendingLitigationMember_5cc9040f-c01a-442a-bb32-60b8019c9f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_fd5a2a2b-eae9-44c9-bdbd-660ca4bc8284" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_fd5a2a2b-eae9-44c9-bdbd-660ca4bc8284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_3f3f558f-7df4-4f30-aac4-2d439109162b" xlink:href="mo-20220630.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fbe5a83c-8dfe-4bab-9921-4fb525f7031e" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_3f3f558f-7df4-4f30-aac4-2d439109162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6ae5bceb-92f5-43fe-9c0c-df32d8f386cd" xlink:to="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_da86d156-5a89-4460-af24-9233f87ea0aa" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_IL_da86d156-5a89-4460-af24-9233f87ea0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_bcf31ce6-0878-4705-a01e-e1119041c544" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_NM_bcf31ce6-0878-4705-a01e-e1119041c544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_de8efb22-2fa2-480a-8a9c-c5679d1a76f4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_MA_de8efb22-2fa2-480a-8a9c-c5679d1a76f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_82c38477-cb97-4913-925c-d61427411653" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_428aa9fa-648a-4b42-a2b1-5d3ae7f91c62" xlink:to="loc_stpr_FL_82c38477-cb97-4913-925c-d61427411653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_178b23d6-f9ca-4e58-8fae-55340a24e715" xlink:to="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_a772f26d-75eb-4e83-b6e9-559e0a209288" xlink:href="mo-20220630.xsd#mo_LitigationCasesResultsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_9b996ce3-3453-4235-83c8-86986eb16e34" xlink:to="loc_mo_LitigationCasesResultsMember_a772f26d-75eb-4e83-b6e9-559e0a209288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0bbbd1dc-2c15-425d-ac3a-bf82de79003b" xlink:to="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d543c03e-19c5-46db-a551-198aff2693d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d543c03e-19c5-46db-a551-198aff2693d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_e3f4f8cd-b47d-440f-848c-b90f856a79e0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfCases_e3f4f8cd-b47d-440f-848c-b90f856a79e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_27d1ce9b-a6c6-4498-8663-94d9ea8a22d7" xlink:href="mo-20220630.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyClassActionLawsuit_27d1ce9b-a6c6-4498-8663-94d9ea8a22d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_068dd297-fa61-49ca-807f-6bfb57b372dd" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_068dd297-fa61-49ca-807f-6bfb57b372dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_f2bed44d-bc8a-44d6-be22-6ac2cd0e06bf" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_f2bed44d-bc8a-44d6-be22-6ac2cd0e06bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fdf04937-a265-49f0-83e1-50e88baba804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_fdf04937-a265-49f0-83e1-50e88baba804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_a7903b02-7b9c-43a2-87d8-946dbeaa78f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_a7903b02-7b9c-43a2-87d8-946dbeaa78f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_77bac0b4-68a9-46c9-903f-b3d711d82100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a47a8ec0-6b0f-4b5e-b016-5e7ea6b5bc58" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_77bac0b4-68a9-46c9-903f-b3d711d82100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_952896e4-15d6-4026-856b-75c95e33c242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_952896e4-15d6-4026-856b-75c95e33c242" xlink:to="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fd814524-79cf-42bb-ae33-cfe63813a5d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0fbe8716-551a-44ba-88dd-82684d55802a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1a25cf94-be7d-492d-90c4-a192cf294322" xlink:to="loc_us-gaap_SubsequentEventMember_0fbe8716-551a-44ba-88dd-82684d55802a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7cc97bf5-db3c-418b-a1b4-b49cfba90d83" xlink:to="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_676e1ebb-6234-4c1e-8a64-fb112b10a142" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:to="loc_mo_PhilipMorrisUSAMember_676e1ebb-6234-4c1e-8a64-fb112b10a142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_3706814c-a139-4f2a-a331-0f581bbf131e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f8d3d2eb-95d1-4051-b02e-86db77125811" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_3706814c-a139-4f2a-a331-0f581bbf131e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_a01a7ae9-0250-4827-9c23-a623caca0b7f" xlink:to="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_04f63313-4969-42f3-afab-0d828bdd5123" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_04f63313-4969-42f3-afab-0d828bdd5123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_4beef17a-970f-4360-aa07-4daea6127292" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_4beef17a-970f-4360-aa07-4daea6127292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_83b20c4c-6820-4810-9148-1161ed49be9d" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_EngleProgenyCasesMember_83b20c4c-6820-4810-9148-1161ed49be9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_8b1d4701-bd28-4cd0-8b35-6f0cba9d57cf" xlink:href="mo-20220630.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_NonEngleProgenyCasesMember_8b1d4701-bd28-4cd0-8b35-6f0cba9d57cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_db229c03-b84d-4d21-b7bb-a6ca509aa168" xlink:href="mo-20220630.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_db229c03-b84d-4d21-b7bb-a6ca509aa168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_06a2aec4-ef6a-4400-af12-f18d3653a3d1" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_31ba3a23-edba-4d11-a21f-9fab92c3a00f" xlink:to="loc_mo_EvaporLitigationMember_06a2aec4-ef6a-4400-af12-f18d3653a3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e5dd7e9f-7a26-4dbb-9d36-7a3ad1880e47" xlink:to="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_bef56957-3282-479a-b526-63a1d455f328" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_country_CA_bef56957-3282-479a-b526-63a1d455f328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_1c3d6349-4aa0-4366-b2ba-bd70ac3f02c0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_AK_1c3d6349-4aa0-4366-b2ba-bd70ac3f02c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_d36461ce-e97e-450f-bd82-e7d67db0613d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_CA_d36461ce-e97e-450f-bd82-e7d67db0613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_1aa37e71-9422-4887-a2a3-daaf6c59354f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_CT_1aa37e71-9422-4887-a2a3-daaf6c59354f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_6e6440b5-f800-410b-b03f-4c01ddb6c077" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_FL_6e6440b5-f800-410b-b03f-4c01ddb6c077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_7f81133e-ceaa-4500-9750-f853d6b79f49" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_LA_7f81133e-ceaa-4500-9750-f853d6b79f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_83dbaa76-689b-4ae9-9609-a58a31930f45" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MA_83dbaa76-689b-4ae9-9609-a58a31930f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_77c89295-8e23-4c9c-a318-8e72282322ba" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MS_77c89295-8e23-4c9c-a318-8e72282322ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_e2beb550-8b82-49a3-a1ba-5479be3c7d0a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_MO_e2beb550-8b82-49a3-a1ba-5479be3c7d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_35987657-39b2-49d4-990c-e0a4532fc527" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NH_35987657-39b2-49d4-990c-e0a4532fc527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_77b10bcc-ff35-4ea6-a44c-3f87dfdaddf3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NJ_77b10bcc-ff35-4ea6-a44c-3f87dfdaddf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_f46c5492-04eb-4cc7-a91a-50e74f3b23b1" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_NY_f46c5492-04eb-4cc7-a91a-50e74f3b23b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_14d5287b-cc77-494e-b4c6-0e25127ed178" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_OH_14d5287b-cc77-494e-b4c6-0e25127ed178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_0fafa7b9-768f-4e14-b992-d8b843a54311" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_PA_0fafa7b9-768f-4e14-b992-d8b843a54311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_27b6b332-2cbd-49da-9e10-004cae4681a8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_RI_27b6b332-2cbd-49da-9e10-004cae4681a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_760edd38-31e1-4ad1-9c3d-f6180d76565e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_TN_760edd38-31e1-4ad1-9c3d-f6180d76565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_03b89726-5972-45bd-962c-ff00f40b3530" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1dd69654-85ef-4174-baa6-e4b25ab627f9" xlink:to="loc_stpr_WV_03b89726-5972-45bd-962c-ff00f40b3530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2bed8bfd-e134-41b5-86bb-b27eb88ca87e" xlink:to="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_309992d9-9b2b-4177-b4ec-8c688e42e592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_309992d9-9b2b-4177-b4ec-8c688e42e592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_643e5c24-514c-49c8-b6eb-a32a2035ea32" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_643e5c24-514c-49c8-b6eb-a32a2035ea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_23ef31f2-1770-45b3-9147-70d726066975" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecided_23ef31f2-1770-45b3-9147-70d726066975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_b694004a-e175-4001-a2fa-a8b5241f43f3" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_b694004a-e175-4001-a2fa-a8b5241f43f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_37a328c1-98ee-4456-81ed-f3f05106ef3d" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_37a328c1-98ee-4456-81ed-f3f05106ef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_7d106f8a-6340-46fd-83ab-d5ab16dce005" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_7d106f8a-6340-46fd-83ab-d5ab16dce005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_8bb19007-57d8-4f9e-a60f-e762a3af098c" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_96f5249b-b647-4a3c-bcda-80def978800e" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_8bb19007-57d8-4f9e-a60f-e762a3af098c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7a297ab3-af77-4644-9df0-7ec32980a1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7a297ab3-af77-4644-9df0-7ec32980a1ff" xlink:to="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:to="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9b0b1ded-c250-4ef8-b7e5-4abe89bddebd" xlink:to="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_26591427-ecbd-4ec5-bcb0-f402a9d35b80" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_26591427-ecbd-4ec5-bcb0-f402a9d35b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_c6bee0fd-4781-4b65-8a81-76e7cf4bd219" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_c6bee0fd-4781-4b65-8a81-76e7cf4bd219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_57ed86f8-a4ac-470d-b8ac-ef3772569a18" xlink:href="mo-20220630.xsd#mo_NonEngleProgenySmokingandHealthCaseLaramieMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_d668db84-4f40-4473-ad02-a3647a1b452e" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseLaramieMember_57ed86f8-a4ac-470d-b8ac-ef3772569a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:to="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ec6f62a3-0de2-4fd3-8fea-8c225ba26ce0" xlink:to="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_5989bb8d-2d33-487a-9079-79eea313fd6e" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f46e7504-af38-48d6-b355-821d813961c8" xlink:to="loc_mo_PhilipMorrisUSAMember_5989bb8d-2d33-487a-9079-79eea313fd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e076d150-d623-43ec-b0dd-41986dcc4b3c" xlink:to="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_82ec080b-7a25-4f8c-bb0a-f2c631020a28" xlink:href="mo-20220630.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_82ec080b-7a25-4f8c-bb0a-f2c631020a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_c5ca7b6c-5740-48c1-b623-f831b16b0588" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_c5ca7b6c-5740-48c1-b623-f831b16b0588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_581e01a5-41a2-4ea9-80f6-78b0a5dd15f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_581e01a5-41a2-4ea9-80f6-78b0a5dd15f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_41ef76e7-eb4d-4b25-8d74-4942528b02d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_33e5227c-69d2-4b18-8c2f-9159ef9eb856" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_41ef76e7-eb4d-4b25-8d74-4942528b02d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_389c56a4-7ff4-4cbe-ad04-77f305a5217c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_389c56a4-7ff4-4cbe-ad04-77f305a5217c" xlink:to="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6616e3d3-df18-4e82-9340-5ccffb3877d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_eacb3433-a79e-4c1b-9cad-4904776081d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e4402baa-bb5a-4f13-879b-a9d39d048a50" xlink:to="loc_us-gaap_SubsequentEventMember_eacb3433-a79e-4c1b-9cad-4904776081d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f22eb25d-c027-4fab-87cc-49ef618dc298" xlink:to="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_ac45d984-dcd4-4736-aa54-cb6bf846d613" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:to="loc_mo_EngleProgenyCasesStateMember_ac45d984-dcd4-4736-aa54-cb6bf846d613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFederalMember_2f73c5ae-61db-470e-97e9-70992682f296" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFederalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_EngleProgenyCasesMember_891efb94-c52d-438f-b0f5-8a2acc578946" xlink:to="loc_mo_EngleProgenyCasesFederalMember_2f73c5ae-61db-470e-97e9-70992682f296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_a2d83b83-c395-4664-8f3d-114dd1b8b0b0" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMember_a2d83b83-c395-4664-8f3d-114dd1b8b0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_3b0e9664-0cf7-45bd-9f4e-8184399cb890" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_3b0e9664-0cf7-45bd-9f4e-8184399cb890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_d8dcaa2e-0b00-44d4-9bf7-c05cec1cd1cc" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_d8dcaa2e-0b00-44d4-9bf7-c05cec1cd1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_e01caafd-1cad-4aea-a1ca-3dfb0d2eed28" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesPollariMember_e01caafd-1cad-4aea-a1ca-3dfb0d2eed28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_07cfdeb0-4dec-440a-b119-f33db2507f84" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_07cfdeb0-4dec-440a-b119-f33db2507f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanMember_3bb17ea6-dd15-426e-8d43-76aaf041af18" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesFreemanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesFreemanMember_3bb17ea6-dd15-426e-8d43-76aaf041af18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember_626e1ea6-70b3-4f69-97b4-d0d5a2deb4db" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_65cc62a7-6804-45ed-87bf-96de1d0b70a5" xlink:to="loc_mo_EngleProgenyCasesKaplanAndSommersMember_626e1ea6-70b3-4f69-97b4-d0d5a2deb4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8b4e2eaf-a71b-4932-93ff-15429e8c8ed7" xlink:to="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_36aec122-1548-4af0-a8d9-b85feb7e3f1c" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bf37e3bb-54ab-440d-b8f9-7cfbd36de599" xlink:to="loc_mo_PhilipMorrisUSAMember_36aec122-1548-4af0-a8d9-b85feb7e3f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e5aca4fb-ec71-436b-97a2-ca44d8b4b140" xlink:to="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_f80ee893-daaa-42a3-ab73-54e71a341bd1" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_f80ee893-daaa-42a3-ab73-54e71a341bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_8887760a-504b-4354-ab20-afc719400485" xlink:href="mo-20220630.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_8887760a-504b-4354-ab20-afc719400485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_64d2f059-5a18-4989-87e0-e67ccc26aafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_64d2f059-5a18-4989-87e0-e67ccc26aafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e81be23a-67f5-466e-9085-3a250eae129a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e81be23a-67f5-466e-9085-3a250eae129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_2f9b97f3-292f-4a20-ad55-34cdeccbf603" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecided_2f9b97f3-292f-4a20-ad55-34cdeccbf603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_61eaad92-c87d-4cd4-89cd-11296c74fb1f" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_61eaad92-c87d-4cd4-89cd-11296c74fb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_f3237b21-63a7-4b9e-80ae-43adea50a39c" xlink:href="mo-20220630.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_f3237b21-63a7-4b9e-80ae-43adea50a39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7409ff75-fe22-4e54-90db-8d189f290913" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_7409ff75-fe22-4e54-90db-8d189f290913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_384464d2-681a-4529-b5e0-f68cf05d6976" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_384464d2-681a-4529-b5e0-f68cf05d6976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_dad23ca7-74f3-4914-8823-767d8f2b04df" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_dad23ca7-74f3-4914-8823-767d8f2b04df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_dcbeeff5-32ab-41b8-a89e-b78cc6fc8c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_dcbeeff5-32ab-41b8-a89e-b78cc6fc8c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_3f339bc7-30c6-41af-87b7-571045a04311" xlink:href="mo-20220630.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d95417b1-4e2e-4f0d-b102-ab4f5f839e14" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_3f339bc7-30c6-41af-87b7-571045a04311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9fc25f70-9efd-48aa-92c0-5ebf3bd47a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9fc25f70-9efd-48aa-92c0-5ebf3bd47a5c" xlink:to="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_64bcdf30-9226-4dff-8dba-f41116970edb" xlink:to="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember_e81ba280-60c2-4729-8638-a8217a834322" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesSchertzerMember_e81ba280-60c2-4729-8638-a8217a834322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_f73ebf7c-d1a0-4584-be6b-e7b8bdb4545a" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesLippMember_f73ebf7c-d1a0-4584-be6b-e7b8bdb4545a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_9fb871a3-42e1-4ab8-9c61-89d214b92029" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_9fb871a3-42e1-4ab8-9c61-89d214b92029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_c0c5304f-8882-4938-b6d9-171bd130feb5" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_c0c5304f-8882-4938-b6d9-171bd130feb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_ed708015-c191-4bc1-b0ea-b792946d6a27" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_ed708015-c191-4bc1-b0ea-b792946d6a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_d743b3d1-5409-4b52-995d-c040099915ff" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_d743b3d1-5409-4b52-995d-c040099915ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_16b3ff5b-1e3e-4457-be18-9e20964c5712" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_16b3ff5b-1e3e-4457-be18-9e20964c5712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember_ba33f67e-53b2-4e5a-91fd-c9ff803e2b70" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesKaplanMcLauighlinMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesKaplanMcLauighlinMember_ba33f67e-53b2-4e5a-91fd-c9ff803e2b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_a740e3bf-e807-4047-b41c-1ee57570b234" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_a740e3bf-e807-4047-b41c-1ee57570b234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_68365dfc-0316-4735-90dc-923948df8bed" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesCooperMember_68365dfc-0316-4735-90dc-923948df8bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_898d95a1-d94c-48d9-b363-4290db77c669" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_898d95a1-d94c-48d9-b363-4290db77c669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_0d27e362-979b-4043-9e95-2e674c4f3a86" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c3d46855-f8a9-44f9-b9e6-5277d109ef98" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_0d27e362-979b-4043-9e95-2e674c4f3a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_3db565d0-cd53-497a-bae7-4aa36b1ece8e" xlink:to="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_c4803ed1-78a8-4781-8023-1672c99e2e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:to="loc_us-gaap_PendingLitigationMember_c4803ed1-78a8-4781-8023-1672c99e2e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_591629fa-e872-41ca-9f9b-c1e65baf29d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d6f7a8b6-b818-43c6-9c93-c64f0b73ce05" xlink:to="loc_us-gaap_SettledLitigationMember_591629fa-e872-41ca-9f9b-c1e65baf29d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8b90e380-a085-4931-85aa-99b460a0fc65" xlink:to="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fba16749-8ecf-4132-b172-709489348719" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e5cb0fca-44f3-4a38-9c9f-8f555af89755" xlink:to="loc_mo_PhilipMorrisUSAMember_fba16749-8ecf-4132-b172-709489348719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_b4a92626-4ef3-4e2e-9cc5-b4e9c464f752" xlink:to="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_8482ed5e-b0ad-4ffc-91d1-c76ed6e79779" xlink:href="mo-20220630.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_8482ed5e-b0ad-4ffc-91d1-c76ed6e79779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_7f5fdbc3-dedd-4ae7-9f29-5e5e2c3f8aa7" xlink:href="mo-20220630.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_7f5fdbc3-dedd-4ae7-9f29-5e5e2c3f8aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_31c22a1b-338d-4d41-b797-e704e45048e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_31c22a1b-338d-4d41-b797-e704e45048e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_20752d6a-8fa1-4bcc-ac39-80cca9b896cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_d02f8ef5-edce-4cac-8f82-25a6e7598eca" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_20752d6a-8fa1-4bcc-ac39-80cca9b896cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d13bc941-f7d2-4eb0-8c83-bf2ff9635892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d13bc941-f7d2-4eb0-8c83-bf2ff9635892" xlink:to="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:to="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1661c894-4215-4ec0-bea0-5b566997e6fc" xlink:to="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_7087dacd-17d7-4f16-bff2-7a9d3d8e9e84" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_31de9e5a-785f-45cc-b721-bdfe7d1a25a6" xlink:to="loc_stpr_FL_7087dacd-17d7-4f16-bff2-7a9d3d8e9e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:to="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_51de30dd-c0bb-4452-8a6b-e49396c8a0a7" xlink:to="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_faa989d7-4f7c-4fa2-a397-d4ccd8fdd4e2" xlink:href="mo-20220630.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_66edcc8d-0d7e-4d5a-96b6-6c039f22c5b9" xlink:to="loc_mo_EngleProgenyCasesStateMember_faa989d7-4f7c-4fa2-a397-d4ccd8fdd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6a152938-a9f9-4c09-b32e-5f3c6b08fb44" xlink:to="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_92176025-249b-4431-b971-be993c0412c2" xlink:href="mo-20220630.xsd#mo_MaximumBondForAllDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1148bff3-ff03-4983-b1a0-c84d2759b67a" xlink:to="loc_mo_MaximumBondForAllDefendants_92176025-249b-4431-b971-be993c0412c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_33151e17-52df-4f2b-8bdb-9206d57d58be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_33151e17-52df-4f2b-8bdb-9206d57d58be" xlink:to="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8052e0da-f8b4-4798-ada7-08a03b3956b9" xlink:to="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_3a314f40-6130-40aa-86af-30138cfb1edd" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_AR_3a314f40-6130-40aa-86af-30138cfb1edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_32b6246f-7b9a-4143-bde0-0b703d7dcad3" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_CA_32b6246f-7b9a-4143-bde0-0b703d7dcad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_f520021b-8ac4-4778-b21c-c1e758cb002a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_DE_f520021b-8ac4-4778-b21c-c1e758cb002a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_c18e0185-a89b-4d3b-9bd6-82a4ebc9e27a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_DC_c18e0185-a89b-4d3b-9bd6-82a4ebc9e27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_75c9f3e3-7504-43bb-bda6-477267f81a8d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_FL_75c9f3e3-7504-43bb-bda6-477267f81a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b4935bfe-c5c2-41f5-93d7-aeafd71d0d37" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_IL_b4935bfe-c5c2-41f5-93d7-aeafd71d0d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_0d83ee45-1dad-480b-ba6d-a818514663b1" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_IA_0d83ee45-1dad-480b-ba6d-a818514663b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_3ba46ac3-6b6c-4be6-a478-402b38769bde" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_KS_3ba46ac3-6b6c-4be6-a478-402b38769bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_2f197a9e-8439-4f2f-a8d4-402006ff11cb" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_LA_2f197a9e-8439-4f2f-a8d4-402006ff11cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_310be9c5-f749-4fac-ae76-5bc8e18b4f0d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MD_310be9c5-f749-4fac-ae76-5bc8e18b4f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_1c9e85e5-41e7-4bf3-b235-236d3bbf8480" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MI_1c9e85e5-41e7-4bf3-b235-236d3bbf8480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_284a646f-9900-45cb-9712-b7ea1457e050" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_MN_284a646f-9900-45cb-9712-b7ea1457e050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_fe4b99a6-8c52-4e04-a717-f81fb4a471c2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NV_fe4b99a6-8c52-4e04-a717-f81fb4a471c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_9597107b-eaee-4e21-94b0-204f1f54fc85" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NJ_9597107b-eaee-4e21-94b0-204f1f54fc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_e2c730aa-7baa-417c-ae0b-e994ddd7ceee" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_NY_e2c730aa-7baa-417c-ae0b-e994ddd7ceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_2786029f-679d-4614-bb39-c02953bf0df5" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OH_2786029f-679d-4614-bb39-c02953bf0df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_257870b3-2b7d-4340-a4eb-3a95af7aab3c" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OK_257870b3-2b7d-4340-a4eb-3a95af7aab3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_9e664713-cce0-4a3e-8651-0082c5e5fc45" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_OR_9e664713-cce0-4a3e-8651-0082c5e5fc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_9f2d126d-10f0-4c85-b869-06fd9c5893b8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_PA_9f2d126d-10f0-4c85-b869-06fd9c5893b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_aa115e53-5617-4988-a403-c98a291916a4" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_country_PR_aa115e53-5617-4988-a403-c98a291916a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_4407d587-9081-4317-8cde-eb54b831e92f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_SC_4407d587-9081-4317-8cde-eb54b831e92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_c4818e5f-6779-4987-a2c1-130b44e6561a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_TX_c4818e5f-6779-4987-a2c1-130b44e6561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_8b3ef7ca-849a-44f2-a85d-2fae37134107" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_stpr_WI_8b3ef7ca-849a-44f2-a85d-2fae37134107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_21e56f7f-d15f-494d-8af2-898f7616c36b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_country_CA_21e56f7f-d15f-494d-8af2-898f7616c36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_37655b8d-66ea-4743-9df3-794556fd8920" xlink:href="mo-20220630.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a5ba5722-c48d-44d9-9565-67c2353a9eea" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_37655b8d-66ea-4743-9df3-794556fd8920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_504182f8-d057-4f5d-950c-552dfaef2cde" xlink:to="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b9d3cf45-b866-4442-aef4-531ba8550bb0" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_PhilipMorrisUSAMember_b9d3cf45-b866-4442-aef4-531ba8550bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_5ca529b7-4e8d-4719-9696-6c97746c5709" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_5ca529b7-4e8d-4719-9696-6c97746c5709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_576885e1-3bf9-43a0-ae5a-784e00fccc7b" xlink:href="mo-20220630.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_576885e1-3bf9-43a0-ae5a-784e00fccc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_314b79fc-5be3-4377-bbb8-3dbfe27a5c36" xlink:href="mo-20220630.xsd#mo_AltriaGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ef634b6e-c7b9-4001-93f7-7ef867ebad61" xlink:to="loc_mo_AltriaGroupMember_314b79fc-5be3-4377-bbb8-3dbfe27a5c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4537e7d4-16fb-439f-92b6-b8427fe42d69" xlink:to="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_0fcaa433-d485-4951-b44b-c16d3e8ea1f4" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b1131402-1fa7-4663-a2e4-69bc16475b13" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_0fcaa433-d485-4951-b44b-c16d3e8ea1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a3fecb52-7a43-4d00-a0f1-57932e4756d6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a2a9fd4e-3cf6-445d-9949-92459e9e9590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e30be8b6-2a26-486b-a935-143f9eb06f0b" xlink:to="loc_us-gaap_SubsequentEventMember_a2a9fd4e-3cf6-445d-9949-92459e9e9590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_72a21b76-33b5-49bb-b249-d16418e09ae6" xlink:to="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_e727eb2c-d34f-4fab-b671-6a42b3f630e9" xlink:href="mo-20220630.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_e727eb2c-d34f-4fab-b671-6a42b3f630e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_794f3957-6976-4040-b71d-66a1b190ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_794f3957-6976-4040-b71d-66a1b190ad06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_b99f4e52-c950-43c9-93d5-d7729584ffb4" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyNumberofManufacturers_b99f4e52-c950-43c9-93d5-d7729584ffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_559c05f2-e067-4522-b6e3-aa89ca96f2f0" xlink:href="mo-20220630.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_LossContingencyVerdictsUpheld_559c05f2-e067-4522-b6e3-aa89ca96f2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_9e0aa9b7-e861-4ce8-a000-c0db2b91b475" xlink:href="mo-20220630.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0f56f75b-ff4a-4467-9ef1-1e99e9383fd9" xlink:to="loc_mo_AmountAwardedtoOtherParty_9e0aa9b7-e861-4ce8-a000-c0db2b91b475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d11acd60-13b7-4f95-b8a6-4aed179765cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d11acd60-13b7-4f95-b8a6-4aed179765cb" xlink:to="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5fbff160-630b-4583-9670-e05be17e6456" xlink:to="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_e1deb354-a19e-42b3-937b-0dc63de80b76" xlink:href="mo-20220630.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b6354961-81f5-45fd-b55a-59dbdcf1c409" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_e1deb354-a19e-42b3-937b-0dc63de80b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_2b776e6f-989d-44a1-a76d-b4e85b345f49" xlink:to="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_36d5a05b-a839-44a0-9965-425c66a0ef36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_b8923ac5-d900-4e79-8790-9f7a0636b0a2" xlink:to="loc_us-gaap_ThreatenedLitigationMember_36d5a05b-a839-44a0-9965-425c66a0ef36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_10ebc099-7a33-40a4-8ed8-0e6f1229f81a" xlink:to="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_a85856f1-bcf0-4aa7-9183-fc0689ec42ea" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_27394a34-b80b-49ef-b2a8-ed7dc353a07a" xlink:to="loc_country_CA_a85856f1-bcf0-4aa7-9183-fc0689ec42ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_3f45c12f-eff5-497f-b614-3525da01c490" xlink:to="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_65287980-e317-46da-90ce-a566e728e06d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_65287980-e317-46da-90ce-a566e728e06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_051bddf2-5857-4f8b-89a2-d3348fcf3101" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a48db859-2ef7-403e-b6e6-d7c3b4a43733" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_051bddf2-5857-4f8b-89a2-d3348fcf3101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_04bf3d2a-d3a1-48ac-aca3-5f0f08aff837" xlink:to="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_c93fb6c1-bbc4-4b23-a911-6629b2fb40ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_c93fb6c1-bbc4-4b23-a911-6629b2fb40ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_3e7d0354-9455-44ab-918e-c19d088011ff" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LossContingencyNumberofManufacturers_3e7d0354-9455-44ab-918e-c19d088011ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_0ca02c5c-0caa-4692-baac-bf1bad849118" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_0ca02c5c-0caa-4692-baac-bf1bad849118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_6287de01-fed2-4ee1-a0ba-7eb17bd1b7ce" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_6287de01-fed2-4ee1-a0ba-7eb17bd1b7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_db29e034-22f6-42d2-afd7-419a9c3f7147" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_db29e034-22f6-42d2-afd7-419a9c3f7147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7be97233-ec53-42ec-8041-3312eddd06cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3b813754-65ca-4336-976e-d98b8075633b" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_7be97233-ec53-42ec-8041-3312eddd06cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_688f1112-cf86-4c26-9626-0e754b1aa21e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_688f1112-cf86-4c26-9626-0e754b1aa21e" xlink:to="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e2f86be2-9f29-45e4-a4f8-69af1201dfa3" xlink:to="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_32d915d3-378b-4529-9dd6-2a37af9063b2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_NY_32d915d3-378b-4529-9dd6-2a37af9063b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_4cb1a5a7-bd3d-4753-b8ba-dc21e3c214dc" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_MT_4cb1a5a7-bd3d-4753-b8ba-dc21e3c214dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_19f9fb44-d37d-4ff6-8330-dedd90c4cb81" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aaf9c9de-3634-4682-a7ab-ed22779296b4" xlink:to="loc_stpr_IL_19f9fb44-d37d-4ff6-8330-dedd90c4cb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2b59e46c-ecb3-43f4-bd15-c74ba4e67888" xlink:to="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_b7036655-0f6e-441e-a8a8-157874a77cb1" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_59aff676-3645-4564-8a30-46db7c2347b2" xlink:to="loc_mo_PhilipMorrisUSAMember_b7036655-0f6e-441e-a8a8-157874a77cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7da6f4b8-f3e0-430e-ad52-62761835ad0b" xlink:to="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_b2929516-3cf0-4f39-8ec5-55012c4a0bce" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_b2929516-3cf0-4f39-8ec5-55012c4a0bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_a5e8e969-9fbb-4561-9ba9-1c5d5ea6a5ff" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_a5e8e969-9fbb-4561-9ba9-1c5d5ea6a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_604795a9-2dcb-4bcb-a879-af517c6e2662" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_604795a9-2dcb-4bcb-a879-af517c6e2662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_8dc07e18-0715-4495-81f5-5bdd1a5745f3" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_8dc07e18-0715-4495-81f5-5bdd1a5745f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_118f31ac-972e-401a-9294-c75fe0ae72f6" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_118f31ac-972e-401a-9294-c75fe0ae72f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_626320c1-55fd-45e9-b7ab-5bfbdc83d23a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_626320c1-55fd-45e9-b7ab-5bfbdc83d23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_48dd357a-f65a-484a-a6e3-c20ae789b2f6" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_48dd357a-f65a-484a-a6e3-c20ae789b2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_af9d5305-725d-4e3a-9fb6-fb82595b560d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_af9d5305-725d-4e3a-9fb6-fb82595b560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_6cce255a-e5c8-4075-9c05-0d236892676e" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_6cce255a-e5c8-4075-9c05-0d236892676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_2f1f240a-81d2-4e9e-a56b-a483cf3add4f" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_2f1f240a-81d2-4e9e-a56b-a483cf3add4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_9da89a6c-25dd-4b8c-9685-4d220ef642f8" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_9da89a6c-25dd-4b8c-9685-4d220ef642f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_db8a9019-a0c1-4dc8-a5f1-1a2eada85823" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_db8a9019-a0c1-4dc8-a5f1-1a2eada85823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_ec1586e1-f92f-4826-bc4c-80e06d72ad6b" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_ec1586e1-f92f-4826-bc4c-80e06d72ad6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_55de34bf-f5da-463a-987b-60512989d6b7" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_55de34bf-f5da-463a-987b-60512989d6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_289935fb-c88e-4ebd-8cdb-f2df55b4a238" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_289935fb-c88e-4ebd-8cdb-f2df55b4a238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_7e91eff5-dc0b-4338-bc60-c5997aec413d" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_7e91eff5-dc0b-4338-bc60-c5997aec413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_fa213793-c83d-4421-ab97-dc36a284211a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_fa213793-c83d-4421-ab97-dc36a284211a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_b514a267-f556-4e9c-8189-2f9d1dd184d2" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_b514a267-f556-4e9c-8189-2f9d1dd184d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_9f5e5a19-6a3a-416c-b104-bd4c1a09d982" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_9f5e5a19-6a3a-416c-b104-bd4c1a09d982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_ab54509d-cb3c-4871-ad99-501098a653f0" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_5a679917-2d55-440f-997f-9d8e44694caf" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_ab54509d-cb3c-4871-ad99-501098a653f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_408b6b4b-1ba0-4c82-97f7-9831c5859a7a" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_408b6b4b-1ba0-4c82-97f7-9831c5859a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_77273b45-0005-43e1-a688-2494c4332e29" xlink:href="mo-20220630.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8a8f0c9e-cdfa-445c-9689-cd49ab1ed0e2" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_77273b45-0005-43e1-a688-2494c4332e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_4d7caa6d-20fd-4c2c-9e1c-833cbb1a892d" xlink:to="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_f51b459b-9c53-4daf-831f-1a504762b02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:to="loc_us-gaap_SettledLitigationMember_f51b459b-9c53-4daf-831f-1a504762b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5d93b7b3-7603-4a57-a823-ccc49199dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d98d345a-f2f0-4231-8c23-b9556a3a2de9" xlink:to="loc_us-gaap_PendingLitigationMember_5d93b7b3-7603-4a57-a823-ccc49199dd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:href="mo-20220630.xsd#mo_ArbitrationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodAxis_078ea031-aa68-4f70-9fda-ae99b9428a0e" xlink:to="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_d75d9642-21db-4f14-94bd-c4aaddbf730b" xlink:href="mo-20220630.xsd#mo_PeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:to="loc_mo_PeriodOneMember_d75d9642-21db-4f14-94bd-c4aaddbf730b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_95f3a3c6-ef83-4654-82a4-a66cea5f3b08" xlink:href="mo-20220630.xsd#mo_PeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_4446656f-e7ca-4dd1-b164-13e8b543a36f" xlink:to="loc_mo_PeriodTwoMember_95f3a3c6-ef83-4654-82a4-a66cea5f3b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fa122ce0-d305-4351-a1da-31d1d934a816" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9b295cc9-045e-400a-bdf2-f24a96eea200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a2e21535-c69d-4d63-91a7-f12557083c26" xlink:to="loc_us-gaap_CostOfSalesMember_9b295cc9-045e-400a-bdf2-f24a96eea200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5c3bc3a9-7d50-495a-bba6-78d97adc3924" xlink:to="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_21397eb1-8e76-4ae3-83a0-88cd6016efc3" xlink:href="mo-20220630.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_21397eb1-8e76-4ae3-83a0-88cd6016efc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_06a140f9-383d-4a7f-8510-ce116dde2ae7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_06a140f9-383d-4a7f-8510-ce116dde2ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_ee113d59-ff23-4448-89d1-9abf242ba5b0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_ee113d59-ff23-4448-89d1-9abf242ba5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_32980524-698d-4432-8c89-b3e8841e5e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_32980524-698d-4432-8c89-b3e8841e5e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_12c03c62-7e70-42ce-9338-a26d82d1a5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_12c03c62-7e70-42ce-9338-a26d82d1a5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_97ab5f67-0369-47f5-b5cf-910893c72865" xlink:href="mo-20220630.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_97ab5f67-0369-47f5-b5cf-910893c72865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_f9a7fbc4-deef-4233-abe0-9e8243fd3653" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_f9a7fbc4-deef-4233-abe0-9e8243fd3653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_e72ab735-0813-462e-b1d9-24d8f9c058e5" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_e72ab735-0813-462e-b1d9-24d8f9c058e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_0076f199-58b1-46fa-8b71-f0f7e39026c6" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_0076f199-58b1-46fa-8b71-f0f7e39026c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_806e474e-539c-425d-8947-5f7e7033afb7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_806e474e-539c-425d-8947-5f7e7033afb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_e58af87b-1715-4759-8f05-92045f224bb6" xlink:href="mo-20220630.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_e58af87b-1715-4759-8f05-92045f224bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_3dc4dc66-22e1-489b-8ecf-0a01999186d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_3dc4dc66-22e1-489b-8ecf-0a01999186d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_77463ada-0391-4b00-9a9d-8380a5eabda6" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_302cc41b-388c-4950-8ff6-08f9411ff426" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_77463ada-0391-4b00-9a9d-8380a5eabda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d78179e-2315-4e89-bdcb-55b1ea15cc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d78179e-2315-4e89-bdcb-55b1ea15cc3c" xlink:to="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:to="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_039d819d-214e-4ed4-88da-f7b7acf8762d" xlink:to="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_0188b750-b26b-4d59-8801-5b3ec5e516f9" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1cfcd7e4-ec85-4872-84bc-e169a9ae0f26" xlink:to="loc_mo_PhilipMorrisUSAMember_0188b750-b26b-4d59-8801-5b3ec5e516f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:to="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2cc7d1eb-b2b0-49e5-9ba4-e8c6fcb97211" xlink:to="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_57a58a00-6f7b-4be9-aa5b-c8071d9fdebe" xlink:href="mo-20220630.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a256ea21-401e-4ae3-8f35-b06f9a25646d" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_57a58a00-6f7b-4be9-aa5b-c8071d9fdebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5e711765-10e8-42c2-953e-a3f21e78f1e1" xlink:to="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_6a71ec22-6e2b-4efd-b95e-fbf2f01aa693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e4d34479-f269-4afb-a382-e85c30252363" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_6a71ec22-6e2b-4efd-b95e-fbf2f01aa693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44f2049a-de46-4dbb-9b28-a44c0a78743a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44f2049a-de46-4dbb-9b28-a44c0a78743a" xlink:to="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_9bf6d3a7-9417-4cd1-aa9f-ac9d04012631" xlink:to="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_1456d034-ed90-4cdb-a7f1-57fb3e325cfa" xlink:href="mo-20220630.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_83e8c0bd-9695-4f8e-bdf7-ee23a86f353d" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_1456d034-ed90-4cdb-a7f1-57fb3e325cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_4cda3a40-5ef3-45ca-b3e8-de7e3f7bca0d" xlink:to="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_a1ee34b2-199d-442d-8899-82d489ca8d68" xlink:href="mo-20220630.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_00cdf923-b1b5-4399-9d8e-a295deb889f0" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_a1ee34b2-199d-442d-8899-82d489ca8d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_17428c31-a877-485c-a3f3-12264fe3cf36" xlink:to="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_c23bfb8c-c87c-4f06-9888-ed5302559705" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:to="loc_mo_PhilipMorrisUSAMember_c23bfb8c-c87c-4f06-9888-ed5302559705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AltriaGroupMember_560baa20-9026-4d3b-8950-cf9392a03c46" xlink:href="mo-20220630.xsd#mo_AltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_74b52318-823f-4416-9dba-5aa533404402" xlink:to="loc_mo_AltriaGroupMember_560baa20-9026-4d3b-8950-cf9392a03c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1a7305d2-0609-4778-80cb-f8edc78e3f24" xlink:to="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_a31a25ed-5bd9-43cc-8f75-c9ccab93b8ce" xlink:href="mo-20220630.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_a31a25ed-5bd9-43cc-8f75-c9ccab93b8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_eba2b088-5e76-4f9b-acb3-9b7fa218315f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e1365420-b247-4567-b9dc-9ae9cddf75f8" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_eba2b088-5e76-4f9b-acb3-9b7fa218315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesEvaporProductLitigationandIQOSLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4b6a0c4-4527-46d3-97cd-f88f7ebc32b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4b6a0c4-4527-46d3-97cd-f88f7ebc32b4" xlink:to="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d4e855ea-d410-4726-b489-b6d48ee0646f" xlink:to="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_5809fbf3-d42e-4e85-834d-c1a51b84124f" xlink:href="mo-20220630.xsd#mo_ClassActionLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_ClassActionLawsuitMember_5809fbf3-d42e-4e85-834d-c1a51b84124f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_4fbe874b-15d2-49c0-bc83-792c143c55ef" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_PendingIndividualLawsuitsMember_4fbe874b-15d2-49c0-bc83-792c143c55ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_ae98f403-8286-4723-90fc-6e1f909970b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_us-gaap_SettledLitigationMember_ae98f403-8286-4723-90fc-6e1f909970b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember_2b79fd7b-1cb3-4255-a27b-b1035f6cacd7" xlink:href="mo-20220630.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_mo_PendingClassActionLawsuitMember_2b79fd7b-1cb3-4255-a27b-b1035f6cacd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_45db4e65-db95-4b18-af10-fb949c8ff2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_946382f2-0bf5-4797-acc3-207082ab069e" xlink:to="loc_us-gaap_PendingLitigationMember_45db4e65-db95-4b18-af10-fb949c8ff2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f70c9417-166e-4649-99a6-07e253a5fa89" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e39f49ca-8c93-4e41-b1c7-c74870bbbdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_99040bcb-764b-42dc-b7b6-35900180524b" xlink:to="loc_us-gaap_SubsequentEventMember_e39f49ca-8c93-4e41-b1c7-c74870bbbdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_38719e83-5f0b-4d1b-a2ff-997536de1751" xlink:to="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_19424b74-214a-4cdf-8e2d-e6b11c8e6370" xlink:href="mo-20220630.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:to="loc_mo_EvaporLitigationMember_19424b74-214a-4cdf-8e2d-e6b11c8e6370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_a1f890ae-4c5e-4850-89f5-472e06e0598e" xlink:href="mo-20220630.xsd#mo_IQOSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_487e39e0-a1d9-4d78-92b6-abd2be3dff1a" xlink:to="loc_mo_IQOSMember_a1f890ae-4c5e-4850-89f5-472e06e0598e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_53ae6c35-3236-4b7e-af70-eaf17dfa5afd" xlink:to="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_37da7b8b-9121-4811-b593-b78f947382d0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_dd88c427-4d6d-499a-bdab-63eb4d6958b5" xlink:to="loc_country_CA_37da7b8b-9121-4811-b593-b78f947382d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_47bbfe7e-54c6-46b6-88c4-0f30d713bc9b" xlink:to="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_b5459d6d-2e6a-486b-87e5-a061b81f419d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_b5459d6d-2e6a-486b-87e5-a061b81f419d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5c704e4e-84da-4cc0-a4c2-68f354ba4d9a" xlink:href="mo-20220630.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5c704e4e-84da-4cc0-a4c2-68f354ba4d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_3e94115e-2095-46ac-8fc6-f1b89d471ec5" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_3e94115e-2095-46ac-8fc6-f1b89d471ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_9f5da63d-43ab-44f0-95be-f793dd6ad578" xlink:href="mo-20220630.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_9f5da63d-43ab-44f0-95be-f793dd6ad578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_4f9eb728-3129-45da-89ef-a4a9ab861e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_4f9eb728-3129-45da-89ef-a4a9ab861e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_f2803362-389c-459e-bc7b-55f1e535d428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_f2803362-389c-459e-bc7b-55f1e535d428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_f67f2826-e954-4414-8239-e40dbda2ec4f" xlink:href="mo-20220630.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f627bcb3-e357-4658-b819-c5220bf868fa" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_f67f2826-e954-4414-8239-e40dbda2ec4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d87eaf8-b7a5-40d0-a506-4edc0dd5c5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1d87eaf8-b7a5-40d0-a506-4edc0dd5c5bd" xlink:to="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b40436fc-3b44-48d9-864a-717d3e00d518" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4e264a19-559d-46b6-987c-86df052f5d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0c5a02a9-1675-4b0c-8d04-b400458dee4c" xlink:to="loc_us-gaap_SubsequentEventMember_4e264a19-559d-46b6-987c-86df052f5d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d0abf301-e2df-4796-a8e1-ef7721dc4f4b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_7d1bc904-3476-4a60-8165-84cfae1179cf" xlink:href="mo-20220630.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_26a008bb-5c98-4f09-92bf-b5d9dbf4480f" xlink:to="loc_mo_JUULMember_7d1bc904-3476-4a60-8165-84cfae1179cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_5aa0d39a-8503-4266-b309-7915fae50c86" xlink:to="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_131ace0b-f94d-4083-b830-f49efc871959" xlink:href="mo-20220630.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_131ace0b-f94d-4083-b830-f49efc871959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_3a6d14d2-3248-4390-a175-cb794638ae76" xlink:href="mo-20220630.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyClassActionLawsuit_3a6d14d2-3248-4390-a175-cb794638ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_e27a5c69-ec47-4f3e-930d-d08c86ccdf5f" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfComplaints_e27a5c69-ec47-4f3e-930d-d08c86ccdf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_536d8722-1448-4e99-b0b6-2d881a782088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_536d8722-1448-4e99-b0b6-2d881a782088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_a8de4845-82d3-4a36-b8e0-8ffdc8e085b0" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_a8de4845-82d3-4a36-b8e0-8ffdc8e085b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_a5b65d63-545a-483b-b8a5-3705ca268081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_a5b65d63-545a-483b-b8a5-3705ca268081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_a132739b-5f40-45e7-956d-9e264794d345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_a132739b-5f40-45e7-956d-9e264794d345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_0cd661f9-c653-47c9-a36a-29921317a89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_0cd661f9-c653-47c9-a36a-29921317a89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_5034b2cd-a47d-49bd-90ff-2bfef78e81d7" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_5034b2cd-a47d-49bd-90ff-2bfef78e81d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_ef64e05b-c113-4f5a-ab31-aff3169f9089" xlink:href="mo-20220630.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_70318492-4251-4b58-8381-b17cda74e475" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_ef64e05b-c113-4f5a-ab31-aff3169f9089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ca15a736-00be-4376-871f-dbfb55b077ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ca15a736-00be-4376-871f-dbfb55b077ef" xlink:to="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_01fc5aa3-e96a-431a-b108-354c3673bd2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe87cf58-5284-4a8b-a029-6f8128086963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bc0f0025-c362-49b1-ba34-0dbe553a83cf" xlink:to="loc_us-gaap_SubsequentEventMember_fe87cf58-5284-4a8b-a029-6f8128086963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_65895d00-f1cd-4581-9312-4bd19983c121" xlink:to="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_3952efd1-8edc-47ee-af04-24039735b4ae" xlink:href="mo-20220630.xsd#mo_LightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_LightsMember_3952efd1-8edc-47ee-af04-24039735b4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_d5cf8277-3101-45e9-baa4-a66d3f2f2491" xlink:href="mo-20220630.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_d5cf8277-3101-45e9-baa4-a66d3f2f2491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_61292039-2b13-4352-b47d-738ab9276758" xlink:href="mo-20220630.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_334a7f4b-e7ce-45b6-bf23-13e1e391539f" xlink:to="loc_mo_USTLitigationMember_61292039-2b13-4352-b47d-738ab9276758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2ed001f7-cdfa-4faa-a3b6-01039f3d98b6" xlink:to="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_41cd671f-3e60-46c0-b440-c2b1853768c0" xlink:href="mo-20220630.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f419a770-0c4e-41bd-83e3-cc0164a94c91" xlink:to="loc_mo_PhilipMorrisUSAMember_41cd671f-3e60-46c0-b440-c2b1853768c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8787fcb7-4ff0-46ac-b20c-51c67f4317c4" xlink:to="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_b971be79-221c-4cb9-a225-f866f38ea96d" xlink:href="mo-20220630.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_b971be79-221c-4cb9-a225-f866f38ea96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5919e49d-f0db-4313-9fb6-7777823468e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5919e49d-f0db-4313-9fb6-7777823468e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_a712d65c-8627-44b1-bd93-229ab64067ab" xlink:href="mo-20220630.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1c33fc2c-29ee-4790-9bf6-724fb245f3aa" xlink:to="loc_mo_LossContingencyStateCourtsNumber_a712d65c-8627-44b1-bd93-229ab64067ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66542752-24e2-48d1-85a5-7f90451fa6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_66542752-24e2-48d1-85a5-7f90451fa6c3" xlink:to="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_b5579ed4-3dad-485f-92e9-d6982f4abb6e" xlink:to="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_c311b599-3812-4ec9-babb-6ad8542f54a2" xlink:href="mo-20220630.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_269b3b92-2bf0-4d89-90ee-35311234bb0b" xlink:to="loc_mo_PendingIndividualLawsuitsMember_c311b599-3812-4ec9-babb-6ad8542f54a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_014d4449-9712-4361-8387-07cfb8ccb3f7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cbe29a73-536f-4f15-bfa1-0eb1e7867d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_929abc9f-b47a-4c63-8281-1b386e7ea3c3" xlink:to="loc_us-gaap_SubsequentEventMember_cbe29a73-536f-4f15-bfa1-0eb1e7867d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_1f512324-77be-4827-b78c-46017e759e2f" xlink:to="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_e3e783ce-3d55-40de-9a5b-4f0d3f38b342" xlink:href="mo-20220630.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9d91c383-d55e-4a81-8ee8-efa5128a3709" xlink:to="loc_mo_USTLitigationMember_e3e783ce-3d55-40de-9a5b-4f0d3f38b342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4ef6c6b6-d441-4dec-9997-b8b2e2dcffd0" xlink:to="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_1eb56bac-a941-4c93-bddf-41c9d6bb7fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7273cc6a-c1b4-4c36-aa9f-cff86fcc6615" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_1eb56bac-a941-4c93-bddf-41c9d6bb7fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20220630.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_002b3b9c-67a5-48c4-bc1d-9490975b4248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_002b3b9c-67a5-48c4-bc1d-9490975b4248" xlink:to="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f1cf7f2e-9c3a-47b2-a19d-fc0445e2a7ef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9dcac4c1-874b-4f4a-842d-967fe8b32775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_38f6f2a8-c6ee-4b6e-b7b7-0ce6f7b7ed26" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9dcac4c1-874b-4f4a-842d-967fe8b32775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cab5e12f-ff23-4ffe-96fd-d773694289b8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_4397f7b9-64bb-40c2-a53d-c754aee1f66a" xlink:href="mo-20220630.xsd#mo_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_65ce4094-5753-4519-8f4f-77f576806126" xlink:to="loc_mo_CreditAgreementMember_4397f7b9-64bb-40c2-a53d-c754aee1f66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_89b66ed3-8ef2-4c98-b7dc-70f3361110de" xlink:to="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bced07ca-2db3-4cd9-a592-2f470f97748f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_02d377c4-2fed-4e31-b798-a86b167af922" xlink:to="loc_us-gaap_LetterOfCreditMember_bced07ca-2db3-4cd9-a592-2f470f97748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1c0a3233-2a31-4c0d-8f42-1614a48c4f2d" xlink:to="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e9d9d0ac-c0be-40da-a1bb-f2210a76b364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e9d9d0ac-c0be-40da-a1bb-f2210a76b364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_6baaca03-4e77-40d4-9aca-12835d6f2fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_63d614e1-468e-4ca7-a0ed-3e5bf302560a" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_6baaca03-4e77-40d4-9aca-12835d6f2fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="simple" xlink:href="mo-20220630.xsd#NewAccountingGuidanceNotYetAdopted"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_fa9ec48c-67f1-403a-a6ca-5db29d3eef60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_409e5ed8-b70a-4f41-8ecc-8b8d38a3ea37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_fa9ec48c-67f1-403a-a6ca-5db29d3eef60" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_409e5ed8-b70a-4f41-8ecc-8b8d38a3ea37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="simple" xlink:href="mo-20220630.xsd#NewAccountingGuidanceNotYetAdoptedTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_44f63a5c-edae-42a1-aa32-66df815a6c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c7bbf080-6aa1-4d2a-9c0d-58b6850756b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_44f63a5c-edae-42a1-aa32-66df815a6c5d" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_c7bbf080-6aa1-4d2a-9c0d-58b6850756b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614694944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-08940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Altria Group, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3260245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6601 West Broad Street,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">274-2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,823,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000764180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember', window );">Common Stock, $0.33 1/3 par value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.33 1/3 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member', window );">1.000% Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO23A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member', window );">1.700% Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.700% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member', window );">2.200% Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.200% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member', window );">3.125% Notes due 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.000NotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613952640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="nump">$ 4,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves', window );">Leaf tobacco</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OtherInventoryRawMaterialsNetofReserves', window );">Other raw materials</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished product</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">6,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,345<span></span>
</td>
<td class="nump">4,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="nump">2,788<span></span>
</td>
<td class="nump">2,879<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">1,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">12,372<span></span>
</td>
<td class="nump">12,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments in equity securities ($451 million and $1,720 million at June 30, 2022 and December 31, 2021, respectively, measured at fair value)</a></td>
<td class="nump">12,590<span></span>
</td>
<td class="nump">13,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">964<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">36,746<span></span>
</td>
<td class="nump">39,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2,634<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AccruedSettlementLiabilityCurrent', window );">Settlement charges</a></td>
<td class="nump">1,749<span></span>
</td>
<td class="nump">3,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">1,630<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,311<span></span>
</td>
<td class="nump">8,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">25,046<span></span>
</td>
<td class="nump">26,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">3,898<span></span>
</td>
<td class="nump">3,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="nump">1,437<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">39,149<span></span>
</td>
<td class="nump">41,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,861<span></span>
</td>
<td class="nump">5,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Earnings reinvested in the business</a></td>
<td class="nump">30,252<span></span>
</td>
<td class="nump">30,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive losses</a></td>
<td class="num">(2,377)<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of repurchased stock (1,003,717,832 shares at June 30, 2022 and 982,785,699 shares at December 31, 2021)</a></td>
<td class="num">(37,074)<span></span>
</td>
<td class="num">(36,006)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">(2,403)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity (Deficit)</a></td>
<td class="nump">$ 36,746<span></span>
</td>
<td class="nump">$ 39,523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AccruedSettlementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Settlement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AccruedSettlementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InventoryRawMaterialsPlantMaterialNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherInventoryRawMaterialsNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Inventory, Raw Materials, Net of Reserves</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherInventoryRawMaterialsNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613938592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value disclosure</a></td>
<td class="nump">$ 451<span></span>
</td>
<td class="nump">$ 1,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.3333<span></span>
</td>
<td class="nump">$ 0.3333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">1,003,717,832<span></span>
</td>
<td class="nump">982,785,699<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615456864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 6,543<span></span>
</td>
<td class="nump">$ 6,936<span></span>
</td>
<td class="nump">$ 12,435<span></span>
</td>
<td class="nump">$ 12,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
<td class="nump">3,154<span></span>
</td>
<td class="nump">3,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Excise taxes on products</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">2,478<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,666<span></span>
</td>
<td class="nump">3,732<span></span>
</td>
<td class="nump">7,039<span></span>
</td>
<td class="nump">7,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MarketingAdministrationandResearchCosts', window );">Marketing, administration and research costs</a></td>
<td class="nump">561<span></span>
</td>
<td class="nump">546<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,105<span></span>
</td>
<td class="nump">3,186<span></span>
</td>
<td class="nump">5,989<span></span>
</td>
<td class="nump">5,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">(Gain) loss on Cronos-related financial instruments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">2,909<span></span>
</td>
<td class="nump">4,278<span></span>
</td>
<td class="nump">4,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">759<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (earnings) losses attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Altria</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 2,149<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share attributable to Altria (in usd per share)</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Altria (in usd per share)</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MarketingAdministrationandResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MarketingAdministrationandResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614561200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive earnings (losses), net of deferred income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Benefit plans</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentAfterTax', window );">ABI</a></td>
<td class="nump">565<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments and other</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">2,322<span></span>
</td>
<td class="nump">3,529<span></span>
</td>
<td class="nump">4,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive (earnings) losses attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings attributable to Altria</a></td>
<td class="nump">$ 1,476<span></span>
</td>
<td class="nump">$ 2,321<span></span>
</td>
<td class="nump">$ 3,529<span></span>
</td>
<td class="nump">$ 4,312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32472-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614262400">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Earnings Reinvested in the Business [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Losses [Member]</div></th>
<th class="th"><div>Cost of Repurchased Stock [Member]</div></th>
<th class="th"><div>Non-controlling Interests [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,925<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,910<span></span>
</td>
<td class="nump">$ 34,679<span></span>
</td>
<td class="num">$ (4,341)<span></span>
</td>
<td class="num">$ (34,344)<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,259<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,840<span></span>
</td>
<td class="nump">35,065<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(34,981)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,995<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,905<span></span>
</td>
<td class="nump">34,507<span></span>
</td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(34,660)<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,259<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,840<span></span>
</td>
<td class="nump">35,065<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(34,981)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,606)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,857<span></span>
</td>
<td class="nump">30,664<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(36,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,403)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,861<span></span>
</td>
<td class="nump">30,252<span></span>
</td>
<td class="num">(2,377)<span></span>
</td>
<td class="num">(37,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,760)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,848<span></span>
</td>
<td class="nump">30,988<span></span>
</td>
<td class="num">(2,962)<span></span>
</td>
<td class="num">(36,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,403)<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,861<span></span>
</td>
<td class="nump">$ 30,252<span></span>
</td>
<td class="num">$ (2,377)<span></span>
</td>
<td class="num">$ (37,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the purchase of the remaining noncontrolling interests in Helix in the second quarter of 2021.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616392448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (usd per share)</a></td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 1.72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614375200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to operating cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from ABI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">(Gain) loss on Cronos-related financial instruments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Cash effects of changes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Accrued liabilities and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncreaseDecreaseInSettlementPayable', window );">Accrued settlement charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600)<span></span>
</td>
<td class="num">(1,584)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitContributions', window );">Pension plan contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Pension provisions and postretirement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Long-term debt issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,083)<span></span>
</td>
<td class="num">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,279)<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premiums and fees related to early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(623)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,373)<span></span>
</td>
<td class="num">(5,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,962)<span></span>
</td>
<td class="num">(3,079)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,594<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at end of period</a></td>
<td class="nump">2,632<span></span>
</td>
<td class="nump">2,632<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">2,567<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 2,632<span></span>
</td>
<td class="nump">$ 2,632<span></span>
</td>
<td class="nump">$ 1,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncreaseDecreaseInSettlementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the period in Settlement payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncreaseDecreaseInSettlementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615764304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Background and Basis of Presentation</a></td>
<td class="text">Background and Basis of Presentation<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the terms </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;) and snus products; Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which has one leveraged lease remaining.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies, and Altria Client Services LLC, which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs.  Altria&#8217;s access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At June&#160;30, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2021, UST sold its subsidiary, International Wine &amp; Spirits, which included Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), Cronos Group Inc. (&#8220;Cronos&#8221;) and JUUL Labs, Inc. (&#8220;JUUL&#8221;).  We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our equity investment in JUUL under the fair value option.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in equity securities, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;) authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October 2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;).  At June&#160;30, 2022, we had $742 million remaining in the January 2021 share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share repurchase activity was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,083</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">507</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.09&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interim condensed consolidated financial statements are unaudited.  Our management believes that all adjustments necessary for a fair statement of the interim results presented have been reflected in our interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements should be read in conjunction with our audited consolidated financial statements and related notes, which appear in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our condensed consolidated financial statements.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616313696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text">Revenues from Contracts with Customers<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate net revenues based on product type.  For further discussion, see Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record payments received in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $303 million and $287 million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  When cash is received in advance of product shipment, we satisfy our performance obligations within three days of receiving payment.  At June&#160;30, 2022 and December&#160;31, 2021, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables were $43 million and $47 million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  At June&#160;30, 2022 and December&#160;31, 2021, there were no expected differences between amounts recorded and subsequently received, and we did not record an allowance for credit losses against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an allowance for returned goods, which is included in other accrued liabilities on our condensed consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Price promotion payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make price promotion payments, substantially all of which are made to our retail partners, to incent the promotion of certain product offerings in select geographic areas.</span></div><div style="margin-bottom:5pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615815440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments in Equity Securities</a></td>
<td class="text">Investments in Equity Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at June&#160;30, 2022 and December 31, 2021 consisted of our equity method investment in Cronos of $437 million and $617 million, respectively, and also included the Cronos warrant and the Fixed-price Preemptive Rights, which are measured at fair value (collectively, &#8220;Investment in Cronos&#8221;).  See below for further discussion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had an approximate 10% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by us into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restricted Shares were subject to a five-year lock-up period that ended October 10, 2021.  As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, the fair value of our equity investment in ABI was $10.6 billion (carrying value of $11.7 billion), which was below its carrying value by $1.1 billion or approximately 9%.  The fair value of our equity investment in ABI at December&#160;31, 2021 was $11.9 billion, which exceeded its carrying value of $11.1 billion by approximately 7%.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity investment until full recovery to its carrying value in the near term.  In preparing our financial statements for the period ended June&#160;30, 2022, we have evaluated these factors, including the macroeconomic and geopolitical factors that have resulted in significant changes to certain foreign exchange rates, including the Euro to U.S. dollar exchange rate.  Additionally, ABI has delivered consistent business and earnings performance over the past several quarters demonstrating its ability to continue to execute its strategies and navigate challenges.  At June 30, 2022, we concluded that the decline in fair value of our equity investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.  At July 25, 2022, the fair value of our equity investment in ABI was below its carrying value by $0.9 billion or approximately 8%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we made an investment in JUUL for $12.8 billion and received a 35% economic interest in JUUL through non-voting shares, which were convertible at our election into voting shares (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  At June&#160;30, 2022, we had a 35% ownership interest in JUUL, consisting of 42 million voting shares.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain our ownership percentage and we are subject to a standstill restriction under which we may not acquire additional JUUL shares above our 35% interest.  Furthermore, we agreed not to sell or transfer any of our JUUL shares until December 20, 2024.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the JUUL Transaction, we entered into a services agreement with JUUL pursuant to which we agreed to provide JUUL with certain commercial services, as requested by JUUL, for an initial term of six years.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  In conjunction with these amendments, the parties agreed that we would discontinue all services as of March 31, 2020 except regulatory affairs support for JUUL&#8217;s pursuit of its pre-market tobacco applications and/or its modified risk tobacco products applications.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  However, we have the option to be released from our non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the United States for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances), (ii) if the carrying value of our investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion or (iii) if we are no longer providing JUUL services as of December 20, 2024.  If any of the conditions described above are met and we elect to be released from our non-competition obligations, we would lose our board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least 10%), preemptive rights, consent rights and certain other rights with respect to our investment in JUUL and, in addition, our JUUL shares would be converted to single vote common stock, which would result in a significant reduction in our voting power.  As discussed below, at June 30, 2022, the carrying value of our investment in JUUL was $450 million, which was less than 10% of our initial carrying value of $12.8 billion.  As a result, we currently have the option to be released from our non-competition obligations.  However, as of this filing, we have not elected to be released from our non-competition obligations.  We retain our option to be released from the non-competition obligations in accordance with our relationship agreement with JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares into voting shares.  We do not currently intend to exercise our additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#8217;s board, as described below, or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we choose to exercise our governance rights, JUUL has agreed to:</span></div><div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;&#160;&#160;&#160;&#160;restructure JUUL&#8217;s current seven-member board of directors to a nine-member board that will include independent board members.  The new structure will include: (i) three independent directors (one of whom will be designated by us and two of whom will be designated by JUUL stockholders other than us) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by us, (iii) three directors designated by JUUL stockholders other than us and (iv) the JUUL chief executive officer; and </span></div><div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;&#160;&#160;&#160;&#160;create a litigation oversight committee, which will include two Altria designated directors (one of whom will chair the litigation oversight committee).  The committee will have oversight authority and review of litigation management for matters in which JUUL and we are co-defendants and have, or reasonably could have, a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#8217;s management being resolved by majority vote of JUUL&#8217;s board of directors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL pre-market tobacco applications that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products currently remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  Under this option, our condensed consolidated statements of earnings include any cash dividends received from our investment in JUUL and any changes in the estimated fair value of our investment, which is calculated quarterly.  We believe the fair value option provides quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the estimated fair value of our investment in JUUL, at June&#160;30, 2022 and December&#160;31, 2021, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency law; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six and three months ended June&#160;30, 2022, we recorded non-cash, pre-tax unrealized losses of $1,255 million and $1,155 million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency law, and (iii) projections of higher operating expenses resulting in lower long-term operating margins.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six and three months ended June&#160;30, 2021, we recorded a non-cash, pre-tax unrealized loss of $100 million and a non-cash, pre-tax unrealized gain of $100 million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  There were no material changes to the significant assumptions used in the valuations, as described above, during the six and three months ended June&#160;30, 2021, compared to the assumptions used for the December 31, 2020 valuation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had a 41.4% ownership interest in Cronos, consisting of 156.6&#160;million shares, which we account for under the equity method of accounting.  We report our share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value and carrying value of our equity method investment in Cronos at December 31, 2021 was $617&#160;million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $55&#160;million or approximately 10%.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June&#160;30, 2022.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#8217;s intent and ability to hold its equity method investment until full recovery to its carrying value in the near-term.  In preparing our financial statements for the period ended June&#160;30, 2022, we evaluated these factors and determined that there was not sufficient evidence to conclude that the impairment was temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $107 million for the six and three months ended June&#160;30, 2022, which was recorded to (income) losses from equity investments in our condensed consolidated statement of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#8217;s share price and the Canadian dollar (&#8220;CAD&#8221;) to U.S. dollar exchange rate at June&#160;30, </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and the carrying value of our equity method investment in Cronos at June&#160;30, 2022.  At June&#160;30, 2022, prior to recording the impairment charge, the fair value of our equity method investment in Cronos was less than its carrying value by approximately 20%.  After recording the impairment charge, the fair value and carrying value of our equity method investment in Cronos at June&#160;30, 2022 were both $437 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Investment in Cronos, at June&#160;30, 2022, we also owned:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $16.25 upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on our assumptions as of June&#160;30, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately 11 million common shares of Cronos; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a warrant providing us the ability to purchase an additional approximate 10% of common shares of Cronos (approximately 84 million common shares at June&#160;30, 2022) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.6 billion and CAD $0.2 billion, respectively (approximately U.S. dollar $1.2 billion and $0.1 billion, respectively, based on the CAD to U.S. dollar exchange rate on July 25, 2022).  At June&#160;30, 2022, upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, we would own approximately 52% of the outstanding common shares of Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights and Cronos warrant are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy).  We elect to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on our condensed consolidated balance sheets in investments in equity securities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record in our condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded non-cash, pre-tax unrealized (gains) losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166701803936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of our investment in ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured and, at June&#160;30, 2022 and December&#160;31, 2021, we had no outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of our total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt above:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the carrying value of our long-term debt was primarily driven by changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during the first six months of 2022.  The decrease in the fair value of our long-term debt was primarily driven by increases in interest rates.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our condensed consolidated statements of earnings based on an amortization approach.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614684800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Components of Net Periodic Benefit (Income) Cost</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make contributions to our pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  We made employer contributions of $8 million to our pension plans and did not make any contributions to our postretirement plans during the six months ended June 30, 2022.  Currently, we anticipate making additional employer contributions of up to approximately $25 million to our pension plan and $30 million to our postretirement plans in 2022.  However, the foregoing estimates of 2022 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan amendments to our postretirement plans for the year ended December 31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $432 million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619383664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166621048416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Earnings/Losses</a></td>
<td class="text">Other Comprehensive Earnings/Losses<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">884</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">689</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,581)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,434)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,962)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">746</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">583</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">587</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">585</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,581)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,421)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our investment in ABI.  For further discussion of designated net investment hedges, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further details, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166701991056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constitute our reportable segments of smokeable products and oral tobacco products at June&#160;30, 2022.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker (&#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,543</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">561</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for our reportable segments was affected by the following:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax income for NPM adjustment items of $60 million and $32 million for the six months ended June 30, 2022 and 2021, respectively, in our smokeable products segment.  We recorded these items in cost of sales in our condensed consolidated statements of earnings.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts shown in the table above for the smokeable products segment in marketing, administration and research costs in our condensed consolidated statements of earnings.  For further discussion, see Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Acquisition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax acquisition-related costs of $37 million for the six months ended June 30, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  We included these costs in marketing, administration and research costs in our condensed consolidated statements of earnings.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619494912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-term Borrowings and Borrowing Arrangements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, we had no short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;) that provides for borrowings up to an aggregate principal amount of $3.0 billion.  The Credit Agreement, which is used for general corporate purposes, expires on August 1, 2024 and includes an option, subject to certain conditions, for us to extend the expiration date for an additional one-year period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#8220;LIBOR&#8221;), or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage for borrowings under the Credit Agreement at June&#160;30, 2022 was 1.0% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At June&#160;30, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 10.7 to 1.0.  At June&#160;30, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value of our total long-term debt at June&#160;30, 2022 and December&#160;31, 2021 was $27.7 billion and $28.0 billion, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we issued long-term senior unsecured notes in the aggregate principal amount of $5.5 billion.  We used the net proceeds from these notes (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $4,042 million and also redeemed all of our outstanding 3.490% notes due 2022 in an aggregate principal amount of $1.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of unamortized debt discounts and debt issuance costs of $26 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022 and December&#160;31, 2021, accrued interest on long-term debt of $376 million and $429 million, respectively, was included in other accrued liabilities on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614684800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings before income taxes, provision for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,278</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,846</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,605</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,428</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">714</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the six and three months ended June 30, 2022 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the six months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances recorded against deferred tax assets related to our investment in JUUL and our Investment in Cronos.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rates for the three months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to our Investment in Cronos, partially offset by a valuation allowance release related to the increase in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on the changes in the estimated fair value of our investment in JUUL and our Investment in Cronos, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended June&#160;30, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized.  In reaching this determination, we consider all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in valuation allowances for the six months ended June 30, 2022 were due primarily to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The cumulative valuation allowance at June&#160;30, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL and our Investment in Cronos.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615681504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record provisions in our condensed consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in our condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation) and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our condensed consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $929 million and interest totaling approximately $228 million as of June 30, 2022.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $421 million and related interest totaling approximately $57 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of July 25, 2022, PM USA has posted appeal bonds totaling approximately $50 million, which have been collateralized with restricted cash that are included in assets on our condensed consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 25, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 26, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of July 25, 2022, 16 cases filed in Illinois, 18 cases filed in New Mexico, 36 cases filed in Massachusetts and 58 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,396 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, 58 class action lawsuits, 2,957 individual lawsuits and 1,015 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 58 class action lawsuits include 32 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement (defined below) between Altria and Philip Morris International Inc. (&#8220;PMI&#8221;) that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, six </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, two individual smoking and health cases and no e-vapor cases are set for trial through September 30, 2022.  Trial dates are subject to change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in 70 tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in 45 of the 70 cases.  These 45 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (5), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).  One case in Massachusetts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Main</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 25 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, 23 have reached final resolution.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of July 25, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#8217;s motion for discretionary review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $2.3 million.  In July 2021, following denial of PM USA&#8217;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laramie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $21 million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $27.1 million in the third quarter of 2021 and paid $30.3 million (including the judgment and interest) in December 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of July 25, 2022, approximately 727 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 911 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are estimates.  While the 2015 federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court, as of July 25, 2022, one case was pending against PM USA in federal court representing the only case excluded from that agreement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, 139 federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  Seventy-six verdicts were returned in favor of plaintiffs, and eight verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frogel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In two cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kaplan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the punitive damages awards were vacated on appeal and remanded for new trials.  In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the trial court granted PM USA&#8217;s motion for summary judgment, and plaintiff has appealed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifty-five verdicts were returned in favor of PM USA, of which 45 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of July 25, 2022.  The jury in one case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  Four verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearson, D. Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">returned zero damages verdicts in favor of PM USA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Juries in two other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  Three cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The verdicts in the retrials in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) were reversed upon appeal and remanded for new trials.  Two cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of July 25, 2022 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defendants&#8217; and PM USA&#8217;s post-trial motions pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8 million</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($5 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">U.S. Court of Appeals for the Eleventh Circuit vacated the punitive damages award and reduced the compensatory damages to $5 million based on plaintiff&#8217;s comparative fault. </span></div></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which is discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr></table></div><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appellate decisions in the following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that in order for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings, described above in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Plaintiffs filed a motion seeking rehearing on the proper remedy for cases in which the court&#8217;s jury instructions did not comply with the Florida Supreme Court&#8217;s decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In May 2022, the Florida Supreme Court denied plaintiffs&#8217; motion for rehearing.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to us) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with us) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#8220;MSA&#8221;) with 46 states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $500 million; these quarterly payments are expected to end in 2024.  For the three months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.0 billion and $1.2 billion, respectively.  For the six months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.9 billion and $2.1 billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $285 million for 2017; $318 million for 2018; $415 million for 2019; $573 million for 2020; and $635 million for 2021.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#8217;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to 37.  As a result, PM USA will receive approximately $80 million for 2004-2021 ($20 million of which relates to the 2019-2021 &#8220;transition years&#8221;).  In connection with this development for Illinois, PM USA recorded $80 million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state settlement, PM USA has received $1.15 billion and expects to receive approximately $410 million in credits to offset PM USA&#8217;s MSA payments through 2036.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $435 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for nine of the 10 states concluded by the end of 2020.  In September 2021, the arbitration panels issued decisions finding that two states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state concluded in March 2022; however, a decision has not yet been issued.  The two states determined by the arbitration panel to be non-diligent have filed motions in applicable state courts and with the arbitration panels challenging these determinations and several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $21 million as a reduction in cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses three years, 2005-2007, for eight of the nine states, and one year, 2005, for one state.  As of July 25, 2022, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enforce have now been resolved either through settlement or exhaustion of appeals.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#8217;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings for the first quarter of 2021 as a reduction in cost of sales.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014 and 2019, we recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  A hearing for the district court to consider and approve any settlement and consent decree proposed by the parties is set for July 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device.  In August 2020, we filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, we are defendants in 58 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 58 class action lawsuits include 32 cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  Three of the class action lawsuits are pending in Canada.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 2,957 individual lawsuits and 1,015 &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#8217; motion to certify a nationwide class based on state law claims against JUUL and RICO claims against Altria and other defendants.  Altria and the other defendants have filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court has set trial dates for five cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for November 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three of the &#8220;third party&#8221; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss each of these three lawsuits and the motions were denied in February 2022, May 2021 and June 2021, respectively.  However, in the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#8217;s claims, the trial court did dismiss plaintiff&#8217;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  JUUL is also named in other attorneys general lawsuits in which we </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are not currently named.  As of July 25, 2022, JUUL settled four such lawsuits by, in each case, agreeing to a monetary payment (on average approximately $20 million) and to certain restrictions on its sales and marketing activities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the IQOS electronic device and HeatSticks in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#8217; claims against the other defendants have been stayed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA, Altria Client Services LLC and Philip Morris Products S.A. filed counterclaims against plaintiffs alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In June 2022, PM USA and Altria Client Services LLC reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#8220;ITC&#8221;), but the remedies sought included a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#8217; motion to stay the orders pending the conclusion of the appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#8217;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#8217;s decision to the FTC.  Oral argument with respect to the appeal is currently scheduled for September 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of July 25, 2022, 17 putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#8217; claims against JUUL be sent to arbitration pursuant to </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an arbitration provision in JUUL&#8217;s online purchase agreement.  The court granted plaintiffs&#8217; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in four new plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  We do not currently intend to exercise our additional governance rights obtained upon conversion, including the right to elect directors to JUUL&#8217;s board or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $90 million, which amount includes attorneys&#8217; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court preliminarily approved the settlement in December 2021 and granted final approval in March 2022.  We recorded pre-tax provisions totaling $90 million in 2021 and, in January 2022, paid $90 million to plaintiffs&#8217; escrow account.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, the court consolidated five of these six state derivative cases into a single consolidated case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and other parties to the federal and state derivative actions have reached an agreement in principle to resolve these actions through the execution of a memorandum of understanding.  The parties are in the process of negotiating formal settlement documentation.  The derivative settlement will be subject to court approval.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in 23 &#8220;Lights&#8221; cases have refused to certify class actions, </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of July 25, 2022, two &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state courts.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July 25, 2022, one smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of July 25, 2022, there is no such case pending against UST and/or its tobacco subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our condensed consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At June&#160;30, 2022, we (i) had $46 million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $19 million for surety bonds recorded on our condensed consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our condensed consolidated balance sheet at June&#160;30, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $3.0 billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 9. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ebt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615780528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Guidance Not Yet Adopted</a></td>
<td class="text">New Accounting Guidance Not Yet Adopted<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614601952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments in Equity Securities</a></td>
<td class="text">We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our equity investment in JUUL under the fair value option.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Our interim condensed consolidated financial statements are unaudited.  Our management believes that all adjustments necessary for a fair statement of the interim results presented have been reflected in our interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our condensed consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Accounting Guidance Not Yet Adopted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our condensed consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contract with Customer</a></td>
<td class="text">We record an allowance for returned goods, which is included in other accrued liabilities on our condensed consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div>We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.The Fixed-price Preemptive Rights and Cronos warrant are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy).  We elect to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on our condensed consolidated balance sheets in investments in equity securities.We record in our condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occu<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock', window );">Equity Securities Without Readily Determinable Fair Value</a></td>
<td class="text">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  Under this option, our condensed consolidated statements of earnings include any cash dividends received from our investment in JUUL and any changes in the estimated fair value of our investment, which is calculated quarterly.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives, Policy</a></td>
<td class="text">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our condensed consolidated statements of earnings based on an amortization approach.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">We determine the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized.  In reaching this determination, we consider all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619434480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchase Activity</a></td>
<td class="text"><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share repurchase activity was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,083</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">507</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.09&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616378288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Investment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at June&#160;30, 2022 and December 31, 2021 consisted of our equity method investment in Cronos of $437 million and $617 million, respectively, and also included the Cronos warrant and the Fixed-price Preemptive Rights, which are measured at fair value (collectively, &#8220;Investment in Cronos&#8221;).  See below for further discussion.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.331%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,255</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,155</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded non-cash, pre-tax unrealized (gains) losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June&#160;30, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619359024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the aggregate carrying value and fair value of our total long-term debt:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,956</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt above:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,444</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our condensed consolidated statements of earnings were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in <br/>Net Earnings</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(168)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619494912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Periodic Benefit (Income) Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit (income) cost consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (income) cost</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615851520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.185%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">891</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,844</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic and diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,809</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619366768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">884</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">689</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">694</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">643</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,581)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,434)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,962)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">746</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">750</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">583</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">587</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">585</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,581)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(869)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,377)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.939%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,421)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings (losses), net of deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,043)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,602)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflects our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our investment in ABI.  For further discussion of designated net investment hedges, see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in net defined benefit plan costs.  For further details, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are included in (income) losses from equity investments.  For further information, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619426208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,873</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,972&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,543</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,936&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,321</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">837</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">561</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(93)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,263</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on Cronos-related financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,605</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock', window );">Schedule of Pre-tax Tobacco and Health Litigation Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Pre-tax Tobacco and Health Litigation Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619350064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes update (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_SummaryOfIncomeTaxesTableTextBlock', window );">Summary of Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Earnings before income taxes, provision for income taxes and income tax rates consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,278</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,846</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,605</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,909</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,428</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">714</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended June&#160;30, 2022:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,456</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_SummaryOfIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Income Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_SummaryOfIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619474304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Contingencies</a></td>
<td class="text">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 25, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">July 26, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of July 25, 2022, 16 cases filed in Illinois, 18 cases filed in New Mexico, 36 cases filed in Massachusetts and 58 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,396 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, 58 class action lawsuits, 2,957 individual lawsuits and 1,015 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 58 class action lawsuits include 32 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defendants&#8217; and PM USA&#8217;s post-trial motions pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mistrial</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeals by plaintiff and defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial ordered on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defendants&#8217; petition for review to the Florida Supreme Court pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">R. Douglas</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 2017</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awaiting entry of final judgment by the trial court.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8 million</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">($5 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%">U.S. Court of Appeals for the Eleventh Circuit vacated the punitive damages award and reduced the compensatory damages to $5 million based on plaintiff&#8217;s comparative fault. </span></div></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which is discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166619536672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Guidance Not Yet Adopted (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.293%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect on Financial Statements </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166620162960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Background and Basis of Presentation (Narrative) (Details) - January 2021 Share Repurchase Program [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Oct. 28, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Planned share repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 742,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614292880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Share Repurchase Table) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total number of shares repurchased (shares)</a></td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">13.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share of shares repurchased (usd per share)</a></td>
<td class="nump">$ 50.35<span></span>
</td>
<td class="nump">$ 49.21<span></span>
</td>
<td class="nump">$ 50.53<span></span>
</td>
<td class="nump">$ 48.09<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614587984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 303,000,000<span></span>
</td>
<td class="nump">$ 287,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Expected period for satisfaction of performance obligation</a></td>
<td class="text">three days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 43,000,000<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for doubtful accounts, receivables</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166706998448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in Equity Securities (Summary of Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 12,590<span></span>
</td>
<td class="nump">$ 13,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">11,702<span></span>
</td>
<td class="nump">11,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityInvestmentFairValueOption', window );">Fair value equity investment</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">1,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights', window );">Cronos</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityInvestmentFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investment, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityInvestmentFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615620448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Earnings in Equity Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments under equity method of accounting</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="num">$ (226)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments under equity method of accounting</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="num">(392)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments under equity method of accounting</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestmentsFairValueOption', window );">JUUL</a></td>
<td class="nump">$ 1,155<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestmentsFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestmentsFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614307904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in ABI Narrative) (Details) - ABI [Member] - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted', window );">Number of restricted shares owned (in shares)</a></td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (in shares)</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_RestrictedSharesLockupPeriod', window );">Restricted shares, lock-up period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">$ 11,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="nump">10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity securities</a></td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue', window );">Equity method investment, difference between carrying amount and fair value</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue', window );">Equity method investment, difference between carrying amount and fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Restricted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_RestrictedSharesLockupPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Shares, Lock-up Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_RestrictedSharesLockupPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126960272&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609317536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in JUUL Narrative) (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Payments to acquire equity securities without readily determinable fair value | $</a></td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityInvestmentsFairValueOptionVotingShares', window );">Equity investments, fair value option, voting shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm', window );">Equity securities without readily determinable fair value, service agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue', window );">Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount', window );">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount | $</a></td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers', window );">Equity securities without readily determinable fair value, number of board members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion', window );">Equity securities without readily determinable fair value, number of independent board members upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion', window );">Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion', window );">Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion', window );">Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion', window );">Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestmentsFairValueOption', window );">Income (loss) from equity investments, fair value option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,155)<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="num">$ (1,255)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityInvestmentsFairValueOptionVotingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investments, Fair Value Option, Voting Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityInvestmentsFairValueOptionVotingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Service Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestmentsFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestmentsFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615714368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details) - Equity Method Investments, Fair Value Option [Member] - JUUL [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,705<span></span>
</td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Unrealized gains (losses) included in (income) losses from equity investments</a></td>
<td class="num">(1,255)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at end of period</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=mo_EquityMethodInvestmentsFairValueOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=mo_EquityMethodInvestmentsFairValueOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613125488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos Narrative) (Details) - Cronos [Member]<br> $ / shares in Units, shares in Thousands, $ in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.40%<span></span>
</td>
<td class="nump">41.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Number of ordinary shares owned (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,600<span></span>
</td>
<td class="nump">156,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue', window );">Equity method investment, difference between carrying amount and fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, shares purchased, (CAD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase (approximately) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase', window );">Equity method investment, percentage of shares eligible for purchase (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentAggregateExercisePrice', window );">Equity method investment, aggregate exercise price</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember', window );">Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage', window );">Equity method investment, warrant exercised, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentAggregateExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Aggregate Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentAggregateExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Percentage of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPricePerShareIfExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Price Per Share If Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPricePerShareIfExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Warrant Exercised, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126960272&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615528704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Fixed-price Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Cronos Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613442752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">$ 27,680<span></span>
</td>
<td class="nump">$ 28,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="nump">23,956<span></span>
</td>
<td class="nump">30,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ForeignCurrencyDenominatedDebtAbstract', window );"><strong>Foreign currency denominated debt included in long-term debt above:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">27,680<span></span>
</td>
<td class="nump">28,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency Denominated Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">4,444<span></span>
</td>
<td class="nump">4,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ForeignCurrencyDenominatedDebtAbstract', window );"><strong>Foreign currency denominated debt included in long-term debt above:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">4,444<span></span>
</td>
<td class="nump">4,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="nump">$ 4,150<span></span>
</td>
<td class="nump">$ 5,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ForeignCurrencyDenominatedDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Denominated Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ForeignCurrencyDenominatedDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613425280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">$ (247)<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="num">$ (375)<span></span>
</td>
<td class="num">$ (168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign currency denominated debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">(247)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="num">(375)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614179056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit (income) cost</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609287296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Defined benefit plan, plan assets, contributions by employer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Decrease in obligation, pension and other postretirement benefits</a></td>
<td class="nump">$ 432,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear', window );">Anticipated additional employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615527568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Basic and Diluted Earnings Per Share) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Altria</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 2,149<span></span>
</td>
<td class="nump">$ 2,850<span></span>
</td>
<td class="nump">$ 3,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted', window );">Less: Distributed and undistributed earnings attributable to share-based awards</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Earnings (losses) for basic EPS</a></td>
<td class="nump">889<span></span>
</td>
<td class="nump">2,146<span></span>
</td>
<td class="nump">2,844<span></span>
</td>
<td class="nump">3,567<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings (losses) for diluted EPS</a></td>
<td class="nump">$ 889<span></span>
</td>
<td class="nump">$ 2,146<span></span>
</td>
<td class="nump">$ 2,844<span></span>
</td>
<td class="nump">$ 3,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares for basic EPS (in shares)</a></td>
<td class="nump">1,809,000<span></span>
</td>
<td class="nump">1,849,000<span></span>
</td>
<td class="nump">1,813,000<span></span>
</td>
<td class="nump">1,853,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares for diluted EPS (in shares)</a></td>
<td class="nump">1,809,000<span></span>
</td>
<td class="nump">1,849,000<span></span>
</td>
<td class="nump">1,813,000<span></span>
</td>
<td class="nump">1,853,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609239808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,760)<span></span>
</td>
<td class="nump">$ 2,995<span></span>
</td>
<td class="num">$ (1,606)<span></span>
</td>
<td class="nump">$ 2,925<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(2,403)<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
<td class="num">(2,403)<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Losses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(2,962)<span></span>
</td>
<td class="num">(3,774)<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">750<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">587<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(2,377)<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(2,377)<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,597)<span></span>
</td>
<td class="num">(2,392)<span></span>
</td>
<td class="num">(1,612)<span></span>
</td>
<td class="num">(2,420)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(2,043)<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(2,043)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,434)<span></span>
</td>
<td class="num">(1,421)<span></span>
</td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">746<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(163)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">583<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">565<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(869)<span></span>
</td>
<td class="num">(1,604)<span></span>
</td>
<td class="num">(869)<span></span>
</td>
<td class="num">(1,604)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency Translation Adjustments and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609282384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">$ (47)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (93)<span></span>
</td>
<td class="num">$ (89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</a></td>
<td class="num">(891)<span></span>
</td>
<td class="num">(2,150)<span></span>
</td>
<td class="num">(2,850)<span></span>
</td>
<td class="num">(3,571)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember', window );">Net loss [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Prior service cost/credit [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Currency Translation Adjustments and Other [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613149520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Segment Data Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 6,543<span></span>
</td>
<td class="nump">$ 6,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,435<span></span>
</td>
<td class="nump">$ 12,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">3,105<span></span>
</td>
<td class="nump">3,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,989<span></span>
</td>
<td class="nump">5,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from equity investments</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
<td class="num">(126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">(Gain) loss on Cronos-related financial instruments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">2,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,278<span></span>
</td>
<td class="nump">4,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">5,873<span></span>
</td>
<td class="nump">6,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,138<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">2,762<span></span>
</td>
<td class="nump">2,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,321<span></span>
</td>
<td class="nump">5,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">665<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">430<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="nump">864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles', window );">OCI</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">General corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General corporate expenses</a></td>
<td class="num">$ (54)<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (120)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166615728608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member] | Operating Segments [Member] | Non-Participating Manufacturer Arbitration Panel Decision [Member] | Operating Income (Loss) [Member] | NPM Adjustment to Cost Of Sales [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (loss) related to litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products Segment [Member] | Operating Segments [Member] | Tobacco and Health Litigation Cases [Member] | Operating Income (Loss) [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination, acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166608840800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member] | General corporate expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member] | Segment Reconciling Items [Member] | Interest and other debt expense, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Tobacco and Health Litigation Cases [Member] | Operating Segments [Member] | Smokeable Products Segment [Member] | Operating Income (Loss) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609842272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">27,680,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,680,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,044,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 6,542,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 649,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 649,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Loss on extinguishment of debt, premiums and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">623,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write-off of amortized debt discounts and issuance costs, debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest on long-term debt</a></td>
<td class="nump">376,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 376,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 429,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,042,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum', window );">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio', window );">Debt instrument, consolidated EBITDA to interest expense ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_DebtInstrumentExtensionTerm', window );">Debt instrument, extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member] | Revolving Credit Facility [Member] | Line of Credit [Member] | Revolving Credit Facility Due August 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616205696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">$ 1,605<span></span>
</td>
<td class="nump">$ 2,909<span></span>
</td>
<td class="nump">$ 4,278<span></span>
</td>
<td class="nump">$ 4,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 759<span></span>
</td>
<td class="nump">$ 1,428<span></span>
</td>
<td class="nump">$ 1,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="nump">44.50%<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
<td class="nump">33.40%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166608819520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceRollforwardRollForward', window );"><strong>Valuation Allowance Rollforward [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 3,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount', window );">Additions to valuation allowance charged to income tax expense</a></td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount', window );">Reductions to valuation allowance credited to income tax benefit</a></td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment', window );">Foreign currency translation</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of period</a></td>
<td class="nump">$ 3,456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Decrease In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase In Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceRollforwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance Rollforward [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceRollforwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166701948256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (General Information) (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond', window );">Number of states that cap bond or require no bond</a></td>
<td class="nump">47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States That Cap Bond or Require No Bond</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609162336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">213 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 25, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at end of period</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember', window );">Related Interest Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Pending Litigation [Member] | PM USA [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationEscrowDeposit', window );">Security posted for appeal of judgments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Tobacco and Health and Certain Other Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest expense (income)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationEscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Escrow Deposit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationEscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166608387216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Schedule of Pending Cases) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>lawsuit </div>
<div>claim </div>
<div>case</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 26, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Pre-tax charge | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember', window );">Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Tobacco and Health and Certain Other Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | New Mexico [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCases', window );">Number of cases | case</a></td>
<td class="nump">1,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Individual Lawsuits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Pending Lawsuits Filed By State Or Local Governments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveCases', window );">Loss contingency, number of inactive cases | case</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits', window );">Loss contingency, number of inactive class action lawsuits | case</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Cases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166610190800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">283 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 26, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">4,030<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsResolvedNumber', window );">Number of claims resolved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Alaska [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Connecticut [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Louisiana [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Mississippi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Missouri [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Hampshire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Ohio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Pennsylvania [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Rhode Island [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Tennessee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | West Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsResolvedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Resolved, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsResolvedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofCasesSetforTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Set for Trial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofCasesSetforTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_RI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_RI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614221600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember', window );">Non-Engle Progeny Smoking And Health Case, Principe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember', window );">Non-Engle Progeny Smoking and Health Case, Greene [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember', window );">Non-Engle Progeny Smoking and Health Case, Laramie [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="nump">$ 30,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseLaramieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166614768512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>USD ($) </div>
<div>case </div>
<div>claim </div>
<div>plantiff</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>claim</div>
</th>
<th class="th"><div>Jul. 31, 2006</div></th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jul. 31, 2000 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants', window );">Loss contingency, period for decertified class members to file individual actions against defendants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plantiff</a></td>
<td class="nump">911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Federal [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Number of verdicts reversed</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdicts', window );">Zero damages verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdictModified', window );">Zero damages verdict modified</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pollari [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Freeman [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases Kaplan And Sommers [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyUnfavorableVerdictsPendingReversed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Unfavorable Verdicts Pending/Reversed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyUnfavorableVerdictsPendingReversed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdictModified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdict Modified</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdictModified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdicts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdicts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdicts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFederalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanAndSommersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanAndSommersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166606644016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember', window );">Engle Progeny Cases, Schertzer [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember', window );">Engle Progeny Cases, Schertzer [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember', window );">Engle Progeny Cases, Garcia [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMcLauighlinMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMcLauighlinMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember', window );">Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMcLauighlinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMcLauighlinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166701921680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Florida Bond Statute) (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2009 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_MaximumBondForAllDefendants', window );">Maximum bond for all defendants</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MaximumBondForAllDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Bond For All Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MaximumBondForAllDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166608924064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking and Health Class Actions and Aggregated Claims Litigation [Member]<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">314 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($) </div>
<div>ruling </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>case </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_AR', window );">Arkansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DE', window );">Delaware [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DC', window );">District of Columbia [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IA', window );">Iowa [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_KS', window );">Kansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_LA', window );">Louisiana [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MD', window );">Maryland [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MI', window );">Michigan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MN', window );">Minnesota [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NV', window );">Nevada [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">New Jersey [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OH', window );">Ohio [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OK', window );">Oklahoma [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OR', window );">Oregon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_PA', window );">Pennsylvania [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">Puerto Rico [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_SC', window );">South Carolina [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WI', window );">Wisconsin [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Canadian Tobacco Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyVerdictsUpheld', window );">Number of verdicts upheld | ruling</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_AmountAwardedtoOtherParty', window );">Amount awarded to other party | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember', window );">British Columbia and Saskatchewan [Member] | Philip Morris USA and Altria Group [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AmountAwardedtoOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount Awarded to Other Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AmountAwardedtoOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictsUpheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdicts Upheld</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictsUpheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_SC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_SC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_AltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_AltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166610084816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Health Care Cost Recovery Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 1998 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>claim </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>claim </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 26, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>manufacture</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualPaymentAmount', window );">State settlement agreements annual payments</a></td>
<td class="nump">$ 9,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum', window );">State settlement agreements attorney fees annual cap</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="nump">$ 2,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember', window );">Threatened Litigation [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember', window );">Canadian Tobacco Manufacturers [Member] | Canada [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Legal Fees Payable, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualLegalFeesPayableMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Payment Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166604480272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (NPM Adjustment Disputes) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>state</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including New York, subsequent expansion | state</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Loss contingency, credits to offset payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty', window );">Litigation settlement, amount expected to be awarded from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesWithConcludedHearings', window );">Loss contingency, number of states with concluded hearings | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues', window );">Loss contingency, number of states not in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues', window );">Loss contingency, number of states in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyReductionToCostOfSales', window );">Loss contingency, reduction to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member] | Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled, arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member] | Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled, arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MT', window );">MONTANA [Member] | PM USA [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Expected To Be Awarded from Other Party</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementEstimateofPossibleGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Estimate of Possible Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementEstimateofPossibleGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled, Arbitration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesWithConcludedHearings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States With Concluded Hearings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesWithConcludedHearings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States Extended with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation, Settlement One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyReductionToCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Reduction To Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyReductionToCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20192021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20192021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166707364912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount ordered to be paid from other party</a></td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613417968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Federal Government's Lawsuit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2006</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember', window );">Federal Governments Lawsuit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_FederalTradeCommissionDisclosurePeriod', window );">Disclosure period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | Federal Governments Lawsuit [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member] | Federal Governments Lawsuit [Member] | Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_FederalTradeCommissionDisclosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Trade Commission, Disclosure Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_FederalTradeCommissionDisclosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_AltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_AltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166609071664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>lawsuit </div>
<div>case</div>
</th>
<th class="th">
<div>Jul. 26, 2021 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_NumberOfThirdPartyLawsuits', window );">Number of third party lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IQOSMember', window );">IQOS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyDamagesRecoverableValue', window );">Loss contingency, damages recoverable, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember', window );">Class Action Lawsuit [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber', window );">Number of pending claims, consolidated for pre-trial purposes</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss contingency, claims settled, number</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately) | $</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember', window );">Pending Class Action Lawsuit [Member] | Subsequent Event [Member] | E-vapor Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesWithSetTrialDates', window );">Loss contingency, number of cases with set trial dates | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyDamagesRecoverableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Recoverable, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyDamagesRecoverableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesWithSetTrialDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases With Set Trial Dates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesWithSetTrialDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberOfThirdPartyLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Third Party Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberOfThirdPartyLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IQOSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IQOSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166607894848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>lawsuit</div>
</th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>complaint</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfComplaints', window );">Loss contingency, number of complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | claim</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits', window );">Loss contingency, number of shareholders filing class action lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency accrual, provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfPendingCasesConsolidated', window );">Loss contingency, number of pending cases consolidated | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits', window );">Loss contingency, number of shareholders filing derivative lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Loss contingency, class action lawsuit | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Complaints</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfPendingCasesConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Pending Cases Consolidated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfPendingCasesConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166613220512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Lights/Ultra Lights Cases) (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>court </div>
<div>claim </div>
<div>case</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyClaimsNotCertifiedNumber', window );">Claims not certified, number | case</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mo_LossContingencyStateCourtsNumber', window );">Number of state courts | court</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyStateCourtsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, State Courts, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyStateCourtsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_LightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_LightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616427824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (UST Litigations Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Jul. 25, 2022 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | UST Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_USTLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_USTLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166616558624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Contingent liability related to performance surety bonds</a></td>
<td class="nump">$ 19,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">46,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140166701917712">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted Cash, Noncurrent</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCashNoncurrent</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted Cash, Current</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCashCurrent</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>mo-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mo="http://www.altria.com/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mo-20220630.xsd" xlink:type="simple"/>
    <context id="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6921171ae08e465e932c11f79502724a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.000NotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iab2de85898814346924624f350e5562e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia7b840b10f44411fb19fdc6d7a05d2f6_I20220719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-07-19</instant>
        </period>
    </context>
    <context id="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i964ab02efa4447bb862d040ab72bdce7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i040c6325db474d64860ba51847e37bfa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i91be2da432a948cfbc579ace82b48610_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ef8abb29b764b4c8ca775c97572d064_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idccb1b2994cd40fbbb5731c88d1d399c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b219eedfb714d8fb1b867d806c10b05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2449a2bfd124fe2ab3313d8a383b536_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if48fb5645cbc4cc196e6db7c24a03af9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i55831b17fc8441a290ddc1bf9c38fa94_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec91f7ffcfe043208c2fbae9bff40d21_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i195abdcdf51a4a099f84b2ae27653186_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i53b0d24d8a90491486fda069a8ee99d0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5f71e968f79944aea5e02c01739659a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0846deffb1664429a509a79024bf0f26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i538011103d4d4bedadad7ef6aa58ff25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43964e9db78c4442b2a6c1bae24600b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibcddf93cb1114af5b696e99fca98b0b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0586e2af9dcd4681a41fbb0b0e0b0e79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5349a45275c54d33af6c9dba5397bc77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i138581f0b65743e59bd88750dcecf150_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8e757a9350804423a1366f4edcb70ffa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idc9b71519dae4e209d412a66a68839cc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9132d76bdc6b46ce939091d328d35fee_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3a159b1f5b8644c382a69af99c56dcc2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if4b9693299744ec9899bea6e3abb91dd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i737149184ecf4228959b9dd0c167bdf5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i825c93cb311e47a19c18659fc18b76d8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7d52eb68d4d748e6aa0dd402d9c0d6f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c6110daa1294fd39e39d73a439bd261_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i803401904f8b457e80587a15d7c74d13_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea1d15baae55479686b0438960a20553_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i46947c74848d4152a49d1bb99f803439_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ied487a078f8f45c08115f899f30d2518_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6bbd121042c745818aabb802a6d44f50_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i540c66305f294fbb945da9a41514ff51_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8a8a4571fc3d4acab135fe43eef795fe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9788f29297284a1d88ff1e6c6548cad3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3f65898626a94e9ea933742220b4c7d5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7aa773030fca4e1f899e5ed5dd14b7d4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2233715bedd740d4a3940763dda60aa8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if4e5356c990d4784a27d514236852917_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie69c7f39e03b4eba8436ad80b94446b0_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-28</instant>
        </period>
    </context>
    <context id="i13871dd12543440895ab2e9a2d7be37e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i456a551753af43a3a51e3142885b59a0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifac8a899318948c599bdf090d2fa77ba_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i36cd43db55f34600bccfbf93673a50c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7eb076cfe6f641f2a07a06b53c206a16_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i01fa611f2a7f4ac18373b103852f2b2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if488a491d85b439783705940ff379d59_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i80a9923020f3440a85a8e77c1756d28c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1faac1f996b4486abd195c7b20753e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie78dea82ae7d4b92b9519c98e6eefa7a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c85ce8790e54af78ef8a2b11e4fb9f9_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4c05c358d1bb48aebde77f979670acd7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i10dd4f1f71584811bc9ce1be4117dc8e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic7229434de434e45a7fba1248a55d390_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7b9574e42f5641358c71bcf9e4257b4b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i392d38c364c74d9ea72ff1e3530414b2_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i60a5c0afbb434e35bbda711cca223cb1_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="ied72379ce65f44d1b138e007119e5e27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4dfcd799dbb04d77a027eb24466e1b75_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i591aee96bde948f381ffaaf7af7d4bdd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f889b38500d46f991a8ea1dc2bff214_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia31a79b3a3b64912992fc8127b6f0253_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mo:EquityMethodInvestmentsFairValueOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5e2fd4010d1f4eceb5b59561d986587a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8022e2eba341430684992380ece3f792_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6943e16458bc4ca2852601e0fa80a2ae_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icd81d8232428439e8af3fc2c52b75b21_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic7724f34336b4837a6779170d66ce1e5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4a65e4417b704c50af9108de96b6b9b3_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i5be1411a627b4cb2955ad80477a30400_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="id53917fedb1842eab0669c6ca15b2879_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantAndEquityContractPreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic6bcff8fcbbc4e029d7f839b563920a1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie77e3add79c947548aa389bbcf1bc640_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f0cc7b4fc994f51b95e2edb4d99dce0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib7ee7b42337247669b6c69451925af0c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73ce0fd62aa842c6addcbbd8362247ca_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i23e04bbbcf2b4dddba8b27254730fe6a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4bbdf8e5b22441f4b146cdf0423fa04e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6d389b0b33184827ac627cf3211504bb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6624310334664ad8b05bff9a8f611a26_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5daf1435da144756965535f298d285e2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if717a65f18fc419694b6890f52e4adce_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie947e667731b40a181535bc591d33c5d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic5e90128024045188206f3b663f58feb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4535f30518454d34a9ae59f849dec461_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4efe104b447e4349b4028ad89097f7aa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7b1baef738ae429aa8454cd5df509063_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b1ed807a4fe4443a7762e06a922c55b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ebc102806994715ad16146f4c465135_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iee1450fe7da747d081507d7cea3a3f5a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i566c0e2a3879453286eaf377b9a994cc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6749d38ea74544afbe22946f715804b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie13b50de35bf49209e674bd75e9e2e9f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3e9c5a285474dabbe7a8a197ec8c8a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i91101d4785604fc9a749636f25538235_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6c83a931fc3445128dca896fc5996863_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2971e561fd5144678760d3bf8b1861d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22f157089c764d978e4b4467c3bb28c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i512cc5d83afb4aa79f389b6fc7d146d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifd280e0972524a94a5802c10e628c014_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib1ef05e22327463983a5721739547724_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i93682eae4e1b4cba8a7db027c701e88b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i42bddaa56c404c9383c99f3a0b6c9eab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7ce748f70124616bdcdd3de3090c9e4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icec1267d474e4789a588d1c86899f643_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7be67789e30248eb8a8984743067eb42_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if5fde125fe824d80b32071a2130ef0fe_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2d6d19ffeee64ff1b5584b7c5aabb4bd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8b25cddbc4ed4d17a6a79d919abc4d22_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4b4810d1ceab46dfb83be9f80e3e4aab_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i51fed6551e784a959a8fd96ee3dd8391_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4de3b3f3b48d41c4ad4828796b656496_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2725c640d5cc48fb9a0ce5d1941b72e6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icef447b72ac047088d37bbe5edc817f9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ice90d1e8bfe848d8b5e0d085479ebb80_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i806001e09fa14faaae11598091f1f498_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i55511d6e0eb14ca08f381602cf9690cd_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i66543092e0e046ca8c1b86aca084bfe7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib96273d2e0d845948f345d07e913c368_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8779bb1a61dd4789bc38ae36caf3dafe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4009a312b9e9481c9ed1f1d8e29d8f11_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie2b530e082794b12975168c91979ce08_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i429b6c1211f54752a9fbc0980c7003cc_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibd9b9f4a38e840c984bc661555d3412d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1b6d5238a8934a91b23047ee5dc570e6_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i48d2ec74dc3743e885b697dfef6ecf65_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8e01747e65a4c47874b561f5f5591d9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if9467a64aae949aa85d911d37de5f523_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic32394b7c33e4adaa729d30f5b7f8492_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ife875847779a4eb0971d8c1bba755f05_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if54b43a0052a4188ada7399179966cb3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i87386dcee92742288df164bf8606efee_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9e3820406df4495e896788d13764aafd_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia9f07419638445eab9c375777cf6a504_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ide49c713466f480384f5feb6704320bf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if6597a9719154f9bbebe60e2abbfae97_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia10ee74830654452a7f2606b4d8c93b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78c606bc0ba64901873c5992d4eff20d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibfc2a0eede234b6486bae3fec8149242_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8be97c192668455c8b81cd42aa504ee4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i93ba44bf6fce4bd5974e74d3b133117d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f65ccbdc8ff41efb0c6806847d43860_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3a8a884562fd49f18dfd6aeeb09a20a8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0c63006a91f04aa0a97e0e25d1afb998_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic6a9924f43b44980bdeea6e55ddeab2a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9d6bc7e58db8428ebf31c693b4236ea7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i46db2dd0967c4895b93fb83754d195c0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ife349d051cc74966a11492b5681f511d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ieedfff3a9a3247c9bb3467f1b57505f3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i10790d601d0144df92ffc1eee752bd0d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i51aba496809142e593bb1b943f268798_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia9269c502f174ba7b95d543c1fe32410_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5096748718454223a3a223a6cfd489a3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie43f576a9e9d4820aedbcd69fd64f322_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idcd2f0a9c69f413b81668b9456672a69_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i844eb97024c84e86b793fb4669de42da_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i03d1c6700b304008a01681c4c742502b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28febc0f256b49e2a19127bac1eefd4f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9e8b966e2d51497780ea70bf9d0c4b17_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i90b9e0213b45474dab5f5de82137fd03_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iad51ca79f2ce481bb8b8ba1aea9c8bfc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i37e492b0fc2d45a8b2e224d8465d9026_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2be9a00b70904e04a6f468eec5058227_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icf22930994534713a83c19ce49bde1ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie526609fec74474d87c0aa3c9e2a3ccc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i904889c18dee449b9c1967209d215e07_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i834f7afe8d0b4966b98bf4be48676817_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib7333de9d7b44fc198078f692ff042c5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i64e7b37987ea44128d943580102fc338_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb300ff50687440da92f6d2d8898e254_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2611638f3f074e30be114be0592513de_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c088115b8af479895ab47b7bff4f51e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i71508c07d42a42569b52bd3ebbac6370_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15710cf918bb4ad0bfe9ff7a338e1fb1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie2626fb7367b400aba3c194f31411f4f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib0e58a9d31fd4b2b9e8753887b69b312_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="if80273ba6b18457cbc2b5182392c76b1_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i5d91ab5e046640bcbabc478601fd21b3_I20210726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-26</instant>
        </period>
    </context>
    <context id="ifc4defe52f8b46b09b0531c0541a5403_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="iac977efcc9484319b8cd4e82324c3fa3_I20210726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-26</instant>
        </period>
    </context>
    <context id="ia3402c70aef94f5b9ca25910ffaecba2_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i87bf8ff853e2425f96934e4e9ddef164_I20210726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-26</instant>
        </period>
    </context>
    <context id="i470465d1a67e47cf963f96112e6bcc56_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i0c6153fbe7224388926901e9703fa838_I20210726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-26</instant>
        </period>
    </context>
    <context id="ib36e57c0c00746cd9d7c260932b94d8e_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i8eb8d2231c6e42c68730b177faaedcd8_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ie41710be5b8c41ee96fe3ba722416d41_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="icf33c42aea2a44e9a567c3723d8ddceb_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i5a4d2c2e9803462e976b555918c63490_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i18fb1c9978ec48949a63f54f3c2ec853_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="iec4f544b33974b84b91ca169738940e5_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i057dcd83a81443d6895e291fa75e63cf_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i602c7b1521144698b0e57a755cdea240_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ifdbc8a7fc0b140448112768ac4469793_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="iff8405d610414876a75ffeb4cb61a3be_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i90bb52ef7113414d8e3846eac30005d0_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i9f105d7b0a5346afb83dd5c09220d92e_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i682d73a693e04609b5d9fbeaba2fcd92_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i6a1559a0e1124131910366a39aff6d12_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i509864cccb2f40b98af72697cece813f_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ica10ed061e3c4768a08c7c6d78a09387_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i4b1143b32ee544e99d873d85d649da2f_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i7f6d5b4f9824425c86ad308c5211697c_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ica1283cfc29e491f80a171844b65131e_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="iba9fd76fee584f7ca0719a4a74458197_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i368a47758f0742e6a4c03e7856369fd6_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ie79e75207b814e8c961e323037e2b7ea_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i2e26448b3750441c87cc00de2ed31100_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ic873084e522446c8862fe8e1fa9cf238_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ib0e31195d77d48bbb3cea0dade509ea8_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ic0abc218a2ef4d91b7ebb3f361f67c37_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i3f81cf3349f04c67bca28e5eb157473e_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="id76f91e8dbc44f6582842261cefc0a50_D19990101-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i0c5245e6da544ef581a1619155446591_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="ie0a6cce22a9241bfbe34dbe658ae9cde_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="iada3831810b84380a34be34e3dbc1ffe_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i8b2ca9e1f1054d9fba499bdf41e121e9_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="id2baa872a94b482c8bb1018ad55264cb_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i94e53bc2b6de4394af0f5e9e5f1faa3a_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ac825808e1a4f3b84e8fee44f14e337_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c7f18929f5e4ba98e6d6041dd284fc6_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseLaramieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9240c78c98394f3cb2cc1b313917c5ad_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i17eebd26ab63497ab584d767938f5d8b_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-07-01</startDate>
            <endDate>2006-07-31</endDate>
        </period>
    </context>
    <context id="if9927761764b40a786f566330b852304_I20080131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-01-31</instant>
        </period>
    </context>
    <context id="ia60506d9acad48209c8c8dcaed0769be_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ieb55d0b8c2e34a54b634281cfd15e7c5_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ifd6affc6fc324b9da397010ae49673c8_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFederalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ibc9177f9baa34fbdbf6605706769f68e_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanAndSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ic4081d6a41ea492c824d20493bcf3dce_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i2a58875756fe4911aa25efd5db88be0b_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i2c068a726b53483290f0d1fd038adfcd_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="ib6e24acdccca4adbaac072d4e4022eae_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="iae106d4c552a4de1b53156ad6d849934_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i259df7aad9264b5a979579e9065bdd22_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i7b3ead33c4fb46be8b5f3121b9156fae_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i50edc02879964eff963fa402576e9210_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie6122c7f81bc4da79b3a3ebea157c058_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4fcf223c1d694ec285210be845848dc5_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i9df9b90b8d244415b8523a07918dc0b2_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="icbe894efd4be468984d251e1e5c76e61_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="iea6cffa455ad48dfb0c461d66ddf84e1_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if38694f1fdb142f8995d60ccb8ade4a4_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ifcd6b27156ef4c5189f7baa650560310_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="iea83e832e8d04b5bb9090996f5901381_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="ia0b7a204571b434cae1afa93d9ad5f88_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="ib7287b41052449eda9a16b7a4c0ec748_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i0f691b340eae41fab60e5ecfae6d3d73_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMcLauighlinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i855a49b8e94a44d8845849b0b6cdafcb_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMcLauighlinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i0bdb791827ba48ab8cd3664a2010e68d_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="icb9002b835be42eeb751f0eeed99f3a6_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="ic88503c7bdfe46aa8828a4d6ab9c1639_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i57f26ea5a3014b9b9729fe7e127386e6_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="idc8ad30209f44f13aa28826ce714e1e3_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="i46aef541c52b44488e878806bd18c603_I20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-31</instant>
        </period>
    </context>
    <context id="i93894bc913ad47c68ff2b60978052595_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9c72bf9fe7e94489a9a55eb6ef0170d2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i494b0e99edea410eab5611b73ffe2f4b_I20090630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-30</instant>
        </period>
    </context>
    <context id="i9a1eedb0c135405eb108bc5d0c630bdc_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i319065433abd4969ae1ac14852b67636_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ide83d291e49e4954a5a0296df977d166_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0ae966d42be24dd582723eae2b55cfaf_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia610c28441d14994af28fe694a231c07_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i30ab1a010fd441a897ef5fce3716965a_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i998145dbc029488dbf42ec885813145a_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4118f17df3314a5b83ef7db05acfe8e7_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i19c5fce8de1e4a369b1fdaaeee2023be_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1edca63a676640e6b6829445de1c62ba_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i55ab3c65ee434f54b6c4e29b1fa9f142_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iee45707683a643b6bbb8071e6dfc639a_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i204541f308ef43d6a18a8ad65ed791a5_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i15ec71c620304120a35b6a786a7af7ca_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic571c755a3174b2f8b0b4330bc60eb8e_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie244b73417994d3d8fc685443c7bab67_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie8c697029cb24766b6430bb454ff76d2_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61bee51f4e7549f7b26494a823b20219_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie263e9c12c0c49598ae4af4a0e29d138_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i21e1760e3dc3429e9de3e8b11b5e3aae_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i95792785b13646e3a52dbef118639cab_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib918bb45881a41b88b31716185a5601b_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i51dbba0c72e44ef8b9724d88a7e26133_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i88a99b9d1e4244df95287f1de8eef4b2_D19960501-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8281813f0706492da71cbfe50a5ba129_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id68e6389cd4f47489796944107883c14_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4852a02f887c486abc8978cdda91ec14_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8536b6fab27d4581bb4d23b4348e4024_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2c93e0173c414555a75af3caf5b31494_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1998-11-01</startDate>
            <endDate>1998-11-30</endDate>
        </period>
    </context>
    <context id="id640778c3952418d9eddb33bdb279309_I19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-11-30</instant>
        </period>
    </context>
    <context id="i7ad4667992974c56b30361191a43c305_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3684944b3b7443d8a34cefbfc60a1e71_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i398ddf29c5ae4d1cba9418e41e0bdc83_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i156ce9dc699a4fa88302b05d0f029496_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i470d9d37b2e54ca2bef0338fb55cea99_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd811b49bbac43eda9afecebc9563fdc_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id180aaaf475140e1b559d11028dd32ad_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if2059686678443feb7b68e80c9cb4cb2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibc032ffd1fbe41ae93ae94b0ece2a49d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i956ef150cdde441bbced0f592c3f89a2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ac9e5fa08264e408b57748a0cb725e9_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic2a140870c1d49dd85a9a4cf55517c3e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4de839768ad94cfab14e39ee519be5eb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia26efd9028144ce997e13ba03004b3e4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6183a39e504c4bf3875e7ca13284f323_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iae5dcbeb354e44d0a63d24ea3d885915_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0f62b64e22cb44d0ad3a08021fc5a3eb_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id3bfca6d5eb04b478cd4cce359cc1b8e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6d910ce0936c4de79d300ec7d603cc96_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idc172e1bfb8a4ca18d58681f22ba1e18_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i01dc1495f92d44cc975d4c4d9ef6db7a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3d5b27f46d834849b12eed1fa7de3baa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2021NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia2bf50e945174e8eb4da9d6fb6259656_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if6e1e56b911e47e2a8a17ad4923c4e1d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i87b1662c87ee4da4894098d4f121317e_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i79edba75585544a1b364c3a2a5272a9a_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9908c88820c8407882fd66aaee5e71fe_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20192021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba9d82d27f974b7fb350c60b0eddb7e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1439f2cfb5bf487799a6201d4441815e_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i69bc69e5749b4429a718b65ce3094b6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc810a366b774b66bbcdcf2086537c48_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4f54360a45714f0c8d17beb27f673520_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaaea83fd15864426afc96fc88210b860_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i346e658d67ab4443b81460637eece234_D20060801-20060831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-08-01</startDate>
            <endDate>2006-08-31</endDate>
        </period>
    </context>
    <context id="i5a1126f30d7047cabf8a35e278d210e4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie90404e480bd486abe1322ee5d399a7e_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="ic402594e8e0340378ab44dfc725a5202_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic17131fdfa6d4b22ab39238b34d989c6_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:AltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i611c10d6dd834dab966ca0225a1eac42_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="ibe88256c0632439c804ad259ee58ac49_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7ee7e14784294b1aa50a20edf7383985_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-25</startDate>
            <endDate>2022-07-25</endDate>
        </period>
    </context>
    <context id="i06aaddc0651c4da18fe616a4c53e7a2e_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i3c099a74ac94476c86a02b82115806c9_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ib39dbb98e8d440f28749e4aee5911bf3_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="id54b8c1baf4c4086bb509612132c190e_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="id41b8120810c4e6d829b0b1591449c2e_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6585b27441174f2ea5fcb1e108ef4379_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i9be017d1acc2442bb23883e51a46e1d2_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iae31955a3e5d46a98b6382848e87c3dc_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic49230ad8f5446c9b722373434519ae5_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="id4b290e9d4bd4c9f8883131d3263103a_D20210701-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i49fc4815acd44dd095f74bae91742f69_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i44d3390cbcd0491bb2a57fa5618b6c6a_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i453bba98eb8743d79202cf42541d0607_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <context id="i8f7dbe193b884cf4a3753d6b4bbf0f5f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i70c873e1e88d4ecaa8226421d8083196_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib54ecad677fe41feb6b487a4b5b5f14a_I20220725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-25</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="director">
        <measure>mo:director</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="state">
        <measure>mo:state</measure>
    </unit>
    <unit id="claim">
        <measure>mo:claim</measure>
    </unit>
    <unit id="case">
        <measure>mo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>mo:lawsuit</measure>
    </unit>
    <unit id="plantiff">
        <measure>mo:plantiff</measure>
    </unit>
    <unit id="manufacture">
        <measure>mo:manufacture</measure>
    </unit>
    <unit id="ruling">
        <measure>mo:ruling</measure>
    </unit>
    <unit id="complaint">
        <measure>mo:complaint</measure>
    </unit>
    <unit id="shareholder">
        <measure>mo:shareholder</measure>
    </unit>
    <unit id="court">
        <measure>mo:court</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8xLTEtMS0xLTEyOTEwOQ_e3a8e060-130b-4538-a2ca-0b3a5f49ce78">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8yLTEtMS0xLTEyOTEwOQ_52f9be05-2f9e-4ca4-a6da-af09604c982f">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF8zLTEtMS0xLTEyOTEwOQ_c5d7ed3d-84bb-4030-92a3-d27c7f249fcc">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF80LTEtMS0xLTEyOTEwOQ_2f74205a-580a-45dc-a674-de6069d9ca3d">0000764180</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80L2ZyYWc6OWRiNDFjMTdkNmUxNDBjMDlkZjA3MzM1NTc4ODA5MTgvdGFibGU6MDBjNmY3ZmE4NzRlNGQ5YTgyNWQwYTUwMWJiYzdlMTAvdGFibGVyYW5nZTowMGM2ZjdmYTg3NGU0ZDlhODI1ZDBhNTAxYmJjN2UxMF81LTEtMS0xLTEyOTEwOQ_7c1596a0-94d6-45cd-a50b-26467e8021e3">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xNi9mcmFnOjQ2OGZhMmE5ZjQ4YjRjM2FiMDBlMDRmNWY2YTk4Zjk5L3RhYmxlOjNlYjczZjhkNGViMzRmZWE4N2Y0NjMxYjMwMWQzMzNlL3RhYmxlcmFuZ2U6M2ViNzNmOGQ0ZWIzNGZlYTg3ZjQ2MzFiMzAxZDMzM2VfMi0xLTEtMS0xMjkxMDk_d2401b62-ce8f-4bf2-82c8-b16944adf1ce"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xNi9mcmFnOjQ2OGZhMmE5ZjQ4YjRjM2FiMDBlMDRmNWY2YTk4Zjk5L3RhYmxlOjNlYjczZjhkNGViMzRmZWE4N2Y0NjMxYjMwMWQzMzNlL3RhYmxlcmFuZ2U6M2ViNzNmOGQ0ZWIzNGZlYTg3ZjQ2MzFiMzAxZDMzM2VfMi0yLTEtMS0xMjkxMDk_c7c4490e-6cac-4f46-9a4b-d10151f89304"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <mo:LossContingencyStateCourtsNumber
      contextRef="ib54ecad677fe41feb6b487a4b5b5f14a_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDkvZnJhZzo3NDYzZTM4OTM2NTA0N2MyOGE1MTQ0ZTM3MWQ5OWY0ZC90ZXh0cmVnaW9uOjc0NjNlMzg5MzY1MDQ3YzI4YTUxNDRlMzcxZDk5ZjRkXzU_263f58dd-9a5f-4517-ae3c-a585b6c618bc"
      unitRef="court">21</mo:LossContingencyStateCourtsNumber>
    <dei:DocumentType
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDgy_2e26f203-4b42-43c9-b64f-2ba5662cebac">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NWVlMjdlN2RlMTU5NDc0Y2I1ZTMxOGNkNDNmMTcwMjkvdGFibGVyYW5nZTo1ZWUyN2U3ZGUxNTk0NzRjYjVlMzE4Y2Q0M2YxNzAyOV8wLTAtMS0xLTEyOTEwOQ_1145311e-6e54-448e-8e53-ecc1efd83b3c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8zMjk4NTM0ODg1NTQ1_891deb94-a581-40da-aa1a-a5214addbc9b">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6YzVmYTFlNzc1ODIyNDliYWIyNmE5ZWZjNDhlZjRkNWIvdGFibGVyYW5nZTpjNWZhMWU3NzU4MjI0OWJhYjI2YTllZmM0OGVmNGQ1Yl8wLTAtMS0xLTEyOTEwOQ_517c807f-9948-4658-80db-c92cf3bfc72a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg3_acfb9bef-e5b7-4696-a7e0-0cb56c61fb27">1-08940</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg0_fe8fe378-191e-4dea-9efd-a0ce68e06607">Altria Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF8xLTAtMS0xLTEyOTEwOQ_4d7ce48d-77ca-4d05-8e25-bd8cb96abae0">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF8xLTMtMS0xLTEyOTEwOQ_e3af965b-ef8d-4701-98a5-37b0b7013dc2">13-3260245</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTAtMS0xLTEyOTEwOQ_0d6bf416-28f2-419c-b697-826b2e3b5c93">6601 West Broad Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTEtMS0xLTEyOTEwOQ_8909418e-f26e-4958-8dc8-4d7982158fcd">Richmond,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTItMS0xLTEyOTEwOQ_38c2c743-69ef-4627-ab43-87a5309c7062">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NDk5YjRkOTY3N2QwNDI1OWFhMmQ5MTgzY2QzNDk1NjAvdGFibGVyYW5nZTo0OTliNGQ5Njc3ZDA0MjU5YWEyZDkxODNjZDM0OTU2MF80LTMtMS0xLTEyOTEwOQ_f541c43a-776a-4e0f-8bf8-5913b313b0b1">23230</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg4_fd354657-fa2a-4b6d-9534-866cc2ae2625">804</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDgx_1c35f58f-237f-4336-b760-89022dba7006">274-2200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTAtMS0xLTEyOTEwOQ_7be15835-0ef1-41ce-8c29-bb207a45e28b">Common Stock, $0.33 1/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTEtMS0xLTEyOTEwOQ_dcbae44d-a54c-42d6-8df2-bbf68c7b1084">MO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie5bf1453a58440f9a1b6fd3bb9510f98_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8xLTItMS0xLTEyOTEwOQ_fc9b6cb7-8568-486f-a220-61852a3bab3b">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTAtMS0xLTEyOTEwOQ_1fbb6131-8899-4be6-9156-1ca3f577a6bf">1.000% Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTEtMS0xLTEyOTEwOQ_3313a6bf-e3d1-480c-ab7a-efed3c43aecc">MO23A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6921171ae08e465e932c11f79502724a_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8yLTItMS0xLTEyOTEwOQ_c5877b4c-413d-4e93-8cba-627b6a592564">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTAtMS0xLTEyOTEwOQ_8ba09be0-fd4a-404a-b9f3-5123535589ff">1.700% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTEtMS0xLTEyOTEwOQ_e740a14c-9133-47f9-8649-4f5b31f933d3">MO25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4799de36479d4cc38e5941a4d9588bcb_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV8zLTItMS0xLTEyOTEwOQ_1abe9698-1932-4043-990e-ebcc710f4199">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTAtMS0xLTEyOTEwOQ_3b79a2e1-9ac3-478e-9cff-2306b0d8eb1d">2.200% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTEtMS0xLTEyOTEwOQ_5c8dae32-3dcd-40cf-87db-3b265ce7f4dd">MO27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic4c0baa23d5946c1aa92708811a3df64_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV80LTItMS0xLTEyOTEwOQ_dba08a66-ff8c-445c-af01-cf85778739a0">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTAtMS0xLTEyOTEwOQ_05746b40-4035-4ab9-bd16-7d42322fbd92">3.125% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTEtMS0xLTEyOTEwOQ_0ccc7f24-499e-4ce7-8348-db140f76f233">MO31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iab2de85898814346924624f350e5562e_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6Yjc0ZjQ5NzQ1YWZmNDA0YWFjNWQyYmUzOGZhMTk2NjkvdGFibGVyYW5nZTpiNzRmNDk3NDVhZmY0MDRhYWM1ZDJiZTM4ZmExOTY2OV81LTItMS0xLTEyOTEwOQ_29f6f804-6713-488b-b5d7-4c8824f47410">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg5_e3b64051-c568-4905-9bed-8140cdea8066">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg1_0bee080c-3657-49e2-8ee6-d185e4a677e8">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8wLTAtMS0xLTEyOTEwOQ_a0867130-931b-466f-9c8b-858269b61f07">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8yLTYtMS0xLTEyOTEwOQ_9ad357cc-e6fe-42bc-b093-ceba5b9e61f5">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGFibGU6NGVjM2M2NmQxZDAwNGJjNWI2NDgyZjM4ZWZhMTgyZDUvdGFibGVyYW5nZTo0ZWMzYzY2ZDFkMDA0YmM1YjY0ODJmMzhlZmExODJkNV8zLTYtMS0xLTEyOTEwOQ_620b8e5e-e758-4da5-b507-8a8ef0b0b2aa">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8yMDg2_d2845300-0da2-4c47-b7ee-899774b7f53d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia7b840b10f44411fb19fdc6d7a05d2f6_I20220719"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xL2ZyYWc6NjMzNGE5Y2QyYjg3NGM1YmE4ZjI0N2MxZTA1OWM2YzIvdGV4dHJlZ2lvbjo2MzM0YTljZDJiODc0YzViYThmMjQ3YzFlMDU5YzZjMl8xOTk2_61637bb8-25da-463d-9080-fc729989b8d1"
      unitRef="shares">1800823383</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMi0yLTEtMS0xMjkxMDk_f9eef227-bfd7-412c-babe-37356544dbfe"
      unitRef="usd">2567000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMi00LTEtMS0xMjkxMDk_7d6aa5bb-bc27-402a-aad8-0d7c1617516a"
      unitRef="usd">4544000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMy0yLTEtMS0xMjkxMDk_2f3e091b-345e-42a8-bb64-c2d2dc6591b0"
      unitRef="usd">43000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMy00LTEtMS0xMjkxMDk_d5657214-9511-429b-a809-e6716e750f9b"
      unitRef="usd">47000000</us-gaap:ReceivablesNetCurrent>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNS0yLTEtMS0xMjkxMDk_2fc1d591-0b77-49ae-9601-25f84d7a564c"
      unitRef="usd">605000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNS00LTEtMS0xMjkxMDk_4eb1551c-87a2-4585-873c-6665578c9c9e"
      unitRef="usd">744000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNi0yLTEtMS0xMjkxMDk_556bac2c-f6f4-4bef-b5fd-2b10e6d3ea2b"
      unitRef="usd">183000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNi00LTEtMS0xMjkxMDk_f8a6ffb7-8b94-49ff-b90b-29c25ade3685"
      unitRef="usd">166000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNy0yLTEtMS0xMjkxMDk_9b4fdfb0-a962-436d-89de-0e6a0b1c99ee"
      unitRef="usd">29000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfNy00LTEtMS0xMjkxMDk_3e13a994-f17d-4047-9aae-821c07a08d36"
      unitRef="usd">23000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOC0yLTEtMS0xMjkxMDk_6ea40507-4a5c-472b-8d32-18a901b50ee4"
      unitRef="usd">327000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOC00LTEtMS0xMjkxMDk_9b868bc2-75c7-48b8-a20f-756036dddafd"
      unitRef="usd">261000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOS0yLTEtMS0xMjkxMDk_cec3284d-1f17-48ae-808e-1cd208f15a32"
      unitRef="usd">1144000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfOS00LTEtMS0xMjkxMDk_a1c8cce7-78e6-4c9d-90af-8faf5ab6bc18"
      unitRef="usd">1194000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTMtMi0xLTEtMTI5MTA5_b19cf88e-650b-4fa0-b9a9-21cc2ab2a29b"
      unitRef="usd">332000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTMtNC0xLTEtMTI5MTA5_d9b1a0e5-3cc3-4c08-9167-ba40432cbf7f"
      unitRef="usd">298000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTQtMi0xLTEtMTI5MTA5_093513db-72f4-42d5-ab87-d16b91199eaf"
      unitRef="usd">4086000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTQtNC0xLTEtMTI5MTA5_21138333-b165-4363-928d-13c80db5891f"
      unitRef="usd">6083000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTUtMi0xLTEtMTI5MTA5_c204d04c-e4bb-43df-92e8-aa38b955b007"
      unitRef="usd">4345000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTUtNC0xLTEtMTI5MTA5_17f4c278-e855-47f6-a0a5-54b6e12e2e15"
      unitRef="usd">4432000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTYtMi0xLTEtMTI5MTA5_3f645ae0-c37c-4fdf-995e-a7c53181847a"
      unitRef="usd">2788000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTYtNC0xLTEtMTI5MTA5_99f08266-10aa-415a-959e-a9dd05680dca"
      unitRef="usd">2879000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTctMi0xLTEtMTI5MTA5_ab543739-1cb4-4440-bcd7-6137e21e2530"
      unitRef="usd">1557000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTctNC0xLTEtMTI5MTA5_dd607f96-74dd-4c55-a0bc-84ed14ded364"
      unitRef="usd">1553000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTgtMi0xLTEtMTI5MTA5_0f7236f7-db7e-4740-a810-de2bfe8aa6bf"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTgtNC0xLTEtMTI5MTA5_00403fe4-f813-453b-ba09-ff2c150ee216"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTktMi0xLTEtMTI5MTA5_1c392bda-6239-4879-9926-b9ca4066d567"
      unitRef="usd">12372000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMTktNC0xLTEtMTI5MTA5_52b0e40e-3f9f-4642-8769-73176b8a55b1"
      unitRef="usd">12306000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MjU3NDg0NTU5NDI0NDIyNzg3MjIzMjQ0MmQ0MGE3MGVfMzg_476b6b01-f380-4418-a970-ed39560d1144"
      unitRef="usd">451000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MjU3NDg0NTU5NDI0NDIyNzg3MjIzMjQ0MmQ0MGE3MGVfNDU_3db21b47-a644-4c0d-a22f-5cbbd6dd8515"
      unitRef="usd">1720000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtMi0xLTEtMTI5MTA5_61e6134b-c363-4ce9-8f89-26af0adc69da"
      unitRef="usd">12590000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjAtNC0xLTEtMTI5MTA5_ec7b66d4-2e6f-4c1f-bc26-915aa9ea0325"
      unitRef="usd">13481000000</us-gaap:Investments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjItMi0xLTEtMTI5MTA5_ae51c32c-d873-4256-bb66-f04928b344fa"
      unitRef="usd">964000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjItNC0xLTEtMTI5MTA5_3cb0c34f-dac2-4d97-9ac0-fe9dc09b696b"
      unitRef="usd">923000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjMtMi0xLTEtMTI5MTA5_0f6d8ca4-309e-44f2-a0d0-b3a19ff2a50d"
      unitRef="usd">36746000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOjUyZGY0MGYwNTRjNDQ2OGFiNDc0MmFhMGJmMTRlMjY0L3RhYmxlcmFuZ2U6NTJkZjQwZjA1NGM0NDY4YWI0NzQyYWEwYmYxNGUyNjRfMjMtNC0xLTEtMTI5MTA5_74e3b701-2747-4b9c-9d3b-ac6e2dcbec2b"
      unitRef="usd">39523000000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMy0yLTEtMS0xMjkxMDk_02e5994c-489c-437d-8cf1-a236980ae2a5"
      unitRef="usd">2634000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMy00LTEtMS0xMjkxMDk_1ced265a-cba2-4ac1-87a6-61cc3c7fd1ac"
      unitRef="usd">1105000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNC0yLTEtMS0xMjkxMDk_bfc4eb30-4afb-4c32-bac9-d51db0d945eb"
      unitRef="usd">396000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNC00LTEtMS0xMjkxMDk_0e183a6c-4ee4-468b-b65e-c3a71525ea20"
      unitRef="usd">449000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNi0yLTEtMS0xMjkxMDk_5f592c4c-a00c-46f0-8e54-542e51637d66"
      unitRef="usd">708000000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfNi00LTEtMS0xMjkxMDk_d6d91a30-5fed-4efc-88ae-8388e6f1f215"
      unitRef="usd">664000000</us-gaap:AccruedMarketingCostsCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfOS0yLTEtMS0xMjkxMDk_d8d37cc7-7c52-439b-9f07-eca1f4f7607b"
      unitRef="usd">1749000000</mo:AccruedSettlementLiabilityCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfOS00LTEtMS0xMjkxMDk_730cc62d-2828-4dcb-a9cd-62e9b2e7e0a8"
      unitRef="usd">3349000000</mo:AccruedSettlementLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTAtMi0xLTEtMTI5MTA5_6fd11651-9fbe-4d2a-b3fb-ef05a362355d"
      unitRef="usd">1194000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTAtNC0xLTEtMTI5MTA5_37016798-46b7-4ffd-97db-706e82132bde"
      unitRef="usd">1365000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTItMi0xLTEtMTI5MTA5_78daa3a2-2573-4722-8c0c-3bfe489896ea"
      unitRef="usd">1630000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTItNC0xLTEtMTI5MTA5_b38812d3-64d6-4e3b-b180-469954e920a1"
      unitRef="usd">1647000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTQtMi0xLTEtMTI5MTA5_7cb85763-0236-49c9-b69f-9fdc01657777"
      unitRef="usd">8311000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTQtNC0xLTEtMTI5MTA5_818d66d0-52cc-489c-b9af-a415b776d649"
      unitRef="usd">8579000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTUtMi0xLTEtMTI5MTA5_aed6469a-a803-4998-aeca-31c76fcda242"
      unitRef="usd">25046000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTUtNC0xLTEtMTI5MTA5_c955037c-963f-46da-af75-d8f41865f1e2"
      unitRef="usd">26939000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTYtMi0xLTEtMTI5MTA5_aba33a4a-f5e1-46da-8ca3-2cc780572cb1"
      unitRef="usd">3898000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTYtNC0xLTEtMTI5MTA5_4f64b40e-c160-49e6-a9a2-174dfd7bd179"
      unitRef="usd">3692000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTctMi0xLTEtMTI5MTA5_1c9df6c2-b2a8-4712-a97a-86898c531479"
      unitRef="usd">197000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTctNC0xLTEtMTI5MTA5_518badf4-0e7a-4257-ad26-07e79abba620"
      unitRef="usd">200000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTgtMi0xLTEtMTI5MTA5_b889fb09-e926-4496-b223-2370d7a8634e"
      unitRef="usd">1437000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTgtNC0xLTEtMTI5MTA5_420a8d72-fe71-4257-a7eb-531a45d893d6"
      unitRef="usd">1436000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTktMi0xLTEtMTI5MTA5_9b259b6f-f4cb-4010-8951-f597c5278bf6"
      unitRef="usd">260000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMTktNC0xLTEtMTI5MTA5_1b4aeb14-3e68-4b89-b7b2-1fe174884228"
      unitRef="usd">283000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjAtMi0xLTEtMTI5MTA5_03db6511-3f3b-4d50-ba9f-66fe9bbe89ad"
      unitRef="usd">39149000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjAtNC0xLTEtMTI5MTA5_80d72038-6aa3-4aa4-9804-4ec750d469f5"
      unitRef="usd">41129000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjEtMi0xLTEtMTI5MTA5_3273f8d4-8bf1-4692-beb9-8bc90670e506"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjEtNC0xLTEtMTI5MTA5_9623d958-bffe-462a-83c5-9250d9a10300"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MzQyZjdjOWE5MjkwNDU4OGJmMzY0ZDFkYjIyYmI4NWRfNTA_7e9709e7-039c-4e36-8ffa-445e5bd30cef"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246MzQyZjdjOWE5MjkwNDU4OGJmMzY0ZDFkYjIyYmI4NWRfNTA_dc4f2e6f-0d94-4141-9ea3-0b57d38f63ad"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtMi0xLTEtMTI5MTA5_dd513274-3b7f-4b5c-b991-1ed49a0bb9d0"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjQtNC0xLTEtMTI5MTA5_a7e0bec0-bfe5-49b7-b80e-3eda97aca817"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjUtMi0xLTEtMTI5MTA5_4db85094-8825-407f-9847-6d76d5815ee0"
      unitRef="usd">5861000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjUtNC0xLTEtMTI5MTA5_eb4aacb7-3e0c-4831-b5e5-a9512b79e107"
      unitRef="usd">5857000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjYtMi0xLTEtMTI5MTA5_db98b48b-e05d-4485-af7d-e3050ddfb0f8"
      unitRef="usd">30252000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjYtNC0xLTEtMTI5MTA5_08a56b4f-ab12-4bec-9041-2a3bdea25759"
      unitRef="usd">30664000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjctMi0xLTEtMTI5MTA5_6eb844d5-f5e0-407f-bca1-56246b21d9d7"
      unitRef="usd">-2377000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjctNC0xLTEtMTI5MTA5_0b5b68f3-0702-462c-838d-899ac02bb940"
      unitRef="usd">-3056000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246ODc0MzE4YzVhNzZkNGQ4YzllYmVhNzE5MTZmYzJkN2FfMzI_ec5d504e-8021-447c-ac44-91707ed895e7"
      unitRef="shares">1003717832</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMC0xLTEtMTI5MTA5L3RleHRyZWdpb246ODc0MzE4YzVhNzZkNGQ4YzllYmVhNzE5MTZmYzJkN2FfNjU_919c8220-d326-40b9-bef6-1dc451a0728b"
      unitRef="shares">982785699</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtMi0xLTEtMTI5MTA5_c0eca3d9-f7c1-456b-afe6-7eca3f223078"
      unitRef="usd">37074000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjgtNC0xLTEtMTI5MTA5_d197402c-6df3-444a-a3fe-d16449333073"
      unitRef="usd">36006000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjktMi0xLTEtMTI5MTA5_825bec99-300f-4ad7-b75d-b2096a1bae6e"
      unitRef="usd">-2403000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMjktNC0xLTEtMTI5MTA5_0f3b5200-4d28-4062-a57d-ee82a060a1ee"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMzAtMi0xLTEtMTI5MTA5_21e57fd0-4cc6-4fa3-9c8e-1a767b670bda"
      unitRef="usd">36746000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMy9mcmFnOmI3ZDg3YzU1MGJlODQwMmE5ZDVlNjViZDgxZjI1NDE3L3RhYmxlOmMzOTJiOTFkYzlhMDQyOTM4MWVhMWIyMWQxOTQxYzM0L3RhYmxlcmFuZ2U6YzM5MmI5MWRjOWEwNDI5MzgxZWExYjIxZDE5NDFjMzRfMzAtNC0xLTEtMTI5MTA5_8802f062-3d77-47e9-aecf-22f74791b109"
      unitRef="usd">39523000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi0yLTEtMS0xMjkxMDk_6598fe6e-ea1f-4afd-a55a-cb4b3d825414"
      unitRef="usd">12435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi00LTEtMS0xMjkxMDk_0562c702-b7d9-41a6-8230-493162700964"
      unitRef="usd">12972000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi02LTEtMS0xMzAyMDk_aa2fa493-2b09-419e-808f-7b63e0adabb3"
      unitRef="usd">6543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMi04LTEtMS0xMzAxMTM_1348952e-9e62-4865-9b62-e56ce087f857"
      unitRef="usd">6936000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy0yLTEtMS0xMjkxMDk_1f5de9fa-0239-4ca2-b8fd-0e27eac75ce3"
      unitRef="usd">3154000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy00LTEtMS0xMjkxMDk_889f7764-e5f2-439b-9ba2-87f20e0894c0"
      unitRef="usd">3490000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy02LTEtMS0xMzAyMjM_0cfe493c-1d4e-482c-910f-40593c4fafca"
      unitRef="usd">1708000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMy04LTEtMS0xMzAxMTk_569f5c54-d96a-4d70-beeb-1b7f590db171"
      unitRef="usd">1882000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC0yLTEtMS0xMjkxMDk_940df0cf-3dcc-4720-b9df-6b945a910e64"
      unitRef="usd">2242000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC00LTEtMS0xMjkxMDk_bc880fd0-fa87-420a-a4b6-b8f803daa41d"
      unitRef="usd">2478000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC02LTEtMS0xMzAyMjY_168d0c4e-e96f-48e7-a62b-aab416f92e05"
      unitRef="usd">1169000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNC04LTEtMS0xMzAxNTA_826a6a3b-4d82-47ce-9e20-10f39aea9c29"
      unitRef="usd">1322000000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:GrossProfit
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS0yLTEtMS0xMjkxMDk_1b68583c-b0d2-4c7f-a371-888f36b3b123"
      unitRef="usd">7039000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS00LTEtMS0xMjkxMDk_7b9d2222-b6a7-4b22-8435-a79b29e7421f"
      unitRef="usd">7004000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS02LTEtMS0xMjkxMDk_e51ab122-ea45-46ad-a4e1-9c88013e0c63"
      unitRef="usd">3666000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNS04LTEtMS0xMjkxMDk_6dfb53f5-8ffc-47f6-a463-ed3ec47eacd7"
      unitRef="usd">3732000000</us-gaap:GrossProfit>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi0yLTEtMS0xMjkxMDk_911c0358-cbf8-4516-83d0-ec48ec81ac50"
      unitRef="usd">1050000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi00LTEtMS0xMjkxMDk_5c05eb81-f058-45bb-b496-47e67e3a44ea"
      unitRef="usd">1128000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi02LTEtMS0xMzAyMjk_1b3794c4-e993-4582-991f-eb9996bc66ac"
      unitRef="usd">561000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNi04LTEtMS0xMzAxNTM_b0aaf86d-d6e1-4b34-a66c-59b7924ad1bd"
      unitRef="usd">546000000</mo:MarketingAdministrationandResearchCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy0yLTEtMS0xMjkxMDk_48728440-c08f-4e7a-a3b1-f8beae7a1fd5"
      unitRef="usd">5989000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy00LTEtMS0xMjkxMDk_1de60849-c97f-4815-853c-4502e6372912"
      unitRef="usd">5876000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy02LTEtMS0xMjkxMDk_4b652693-e86d-4edf-b5d0-b43502fea257"
      unitRef="usd">3105000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfNy04LTEtMS0xMjkxMDk_dbf65f5d-edc9-4293-b4d5-97a6e2bd2a9b"
      unitRef="usd">3186000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC0yLTEtMS0xMjkxMDk_8c0c1b7e-da6f-43c6-807c-a820bd3950f5"
      unitRef="usd">-561000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC00LTEtMS0xMjkxMDk_816d4873-fc8b-42f6-8cf3-a2b6f13e2c31"
      unitRef="usd">-603000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC02LTEtMS0xMzAyMzg_6a682dfc-c2c6-40e7-ad72-7ac3748ba0b9"
      unitRef="usd">-280000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOC04LTEtMS0xMzAxNjI_93817cbe-868a-4a31-9796-41f5718466a5"
      unitRef="usd">-295000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS0yLTEtMS0xNDYyNzU_0bfe1628-f141-4c8d-a26b-232adde50b92"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS00LTEtMS0xNDYyNzU_02720d3a-856f-411f-b617-8f1b1b1b3304"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS02LTEtMS0xNDYyNzU_220a44cc-df6e-4393-833a-ed41be3fffa8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS04LTEtMS0xNDYyNzU_7dff7384-0137-4c05-82ec-bdaf88d0de9b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS0yLTEtMS0xMjkxMDk_9618708e-364d-4747-a4e7-43b26db252ee"
      unitRef="usd">-93000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS00LTEtMS0xMjkxMDk_3e0b07bc-e905-4d1b-af99-859c1e9a32de"
      unitRef="usd">-89000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS02LTEtMS0xMzAyNDE_351b5a20-ac20-4885-ba74-f067582e9cc9"
      unitRef="usd">-47000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfOS04LTEtMS0xMzAxNjI_425df93d-bd18-43bb-8bdb-d7ea744fce15"
      unitRef="usd">-46000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtMi0xLTEtMTI5MTA5_67749fec-2554-4b4a-80c2-3da94bb3ca95"
      unitRef="usd">-1229000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtNC0xLTEtMTI5MTA5_29d3edfb-a743-4d23-a953-473f4fe799ee"
      unitRef="usd">126000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtNi0xLTEtMTMwMjQ0_fa499363-0e32-4244-85fc-93480a45644b"
      unitRef="usd">-1263000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTEtOC0xLTEtMTMwMTcw_a3490d89-fc01-414b-8c52-7cd710642d07"
      unitRef="usd">75000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtMi0xLTEtMTI5MTA5_124d19ec-c22a-48ac-9773-76446a5a398c"
      unitRef="usd">-14000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtNC0xLTEtMTI5MTA5_534dfb72-ae4c-4ce2-bfe9-f10c8b91ae37"
      unitRef="usd">7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtNi0xLTEtMTMwMjQ3_701a3cdb-2c25-4593-8bc7-46f8beb049c0"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTMtOC0xLTEtMTMwMjAy_68cf8a06-56bd-4515-a286-449a213347e5"
      unitRef="usd">-103000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtMi0xLTEtMTI5MTA5_9e299253-b1dc-465c-8bfb-bf70caa4a3a3"
      unitRef="usd">4278000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNC0xLTEtMTI5MTA5_b22bde34-054f-4093-84ae-c918fd1768c3"
      unitRef="usd">4846000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNi0xLTEtMTI5MTA5_b63e355e-fc7c-4e29-8e68-8191b7f554fc"
      unitRef="usd">1605000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtOC0xLTEtMTI5MTA5_f89bda50-189d-436a-933b-bb982ec231f0"
      unitRef="usd">2909000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTYtMi0xLTEtMTI5MTA5_2c06d624-f8a6-4aac-b35a-891ad198534e"
      unitRef="usd">1428000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTYtNC0xLTEtMTI5MTA5_95ea14fe-d1a2-495a-b27f-5de6a95f0e3a"
      unitRef="usd">1275000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtNi0xLTEtMTMwMjUw_85127633-40ed-4daf-9bdb-8d7916cce633"
      unitRef="usd">714000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTUtOC0xLTEtMTMwMTg4_583ed364-308e-440e-a0a1-5a68e2b4f15c"
      unitRef="usd">759000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctMi0xLTEtMTI5MTA5_a874030b-00d3-4396-855b-eb96b708931e"
      unitRef="usd">2850000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNC0xLTEtMTI5MTA5_1f7a1855-fef6-48d3-94e3-489588770bcc"
      unitRef="usd">3571000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNi0xLTEtMTI5MTA5_7b4aa128-cc39-46a1-9dbe-7d1d39fa0816"
      unitRef="usd">891000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctOC0xLTEtMTI5MTA5_a3883295-5818-4023-8bbe-21b8525ba9f3"
      unitRef="usd">2150000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTgtMi0xLTEtMTI5MTA5_ec4f3aeb-f783-41d5-8743-c57009bb2694"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTgtNC0xLTEtMTI5MTA5_43d3db44-5ce0-472d-bb12-c5c9ea5555be"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctNi0xLTEtMTMwMjUz_0854a320-d7cc-462a-a8a8-6a93dccb8a32"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTctOC0xLTEtMTMwMTkx_0de95d50-6f0f-4375-b399-2f5204bfe70f"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktMi0xLTEtMTI5MTA5_1b9da82b-6ac6-4586-9898-0affd1d28030"
      unitRef="usd">2850000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktNC0xLTEtMTI5MTA5_89c4855b-69c5-43d2-beab-399c400f1ec7"
      unitRef="usd">3573000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktNi0xLTEtMTI5MTA5_a08d86e0-f545-4d9a-8a7e-079eb84a2c52"
      unitRef="usd">891000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMTktOC0xLTEtMTI5MTA5_835cf747-d43a-48ba-9806-8628529d16b8"
      unitRef="usd">2149000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItMi0xLTEtMTI5MTA5_da297e87-b856-4799-9c6e-f4a2e7ea65de"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItMi0xLTEtMTI5MTA5_e9e53606-7021-4797-b604-574856fe57f4"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItNC0xLTEtMTI5MTA5_3eb1bebe-844f-4b3d-9e32-b7c442d33d21"
      unitRef="usdPerShare">1.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjItNC0xLTEtMTI5MTA5_e4eb38c1-c434-46f2-9162-4265a6b08950"
      unitRef="usdPerShare">1.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtNi0xLTEtMTQzODk0_ad80ea14-e761-4941-a990-8418c984f957"
      unitRef="usdPerShare">0.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtNi0xLTEtMTQzODk0_ce030d26-8bf8-4176-a04a-c63c52102766"
      unitRef="usdPerShare">0.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtOC0xLTEtMTMwMTk1_24f601a6-203b-41b1-94f2-16fe62783233"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xOS9mcmFnOmJkNjI3MDBmNDE2NjQwYzg5ZGVhNTM3MWQyNTM0Y2U1L3RhYmxlOmEwMjlhMzUzZGFkNTRmY2Y4MzkzZmU1ZDhhMWFhMGI4L3RhYmxlcmFuZ2U6YTAyOWEzNTNkYWQ1NGZjZjgzOTNmZTVkOGExYWEwYjhfMjEtOC0xLTEtMTMwMTk1_e5e81d58-da45-4984-ae70-af4e5199a380"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi0yLTEtMS0xMjkxMDk_747d3b42-66df-455c-826c-caf12c9c1412"
      unitRef="usd">2850000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi00LTEtMS0xMjkxMDk_15547dc1-3e7a-44fc-86e8-3354cdca5b0a"
      unitRef="usd">3571000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi02LTEtMS0xMzk2MTE_75c21eb1-4d68-42a9-a350-41ac96567155"
      unitRef="usd">891000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMi04LTEtMS0xMzAzNDE_dead28b9-ee81-4114-86f8-6114077b2b1e"
      unitRef="usd">2150000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC0yLTEtMS0xMjkxMDk_4e3abae3-14c8-4409-a11b-0da81cb5ea15"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC00LTEtMS0xMjkxMDk_83372ca6-bb07-4135-bf2e-3f22ca2fb936"
      unitRef="usd">-377000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC02LTEtMS0xMzk2MTE_ad1b9140-f76e-4771-8c02-497c8470ca64"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNC04LTEtMS0xMzAzNDY_e494a941-0748-48ac-bf00-6bdff808095e"
      unitRef="usd">-349000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS0yLTEtMS0xMjkxMDk_08cd4084-6c54-496c-b29c-f83bd41f5f15"
      unitRef="usd">643000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS00LTEtMS0xMjkxMDk_ec1c0092-11da-4238-b7f9-a82630f0dfe2"
      unitRef="usd">334000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS02LTEtMS0xMzk2MTE_4da76919-dc7d-456d-9e87-a566feedf897"
      unitRef="usd">565000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNS04LTEtMS0xMzAzNTQ_86042868-bcf9-4f83-866f-971c60cfd38f"
      unitRef="usd">-183000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi0yLTEtMS0xMjkxMDk_44c557eb-2909-4d56-ace0-9e93ed88120c"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi00LTEtMS0xMjkxMDk_db6963fe-ef30-4a48-ad10-57693d5c4855"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi02LTEtMS0xMzk2MTE_160b43c8-b600-46d0-8ded-15ec4b4031d4"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNi04LTEtMS0xMzAzOTA_452676ad-368e-4ff8-ad0e-644e628ed5cf"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy0yLTEtMS0xMjkxMDk_d039f55e-3a1c-4d15-ae3d-f2acc71b84f3"
      unitRef="usd">679000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy00LTEtMS0xMjkxMDk_d8058284-d570-49d7-92a4-1442a75006ca"
      unitRef="usd">739000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy02LTEtMS0xMjkxMDk_b8af9f50-7b49-4cdc-ab1e-0efb6e3ee5ad"
      unitRef="usd">585000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfNy04LTEtMS0xMjkxMDk_bd3a04ed-dee3-44ab-ad0b-ee8aef243154"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS0yLTEtMS0xMjkxMDk_ac283256-44af-4d5e-aa98-3e78dc44e05d"
      unitRef="usd">3529000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS00LTEtMS0xMjkxMDk_dd36b600-c5a3-4821-b33e-3e0776934bc6"
      unitRef="usd">4310000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS02LTEtMS0xMjkxMDk_8e19d169-89a9-41a1-8307-2917a83f9394"
      unitRef="usd">1476000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfOS04LTEtMS0xMjkxMDk_cc547069-b119-4c9c-991e-06e6f838a35e"
      unitRef="usd">2322000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtMi0xLTEtMTI5MTA5_7ef00ef3-8219-4980-b888-0a4f9da9203d"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtNC0xLTEtMTI5MTA5_4d9f6e19-3c3e-431e-8652-03c6fb082a42"
      unitRef="usd">-2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtNi0xLTEtMTM5NjIy_bf219729-5f4e-4521-9109-d1951eb4705d"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTAtOC0xLTEtMTMwNDAy_c16f481d-fab6-4d5c-988d-a076b589a2be"
      unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtMi0xLTEtMTI5MTA5_8080beb7-a488-432c-9c78-1c21375235b5"
      unitRef="usd">3529000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtNC0xLTEtMTI5MTA5_5f7e893f-37c0-4c3c-8b3c-9c755222aef3"
      unitRef="usd">4312000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtNi0xLTEtMTI5MTA5_866bc692-3b1c-4fd6-9c93-893640b68870"
      unitRef="usd">1476000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yMi9mcmFnOjZjNGVhMzY1NDEzNjQ4MTQ4YWY2YTYyOTg5YzY0NDYzL3RhYmxlOmRmYTFmMjc0ZTBhMTQ3Njc5YzdjMTVmZGRlZmZhYWUwL3RhYmxlcmFuZ2U6ZGZhMWYyNzRlMGExNDc2NzljN2MxNWZkZGVmZmFhZTBfMTEtOC0xLTEtMTI5MTA5_1518e1c7-fa46-4013-9c09-5b32c13c7aab"
      unitRef="usd">2321000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ef8abb29b764b4c8ca775c97572d064_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0yLTEtMS0xMjkxMDk_b00834e0-f18e-41dc-9c92-6f294b95a4e1"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idccb1b2994cd40fbbb5731c88d1d399c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi00LTEtMS0xMjkxMDk_9e223f1b-4e60-40ee-b981-84a8f9339ece"
      unitRef="usd">5857000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b219eedfb714d8fb1b867d806c10b05_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi02LTEtMS0xMjkxMDk_0417346b-f60c-4eca-a21c-6ac896fd21ce"
      unitRef="usd">30664000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi04LTEtMS0xMjkxMDk_f4b28f98-fd2a-45e2-b25f-6b348af1bbfc"
      unitRef="usd">-3056000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2449a2bfd124fe2ab3313d8a383b536_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0xMC0xLTEtMTI5MTA5_a38530df-cf6e-435e-a913-f92f8772a4e5"
      unitRef="usd">-36006000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMi0xNC0xLTEtMTI5MTA5_fa86a2f4-b32c-4c5d-9faa-ad4e04fbb018"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMy02LTEtMS0xMjkxMDk_a03d0817-01f9-413c-a871-360d3b67544c"
      unitRef="usd">2850000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMy0xNC0xLTEtMTI5MTA5_71b415bf-663b-4058-acae-4c0fc950690d"
      unitRef="usd">2850000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNC04LTEtMS0xMjkxMDk_f61918dd-9a00-4ebb-9bcc-4df26e5316d8"
      unitRef="usd">679000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNC0xNC0xLTEtMTI5MTA5_280d4a8c-e59e-439f-b528-6ad4f33481a0"
      unitRef="usd">679000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="if48fb5645cbc4cc196e6db7c24a03af9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS00LTEtMS0xMjkxMDk_68f2ce89-83c2-4cef-b431-7a6d5055a6b0"
      unitRef="usd">4000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS0xMC0xLTEtMTI5MTA5_862bf842-a639-4fa6-8f17-b6ff205dcee5"
      unitRef="usd">15000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNS0xNC0xLTEtMTI5MTA5_8bb3ce21-958c-49aa-8f76-43083b51f97a"
      unitRef="usd">19000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjoxMDY2MmE0ZDZhNjg0M2JkODA3MzQzZTNlYjBjZmFlY18yNzQ4Nzc5MDY5NDg2_db10a1da-147e-4418-b6ea-d6e7413282f5"
      unitRef="usdPerShare">1.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3cf3943d77fb4f5db8232d7edf7ed6ca_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi02LTEtMS0xMjkxMDk_7c6a0351-b4dd-41c1-9691-86eee525e499"
      unitRef="usd">3262000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNi0xNC0xLTEtMTI5MTA5_dba1f45d-63d1-4606-ae2d-09738bf82436"
      unitRef="usd">3262000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5256368abae1461ebcb4f315697d63a8_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNy0xMC0xLTEtMTI5MTA5_661e1db0-56ed-44f2-ade8-a6f52bf612ef"
      unitRef="usd">1083000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfNy0xNC0xLTEtMTI5MTA5_0c359dab-2fd9-4000-b9e3-8e563072a450"
      unitRef="usd">1083000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55831b17fc8441a290ddc1bf9c38fa94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMi0xLTEtMTI5MTA5_ed0c83a7-6a07-49da-ad88-56a87bb7c02b"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec91f7ffcfe043208c2fbae9bff40d21_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtNC0xLTEtMTI5MTA5_6d055f15-c7c1-4d73-bf24-947e61509a3f"
      unitRef="usd">5861000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i195abdcdf51a4a099f84b2ae27653186_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtNi0xLTEtMTI5MTA5_b1f26b5f-d032-47b2-a467-59dd0ac088ee"
      unitRef="usd">30252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtOC0xLTEtMTI5MTA5_58659e4e-32c7-445a-9929-5714d9f7775d"
      unitRef="usd">-2377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53b0d24d8a90491486fda069a8ee99d0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMTAtMS0xLTEyOTEwOQ_125498f9-5558-4636-a62d-b774234d3164"
      unitRef="usd">-37074000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmUzNzVjNjAyOTkzMjQ4YWRiOWFkN2JjYzQ1MGZmOGFiL3RhYmxlcmFuZ2U6ZTM3NWM2MDI5OTMyNDhhZGI5YWQ3YmNjNDUwZmY4YWJfMTAtMTQtMS0xLTEyOTEwOQ_8f0d44dc-5332-48c5-8178-d531e860d1ab"
      unitRef="usd">-2403000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f71e968f79944aea5e02c01739659a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0yLTEtMS0xMjkxMDk_07a18e58-130a-463e-aa95-7607389a8b1e"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0846deffb1664429a509a79024bf0f26_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi00LTEtMS0xMjkxMDk_0af11e53-0501-4ef8-bfd4-2c75127892c4"
      unitRef="usd">5910000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i538011103d4d4bedadad7ef6aa58ff25_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi02LTEtMS0xMjkxMDk_e540779c-8fca-4e53-b6a6-da5062ff4269"
      unitRef="usd">34679000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43964e9db78c4442b2a6c1bae24600b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi04LTEtMS0xMjkxMDk_c32f22be-95f4-4522-ad94-9ee67e5834d4"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcddf93cb1114af5b696e99fca98b0b2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xMC0xLTEtMTI5MTA5_0db0d76a-3fef-487d-9415-59181e53a350"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0586e2af9dcd4681a41fbb0b0e0b0e79_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xMi0xLTEtMTI5MTA5_1f1840c0-a51f-431b-8be3-3a15034f5301"
      unitRef="usd">86000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMi0xNC0xLTEtMTI5MTA5_ce589341-73ef-436d-bd76-6d1ed5bd213f"
      unitRef="usd">2925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy02LTEtMS0xMjkxMDk_e4dd0dc9-a2c1-416e-b059-e5386f08a393"
      unitRef="usd">3573000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy0xMi0xLTEtMTI5MTA5_676d6f87-b287-401c-9d79-5d207955bedc"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMy0xNC0xLTEtMTI5MTA5_c793b84b-2f95-4d05-a148-8ab9e6ba9766"
      unitRef="usd">3569000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNC04LTEtMS0xMjkxMDk_4a4e1efe-fb9b-4c12-9968-5a531b56933e"
      unitRef="usd">739000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNC0xNC0xLTEtMTI5MTA5_733bd536-9894-4aa1-9a20-615e9d411e2c"
      unitRef="usd">739000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i138581f0b65743e59bd88750dcecf150_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS00LTEtMS0xMjkxMDk_90ddfbe5-82ab-448a-80de-02c887e564b0"
      unitRef="usd">7000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS0xMC0xLTEtMTI5MTA5_5fbd8a2b-67f6-488c-a623-337ae6ed822b"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNS0xNC0xLTEtMTI5MTA5_8971438e-6ff4-41e7-933f-7232d116d2a3"
      unitRef="usd">20000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjo4MmJlMDVmNWIwYjA0NTYzOTBkZmMzYjUwOWQxZWRmMF8yNzQ4Nzc5MDY5NDgz_620a5699-121e-467a-9e5e-ac491c50d9a9"
      unitRef="usdPerShare">1.72</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="id5df94b6826d4ae083f840ab04e2a1cd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi02LTEtMS0xMjkxMDk_dc239d04-7231-4b47-8926-88da24ed1b0b"
      unitRef="usd">3187000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNi0xNC0xLTEtMTI5MTA5_82d7b0a3-fcb4-4d0a-9637-d3fcabfab97b"
      unitRef="usd">3187000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6966a45a9fd84d73845136b7a60438e6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNy0xMC0xLTEtMTI5MTA5_d2810bda-f96a-4722-ac7b-ddd53453ebaa"
      unitRef="usd">650000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfNy0xNC0xLTEtMTI5MTA5_ae96eef3-7e50-445d-ad3a-f01058158b66"
      unitRef="usd">650000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i138581f0b65743e59bd88750dcecf150_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba"
      unitRef="usd">77000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i237c1ce0d5d84232a62a9332b0d81e4a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712"
      unitRef="usd">80000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8"
      unitRef="usd">157000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e757a9350804423a1366f4edcb70ffa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMi0xLTEtMTI5MTA5_d61e6946-838f-4c41-8a2d-a48a7512ef4d"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc9b71519dae4e209d412a66a68839cc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtNC0xLTEtMTI5MTA5_654d6b77-f248-48d4-8951-41b280512ce9"
      unitRef="usd">5840000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtNi0xLTEtMTI5MTA5_656d0f70-49b7-4a57-b868-2f7693b48f90"
      unitRef="usd">35065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtOC0xLTEtMTI5MTA5_d654b650-cdfc-49ab-a11f-073de6c6e344"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a159b1f5b8644c382a69af99c56dcc2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTAtMS0xLTEyOTEwOQ_cf49de96-c47c-4157-baf3-3a88b1f61916"
      unitRef="usd">-34981000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4b9693299744ec9899bea6e3abb91dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTItMS0xLTEyOTEwOQ_6a05941a-940c-4275-9606-d0ec1603ae01"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfMTAtMTQtMS0xLTEyOTEwOQ_eb7b5632-a167-46f5-a3ce-4ac635436fb0"
      unitRef="usd">3259000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i825c93cb311e47a19c18659fc18b76d8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0yLTEtMS0xMjkxMDk_3c98c95d-5bb4-45a9-bc86-d48649d78059"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d52eb68d4d748e6aa0dd402d9c0d6f8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi00LTEtMS0xMjkxMDk_3e3d45d9-873e-4482-9ea6-3bf4c03b9867"
      unitRef="usd">5848000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c6110daa1294fd39e39d73a439bd261_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi02LTEtMS0xMjkxMDk_e1a4bf09-6274-4ffe-9335-06f981f76ecc"
      unitRef="usd">30988000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi04LTEtMS0xMjkxMDk_5aca1614-f8d0-4a36-90d3-d0ef0ca6ff98"
      unitRef="usd">-2962000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i803401904f8b457e80587a15d7c74d13_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0xMC0xLTEtMTI5MTA5_ec08f59a-6d45-42e6-a3dd-f2c191fd98f9"
      unitRef="usd">-36569000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea1d15baae55479686b0438960a20553_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMi0xNC0xLTEtMTI5MTA5_bc394e6c-289c-4af3-9b67-f586e9c87586"
      unitRef="usd">-1760000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMy02LTEtMS0xMjkxMDk_8399741e-15db-4a9d-b5d0-2572806a8559"
      unitRef="usd">891000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfMy0xNC0xLTEtMTI5MTA5_fcb9851b-e839-4b2e-8880-1f0c78808256"
      unitRef="usd">891000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNC04LTEtMS0xMjkxMDk_81bc375d-6bbd-4113-b4dc-26262ba5f2e0"
      unitRef="usd">585000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNC0xNC0xLTEtMTI5MTA5_967f467a-6229-46e8-a1a8-1f76be041455"
      unitRef="usd">585000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ied487a078f8f45c08115f899f30d2518_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS00LTEtMS0xMjkxMDk_841cde5d-1d85-4873-b90d-2aa3daa9d172"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS0xMC0xLTEtMTI5MTA5_7401d1db-8864-4951-b334-6d4b4aae734d"
      unitRef="usd">2000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNS0xNC0xLTEtMTI5MTA5_90be72e9-1159-47fe-8a32-2d310a5b9798"
      unitRef="usd">15000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjoxNDlmNjEwMWE3MDY0Nzg4ODI1ZGI1ZDVhNzIzNWY2MV8yNzQ4Nzc5MDY5NDgz_0a943b14-9765-46d2-a5b5-3c833997f401"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i69ca049ce1e24012952c7b3e910244d4_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi02LTEtMS0xMjkxMDk_263f75e2-bc2d-41f4-9226-5a43a0c8ccf8"
      unitRef="usd">1627000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNi0xNC0xLTEtMTI5MTA5_d8f35b46-f128-4ce1-ab5e-d6e3ff6d86af"
      unitRef="usd">1627000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5290ece99bf8461386b4b6c4be3f28bb_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNy0xMC0xLTEtMTI5MTA5_e311773d-241f-43dd-abd1-ab7ae34c4a45"
      unitRef="usd">507000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfNy0xNC0xLTEtMTI5MTA5_3e8345e3-2163-45a1-ad76-61a78f2f75bc"
      unitRef="usd">507000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55831b17fc8441a290ddc1bf9c38fa94_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0yLTEtMS0xMjkxMDk_8ac5fe07-7a72-4a45-8f2f-0b6150055df6"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec91f7ffcfe043208c2fbae9bff40d21_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS00LTEtMS0xMjkxMDk_ea2c7b92-2655-4672-baa8-44a3a87c021a"
      unitRef="usd">5861000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i195abdcdf51a4a099f84b2ae27653186_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS02LTEtMS0xMjkxMDk_1fe9e2b8-dc22-48a6-b1c5-bb89459bcff4"
      unitRef="usd">30252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS04LTEtMS0xMjkxMDk_6ee5a7f7-d5de-4fbe-9a2c-5d41435cbd97"
      unitRef="usd">-2377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53b0d24d8a90491486fda069a8ee99d0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0xMC0xLTEtMTI5MTA5_e66b5077-176f-41b5-ba19-6f7ab320060f"
      unitRef="usd">-37074000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOjFjMmM1MDJjYmNhZDRmM2Y5ZGVjMGYwNzc3ZjcwOThhL3RhYmxlcmFuZ2U6MWMyYzUwMmNiY2FkNGYzZjlkZWMwZjA3NzdmNzA5OGFfOS0xNC0xLTEtMTI5MTA5_3a587562-9137-4533-8e86-b75deced5857"
      unitRef="usd">-2403000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bbd121042c745818aabb802a6d44f50_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0yLTEtMS0xMjkxMDk_1c9c3dba-5182-4e4b-a125-584215a193a3"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i540c66305f294fbb945da9a41514ff51_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi00LTEtMS0xMjkxMDk_01697121-09f6-496b-ad99-2ab467c96359"
      unitRef="usd">5905000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a8a4571fc3d4acab135fe43eef795fe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi02LTEtMS0xMjkxMDk_7ece5c2f-b186-421c-b425-97c460731812"
      unitRef="usd">34507000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9788f29297284a1d88ff1e6c6548cad3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi04LTEtMS0xMjkxMDk_79fb15d4-13f2-4ed1-8adf-bb8183138708"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f65898626a94e9ea933742220b4c7d5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xMC0xLTEtMTI5MTA5_a6ef792d-e286-47e0-a0d8-e5d7560539a3"
      unitRef="usd">-34660000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7aa773030fca4e1f899e5ed5dd14b7d4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xMi0xLTEtMTI5MTA5_387f133f-7ea7-444e-b9ef-fedb287202cb"
      unitRef="usd">82000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2233715bedd740d4a3940763dda60aa8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMi0xNC0xLTEtMTI5MTA5_9cbeb9de-b2c6-4978-9b87-f0826e50e8c5"
      unitRef="usd">2995000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy02LTEtMS0xMjkxMDk_ec7714e7-a797-4d51-bbe4-d83536effc52"
      unitRef="usd">2149000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy0xMi0xLTEtMTI5MTA5_eddee955-dabb-4bcd-9585-6f2c17e7da73"
      unitRef="usd">0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfMy0xNC0xLTEtMTI5MTA5_1ee7e8a4-18bb-4a69-9386-54d5f71e612c"
      unitRef="usd">2149000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNC04LTEtMS0xMjkxMDk_d3a17e66-b129-40d6-b0e8-2d49c204c3d3"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNC0xNC0xLTEtMTI5MTA5_44fba74d-8198-4c00-bb91-ca167a5af460"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS00LTEtMS0xMjkxMDk_370b7384-4435-442a-80f8-fe96f6a54cf0"
      unitRef="usd">12000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS0xMC0xLTEtMTI5MTA5_6fee7f6a-46c8-4ee3-a5e8-80cb63d60c47"
      unitRef="usd">4000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNS0xNC0xLTEtMTI5MTA5_79306cec-f935-4e3f-8aa6-ed5959965dc7"
      unitRef="usd">16000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi0wLTEtMS0xMjkxMDkvdGV4dHJlZ2lvbjo2ZjEzZjI1YjE5YTk0ZjlmYmQ3NjQ5NWNkNmQxNjMxNV8yNzQ4Nzc5MDY5NDgz_461c8211-0ff4-4e96-bbfa-682515e9868f"
      unitRef="usdPerShare">0.86</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7acccc2f6b904f03a012e0fc4182ab76_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi02LTEtMS0xMjkxMDk_ad94ca17-e094-460d-bf3b-7f6a33aa1e1f"
      unitRef="usd">1591000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNi0xNC0xLTEtMTI5MTA5_d20dc957-7d54-4bf2-893a-8811a9b2fb84"
      unitRef="usd">1591000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iafd2e9e3fed64c119851b0823fd77749_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNy0xMC0xLTEtMTI5MTA5_c9e68a37-cfed-4ef8-8593-b503e38db66f"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfNy0xNC0xLTEtMTI5MTA5_8c36bcff-1261-4fab-b048-35919311d753"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i9a13e6570f92416cb22964471f9322dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da"
      unitRef="usd">77000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9a3b42061afc4a0695bc39a27c6e9be4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b"
      unitRef="usd">80000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf"
      unitRef="usd">157000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e757a9350804423a1366f4edcb70ffa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0yLTEtMS0xMjkxMDk_34f18154-ea38-4b5b-a9ab-b8e44c7c12a1"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc9b71519dae4e209d412a66a68839cc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS00LTEtMS0xMjkxMDk_8f8662fc-71c9-4247-9e5d-09c5338983e1"
      unitRef="usd">5840000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia48566f736bb4facbc1a3e047bd6b5d3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS02LTEtMS0xMjkxMDk_e133518f-e0bf-4432-b41e-b9231d18c886"
      unitRef="usd">35065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS04LTEtMS0xMjkxMDk_016eed7d-90c4-44a6-9a91-40e111a719ef"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a159b1f5b8644c382a69af99c56dcc2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xMC0xLTEtMTI5MTA5_38b9f1ff-9ed7-404c-a34f-4a9e692ce5de"
      unitRef="usd">-34981000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4b9693299744ec9899bea6e3abb91dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xMi0xLTEtMTI5MTA5_e1237cd1-be64-4621-aa9e-9fce00982c5d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOS0xNC0xLTEtMTI5MTA5_89ecf448-02da-4ef3-8df5-d9ec5cb7836a"
      unitRef="usd">3259000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMi0yLTEtMS0xMjkxMDk_0038383f-df90-4292-9c14-9dae1c7549a9"
      unitRef="usd">2850000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMi00LTEtMS0xMjkxMDk_f224557e-8a62-478a-a664-3acb9a9526b9"
      unitRef="usd">3571000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNC0yLTEtMS0xMjkxMDk_8696c114-77f8-4ce9-9fe7-745efd619fa5"
      unitRef="usd">109000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNC00LTEtMS0xMjkxMDk_ec08223d-9994-403c-9c54-d909a5103e1a"
      unitRef="usd">128000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNS0yLTEtMS0xMjkxMDk_e8e020c2-1b18-41f3-a750-46a79f5927be"
      unitRef="usd">20000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNS00LTEtMS0xMjkxMDk_2ef5aaef-2b33-4e43-bc79-d1b389fe6191"
      unitRef="usd">64000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNi0yLTEtMS0xMjkxMDk_96ccb35f-b4b4-4a7c-987d-2dc171daaf61"
      unitRef="usd">-1229000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNi00LTEtMS0xMjkxMDk_f253cdc1-1f55-4d6e-b955-522e8d936415"
      unitRef="usd">126000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNy0yLTEtMS0xMjkxMDk_a40d0406-9390-4848-a839-6cc178c034a4"
      unitRef="usd">104000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfNy00LTEtMS0xMjkxMDk_196cc1fd-2e07-4e91-bb1e-625dd8373e29"
      unitRef="usd">119000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfOS0yLTEtMS0xMjkxMDk_459e2c99-5c13-48c7-9074-f8e208774b1e"
      unitRef="usd">-14000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfOS00LTEtMS0xMjkxMDk_a44ad4a5-cfee-40a4-93e4-16710769abc5"
      unitRef="usd">7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTMtMi0xLTEtMTI5MTA5_a5a79afe-cb37-454a-9341-a90412ac8023"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTMtNC0xLTEtMTI5MTA5_ffb2f673-1409-49c5-b274-9cb302ba1c3a"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTYtMi0xLTEtMTI5MTA5_316fc2d9-8c66-4316-98ad-6f78254caa9e"
      unitRef="usd">-4000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTYtNC0xLTEtMTI5MTA5_f6c0b84d-037a-4df0-a52f-701f219202e9"
      unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTctMi0xLTEtMTI5MTA5_6d450851-22c8-401e-92ab-3ced9e27c68d"
      unitRef="usd">-50000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTctNC0xLTEtMTI5MTA5_14eacb57-ca6e-4117-8781-8f9e601d70c5"
      unitRef="usd">-172000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTgtMi0xLTEtMTI5MTA5_3f3224e3-6422-4426-bd62-3407c190b3d0"
      unitRef="usd">-47000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTgtNC0xLTEtMTI5MTA5_f8f2bcb2-287e-4bc1-9408-e55e3bcadf14"
      unitRef="usd">-113000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTktMi0xLTEtMTI5MTA5_0afb4da1-9283-4170-ab05-923ca867ec56"
      unitRef="usd">6000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMTktNC0xLTEtMTI5MTA5_17fb06cc-11f5-4a05-9f05-0184c9b94854"
      unitRef="usd">-171000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjAtMi0xLTEtMTI5MTA5_b658f802-c71a-4409-ba50-67d1c351d1d0"
      unitRef="usd">177000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjAtNC0xLTEtMTI5MTA5_bb7d5a23-cedf-4586-9f7b-a6158bc3639f"
      unitRef="usd">-3000000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjEtMi0xLTEtMTI5MTA5_2c69aeb8-f921-47b5-a4d9-7f8e123b217a"
      unitRef="usd">-1600000000</mo:IncreaseDecreaseInSettlementPayable>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjEtNC0xLTEtMTI5MTA5_f4e37217-005e-41f8-ab97-56999f95b9ce"
      unitRef="usd">-1584000000</mo:IncreaseDecreaseInSettlementPayable>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjItMi0xLTEtMTI5MTA5_ad3ea58d-4159-4e76-8742-504a971a0ff2"
      unitRef="usd">8000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjItNC0xLTEtMTI5MTA5_3543bc55-a4a5-4da5-aa35-e8fba3d4e377"
      unitRef="usd">6000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjMtMi0xLTEtMTI5MTA5_450a09da-db2f-436a-a115-0643dab6182e"
      unitRef="usd">-74000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjMtNC0xLTEtMTI5MTA5_2c6587b6-078a-48ce-9622-1810cbcc2a71"
      unitRef="usd">-73000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjQtMi0xLTEtMTI5MTA5_8e35055a-ab1a-4ad8-bf89-828d747d8dd8"
      unitRef="usd">81000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjQtNC0xLTEtMTI5MTA5_315eb97b-dee0-4445-a9c4-8f9559b7d120"
      unitRef="usd">48000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjUtMi0xLTEtMTI5MTA5_64d9620d-b764-409b-af44-95336758c413"
      unitRef="usd">2561000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjUtNC0xLTEtMTI5MTA5_f38d17ef-9b95-4491-8dbe-efc3b2ff5923"
      unitRef="usd">2679000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjctMi0xLTEtMTI5MTA5_2621f096-9396-48e2-8866-a2250fa75f38"
      unitRef="usd">83000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMjctNC0xLTEtMTI5MTA5_27010a88-cc22-4659-8302-ef25cdc9e8ed"
      unitRef="usd">53000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzEtMi0xLTEtMTI5MTA5_a41eb5d3-201e-4cae-b5fe-518c2d543520"
      unitRef="usd">67000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzEtNC0xLTEtMTI5MTA5_7914dc89-d838-447a-8c20-22d6ba983a36"
      unitRef="usd">-44000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzItMi0xLTEtMTI5MTA5_79e56b69-74ed-4f62-a520-d6656bbe9e03"
      unitRef="usd">-150000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOmRiNTEwYmFmMzMzODRhNDM4NTdkNDYxMTcyMThlZjNlL3RhYmxlcmFuZ2U6ZGI1MTBiYWYzMzM4NGE0Mzg1N2Q0NjExNzIxOGVmM2VfMzItNC0xLTEtMTI5MTA5_20fe0195-864d-4da3-b7c8-06b1f9d4e090"
      unitRef="usd">-9000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNC0yLTEtMS0xMjkxMDk_7f611ff5-5080-4eaa-b43e-fdf3954dd4bf"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNC00LTEtMS0xMjkxMDk_17f257e2-cccc-44fa-b74b-89406767f24e"
      unitRef="usd">5472000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNS0yLTEtMS0xMjkxMDk_bf91ab5c-eaf7-425a-8c34-b490cc97031c"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNS00LTEtMS0xMjkxMDk_f3923ad6-f47a-4486-8621-a131b021d872"
      unitRef="usd">6542000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNi0yLTEtMS0xMjkxMDk_21a0fe6a-b178-40a2-b1fe-7ba0a2c16445"
      unitRef="usd">1083000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNi00LTEtMS0xMjkxMDk_94603574-afad-4cef-9ea8-b562dc5ed60f"
      unitRef="usd">650000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNy0yLTEtMS0xMjkxMDk_b8ea3aa8-a0f8-4ec7-8614-988e9ee42aa0"
      unitRef="usd">3279000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfNy00LTEtMS0xMjkxMDk_4a2c27d6-b025-4817-afcf-2f2c6dbfc04b"
      unitRef="usd">3196000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTAtMi0xLTEtMTI5MTA5_53e3b305-f4bb-4b1a-9c24-d368dbb5fcc2"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTAtNC0xLTEtMTI5MTA5_92987842-0b8e-4d07-9a7f-be7835a0de74"
      unitRef="usd">623000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTEtMi0xLTEtMTI5MTA5_06046864-f4f7-431d-94c1-6aa9a785f6b7"
      unitRef="usd">-11000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTEtNC0xLTEtMTI5MTA5_1caf5642-651c-414a-b0b5-fb5fa1b229ad"
      unitRef="usd">-210000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTItMi0xLTEtMTI5MTA5_dac788d1-3c54-470a-b451-8f0285f213cd"
      unitRef="usd">-4373000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTItNC0xLTEtMTI5MTA5_1e27ebbe-3002-4ee6-998d-c82ba925fc0a"
      unitRef="usd">-5749000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTQtMi0xLTEtMTI5MTA5_43384f97-9fa1-462f-b612-c95be72768b0"
      unitRef="usd">-1962000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTQtNC0xLTEtMTI5MTA5_5a3b362b-02d5-44e7-919e-dd9992b1e2cf"
      unitRef="usd">-3079000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTUtMi0xLTEtMTI5MTA5_9464acef-585a-4c72-8c93-3ecb00b97dc5"
      unitRef="usd">4594000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTUtNC0xLTEtMTI5MTA5_94c9bea5-77dc-40b5-bfea-27af8df1db87"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTYtMi0xLTEtMTI5MTA5_cb375dc2-dc91-4072-a017-c9b2d8835a4c"
      unitRef="usd">2632000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMTYtNC0xLTEtMTI5MTA5_3c7c0b15-82ec-4e17-adc6-4f78a4dff44d"
      unitRef="usd">1927000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjAtMi0xLTEtMTI5MTA5_e78867cb-b4dd-431d-8031-e9cf8e930d3a"
      unitRef="usd">2567000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjAtNC0xLTEtMTI5MTA5_4fa7003d-5e4d-4cf0-ace4-f7c6a5b682cc"
      unitRef="usd">4544000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjEtMi0xLTEtMTI5MTA5_fc5dd51f-d5a2-4332-bc5c-900fb5d8fd80"
      unitRef="usd">24000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjEtNC0xLTEtMTI5MTA5_a1fa4ac3-0b34-47fc-8874-2fc08365d9f3"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjItMi0xLTEtMTI5MTA5_44cf312b-ef5d-43a4-b6ed-8d9f10fd5237"
      unitRef="usd">41000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjItNC0xLTEtMTI5MTA5_569160c8-093b-44f7-b864-02097e08a893"
      unitRef="usd">50000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjQtMi0xLTEtMTI5MTA5_d7e0d766-ecf7-4474-8851-dcf04cc1d4db"
      unitRef="usd">2632000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zMS9mcmFnOmQ3OGE0ZTdlMTExZjRmMWNiYmQwNzRjMjc2MGJmMjAwL3RhYmxlOjUyNzdjY2FmNjM1MDQwOTA5NjAxY2EzZjVkN2VlYzE1L3RhYmxlcmFuZ2U6NTI3N2NjYWY2MzUwNDA5MDk2MDFjYTNmNWQ3ZWVjMTVfMjQtNC0xLTEtMTI5MTA5_94fa8b8f-bf0a-418f-8f9e-908e9edd9216"
      unitRef="usd">4594000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNA_17df1f23-311c-4a86-b883-aa1cff891d39">Background and Basis of Presentation&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;When used in these notes, the terms &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Altria,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Background: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#x201c;PM USA&#x201d;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#x201c;Middleton&#x201d;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#x201c;UST&#x201d;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#x201c;USSTC&#x201d;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#x201c;MST&#x201d;) and snus products; Helix Innovations LLC (&#x201c;Helix&#x201d;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#x201c;Helix ROW&#x201d;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches; and Philip Morris Capital Corporation (&#x201c;PMCC&#x201d;), which has one leveraged lease remaining.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies, and Altria Client Services LLC, which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs.  Altria&#x2019;s access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At June&#160;30, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2021, UST sold its subsidiary, International Wine &amp;amp; Spirits, which included Ste. Michelle Wine Estates Ltd. (&#x201c;Ste. Michelle&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#x201c;ABI&#x201d;), Cronos Group Inc. (&#x201c;Cronos&#x201d;) and JUUL Labs, Inc. (&#x201c;JUUL&#x201d;).  We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our equity investment in JUUL under the fair value option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further discussion of our investments in equity securities, see Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Share Repurchases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, our Board of Directors (&#x201c;Board of Directors&#x201d; or &#x201c;Board&#x201d;) authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October 2021 (as expanded, the &#x201c;January 2021 share repurchase program&#x201d;).  At June&#160;30, 2022, we had $742 million remaining in the January 2021 share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share repurchase activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,083&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50.53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our interim condensed consolidated financial statements are unaudited.  Our management believes that all adjustments necessary for a fair statement of the interim results presented have been reflected in our interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These statements should be read in conjunction with our audited consolidated financial statements and related notes, which appear in our Annual Report on Form 10-K for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2020-06&#x201d;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNQ_a3bb78a3-66a9-4990-b69e-acc912161f1c">We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our equity investment in JUUL under the fair value option.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie69c7f39e03b4eba8436ad80b94446b0_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjc3OQ_4b885ea7-6235-416a-8ff6-3c6fe6a20bf6"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjgyNw_3e571c77-515a-4429-a378-a7ea3337a328"
      unitRef="usd">3500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i13871dd12543440895ab2e9a2d7be37e_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfMjkyMQ_c87145c9-c629-4a9b-ad31-5cbf37dfd3c1"
      unitRef="usd">742000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUyMA_6bb3fc81-4404-41b1-b62f-f5661493ae44">&lt;div style="padding-right:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share repurchase activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,083&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;507&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50.53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0xLTEtMS0xMjkxMDk_927f828f-3d49-472f-aa93-0964b1d07fc9"
      unitRef="shares">21400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0zLTEtMS0xMzI2ODI_fcd3cabe-1440-4982-9d1b-2e514f953f71"
      unitRef="shares">13500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi01LTEtMS0xMzI3MDc_650ee34d-07eb-416b-963c-5ff7a1815017"
      unitRef="shares">10100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMi0zLTEtMS0xMjkxMDk_ced89ede-6528-4fbf-8d0c-7a186071e4f8"
      unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0xLTEtMS0xMjkxMDk_bb7cdf0a-e2d0-4bcd-82ca-d1517ee8f8b8"
      unitRef="usd">1083000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0zLTEtMS0xMzI2ODI_dbe15dc9-7cfd-43d4-a544-3e81d3953d59"
      unitRef="usd">650000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy01LTEtMS0xMzI3MDc_ec107e38-cf7f-4ca9-8058-3c1b79188780"
      unitRef="usd">507000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfMy0zLTEtMS0xMjkxMDk_9e8f04df-4fda-4280-a20a-2678917ea07e"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i3f1adb372c3846bea37808f7a7aa2649_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0xLTEtMS0xMjkxMDk_5a7e4da8-cd6f-44ce-84c7-8945a8e1bf57"
      unitRef="usdPerShare">50.53</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="iea22b22ff0824d06ace6bff3973c6779_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0zLTEtMS0xMzI2ODI_c4ed8e1e-0022-4b3c-a16e-7f1b521b0752"
      unitRef="usdPerShare">48.09</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i456a551753af43a3a51e3142885b59a0_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC01LTEtMS0xMzI3MDc_b83bd564-f818-4bb9-9f7c-fe3ff6db2e11"
      unitRef="usdPerShare">50.35</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9a97b3d4a0024df390161bcad8ff5c15_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RhYmxlOmUzY2Y3MzUxZTlmMjRkNmE4NGYwNjg2YjMzMTM0OWI4L3RhYmxlcmFuZ2U6ZTNjZjczNTFlOWYyNGQ2YTg0ZjA2ODZiMzMxMzQ5YjhfNC0zLTEtMS0xMjkxMDk_994e74d2-3d7b-40f6-90fa-90a6b8639dfa"
      unitRef="usdPerShare">49.21</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNw_dea98a9d-8322-49b6-b853-bf6bf966c796">Our interim condensed consolidated financial statements are unaudited.  Our management believes that all adjustments necessary for a fair statement of the interim results presented have been reflected in our interim condensed consolidated financial statements.  All such adjustments were of a normal recurring nature.  Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8zNy9mcmFnOmFiMTY0ZGVhM2Y4ZjQxNTJhYmU1Y2FkYjQ1OGJlZTExL3RleHRyZWdpb246YWIxNjRkZWEzZjhmNDE1MmFiZTVjYWRiNDU4YmVlMTFfNDUzNg_8f61046e-323e-46e5-8182-80fb17e68690">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2020-06&#x201d;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of issued accounting guidance applicable to, but not yet adopted by, us, see Note 12. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Accounting Guidance Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0Ng_4306012f-2e5d-4018-8c12-e016814ad9fd">Revenues from Contracts with Customers&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate net revenues based on product type.  For further discussion, see Note 8. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record payments received in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our condensed consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue was $303 million and $287 million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  When cash is received in advance of product shipment, we satisfy our performance obligations within three days of receiving payment.  At June&#160;30, 2022 and December&#160;31, 2021, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables were $43 million and $47 million at June&#160;30, 2022 and December&#160;31, 2021, respectively.  At June&#160;30, 2022 and December&#160;31, 2021, there were no expected differences between amounts recorded and subsequently received, and we did not record an allowance for credit losses against these receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an allowance for returned goods, which is included in other accrued liabilities on our condensed consolidated balance sheets.  It is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#x2019;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#x2019;s right to recover goods from customers upon return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales incentives include variable payments related to goods sold.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Price promotion payments-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We make price promotion payments, substantially all of which are made to our retail partners, to incent the promotion of certain product offerings in select geographic areas.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wholesale and retail participation payments-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <mo:CashDiscountsPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0OA_57cd0e18-8b50-4679-a1d8-89b8db2de8a1">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our condensed consolidated balance sheets.</mo:CashDiscountsPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfODc1_61705c06-e7fb-4113-8ed6-94fc47d171ac"
      unitRef="usd">303000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfODgy_6202e2c2-729b-4b38-b88f-767a2d3dd197"
      unitRef="usd">287000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTAxNA_adafdb5f-9f99-4f1e-9d0c-b4b0612470b8">three days</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTE5MA_58fbf559-96c6-4978-81b1-f2ab8d11a92b"
      unitRef="usd">43000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTE5Nw_28d46e76-89cd-4ed1-b2c5-e6144bf61c53"
      unitRef="usd">47000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTM0MQ_13067ec0-2627-4953-8159-d943456761e0"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMTM0MQ_f40d9670-bda8-4339-bf41-1465e3ff161f"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV80MC9mcmFnOjkzOTViNWIxNWNkMzQ5MWVhNDljNWVjMTc0YWUyZmUzL3RleHRyZWdpb246OTM5NWI1YjE1Y2QzNDkxZWE0OWM1ZWMxNzRhZTJmZTNfMzY0OQ_912f3b6d-cb28-4c2e-9b97-f6f27f96b71d">We record an allowance for returned goods, which is included in other accrued liabilities on our condensed consolidated balance sheets.  It is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#x2019;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our condensed consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#x2019;s right to recover goods from customers upon return.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:InvestmentTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxNQ_64957583-1625-4566-b4d3-4153f906df5e">Investments in Equity Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of our investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investment in Cronos at June&#160;30, 2022 and December 31, 2021 consisted of our equity method investment in Cronos of $437 million and $617 million, respectively, and also included the Cronos warrant and the Fixed-price Preemptive Rights, which are measured at fair value (collectively, &#x201c;Investment in Cronos&#x201d;).  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Income) losses from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in ABI&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, we had an approximate 10% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#x201c;Restricted Shares&#x201d;) and 12 million ordinary shares of ABI.  The Restricted Shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are unlisted and not admitted to trading on any stock exchange;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are convertible by us into ordinary shares of ABI on a one-for-one basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;rank equally with ordinary shares of ABI with regards to dividends and voting rights; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;have director nomination rights with respect to ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restricted Shares were subject to a five-year lock-up period that ended October 10, 2021.  As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#x2019;s policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report our share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, the fair value of our equity investment in ABI was $10.6 billion (carrying value of $11.7 billion), which was below its carrying value by $1.1 billion or approximately 9%.  The fair value of our equity investment in ABI at December&#160;31, 2021 was $11.9 billion, which exceeded its carrying value of $11.1 billion by approximately 7%.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#x2019;s intent and ability to hold its equity investment until full recovery to its carrying value in the near term.  In preparing our financial statements for the period ended June&#160;30, 2022, we have evaluated these factors, including the macroeconomic and geopolitical factors that have resulted in significant changes to certain foreign exchange rates, including the Euro to U.S. dollar exchange rate.  Additionally, ABI has delivered consistent business and earnings performance over the past several quarters demonstrating its ability to continue to execute its strategies and navigate challenges.  At June 30, 2022, we concluded that the decline in fair value of our equity investment in ABI below its carrying value was temporary and, therefore, no impairment was recorded.  At July 25, 2022, the fair value of our equity investment in ABI was below its carrying value by $0.9 billion or approximately 8%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in JUUL&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, we made an investment in JUUL for $12.8 billion and received a 35% economic interest in JUUL through non-voting shares, which were convertible at our election into voting shares (&#x201c;Share Conversion&#x201d;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#x201c;JUUL Transaction&#x201d;).  At June&#160;30, 2022, we had a 35% ownership interest in JUUL, consisting of 42 million voting shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received a broad preemptive right to purchase JUUL shares, exercisable each quarter upon dilution, to maintain our ownership percentage and we are subject to a standstill restriction under which we may not acquire additional JUUL shares above our 35% interest.  Furthermore, we agreed not to sell or transfer any of our JUUL shares until December 20, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the JUUL Transaction, we entered into a services agreement with JUUL pursuant to which we agreed to provide JUUL with certain commercial services, as requested by JUUL, for an initial term of six years.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  In conjunction with these amendments, the parties agreed that we would discontinue all services as of March 31, 2020 except regulatory affairs support for JUUL&#x2019;s pursuit of its pre-market tobacco applications and/or its modified risk tobacco products applications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  However, we have the option to be released from our non-compete obligation (i) in the event JUUL is prohibited by federal law from selling e-vapor products in the United States for a continuous period of at least 12 months (subject to tolling of this period in certain circumstances), (ii) if the carrying value of our investment in JUUL is not more than 10% of its initial carrying value of $12.8 billion or (iii) if we are no longer providing JUUL services as of December 20, 2024.  If any of the conditions described above are met and we elect to be released from our non-competition obligations, we would lose our board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least 10%), preemptive rights, consent rights and certain other rights with respect to our investment in JUUL and, in addition, our JUUL shares would be converted to single vote common stock, which would result in a significant reduction in our voting power.  As discussed below, at June 30, 2022, the carrying value of our investment in JUUL was $450 million, which was less than 10% of our initial carrying value of $12.8 billion.  As a result, we currently have the option to be released from our non-competition obligations.  However, as of this filing, we have not elected to be released from our non-competition obligations.  We retain our option to be released from the non-competition obligations in accordance with our relationship agreement with JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the U.S. Federal Trade Commission (&#x201c;FTC&#x201d;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#x2019;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 11. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies -&#160;Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, we exercised our rights to convert our non-voting JUUL shares into voting shares.  We do not currently intend to exercise our additional governance rights obtained upon Share Conversion, including the right to elect directors to JUUL&#x2019;s board, as described below, or to vote our JUUL shares other than as a passive investor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we choose to exercise our governance rights, JUUL has agreed to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&#160;&#160;&#160;&#160;restructure JUUL&#x2019;s current seven-member board of directors to a nine-member board that will include independent board members.  The new structure will include: (i) three independent directors (one of whom will be designated by us and two of whom will be designated by JUUL stockholders other than us) unanimously certified as independent by a nominating committee, which will include at least one Altria designee, (ii) two directors designated by us, (iii) three directors designated by JUUL stockholders other than us and (iv) the JUUL chief executive officer; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&#160;&#160;&#160;&#160;create a litigation oversight committee, which will include two Altria designated directors (one of whom will chair the litigation oversight committee).  The committee will have oversight authority and review of litigation management for matters in which JUUL and we are co-defendants and have, or reasonably could have, a written joint defense agreement in effect between them.  Subject to certain limitations, the Litigation Oversight Committee will recommend to JUUL changes to outside counsel and litigation strategy by majority vote, with disagreements by JUUL&#x2019;s management being resolved by majority vote of JUUL&#x2019;s board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) issued marketing denial orders (&#x201c;MDOs&#x201d;) to JUUL ordering all of JUUL&#x2019;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL pre-market tobacco applications that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#x2019;s products currently remain on the market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  Under this option, our condensed consolidated statements of earnings include any cash dividends received from our investment in JUUL and any changes in the estimated fair value of our investment, which is calculated quarterly.  We believe the fair value option provides quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#x2019;s business or a market-derived valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the estimated fair value of our investment in JUUL, at June&#160;30, 2022 and December&#160;31, 2021, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#x2019;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency law; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six and three months ended June&#160;30, 2022, we recorded non-cash, pre-tax unrealized losses of $1,255 million and $1,155 million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#x2019;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency law, and (iii) projections of higher operating expenses resulting in lower long-term operating margins.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six and three months ended June&#160;30, 2021, we recorded a non-cash, pre-tax unrealized loss of $100 million and a non-cash, pre-tax unrealized gain of $100 million, respectively, as a result of changes in the estimated fair value of our investment in JUUL.  There were no material changes to the significant assumptions used in the valuations, as described above, during the six and three months ended June&#160;30, 2021, compared to the assumptions used for the December 31, 2020 valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in Cronos&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, we had a 41.4% ownership interest in Cronos, consisting of 156.6&#160;million shares, which we account for under the equity method of accounting.  We report our share of Cronos&#x2019;s results using a one-quarter lag because Cronos&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.  The fair value and carrying value of our equity method investment in Cronos at December 31, 2021 was $617&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $55&#160;million or approximately 10%.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June&#160;30, 2022.  Accounting guidance requires the evaluation of the following factors when determining if the decline in fair value is other than temporary: (i) the duration and magnitude of the fair value decline; (ii) the financial condition and near-term prospects of the investee; and (iii) the investor&#x2019;s intent and ability to hold its equity method investment until full recovery to its carrying value in the near-term.  In preparing our financial statements for the period ended June&#160;30, 2022, we evaluated these factors and determined that there was not sufficient evidence to conclude that the impairment was temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $107 million for the six and three months ended June&#160;30, 2022, which was recorded to (income) losses from equity investments in our condensed consolidated statement of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#x2019;s share price and the Canadian dollar (&#x201c;CAD&#x201d;) to U.S. dollar exchange rate at June&#160;30, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022 and the carrying value of our equity method investment in Cronos at June&#160;30, 2022.  At June&#160;30, 2022, prior to recording the impairment charge, the fair value of our equity method investment in Cronos was less than its carrying value by approximately 20%.  After recording the impairment charge, the fair value and carrying value of our equity method investment in Cronos at June&#160;30, 2022 were both $437 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our Investment in Cronos, at June&#160;30, 2022, we also owned:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $16.25 upon the occurrence of specified events (&#x201c;Fixed-price Preemptive Rights&#x201d;).  Based on our assumptions as of June&#160;30, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately 11 million common shares of Cronos; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;a warrant providing us the ability to purchase an additional approximate 10% of common shares of Cronos (approximately 84 million common shares at June&#160;30, 2022) at a per share exercise price of CAD $19.00, which expires on March 8, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If exercised in full, the exercise prices for the warrant and Fixed-price Preemptive Rights are approximately CAD $1.6 billion and CAD $0.2 billion, respectively (approximately U.S. dollar $1.2 billion and $0.1 billion, respectively, based on the CAD to U.S. dollar exchange rate on July 25, 2022).  At June&#160;30, 2022, upon full exercise of the Fixed-price Preemptive Rights, to the extent such rights become available, and the warrant, we would own approximately 52% of the outstanding common shares of Cronos.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fixed-price Preemptive Rights and Cronos warrant are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy).  We elect to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on our condensed consolidated balance sheets in investments in equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record in our condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded non-cash, pre-tax unrealized (gains) losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIwOA_9eedef2f-9340-47f0-b79f-a45f9a2f18d3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of our investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investment in Cronos at June&#160;30, 2022 and December 31, 2021 consisted of our equity method investment in Cronos of $437 million and $617 million, respectively, and also included the Cronos warrant and the Fixed-price Preemptive Rights, which are measured at fair value (collectively, &#x201c;Investment in Cronos&#x201d;).  See below for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMS0yLTEtMS0xMjkxMDk_d61dd46b-6966-4b1a-9c63-178adb90d1d1"
      unitRef="usd">11702000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i36cd43db55f34600bccfbf93673a50c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMS00LTEtMS0xMjkxMDk_1219b232-eb2a-44a4-b8ca-cc914cbf7bfb"
      unitRef="usd">11144000000</us-gaap:EquityMethodInvestments>
    <mo:EquityInvestmentFairValueOption
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMi0yLTEtMS0xMjkxMDk_db65ff56-f58d-4683-8618-b7cc82ff5751"
      unitRef="usd">450000000</mo:EquityInvestmentFairValueOption>
    <mo:EquityInvestmentFairValueOption
      contextRef="i01fa611f2a7f4ac18373b103852f2b2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMi00LTEtMS0xMjkxMDk_19d4e57f-9a43-4fde-8159-505ec7c5d014"
      unitRef="usd">1705000000</mo:EquityInvestmentFairValueOption>
    <mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMy0yLTEtMS0xMjkxMDk_6c8187b7-68d2-462d-9851-5ce55c18cbcb"
      unitRef="usd">438000000</mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights>
    <mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights
      contextRef="i80a9923020f3440a85a8e77c1756d28c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfMy00LTEtMS0xMjkxMDk_b862702a-5fa9-4c09-9677-074ec24d3897"
      unitRef="usd">632000000</mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights>
    <us-gaap:Investments
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfNC0yLTEtMS0xMjkxMDk_f23ee4e7-0dae-4d34-a2f5-4768bf1edf59"
      unitRef="usd">12590000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjg1YTJhZTMzNWY1OTQyZGJiZjMwYjc2NmJiYzZhZGJkL3RhYmxlcmFuZ2U6ODVhMmFlMzM1ZjU5NDJkYmJmMzBiNzY2YmJjNmFkYmRfNC00LTEtMS0xMjkxMDk_25afd38f-4f1e-4cda-aae1-1820cdcd2339"
      unitRef="usd">13481000000</us-gaap:Investments>
    <us-gaap:EquityMethodInvestments
      contextRef="ic1faac1f996b4486abd195c7b20753e5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMjI0_1d67d9fb-a97f-423e-9da4-ee2cac277aee"
      unitRef="usd">437000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMjMy_9492908c-a783-4974-8cbd-b7d8445ddeb8"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxNw_6a01df02-c4af-4633-aea9-dbae34bcbde6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Income) losses from equity investments accounted for under the equity method of accounting and fair value option consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,255&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,155&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded non-cash, pre-tax unrealized (gains) losses, representing the changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi0xLTEtMS0xMjkxMDk_7f8d0f16-0dad-4789-ba7d-896f7416ead0"
      unitRef="usd">212000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie78dea82ae7d4b92b9519c98e6eefa7a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi0zLTEtMS0xMjkxMDk_63ee1775-665b-46da-b705-1437899015dc"
      unitRef="usd">392000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c85ce8790e54af78ef8a2b11e4fb9f9_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi01LTEtMS0xMjkxMDk_d18fdc1b-fb91-4e9b-a68b-162407cb7177"
      unitRef="usd">12000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4c05c358d1bb48aebde77f979670acd7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMi03LTEtMS0xMjkxMDk_6ae67049-f08a-466f-8a58-d55152cfd300"
      unitRef="usd">74000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy0xLTEtMS0xMjkxMDk_417b39fe-2a81-4fe2-8400-0c0c59e6f326"
      unitRef="usd">-186000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i10dd4f1f71584811bc9ce1be4117dc8e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy0zLTEtMS0xMjkxMDk_182e853e-5bc2-4dbe-b7e3-c363e1b2219d"
      unitRef="usd">-166000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy01LTEtMS0xMjkxMDk_2363f307-9027-43d2-b171-7341ea89c7b0"
      unitRef="usd">-120000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic7229434de434e45a7fba1248a55d390_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfMy03LTEtMS0xMjkxMDk_3b844efd-a6e7-4c9a-ad3e-4618b2298a52"
      unitRef="usd">-99000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC0xLTEtMS0xMjkxMDk_d469c212-bc4a-440b-8a81-69892202fa25"
      unitRef="usd">26000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC0zLTEtMS0xMjkxMDk_61f37e80-17b5-4bfb-8df2-03fd1cbe6928"
      unitRef="usd">226000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC01LTEtMS0xMjkxMDk_6f0c18df-d394-4f20-b58a-a6815de0cd75"
      unitRef="usd">-108000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNC03LTEtMS0xMjkxMDk_b6e1f9de-fdf2-4061-8f3d-97ebb1587eca"
      unitRef="usd">-25000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS0xLTEtMS0xMjkxMDk_2057f848-9e0d-4fa9-95c7-9f5c4e795a89"
      unitRef="usd">-1255000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS0zLTEtMS0xMjkxMDk_e7631422-251f-4878-a9d1-2ffdaca5dcd3"
      unitRef="usd">-100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS01LTEtMS0xMjkxMDk_0d0c9e29-8d9c-4a4e-8f0d-cb873c7069b1"
      unitRef="usd">-1155000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNS03LTEtMS0xMjkxMDk_ee1f5835-050a-4b5b-90ab-3f9ad80e6af1"
      unitRef="usd">100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi0xLTEtMS0xMjkxMDk_5ec68acd-b34e-4e2b-8761-cccdaca7623d"
      unitRef="usd">-1229000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi0zLTEtMS0xMjkxMDk_899b0dc1-15b6-4ebf-ac1c-2fc06c7279c1"
      unitRef="usd">126000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi01LTEtMS0xMjkxMDk_5ce3bfad-5bee-4b18-a148-9f9b23f6b645"
      unitRef="usd">-1263000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RhYmxlOjFiYzU2YzY1MWRhMDRlNjRiNTFlZmE2YTAxNTRlMGRmL3RhYmxlcmFuZ2U6MWJjNTZjNjUxZGEwNGU2NGI1MWVmYTZhMDE1NGUwZGZfNi03LTEtMS0xMjkxMDk_dd180f19-7f9e-4644-ad75-3a8e2b0df3da"
      unitRef="usd">75000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfOTAw_64be11dc-0fe1-4732-8db0-c8f6425a5304"
      unitRef="number">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedRestricted
      contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfOTQ0_e0dd23fc-fe04-43ae-a257-f9c98dcd0080"
      unitRef="shares">185000000</mo:EquityMethodInvestmentNumberofSharesOwnedRestricted>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="ifac8a899318948c599bdf090d2fa77ba_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTAwMg_19398c22-392f-449a-859a-b7cd9d311531"
      unitRef="shares">12000000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <mo:RestrictedSharesLockupPeriod
      contextRef="iccdaf47998cc4b838b74fd07a6aee1ac_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIxMA_05c5e21d-daf1-498e-b852-1e43b77a2bfa">P5Y</mo:RestrictedSharesLockupPeriod>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzIwNQ_6aad8272-faea-4cd2-9c48-76280a26deaa">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#x2019;s policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report our share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.The Fixed-price Preemptive Rights and Cronos warrant are derivative financial instruments, which are required to be recorded at fair value.  The fair values of the Fixed-price Preemptive Rights and Cronos warrant are estimated using Black-Scholes option-pricing models, adjusted for observable inputs (which are classified in Level 1 of the fair value hierarchy), including share price, and unobservable inputs, including probability factors and weighting of expected life, volatility levels and risk-free interest rates (which are classified in Level 3 of the fair value hierarchy).  We elect to record the gross assets and liabilities of derivative financial instruments executed with the same counterparty on our condensed consolidated balance sheets in investments in equity securities.We record in our condensed consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occu</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTg5Ng_232ad781-23ca-4aa9-a3f6-5ea332413b03"
      unitRef="usd">10600000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTkxMw_989ec070-b9ad-4005-8b84-51f5876967a0"
      unitRef="usd">11700000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk1NA_7decb96e-7baf-4b93-a56d-7f0c0501161b"
      unitRef="usd">1100000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i7b9574e42f5641358c71bcf9e4257b4b_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk2OQ_e763f549-64ea-4a39-a4a0-6c249904bfa4"
      unitRef="number">-0.09</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTM3NDM4OTUzNTI2MjA_e87bdd3c-1d8e-478e-88f8-f32341c0420c"
      unitRef="usd">11900000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMTM3NDM4OTUzNTI2Mjk_d866d421-5011-43f2-bde7-0c9324e088a6"
      unitRef="usd">11100000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="ibf7d0c9b6f954af9a8bd6e104365d78a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk3NQ_ec3ce60b-8862-4e90-a886-943397fccf69"
      unitRef="number">0.07</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i392d38c364c74d9ea72ff1e3530414b2_I20220725"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg4OTk5NA_a5a9e374-dda0-481f-9319-4ac0f7e70c3a"
      unitRef="usd">900000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i392d38c364c74d9ea72ff1e3530414b2_I20220725"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV81OC9mcmFnOmJlZTc0YzhkMWJkZjRkYjE4ZmY5NjdiNjZiNzdkY2ExL3RleHRyZWdpb246YmVlNzRjOGQxYmRmNGRiMThmZjk2N2I2NmI3N2RjYTFfMzI5ODUzNDg5MDAwOQ_87a5e889-c6b8-4ee5-8c45-b2f2e053940f"
      unitRef="number">-0.08</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
      contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzY_83960249-9ef1-48a1-9d7e-f0352c5b0cd5"
      unitRef="usd">12800000000</mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfOTQ_8c3d3b8f-e906-4e92-a470-5654772f8a42"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDI3_546a9921-03cf-451e-940e-3994d3a47fc0"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquityInvestmentsFairValueOptionVotingShares
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDcy_84552652-a52b-4937-900a-e4a754c4e271"
      unitRef="shares">42000000</mo:EquityInvestmentsFairValueOptionVotingShares>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="ie9f2e946faf34bbda7f3bf1f447ecd24_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQw_b74c8d88-051a-43e4-b794-b49f91c2f57a"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm
      contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQ4OQ_a08631b0-3dc5-4023-8cfc-a6b11860de90">P6Y</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMTkyNQ_ad2d0b9f-a86a-4ab6-bb2a-247b00a1095b"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount
      contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMTk2MQ_260991d1-30da-46f7-9a72-3f51dad082be"
      unitRef="usd">12800000000</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYxNQ_fb83a397-1947-4f75-b897-8e0b32bc047e"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYyMQ_ad850264-95f6-41ba-871c-03cb49f00da7"
      unitRef="usd">450000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="i60a5c0afbb434e35bbda711cca223cb1_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTYzOA_6bdbcd0e-0d46-429c-8d62-7ce43e34dfb7"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount
      contextRef="i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4MTY0NA_cb8a8bc7-e614-46fa-a8b1-05cb99fd23d9"
      unitRef="usd">12800000000</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzIxNw_0f5e439a-0e74-4853-b324-af9825836235"
      unitRef="director">7</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzI1MQ_8934dfe7-4baf-4740-9fa3-7a1f116310a9"
      unitRef="director">9</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzM0OQ_c327fa0e-7ba6-4248-80c6-249c18b44ef2"
      unitRef="director">3</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion
      contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzM3NQ_ec0e35d8-894d-4ef5-9c41-9fe390487c7b"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzQxNQ_d98fa965-c67a-4d45-b442-4490c408bfa3"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzU3Mw_aa133ac0-4130-472c-879e-5b8d468e99ff"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzU5OA_d524b320-5a58-4abd-8dd1-08d49b045117"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMzYzNQ_50054bcd-4f9f-4603-847d-de7065ac057c"
      unitRef="director">3</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion
      contextRef="i7eb076cfe6f641f2a07a06b53c206a16_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4NDgwMw_7cc3fbab-dca4-4bde-a344-fb03da5549a2"
      unitRef="director">2</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjc0ODc3OTA4NDgxMA_938ea047-f8de-4cdd-bf68-fae0430fa19e"
      unitRef="director">1</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNDk0NzgwMjMzNDgyOQ_70c84373-7fab-4591-92dc-50511512b4be">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  Under this option, our condensed consolidated statements of earnings include any cash dividends received from our investment in JUUL and any changes in the estimated fair value of our investment, which is calculated quarterly.</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNzQ4NQ_06ab1c6b-8ed1-4186-a67e-38132a5335e0">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ied72379ce65f44d1b138e007119e5e27_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfMi0yLTEtMS0xMjkxMDk_2bfccbc4-1806-4810-b276-23d0c70d98d6"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i4dfcd799dbb04d77a027eb24466e1b75_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfMy0yLTEtMS0xMjkxMDk_80a3c114-17ca-4ec6-b111-cc7a47c7b52d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i591aee96bde948f381ffaaf7af7d4bdd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNC0yLTEtMS0xMjkxMDk_ef17d077-eae3-44fc-9428-e622e23e09e8"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i1f889b38500d46f991a8ea1dc2bff214_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNS0yLTEtMS0xMjkxMDk_cee784c0-8955-4db1-a75d-83391cbef730"
      unitRef="usd">-1255000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia31a79b3a3b64912992fc8127b6f0253_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RhYmxlOjA0ZDYyZTI4OWVmMDQ1YmY5NDZjMjdkNTZlYTc0MzY4L3RhYmxlcmFuZ2U6MDRkNjJlMjg5ZWYwNDViZjk0NmMyN2Q1NmVhNzQzNjhfNi0yLTEtMS0xMjkxMDk_68b1798c-7a2c-4ecc-bef4-c4451f7e4873"
      unitRef="usd">450000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i0a7e0fc5cd814cadb01ca27d43ec24ce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfNjY3NQ_dc5f1ea1-055a-427d-b3b1-5f9c0200f3f2"
      unitRef="usd">-1255000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="i1c771e7f763543d9a213e04ff03d1693_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzczNg_e6cbd912-fa7f-4e98-a329-a68f11a1347d"
      unitRef="usd">-1155000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="ie284c7b3bc464b739cff2bfb4a8f3530_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzA2OA_358a4490-a86d-4e7e-b6a7-4685e37c079d"
      unitRef="usd">-100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <mo:IncomeLossFromEquityInvestmentsFairValueOption
      contextRef="ic5d81d37a11d4a95826f931e30565af8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82MS9mcmFnOmM1NjRmY2I2YjE2ZDQwOTc5NTQ0YTlmMWFjMTVkMjdiL3RleHRyZWdpb246YzU2NGZjYjZiMTZkNDA5Nzk1NDRhOWYxYWMxNWQyN2JfMjE5OTAyMzI2MzEyMA_558ae0d7-469c-4456-80d1-a1cf7d70522e"
      unitRef="usd">100000000</mo:IncomeLossFromEquityInvestmentsFairValueOption>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfNDI_5c53c0a4-0992-4717-b97e-4642b61b7169"
      unitRef="number">0.414</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfODk_99880aac-d887-4c71-b87e-f535f326fee6"
      unitRef="shares">156600000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestments
      contextRef="i22f58ca5a6ab4247a7068ed7c19dc3f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk0MzE_2227ec54-88d4-481a-980d-888d41c793c1"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i80a9923020f3440a85a8e77c1756d28c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk0MzE_40eb2e4f-30e1-4d6f-b040-86ec8dea4d42"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i5e2fd4010d1f4eceb5b59561d986587a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY1NA_8532db42-49c1-43de-a71e-1e8cdcd59f02"
      unitRef="usd">55000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="i5e2fd4010d1f4eceb5b59561d986587a_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3Mg_d2b87e17-39a8-40b0-8a64-0eeffe38962b"
      unitRef="number">0.10</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i6d04fb441d2144fa89d454ea89a7fba2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3OQ_4d6af68a-b7a3-403c-9942-e9561584554e"
      unitRef="usd">107000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i800ccf3aced24591aa2ab3f9a8ac8a33_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY3OQ_bc2a455b-d75d-4f42-845a-cbd4fa79f575"
      unitRef="usd">107000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjAzNDA5NjUxMTk1NTQ_506a0f25-c6f6-4f3f-ae6a-b2105f89b472"
      unitRef="number">0.20</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY5NA_636c3459-7dc8-4dee-af8c-75ce6165f07d"
      unitRef="usd">437000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="if488a491d85b439783705940ff379d59_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjc0ODc3OTA3NTY5NA_c33db982-140a-4f62-a67a-62e9d99b2427"
      unitRef="usd">437000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i8022e2eba341430684992380ece3f792_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTIzMQ_2c8aa7a4-a1cb-4b70-8712-08f59eef614c"
      unitRef="cadPerShare">16.25</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="i8022e2eba341430684992380ece3f792_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTQ0Nw_67d2e3a0-65d8-47f2-8202-98d9dabe5958"
      unitRef="shares">11000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase
      contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTU1Mg_647f5a1a-f948-410c-8b39-b0ff3be1006b"
      unitRef="number">0.10</mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTU5Nw_4f480901-695a-4a9a-9aec-e21788fe8032"
      unitRef="shares">84000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i6943e16458bc4ca2852601e0fa80a2ae_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTY1OA_b99d1eba-eadc-4ae3-af37-3825fd09b846"
      unitRef="cadPerShare">19.00</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="icd81d8232428439e8af3fc2c52b75b21_D20220101-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTgwOQ_2a52bd4d-d30d-447a-afd3-271b993a700b"
      unitRef="cad">1600000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="ic7724f34336b4837a6779170d66ce1e5_D20220101-20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTgyMA_2ace92d5-ffa8-4554-9ddf-ee2786b83326"
      unitRef="cad">200000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i4a65e4417b704c50af9108de96b6b9b3_D20220725-20220725"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTg2NA_72354826-e6ee-49a0-9366-ce0412f052c0"
      unitRef="usd">1200000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentAggregateExercisePrice
      contextRef="i5be1411a627b4cb2955ad80477a30400_D20220725-20220725"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMTg3MQ_44b4f7cb-a39b-4311-a7a4-086644c8ceb1"
      unitRef="usd">100000000</mo:EquityMethodInvestmentAggregateExercisePrice>
    <mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage
      contextRef="id53917fedb1842eab0669c6ca15b2879_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RleHRyZWdpb246NTNjMTI1NWQ4MGE4NDE0ODg2MTQ3MTkzNDIzMTQyNDNfMjEwOA_225d2c84-9997-4a28-84de-226a9e6f1e6e"
      unitRef="number">0.52</mo:EquityMethodInvestmentWarrantExercisedOwnershipPercentage>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic6bcff8fcbbc4e029d7f839b563920a1_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi0xLTEtMS0xMjkxMDk_78b86630-9742-4be9-99d2-435561c6184a"
      unitRef="usd">1000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ie77e3add79c947548aa389bbcf1bc640_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi0zLTEtMS0xMjkxMDk_02ef07d8-6749-43a5-9c3c-cb01bfc177bf"
      unitRef="usd">4000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i6f0cc7b4fc994f51b95e2edb4d99dce0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi01LTEtMS0xMjkxMDk_38597835-f5b5-43a2-97bd-087ca779a5e8"
      unitRef="usd">1000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib7ee7b42337247669b6c69451925af0c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMi03LTEtMS0xMjkxMDk_a65534f8-26a0-4f7c-a7e9-357993cabb34"
      unitRef="usd">18000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i73ce0fd62aa842c6addcbbd8362247ca_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy0xLTEtMS0xMjkxMDk_ee5eb239-8d7c-4858-b599-1a439f003b7d"
      unitRef="usd">13000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i23e04bbbcf2b4dddba8b27254730fe6a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy0zLTEtMS0xMjkxMDk_2b0d1c37-63f7-496c-9c69-472108f6dfde"
      unitRef="usd">-11000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i4bbdf8e5b22441f4b146cdf0423fa04e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy01LTEtMS0xMjkxMDk_c5b3e501-004e-4aae-9ce3-d54b3ad18cea"
      unitRef="usd">3000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i6d389b0b33184827ac627cf3211504bb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfMy03LTEtMS0xMjkxMDk_dac3912e-9d29-4341-ba8a-0e1e6bc283a0"
      unitRef="usd">85000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC0xLTEtMS0xMjkxMDk_f352b7b9-31b8-4e81-8588-4a9d1d9153c0"
      unitRef="usd">14000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC0zLTEtMS0xMjkxMDk_75a07cda-c5b5-4059-96df-3c60dbd191f0"
      unitRef="usd">-7000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC01LTEtMS0xMzU4Mzc_0e3f8a96-de14-4558-8357-80e804623916"
      unitRef="usd">4000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82NC9mcmFnOjUzYzEyNTVkODBhODQxNDg4NjE0NzE5MzQyMzE0MjQzL3RhYmxlOjcxNjhhZmI4NTQ0NjRlYjA5Y2I1MzBhZWI3NmQ0NTBmL3RhYmxlcmFuZ2U6NzE2OGFmYjg1NDQ2NGViMDljYjUzMGFlYjc2ZDQ1MGZfNC03LTEtMS0xMzU4NTA_d6369bb0-4079-42f2-8c7c-6476d2296f91"
      unitRef="usd">103000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjg0MQ_1805a55f-dd22-415d-8528-c5ca5f205212">Financial Instruments&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#x201c;foreign currency contracts&#x201d;), and Euro denominated unsecured long-term notes (&#x201c;foreign currency denominated debt&#x201d;) as net investment hedges of our investment in ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, all outstanding foreign currency contracts matured and, at June&#160;30, 2022 and December&#160;31, 2021, we had no outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the aggregate carrying value and fair value of our total long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt included in long-term debt above:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in the carrying value of our long-term debt was primarily driven by changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during the first six months of 2022.  The decrease in the fair value of our long-term debt was primarily driven by increases in interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our condensed consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in &lt;br/&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in &lt;br/&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our condensed consolidated statements of earnings based on an amortization approach.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjgzNg_08c631b7-998b-4e54-861e-84268e627fe5">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the aggregate carrying value and fair value of our total long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,956&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt included in long-term debt above:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMS0xLTEtMS0xMjkxMDk_efe2de83-0788-4ddb-8063-81f210feafa9"
      unitRef="usd">27680000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMS0zLTEtMS0xMjkxMDk_e9f1039e-0d95-4831-8e8c-b385d7c2ff05"
      unitRef="usd">28044000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMi0xLTEtMS0xMjkxMDk_336605fa-c1a0-4402-9f21-d549dad07d29"
      unitRef="usd">23956000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfMi0zLTEtMS0xMjkxMDk_89b7ea3b-7ab0-488e-9b35-93748e817011"
      unitRef="usd">30459000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNC0xLTEtMS0xMzQwMzE_84c50e26-7996-4feb-b98f-5e9d79b00ed4"
      unitRef="usd">4444000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6624310334664ad8b05bff9a8f611a26_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNC0zLTEtMS0xMzQwMjU_5873d175-b101-4d81-b555-38f6a26ade77"
      unitRef="usd">4817000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5d874f8ce33a42adb5f9f7a5209f1d6b_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNS0xLTEtMS0xMzQwNDc_8b712013-f115-414a-b46c-91809c2f39e4"
      unitRef="usd">4150000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6624310334664ad8b05bff9a8f611a26_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOmYzMzBjNTczODcwYTQ3ZTVhOTgwNTgxOTMxNmFiODkwL3RhYmxlcmFuZ2U6ZjMzMGM1NzM4NzBhNDdlNWE5ODA1ODE5MzE2YWI4OTBfNS0zLTEtMS0xMzQwMjg_edc1e333-c96e-4d01-8cae-6563342a7740"
      unitRef="usd">5114000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfMjgzOA_eb7d91cd-35bb-426f-b5cd-8d0b83935762">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our condensed consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in &lt;br/&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in &lt;br/&gt;Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0yLTEtMS0xMjkxMDk_4846ab8e-57fd-421c-b3a4-81259687436f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy00LTEtMS0xMjkxMDk_174b00f5-aecd-46cb-aad5-528968f5246a"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i477136e60c154d1ca892f74742dfc72c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy02LTEtMS0xMjkxMDk_640852e9-1f38-4bf3-ad9b-2c49b08b4fe5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="icf52d5e46f284f39a3a7b056629b8621_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy04LTEtMS0xMjkxMDk_154f6313-9b55-4d83-b8f2-5599cfe421cd"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5daf1435da144756965535f298d285e2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xMC0xLTEtMTI5MTA5_8e00abab-68af-4ffc-84d4-717950be9ad3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xMi0xLTEtMTI5MTA5_f3de4623-2ab5-48e9-b276-ca3421e8f190"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i5daf1435da144756965535f298d285e2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xNC0xLTEtMTI5MTA5_a7f2dddb-a567-4643-8b6d-461f68c8577a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia8be55b886ac4af480d6c688d6c80dbc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfMy0xNi0xLTEtMTI5MTA5_6bf724b9-ac50-4748-bcc1-be76691b4e66"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0yLTEtMS0xMjkxMDk_d79ce4bb-4efb-4974-8c6a-8b66054e8990"
      unitRef="usd">-375000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC00LTEtMS0xMjkxMDk_f7be5fde-0f9a-4f39-947d-57f9235cfee3"
      unitRef="usd">-152000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="id4818b84c0e4479b9ea119f3a8598a08_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC02LTEtMS0xMjkxMDk_3d96a74a-4573-4b43-a06e-c12697a25e06"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="if184f3b7ff15480ca7cbe600313145d9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC04LTEtMS0xMjkxMDk_d685f4e4-c46b-45f3-85fc-4716f93fa090"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xMC0xLTEtMTI5MTA5_4d03c9c5-3c66-4bfd-911b-375e0ae32145"
      unitRef="usd">-247000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xMi0xLTEtMTI5MTA5_1d6c6345-e689-4b95-a9c8-3b5993b0dae7"
      unitRef="usd">54000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i5dfc87358ee94a7588bb0c202c6adcb2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xNC0xLTEtMTI5MTA5_f5718f87-989f-4c64-bf26-a00f36bfe369"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i15e6a8de9827426a9ab57ed6190bfd2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNC0xNi0xLTEtMTI5MTA5_d7818027-e189-4c44-9837-f40499ddf075"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0yLTEtMS0xMjkxMDk_8f8de403-942d-48cc-96bc-9045049de2af"
      unitRef="usd">-375000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS00LTEtMS0xMjkxMDk_5c9b917a-7fa8-496d-a584-7b9bd6b2bf00"
      unitRef="usd">-168000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia6f773d6ede34c2eb8b5bc7bafe0dcc6_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS02LTEtMS0xMjkxMDk_1f93e08e-5567-4c63-adf8-1f140047a008"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ib2a9346b7b0f47b9a29b6fcb2032a280_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS04LTEtMS0xMjkxMDk_cd02507f-0a90-4f65-8a3f-96a531b5126d"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xMC0xLTEtMTI5MTA5_62a2d7ee-9952-4b3f-ac63-7c415d6e7833"
      unitRef="usd">-247000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xMi0xLTEtMTI5MTA5_e5c02cca-1497-4fde-b162-be24ff070d19"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xNC0xLTEtMTI5MTA5_c94a5a14-d029-488a-8342-659772c54e67"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i7bd73837b832475e9b02d09d8fc6aff0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RhYmxlOjVjNTA0MmM4ZDRmNDRmOTliMDMwMDg2YmIyMzZjYzYwL3RhYmxlcmFuZ2U6NWM1MDQyYzhkNGY0NGY5OWIwMzAwODZiYjIzNmNjNjBfNS0xNi0xLTEtMTI5MTA5_232f2d13-8bda-4827-b43a-7e8c50c2c630"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV82Ny9mcmFnOmZiZDk1MTFhMWUzYTRhYTdhNTAyZjRjOTA1NjkwNWEzL3RleHRyZWdpb246ZmJkOTUxMWExZTNhNGFhN2E1MDJmNGM5MDU2OTA1YTNfNDk0NzgwMjMyODA5NQ_7173824b-94c4-46ef-b570-c9a6f67af1ff">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our condensed consolidated statements of earnings based on an amortization approach.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfMTAxNg_f4e5cc7e-9de0-43f5-9caa-21d9e2a256d5">Benefit Plans&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Components of Net Periodic Benefit (Income) Cost&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (income) cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employer Contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make contributions to our pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service regulations.  We made employer contributions of $8 million to our pension plans and did not make any contributions to our postretirement plans during the six months ended June 30, 2022.  Currently, we anticipate making additional employer contributions of up to approximately $25 million to our pension plan and $30 million to our postretirement plans in 2022.  However, the foregoing estimates of 2022 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan amendments to our postretirement plans for the year ended December 31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $432 million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfMTAxMw_2859ace5-4eaf-4fd0-b505-38342ec9c73c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net periodic benefit (income) cost consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit (income) cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xLTEtMS0xMjkxMDk_66f6177c-3f5a-4e25-85cf-34d267fbe64f"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0zLTEtMS0xMjkxMDk_166beba8-ddb1-41fa-bfe6-df1a0d947d2a"
      unitRef="usd">34000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy01LTEtMS0xMjkxMDk_4cf9b706-f092-4a78-8e8f-b6c4b652637f"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy03LTEtMS0xMjkxMDk_adc36226-7526-4883-9aa1-a0842293c328"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy05LTEtMS0xMzExMjA_8927bd29-9e72-4095-b5b9-c973724a1390"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xMS0xLTEtMTMxMTA2_a7a8b0f3-dbf6-4dbe-8fcf-9084914ba91c"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xMy0xLTEtMTMxMTU1_bec11a59-20d7-4b7e-9409-fde6e834c33f"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMy0xNS0xLTEtMTMxMTY5_481b4213-367e-40ac-91a4-5588626e2851"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xLTEtMS0xMjkxMDk_df1cd856-b3eb-4d67-895a-76810de86150"
      unitRef="usd">104000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0zLTEtMS0xMjkxMDk_8c6289b0-e337-4ac0-8f28-191b0263f8a4"
      unitRef="usd">93000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC01LTEtMS0xMjkxMDk_04a2e4b4-efa8-4389-9cf7-3191644dffd3"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC03LTEtMS0xMjkxMDk_5b1ce26d-f63d-4634-b79c-52051b16f472"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC05LTEtMS0xMzExMjA_c66923e5-239f-40cc-824b-605dc294d4dc"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xMS0xLTEtMTMxMTA2_83b4018c-2e73-40d9-94d9-004cf7723597"
      unitRef="usd">47000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xMy0xLTEtMTMxMTU1_e136deee-31dd-43cc-b790-dc793a8b4ca1"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNC0xNS0xLTEtMTMxMTY5_c49874e4-9467-4f79-8ac3-e89645d19036"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xLTEtMS0xMjkxMDk_f40725a7-d289-42b3-bdd8-b0fdeb3f732d"
      unitRef="usd">247000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0zLTEtMS0xMjkxMDk_3e5aaa44-1a7a-48ec-83c3-cf805805879f"
      unitRef="usd">262000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS01LTEtMS0xMjkxMDk_da0539d7-e9cd-4325-94fc-038a7c8268b4"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS03LTEtMS0xMjkxMDk_2fc5f069-9978-48e9-8e20-a4b62b82de0f"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS05LTEtMS0xMzExMjA_9cbb1009-00eb-4fa6-b446-c97d5b5522e3"
      unitRef="usd">124000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xMS0xLTEtMTMxMTA2_1a362bd3-c984-43d3-b8f8-3764fd145742"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xMy0xLTEtMTMxMTU1_d7663412-5cb8-418d-aae6-86b24f273af0"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNS0xNS0xLTEtMTMxMTY5_3955dfc7-23cd-4980-a17b-eb154716fc77"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xLTEtMS0xMjkxMDk_020aee24-aaab-4d54-852e-b5e883387023"
      unitRef="usd">-48000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0zLTEtMS0xMjkxMDk_0d2a44cb-69f5-4441-8c12-eefbe601e9d1"
      unitRef="usd">-66000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy01LTEtMS0xMjkxMDk_e371d1af-3500-4082-b5e0-11c8e0ddca1e"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy03LTEtMS0xMjkxMDk_dc8bb513-ceea-415f-a5fe-5c5075347def"
      unitRef="usd">-14000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy05LTEtMS0xMzExMzU_b03e3fd3-58a8-4c67-9bc0-2e6b4c06093a"
      unitRef="usd">-24000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xMS0xLTEtMTMxMTEz_2e83ccea-8c64-477f-89a8-5924f5eb74d5"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xMy0xLTEtMTMxMTYy_4c1298c1-3942-423c-bcde-50a3f7b0975d"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfNy0xNS0xLTEtMTMxMTc4_2f9bdc0f-69db-4f3f-add5-6c78fb66c450"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xLTEtMS0xMjkxMDk_ef5e0f46-b60a-4cbe-b4ae-598c713371bd"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0zLTEtMS0xMjkxMDk_9dde1d46-83eb-46f0-b23f-c08b24e1dcfa"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC01LTEtMS0xMjkxMDk_4f98a4f5-311c-4f8e-af01-cdaddfaa45d3"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC03LTEtMS0xMjkxMDk_3f8bb7bd-0acc-452e-b48e-acca13432e57"
      unitRef="usd">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC05LTEtMS0xMzExMzU_4b1c25df-1465-44ea-93fb-ef1ab2ee66d8"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xMS0xLTEtMTMxMTEz_ed0129a7-bb38-4ec2-bae4-c56fa4139f6d"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xMy0xLTEtMTMxMTYy_9df72546-ae1d-47de-88ac-b820917f5cc1"
      unitRef="usd">-11000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfOC0xNS0xLTEtMTMxMTc4_ef3737d9-0809-4e37-b60f-8f73df215f81"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMS0xLTEtMTI5MTA5_5ac0c400-7930-4eef-ab5c-46a4e6a4acc0"
      unitRef="usd">-60000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ifbdd6b4b79264f6b9206024fd8a8f340_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMy0xLTEtMTI5MTA5_ad5928fb-3c61-49e2-97db-e8d59b324c14"
      unitRef="usd">-67000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtNS0xLTEtMTI5MTA5_e2ce5f75-3ade-4ff3-b12e-db82a0e6819a"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie947e667731b40a181535bc591d33c5d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtNy0xLTEtMTI5MTA5_abc15039-a52e-4a49-9de2-4fa6f715c430"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtOS0xLTEtMTI5MTA5_6bb87320-c0cb-4eac-9886-0a9075daba40"
      unitRef="usd">-30000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7a0aa174339f448f8afcb7d233174349_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTEtMS0xLTEyOTEwOQ_8e24d6b6-7c13-4824-8c08-9223d224ca1f"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i243eb7b856a04876b5fcd3390f906240_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTMtMS0xLTEyOTEwOQ_e561dae4-ad5d-4f7d-a53a-51071cb1ea93"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RhYmxlOmRjMDMyM2NmYTM1YzRiMGU4Y2MzY2UxZDlmYTY2MGY4L3RhYmxlcmFuZ2U6ZGMwMzIzY2ZhMzVjNGIwZThjYzNjZTFkOWZhNjYwZjhfMTAtMTUtMS0xLTEyOTEwOQ_3dc231d9-908e-4e3a-ad60-f9782d15c7d1"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNDIy_3729cac5-484b-4dc2-8f5b-c13e9df5a0ff"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="if717a65f18fc419694b6890f52e4adce_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNDU0_ce905594-a7b1-48e4-bbc9-84b574dd2829"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i4535f30518454d34a9ae59f849dec461_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTg3NQ_6bdff4e9-a082-4861-a0b7-44655b8faf0d"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
      contextRef="i4efe104b447e4349b4028ad89097f7aa_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTk1OA_0a603446-9603-479b-b8a9-bd49115d8cf9"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="ic5e90128024045188206f3b663f58feb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83My9mcmFnOmZjYjk3ZGUzNzBkNzQ4NTViOTg1NWRlZGEyZmVjMTAwL3RleHRyZWdpb246ZmNiOTdkZTM3MGQ3NDg1NWI5ODU1ZGVkYTJmZWMxMDBfNTQ5NzU1ODE0MTE4Mg_90f26a72-96cf-4099-8afc-c7b910c23f64"
      unitRef="usd">-432000000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RleHRyZWdpb246ZmZhMDM2MmEyMTI1NDBjNDg0MmUzOWY3YmExZDZmMjBfMTEw_98cef055-3750-4b78-ac7c-6ffac13d5368">Earnings per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculated basic and diluted earnings per share (&#x201c;EPS&#x201d;) using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,850&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;891&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,844&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RleHRyZWdpb246ZmZhMDM2MmEyMTI1NDBjNDg0MmUzOWY3YmExZDZmMjBfMTMw_8c9ad253-baa9-43b6-8b71-6acf5930cab9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculated basic and diluted earnings per share (&#x201c;EPS&#x201d;) using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,850&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;891&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,844&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,809&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi0yLTEtMS0xMjkxMDk_e809c68b-0d9b-4b06-b411-4692730f623f"
      unitRef="usd">2850000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi00LTEtMS0xMjkxMDk_5ba08567-a9c7-4b59-973d-371ebddedf2c"
      unitRef="usd">3573000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi02LTEtMS0xMzEwMjg_4014b8ae-dbb9-43cb-bc73-6e4a7570d226"
      unitRef="usd">891000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMi04LTEtMS0xMzEwMjA_4f32e54a-91e1-4c8c-91a1-31b34e01f169"
      unitRef="usd">2149000000</us-gaap:NetIncomeLoss>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy0yLTEtMS0xMjkxMDk_ab10907b-8525-4afa-923f-5f3dc7df667a"
      unitRef="usd">6000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy00LTEtMS0xMjkxMDk_4fc82dbd-748a-4665-9971-77d63c672285"
      unitRef="usd">6000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy02LTEtMS0xMzEwMjg_28c063f0-0f60-4441-bc1d-264cbd6a7291"
      unitRef="usd">2000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfMy04LTEtMS0xMzEwMjA_a26bdba8-fba0-43fd-a82f-0d5e4162384c"
      unitRef="usd">3000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC0yLTEtMS0xMjkxMDk_6cb18ef9-097a-4977-9385-ab0b03d758cf"
      unitRef="usd">2844000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC0yLTEtMS0xMjkxMDk_6dbe8825-8fd3-4c67-9ae3-dbfeb2305d0c"
      unitRef="usd">2844000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC00LTEtMS0xMjkxMDk_3cd31bd7-f926-46cf-9aab-b06283c81afd"
      unitRef="usd">3567000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC00LTEtMS0xMjkxMDk_af81933c-9d1e-4ed8-bb61-30aa444c28eb"
      unitRef="usd">3567000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC02LTEtMS0xMjkxMDk_5fc3a25d-cec9-4666-a8ff-bb3d44a4afeb"
      unitRef="usd">889000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC02LTEtMS0xMjkxMDk_af443e1d-2522-4b70-b937-1b75069d9ee6"
      unitRef="usd">889000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC04LTEtMS0xMjkxMDk_e994b46d-90e2-4a43-9af1-17109bcb7567"
      unitRef="usd">2146000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfNC04LTEtMS0xMjkxMDk_fcc05ea4-7892-46b5-9d56-7e10c0155714"
      unitRef="usd">2146000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC0yLTEtMS0xMjkxMDk_05541967-ed32-4265-8610-57b1fe2c3a7e"
      unitRef="shares">1813000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC0yLTEtMS0xMjkxMDk_46a92b9d-cbfc-4426-9c48-01791c5a8363"
      unitRef="shares">1813000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC00LTEtMS0xMjkxMDk_125b923e-ee02-423c-8330-bef09a0f2cf8"
      unitRef="shares">1853000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC00LTEtMS0xMjkxMDk_e2f31f91-a928-43d5-a84b-9d685dcacb34"
      unitRef="shares">1853000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC02LTEtMS0xMzEwNDM_7c4cae34-51ad-4017-b971-2a16a3d3ad38"
      unitRef="shares">1809000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC02LTEtMS0xMzEwNDM_c2efb872-80ef-4a9f-b5f3-3f19c4238dfe"
      unitRef="shares">1809000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC04LTEtMS0xMzEwMzE_4d860d8d-f8c1-4d01-869f-3763ab2cdb37"
      unitRef="shares">1849000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83Ni9mcmFnOmZmYTAzNjJhMjEyNTQwYzQ4NDJlMzlmN2JhMWQ2ZjIwL3RhYmxlOjg0NTk0MThmOWIzODRhYTliODhhZmQyYWE0MzZlMTM5L3RhYmxlcmFuZ2U6ODQ1OTQxOGY5YjM4NGFhOWI4OGFmZDJhYTQzNmUxMzlfOC04LTEtMS0xMzEwMzE_cbb99522-8ecf-4d1b-9ebb-7986bae1b5f6"
      unitRef="shares">1849000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RleHRyZWdpb246ODdiMWE3ODFlNTU3NDc2OTkxNzIxOThmMDJlODdiZjlfNDI5_0efb38e5-d393-444b-a556-65d5d1fdb679">Other Comprehensive Earnings/Losses&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;746&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;585&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflects our share of ABI&#x2019;s currency translation adjustments and the impact of our designated net investment hedges related to our investment in ABI.  For further discussion of designated net investment hedges, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in net defined benefit plan costs.  For further details, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in (income) losses from equity investments.  For further information, see Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RleHRyZWdpb246ODdiMWE3ODFlNTU3NDc2OTkxNzIxOThmMDJlODdiZjlfNDE0_99e35399-39c5-47a9-b90f-6d6b64fd16af">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;689&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;694&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;643&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,962)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;746&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;750&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;585&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.939%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflects our share of ABI&#x2019;s currency translation adjustments and the impact of our designated net investment hedges related to our investment in ABI.  For further discussion of designated net investment hedges, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects the remeasurement impact of salaried retiree healthcare plan amendments.  For further discussion, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b1baef738ae429aa8454cd5df509063_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi0yLTEtMS0xMjkxMDk_edff70d1-8307-435f-9611-1cc95e391970"
      unitRef="usd">-1612000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b1ed807a4fe4443a7762e06a922c55b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi00LTEtMS0xMjkxMDk_6e116bde-a4e1-4143-bf36-2c1951bae669"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ebc102806994715ad16146f4c465135_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi02LTEtMS0xMjkxMDk_25f05285-bce6-493a-8bb8-260939ac872d"
      unitRef="usd">68000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a4f3a31983e4c2d9a6740fb5906beb2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMi04LTEtMS0xMjkxMDk_71e36b28-191d-45a0-965a-387f07d6c0ee"
      unitRef="usd">-3056000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC0yLTEtMS0xMjkxMDk_231dcafc-1495-47a5-94ec-e040b73a764b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC00LTEtMS0xMjkxMDk_9cd5285f-888c-4369-8b1d-fd6940cbd5cd"
      unitRef="usd">884000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC02LTEtMS0xMjkxMDk_3ec07156-5975-4c6c-81aa-81b5191a1cd0"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNC04LTEtMS0xMjkxMDk_ab30179b-c9c9-49ed-9763-cc475e11aef0"
      unitRef="usd">889000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS0yLTEtMS0xMjkxMDk_bc1706d8-959e-4e24-9268-19f2f54207c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS00LTEtMS0xMjkxMDk_78126e89-4866-4cd4-b7f5-088310e2d250"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS02LTEtMS0xMjkxMDk_d68c1853-fbd8-49fa-8ee9-4d728627ba1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNS04LTEtMS0xMjkxMDk_6e48e1f3-92b3-402c-a446-19ac382c525b"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi0yLTEtMS0xMjkxMDk_f00fa9f2-5fb7-415b-bbd4-76facb011096"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi00LTEtMS0xMjkxMDk_059df55d-ea03-4dc1-8168-c65157182be9"
      unitRef="usd">689000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi02LTEtMS0xMjkxMDk_821043b6-5170-4900-8d3a-cb26bf32169a"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfNi04LTEtMS0xMjkxMDk_fbd6b137-322b-460b-8e55-88f061a4c7cf"
      unitRef="usd">694000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC0yLTEtMS0xMjkxMDk_aa504d97-c6d0-4c84-83b0-2b74124d228a"
      unitRef="usd">-41000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC00LTEtMS0xMjkxMDk_41acb34b-dd86-4321-a3e3-8eb336c1beea"
      unitRef="usd">58000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC02LTEtMS0xMjkxMDk_7ccf3436-b6c9-490b-bab0-f0717294c73d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOC04LTEtMS0xMjkxMDk_e3765a8c-f661-4652-a158-f0cef3536c4b"
      unitRef="usd">17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS0yLTEtMS0xMjkxMDk_fead3952-b97b-4f60-908d-6cecb0ee888f"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS00LTEtMS0xMjkxMDk_d73e2c38-498b-458c-9da6-14d1a2c044da"
      unitRef="usd">12000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS02LTEtMS0xMjkxMDk_4e8e4cf3-1476-4a3d-bfe5-ed67435a6d0e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfOS04LTEtMS0xMjkxMDk_e79f47da-2d1a-467f-9c1b-c060036a31c8"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtMi0xLTEtMTI5MTA5_abfc6c36-5c0c-4fa4-b6fe-6919908d2547"
      unitRef="usd">-31000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtNC0xLTEtMTI5MTA5_70cfbfdd-0c21-49c2-ab8b-693e9737b5b4"
      unitRef="usd">46000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtNi0xLTEtMTI5MTA5_72ea0feb-df40-4bbb-b071-c446160f0de9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTAtOC0xLTEtMTI5MTA5_4f558a54-f9d1-44cb-9cac-605290ee1b11"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i808cea6937e147d9b9bc4300c62c5c54_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItMi0xLTEtMTI5MTA5_b0006bdd-7f1f-4d42-9a47-da76c8351ab4"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1cf5edbcc315413092ce864243a13bf0_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItNC0xLTEtMTI5MTA5_f4dce6aa-7000-48d5-97a4-1ef38523f249"
      unitRef="usd">643000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9833bbb09a0b496f80dc65ca5d100569_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItNi0xLTEtMTI5MTA5_6c10ede0-fde7-4f2b-8f76-0537884d7c44"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c4623758ac24693bda23a81b9dd7aaa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTItOC0xLTEtMTI5MTA5_2fd48bdd-9bfb-409c-a1eb-e7266e4ebc05"
      unitRef="usd">679000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee1450fe7da747d081507d7cea3a3f5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtMi0xLTEtMTI5MTA5_7191d2d1-5387-4397-8717-afa81e9939e9"
      unitRef="usd">-1581000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtNC0xLTEtMTI5MTA5_477c325d-e012-4c98-ae70-4abf6af241be"
      unitRef="usd">-869000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i566c0e2a3879453286eaf377b9a994cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtNi0xLTEtMTI5MTA5_0467e230-01f5-4a5c-b55c-bc9e39df72ce"
      unitRef="usd">73000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV83OS9mcmFnOjg3YjFhNzgxZTU1NzQ3Njk5MTcyMTk4ZjAyZTg3YmY5L3RhYmxlOmQwOGQ3MTMwOTA0NDQ5ZTZiNzEwNjAxZTE0NWEzZGI2L3RhYmxlcmFuZ2U6ZDA4ZDcxMzA5MDQ0NDllNmI3MTA2MDFlMTQ1YTNkYjZfMTQtOC0xLTEtMTI5MTA5_4a683ce1-5f39-4b14-b3aa-06b9b9072dd5"
      unitRef="usd">-2377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6749d38ea74544afbe22946f715804b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi0yLTEtMS0xMjkxMDk_a988428c-4061-466a-94cb-6e7a372010a1"
      unitRef="usd">-1597000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie13b50de35bf49209e674bd75e9e2e9f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi00LTEtMS0xMjkxMDk_e4458947-8605-4e1c-be8f-2836a79b4b87"
      unitRef="usd">-1434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3e9c5a285474dabbe7a8a197ec8c8a1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi02LTEtMS0xMjkxMDk_fc97d450-427f-4bf9-8695-99b207c22ba1"
      unitRef="usd">69000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfe9a7164df7460d90a1e1a4f996fcc0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMi04LTEtMS0xMjkxMDk_20bb3abd-5121-4687-8d95-1f8772cf3cbe"
      unitRef="usd">-2962000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC0yLTEtMS0xMjkxMDk_8f844411-d4b5-4ec0-b24e-65850b98e872"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC00LTEtMS0xMjkxMDk_59baf23c-ead1-44a3-96b8-1890796f8d0a"
      unitRef="usd">746000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC02LTEtMS0xMjkxMDk_1fce9dea-66fb-48a9-a358-1d46ccdb195c"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNC04LTEtMS0xMjkxMDk_fd0687e3-8b8c-46d1-9880-4532246c7bf6"
      unitRef="usd">750000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS0yLTEtMS0xMjkxMDk_1f61bb00-7733-4627-808a-555fe9fd15e7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS00LTEtMS0xMjkxMDk_18394f3b-3d69-4efb-9563-e61aa813388d"
      unitRef="usd">163000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS02LTEtMS0xMjkxMDk_be63496e-1c1d-4daa-9b7d-ee94d1c87dbf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNS04LTEtMS0xMjkxMDk_49ea9bd6-2e8b-4c42-b18c-c2a828afd1ed"
      unitRef="usd">163000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi0yLTEtMS0xMjkxMDk_f1c8a0bf-2606-4d95-ac3b-26b51d0d67d0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi00LTEtMS0xMjkxMDk_32e400ab-cd0e-427a-ad52-b8e758ada8c4"
      unitRef="usd">583000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi02LTEtMS0xMjkxMDk_22781cd3-9bc6-49b4-bc48-7cc98e763dc9"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfNi04LTEtMS0xMjkxMDk_68e22a98-2e21-49b6-bc5a-885305db84c5"
      unitRef="usd">587000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC0yLTEtMS0xMjkxMDk_e64aed0e-c01f-40c0-a0d1-287049b3c37e"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC00LTEtMS0xMjkxMDk_63ec287d-0edd-4f57-80d6-65f75b8d06e8"
      unitRef="usd">23000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC02LTEtMS0xMjkxMDk_c8bc0bb6-c89f-4637-9cde-b1354887a00d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOC04LTEtMS0xMjkxMDk_194eba94-96ca-472a-93ad-1fd36b5d1959"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS0yLTEtMS0xMjkxMDk_29842832-4849-457e-830a-dfc57d081c7f"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS00LTEtMS0xMjkxMDk_604648eb-cb23-45b5-a873-0bc8801f2bbd"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS02LTEtMS0xMjkxMDk_367e7613-63d1-4e0d-988c-23d10630bc8a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfOS04LTEtMS0xMjkxMDk_ea326dbc-8cf5-412b-a993-5dfc762b1051"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtMi0xLTEtMTI5MTA5_33151525-29cb-4f78-b339-35ceb05db44e"
      unitRef="usd">-16000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtNC0xLTEtMTI5MTA5_89aebae3-458e-46df-9851-033df870363c"
      unitRef="usd">18000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtNi0xLTEtMTI5MTA5_4d7b763a-8dca-4b6a-8e96-2ca631eeb6ac"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTAtOC0xLTEtMTI5MTA5_c7c74718-050f-4f85-9446-746140630cc0"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bb410f15a7e4de6bba15aa2f21eb97a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItMi0xLTEtMTI5MTA5_6f97a428-2d4f-4590-a552-7ff09533908a"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91101d4785604fc9a749636f25538235_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItNC0xLTEtMTI5MTA5_6152cc5a-f828-49d2-8cd9-c8166b39715a"
      unitRef="usd">565000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c83a931fc3445128dca896fc5996863_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItNi0xLTEtMTI5MTA5_c5ec471f-739a-47b1-8284-c3401043775f"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46947c74848d4152a49d1bb99f803439_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTItOC0xLTEtMTI5MTA5_fb84bd23-ba21-485c-9b5d-99fe41dff753"
      unitRef="usd">585000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee1450fe7da747d081507d7cea3a3f5a_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtMi0xLTEtMTI5MTA5_7c99ef32-3576-41c9-ad01-4a899e1a68fd"
      unitRef="usd">-1581000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i143710f5f0f745ef9ed6dfc07f7f4654_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtNC0xLTEtMTI5MTA5_2040d5a3-eafa-4740-9c65-7c4539453b4a"
      unitRef="usd">-869000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i566c0e2a3879453286eaf377b9a994cc_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtNi0xLTEtMTI5MTA5_3553b627-b0a1-4a94-bb20-c6cc42de2c56"
      unitRef="usd">73000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28d55e37787b4686ae6c2e1b9b9c5ed8_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84Mi9mcmFnOjExYzcyMGNjMjAzODQ2MTJhNWJiNWVjNmMwOTVhOTdmL3RhYmxlOmQ3ZDg4MWI5Njk2YzQ2MTQ4Zjc0NjE5ZGU2ZjE1ZDBhL3RhYmxlcmFuZ2U6ZDdkODgxYjk2OTZjNDYxNDhmNzQ2MTlkZTZmMTVkMGFfMTQtOC0xLTEtMTI5MTA5_dcf6957a-8469-4691-a14f-f05c6b50b8c7"
      unitRef="usd">-2377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2971e561fd5144678760d3bf8b1861d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi0yLTEtMS0xMjkxMDk_2aca5b44-146c-4975-90be-afb029509336"
      unitRef="usd">-2420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22f157089c764d978e4b4467c3bb28c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi00LTEtMS0xMjkxMDk_08d95986-921e-4dde-bb21-94d1a039e6b0"
      unitRef="usd">-1938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i512cc5d83afb4aa79f389b6fc7d146d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi02LTEtMS0xMjkxMDk_f2dfad1f-4904-4b28-8085-4327614eaa8f"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i43964e9db78c4442b2a6c1bae24600b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMi04LTEtMS0xMjkxMDk_b0485fb7-63d5-4d63-94aa-4a3a963b1c6f"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC0yLTEtMS0xMjkxMDk_d9306d74-e3c4-4896-be60-dc2b085f2587"
      unitRef="usd">432000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC00LTEtMS0xMjkxMDk_45bf3ce5-a487-4147-98dc-d44e6e5745d0"
      unitRef="usd">470000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC02LTEtMS0xMjkxMDk_1544eaa9-befa-4051-bbde-4df07477410a"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNC04LTEtMS0xMjkxMDk_2e43a5f0-aac1-48ee-b900-dfc61b04ecb6"
      unitRef="usd">931000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS0yLTEtMS0xMjkxMDk_3a6d21e1-9910-4674-900b-f215d356b905"
      unitRef="usd">109000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS00LTEtMS0xMjkxMDk_de7dae4e-780e-4a31-9df6-916a182fd218"
      unitRef="usd">103000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS02LTEtMS0xMjkxMDk_adc3ec8e-1648-4d00-a26a-8393a4e12a6a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNS04LTEtMS0xMjkxMDk_a0a61e32-4f66-47a6-a1a5-7ad2322bae7f"
      unitRef="usd">212000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi0yLTEtMS0xMjkxMDk_e3b9a5fa-db6c-42e6-8261-b9a5dfbf9f2f"
      unitRef="usd">323000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi00LTEtMS0xMjkxMDk_effe297f-b9ea-45e0-a460-326cbadbb443"
      unitRef="usd">367000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi02LTEtMS0xMjkxMDk_14a5ab4a-90c8-4b1b-b87e-4bc9b8821f89"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfNi04LTEtMS0xMjkxMDk_2c8aa587-ba98-4dd8-8009-e2dbdb029065"
      unitRef="usd">719000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC0yLTEtMS0xMjkxMDk_8553cf7f-b563-46cb-b6ca-44b531f14e5c"
      unitRef="usd">-72000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC00LTEtMS0xMjkxMDk_295225e7-f309-4743-9b80-1b4e5b74db31"
      unitRef="usd">42000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC02LTEtMS0xMjkxMDk_9089ad6f-4770-45db-b3df-b4ad193f5e08"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOC04LTEtMS0xMjkxMDk_7ad49184-1e74-46b9-b8cc-63ab0739446c"
      unitRef="usd">-29000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS0yLTEtMS0xMjkxMDk_a83a331c-f5aa-47bf-87c8-0b6c5cccca96"
      unitRef="usd">-18000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS00LTEtMS0xMjkxMDk_980699cb-6d91-4c6a-b7c8-db6a7028556d"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS02LTEtMS0xMjkxMDk_46f2668d-660f-41c8-b2ea-b24bb185454e"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfOS04LTEtMS0xMjkxMDk_2d42dfb2-ee77-4a4d-ab8e-482cce76b905"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtMi0xLTEtMTI5MTA5_a8e5b4a6-da74-4b24-af26-06697e03ef37"
      unitRef="usd">-54000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtNC0xLTEtMTI5MTA5_a6b4ffda-585f-4fd3-b730-f6404d3889a5"
      unitRef="usd">33000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtNi0xLTEtMTI5MTA5_d6f2ceba-98e3-40b7-ae60-1c76b23613b0"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTAtOC0xLTEtMTI5MTA5_16dd9862-1fb9-4e75-8bb7-a32901165431"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibdaa73bbc58d43549c6e7ee88f4eecd9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItMi0xLTEtMTI5MTA5_767a78d9-bb3b-4aea-b257-cbf18fc5f682"
      unitRef="usd">377000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b2cec5611fc406cb6396419816a7727_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItNC0xLTEtMTI5MTA5_135fd01f-82b6-4dbb-b12e-95027d6e9355"
      unitRef="usd">334000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibffd50eb6e0e49989f6483e9b19f9736_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItNi0xLTEtMTI5MTA5_a4a9172f-70cb-40f2-bd37-958142845a3b"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d6d015493ac4c41a4e7993b116ac0fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTItOC0xLTEtMTI5MTA5_e7dc952c-dea9-41f5-b7ee-8ceb79d9ead4"
      unitRef="usd">739000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd280e0972524a94a5802c10e628c014_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtMi0xLTEtMTI5MTA5_c385d334-8b34-4920-9f31-cd5e8b59a133"
      unitRef="usd">-2043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1ef05e22327463983a5721739547724_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtNC0xLTEtMTI5MTA5_e1ed6a09-c10f-43f9-9710-bb343cfbad7a"
      unitRef="usd">-1604000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtNi0xLTEtMTI5MTA5_7bf2e011-1fb6-47f2-ba5f-f1aa33f2dfdd"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84NS9mcmFnOmYyNzRjNWJkYjdlMzQxYTNiZjgxMzA3NGJmYzA0YmI0L3RhYmxlOjZhMjhmMjE0YTBjNTRhMmRhOWQwNjc2YTJlNjhjYmJlL3RhYmxlcmFuZ2U6NmEyOGYyMTRhMGM1NGEyZGE5ZDA2NzZhMmU2OGNiYmVfMTQtOC0xLTEtMTI5MTA5_1499912b-5d85-4d7a-aefb-0f83a9cdf20e"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i93682eae4e1b4cba8a7db027c701e88b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi0yLTEtMS0xMjkxMDk_646f9f65-efca-4faa-8654-9a51c799d631"
      unitRef="usd">-2392000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42bddaa56c404c9383c99f3a0b6c9eab_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi00LTEtMS0xMjkxMDk_fab92e0c-4cd3-48a5-9a2a-46f2a92df155"
      unitRef="usd">-1421000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7ce748f70124616bdcdd3de3090c9e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi02LTEtMS0xMjkxMDk_171067cf-b261-40f6-9b60-9e4ad525f17a"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9788f29297284a1d88ff1e6c6548cad3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMi04LTEtMS0xMjkxMDk_b99a8634-bbe9-42cb-8ae5-2ceef3c18a3c"
      unitRef="usd">-3774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC0yLTEtMS0xMjkxMDk_b27d8f8a-d43d-41eb-914d-27a69f45c969"
      unitRef="usd">432000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC00LTEtMS0xMjkxMDk_6c3d5832-5f94-4529-b75f-0efd2e920e43"
      unitRef="usd">-220000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC02LTEtMS0xMjkxMDk_8d9537f8-1985-49a2-b5a8-7c9d05122d7f"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNC04LTEtMS0xMjkxMDk_50fe6a24-e526-4a8d-9a1c-96eb60e332e8"
      unitRef="usd">219000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS0yLTEtMS0xMjkxMDk_18a75051-aa52-4015-8c3c-2e101980cfd3"
      unitRef="usd">109000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS00LTEtMS0xMjkxMDk_51ab6b49-14c0-4a80-afdf-3b1c21b5c4e9"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS02LTEtMS0xMjkxMDk_6d9ec10b-afc0-4ece-a9ad-33710d38ca58"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNS04LTEtMS0xMjkxMDk_ce56dde4-2ce8-4c3c-9754-6838319e90af"
      unitRef="usd">61000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi0yLTEtMS0xMjkxMDk_02aa1ff9-26a0-4c41-af56-2e2501027a78"
      unitRef="usd">323000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi00LTEtMS0xMjkxMDk_519f8f15-f22c-42c9-b6c8-e5f5f89bbe16"
      unitRef="usd">-172000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi02LTEtMS0xMjkxMDk_b649ebbe-e8cb-4aa0-b98d-52985f0b47e3"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfNi04LTEtMS0xMjkxMDk_a657a0dc-72b3-44b0-aa8b-9910ac82509e"
      unitRef="usd">158000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC0yLTEtMS0xMjkxMDk_d940f5a6-4990-407a-9e2b-bb81faa35df8"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC00LTEtMS0xMjkxMDk_75c0f977-42c9-4555-a027-2ff8c4ce1139"
      unitRef="usd">14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC02LTEtMS0xMjkxMDk_6c9688f6-531c-4171-a2ed-b29d38c108dc"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOC04LTEtMS0xMjkxMDk_1d1d001e-8106-444e-8572-47aa74044964"
      unitRef="usd">-19000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS0yLTEtMS0xMjkxMDk_e194f004-29d0-49f3-8613-dd0a46f8c867"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS00LTEtMS0xMjkxMDk_6dbd5d78-29d5-4ae2-b98d-0025b1d23b90"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS02LTEtMS0xMjkxMDk_2cbbcd26-6cf0-4331-b4c2-f0d992b9b671"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfOS04LTEtMS0xMjkxMDk_ca48ade5-1409-41dc-b08d-03500ca5554e"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtMi0xLTEtMTI5MTA5_71c0936c-271e-4b95-8189-d1e92dd58a67"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtNC0xLTEtMTI5MTA5_50c3a290-8540-46a8-ba58-e5b21082e902"
      unitRef="usd">11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtNi0xLTEtMTI5MTA5_41518cd1-8bcf-4bfb-bb44-c64d6c0a29e6"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTAtOC0xLTEtMTI5MTA5_98ea53ab-bf74-4e4d-8239-3e5ebbfb0880"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icec1267d474e4789a588d1c86899f643_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItMi0xLTEtMTI5MTA5_cf224ce9-7473-4c6f-86e0-7e71ffe662d9"
      unitRef="usd">349000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7be67789e30248eb8a8984743067eb42_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItNC0xLTEtMTI5MTA5_3115d69b-f017-4056-aac1-63ec9f0bfb03"
      unitRef="usd">-183000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia555cb670ba64197b37e75bae3f7dd2f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItNi0xLTEtMTI5MTA5_3beb7376-d6d3-425f-8c0b-b31fd59955bc"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if4e5356c990d4784a27d514236852917_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTItOC0xLTEtMTI5MTA5_3b3f8ddd-8db1-4bee-80b7-8257693302b0"
      unitRef="usd">172000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd280e0972524a94a5802c10e628c014_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtMi0xLTEtMTI5MTA5_3c19cc4c-bab5-40e2-a347-612627a2a15a"
      unitRef="usd">-2043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1ef05e22327463983a5721739547724_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtNC0xLTEtMTI5MTA5_41c0b69b-c5d8-41d5-8119-c90dcc51f25a"
      unitRef="usd">-1604000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i977d4a5b65c74e91b337b9be22e3a8cd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtNi0xLTEtMTI5MTA5_64e866ea-8c5a-409b-9964-4dca9654ae96"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9132d76bdc6b46ce939091d328d35fee_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV84OC9mcmFnOmFkMTFlOGIwMDJlYTQ4YzA5OWQzZWViZGIxY2EyMDVkL3RhYmxlOmM2NDhhNGM2ZTBmYjRiZjRhYTE5ZDVmYTNhMmE3MjBjL3RhYmxlcmFuZ2U6YzY0OGE0YzZlMGZiNGJmNGFhMTlkNWZhM2EyYTcyMGNfMTQtOC0xLTEtMTI5MTA5_245aaae0-59d1-4e34-b389-8a6015b7344d"
      unitRef="usd">-3602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RleHRyZWdpb246ZTA0MjExM2IyYzEzNDc4ZjhhYTk4Y2EzNzYzZDdlYzBfNDAx_0dce4e0e-cbcc-488f-8f35-b10cbe48555b">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in net defined benefit plan costs.  For further details, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts are included in (income) losses from equity investments.  For further information, see Note 3. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="if5fde125fe824d80b32071a2130ef0fe_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy0yLTEtMS0xMjkxMDk_ce0d7065-1f46-479f-a386-c17e458a8a43"
      unitRef="usd">61000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i2d6d19ffeee64ff1b5584b7c5aabb4bd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy00LTEtMS0xMjkxMDk_10aca4ba-9690-4f20-9035-4588775fd7d9"
      unitRef="usd">85000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i8b25cddbc4ed4d17a6a79d919abc4d22_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy02LTEtMS0xMzI4NDc_fe20c8aa-c4fb-4d56-87a6-5fe4778ef99a"
      unitRef="usd">30000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i4b4810d1ceab46dfb83be9f80e3e4aab_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfMy04LTEtMS0xMzI1NjM_f7678d61-fd54-4ca5-9c95-8bbb81fa7f18"
      unitRef="usd">42000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i51fed6551e784a959a8fd96ee3dd8391_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC0yLTEtMS0xMjkxMDk_6034da20-79a4-4d42-953a-a6ff0c1009c9"
      unitRef="usd">-20000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i4de3b3f3b48d41c4ad4828796b656496_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC00LTEtMS0xMjkxMDk_660470d3-7cde-4bd9-9f46-dd4360f4dbee"
      unitRef="usd">-13000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i2725c640d5cc48fb9a0ce5d1941b72e6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC02LTEtMS0xMzI4NDk_854f30a5-f42a-48ef-9735-c01445cd0996"
      unitRef="usd">-10000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="icef447b72ac047088d37bbe5edc817f9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNC04LTEtMS0xMzI1NjM_1011c071-eeed-4512-8b49-85fc92bbb303"
      unitRef="usd">-8000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ice90d1e8bfe848d8b5e0d085479ebb80_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS0yLTEtMS0xMjkxMDk_6462da0d-9493-4b5f-af05-882535498dff"
      unitRef="usd">41000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i806001e09fa14faaae11598091f1f498_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS00LTEtMS0xMjkxMDk_4543b3ea-c482-46be-a3b5-e9a668e05ce7"
      unitRef="usd">72000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i55511d6e0eb14ca08f381602cf9690cd_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS02LTEtMS0xMjkxMDk_b9e5526c-a896-4e8c-a117-9697ea666503"
      unitRef="usd">20000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i66543092e0e046ca8c1b86aca084bfe7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNS04LTEtMS0xMjkxMDk_5a86b993-e60d-43e1-988f-dca1f871f98f"
      unitRef="usd">34000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib96273d2e0d845948f345d07e913c368_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi0yLTEtMS0xMjkxMDk_03ca648d-c736-47d1-a0e3-6e0a6fde450b"
      unitRef="usd">58000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8779bb1a61dd4789bc38ae36caf3dafe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi00LTEtMS0xMjkxMDk_d22ff1b8-af23-4b06-9d71-093e42b6acd1"
      unitRef="usd">42000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4009a312b9e9481c9ed1f1d8e29d8f11_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi02LTEtMS0xMzI4NTM_5167ca1d-0860-4e74-9b37-14452a4c4d8c"
      unitRef="usd">23000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie2b530e082794b12975168c91979ce08_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNi04LTEtMS0xMzI1NjY_9a56654b-5c11-4657-a4c8-bb399d52241b"
      unitRef="usd">14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i429b6c1211f54752a9fbc0980c7003cc_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy0yLTEtMS0xMjkxMDk_87a40793-9886-43df-b309-fe08bc67ebdc"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibd9b9f4a38e840c984bc661555d3412d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy00LTEtMS0xMjkxMDk_2c71ff7a-384a-4e48-bacf-47b8f5444953"
      unitRef="usd">1000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1b6d5238a8934a91b23047ee5dc570e6_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy02LTEtMS0xMjkxMDk_86177a2e-7784-4ca6-be5c-0c980b47ea76"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i48d2ec74dc3743e885b697dfef6ecf65_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfNy04LTEtMS0xMzI1NzQ_c701faa8-6682-4322-a6a5-af4032501722"
      unitRef="usd">1000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="ic8e01747e65a4c47874b561f5f5591d9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC0yLTEtMS0xMjkxMDk_c3ff0ff6-0617-48d2-9ab5-f63106fa4204"
      unitRef="usd">17000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if9467a64aae949aa85d911d37de5f523_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC00LTEtMS0xMjkxMDk_6faa218a-71e2-4177-8839-ef2aa2b7a4b4"
      unitRef="usd">-29000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic32394b7c33e4adaa729d30f5b7f8492_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC02LTEtMS0xMjkxMDk_5c5819ca-bc9a-4694-b473-cbcef77f87d4"
      unitRef="usd">3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife875847779a4eb0971d8c1bba755f05_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85MS9mcmFnOmUwNDIxMTNiMmMxMzQ3OGY4YWE5OGNhMzc2M2Q3ZWMwL3RhYmxlOjU4N2U5ODhhYTNmNjRhMTQ5NTE3ZTk0NWM1OGFlNDY1L3RhYmxlcmFuZ2U6NTg3ZTk4OGFhM2Y2NGExNDk1MTdlOTQ1YzU4YWU0NjVfOC04LTEtMS0xMjkxMDk_6c453547-5721-4844-b10f-407241af0bec"
      unitRef="usd">-19000000</us-gaap:ProfitLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjkxOA_0cb0a772-3c74-490f-8de3-80ed3e2e5031">Segment Reporting&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constitute our reportable segments of smokeable products and oral tobacco products at June&#160;30, 2022.  The financial services and the innovative tobacco products businesses, which include the heated tobacco business and Helix ROW, are included in all other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our chief operating decision maker (&#x201c;CODM&#x201d;) reviews operating companies income (loss) (&#x201c;OCI&#x201d;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit income/cost, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings before Income Taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;837&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;561&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The comparability of OCI for our reportable segments was affected by the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Non-Participating Manufacturer (&#x201c;NPM&#x201d;) Adjustment Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We recorded pre-tax income for NPM adjustment items of $60 million and $32 million for the six months ended June 30, 2022 and 2021, respectively, in our smokeable products segment.  We recorded these items in cost of sales in our condensed consolidated statements of earnings.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#x201c;NPM Adjustment Items&#x201d; and are more fully described in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in Note 11. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Tobacco and Health and Certain Other Litigation Items:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the amounts shown in the table above for the smokeable products segment in marketing, administration and research costs in our condensed consolidated statements of earnings.  For further discussion, see Note 11. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Acquisition-Related Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We recorded pre-tax acquisition-related costs of $37 million for the six months ended June 30, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on!&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; transaction.  We included these costs in marketing, administration and research costs in our condensed consolidated statements of earnings.&lt;/span&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjkwOA_1712d3e2-a15c-4345-811b-0891a3267979">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.476%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,873&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings before Income Taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;837&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;561&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,263&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,605&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy0yLTEtMS0xMjkxMDk_d87c716e-0031-4f85-9d19-c3f05bec9392"
      unitRef="usd">11138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy00LTEtMS0xMjkxMDk_a03d22f9-6c92-4412-8831-62e8561ea6fa"
      unitRef="usd">11300000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy02LTEtMS0xMzM0NDQ_f4656f73-ab72-400a-8c39-15e13adabf32"
      unitRef="usd">5873000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if54b43a0052a4188ada7399179966cb3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMy04LTEtMS0xMzM0NDQ_89283c30-a5fe-457d-b42f-ef388645907f"
      unitRef="usd">6050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87386dcee92742288df164bf8606efee_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC0yLTEtMS0xMjkxMDk_84d13989-6838-4831-ae31-88af7afd68a4"
      unitRef="usd">1278000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC00LTEtMS0xMjkxMDk_e581c3c0-0b7b-4751-94b2-91547b664e5c"
      unitRef="usd">1319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e3820406df4495e896788d13764aafd_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC02LTEtMS0xMzM0NTA_c1cd6138-61cd-4fe6-87e3-f1d4d1363da8"
      unitRef="usd">665000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9f07419638445eab9c375777cf6a504_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNC04LTEtMS0xMzM0NTA_ef944956-4336-4f19-b183-3aea676ee173"
      unitRef="usd">693000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS0yLTEtMS0xMjkxMDk_ce2d6ddd-7b51-4aac-946e-23d649b65359"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide49c713466f480384f5feb6704320bf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS00LTEtMS0xMjkxMDk_5cac7ab2-a4c2-4cef-a875-14f5fc55fbdf"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS02LTEtMS0xMzM0NTY_7ed84fdb-e190-428d-97ee-b11e2bcb7280"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNS04LTEtMS0xMzM0NTY_133ddb28-bf17-49b9-8b76-38941f58d02c"
      unitRef="usd">167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi0yLTEtMS0xMjkxMDk_413a4022-f655-4790-b41b-1c382fd9def5"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi00LTEtMS0xMjkxMDk_d0b23348-8c49-4adf-b3fd-ac6c216f7243"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi02LTEtMS0xMzM0Njc_c39ad909-75b7-4887-80b9-a08f4f4aad97"
      unitRef="usd">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNi04LTEtMS0xMzM0NjM_fc9ed766-8718-4dcb-99f9-2187822d615f"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy0yLTEtMS0xMjkxMDk_af0f1cf4-11ab-454e-bb3a-85dcd8ebcc09"
      unitRef="usd">12435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy00LTEtMS0xMjkxMDk_8643b4bc-498c-4a55-8a61-09d054b2054d"
      unitRef="usd">12972000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy02LTEtMS0xMjkxMDk_28c554f7-3e9c-4a14-bec5-df1d44dba386"
      unitRef="usd">6543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfNy04LTEtMS0xMjkxMDk_3897c0e2-baaa-43c1-bb25-2097e6c67460"
      unitRef="usd">6936000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="iccb27f10a3b9495ca3c9fc34df868dac_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtMi0xLTEtMTI5MTA5_535740f8-ed9f-4a1e-8ba2-31fc5e6d46f5"
      unitRef="usd">5321000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i9b8ef7f27eda4404924a745fc9136f70_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtNC0xLTEtMTI5MTA5_e4cc5f0a-de9f-4187-8a49-16e8a28a3ceb"
      unitRef="usd">5148000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="icc496503d8eb423a9c0790379753eb4a_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtNi0xLTEtMTMzNDQ3_3c63523d-5ad5-49fb-ae4b-fef5ad28adfe"
      unitRef="usd">2762000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="if54b43a0052a4188ada7399179966cb3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTAtOC0xLTEtMTMzNDQ3_802ac820-7d08-455d-b342-588a6f361b0b"
      unitRef="usd">2776000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i87386dcee92742288df164bf8606efee_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtMi0xLTEtMTI5MTA5_9d7e9060-0db5-465b-af5e-c36cc1d3eb8e"
      unitRef="usd">837000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtNC0xLTEtMTI5MTA5_42391841-e366-42a4-8ab7-58fea23abec6"
      unitRef="usd">864000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i9e3820406df4495e896788d13764aafd_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtNi0xLTEtMTMzNDUz_bc8dadf0-9a9a-4ed1-9458-90dffb5f735f"
      unitRef="usd">430000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ia9f07419638445eab9c375777cf6a504_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTEtOC0xLTEtMTMzNDUz_b2d940d3-85de-4ec7-be16-c4d835391d98"
      unitRef="usd">472000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ifb694e45217541298e1344b0cc7ec4c7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItMi0xLTEtMTI5MTA5_248af0b6-72af-4a78-ad16-c51010b933b6"
      unitRef="usd">0</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="ide49c713466f480384f5feb6704320bf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItNC0xLTEtMTI5MTA5_28fe0759-9087-4238-8a51-dd8a960d0ade"
      unitRef="usd">45000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i1af418e74f5e492cb0fbd7f433c45167_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItNi0xLTEtMTMzNDU5_16dd6b17-7ad3-4bb5-8987-375280c406e9"
      unitRef="usd">0</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i6efb2408408b400eb923c0885002eeb6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTItOC0xLTEtMTMzNDU5_c7b18017-c0a8-47c4-bf6e-61fc5361516d"
      unitRef="usd">27000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i7012a01e581642eaa7c2d703e543e4e4_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtMi0xLTEtMTI5MTA5_2d4d6fa4-ac74-45a3-94c1-734ce4221350"
      unitRef="usd">-20000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i580d5042833e4c6eb280bf9dda9f759a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtNC0xLTEtMTI5MTA5_6bb5fe0e-5a55-4f51-aab9-cd685c16dc0f"
      unitRef="usd">-26000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="if9cab249e5aa4d258a6184bc3a809f6e_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtNi0xLTEtMTMzNDc1_89872a75-1be4-41f6-af9e-5b159d10c906"
      unitRef="usd">-15000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles
      contextRef="i56d95b2d2a4a421ba23c61e92429847d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTMtOC0xLTEtMTMzNDcy_36186a45-6a6f-49b4-8d43-b2ecbddde120"
      unitRef="usd">-12000000</mo:OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if6597a9719154f9bbebe60e2abbfae97_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtMi0xLTEtMTI5MTA5_173192ad-2a76-4cf1-bf47-197a036f769e"
      unitRef="usd">35000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia10ee74830654452a7f2606b4d8c93b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtNC0xLTEtMTI5MTA5_a6f5dda7-2107-4c86-bbd2-a0277b9e1949"
      unitRef="usd">35000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i78c606bc0ba64901873c5992d4eff20d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtNi0xLTEtMTMzNDkw_0fb8a5e6-741d-43d1-85f0-084c739db4bc"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibfc2a0eede234b6486bae3fec8149242_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTQtOC0xLTEtMTMzNDgy_47527d96-5a13-4cc0-9cd2-1668aa01caf5"
      unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8be97c192668455c8b81cd42aa504ee4_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtMi0xLTEtMTI5MTA5_3e5c0a11-33ac-4807-97e8-6c807d4393b4"
      unitRef="usd">114000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i93ba44bf6fce4bd5974e74d3b133117d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtNC0xLTEtMTI5MTA5_b855744d-4b9c-4585-8464-5848a357472e"
      unitRef="usd">120000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0f65ccbdc8ff41efb0c6806847d43860_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtNi0xLTEtMTMzNDkw_24284b9d-2db1-4fb2-a01e-7fca5c1b3569"
      unitRef="usd">54000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i3a8a884562fd49f18dfd6aeeb09a20a8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTUtOC0xLTEtMTMzNDgy_3e8ab264-d3b4-4920-9ec9-ae7ad153dcae"
      unitRef="usd">59000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctMi0xLTEtMTI5MTA5_8c8d6abc-b827-4c83-b435-4603d5611878"
      unitRef="usd">5989000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctNC0xLTEtMTI5MTA5_d42f9e53-03c2-42fc-8430-309b85951cc2"
      unitRef="usd">5876000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctNi0xLTEtMTI5MTA5_2c125ffb-e64e-452c-aa9f-6d5323c5ac47"
      unitRef="usd">3105000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTctOC0xLTEtMTI5MTA5_20c19c89-6704-4bc8-9919-c50931e1d03d"
      unitRef="usd">3186000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtMi0xLTEtMTI5MTA5_8c0c1b7e-da6f-43c6-807c-a820bd3950f5"
      unitRef="usd">-561000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtNC0xLTEtMTI5MTA5_816d4873-fc8b-42f6-8cf3-a2b6f13e2c31"
      unitRef="usd">-603000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtNi0xLTEtMTMzNTIw_6a682dfc-c2c6-40e7-ad72-7ac3748ba0b9"
      unitRef="usd">-280000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTgtOC0xLTEtMTMzNTAw_93817cbe-868a-4a31-9796-41f5718466a5"
      unitRef="usd">-295000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktMi0xLTEtMTQ2MjYz_0ffe0f35-9836-4e62-8bfa-90e7e72c82e7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNC0xLTEtMTQ2MjYz_02720d3a-856f-411f-b617-8f1b1b1b3304"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNi0xLTEtMTQ2MjYz_220a44cc-df6e-4393-833a-ed41be3fffa8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktOC0xLTEtMTQ2MjYz_7dff7384-0137-4c05-82ec-bdaf88d0de9b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktMi0xLTEtMTI5MTA5_9618708e-364d-4747-a4e7-43b26db252ee"
      unitRef="usd">-93000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNC0xLTEtMTI5MTA5_3e0b07bc-e905-4d1b-af99-859c1e9a32de"
      unitRef="usd">-89000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktNi0xLTEtMTMzNTE3_351b5a20-ac20-4885-ba74-f067582e9cc9"
      unitRef="usd">-47000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMTktOC0xLTEtMTMzNDk3_425df93d-bd18-43bb-8bdb-d7ea744fce15"
      unitRef="usd">-46000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtMi0xLTEtMTI5MTA5_67749fec-2554-4b4a-80c2-3da94bb3ca95"
      unitRef="usd">-1229000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtNC0xLTEtMTI5MTA5_29d3edfb-a743-4d23-a953-473f4fe799ee"
      unitRef="usd">126000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtNi0xLTEtMTMzNTE0_fa499363-0e32-4244-85fc-93480a45644b"
      unitRef="usd">-1263000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjEtOC0xLTEtMTMzNTAz_a3490d89-fc01-414b-8c52-7cd710642d07"
      unitRef="usd">75000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtMi0xLTEtMTI5MTA5_124d19ec-c22a-48ac-9773-76446a5a398c"
      unitRef="usd">-14000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtNC0xLTEtMTI5MTA5_534dfb72-ae4c-4ce2-bfe9-f10c8b91ae37"
      unitRef="usd">7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtNi0xLTEtMTMzNTEx_701a3cdb-2c25-4593-8bc7-46f8beb049c0"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjMtOC0xLTEtMTMzNTA2_68cf8a06-56bd-4515-a286-449a213347e5"
      unitRef="usd">-103000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtMi0xLTEtMTI5MTA5_7f178b03-3721-4eee-ba61-c14444db5686"
      unitRef="usd">4278000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtNC0xLTEtMTI5MTA5_05057912-aa81-49c6-9af6-1790e9227211"
      unitRef="usd">4846000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtNi0xLTEtMTI5MTA5_29fbfd61-d5c5-4e1a-9a22-2a072c728159"
      unitRef="usd">1605000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjcyM2ViMDYzZTVlZTRkODBiOWRmMjliOWY5Mjg5OWI4L3RhYmxlcmFuZ2U6NzIzZWIwNjNlNWVlNGQ4MGI5ZGYyOWI5ZjkyODk5YjhfMjQtOC0xLTEtMTI5MTA5_60c1b6c0-f4c4-409e-99eb-2eb122bdea31"
      unitRef="usd">2909000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i0c63006a91f04aa0a97e0e25d1afb998_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfNTQ5NzU1ODE0NDI4Mw_7eb39f5e-c96a-474f-85ee-71bf18529e2d"
      unitRef="usd">60000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic6a9924f43b44980bdeea6e55ddeab2a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMTYzMw_0efbc9dc-4672-4f65-af47-5bc2480004eb"
      unitRef="usd">32000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <mo:ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfNDk0NzgwMjMyOTgxNg_561fe959-3648-4bc0-97e7-b733e425efc3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</mo:ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9d6bc7e58db8428ebf31c693b4236ea7_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi0yLTEtMS0xMzM0MzU_89e2f2bc-1b9c-4723-a511-3ab17dc85e00"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i46db2dd0967c4895b93fb83754d195c0_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi00LTEtMS0xMzM0MjM_5d4b3409-ffe4-4d1d-877a-8403274e0774"
      unitRef="usd">43000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ife349d051cc74966a11492b5681f511d_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi02LTEtMS0xMzM0Mzg_e780031c-f797-4966-af6a-8fc1161aa7b6"
      unitRef="usd">38000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ieedfff3a9a3247c9bb3467f1b57505f3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMi04LTEtMS0xMzM0Mjg_53cb31bd-d018-4e25-908a-d6bc44aeac21"
      unitRef="usd">8000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i10790d601d0144df92ffc1eee752bd0d_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy0yLTEtMS0xNDU3NTM_3b74cb5c-fe6b-4cd6-afaf-aa640e6a99ce"
      unitRef="usd">7000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i51aba496809142e593bb1b943f268798_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy00LTEtMS0xNDk3NjQ_449cb735-2261-4c64-af58-74df3b9c77e6"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ia9269c502f174ba7b95d543c1fe32410_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy02LTEtMS0xNDU3Mzg_7608a63d-08a7-4e1e-87d0-ea7d5916f35c"
      unitRef="usd">7000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5096748718454223a3a223a6cfd489a3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy04LTEtMS0xNDk3NjQ_b9674177-a563-46ca-925b-916d4ab227f3"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ie43f576a9e9d4820aedbcd69fd64f322_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy0yLTEtMS0xNDExNDc_bb15d91b-b5a9-4387-bfe1-4641034b50c4"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="idcd2f0a9c69f413b81668b9456672a69_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy00LTEtMS0xNDExNzI_f16ec07b-d91e-40b0-9b0b-ee5c4a97e1dd"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i844eb97024c84e86b793fb4669de42da_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy02LTEtMS0xNDExNTA_0a1e59a5-b79e-4a7b-87e8-db627607b204"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i03d1c6700b304008a01681c4c742502b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfMy04LTEtMS0xNDExNTg_f88fd4f3-1180-47f9-bfec-a384ca1d4980"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i28febc0f256b49e2a19127bac1eefd4f_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC0yLTEtMS0xNDEyNjg_4f859c54-7a43-4c99-b1e2-4cbc0b2bae27"
      unitRef="usd">58000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9e8b966e2d51497780ea70bf9d0c4b17_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC00LTEtMS0xNDEyODc_aec4721e-afe3-42f3-9a64-820e2bd3b51a"
      unitRef="usd">43000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i90b9e0213b45474dab5f5de82137fd03_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC02LTEtMS0xNDEyOTA_daaeb7ab-3817-4b85-bf5a-83beedbadc69"
      unitRef="usd">46000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iad51ca79f2ce481bb8b8ba1aea9c8bfc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RhYmxlOjkzMGJjNmFlZWQxZjRlNjc5NGIxYzAwMTAzMmJmOTM2L3RhYmxlcmFuZ2U6OTMwYmM2YWVlZDFmNGU2Nzk0YjFjMDAxMDMyYmY5MzZfNC04LTEtMS0xNDEyOTI_a387515e-4de8-47c2-93cb-8131e52b445f"
      unitRef="usd">8000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ieccd2d6f4dd14fa390abcaff005b10fe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV85NC9mcmFnOjQzOTY1ZTQ0N2U0YjQ0ZjY4OWUxNTcwZTY4YzFhZWM1L3RleHRyZWdpb246NDM5NjVlNDQ3ZTRiNDRmNjg5ZTE1NzBlNjhjMWFlYzVfMjYwMw_71a095e1-74cb-4ec5-9b54-86f193e3adb1"
      unitRef="usd">37000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NjE_aff4a8d4-ea88-4920-9c1a-b89d82444c28">Debt&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Short-term Borrowings and Borrowing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and December&#160;31, 2021, we had no short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a senior unsecured 5-year revolving credit agreement (as amended, the &#x201c;Credit Agreement&#x201d;) that provides for borrowings up to an aggregate principal amount of $3.0 billion.  The Credit Agreement, which is used for general corporate purposes, expires on August 1, 2024 and includes an option, subject to certain conditions, for us to extend the expiration date for an additional one-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), or a fallback benchmark rate determined based on prevailing market convention, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#x2019;s Investors Service, Inc. (&#x201c;Moody&#x2019;s&#x201d;) and Standard&#160;&amp;amp; Poor&#x2019;s Financial Services LLC (&#x201c;S&amp;amp;P&#x201d;).  The applicable percentage for borrowings under the Credit Agreement at June&#160;30, 2022 was 1.0% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At June&#160;30, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 10.7 to 1.0.  At June&#160;30, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#x201c;Consolidated EBITDA&#x201d; and &#x201c;Consolidated Interest Expense,&#x201d; each as defined in the Credit Agreement, include certain adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying value of our total long-term debt at June&#160;30, 2022 and December&#160;31, 2021 was $27.7 billion and $28.0 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, we issued long-term senior unsecured notes in the aggregate principal amount of $5.5 billion.  We used the net proceeds from these notes (i) to fund the purchase and redemption of certain unsecured notes and payment of related fees and expenses, as described below, and (ii) for other general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $4,042 million and also redeemed all of our outstanding 3.490% notes due 2022 in an aggregate principal amount of $1.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of unamortized debt discounts and debt issuance costs of $26 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2022 and December&#160;31, 2021, accrued interest on long-term debt of $376 million and $429 million, respectively, was included in other accrued liabilities on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzg0_63746755-a066-43f8-ada4-da379e7c0d64"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzg0_d1348cbf-3760-40d2-8718-24949792e8a9"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentTerm
      contextRef="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NjI_dd2b0eab-0d4e-4391-91f1-5a610906338e">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37e492b0fc2d45a8b2e224d8465d9026_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI3Nw_868bd5b1-bc9e-4e8d-964e-e439b60c71d7"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <mo:DebtInstrumentExtensionTerm
      contextRef="i8909ba74b6764ebd88608d38555f9894_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzM1NzE_a3ad044a-db57-45ef-989e-ce69f8b402fa">P1Y</mo:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37e492b0fc2d45a8b2e224d8465d9026_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzYxNw_4300039c-5cca-4da1-883e-d436877288ab"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2be9a00b70904e04a6f468eec5058227_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzEyNzE_ac3b57da-6a2d-4a7b-9151-1022d53e94d0"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum
      contextRef="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzE2Mzg_89619ecd-6968-45ce-9266-17caec0ed92d"
      unitRef="number">4.0</mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum>
    <mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio
      contextRef="i54bf02b6902a4e7e811540c30718f785_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzE4NjU_47fa1485-f794-49ce-8b60-92d95d6a1ab1"
      unitRef="number">10.7</mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio>
    <us-gaap:LongTermDebt
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzIyODE_ea76f50d-31b6-46bc-aec6-feb384e0e92f"
      unitRef="usd">27700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzIyODg_9f0a4650-a541-42e5-9f96-86f4588d8f29"
      unitRef="usd">28000000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icf22930994534713a83c19ce49bde1ba_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI0MjA_545e0bc2-1678-4274-85ab-17bf680bfeea"
      unitRef="usd">5500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ie526609fec74474d87c0aa3c9e2a3ccc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI4MTQ_c8df8528-377f-4d0b-8324-e016419395a6"
      unitRef="usd">4042000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i904889c18dee449b9c1967209d215e07_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI4NTg_ad407d47-02b2-41ea-835d-c60ce84e7897"
      unitRef="number">0.03490</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i834f7afe8d0b4966b98bf4be48676817_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzI5MTI_0927ad92-07a7-4f0a-ad00-26096ef17de5"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMwNjY_2cd6b382-8515-42ab-becc-ff6d8746f5c9"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMxMDY_98121317-84fe-43ec-a3f7-4b24ef398e2a"
      unitRef="usd">-623000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i719f39d2114f46edb9bef50a488308bb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMxODQ_a2ad702f-e8ea-4a66-9df4-a2cf3401ca03"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMyNDA_196e37cd-195a-4345-a908-50bb3e92e227"
      unitRef="usd">376000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDAvZnJhZzpiZDdjM2FkOGI1ZjY0ODYxYThjM2U2MDUxOGU5NmE5Mi90ZXh0cmVnaW9uOmJkN2MzYWQ4YjVmNjQ4NjFhOGMzZTYwNTE4ZTk2YTkyXzMyNDc_9d132283-69bd-4f0e-b4cc-5a7994c01489"
      unitRef="usd">429000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzM_fa504991-a4d6-4c6e-bcff-d3f4cdc0ba0d">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Earnings before income taxes, provision for income taxes and income tax rates consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,846&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,605&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our income tax rates for the six and three months ended June 30, 2022 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our income tax rates for the six months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to valuation allowances recorded against deferred tax assets related to our investment in JUUL and our Investment in Cronos.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our income tax rates for the three months ended June 30, 2021 differ from the U.S. federal statutory rate of 21%, due primarily to a valuation allowance recorded against a deferred tax asset related to our Investment in Cronos, partially offset by a valuation allowance release related to the increase in the estimated fair value of our investment in JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further information on the changes in the estimated fair value of our investment in JUUL and our Investment in Cronos, see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized.  In reaching this determination, we consider all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in valuation allowances for the six months ended June 30, 2022 were due primarily to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The cumulative valuation allowance at June&#160;30, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL and our Investment in Cronos.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <mo:SummaryOfIncomeTaxesTableTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzk_6cd482a8-c6bf-4925-8f8d-c7b545dabd91">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Earnings before income taxes, provision for income taxes and income tax rates consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,278&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,846&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,605&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,909&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;714&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mo:SummaryOfIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItMi0xLTEtMTI5MTA5_8224f05a-ed16-4593-95a0-4b98e7ce446e"
      unitRef="usd">4278000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItNC0xLTEtMTI5MTA5_ba07c82d-a32f-4b4f-a5a5-6b19c0649bc6"
      unitRef="usd">4846000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItNi0xLTEtMTI5MTA5_9b84b99f-4ab8-46bb-9e26-8f87cf079d0a"
      unitRef="usd">1605000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzItOC0xLTEtMTI5MTA5_70715f55-957c-46db-9d56-7d43094fb14e"
      unitRef="usd">2909000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtMi0xLTEtMTI5MTA5_0c425ed0-c984-47f1-9f85-ede49cd008eb"
      unitRef="usd">1428000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtNC0xLTEtMTI5MTA5_2608f084-62bb-40a2-a29c-a3b67586e15a"
      unitRef="usd">1275000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtNi0xLTEtMTI5MTA5_3e395f76-864a-42a0-88bd-c8cea8a8bbc8"
      unitRef="usd">714000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzMtOC0xLTEtMTI5MTA5_192222bd-95b0-43d9-8a4b-db62db2e7d94"
      unitRef="usd">759000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtMi0xLTEtMTI5MTA5_a68e5621-5044-4a56-a8a4-fcbfbd21c7d8"
      unitRef="number">0.334</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtNC0xLTEtMTI5MTA5_54d525e5-f8e1-4719-9dca-c2a70acce0dd"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtNi0xLTEtMTI5MTA5_0ce85e72-a4c7-4fbc-87ce-378d1282f29f"
      unitRef="number">0.445</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTo4OTljNmNmN2YwMjU0NWQxYTJmNDA2YjRkMDczZjRhNS90YWJsZXJhbmdlOjg5OWM2Y2Y3ZjAyNTQ1ZDFhMmY0MDZiNGQwNzNmNGE1XzQtOC0xLTEtMTI5MTA5_97ea0f41-e552-41e1-9a96-70c4d2e36d99"
      unitRef="number">0.261</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzIxMzQ_74e6b06a-013d-4800-9af1-8ca81567de42">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following chart provides a reconciliation of the beginning and ending valuation allowances for the period ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzEtMi0xLTEtMTI5MTA5_5749352c-85b4-4211-a5da-456afb6b1819"
      unitRef="usd">3097000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzItMi0xLTEtMTI5MTA5_ed49876c-40cd-4bbc-a4d2-efdcd654f214"
      unitRef="usd">368000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseInAmount>
    <mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzMtMi0xLTEtMTI5MTA5_fb95a0df-f251-4a75-87b7-a2ce34eb23e5"
      unitRef="usd">8000000</mo:ValuationAllowanceDeferredTaxAssetDecreaseInAmount>
    <mo:ValuationAllowanceForeignCurrencyTranslationAdjustment
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzQtMi0xLTEtMTI5MTA5_7cb4620d-e174-4fca-80cd-30fff500710c"
      unitRef="usd">-1000000</mo:ValuationAllowanceForeignCurrencyTranslationAdjustment>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90YWJsZTpiZmUxOTUyOTQxOGY0YmEzOTZlZTNmNTRiNDc0YjdjMS90YWJsZXJhbmdlOmJmZTE5NTI5NDE4ZjRiYTM5NmVlM2Y1NGI0NzRiN2MxXzUtMi0xLTEtMTI5MTA5_e64a1bec-1dd1-472e-a36a-f33030f5b5eb"
      unitRef="usd">3456000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDMvZnJhZzoyZWU0MzMxNDI1MTY0NWU2OTRkNzBhZGMzN2RjM2IyNy90ZXh0cmVnaW9uOjJlZTQzMzE0MjUxNjQ1ZTY5NGQ3MGFkYzM3ZGMzYjI3XzQ5NDc4MDIzMjc2MDU_b2e516a6-c6fc-4a2f-a8fd-e433707f3a4e">We determine the realizability of deferred tax assets based on the weight of available evidence, that it is more-likely-than-not that the deferred tax asset will not be realized.  In reaching this determination, we consider all available positive and negative evidence, including the character of the loss, carryback and carryforward considerations, future reversals of temporary differences and available tax planning strategies.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0ODk2_ac816430-a14f-4b40-8c84-6982dacc6894">Contingencies&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#x2019; liability is joint and several.  In such &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#x2019; fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#x2019;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record provisions in our condensed consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 11. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not provided any amounts in our condensed consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Judgments Paid and Provisions for Tobacco and Health (Including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation) and Certain Other Litigation Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our condensed consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our condensed consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $929 million and interest totaling approximately $228 million as of June 30, 2022.  These amounts include payments for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny judgments (and related costs and fees) totaling approximately $421 million and related interest totaling approximately $57 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Security for Judgments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of July 25, 2022, PM USA has posted appeal bonds totaling approximately $50 million, which have been collateralized with restricted cash that are included in assets on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview of Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Types and Number of U.S. Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#x2019; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the United States against us as of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes as of July 25, 2022, 16 cases filed in Illinois, 18 cases filed in New Mexico, 36 cases filed in Massachusetts and 58 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,396 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of July 25, 2022, 58 class action lawsuits, 2,957 individual lawsuits and 1,015 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 58 class action lawsuits include 32 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;International Tobacco-Related Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement (defined below) between Altria and Philip Morris International Inc. (&#x201c;PMI&#x201d;) that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tobacco-Related Cases Set for Trial: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, six &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases, two individual smoking and health cases and no e-vapor cases are set for trial through September 30, 2022.  Trial dates are subject to change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1999, excluding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases (separately discussed below), verdicts have been returned in 70 tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in 45 of the 70 cases.  These 45 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (5), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).  One case in Massachusetts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Main&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 25 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs, 23 have reached final resolution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Liti&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;gation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of verdicts in state and federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA as of July 25, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Smoking and Health Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs&#x2019; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consumer protection statutes, and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases can be found in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#x2019;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#x2019;s motion for discretionary review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Greene&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#x2019; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#x2019; fees and costs in the amount of approximately $2.3 million.  In July 2021, following denial of PM USA&#x2019;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts, which appeal remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laramie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In August 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $11 million in compensatory damages and $10 million in punitive damages.  PM USA appealed and, in February 2021, the Massachusetts Supreme Judicial Court asserted jurisdiction over the appeal.  In September 2021, the Massachusetts Supreme Judicial Court affirmed the trial court award of $21 million in compensatory and punitive damages.  PM USA recorded a pre-tax provision of approximately $27.1 million in the third quarter of 2021 and paid $30.3 million (including the judgment and interest) in December 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Class Action: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2000, in the second phase of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#x2019; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;e Progeny Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deadline for filing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of July 25, 2022, approximately 727 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 911 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are estimates.  While the 2015 federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;agreement resolved nearly all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases pending in federal court, as of July 25, 2022, one case was pending against PM USA in federal court representing the only case excluded from that agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, 139 federal and state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; decision.  Seventy-six verdicts were returned in favor of plaintiffs, and eight verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skolnick&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Calloway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oshinsky-Blacker,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McCoy, Mahfuz, Neff,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Frogel &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Gloger&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In two cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kaplan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sommers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the punitive damages awards were vacated on appeal and remanded for new trials.  In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sommers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the trial court granted PM USA&#x2019;s motion for summary judgment, and plaintiff has appealed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fifty-five verdicts were returned in favor of PM USA, of which 45 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of July 25, 2022.  The jury in one case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Garcia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, awarded plaintiff compensatory damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  Four verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearson, D. Cohen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collar &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Chacon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reider &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Banks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;returned zero damages verdicts in favor of PM USA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Juries in two other cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Weingart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hancock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pollari, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  Three cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The verdicts in the retrials in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) were reversed upon appeal and remanded for new trials.  Two cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freeman &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Harris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charts below list the verdicts and post-trial developments in certain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of July 25, 2022 but where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated.  The second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#x2019;s award for compensatory damages will not be reduced by any finding of plaintiff&#x2019;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;References below to &#x201c;R.J. Reynolds,&#x201d; &#x201c;Lorillard&#x201d; and &#x201c;Liggett Group&#x201d; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schertzer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Defendants&#x2019; and PM USA&#x2019;s post-trial motions pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mistrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendants&#x2019; petition for review to the Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendants&#x2019; petition for review to the Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Florida Supreme Court vacated the punitive damages award in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Blackwood&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8 million&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;($5 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"&gt;U.S. Court of Appeals for the Eleventh Circuit vacated the punitive damages award and reduced the compensatory damages to $5 million based on plaintiff&#x2019;s comparative fault. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which is discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount (if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Appellate Issues: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Appellate decisions in the following &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases may have wide application to other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mary Sheffield v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#x2019;s District Courts of Appeal finding that the 1999 amendments to Florida&#x2019;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Linda Prentice v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#x2019;s District Courts of Appeal finding that in order for an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Phase I findings, described above in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  Plaintiffs filed a motion seeking rehearing on the proper remedy for cases in which the court&#x2019;s jury instructions did not comply with the Florida Supreme Court&#x2019;s decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  In May 2022, the Florida Supreme Court denied plaintiffs&#x2019; motion for rehearing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Florida Bond Statute: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny lawsuits in the aggregate and establishes individual bond caps for individual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases tried in federal court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Smoking and Health Class Actions: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for a discussion of &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; class action cases and medical monitoring class action cases pending against PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#x2019; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#x2019; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to us) seeking protection under Canada&#x2019;s Companies&#x2019; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Care Cost Recovery Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#x2019; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#x2019; appeals from the cases decided by five federal circuit courts of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with us) under the Companies&#x2019; Creditors Arrangement Act discussed above.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for a discussion of these proceedings.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Settlements of Health Care Cost Recovery Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#x201c;MSA&#x201d;) with 46 states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#x201c;State Settlement Agreements&#x201d;).  The State Settlement Agreements require that the original participating manufacturers or &#x201c;OPMs&#x201d; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#x201c;ITG&#x201d;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#x2019; attorneys&#x2019; fees, subject to an annual cap of $500 million; these quarterly payments are expected to end in 2024.  For the three months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.0 billion and $1.2 billion, respectively.  For the six months ended June 30, 2022 and 2021, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $1.9 billion and $2.1 billion, respectively.  These amounts include PM USA&#x2019;s estimate of amounts related to NPM Adjustments discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NPM Adjustment Disputes: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The &#x201c;NPM Adjustment&#x201d; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#x201c;participating manufacturers&#x201d; or &#x201c;PMs&#x201d;) that &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The independent auditor (&#x201c;IA&#x201d;) appointed under the MSA has calculated that PM USA&#x2019;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $285 million for 2017; $318 million for 2018; $415 million for 2019; $573 million for 2020; and $635 million for 2021.  These maximum amounts will be reduced, likely substantially, to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  In addition, PM USA&#x2019;s recovery of these amounts, even as reduced, is dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Settlements of NPM Adjustment Disputes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt"&gt;Multi-State Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to 37.  As a result, PM USA will receive approximately $80 million for 2004-2021 ($20 million of which relates to the 2019-2021 &#x201c;transition years&#x201d;).  In connection with this development for Illinois, PM USA recorded $80 million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state settlement, PM USA has received $1.15 billion and expects to receive approximately $410 million in credits to offset PM USA&#x2019;s MSA payments through 2036.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;New York Settlement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $435 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Montana Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Continuing NPM Adjustment Disputes with States That Have Not Settled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2004 NPM Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes for 2004 in a multi-state arbitration.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for nine of the 10 states concluded by the end of 2020.  In September 2021, the arbitration panels issued decisions finding that two states, Missouri and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  The hearing for one remaining state concluded in March 2022; however, a decision has not yet been issued.  The two states determined by the arbitration panel to be non-diligent have filed motions in applicable state courts and with the arbitration panels challenging these determinations and several issues remain to be resolved by the arbitration panels that will affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $21 million as a reduction in cost of sales in the third quarter of 2021 for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2005-2007 NPM Adjustments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses three years, 2005-2007, for eight of the nine states, and one year, 2005, for one state.  As of July 25, 2022, no decisions have resulted from the arbitration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Subsequent Years.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Disputes Under the State Settlement Agreements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#x2019;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#x201c;ITG transferred brands&#x201d;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enforce have now been resolved either through settlement or exhaustion of appeals.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  Despite these resolutions, PM USA continues to dispute the accuracy of certain submissions made by R.J. Reynolds and ITG concerning the calculation of certain payments relating to the ITG transferred brands and may pursue such claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#x2019;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#x2019; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;amp;M Brands, Inc. (&#x201c;S&amp;amp;M Brands&#x201d;), under which the states released certain claims against S&amp;amp;M Brands in exchange for receiving a portion of the funds S&amp;amp;M Brands deposited into escrow accounts in those states pursuant to the states&#x2019; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings for the first quarter of 2021 as a reduction in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#x201c;sub-schemes&#x201d; to defraud that the government had alleged.  Specifically, the court found that:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants hid from the public that cigarette smoking and nicotine are addictive;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely marketed and promoted &#x201c;low tar/light&#x201d; cigarettes as less harmful than full-flavor cigarettes;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they intentionally marketed to youth;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants publicly and falsely denied that ETS is hazardous to non-smokers; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants suppressed scientific research.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#x201c;committing any act of racketeering&#x201d; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#x201c;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#x201d; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#x201c;lights,&#x201d; &#x201c;ultra lights&#x201d; and &#x201c;low tar,&#x201d; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#x201c;corrective statements&#x201d; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#x201c;low tar&#x201d; or &#x201c;light&#x201d; cigarettes, defendants&#x2019; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#x2019; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#x2019;s costs in bringing the action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#x2019; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014 and 2019, we recorded provisions totaling approximately $36 million for the estimated costs of implementing the corrective communications remedy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The requirements related to corrective statements at point-of-sale remain outstanding.  In May 2014, the district court ordered further briefing on the issue, which was completed in June 2014.  In May 2018, the parties submitted a joint status report and additional briefing on point-of-sale signage to the district court.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  A hearing for the district court to consider and approve any settlement and consent decree proposed by the parties is set for July 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a heated tobacco product used with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device.  In August 2020, we filed an opposition to the government&#x2019;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#x2019;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;E-vapor Product Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, we are defendants in 58 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 58 class action lawsuits include 32 cases involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  Three of the class action lawsuits are pending in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 2,957 individual lawsuits and 1,015 &#x201c;third party&#x201d; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#x2019; motion to certify a nationwide class based on state law claims against JUUL and RICO claims against Altria and other defendants.  Altria and the other defendants have filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court has set trial dates for five cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for November 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three of the &#x201c;third party&#x201d; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii and Minnesota alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss each of these three lawsuits and the motions were denied in February 2022, May 2021 and June 2021, respectively.  However, in the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#x2019;s claims, the trial court did dismiss plaintiff&#x2019;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  JUUL is also named in other attorneys general lawsuits in which we &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are not currently named.  As of July 25, 2022, JUUL settled four such lawsuits by, in each case, agreeing to a monetary payment (on average approximately $20 million) and to certain restrictions on its sales and marketing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, Altria Client Services LLC, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the IQOS electronic device and HeatSticks in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#x2019; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#x2019; claims against the other defendants have been stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA, Altria Client Services LLC and Philip Morris Products S.A. filed counterclaims against plaintiffs alleging patent infringement by R.J. Reynolds&#x2019; e-vapor products.  In June 2022, PM USA and Altria Client Services LLC reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#x201c;ITC&#x201d;), but the remedies sought included a prohibition on the importation of the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;electronic device,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;electronic device and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#x2019; motion to stay the orders pending the conclusion of the appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional unrelated patent infringement case regarding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#x2019;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#x201c;Sherman Act&#x201d;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#x201c;Clayton Act&#x201d;).  If the FTC&#x2019;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#x2019;s board of directors or attending meetings of the other party&#x2019;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#x2019;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#x2019;s decision to the FTC.  Oral argument with respect to the appeal is currently scheduled for September 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also as of July 25, 2022, 17 putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#x2019; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#x2019; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#x2019; claims against JUUL be sent to arbitration pursuant to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;an arbitration provision in JUUL&#x2019;s online purchase agreement.  The court granted plaintiffs&#x2019; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in four new plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  We do not currently intend to exercise our additional governance rights obtained upon conversion, including the right to elect directors to JUUL&#x2019;s board or to vote our JUUL shares other than as a passive investor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholder Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#x2019; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#x2019; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $90 million, which amount includes attorneys&#x2019; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court preliminarily approved the settlement in December 2021 and granted final approval in March 2022.  We recorded pre-tax provisions totaling $90 million in 2021 and, in January 2022, paid $90 million to plaintiffs&#x2019; escrow account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Federal and State Shareholder Derivative Lawsuits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#x2019; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#x2019; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#x2019;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, the court consolidated five of these six state derivative cases into a single consolidated case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and other parties to the federal and state derivative actions have reached an agreement in principle to resolve these actions through the execution of a memorandum of understanding.  The parties are in the process of negotiating formal settlement documentation.  The derivative settlement will be subject to court approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Certain Other Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Lights/Ultra Lights&#x201d; Cases and Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#x201c;Lights&#x201d; and/or &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in 23 &#x201c;Lights&#x201d; cases have refused to certify class actions, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of July 25, 2022, two &#x201c;Lights/Ultra Lights&#x201d; class actions are pending in U.S. state courts.  Neither case is active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of July 25, 2022, one smoking and health case alleging personal injury or seeking court-supervised programs or ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;UST Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#x2019; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of July 25, 2022, there is no such case pending against UST and/or its tobacco subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Regulation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#x201c;Superfund&#x201d;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our condensed consolidated results of operations, capital expenditures, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At June&#160;30, 2022, we (i) had $46 million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $19 million for surety bonds recorded on our condensed consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of a distribution agreement between Altria and PMI (the &#x201c;Distribution Agreement&#x201d;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our condensed consolidated balance sheet at June&#160;30, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patent litigation discussed above under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS Litigation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $3.0 billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 9. D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ebt.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIzNTE_fe9181e7-e9b4-4b25-9f30-eb2a811d9d70"
      unitRef="state">47</mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0OTAy_bf453cad-6b6e-4463-a481-4beb11280752">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the United States against us as of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 25, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;July 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes as of July 25, 2022, 16 cases filed in Illinois, 18 cases filed in New Mexico, 36 cases filed in Massachusetts and 58 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,396 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of July 25, 2022, 58 class action lawsuits, 2,957 individual lawsuits and 1,015 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 58 class action lawsuits include 32 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of July 25, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schertzer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Defendants&#x2019; and PM USA&#x2019;s post-trial motions pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mistrial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeals by plaintiff and defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendants&#x2019; petition for review to the Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial ordered on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Defendants&#x2019; petition for review to the Florida Supreme Court pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Florida Supreme Court vacated the punitive damages award in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;R. Douglas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;November 2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Blackwood&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8 million&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;($5 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:105%"&gt;U.S. Court of Appeals for the Eleventh Circuit vacated the punitive damages award and reduced the compensatory damages to $5 million based on plaintiff&#x2019;s comparative fault. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which is discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount (if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i964ab02efa4447bb862d040ab72bdce7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItMS0xLTEtMTI5MTA5_4d98a9f2-67d9-405a-b078-281d5a33f52b"
      unitRef="usd">91000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i5349a45275c54d33af6c9dba5397bc77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItMy0xLTEtMTI5MTA5_822b8f9c-c566-48ac-a9a6-3d1f1c825e97"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="iea1d15baae55479686b0438960a20553_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItNS0xLTEtMTI5MTA5_20026b41-3370-44ad-a4dd-2d53f81660ce"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i2233715bedd740d4a3940763dda60aa8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzItNy0xLTEtMTI5MTA5_ffead1dd-f538-49fe-b24b-f5389e6aa640"
      unitRef="usd">8000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib7333de9d7b44fc198078f692ff042c5_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtMS0xLTEtMTI5MTA5_6aaf957b-fa45-4e53-b741-89cccb703b88"
      unitRef="usd">57000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i64e7b37987ea44128d943580102fc338_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtMy0xLTEtMTI5MTA5_d71464d9-af0c-4406-839c-e63ed6216a51"
      unitRef="usd">43000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="idb300ff50687440da92f6d2d8898e254_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtNS0xLTEtMTI5MTA5_0fcfa823-0648-46bd-95bb-0c0e1e09260e"
      unitRef="usd">45000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i2611638f3f074e30be114be0592513de_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzQtNy0xLTEtMTI5MTA5_9a2d29e6-0f96-40bf-96c7-5c4aac7b451f"
      unitRef="usd">8000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9c088115b8af479895ab47b7bff4f51e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtMS0xLTEtMTI5MTA5_b00d83c0-9bd3-44dd-b340-0832fea57bc3"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i71508c07d42a42569b52bd3ebbac6370_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtMy0xLTEtMTI5MTA5_e09e9c7f-1f24-4eca-9c87-e30729d5890e"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i15710cf918bb4ad0bfe9ff7a338e1fb1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtNS0xLTEtMTI5MTA5_2d136667-88d3-4e55-b12c-20343bb8b573"
      unitRef="usd">1000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ie2626fb7367b400aba3c194f31411f4f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzUtNy0xLTEtMTI5MTA5_db4b4d7c-8a1f-4c61-a8a4-b7fa3704227f"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktMS0xLTEtMTI5MTA5_ff74b9c6-eb53-4ff0-b037-61efc80f1323"
      unitRef="usd">124000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i040c6325db474d64860ba51847e37bfa_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktMy0xLTEtMTI5MTA5_44340fba-6315-42d8-9a09-72fcc0be26ba"
      unitRef="usd">52000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i91be2da432a948cfbc579ace82b48610_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktNS0xLTEtMTI5MTA5_550e637b-0972-4a17-ae16-7a456d7a6eb0"
      unitRef="usd">21000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i5dac6fa731d647f1a3c027330a1396dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzktNy0xLTEtMTI5MTA5_1a135640-68b6-475c-9856-3f33a2fd801d"
      unitRef="usd">16000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTEtMS0xLTEyOTEwOQ_0935c2ad-c786-4b3e-84c0-b235e2a7a277"
      unitRef="usd">25000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTMtMS0xLTEyOTEwOQ_d990ea02-1259-4057-819e-aea1e6ba8007"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTUtMS0xLTEyOTEwOQ_9232a3ee-5c7d-4ae0-b7a2-883902c8bccc"
      unitRef="usd">25000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i737149184ecf4228959b9dd0c167bdf5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo2ZDhkMzYxMDZiZGI0NTVlOTk0MGRmNzBmNzdiZjY3OS90YWJsZXJhbmdlOjZkOGQzNjEwNmJkYjQ1NWU5OTQwZGY3MGY3N2JmNjc5XzEwLTctMS0xLTEyOTEwOQ_de4a08be-e3e7-4e1c-97c0-c1a041ce4250"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU5NzU_9fb1b016-42d0-4240-9880-1ce6d8f50538"
      unitRef="usd">929000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i96a1a3f64a614fa699e1b641f6d48b49_D20041001-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMTQ_04b67683-0c12-4fbf-ad4d-716763d0d624"
      unitRef="usd">228000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxNTE_ddb4fb19-9581-47f0-8a05-4fefec6ba399"
      unitRef="usd">421000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i2a115a7cd0e544de8aaf76cd6e4b4fef_D20041001-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxOTg_9023c3cf-feee-4376-a791-119f3c70c20f"
      unitRef="usd">57000000</us-gaap:LitigationSettlementInterest>
    <mo:LitigationEscrowDeposit
      contextRef="ib0e58a9d31fd4b2b9e8753887b69b312_I20220725"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzOTM_1d42f9eb-cf2d-4bd1-b06f-73382ae7d9a5"
      unitRef="usd">50000000</mo:LitigationEscrowDeposit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if80273ba6b18457cbc2b5182392c76b1_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzEtMS0xLTEtMTI5MTA5_dc8376b0-dcc3-43b3-b185-68770b83f6d4"
      unitRef="claim">162</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i5d91ab5e046640bcbabc478601fd21b3_I20210726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzEtMy0xLTEtMTI5MTA5_58d0737f-b8d4-4180-b214-c90b8bd09659"
      unitRef="claim">169</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ifc4defe52f8b46b09b0531c0541a5403_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzItMS0xLTEtMTI5MTA5_35794465-cc3b-4828-8ab5-5b0a40d6f7ca"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iac977efcc9484319b8cd4e82324c3fa3_I20210726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzItMy0xLTEtMTI5MTA5_53703694-9e07-46a6-aa0c-f997629929bc"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzMtMS0xLTEtMTI5MTA5_25291631-3a97-4a40-9c83-74424e3821cb"
      unitRef="claim">4030</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i87bf8ff853e2425f96934e4e9ddef164_I20210726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzMtMy0xLTEtMTI5MTA5_caef98e2-432f-4f5b-b6cc-fbc1e75a37ec"
      unitRef="claim">2626</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzQtMS0xLTEtMTI5MTA5_6be9e32e-a1d7-4960-9d72-95a18328cf26"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i0c6153fbe7224388926901e9703fa838_I20210726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpmYjI2ZGM0ZDQ0Mzg0MzcyYTBiMDFjYjhkODE2MzdjYi90YWJsZXJhbmdlOmZiMjZkYzRkNDQzODQzNzJhMGIwMWNiOGQ4MTYzN2NiXzQtMy0xLTEtMTI5MTA5_95f07e77-7cd1-4706-9a2e-abd6d7e7b173"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib36e57c0c00746cd9d7c260932b94d8e_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc0NTE_00b4330e-4de1-4e56-a3a5-e8b4850931b8"
      unitRef="claim">16</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8eb8d2231c6e42c68730b177faaedcd8_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc0Nzk_a313d96d-2e7d-4adf-a59c-aa69841560bf"
      unitRef="claim">18</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie41710be5b8c41ee96fe3ba722416d41_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc1MDk_e7dd526d-1a3e-4956-952d-2b3053c5f9e3"
      unitRef="claim">36</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icf33c42aea2a44e9a567c3723d8ddceb_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc1NDU_8a98435f-0b5a-4d72-bf6d-4ea0fb0fbaef"
      unitRef="claim">58</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCases
      contextRef="i5a4d2c2e9803462e976b555918c63490_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzc4ODQ_36f6dbab-2e5b-4a54-920d-f4c05831cc61"
      unitRef="case">1396</mo:LossContingencyNumberOfCases>
    <mo:LossContingencyClassActionLawsuit
      contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2MDA_79225e69-93dd-45ea-b501-de44b2da9ed0"
      unitRef="lawsuit">58</mo:LossContingencyClassActionLawsuit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i18fb1c9978ec48949a63f54f3c2ec853_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2MjY_ac5086c3-790a-499e-8c87-d13e43219b74"
      unitRef="claim">2957</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iec4f544b33974b84b91ca169738940e5_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg2NTM_f42de754-d70f-4ec6-b0ac-01648906771c"
      unitRef="claim">1015</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClassActionLawsuit
      contextRef="ia3402c70aef94f5b9ca25910ffaecba2_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg4OTA_79225e69-93dd-45ea-b501-de44b2da9ed0"
      unitRef="lawsuit">58</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzg5MjM_1437cb7a-9d6e-4b78-b6be-f729f53dcf98"
      unitRef="claim">32</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <mo:LossContingencyNumberOfInactiveCases
      contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzkyMjU_46f3e8f2-7ec8-4fa2-a487-6b4327385fbc"
      unitRef="case">1</mo:LossContingencyNumberOfInactiveCases>
    <mo:LossContingencyNumberOfInactiveClassActionLawsuits
      contextRef="i470465d1a67e47cf963f96112e6bcc56_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzkzNjU_50670a25-cd1e-4e6a-8c3c-d6a45992e80c"
      unitRef="case">2</mo:LossContingencyNumberOfInactiveClassActionLawsuits>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i057dcd83a81443d6895e291fa75e63cf_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk2OTY_973ea5b2-b535-4ded-9125-13004c6ff53c"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i602c7b1521144698b0e57a755cdea240_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk3NzY_06441e91-a6f1-4d58-aa3c-4fc9f39310a0"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ifdbc8a7fc0b140448112768ac4469793_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk4MjQ_6c677aa2-27cf-4a33-88e0-efccb5046ebb"
      unitRef="claim">8</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4Xzk5MjQ_7965dc43-128d-4c4c-8eb0-8fac528ebaa1"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="iff8405d610414876a75ffeb4cb61a3be_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwMzEw_0fa67d25-bea8-4348-8a8d-12dd80806497"
      unitRef="case">6</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i90bb52ef7113414d8e3846eac30005d0_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTAxMDk_8e69e7c5-1b74-448c-9694-ec30f10d2697"
      unitRef="case">2</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i9f105d7b0a5346afb83dd5c09220d92e_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTA5NDI_7df957c0-c887-4b20-815a-c0deeb9214a1"
      unitRef="case">0</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyClaimsDecided
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwNzY1_60d05815-a3cb-4444-b9c3-f24d02feb2de"
      unitRef="case">70</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwODkw_bc4f74a1-4fed-4bb2-897c-feb216b219e9"
      unitRef="case">45</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTAw_60d05815-a3cb-4444-b9c3-f24d02feb2de"
      unitRef="case">70</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTE3_bc4f74a1-4fed-4bb2-897c-feb216b219e9"
      unitRef="case">45</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i682d73a693e04609b5d9fbeaba2fcd92_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTQ4_7ef03fa6-3fec-4ad4-8dc7-91af93d194d6"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i6a1559a0e1124131910366a39aff6d12_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTY1_9c7c5f0d-617a-4e42-8042-b617281e2b24"
      unitRef="case">7</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i509864cccb2f40b98af72697cece813f_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTgz_a8e2e311-369b-483b-869b-ceba0e45a71c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ica10ed061e3c4768a08c7c6d78a09387_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEwOTk3_8da049d2-297f-4e11-a370-497ff84b6cdc"
      unitRef="case">10</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i4b1143b32ee544e99d873d85d649da2f_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDEz_574c4f23-7784-4c20-b0f0-d05fd035ae68"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i7f6d5b4f9824425c86ad308c5211697c_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDMz_25a8a46c-c193-424f-8484-5332406aedd6"
      unitRef="case">5</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ica1283cfc29e491f80a171844b65131e_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDUx_028b9a3d-7b08-4720-8db7-558b96c5d52a"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="iba9fd76fee584f7ca0719a4a74458197_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDY2_ea49240b-390b-4f77-8318-e95abedfd993"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i368a47758f0742e6a4c03e7856369fd6_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMDg2_fb7a65af-1b94-4895-89ce-7e89ce98b20c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ie79e75207b814e8c961e323037e2b7ea_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTAz_23af87d1-b6b2-4cbe-b862-c498a833e33a"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i2e26448b3750441c87cc00de2ed31100_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTE4_57712b95-afe4-4bfa-8d04-def924b68bf7"
      unitRef="case">5</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic873084e522446c8862fe8e1fa9cf238_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTI5_b0be9873-7a8c-471a-b072-830952d4600e"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ib0e31195d77d48bbb3cea0dade509ea8_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTQ4_dc9dae70-7c3b-47e8-b428-d0258e45c337"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic0abc218a2ef4d91b7ebb3f361f67c37_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTY3_5f107b44-0fd3-45d1-9d94-0dcdeb156496"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i3f81cf3349f04c67bca28e5eb157473e_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMTgz_1edf0392-d637-4974-bea9-24606601b2cb"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="id76f91e8dbc44f6582842261cefc0a50_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMjA2_298f633f-aff0-4d66-8451-96fb9539a05d"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExMzY2_3f3c51eb-079e-44b6-9fbe-073bb1eb7ebc"
      unitRef="case">25</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyClaimsResolvedNumber
      contextRef="ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzExNDQ5_ee66e123-c7b3-4ca9-8bb1-89fe0a3bbacd"
      unitRef="case">23</mo:LossContingencyClaimsResolvedNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i0c5245e6da544ef581a1619155446591_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzMzUz_c029abb6-5388-4a66-81d7-5f30c360e777"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i0c5245e6da544ef581a1619155446591_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzMzky_cbd33692-2ded-4598-968f-d9792c493466"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie0a6cce22a9241bfbe34dbe658ae9cde_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzEzOTg4_48c204e7-b6a5-4d96-a9ea-08198affc697"
      unitRef="usd">10000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="iada3831810b84380a34be34e3dbc1ffe_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0MTM3_47d78340-13bc-4d3b-b4d9-022ba9f6711c"
      unitRef="usd">30000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i8b2ca9e1f1054d9fba499bdf41e121e9_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0MjUy_2b56c155-8855-4c71-91cc-e4a40b90281b"
      unitRef="usd">2300000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="id2baa872a94b482c8bb1018ad55264cb_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0NTUx_6990b978-5168-4ad8-8175-09c53a83d8f4"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="id2baa872a94b482c8bb1018ad55264cb_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0NTgy_fd2b4ef9-ee86-44b8-b7c8-e595010d3b00"
      unitRef="usd">10000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i94e53bc2b6de4394af0f5e9e5f1faa3a_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0ODIx_049c3026-d084-4e1b-857d-db73d03f6af0"
      unitRef="usd">21000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5ac825808e1a4f3b84e8fee44f14e337_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0OTE2_8f9e25ba-9829-48be-b638-76870d1e2aef"
      unitRef="usd">27100000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i8c7f18929f5e4ba98e6d6041dd284fc6_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE0OTU3_ce841752-779c-4075-ac8d-e9a84ddd08a9"
      unitRef="usd">30300000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i9240c78c98394f3cb2cc1b313917c5ad_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2MDUw_670b795d-3021-4a2e-b359-6755d9cfd224"
      unitRef="usd">145000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i17eebd26ab63497ab584d767938f5d8b_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2MDkx_9e9f3434-6dcf-40f8-849d-e2eb33cb2f06"
      unitRef="usd">74000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2NjU0_0caabcfe-4494-490f-a2bf-ac57f152e1ab">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i9e58627ab487468ab9795d29a9420a23_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE2ODIy_0ce6d524-d436-4815-ae48-e79ac7dcd477">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if9927761764b40a786f566330b852304_I20080131"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NTUw_0f228f98-4b26-4047-92fb-5584b62480df"
      unitRef="claim">9300</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia60506d9acad48209c8c8dcaed0769be_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NjI5_d96bff0e-b0ff-4d71-908f-524e6b29868c"
      unitRef="claim">727</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ieb55d0b8c2e34a54b634281cfd15e7c5_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE4NzQ5_923f5bbe-d343-4e12-a9c8-354cefa15647"
      unitRef="plantiff">911</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ifd6affc6fc324b9da397010ae49673c8_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MDQ3_477aa0cb-29a2-4a56-8fb7-c922a4959391"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MjA1_953c2df7-0b3e-4253-be21-59a51745f8e8"
      unitRef="case">139</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5MzM4_d700455d-ac14-41fc-bbcb-99ed380d379b"
      unitRef="case">76</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="iff8405d610414876a75ffeb4cb61a3be_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5Mzkx_56af8618-c867-42cc-96ec-ed66550389c6"
      unitRef="case">8</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="ibc9177f9baa34fbdbf6605706769f68e_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDk5MTI_2f726066-12ab-4a4f-bd96-382751293375"
      unitRef="case">2</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i69cc9785025d4642bec18de2adf8b495_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5NTky_fe7e3fde-b309-4315-9fb9-5f2dfcdd2494"
      unitRef="case">55</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic4081d6a41ea492c824d20493bcf3dce_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzE5NjQ3_22c488c5-6252-4060-85b9-d5b677c9a2b7"
      unitRef="case">45</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="i2a58875756fe4911aa25efd5db88be0b_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMDkx_faee46e4-047f-44a5-b0e9-2180dc441774"
      unitRef="case">4</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyZeroDamagesVerdicts
      contextRef="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMjM0_756dc30f-9d6f-49ab-b1ae-75e68c0b9c82"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdicts>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i6f05286dea1b4ad0a69cf9781c0876a4_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMjcx_f135ba68-cdc0-4ed0-b420-2dbb096db718"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyZeroDamagesVerdictModified
      contextRef="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwMzIy_af575575-9fe2-4dfa-8cbc-e58b8bcfb551"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdictModified>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i26375a9b5c66461986e2c3b3c7535231_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNDAy_c2388a87-de2a-44d8-af57-ddc4d2c4c118"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i2c068a726b53483290f0d1fd038adfcd_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNDg1_af23eed1-b4f8-4f5b-ad0e-a0d2d467272f"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ib6e24acdccca4adbaac072d4e4022eae_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIwNzQw_1ae35608-af50-4beb-8517-6e1f59212e2a"
      unitRef="case">3</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="iae106d4c552a4de1b53156ad6d849934_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzIxMDY1_062bdead-48d4-42ca-9d0e-089fb30dd462"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i259df7aad9264b5a979579e9065bdd22_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246ZDA5Nzk4MzNkY2JhNGM2MTk3YjgzMzBhMWQyMDBjYjFfNA_2d4f0ab6-d200-490c-b19e-fb57267bc963"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i7b3ead33c4fb46be8b5f3121b9156fae_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246NDIyNWU3YjJkMDhkNGM4Yjk1MWNlZGJiNDdlOTYyNWVfNA_c273deb4-71a3-4035-9d32-5c503f3ead24"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i50edc02879964eff963fa402576e9210_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzItNC0xLTEtMTI5MTA5L3RleHRyZWdpb246MTZiZDk2NjExMzgwNDg3NTliZDZiZjY3YjFlNjlhNWZfNA_97653c37-8859-4841-a09f-e254417385f2"
      unitRef="usd">15000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ie6122c7f81bc4da79b3a3ebea157c058_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzItNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZGI3Yzc0NTA1ZjhkNDI5OWE1NTc5ODFhNGMwODNjZjBfNA_07f8ab34-a0e9-43bd-8ce0-97d2804c3df1"
      unitRef="usd">28000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i4fcf223c1d694ec285210be845848dc5_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzMtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246OGVjMDZiYzJlZmFjNGM4NmJlNTE1NWU3Y2VjYWRkM2RfNA_79abf100-c0f5-463d-926c-fee68c966f66"
      unitRef="usd">6000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i9df9b90b8d244415b8523a07918dc0b2_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzQtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246MTM1ODdhOGNmNDU5NDg1Y2EzZTlmZjhlYzA4ZmQxMzhfNA_01094322-5c63-48bf-a10d-5afd1ec2ae3a"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="icbe894efd4be468984d251e1e5c76e61_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzQtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZTIwNjIzYjJkNGNlNDlhOTkzNzJkMzQzODQxYTlhZjhfNA_9b4aa1ba-47c0-482e-82d8-07bc79524d18"
      unitRef="usd">12000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="iea6cffa455ad48dfb0c461d66ddf84e1_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246N2I0NWYyMGJkYjE4NDA4YWJjZjExMWZiZWE5ZTcxMjJfNQ_48053163-b5b8-49a7-a0e9-588ba467e286"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="if38694f1fdb142f8995d60ccb8ade4a4_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNC0xLTEtMTI5MTA5L3RleHRyZWdpb246N2I0NWYyMGJkYjE4NDA4YWJjZjExMWZiZWE5ZTcxMjJfMTA_a761e222-1c08-4034-b5db-6dded017ab50"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="if38694f1fdb142f8995d60ccb8ade4a4_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzgtNS0xLTEtMTI5MTA5L3RleHRyZWdpb246ZjA1YjRhMjExYThmNGUzNjhlMWZmOGY5MjRiY2U4NWRfNA_ad64ddb6-137d-4d0d-acf2-19e8ac089d08"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ifcd6b27156ef4c5189f7baa650560310_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzExLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmRlNTNkZTcwMWU1NDQ4NzhhZmFjZGMxYzUyYTg5NWFjXzQ_712eca3a-189c-4c2e-8677-84c03fe10ebf"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="iea83e832e8d04b5bb9090996f5901381_I20190228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzExLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjhiZjU5YjA3OGM0ZDRiYWU5ZDRlOWE4ZmUzYTk4ZmMwXzQ_ca221a82-5b4e-438b-b767-fbb7369f9fb4"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ia0b7a204571b434cae1afa93d9ad5f88_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEyLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmNkZmViM2EyZjdlZDQ4YTI4YTk5ZDQ4MmVhZTg0OGJjXzQ_0f3e3e3f-b5c1-449a-8585-304292804e2b"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ib7287b41052449eda9a16b7a4c0ec748_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEyLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjM2M2RhNmRkNmMzNTRjMjM4ZmI2MTJiYWQ0YzliNGY1XzQ_31d6f04b-a2e9-4aff-aead-43620f8aaaca"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i0f691b340eae41fab60e5ecfae6d3d73_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEzLTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmRlZDE5Mzg0MWY3ZjRjMWM5NTUzOWIzMDFmNjk4M2ZhXzQ_82982ddb-6227-4af5-8b75-7bbcf7766a96"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i855a49b8e94a44d8845849b0b6cdafcb_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzEzLTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjU3YzYyMDhiMjc3MjQ3NjJiZTRiOTdlM2ZjZTY3MzVjXzQ_016f319f-7efa-4d82-97ec-154ce22d9f45"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i0bdb791827ba48ab8cd3664a2010e68d_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE0LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmY1MTZkMjIyZWMzNTRmOWY4ODkwOTEyOWM3YzIxZDY4XzU_5f47d810-794e-4436-ab1b-fb00e5d77e41"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="icb9002b835be42eeb751f0eeed99f3a6_I20171130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE0LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmY1MjA1Y2VhODY4NjRhODU5OTIzMWMwODg2NDgwMGZjXzQ_2bf3ad84-8f03-40cd-b590-babcee9ae600"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ic88503c7bdfe46aa8828a4d6ab9c1639_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmFhMGNkOWIzNTJmMzQxMTBiZTYxNTRkMTEzNDJiNTc3XzQ_c47bfcf6-5141-46b2-9804-3629f6bcc136"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i57f26ea5a3014b9b9729fe7e127386e6_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmFhMGNkOWIzNTJmMzQxMTBiZTYxNTRkMTEzNDJiNTc3XzEw_8eb7716b-8d2f-409a-ad64-8b7595feaa7c"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i57f26ea5a3014b9b9729fe7e127386e6_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE2LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmE3ZDNlN2ZjNWFjODQ5OTdhNGQ3NGQ5MDE2ZDcxNmI0XzQ_4df6a8aa-9fa8-4016-b3f1-a475f72692ef"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="idc8ad30209f44f13aa28826ce714e1e3_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjE1MzRmZGI1NTVmYzQ3ODQ5NDZkYWFjZTM5Y2ZjOTJiXzI3NDg3NzkwNjk1NTY_e9d719e9-b4f1-4a0f-b05b-69faa57afea2"
      unitRef="usd">8000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i46aef541c52b44488e878806bd18c603_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTQtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjE1MzRmZGI1NTVmYzQ3ODQ5NDZkYWFjZTM5Y2ZjOTJiXzI3NDg3NzkwNjk1NTE_d6404cc1-eeef-4bbc-90e1-655e5b8df8db"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i46aef541c52b44488e878806bd18c603_I20150131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTUtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOjA3MWE1NWQ1ZDUwOTQ5NmFhMDJhMGM1ZDMwNTc5MTVlXzQ_dbedf5d8-4583-4b7b-b010-9922f0af259d"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i93894bc913ad47c68ff2b60978052595_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTo0ZTA3Zjk4YjkzZjY0ZWQwYmM0NGMzODM4NmQxMmY4Ni90YWJsZXJhbmdlOjRlMDdmOThiOTNmNjRlZDBiYzQ0YzM4Mzg2ZDEyZjg2XzE3LTYtMS0xLTEyOTEwOS90ZXh0cmVnaW9uOmQyYzEwNmUwNmZkMzQ1YWE5MTAwN2IxZDZhNWU0MTc3XzI3NDg3NzkwNjk2Nzc_a9444093-a693-445e-b025-d2da809a93e0"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i9c72bf9fe7e94489a9a55eb6ef0170d2_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90YWJsZTpkNTU2OTFiOTAyZjI0NWMxODYwMTcxZjkxYjZjMDEwMi90YWJsZXJhbmdlOmQ1NTY5MWI5MDJmMjQ1YzE4NjAxNzFmOTFiNmMwMTAyXzE1LTUtMS0xLTEzOTMwNQ_396c528d-5c31-470e-8a12-f47509d28b12"
      unitRef="usd">2000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:MaximumBondForAllDefendants
      contextRef="i494b0e99edea410eab5611b73ffe2f4b_I20090630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI0MzEz_fbb5e348-f477-4c63-8798-dd0544187c90"
      unitRef="usd">200000000</mo:MaximumBondForAllDefendants>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i9a1eedb0c135405eb108bc5d0c630bdc_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NTk4_1198c6ad-85ae-4138-a0b8-9568cbeb3115"
      unitRef="case">61</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i319065433abd4969ae1ac14852b67636_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NjY0_90913822-2f2b-48ab-88d9-b8c1111b702e"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ide83d291e49e4954a5a0296df977d166_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Njgx_61b86f9e-0211-4fb0-8f8d-16f0fbba4c7e"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i0ae966d42be24dd582723eae2b55cfaf_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Njk2_621b3aa2-ba79-46aa-a1f7-7c61ac9d3bb0"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ia610c28441d14994af28fe694a231c07_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzI3_c9636094-f5be-4d67-a2f8-472c3d50ac83"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i30ab1a010fd441a897ef5fce3716965a_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzQx_d350bf8b-fe5b-4c2d-b84c-dfd51b43acc7"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i998145dbc029488dbf42ec885813145a_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzU2_b3fb5508-1e66-4fa7-8ea3-5373a1ac9c76"
      unitRef="case">3</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i4118f17df3314a5b83ef7db05acfe8e7_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1NzY3_b1092801-2f72-4dad-95d2-03969e106fc1"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i19c5fce8de1e4a369b1fdaaeee2023be_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Nzgw_9caa025c-a320-4d36-80ac-318a718f09aa"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i1edca63a676640e6b6829445de1c62ba_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1Nzk2_ba7f783b-1d8d-45e0-aa8e-29ecceef4bc0"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i55ab3c65ee434f54b6c4e29b1fa9f142_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODEx_4000eb60-06c0-454e-a4e0-1eb9a04c5739"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="iee45707683a643b6bbb8071e6dfc639a_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODI2_7cfc9597-7a3e-4198-b118-a3179c011048"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i204541f308ef43d6a18a8ad65ed791a5_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODQy_00785f7b-7443-4c51-b50a-56a18585732d"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i15ec71c620304120a35b6a786a7af7ca_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODU1_888ed7d4-c5a4-43d9-8f25-ebbcfe1d1aad"
      unitRef="case">29</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ic571c755a3174b2f8b0b4330bc60eb8e_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODcy_9e656f4e-e826-458e-9284-bcc767e6f243"
      unitRef="case">6</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ie244b73417994d3d8fc685443c7bab67_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODg3_e8c977c3-bace-4e08-9a0d-2d7f7b129e05"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ie8c697029cb24766b6430bb454ff76d2_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1ODk4_f17c1e24-7824-4277-a99c-5ec5f7a908ce"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i61bee51f4e7549f7b26494a823b20219_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTEz_8e6c65c2-1b59-41e7-93cc-b92481c28774"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ie263e9c12c0c49598ae4af4a0e29d138_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTI2_53ecf793-6870-4425-bb88-12bd87b019fc"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i21e1760e3dc3429e9de3e8b11b5e3aae_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTQ1_15939c4f-af97-4da9-b06c-f72af634bdca"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i95792785b13646e3a52dbef118639cab_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTYz_34927662-2c49-4cc5-b8f0-ee905a1da150"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib918bb45881a41b88b31716185a5601b_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTg0_6a6fffcd-cfa5-4262-aead-af462b680448"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i51dbba0c72e44ef8b9724d88a7e26133_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI1OTk2_b07df914-741f-4bfa-97fe-46a400feffc3"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i88a99b9d1e4244df95287f1de8eef4b2_D19960501-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2MDE1_c6e0d96c-eac2-45dc-b47b-a42920830e3e"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie5ae1a7f14cc4f119dcaed471cf816b7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2MzE1_7965dc43-128d-4c4c-8eb0-8fac528ebaa1"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8281813f0706492da71cbfe50a5ba129_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2NDc5_3f35374f-c091-4c36-9b47-7a9f9bb67207"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI2OTcx_7d50b5ee-b3ef-49fb-ad88-6d73b3bcb672"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofManufacturers
      contextRef="id68e6389cd4f47489796944107883c14_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MDA2_0d063de7-edd0-4c4c-9364-f326474de3e6"
      unitRef="manufacture">0</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyVerdictsUpheld
      contextRef="i7a0b9ff06f74413fadcdde65d5c567f7_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MjY4_5afcd888-bbaf-4215-98c1-519612bc05af"
      unitRef="ruling">2</mo:LossContingencyVerdictsUpheld>
    <mo:AmountAwardedtoOtherParty
      contextRef="i4852a02f887c486abc8978cdda91ec14_D20190301-20190331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3MzYz_df565ad3-0a18-4a8d-b511-1c53269d7ec4"
      unitRef="cad">13000000000</mo:AmountAwardedtoOtherParty>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8536b6fab27d4581bb4d23b4348e4024_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI4OTM2_b2fe396e-12d1-4bb1-a4f1-5c45fcab0582"
      unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i2c93e0173c414555a75af3caf5b31494_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI5ODE3_79771dee-a87c-41f6-aa63-37b2beab47af"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMwNDU1_e8831999-097c-4777-ac33-81d087abc5b0"
      unitRef="state">46</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LitigationSettlementAnnualPaymentAmount
      contextRef="id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMxMDY0_e7cf658e-f438-4aa8-8c78-4e1782480013"
      unitRef="usd">9400000000</mo:LitigationSettlementAnnualPaymentAmount>
    <mo:LitigationSettlementAnnualLegalFeesPayableMaximum
      contextRef="id640778c3952418d9eddb33bdb279309_I19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMxMjc2_cd25b412-8248-4b3f-80cd-deb95d4e9548"
      unitRef="usd">500000000</mo:LitigationSettlementAnnualLegalFeesPayableMaximum>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i7ad4667992974c56b30361191a43c305_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNjM_8c1f6841-e44e-4ac1-9783-33f19415af2e"
      unitRef="usd">1000000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i3684944b3b7443d8a34cefbfc60a1e71_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNDc_eb160e0c-5761-448c-b708-4d951aef9948"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i398ddf29c5ae4d1cba9418e41e0bdc83_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNzY_fe717129-8601-47d1-b38d-8af4b1ed8f74"
      unitRef="usd">1900000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i156ce9dc699a4fa88302b05d0f029496_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNDIyNzI_81bd3a41-57da-4c93-8b0a-96c72cf61803"
      unitRef="usd">2100000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i470d9d37b2e54ca2bef0338fb55cea99_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMTk3_76de4783-981f-4cb1-8605-2ede3fa0a5ef"
      unitRef="usd">388000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="idd811b49bbac43eda9afecebc9563fdc_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjEw_b8cc0dd2-e599-4bb6-b615-fbe284631f8c"
      unitRef="usd">181000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="id180aaaf475140e1b559d11028dd32ad_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjIz_1893c6cc-36a2-495c-a1bd-998d7b7247af"
      unitRef="usd">154000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="if2059686678443feb7b68e80c9cb4cb2_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjM2_5939b294-d6df-44d3-a6fa-fb457c1b6b57"
      unitRef="usd">185000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ibc032ffd1fbe41ae93ae94b0ece2a49d_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjQ5_0aedc1b7-6ac5-464f-bc4a-7b91912c1cd0"
      unitRef="usd">250000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i956ef150cdde441bbced0f592c3f89a2_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjYy_27f43dbe-1e90-45da-90ac-b73e56a2bc08"
      unitRef="usd">211000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4ac9e5fa08264e408b57748a0cb725e9_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjc1_2f790ec7-2c25-4cb3-a27a-ccc60255cf1d"
      unitRef="usd">218000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ic2a140870c1d49dd85a9a4cf55517c3e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMjg4_9a9ee49a-aeb0-484d-801e-5222a7c0cd69"
      unitRef="usd">166000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4de839768ad94cfab14e39ee519be5eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzAx_b52e76f5-2890-4134-8619-d1ef5013307f"
      unitRef="usd">214000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ia26efd9028144ce997e13ba03004b3e4_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzE0_533a19cb-c2ce-4970-87f1-a89aa555c7fd"
      unitRef="usd">224000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i6183a39e504c4bf3875e7ca13284f323_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzI3_7ad6a31a-430b-40ed-8492-2ac57b21d0db"
      unitRef="usd">258000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="iae5dcbeb354e44d0a63d24ea3d885915_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzQw_4ff34ff8-382f-4b7b-8f1b-2e0fc42b1f24"
      unitRef="usd">313000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i0f62b64e22cb44d0ad3a08021fc5a3eb_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzUz_7c32350a-4758-4ee8-8bc2-b94b69ed6010"
      unitRef="usd">292000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="id3bfca6d5eb04b478cd4cce359cc1b8e_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzY2_9c02f6e4-1f92-4785-9a74-76c9e914e095"
      unitRef="usd">285000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i6d910ce0936c4de79d300ec7d603cc96_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzc5_b558d703-8152-4695-875c-9215fd1b7723"
      unitRef="usd">318000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="idc172e1bfb8a4ca18d58681f22ba1e18_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyMzky_2129d557-324d-4351-a867-3d86b2ec2dcb"
      unitRef="usd">415000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i01dc1495f92d44cc975d4c4d9ef6db7a_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyNDA1_b85added-625c-4b8b-8d9c-648206063bcc"
      unitRef="usd">573000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i3d5b27f46d834849b12eed1fa7de3baa_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyNDIy_864b5e22-d921-4131-bfaf-209a137b777c"
      unitRef="usd">635000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMyOTg3_e2ad2e9a-5ab6-49ab-8f52-a964cd9fdeee"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="ia2bf50e945174e8eb4da9d6fb6259656_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMDg3_e79cd743-3721-4766-8310-694dcf395278"
      unitRef="state">35</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i4ab2bac42ede4b478a675827aa236c72_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMDk3_8c615c1e-c6e0-46ff-b76e-49862e84a534"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="if6e1e56b911e47e2a8a17ad4923c4e1d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMTMw_a7924a97-15ae-4bbd-b575-6c89e2f58ef1"
      unitRef="state">1</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i87b1662c87ee4da4894098d4f121317e_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzE4_f8e69409-ef2e-41b8-abfa-3f2b99ed4a83"
      unitRef="state">37</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i79edba75585544a1b364c3a2a5272a9a_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzcw_846a936e-4195-4937-a8ad-62d83cdc478a"
      unitRef="usd">80000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9908c88820c8407882fd66aaee5e71fe_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzMzg4_7fd68556-d69e-4b38-bc83-4a0ebf15942d"
      unitRef="usd">20000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="iba9d82d27f974b7fb350c60b0eddb7e9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNTEz_030a2622-22dc-483d-8242-865932a0034f"
      unitRef="usd">80000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNjM5_4e6b80df-8a38-4f31-93ec-0f87e42f5702"
      unitRef="usd">1150000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
      contextRef="i7d21cc36ab83443bac66ca492d639fba_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzNjc5_1bb08801-059f-4883-9462-c230162958e1"
      unitRef="usd">410000000</mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i1439f2cfb5bf487799a6201d4441815e_D20150101-20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzMzOTQz_b73fd8f0-be9b-4f22-9a03-53719d2aaee0"
      unitRef="usd">435000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i69bc69e5749b4429a718b65ce3094b6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0MzE1_9899e51a-2b3c-4b7b-902b-e9c1c3af5c09"
      unitRef="usd">4000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LossContingencyNumberOfStatesWithConcludedHearings
      contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NDI3_ee51c5b4-72dc-43c1-a4a1-24a85e1bb942"
      unitRef="state">9</mo:LossContingencyNumberOfStatesWithConcludedHearings>
    <mo:LossContingencyNumberOfStatesWithConcludedHearings
      contextRef="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NzU4_847dbcad-ba81-4e6c-8f1d-70cf41f34b3e"
      unitRef="state">9</mo:LossContingencyNumberOfStatesWithConcludedHearings>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="ib3ba08a7135e4075bed19d7302b8fd74_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0NzY4_be85a368-8051-47b8-a454-962bd2ce70b6"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues
      contextRef="icc810a366b774b66bbcdcf2086537c48_D20210901-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM0ODgx_8e91a58f-19e4-4b15-a51c-e4ffb872741f"
      unitRef="state">2</mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues>
    <mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues
      contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1MTA2_50b4f22e-9e12-467b-b47f-4dd845a0326f"
      unitRef="state">7</mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="i4f54360a45714f0c8d17beb27f673520_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1Njg0_2cd72c16-19b5-485e-8df9-8ddf65463124"
      unitRef="usd">21000000</mo:LossContingencyReductionToCostOfSales>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ie5bdfc5d776745c0abf4cefe27564741_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM1ODkz_c8fcf617-9ca1-4d46-a81f-3f85ca17d231"
      unitRef="usd">23000000</us-gaap:LossContingencyDamagesSoughtValue>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="iaaea83fd15864426afc96fc88210b860_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MDUx_6c0dc89f-2e6f-492b-9ef1-7eda23982fa2"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0ODk3_880fe98e-1de9-4b03-8862-1ff3a5908abe">P3Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i791b978ac7c744399a729dc917a4cd02_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MjUz_45dd30df-1099-4a3d-8ee9-690c10d22fd6"
      unitRef="state">8</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="iaaea83fd15864426afc96fc88210b860_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2MjYz_159517d9-c3ed-4708-9e1a-c694e25f2e75"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0OTAx_8c0eb87f-3e8b-40d2-83d9-f2bd86dd5290">P1Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i8c82987d8c0f449b8ebd70195c6edf4d_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM2Mjk4_3a83b4c5-d071-47ca-8fc5-ce991f4e715c"
      unitRef="state">1</mo:LossContingencyNumberOfStatesNotSettled>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzM4NjA3_1221e5bf-9d06-4f81-bf5e-062d09f70138"
      unitRef="usd">32000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:FederalTradeCommissionDisclosurePeriod
      contextRef="i346e658d67ab4443b81460637eece234_D20060801-20060831"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQyMTkx_6e047c27-1646-4763-9d1f-159864a023f0">P10Y</mo:FederalTradeCommissionDisclosurePeriod>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i5a1126f30d7047cabf8a35e278d210e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_050b50f1-2b15-4b65-bc6c-3fb1f42ccd65"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ie90404e480bd486abe1322ee5d399a7e_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_648ca754-c29e-422d-aa85-d03c34b1980d"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic402594e8e0340378ab44dfc725a5202_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_65ca27ea-afd0-40ba-9a3c-f9cd94163c3c"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic17131fdfa6d4b22ab39238b34d989c6_D20140101-20141231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQzMTQw_a87fc328-2a30-4b57-97a9-72bad7cd5e43"
      unitRef="usd">36000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0NDcw_82d0c0d3-1682-4bab-bc0d-9c7958e556e3"
      unitRef="claim">58</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0ODU2_5512f943-cfbd-4aff-ac65-26b5ea49ef21"
      unitRef="claim">58</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="i33e465f0b90f4155a37f4b1dbe2174d7_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ0ODg5_aebddeb1-35c2-495c-94d2-d10c6704bd0a"
      unitRef="claim">32</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i611c10d6dd834dab966ca0225a1eac42_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MDgw_815feaf5-fa8f-4739-8adc-556f1ac73d75"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i18fb1c9978ec48949a63f54f3c2ec853_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MjM0_f7010e5f-f871-4c16-b499-469dc70699c7"
      unitRef="claim">2957</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iec4f544b33974b84b91ca169738940e5_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ1MjYx_0012472e-fd6e-495b-9e71-8742b22e1f84"
      unitRef="claim">1015</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCasesWithSetTrialDates
      contextRef="ibe88256c0632439c804ad259ee58ac49_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzI3NDg3NzkxNTAxMTk_42887e93-280e-42ea-9856-fe34ea29e838"
      unitRef="case">5</mo:LossContingencyNumberOfCasesWithSetTrialDates>
    <mo:NumberOfThirdPartyLawsuits
      contextRef="i7ee7e14784294b1aa50a20edf7383985_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3MTk1_83fd260d-41c5-4c64-b358-6230b3009ed3"
      unitRef="lawsuit">3</mo:NumberOfThirdPartyLawsuits>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3ODY0_c805f434-93d6-4dd8-a495-5cefe0d37d56"
      unitRef="claim">4</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i8e4da3ea3f9a456ab74fa36883f5c933_D20220725-20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ3OTU2_0bf31075-6dce-4946-a634-7c8f8394c340"
      unitRef="usd">20000000</us-gaap:LossContingencyDamagesPaidValue>
    <mo:LossContingencyDamagesRecoverableValue
      contextRef="i06aaddc0651c4da18fe616a4c53e7a2e_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzQ5NTEz_b6956dba-4a5b-42c8-9bec-4c85ce700f0e"
      unitRef="usd">0</mo:LossContingencyDamagesRecoverableValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i3c099a74ac94476c86a02b82115806c9_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUwOTI3_1e428697-8878-4fde-bf9a-9e42c45a410c"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:LossContingencyClassActionLawsuit
      contextRef="ib39dbb98e8d440f28749e4aee5911bf3_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUyMjkx_1f33ad87-0533-4da3-814d-4fbdb9d19a2f"
      unitRef="lawsuit">17</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyNumberOfComplaints
      contextRef="id54b8c1baf4c4086bb509612132c190e_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzUyNzUy_7f816804-0fd8-47e7-8830-9f552136a9b7"
      unitRef="complaint">3</mo:LossContingencyNumberOfComplaints>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="id41b8120810c4e6d829b0b1591449c2e_D20220201-20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU0MjM4_11362d02-9dc4-4157-a17a-ef31acd20cb7"
      unitRef="claim">4</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU0NzU3_79d61fc4-c636-41a2-9551-d31f4fb435d4"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i5fffc6b1edf3429d95ebdad004d40282_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU1MTQ1_79d61fc4-c636-41a2-9551-d31f4fb435d4"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2MTU4_6ba5adb8-e152-44f3-94a4-d0e75fc27a1e"
      unitRef="usd">90000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2NTQy_958b40ff-ac93-40c5-8fbf-cd88aa5206e9"
      unitRef="usd">90000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i6585b27441174f2ea5fcb1e108ef4379_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2NTgw_30b71fe7-c75b-42ed-9568-4b5e241b08f6"
      unitRef="usd">90000000</us-gaap:PaymentsForLegalSettlements>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="i9be017d1acc2442bb23883e51a46e1d2_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU2Njcx_49e105b3-c0ad-4952-b8c4-2981b7199ce5"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="iae31955a3e5d46a98b6382848e87c3dc_D20201001-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU3MzUw_5d9e3acc-f75e-48ea-85c4-b7596b38b06c"
      unitRef="shareholder">3</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfPendingCasesConsolidated
      contextRef="ic49230ad8f5446c9b722373434519ae5_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4MDY1_012a2fb8-7898-4604-9ea4-abe323d888dd"
      unitRef="claim">5</mo:LossContingencyNumberOfPendingCasesConsolidated>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4MTc3_480af928-3567-4de4-8caf-dceb5180bf8a"
      unitRef="shareholder">6</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfPendingCasesConsolidated
      contextRef="id4b290e9d4bd4c9f8883131d3263103a_D20210701-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4ODk1_f5ce8ef6-9bbb-45fc-a1ae-04e1db4318ee"
      unitRef="claim">5</mo:LossContingencyNumberOfPendingCasesConsolidated>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i7c4c751e33c24ebdb36628d5468659a6_D20200901-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU4OTA3_43d8b78e-928c-4042-b659-6136f6ffc682"
      unitRef="shareholder">6</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyClaimsNotCertifiedNumber
      contextRef="i49fc4815acd44dd095f74bae91742f69_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzU5OTY4_9e409350-acce-412c-9eee-e20bdd00c5e5"
      unitRef="case">23</mo:LossContingencyClaimsNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i49fc4815acd44dd095f74bae91742f69_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMTc0_7f395757-c96e-40f6-a682-5e630d39c6d3"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i44d3390cbcd0491bb2a57fa5618b6c6a_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYwMjk0_2ecbc880-e20f-44e5-848e-6d795747b674"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i453bba98eb8743d79202cf42541d0607_I20220725"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYxMzQ2_c62d8a7c-cd1e-4971-94ca-a30e68c49495"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8f7dbe193b884cf4a3753d6b4bbf0f5f_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzMjY0_d2e91972-ba1e-4fc5-8a4b-898d56f55762"
      unitRef="usd">46000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i0ad5f8c024af410fa48d33f23c6f16f4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzYzNDMw_2195b684-a48e-495b-87ca-bcaeba957d73"
      unitRef="usd">19000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i70c873e1e88d4ecaa8226421d8083196_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMDYvZnJhZzphZWQ0NTZlNjBkMmQ0MTE3YjJjYmIxNGM5OWFmZjJkOC90ZXh0cmVnaW9uOmFlZDQ1NmU2MGQyZDQxMTdiMmNiYjE0Yzk5YWZmMmQ4XzY0Nzc0_eed85b9f-e278-4ecb-b34a-df2cfe882a23"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMTIvZnJhZzpjZDk5ZWVkODRmNDM0ZTlkYjI3YzA4MDFiMGYyM2Q5ZS90ZXh0cmVnaW9uOmNkOTllZWQ4NGY0MzRlOWRiMjdjMDgwMWIwZjIzZDllXzE3Mg_43ac2fe2-6321-4dd6-b264-dcbd85e752ec">New Accounting Guidance Not Yet Adopted&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8xMTIvZnJhZzpjZDk5ZWVkODRmNDM0ZTlkYjI3YzA4MDFiMGYyM2Q5ZS90ZXh0cmVnaW9uOmNkOTllZWQ4NGY0MzRlOWRiMjdjMDgwMWIwZjIzZDllXzE4OQ_d599d52b-ad3c-4c1e-8548-8a285e2ea1a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect on Financial Statements &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We are in the process of evaluating the impact of this guidance on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the purchase of the remaining noncontrolling interests in Helix in the second quarter of 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xMi0xLTEtMTI5MTA5_82071d11-de2b-4f8d-9b0f-4236ae022712"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS00LTEtMS0xMjkxMDk_006359b7-7a21-4843-9b2b-a40e715cc4ba"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xMi0xLTEtMTMwNjYw_9ea92e84-5b00-4ba6-9bcf-5edefa911b5b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC00LTEtMS0xMzA2NTQ_ea03e715-5549-41e0-9d0f-b190463149da"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yOC9mcmFnOjMyNzY5Njk4NzQ5YzQ0MTg4ZDRjNDA0NzE1MzgwNzgyL3RhYmxlOmQ4ZmUxNjZhMmZmODRmNGNiN2Q5YjY5ODAyZmI1ZmJmL3RhYmxlcmFuZ2U6ZDhmZTE2NmEyZmY4NGY0Y2I3ZDliNjk4MDJmYjVmYmZfOC0xNC0xLTEtMTI5MTA5_4e3bd574-ed6c-4067-ac49-c3a4aabf3eaf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RhYmxlOmQ4MjU5ODFkOWY2ODRmNzVhNWQ0ZjUwYWZiODcxNmUxL3RhYmxlcmFuZ2U6ZDgyNTk4MWQ5ZjY4NGY3NWE1ZDRmNTBhZmI4NzE2ZTFfOS0xNC0xLTEtMTI5MTA5_67b7e6e7-4fc3-4153-b47e-7816a993f8f8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjhhYjFmNmJhODBkNjQyYzZhYmM0MDEwMThhMTA2M2ExL3NlYzo4YWIxZjZiYTgwZDY0MmM2YWJjNDAxMDE4YTEwNjNhMV8yNS9mcmFnOjVkYzFhMTAxZjI0NTRjODM5YWQ0YTM4Njc3Y2UzNWUxL3RleHRyZWdpb246NWRjMWExMDFmMjQ1NGM4MzlhZDRhMzg2NzdjZTM1ZTFfNDk0NzgwMjMyNjM1Ng_e3b05f91-f990-45ed-bd63-d2bb76a02c10"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>87
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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ME@  ").!&B>= ,FH +_MF"%<W6M+8/8-B&0"S#?/6E06$"BV:;J@61+;=09
M<13"-+'76R5OE.C'2C%=3]44EJL-$]J2KA1B3SMCH4Y1Q< FWZ<]FEFQ59D%
M!$HLA98 R&F6% "%GC] _L GXE'ROYB)K)M:=W/Y35,V!:\+N6G\@5ZTC1(@
M>>S<C4/]1<CR94@*0,(@&:!->MKDQ8U7]W?!\R)#*U8QO9#M^_Q4JY"5=6XZ
MW^SW1<::60ZJ0)R;.PLB6P<(9/<_!$I\6PL % ]IT;M"/&IQYB>M+WR/2MT+
M>OM:"[Y%[&M=J&]:D@<],YHG!I"_[RX\)+0-"H ZBYPY *4B]@H I=(C#DC0
MVS \[L-./NAG[U8 ,QD6@E=<G@E6-D]-ZZ*B55;04LNA=X%Z6([ N;O UL*%
M8,^WM0! MHL!,&?1@ Z]4\/C5JU[(ERQ-1=L/R-:6P,2!EQ9Z&P  (HD7F*3
M=E$!B6*;-H"*@Z$&Z.T;'O=OMX(_%,U;$LW[9=JNIXKL BT@T,PA#?B\@#BD
M 10YF$''I'L3A\==G%D$V;[B($W75\6)[6$ $,&V05E"J-BQ,0#*GT5X@&?O
MY/"XE3,\3YZ)=LL<54H4JUK15:E+S5'%==4K)7A9MJ:G=06P,J[A<G8_%W*&
M;55>3),"D('',=P;.SSN[ [K[LAP7>IS"I).G*=#H!U<$,&!T_8 "F@'%Z7;
M8<#RD-[O$6_T-<BM-GAR0_7REE-%+R"J9-0Q_MMW'V^:;?FFV=*WRG9<B]Y^
MDG'[>4.E-F!=,^ZZTL!MB4Z*"M4R[X'OP?*U@\:'\^K<;L(%@,+GV#9F(&IF
M>;P41"5#K=K;5#)N4Y=%61L'\N8"D5<)Y*(@@2"4*Q"$<@2:'KSQWC)QWWQJ
MD-I^UY5JWW-V5[O/&=?-2WSK^@V^6&#@^A)?I.W'BCY]^^U$/^_?:WN'2K;6
M0WGGD5YR1?LYHCU1?->\;U]QI?BV.=PPFC-A /K_:\[5\XD9H/LH-/\'4$L#
M!!0    ( 'PY_%0*;W<N&00  '40   8    >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&ULK5AM;^HV&/TK5G8UM=)M\TZ  5*!3.ND;M6M[O9AV@=##&0WL9EM
MH/??[W$24K!-UMWQI<3)>8Y]CH\3NZ,#XU_$AA")7LN"BK&SD7([=%VQW) 2
MBWNV)12>K!@OL80F7[MBRPG.JJ*R< //Z[DESJDS&57WGOEDQ':RR"EYYDCL
MRA+SKU-2L,/8\9WCC4_Y>B/5#7<RVN(U>2'R\_:90\MM6;*\)%3DC").5F/G
MP1^F?J **L1O.3F(DVNDI"P8^Z(:C]G8\=2(2$&64E%@^-F3&2D*Q03C^+LA
M==H^5>'I]9']QTH\B%E@06:L^#W/Y&;L]!V4D17>%?(3._Q$&D&QXENR0E1_
MT:'!>@Y:[H1D95,,(RAS6O_BU\:(DP+@L1<$34&@%T07"L*F('QO#U%3$+VW
MA[@IJ*2[M?;*N#F6>#+B[("X0@.;NJC<KZK!KYRJH+Q(#D]SJ).3&:,93#O)
M$%P)5N09EM!XD? #>9 "L14\*B&%&Q6//4$IYC2G:X'NT.>7.;KY<(L^H)RB
MI[PH8.[%R)4P,$7O+IM!3.M!!!<&$:(G1N5&H!0&DUGJY]WUO8YZ%PQI70F.
MKDR#3L*?=_0>A=Y'%'A!8!G/[/WEODW._^L]_>;>S\P(VXB$%5]X@:_-@AF%
M1[ID)4%_/"R$Y+#F_[3-?<T>V=G5BW HMGA)Q@X0"\+WQ)E\_YW?\WZP&7]-
MLODUR=(KD9U-4=1.4=3%/OD%OBBD69:V*:BK>U6U^G3L)_T!1&-_ZJR)"?S8
M.P?-+:"^#DI-4!@G;]V=*8Q;A7%G"'^5&\+1\BQ]1\7HIF!"$''[$5%2I12^
M%(1S>(_E=4 E?B5B:',FOF8XKTDVOR99>B6RLZGKM5/7ZPSGE%"RRB7:%MC^
M<:C+XY.\^#TMG"8DC 9:-BT8+>.I!9(D]F FK;JD4]W#]-&F*3%ZBGNQ)LK$
MW/G]4%-E@GJ1ADE-3!A&=EG]5E:_4]9L!^N'+K\B>*]34>!Z5Y?]!3N2>EN
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M;@C."%< >+YB3!X;JH/V/PV3?P!02P,$%     @ ?#G\5.7L%O%M"0  B4T
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M[ !4@(BJY@_;A0 U:8BJ%F&I]?W204>BIXXC<1*!T)WR7;4^YVC+H+)'5+4
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M8M.5]<BI!2U*VU-70F.'MML,IS1(8X#_4R'T3C .VKD?_0902P,$%     @
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M!?V[_L(61J^[2\/8.!L?C)PPF'5&E\4&3NV#:]**GIP0O2:<UTDF93D! K^
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M8)I,V,+HW LN^)K0THI$DFM4<C<DE7NWUOLT1V200>%[7!%(ICG*:+[VZ+J
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M)HP4T!H5X):9H[SUN $HY;<"*H2_\J*[JS#5ZM\SA::AK!JX.B#]!$#LC3'
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MASUFPHUY>'"Z\+?4<^V<SOW7%.4M#"W [PL-DZH'4M#\M\79_P%02P,$%
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MN(,L<.N!%D_H8,*:=+QF]^5*4E!$@-'15I5O]#!9Y_ <M<>R'YWC\P(6)U8
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MIJ">T7CS&@U];IA4F5.E7GQGA6]T'1L56% ;^(5X21GE-,+##5MN93-5EC8
M@!9U3# 971/T4AFZYR<N:]XDCN-E;6)T_+ Q,><.T_V#,0KEX*1+TK<M%PMR
MG9-PB-Y2Y<L.C[TNHD8]KQT*,#K+HYJ*IE+X=:5(]@_IIG8.BN9E0&O9)NA,
M5^(F;"L8*D?>8$/8O-N<NA(ZJJJ<?=8X&-F\T$%RM,_&:.)!.OZ7S%OVH*8;
MMA_M&HYW@[;3P.M62*(,X[:13*SJO=D5\^.M?227?#W_$Q4K.ME*E4LX!1\0
M8(]C7?";U4A*\D[ +.BX3<T8M?:#;3'=M0HG' <"N,:M(P)+&Y"RB[>I,I.
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M'Q;T*T'M FA^H93=&FZ!YN<T_@U02P,$%     @ ?#G\5+$0=J9$!@  =14
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MJHDWX/G<PO[FAA5TG_8N_@902P,$%     @ ?#G\5$R[T;A*!0  U0X  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULK5=;;]LV%/XK!]HZM(#KBWR)
MDR4&DEZP%.L6-,WZ,.R!EHYL(A3IDI0=[]?O'%)VY<9VMJXODDB>^_GXB3Q?
M&7OOYH@>'DJEW44R]WYQUNFX;(ZE<&VS0$TKA;&E\#2TLXY;6!1Y4"I5)^UV
M1YU22)U,SL/<C9V<F\HKJ?'&@JO*4MCU%2JSNDAZR6;B@YS-/4]T)N<+,<-;
M]'>+&TNCSM9*+DO43AH-%HN+Y+)W=C5@^2#PA\25:WP#9S(UYIX'U_E%TN6
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M,LH*V_S)99W/H1WLMX5I:PZHP0$7O57W0R)B1. F8+(?#-A#GB'J$N%/=.Z
MTL]3NH=F/SL]?3Q*8R KJ(\8?9"P6.2,HUVZ4[M-6(;$8%,VAK4^;:4JO['%
M2ZKS_HNS%UY8:JI!(;OO@;.SY_$!AET0O!"PS%2U3>Q4<9577O( S:+75JK7
MXKZ.A+B^;P>/2:"G.]BAH7T/D@C5Y\@EMV30>N8/:ANBV4>9B%ZVO-VXW&#\
M,'5T$4:+IS7XG!)2SOQPK?-P"(5A1RLY>R*P&QI!+2:)R.S=R:G?";M]Q)C1
M"$3L"J8J/?AO3XD 2^789&6#5URK'H\1^=I;F;LOC#X3]:^1P::]J5I[X/53
M8J%\Y:0'L/6I78+BZ?;?3J[(4P1?O<PN)!?B4<E)%)%HFKFJ,R(=;"I'!#C/
M>5\:M!5S0ERMQI*5Z# D?,YZ67)(+Q&+&CGRV2=25C4G&%R!V&TVX=@*RY*)
M)9MRCI4Z0CMY9 C*QW"3>IEAV$I\)XXT$%"V.I,?D SR:UPO0$HTT-&$Q!C9
MC4NXH],T[7B<QK1\4))^64Y:$C=LNX)HTXE9#,X<<C:Z-SO+L8+6^P*$B(H$
MB$U!\E 27 2PZYC"J<JY:V1SM#O[8&U69=6'6B=GAZ0;F7Z5:<E*1VP=F2/"
MX(9$+-(2\-[8BI\VD-/7N4-@P":91M[]<#[2^\WK8Q7[^X4JIII6;N*M3=(X
M 8X^ZDQ#,'E@W0%1/@H3W)XDJ;I_-L"]%Q,5 Z-AUTX,WMRQ@T!7BT#W7BGW
MQQ88>QFCM-U+3@>O2T3QRZX\T6]/1V+UOH]D>Y4P@KH=S'ELAXV?GM&?%_$'
MVMD%2/F+A]"Y!DF/R'P<TW\_*5GH&(^.L\>CTT>GV=GHZ=E3]4_ZTD#O)2OT
M$?W7L?_,D&@</U6(S%TNR'A/$J\H'1E5X^?]WSZ1"/IHO[EI.<H>[3SYD62;
MF2Y:Z% 10T^>9T59/%#-U+M=H[,GV=O22DC&:[5$$NR5+0G'(^V4"I*$L>,T
M&D 6Q9?$C>M$L EY@G(X#I*FR^,.LB.I >AJ6V7=76K%$@;H(I':'CPDG>M:
MB2 [1K"YALO;@\UX].C%TUT8S'-4%R$!Y)-R7J9QYKVH35,2B<TTJ2LQUE0H
MNSTRC82>U+\@IE>L755ZV>IU!U!D0W' 3U^O?&V ,.KNRF2:D#[=,MB6%IQ;
M2V(MHU$&4<\@DJ* !+=>/<,+$ .."6S\XL6S["A[4Y6. <IBPZK)( D2(H '
MK/4YQA;#%D[S/(QP9!HW=J:S^X42/.8<"H[$JLG=P[ ?99.6HX\+-V&I0RM9
M=G-CJY;D$8)'^LB)TH:?F@WW9 1^F!8C$FUW.8:-;S)_3S43>G#S)RR KL@E
MW"^J.N3[3OGIYZ!Y0W;I0TAWL^"&##LLCTAB=)#L]T"_CUZ0:3FX/2*0\>AT
M_"13&B2;!5D(4S5;I<5X,^L!34#^^MMO'X+R]2:0)R;/</5T49:YUJCP[U&2
M( .=)Q;'*$,="UV*-#N54HA82Q.6<B+SNYI3W[$(HS HMPCI=="B);&J1$OT
M& < 1>^#6-C HS,?:Q-E]ZGD;'2!XC;>$D:^($.6A$+A3.#DCW#"_+83C'N0
M$LS\G6\_>)Y'4569KYF*HQC>B'<GYJ=2KUT[B3.FUK%8'YW]@(=XI)H99R-I
M7]$BS.^$9\[+-P3T!R9'CBH=0(4=*K9F;:6XD7DD?T-PA+X\3)<8U152(KI/
M*>VW=SF%VE9<12"D-['#1K#1M>^SA\6,VI1Q,</(#TMA,4;"W,L\$8"*N \0
MS;5'*(;6'W[+R4+,NC^'=+(HR944:.VU*4=<:"1KXM [9U8A"-6(;0DV->)9
M1%\+X9Y)Y2F=S-K*(#-!3P8[N/:&,*I6:".%4989M()>#CN#\%BTN!"Y,&8V
M@PJ"#L<U' D-AOD>!J.)"C,SZJ2HFPF&'F+B\>D!-\;3:AASE'&],,."Y1'G
ML#%L*(WL+#I-?265D/Y>5!OXK2:5.YKL+VY3MHG9YIUO7J8CT<6)-)32G+#2
M^+DUP)POLA0S]<J1)VTJ,A&E9%1,(\Y=)"D"3Z-O?3T@KIU?$R98*1_1PEWA
M#:MC^J?9P!=/2D4O%Z0%5]G'LJH(#5TB(08_"<+M\N/[(+*8130=*-+"5XHZ
M_>Z=B32<B-2JY?#6CA=]LL<LO[+B5'Y%AFL/>=;NVY!I.5*FO]TPQH6B[/N4
M2-CK[ !6'NH;KHB1V:Q(8TU\QTR<(4[UAZ2A9#[\+5\DW?>2\(MPQ:^F:%$&
M1X;7"TYL:_0L&M!=<_G("V^"0,]L/AX-E?^0<]U66EC\['2/;^<*Y1AE@TV7
M44ZR?_J!44."+"'0D/",CWP&+E&=$^=^_,23*JTBE!%!-],O6M>%9PC4\L Y
M\=*-@3\VZJC:9_A>%@62A5/2;GR#]UB.QJ?T[4/9NIKX3)_N.EE'3W#)$??0
M_ZN5TWOH&UEW#GIMQ$[;+V:YJA>H.>(;<.E7A%6W\?O_+JL;&>_SPI6P 4?9
MI2V*>INO#2\6=WY9E"3DW]<Y2QM<^4KW6$*<9;,1EW]'>/"?KB+]@\?.R/3^
M7*CSU'<3L2&Z-M(Z.(!4\:XQ?1>*L"+X>TB3\#_JS2K03QD*";7HUW B2X1-
M03ME!J U"0;/GJ0^:I=  RD%6MPAA;"6J*.)C1YI02O4F18.Y(@/EGG;:&34
M[G,+LYY?Z!.5'98[($'7"7GO.KW#V_0VF^>"7<ET<HL7ZT.4+P?B06R,1 V>
MI]6[^^48 1HI;D:H5SI#D:4T/Y0&OJXKU):D5]243:KLU119NKJR6N>CJ8->
M1&TGXE805QH>-1HMY"M7*,S@B#]9K6!^-63XK$*\DU.VD+&MUOK7*T>&DWR&
MMF%;4(O?N_;/H+7%1HDDH^BV=FG9XFWT9),O:ANE1?G1$_2DP?D/)9C&/:C\
M"0$ U@^1AON\0[$7A5QMMQ.LE]+,%&L=-UELY:X##+_*3G+[,)1W^T!&E-?1
MODQ_HW%I00S]*8ZE*(_@( !<-[)/<2;!K][O!.4U<N^<P(2R[^$ [DB3.W^T
MQ328PRCNE.BD[/0D>SL0\F1MX=E/'+6< *Z#2Q)"PC H_2"4KM)P%,I5V<!F
M_8F9^9B9CS>'@Q@ 1Y<#M+R1V7#I&J4K!A7L+)EEPJ77P;&_"''M#P:E&@JM
M<Z3F&E).]/U\2HKU4Y2CN]459"3PN3[.E\1"!8[:[LK?O33E([?DR^$?#L@>
M<8YS2KA!Z,J7O!U'\6TZ2N6P^)9":@T!BSP\R2X6!J%"!)J%/L0>#**67<P=
MQAB2M5IQ."];IIP[Q@8/Z "D?(F"W,IF+U',_\Y.*K;""#1DT1FNEI<:JFXH
ME - $1@11G<%"PU.TLWGZM+,V3CF#ETQ& 5C>XG0O^%J/#W!P%#<B7UYG:2E
MW^+%,AQD!W[96D;UE8,_(;9QP??03LZ#3< U^-'N111_Y(N.+:?U FS4I.A-
M&<);Y =SU9$FEA2E/?,D$9DD;];!%*DL$383\<3.2V6%PZOWL:D0OZ,5%,Y'
MWU$Z(*J:R.!\5;E<?8J(1 V;(*+LY+@)=/^-S TS@L@!WE*U[11N>['C">BJ
M7:'F7Y;'TXFMP+/MO=$O-BPGP'%9BK"55%FR"$2)+)'XSR2;"B7P%'/C%UT*
M[UK'?X;.Z^\C]-/;"?T]<./9,6*N:G.Q;58[]I*47(9C1Q+S807H"_L'0OJ\
M1&"TM\1'IS$?WQ,/2O8I,_$HME/P/WBH1&V-N@G"+E97]TL;3AYU5N!)93Q*
M4B\@#2EA%) 'TD#"_H&L4*BD'@U*!%\_X,7 N=:6! [JN1VJ&$0H^&,DJEQ.
M2,]59NF4X,[;:P2J_@YJ.TQL=Y"C/$"/#&\7H5X(#A!#=T^>?W\E0XT-5@$G
MBA@J>-Q=(;%6@U+F.>DSZ_=-,9^[:CD@[H7."8CWS_9#9\B(#&"04PJ,G)56
M2X43"T/T^^RD,Q$OB,5TJ$">2RJ89T5-$3%=)/JTCJA#J6EA$!LK;\F&"; Z
MN4M>Y>7?D:?9&Y?SI,S[C'S9/^&ZFU&' B.?A$SN6RHY3@9RH2\3H7%Z.@I>
MAT7Q3+9:F!C<EH>_)W&H[#S KZ#QNAY*Q^TM&!H_?N)/K0:F]NY/#">EGL_]
M9X]WGO!6P[L@' FPU38MDMH1@8F6.7W45<&WV$,=&R>0)A=S2P)XA_^8:FFT
M=MH,L"<.$%;>L]R33&=L=#Q)/AM.=^B P^;#G(],5YJZ$<,@(8VGATP/7I,_
M!L/%TWVDBER9H#J?CY6.XKU*/3Y5.@"42;)7D:]Z"#AFM3OP"-ED.?C03R2;
M7C.$-!8I%5G(1_%Q!R2*R#TT>H"9CR/3]+0#20_*^CS8<%+75 KEJ'TOF8G>
M(TXE)ZFYW F%0[G4B552/PP\FLSRP0P.WK2<*-U9MT]M#2P6$^]9L%23R1E.
M[XC# :XC$Y'[G)P]XEL+-R6[@--SL0"KYBS,C#73VOHZJSTGI).G.+PG,9^8
MW4J.><T0_<;YB!^D6JHWHD1O6,5"T9-_#1;Q9UIHA=(D!ZR FHYX6/JF*#<%
M'T<,K0EP*23P!$HZ#'RF.=DV<A;/U7K^G0_"&*<8FTGG$MI#?'!.^.GD+6A4
M%9""4SZ>$\"6%8;[$R!>)?B@70]LVB!#PY.F<;3.;BM[K3;-W>=,T>(/[4-=
M%EZ4@#C\D*MVDKNID"KAJ=2S<ND:Q#!T8 )B78@Y;&>7+)+]*#H],K]C2YWE
MR^D*-[#-@8T%^N=*#ST4Y[=D[[(COR44<";;JLN<R;)N5Q*:3%:HQY-2XM>$
MXGJ(<^16'U@2#S!8R1#$238E+;,4J1 =7RY<.2"TY<"09,/IGR#ILW)%_I'Z
M$XG5=%@'5';.54U,)#C U1N4/#(NS?<G,O7$I-P[4Z.#=>>.O+Q-5G(AE5?Z
M^A3S$B)*4!@3TBS945J<8D+>\P!C'4L$DNC*RW0=NX^PVY _RE3*X)0K<[S)
M;7A@BPCHC&46L01F]VY6-VS.F&(ILT1TFG8=E]#W/D^?[WJ?J7Y,#06-^<&\
MRV(P3+/\7UFQFAFWH& ;02JAAJ)O]MO*Z;E6GZR4E8#\V2-<28<,L?%VO8$7
MHT>GIP,1\TYMB_<B!Q.\W?&>G3WK.(Y)\K!_"%!YBC88"@#@A?6*OG0A V61
MO8V0;YE.G+;!>6-9[TH]2BRI!6*Y?T^T7V?E5 ZT$ 9RLT6DO.6#^W)<-A=C
M C%ZLC)S6@'?ZFJBYYKEZHR[%4DT7&92XT./#^,$(Y^XYE0=:KRZB:S()9Q=
M@WE6D'#!\<5\.-F5E/YV"D%'^PM_.',)K;L')?VA(E=X]5 6N<RO8L 7[8F<
M]GLX.13MW5,O,'[T8H <[Y3ETQ0E1M?2#A_.EG,S^R6I#.^CG\AFHM?']@&*
M%[XS5<H9$ZYT"0\>95<W94YVW4W&V7(R4LFS&66?:S(FZYOM@S?(E.#HZ<?I
M1;E%"GDQ;_^--/9\/LK>8=<"C)]S^EAEQXE^NR6CG!:MR?K5/4K\76&L7HXY
M'B-F08=J#2W<^$]#@Q:TJX_3#X848(YJ5'[N"IV8B.!'!SP278<Z)8>2VR&U
M+:*V.W@J9:^Y/F?6C[0E05CMP)CXFQU-SB=IHNOYSLT)]W,L_0[(]U&N4-A$
M3C/?K=)(JBG>QY)(W^LEZ0*3"*4E.[:TZ9$P6:VM*I(#.RF)1R -)[F_LA<L
M 3[/^J/L9U--2>".=L.C^X-RD@Z(-T)^I&9"']T_)*U>DO"^^FLF;/10_$-N
MB);I#DE-5+(W?IM856S:D/;6Z/?+V VGO<,)IH1K+]'3"OAZB]X4:->!XA9I
M@H.#U0LS165[PHP'"$1IHIW4]E^M9/8"+_:I_5<I7W<)V]%ROEB'. 2F?F.*
MFYIF#O/]FYRX )3U@7J@_N!:H*I3_&X)RD:#(K^02TOJ,)TF'EKL*HP0X2W*
M;EEXGU5][2^K#LC;F1"/!"L28160\CD0[26#WHTZ]#\<C]9EQ8  LE,J[+@>
M7Z5F>/BP[$PS7H!,ZENE,?LTGCB4?^O$@$-L*ITR'"A2$U,.L*O@5>D_RKZ@
M*T&;$\(NS*IRI8K?MZV[+@RH=% )[E$+$4@)B'KPN2W'C .QJ491D>XZUHDN
M3WO>):L2NUNE&'W7?6)+ SOMJK%V=4<-\C4JL'<P3TRA1,Z5E3VB*A+4R51*
M.2)D#J9 U(,9QJ^/A7Z5I@M5*'R"WY324'U;4-JG[/^Z,B\]WN*JNI&UZ3DT
M&3,<_@PVXZZZD8)V5F[)$=4@A&?[&IGT>_@$_@D"VS<WTMYGP_V-OD8MLF?]
MTE6L3 KT61,8VO'X#,4SS8+ \%N!3C-)-(MF#5GN7L>/45 ]P>X062;]0P=T
M*;<J"?N03FS<XV4;G-T4+6'8G>*8T(=/UN#'E\56=LZ]Z,P,1>E"-:'ZK&O[
M):3. 0."P!<2014J;#QYDHCVS5)/?L7OVX(<\'KD:^E]_3T9UQ#2LX$2_ _N
M^IK\\^SGJFQ7X7<I0>L,&AI=7&#'Q18EHSIL_R<>OS,PW?SA8I0TK,FWI+S1
MA8A5;NIY6ZUBYIA5J*$][VJVHPIFCR@I.&(H!;WO,V''B5[0 ;*W .1;+\*/
MZF-U,2Y26O"]2'&>\=+;(?[B); CKA+236V=74T)RPWI^*0*(@U)=<'WT9FE
M>_ 6 8O[,6EW_S2N*A8R%CM6\VY^.LDBN]6JEP'URT@G):<VS)JT = $31I$
M 51OR>>$R=5FU=*#P8F?AKD^>N/2I\UIUM6P#O^>-7@-VZE)XCKAO=BX),%'
MM%MW< %AHY]WD>)S1]KJ@L_):W1JV'L-RR/W$5$"7SDS?N&7]:8J62C](V]^
MN!^3OT>][W+W,6CEDU>=(=-4#B7B?R'CP2V[$(G3[J7$_R(ID.4]X]Y1G=*9
MYT/3GAUF@#\/ZV$O6(.O<2V[!.%QT5W:\&S>2SZ0X'.%=H;C!%2(OX=*+I2&
M+2P9GC:?\7E%T9/P=>C6?;"NN[;J@0(=;- [X$DY^C"Y_/>(RR\X@MU>@^D^
ME>M '\\\3MZV:[JY1_N@RHUQ32<_+77NP9+;393",41C.!S+11!G4Y:S[+A+
MET_N0 M/[L*3M^#L[T$9^;Y891I?CCL*!;6\D@?$>;-9;CL',3UAWX^*X"C9
M;K(]Z>S1IT/?'.RGG&-RB^P"W8[=G7A#' (QL?;"A-@]64^TD>YB@#%!]O5G
MU2D-V(\&YVTU&A4[(U$DW8OCT1%Q&V%$2W6=-I;<J9+F'$@M!YTO=Q;NW96[
MN\-[O&"(CW@H$#9L[Y1AE#3AU/%."^ L."T^+'P>#-#W==T2?$XZ]ME%L-=_
ME_3[I=KKVM?M+S/1N+$908%_UQYHV;GX($?2_/(X7.>;+MK9S"VL39B#[(&.
MF+D2AZ1;6G662G]NC,07#X/E97+%B_?@/T?<#CF$H1\XO_!">Q'[E*N$@ 8>
M>RE%.+2MB-?UR6%C'3'%(:<T1(RZ3R/$>3C%J4D0PXFZG*,KY*==[_1][DK%
M.A&+G10BIL)Q/AJ%T"]^$<&@/]J.0/'=I)/:-\>^Y4H\]8GA('HXS[$O^.W%
M68V#KV!O"7:"1MII<\RXX6#MIJ)=SELX_B8<%HB2 9G%&>A03I61 PI!4CGI
M-8\[?)>P\4@V+)E;65(3(JP)&."\SYS/Y*#:@/L%55GLI\%]%[A(ICL:Q[<_
M$)P-^K457(O]/YU2G&_^KLW\=:5!FFA/>+P5 /8C#EZ1C"X:7V012B+C::CP
MUH4XRA(U!ER'%>E3BB7DM U+M007H3*",R>Q/9U7#7<MUS&34L.S6NF!$SC=
MTI7"RKE]K951NW%/(3R_,"&6(J"V!*W/F""CL+IVTDFAHOO;&M2C]01*LRH
M>]4(HZ1'DQ06!!72Z3'3J<#S)P,T"Q0[8OE:#:T_P<L0&-AD.$E?MUX,+>CA
M0$":3Y&20=Y7+"98@GV#%3X(K=W3%M!IGFW2^OKO.GP0?)HD[Q5V>Q(&>0-M
M="723"M16?V<OH@'=5DH(#[6H,) SPCM--9'T&HFH4!29Z>Q9#O<*3%#,4XX
MRI_G@_G<M ,!"Z7K:^1\]*0GZ7,SR5V]8*R$PH#8.E]/N/L?]D1$?:M!7M0:
M6FUFP[MK9-Z8A8O=^Y"Q$!KEON+ZS@2'=Y@DU!9S>6T17W:1MA=(.E KL0^]
MJ6#@1!..H?72\3 (MQ;!O1G.9P;K=N#U"(,3E:&LO?M.@L[-M,HA2(8CX+VW
M%;SC]+];RCM?N+5\\JJ!V(I="PE$5J34[>]N*Q6%OE:,1?/0/D*&D5-]!+ 1
M\D_IK/*P+UKPVY=6F8#;B6_G,-#H+)$LH2% (Z>*M-K#":.2=GTJR0%MB8*:
M#9Z?K:U.J?9PCY30IDIDKYWY>KG.6W&8QD2L%3@1"ZI:M8W9V\(EG3CPEZ?'
M?>W#6/YHUT1?R"*8Y_GC%@\T?2$4NYGOF=H)F<NLVCT%'KWQ;Z PM([-H9D2
MD*)2=TIB6])>^JHEKFE3Y84V.^$]65QAOS2Q\T1\B]=JL:WYW*SO:^-?YR'8
M[Q9[!Q)6R2L1(TE#2>/T2D#\='Q[^Y&=XA4T5:AN#+F*]6Y;!7Q_:W/8D-KQ
M )38Z7=4YB2\I#U!TG$!7WP#/+AO]*W<Z(#_F4RVTY2AVL:."!])#;IK4_AO
MZ(]0-L:W6E@;GNE%KP_#TTX?AK/0AP$/?;[)S:)<ZA"?2=B7.OINAX;T931\
MX8HL%SX<4M*^C&_:\$VV(@T;R.,D(#L>4WH3=+N@'^@YNO_$R)_J,=3I_!3Z
MF0P<UQZX<[@ZZW!/V-M[Y.#M,3"+V4C1]'\X#TULTJ(LCH2P%,9I.YT]O7-
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MRM("?+\TX"7Q#1W0_,CFY+]02P,$%     @ ?#G\5&8=NWSI @  = 8  !D
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MKLMV,2 H167_V5.;AXT%L7-@ 6T74(/;.C(H/S+-)N>R?B029X,UO#"AFM4
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M E7A8'&#O,#O)EVH^VJ1O52EJ$>\,$)LD9N<1KL(0O+IP&P\/?0>,HQ+UJ%
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MH6$%^K[2VNT?.,!P)U[\ U!+ P04    " !\.?Q4S R8L6(#   R"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R-5FUOXS8,_BN$=S>T0!"_YJ59
M$B"YNV$WX("B[6X?AGU0;"863I8\26[2?S]*3GSNEGK[8KV1#TD]I.CE4>EO
MID2T<*J$-*N@M+9>A*')2ZR8&:L:)9WLE:Z8I:4^A*;6R JO5(DPB:)I6#$N
M@_72[]WK]5(U5G")]QI,4U5,OVQ1J.,JB(/+Q@,_E-9MA.MES0[XB/:W^E[3
M*NQ0"EZA-%Q)T+A?!9MXL9TX>2_PE>/1].;@(MDI]<TM/A>K('(.H<#<.@1&
MPS-^0"$<$+GQUQDSZ$PZQ?[\@OZSCYUBV3&#'Y3XG1>V7 7S  K<LT;8!W7\
M!<_Q> =S)8S_PK&53=, \L9859V5R8.*RW9DI_,]]!3FT1L*R5DA\7ZWAKR7
M'YEEZZ561]!.FM#<Q(?JM<DY+ATICU;3*2<]N_XL<U4A/+$3&FCJ@EF$FR>V
M$VANEZ$E"TXNS,]HVQ8M>0-M"E^4M*6!3[+ XK5^2)YU[B47][;)(."OC1Q#
M&HT@B9)D "_MPDT]7OJ?X<)';G*A3*,1_MCLC-64(']>"[E%S*XCNJ)9F)KE
MN JH*@SJ9PS6/_X03Z.?!OS-.G^S(?3U8ULKH/;09^J:F\- GYB67!X,[) J
M&8&W:-:AC:#6ZIG[.J/#5V? 9-'; $T)8B!75)7&8N$<LR62FJ#R)@,+H&+Q
M6X_\]"H;@+A$S^5%XJG4B&_(W'!)Z2X$^61N/?ON$_=F0Q'!.\A&R6SNQWDV
MI3$>3:,)C<GH+KJ#^[<#CD=9,J=O,IO +,Y@-KF[W/WE B!-QQF\AV0Z3FG(
MLO&D7<7P?H#T24?ZY/^2_I6)AOGG:^,NF,D<KW$_B'<]19_ZK$%>,FW;-"@<
MZ?3>$L<Y%[RU?J9YAP<NW:W[M$!9N.ESYR.[^&C\M3J-&C577K3/KF-Q\0^.
MMTPX56"V9X;LOB#3Q%LZBNYFL"D*[DP9L.J:81_(@4S1<2]K\41-S)#MZ1P>
ML&CR80R-9.5?(#N4N.<6;N:W+H7IO9?T0FN-,G\!>CZD$2W23?PJ&HK=Q7&^
M"1=)-IG"M3P)>^]XA12'ZU:NVAIIVR>]V^T:XJ;M ]_%VV[ZA:Z!4X@"]Z0:
MC6>4(KKM4.W"JMIWA9VRU&/\M*2FCMH)T/E>*7M9. /=;\+Z;U!+ P04
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M%EW5=N^VY"F/7=\#YS/NQ4AZ(9HB2+Q,13PBAY.)M+'QG>9B/I="9;ZE"HW
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M*CHVH/W"VK!_X03]]7?Q#U!+ P04    " !\.?Q4,VIRQ+H"  "U!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6RM56UOVC 0_BM6-DVMU)$0TA=U
M$&G IK5:-U36[4/5#T<XB$5B9[8#[7[]SD[*Z ALE1J)Q"_W/+Y[[CAW5U(M
M=(IHV'V>"=WS4F.*<]_728HYZ)8L4-#.3*H<#$W5W->%0I@Z4)[Y81"<^#EP
MX<5=MS92<5>6)N,"1XKI,L]!/?0QDZN>U_8>%Z[Y/#5VP8^[!<QQC.:F&"F:
M^6N6*<]1:"X%4SCK>>_;Y\/(VCN#[QQ7>F/,;"03*1=V<C'M>8%U"#-,C&4
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M4^X9^ZHG-^G,\?2.@$(B-056CRW,@5+-I/;QK29U&IT:>#C>LU\;XY4Q]UC
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MXU5;6TTD*TS?=L^DZ@+-< -8.5@+J/<KQN1^HA4T?RZ$_P)02P,$%     @
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MK"+??WKFN8V'H'V%WU"5,:$)AP7"O(L^2E/EP[;L&+DJWH8S:?"E6327^#$
MRAK@_$)*L^O8YV;]>9'\ E!+ P04    " !\.?Q4!E GV@4$   '%   &0
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MFTO ,7 MH.;GC,EM1QNH:G^3_P%02P,$%     @ ?#G\5,"?:([5!   S1D
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M] 'XSGO@.9YGR&?Y\G#7).?_S;YZ]>P=,_QV__@5G_^]_=/N#/#7XU9(KDZ
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M$HH'NOV)%!WJIWP>#7GV%VP+K&4 +^&"1H6Q]" *XOP_?BX"L6<@>=0&L#"
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MPFB16PUPDD[5IUC*"4>W?!Q)G@^^(4X(16HMENE27\5]$K*8H!,M[&FEGN$
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M^]E.R""XM-KZ K%]SKD^]SKQ[6T9?Q!+ (D>RX**OK.4<G7ENB)?0HE%AZV
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MP>]ZG[ZCST'["OZ1V_[UEC_TB )%H^76W0+_]$GR)QG=QW05Y9%,6JP.VG2
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MA$V!\-P:IDV!:;_ J768-05F];;?;ZQZ2T>\Y/,;)5^)JMZM:=6#.JZZM-[
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MR@*W*CMV]$0R&=<7TQP-[_K]HRBHL(+2*)3&4#3[3AU&6(5.3?(=GK.VFLG
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M!TN>%@<?G7.=Y7?LG!5H,Q;5)*HI5-.H9E#-HII#-8]J =7BCCO?R?;.EP9
MVXP=?T<SMN-DL^?!,-J61;42U02J2513J*91S:":136':A[5 JI%2DL#J6W+
MCO&V[!AMRZ):B6H"U22J*533J&90S:*:0S6/:@'5(J6ER=*V9<=L6S;/=8X5
MM"V+:@+5)*HI5-.H9E#-HII#-8]J =7B1GMXS#S:/18=MVW98^Y)9_-4UYQ
MM1+5!*I)5%.HIE'-H)I%-8=J'M4"JL7CW-/KICG1UEB/O^-)9\]N+RXF5W7]
M\ &2#_5J-:TO]CT8SF_;.5/0KBNJ"523J*903:.:036+:@[5/*H%5(N4EL9/
MOXT?_"EGC]&Z*ZJ5J"903:*:0C6-:@;5+*HY5/.H%E M4EJ:+&TS]CC?C"W3
MN>>GXG,UO:UW!LK3]MZC/^-VEM^K<TJ@95=4DZBF4$VCFD$UBVH.U3RJ!52+
ME/8M)0Z7S=2R*JM5=?KFNEY<UF?U=+HLSN>WLX9?#T7;MQ:+^E.3(KV??^D?
M'#8KVP\_?7/3)$>H%I>3V;*8UI^:I4>OCD<'Q6)R>;5]936_69/%Q_EJ-;^^
M>_&JKB[JQ?H#FO=_FL]7]Z^L-_@R7_Q^=WFG_P%02P,$%     @ ?#G\5*5>
M;0<Z @  ] 0  !D   !X;"]W;W)K<VAE971S+W-H965T-C(N>&ULM53;;M-
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M'HZNE'6R$C"VIH(9"6H(C^'H$DE(Y8_SE/C,@$S++?^XY<\.\']KS"GT>R?
M6?(1[F>7</3V'YJ4)7>ZLTYW%GD'!WAW0A]N4<_1_83?\,4L%<+467;S#!.^
M*G\2/6 7]9+^5\\)-7'A:U'B*.&D]^C6F!3OWIR=]SZ]XJ+?N>A']OX!%S?6
M>_C["AYN. :N";5_46[_/\@=='('K_[T6_$D=:-A'K*#&P((I4()H*F$(?^2
MW);P/!*&!K$N.!':)T_7^UK2O20._>!6N*4T'A0N&-L[?<\5Y-H::R=DZYC7
M<TM<)7&XXK:$+@3P_L):VDU"J72-KO@#4$L#!!0    ( 'PY_%0:Y-EO1@H
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M4S-1F6_90E4"2I,HFMMV3-81P[NE8JAS0&D217/3).>((=U2/,4[P?9N*=2
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M"QP9R #>+C6 ^@>4)E$T-TWRCP&D78JG>"?8WBZ%&M"-A41BP(O$;_J+]X%
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MKH O=R1?%\NC'[B4/"DV5XS.698W4.<7G,O=3NZ@_C^$Z;]02P,$%     @
M?#G\5/ER;>;>%@  C;@! !D   !X;"]W;W)K<VAE971S+W-H965T-C4N>&UL
MO=WM;MM(FH;A4R&\@T4/D&F;^E8V"9 VZXM5U1-TNG?16.P/Q69L;<N21Z+C
M#C '/Y2LF"I*+IO.[?F3V+)X%2VY7O&E'K'>W"Z6?ZPNBZ),_KR:S5=OCR[+
M\OKU\?'J[+*XFJQ^7%P7\^HGGQ?+JTE9?;N\.%Y=+XO)^6:CJ]EQY^1D<'PU
MF<Z/WKW9W/9A^>[-XJ:<3>?%AV6RNKFZFBR__E3,%K=OC]*C;S?\,KVX+-<W
M'+][<SVY*#X6Y6_7'Y;5=\?WROGTJIBOIHMYLBP^OSUZG[[VZ<EHO<7F+O\]
M+6Y7.U\GZ]_ETV+QQ_H;<_[VZ&2]2\6L."O7QJ3Z[TMQ6LQF:ZK:D7]LU:/[
M0=<;[G[]39>;W[[Z;3Y-5L7I8O8_T_/R\NW1Z"@Y+SY/;F;E+XM;76Q_H_[:
M.UO,5IM_D]OM?4^.DK.;5;FXVFY<[<'5='[W_^3/[2.QLT%G], &G>T&G>8&
M#XW0W6[0;6[0>6"#WG:#WE,WZ&\WZ#]U@\%V@\%3-QAN-Q@^=8/1=H/14Q_6
M\7:#\5-'2$^^/7,G3QTCO7^R]Y[M!_\\OCW=Z=[S_>".?7O"T\TS?GSWM[CY
M0\XFY>3=F^7B-EFN[U]YZR\VLV&S??7W.YVO9^['<EG]=%IM5[X[7<S+Z?RB
MF)]-BU7RP\\??/+^_/^KD:O962;9='5]4Q:KOR8_9$4YF<ZJK_Z23.>)G\YF
MU;Q;O3DNJYU84\=GVP%_NANP\\" :>*K(2]7B9B?%^<'ML_BVW<?V][$MQ\\
MMKU]9/\[$>"X>O3OGX+.MZ?@ITY4])/ECTDW?95T3CJ=Y+>/6?+#7_Z:K,I)
M61S8O=,X]K&XKK"3#98^B&1Q)+^9WR/W>W2 $<_XQ0XP,LYDQ=D]DT88U>:1
M>9C13W]L8HQYQD/\X/.5,_MDG_Y GSRZ3^[)6#IZ$/%/1_J'?[%@RG7OJUYW
MXW8?<-UBM4K"TO>_KKI/8LKB:O5_AZK:'=@[#*Z/KUZOKB=GQ=NCZ@!J52R_
M%$?O_O,_TL')?QV:PR26D9@@,4EBBL0TB1D2RTG,DI@C,0]AP>SOW<_^7DQ_
MYZ;E]&*RZ1M615G.BO6QSJ$Y'V7:SGD2RTA,D)B\PP8;;-TV?GDW/GES_&5W
M)I/C:1(S)):3F"4Q1V(>PH*9W+^?R?WH3-;%9%9>)J>395&]G*_*Y)?B;/&E
M6'Y-WF_."U0OZ[ZX^E0L#[ZD1^VVTYO$,A(3)"9)3)&8)C%#8CF)61)S).8A
M+"@$@_M",* /Z ?D[">QC,0$B4D24R2F2<R06$YBEL0<B7D("V;_\'[V#YD#
M^BC3=LZ36#;<.VQ.3TX:!\Z"'%&2F"(Q?>"QZ#0?"W/@3N/FG?+].W72YITL
MN>^.Q#R$!7-J=#^G1M$Y]<$GOWU\?W_\G/PS^;Z#[>AH;:<>B64D)DA,DI@B
M,4UBAL1R$K,DYDC,0UA0&L;WI6%,'VR/R=E/8AF)"1*3)*9(3).8(;&<Q"R)
M.1+S$!;,_O2DC@R<Q ^WU_/_['[^?WV5S&_6K_O)XO/=&WVKY'9:'2G<'8N?
M)[/Z\'PZ/YO=G%?;)3\7M\GOB^4?KY+5S:=5\8^;==Z@^/-Z<A<*^N>#;QG^
MM-V[_LY177<8'M.=QG^#MC4"U02J2513J*91S:!:CFH6U=RAO_!!^!?NJ1'#
M&K 3&TI;UH"S97$^+5=)N:CJP.=J[B?7DZ_K1OQP2"C*MSTB0+4,U02J2513
MJ*91S6RUW4F0IOUFAX^.:5'-H9JGM'#"=^H)WVE_CNU5,KE:W-R]<!=G9?5:
M7\W^3T4RN9TLSZOO/B\75\FBO*R.#:XGR_+KP4H0';=U)2"U#-4$JDE44ZBF
M4<ULM=U*T$OW"@$YI$4UAVJ>TL)"4$?GTF@VY[M.#%9W_KAM"G;J2>RT87QG
M6E<'-'B':@+5)*HI5-.H9E M1S6+:@[5/*6%9:3.X*4]^B1B2N:63E$M0S6!
M:A+5%*II5#.HEJ.:136':I[2PEI0I_C2>(PO=D)Q<GX^71\E3&;?SBT6?Y;%
M^J,W#YYDC)T[1#-_J):AFD UB6H*U32J&53+4<VBFMMJP5G&?O,LXTN$^M(Z
MU9=&8T/?VVM\J.K$^KV&I_8::"00U3)4$Z@F44VAFD8U@VHYJEE4<ZCF*2TL
M(W4\,!WBO08:%42U#-4$JDE44ZBF4<V@6HYJ%M4<JGE*"VM!'6M,X[G&?V.O
M@48>42U#-8%J$M44JFE4,ZB6HYI%-;?5@C=SFZW&2T0:TSK3F$9#4\]I-=:7
M)3CI)8UKID0[##0'B6H9J@E4DZBF4$VCFD&U'-4LJCE4\Y067L&GCD1V3N@.
MHT-&QDY1+4,U@6H2U12J:50SJ):CFD4UAVJ>TL):4$<C._%HI%B5TZNJ)UAW
M%-=579A^FA7)Q60Z/U@%T!PDJF6H)E!-HII"-8UJ9JOM?HBQ.QHUTD_HD!;5
M'*IY2@LG=QV#[,1CD'B;T/YMBO@>MBX9:& 2U02J2513J*91S:!:CFH6U1RJ
M>4H+:TN=K.S@5R7LH/%(5,M03:":1#6%:AK5#*KEJ&91S:&:I[2P%M3QR$XT
M<O7DSUA6=UE_HK(X3RZ+R;*Z\RKVED1\T-;E@M0R5!.H)E%-H9I&-;/5=D_4
MCYN]!CF@?7Q AP[H*2V<V'76L?/\K.-V8L\7Y?U;C;')C&8942U#-8%J$M44
MJFE4,ZB6HYKM[*</FY_I<NB(GM+"B5]G&3OQ+.,3)_YT7MWIZGHVG<S/BKO7
M^&)UMAYM?:>;(O[ZCB88M]KN4]0)GZ$,'5"@FD0UA6H:U0RJY:AF4<VAFJ>T
ML"+4L<3.(Y<M?+PB?%\U0#.,J):AFD UB6H*U32JF:VV6^&'S:-]-)B(:@[5
M/*6%U: .)G;:!A//)U>3BVJ*KQ8W%Y?EJ^3+9'9S>**C24-4RU!-H)I$-85J
M&M7,5@NNA-IMSG0T/XAJ#M4\I84SO8X:=O[-4</X>XC53S=F=53Q<3(KXI=I
MC>]ZZU*")A113:":1#6%:AK5#*KEJ&91S:&:I[1PP;,ZH=C%$XI=-*&(:AFJ
M"523J*903:.:0;4<U2RJ.53SE!;6@CJAV&U[\<9E<7YSMY)RN:A^<G>TL%H?
M+1PL#&AH$=4R5!.H)E%-=?>#@9W&AVHT.J)!M1S5+*HY5/.4%D[W.K/8?9G,
M8K_-1YOB^]"Z)J"I1%03J"913:&:1C6#:CFJ651SJ.8I+:P>.TLE\VLELXLE
MLZLEL\LEL^LELPLFLRLFLTLFLVLFLXLFLZLFL\LFOT0JL5NG$KO1<%2[CS;%
MK=95@-0R5!.H)E%-H9I&-;/5@@S0J-'"Y.B0%M4<JGE*"R=WG4SLQI.)SVT3
M!JW:!#2TB&H9J@E4DZBF4$VCFD&U'-4LJCE4\Y065H\ZWMC%5V#NHFE%5,M0
M3:":1#6%:AK5#*KEJ&91S:&:I[2P%M3!QFX\V-BN34!3BJB6H9I -8EJ"M4T
MJIGN?DHQ[?>:;0*:4T0UAVJ>TL+)7><4N_C"T)LV8=BJ34 3C:B6H9I -8EJ
M"M4TJAE4RU'-HII#-4]I8?6HLX]=?.WH+AI)1+4,U02J2513J*91S:!:CFH6
MU1RJ>4H+:D&OCB3VXNM(MVH3XE;;*H!J&:H)5).HIE!-HYKI[:^:G(X:"YKD
MZ) 6U1RJ>4H+)W>=,>S%,X;/;1-&;=J$^#ZT+@IH$!'5!*I)5%.HIE'-H%J.
M:A;5'*IY2@NK1QU9['7H-J&'!A!1+4,U@6H2U12J:50SJ):CFD4UAVJ>TL):
M4 <0>_$%I]NU"6CT$-4R5!.H)E%-H9I&-;/5@JO:])NKR:-#6E1SJ.8I+9S<
M=:*P%PTU/;M-&+=J$\B8UBFJ9:@F4$VBFD(UC6H&U7)4LZCF4,U36E@]ZLAB
MKX^W"6@ $=4R5!.H)E%-H9I&-8-J.:I95'.HYBDMK 5U +$7O[YBNS8!C1ZB
M6H9J M4DJBE4TZAF>@<N?IDV/YN #FE1S:&:I[1P<M>)PEX\4?C,-B$]:=4F
MH$E$5,M03:":1#6%:AK5#*KEJ&91S:&:I[2P>M21Q=X(;Q/0 "*J9:@F4$VB
MFD(UC6H&U7)4LZCF4,U36E@+Z@!B+W[QQ79M AH]1+4,U02J2513J*91S6RU
ML$UHKLZ(#FE1S:&:I[1@<O?K1&$_GBA\;IN0MFD3XOO0MBB@6H9J M4DJBE4
MTZAF4"U'-8MJ#M4\I875HXXL]E.Z3>BC 414RU!-H)I$-85J&M4,JN6H9E'-
MH9JGM+ 6U '$?OR:B:W:A+C5N@J@T4-4$Z@F44VAFD8UL]6"SR8,!HTV 1W2
MHII#-4]IX>2N$X7]>*+PN6U"IU6;@"8142U#-8%J$M44JFE4,ZB6HYI%-8=J
MGM+"ZE%'%OL]O$T@0U>GJ):AFD UB6H*U32J&53+4<VBFD,U3VEA+:@#B/WX
M-1/;M0EH]!#5,E03J"913:&:1C73WU\4N9,VKW2$#FE1S:&:I[1P<M>)PGX\
M4?C<-J';JDU DXBHEJ&:0#6):@K5-*H95,M1S:*:0S5/:6'UJ".+_2'>)J !
M1%3+4$V@FD0UA6H:U0RJY:AF4<VAFJ>TL!;4 <1^_)J)[=H$-'J(:AFJ"523
MJ*903:.:V6I!F]#9:Q/01"&J.53SE!9.[CI1V'^1Y9S3!Y=S/E@4T"0BJF6H
M)E!-HII"-8UJ!M5R5+.HYE#-4UI0/09U9'& K\L\0 .(J):AFD UB6H*U32J
M&53+4<VBFD,U3VEA+:@#B(/X-1-;M0EQJW450*.'J"903:*:0C6-:F:KA5<Z
M:GXV 1W2HII#-4]IX>2N$X6#%UF%.6VNPKR*]@GQG6A=%= H(JH)5).HIE!-
MHYI!M1S5+*HY5/.4%I:/.K,XP)=A'J )1%3+4$V@FD0UA6H:U0RJY:AF4<VA
MFJ>TL!;4"<1!--74LD\@\U:GJ):AFD UB6H*U32JF:VVVR=TTVZS3R"'M*CF
M4,U36CBYZTCAX$6684Z;RS _TB>@6414RU!-H)I$-85J&M4,JN6H9E'-H9JG
MM+!\U*'% ;X.\P"-(*):AFH"U22J*533J&90+4<UBVH.U3REA;6@CB .P'68
MXU;K*H"&#U%-H)I$-85J&M7,8'\=YLZXT^P3T$PAJCE4\Y063NXZ4SAXD768
MT^8ZS(_T"6@8$=4R5!.H)E%-H9I&-8-J.:I95'.HYBDM+!]U:G& +\0\0#.(
MJ):AFD UB6H*U32J&53+4<VBFD,U3VE!+1C6&<0AN!!SW&I;!5 M0S6!:A+5
M%*II5#/#_868.WL+,:-#6E1SJ.8I+9S<=:AP^"(+,:?-A9CC?4)\)UI7!32-
MB&H"U22J*533J&90+4<UBVH.U3REA>6CCBT.\968AV@&$=4R5!.H)E%-H9I&
M-8-J.:I95'.HYBDMK 5U!G$(KL0<MUI7 31]B&H"U22J*533J&:&^RLQ=_?6
M3D"'M*CF4,U36CBYZU#A,)IK>G:?T%R)^9$^@8QJG:):AFH"U22J*533J&90
M+4<UBVH.U3REA>6CCBT.\:68AV@&$=4R5!.H)E%-H9I&-8-J.:I95'.HYBDM
MK 5U!G$(+L4<MUI7 31]B&H"U22J*533J&:&^TLQ]]*]]Q/04"&J.53SE!9.
M[CI4.'R1I9@[S:68'^D3T#0BJF6H)E!-HII"-8UJ!M5R5+.HYE#-4UI8/NK8
MXA!?BWF(9A!1+4,U@6H2U12J:50SJ):CFD4UAVJ>TL):4&<0A^!:S'&K=15
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M@%-:7-/L><W:IHJEOU=TRX"O3+53!ZO,955M:JXV%=6IJ2,^NC[3E593S'O
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M)7N0YI774"*>L%1QD2+)EM>#F^ #P5=%0'G$7YQMU=YS5$SE28A_BQ=WT?7
M+\Z(Q6RA"P0U#QLV9W%<D,QY?*NA@V;,(G#_^8[^:SEY,YDGJMA<Q'_S2*^O
M!Y<#%+$ES6/]66Q_8_6$Q@5O(6)5_D?;^EA_@!:YTB*I@\T9)#RM'NGW.A%[
M ?CR2 "N _!A #X2,*P#AH<!%T<"1G7 Z##@V!S&=4 Y=:^:>YFXD&HZFTJQ
M1;(XVM"*)V7VRVB3+YX67Y1'+<VGW,3IV5RDFJ<KEBXX4^B$O-_03$CT($64
M+S2ZYYJO:"5I&J&[/_]XW'OO%)V$3%,>J].II\W9%$QO48\\KT;&1T8.T"<S
M]EHADD8LLN,],XMF*G@WE5OL!'[,XW.$QV<(^QBC+X\A.GEWBA8QY4G7V;EA
M-YD\1T._A/D[6 <F?.V<T@:#44RW*N<:+<PWNX-%WC*_2<D*NN9E96W8? &&
M)75TA+I3?$_IKY]8\L3D/QVG>.N$%57M@\KH@ET/3-E23&[88/;S3\'$_Z5+
M DA8" DC0#!+D5&CR*BD#X\H<B^40O9U^?7>'(/N-$M4IRHC2%4@82$DC #!
M+%7&C2ICYW7R>UY<$T@LRZM7(7.GCHQ 76HX07W5@(2%D#!2P<8EK%B/;&9X
M@B=3;].1Y4F3Y<D;LZS77$8HHU(_[^JF0O_MGG:EW4GNFW9(6#AYD:EADZ8J
MET##63F_:')^X<QY>5-WU7QG>-_$0L)"2!@!@ED:7#8:7$+7_$M(52!A(22,
M ,$L5:X:5:Z<5T:IRJ)1Y?D,130Q[9,R+=)";)BD3S$[0QL:Y\S4IG==,CE'
MZ"M3!9OL%1+?+B0AY' $"&;E/O#;SL1W9O\Q?U+L6\Y2C<BF^+^K42;5/5>M
M[I'ZJ@!*"T%I!(IF:[;730;0=:PF0FD#20M!:02*9FN#6VTPU JV)NVO6$;^
M\*#6S-WC]<XU)(U T>Q<MTUUX.ZJYS$U%\)-98;=UVW_7OV"K&V@+3DH+02E
M$2B:K6G;E@?@?7D VIB#TD)0&H&BV=JTS7D UIT'+_O6\>5A90/MND%I!(IF
M9[IMT(.W=NAUCBLG4IT5"V4E8AY1S2*T- 7,C/]>2TYCE.4R$T:73CTZNF-\
MJ =H.PY*(U T6X^V>0_<W?M#K<*=>=CP*#?9OM_9)3_HA@/J!X#20E :@:+9
MTK:>0 !N"@2@K@ H+02E$2B:K4WK# 1N:Z#/#>?JI5%Z-;XX+'&0G7L(2B-0
M-/MGO=8(P*\8 4SKV-Q3.NH3;&5SGT??JP>4%H+2"!3-5K2U"3"X38!!;0)0
M6@A*(U T6YO6)L!NF^"EZ5DM\)"J+L,SE):UKU.D#M_@H,ZY1^^=>5#3 (IF
M9[XU#;#;-/B81ZO$5#!S-Z$\0B<TRZ3XSA.SH(Z?3X\9S#5TWQ3&?O5WF'K0
MWAZ41J!H=NK;WAX[^]-F%?V#?!OSZ9RF-*+NVP^H6P!*"T%I!(IFJ]VZ!7@,
M?OL!_5$?E!:"T@@4S=:F]1?P6_V%5Q?6^-7?U>?NP7HG&M0X@*+9B6Z- _PV
MXZ"[7/5=.8-Z J"T$)1&H&BV:JTG@,$] 0SJ"8#20E :@:+9VK2> .Z[72 ]
M*&9;KM?%.AI5MFAAE1:;FH[L![UUC]=;.5"' ;]T-<8'FYJ@!JSD\/8V.2=,
MKLK=Y46^\U17^YV;=YL=[#?EOFVO/;S:_OZ)RA5/%8K9TH3ZYQ=F%K+:45Z]
MT"(KMTP_":U%4CY=,QHQ61Q@/E\*H7<OB@&:??VS_P%02P,$%     @ ?#G\
M5,VLGV%L!P  MU,  !D   !X;"]W;W)K<VAE971S+W-H965T-CDN>&ULK=QK
M;Z)*' ;PKS+Q;$[V)$T5K)?VM"9MN=\DV^PY+S;G!=51R7)Q 76;[(<_ R)*
MBZ-NGC>M4O^_&1A\"CAROXF3[^F"THS\#(,H?6@MLFQYUVZGDP4-O?0Z7M*(
M_646)Z&7L:?)O)TN$^I-BZ(P:(N=3K\=>G[4&MT7R]QD=!^OLL"/J)N0=!6&
M7O+V1(-X\] 26KL%7_SY(LL7M$?W2V].7VCV=>DF[%F[4J9^2*/4CR.2T-E#
MZU&X<X5!7E"\XA^?;M*#QR1?E=<X_IX_T:</K4[>(QK02983'ONUIL\T"'*)
M]>-'B;:J-O/"P\<[72E6GJW,JY?2YSCXUY]FBX?6L$6F=.:M@NQ+O-%HN4*]
MW)O$05K\))ORM9T6F:S2+ [+8M:#T(^VO[V?Y88X*!"/%8AE@?B^0#Q2T"T+
MNN>V<%,6W+POZ!\IZ)4%O7.[U"\+^N>V,"@+!N<6#,N"X;DK?5L6W)Z[#D)G
M-W*=<SLE5(/]8;2/MK(;;N']> LWQTIV RY\&/&C);LA%]Z/^?%6=H,NO!_U
MXR6[81>*<6]OWR3%.TSR,F]TG\0;DN2O9U[^H'B;%O7LC>5'>:*\9 G[J\_J
MLM%S'&5^-*?1Q*<I^?S(GF4):YA8?N;/O>V[/IJ2EX67T$4<3&E"G@,O3<GC
MI/&/$DW\M9?'!+&\3;KRL_0O\EFBF><'[-$GXD?$]H. U:;W[8RM0MZ1]J3L
M[M.VN^*1[@K$9AU>I$2.IG3:4*_PZ[NGZC5^??]4O<ZO'YRJ-TZLO\@!VFSL
MJQU W.T 3R)75.CK-1&'5T3LB"*9!)X?-G3KF8\87G1-ND*)?'V1R.=/?S4P
M$I]Y7":,Z12,<+0O\@ED-:_ZTB'I?M=LVEOXE$0G%25P5DL]FQ%N3_1(XU.V
MEQSTB$_IEXS9L8UM8+:0>?Z8G5HMZ\1JK0*V/_?*U0JV$=3 V*>8J-H5Q89R
MAU_NQ.NJO$,F<;ADVS=JZL?X_+=$IZ'</7_7&W+2HEO]N^@67O>(9\4L^>O_
M,[Y9[#5$SVB8_M<4Z%OPIAG,#YCOTJ4WH0\M=D2<TF1-6Z,__Q#ZG;^;8@B)
M24A,1F(*$E.1F(;$="1F(#$3B5E(S$9B#A(;(S$7A-5"[J8*N1N>O@VY215R
M;U<D6H6O[-@VGNVC/"6_N+G^Q&WCTMQ#8A(2DY&8@L14)*8A,1V)&4C,1&(6
M$K.1F+/%>@667W-;C[KW[?5AF"&;<T%8+<QZ59CUN&'F5-&UC2I_-BNBZ\CQ
M_E/OPZ:YJ6^:9VY[EV81$I.1F(+$5"2F(3$=B1E(S$1B%A*SD9B#Q,9(S 5A
MM=CJ5['5_^UCL(/K RF9^:QTGN<9*_"VUR3+L_X\Y_C7$IZXG;CT( V)24A,
M[G\(=;$>Z@JR.?5D<QJR.1V)&4C,1&(6$K.1F(/$QDC,!6&U"!M4$3;@1]C^
M$Y249EE 0]I\ILAE+@TA)"8A,1F)*5NL?Q QMYUZQJC(]C0DIB,Q XF92,Q"
M8C82<Y#8&(FY(*P66,,JL(87'7.QPZE)LO*"*[),XK6?3R)IBB\N>FE\(3$)
MB<E(3$%B*A+3D)B.Q(SAR<@WD>U92,Q&8@X2&R,Q%X35XNNVBJ];;GRYWEM^
MA,5.">.$6'3N!>2E.NYJG&O"]2Y-KMN3NZ>$;$]&8@H24Y&8AL1T)&8@,1.)
M64C,1F(.$ALC,1>$U9)+Z%31E<]T_,W+74L:38M+7%Y*BQ>E<>!/O8Q.>=?Q
M^0U>&FY032JUPPM$O7I4RM &%:BF0C4-JNFG-ZT!;="$:A94LZ&: ]7&4,U%
M:?7X.IA$+$"OUD_WDX3/OU;/[\/%B8;4)*@F0S4%JJE032LUSB?Q.K1! ZJ9
M#=WOU[MO01NTH9H#U<90S45I]403]XDF<A/-^/K5(M]LFJ=8X[16?OW%:834
M)*@F0S4%JJE038-J.E0SH)H)U2RH9D,U!ZJ-H9J+TNH9MY_++\ G\PO0V?Q0
M38)J,E13H)H*U32HID,U ZJ94,V":C94<Z#:&*JY**V>>OO)_?EW9SE'=O(/
M=KKY1E(Z625^QD+OBL2;B)V<+OPE6=)D0J/,F]/&]./*%Z<?4I.@F@S5%*BF
M0C4-JNE0S8!J)E2SH)I=:OEEK.I,NG/=?7?ITH$V.CZO4??DR^I!M)^8+_!G
MYK^L7E/Z8\7BALCK_"?W=!,YL_<9JDE0389J"E13H9H&U72H9D U$ZI94,V&
M:@Y4&T,U%Z75\VX_HU_HPT\WH?/SH9H$U62HID U%:II4$V':@94,Z&:!=5L
MJ.9 M3%4<U%:/?7V7P(03GP+X,-'HTU?52*_.+<J>>(W<7$,0K\B -5DJ*9
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M9$>27R[M-P!J)V#OYTI1M7%SJ?ZJ2/X 4$L#!!0    ( 'PY_%2U8=5;X@$
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MK:K^^2U5]=Q! D$R?Y!"D,X?9!!D\P<Y!/G\00%!,7]0AJ \?] ]!-W/'_0
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M0/KX!M+'-4@??('2"(JH'(54CF(J1T&5HZC*45CE**YR%%@YBJP"15:!(JM
MD56@R"I09!4HL@H4606*K )%5H$BJT215:+(*E%DE2BR2A19)8JL$D56B2*K
M1)%5HLBJ4&15*+(J%%D5BJP*15:%(JM"D56AR*I09%4HLFH4636*K!I%5HTB
MJT:15:/(JE%DU2BR:A19-8JL!D56@R*K09'5H,AJ4&0U*+(:%%D-BJP&15:#
M(FN%(FN%(FN%(FOUE;+>.;?_S_'3L^QM.[SDL^E_I.L_4$L! A0#%     @
M?#G\5 =!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " !\.?Q4)AMOLN\    K @  $0
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M965T-"YX;6Q02P$"% ,4    " !\.?Q4"F]W+AD$  !U$   &
M    @('<(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M?#G\5.7L%O%M"0  B4T  !@              ("!*R4  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( 'PY_%34$,/+L0(   ,(   8
M          " @<XN  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " !\.?Q4OCXYB0@(   Q+0  &               @(&U,0  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ?#G\5(^*:2K7"0  PA@
M !@              ("!\SD  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( 'PY_%1VPFA9$ <  #$3   9              " @0!$  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ?#G\5#N[[$J&
M&0  )50  !D              ("!1TL  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " !\.?Q4WES2[50'  "_$P  &0
M@($$90  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( 'PY
M_%2[3]95>@4  -,,   9              " @8]L  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ ?#G\5/Z,,)_< @  J 8  !D
M         ("!0'(  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " !\.?Q4L1!VID0&  !U%0  &0              @(%3=0  >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( 'PY_%0+LXJ<<P@  %H5
M   9              " @<Y[  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ ?#G\5)*P98[5!P  YA,  !D              ("!>(0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !\.?Q43+O1
MN$H%  #5#@  &0              @(&$C   >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( 'PY_%2N*4J.BRD  $2&   9
M  " @062  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M?#G\5%=2M=V6!   )@L  !D              ("!Q[L  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " !\.?Q4B&$FA)8,  !P(P  &0
M            @(&4P   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( 'PY_%1F';M\Z0(  '0&   9              " @6'-  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ?#G\5.N[:L^&!0
MFPX  !D              ("!@=   'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " !\.?Q4/4CMXN #  "G"0  &0              @($^
MU@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( 'PY_%2O
MK+05( ,   ('   9              " @57:  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ ?#G\5)E IS_@ @  G@8  !D
M     ("!K-T  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'PY_%3^7S?8I 0   H+   9              "
M@<OZ  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ ?#G\
M5#-J<L2Z @  M0<  !D              ("!IO\  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    " !\.?Q4YTY43:T#  "%#@  &0
M        @(&7 @$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   ( 'PY_%147D8(W (   H(   9              " @7L& 0!X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ ?#G\5!Q6A=9= P  ,A
M !D              ("!C@D! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    " !\.?Q488UFV_L#  #2%0  &0              @($B#0$
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( 'PY_%00V!@#
MN00  -08   9              " @501 0!X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ ?#G\5!NNS-$>!P  OSL  !D
M ("!1!8! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !\
M.?Q4CP[3PS(#   ="   &0              @(&9'0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( 'PY_%1A/E"+(0@  '12   9
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M970T-"YX;6Q02P$"% ,4    " !\.?Q4H0:]8(T#  #T$   &0
M    @(',.0$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M 'PY_%1_)B_9J ,  #H-   9              " @9 ] 0!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ ?#G\5 0W90E\"   WCL  !D
M             ("!;T$! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    " !\.?Q4R< HP8$%  "T)@  &0              @($B2@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( 'PY_%3'G%19<@<
M ,4T   9              " @=I/ 0!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ ?#G\5+>F FCV!   4R   !D              ("!
M@U<! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !\.?Q4
M#=A8>\($  #X'P  &0              @(&P7 $ >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;%!+ 0(4 Q0    ( 'PY_%1>L+[RL <  *A%   9
M      " @:EA 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%
M  @ ?#G\5"=T]YOU @  N D  !D              ("!D&D! 'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !\.?Q4V6J;\,0"   $!P
M&0              @(&\; $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+
M 0(4 Q0    ( 'PY_%3&U]+@&P(  $H$   9              " @;=O 0!X
M;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ ?#G\5/[%H,G)
M!@  XSH  !D              ("!"7(! 'AL+W=O<FMS:&5E=',O<VAE970U
M-BYX;6Q02P$"% ,4    " !\.?Q4SE=R"QP-  "VS   &0
M@($)>0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( 'PY
M_%3[QPBZ$@T   VH   9              " @5R& 0!X;"]W;W)K<VAE971S
M+W-H965T-3@N>&UL4$L! A0#%     @ ?#G\5(?V#*!N!0  _30  !D
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M=#8S+GAM;%!+ 0(4 Q0    ( 'PY_%2R6NOPL 4  ),P   9
M  " @<"_ 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @
M?#G\5/ER;>;>%@  C;@! !D              ("!I\4! 'AL+W=O<FMS:&5E
M=',O<VAE970V-2YX;6Q02P$"% ,4    " !\.?Q4,?MZ870"  #+!0  &0
M            @(&\W $ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4
M Q0    ( 'PY_%0]P\7HSP,  (L6   9              " @6?? 0!X;"]W
M;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ ?#G\5-ZL1E;<!0
MXR\  !D              ("!;>,! 'AL+W=O<FMS:&5E=',O<VAE970V."YX
M;6Q02P$"% ,4    " !\.?Q4S:R?86P'  "W4P  &0              @(&
MZ0$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( 'PY_%3-
M\[;5W (  & )   9              " @2/Q 0!X;"]W;W)K<VAE971S+W-H
M965T-S N>&UL4$L! A0#%     @ ?#G\5 XCZ5\^ @  "P4  !D
M     ("!-O0! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4
M" !\.?Q4,B2=(<("  !A"   &0              @(&K]@$ >&PO=V]R:W-H
M965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( 'PY_%2U8=5;X@$  ,D$   9
M              " @:3Y 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L!
M A0#%     @ ?#G\5(K#YNU" P  *!0   T              ( !O?L! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !\.?Q4EXJ[',     3 @  "P
M        @ $J_P$ 7W)E;',O+G)E;'-02P$"% ,4    " !\.?Q4@55ZCLD%
M  !K,   #P              @ $3  ( >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ ?#G\5+?' S!" @  0BL  !H              ( !"08" 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ?#G\5/C# AT& @
M3RH  !,              ( !@P@" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     %$ 40 N%@  N@H"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>450</ContextCount>
  <ElementCount>320</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>171</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>17</UnitCount>
  <MyReports>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Background and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentation</Role>
      <ShortName>Background and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Investments in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecurities</Role>
      <ShortName>Investments in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121105 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2125106 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - Other Comprehensive Earnings/Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLosses</Role>
      <ShortName>Other Comprehensive Earnings/Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132108 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143111 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2163112 - Disclosure - New Accounting Guidance Not Yet Adopted</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Background and Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationPolicies</Role>
      <ShortName>Background and Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Background and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationTables</Role>
      <ShortName>Background and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentation</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Investments in Equity Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</Role>
      <ShortName>Investments in Equity Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecurities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstruments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlans</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsperShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - Other Comprehensive Earnings/Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLosses</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReporting</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Income Taxes update (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesupdateTables</Role>
      <ShortName>Income Taxes update (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesTables</Role>
      <ShortName>Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/Contingencies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2364310 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables</Role>
      <ShortName>New Accounting Guidance Not Yet Adopted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails</Role>
      <ShortName>Background and Basis of Presentation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails</Role>
      <ShortName>Background and Basis of Presentation (Share Repurchase Table) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenues from Contracts with Customers (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/RevenuesfromContractswithCustomers</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails</Role>
      <ShortName>Investments in Equity Securities (Summary of Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails</Role>
      <ShortName>Investments in Equity Securities (Earnings in Equity Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in ABI Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in JUUL Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details</Role>
      <ShortName>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails</Role>
      <ShortName>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails</Role>
      <ShortName>Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Benefit Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Earnings per Share (Basic and Diluted Earnings Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings per Share (Basic and Diluted Earnings Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsperShareTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Reclassifications) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLossesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails</Role>
      <ShortName>Segment Reporting (Segment Data Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Segment Reporting (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails</Role>
      <ShortName>Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/Debt</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - Income Taxes - Summary of Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Summary of Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesupdateTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - Contingencies (General Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGeneralInformationDetails</Role>
      <ShortName>Contingencies (General Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2446425 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails</Role>
      <ShortName>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447426 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails</Role>
      <ShortName>Contingencies (Schedule of Pending Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448427 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails</Role>
      <ShortName>Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2449428 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails</Role>
      <ShortName>Contingencies (Non-Engle Progeny Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2450429 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails</Role>
      <ShortName>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails</Role>
      <ShortName>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2452431 - Disclosure - Contingencies (Florida Bond Statute) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails</Role>
      <ShortName>Contingencies (Florida Bond Statute) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2453432 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails</Role>
      <ShortName>Contingencies (Other Smoking and Health Class Actions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails</Role>
      <ShortName>Contingencies (Health Care Cost Recovery Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails</Role>
      <ShortName>Contingencies (NPM Adjustment Disputes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2456435 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails</Role>
      <ShortName>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457436 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails</Role>
      <ShortName>Contingencies (Federal Government's Lawsuit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2458437 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails</Role>
      <ShortName>Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459438 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails</Role>
      <ShortName>Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2460439 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails</Role>
      <ShortName>Contingencies (Lights/Ultra Lights Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2461440 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails</Role>
      <ShortName>Contingencies (UST Litigations Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462441 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails</Role>
      <ShortName>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="mo-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - mo-20220630.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - mo-20220630.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mo-20220630.htm">mo-20220630.htm</File>
    <File>exhibit311q22022-quarter.htm</File>
    <File>exhibit312q22022-quarter.htm</File>
    <File>exhibit321q22022-quarter.htm</File>
    <File>exhibit322q22022-quarter.htm</File>
    <File>exhibit991q22022-quarter.htm</File>
    <File>exhibit992q22022-quarter.htm</File>
    <File>mo-20220630.xsd</File>
    <File>mo-20220630_cal.xml</File>
    <File>mo-20220630_def.xml</File>
    <File>mo-20220630_lab.xml</File>
    <File>mo-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="901">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mo-20220630.htm": {
   "axisCustom": 1,
   "axisStandard": 27,
   "contextCount": 450,
   "dts": {
    "calculationLink": {
     "local": [
      "mo-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mo-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mo-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mo-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mo-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mo-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 610,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://www.altria.com/20220630": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 94,
   "keyStandard": 226,
   "memberCustom": 100,
   "memberStandard": 68,
   "nsprefix": "mo",
   "nsuri": "http://www.altria.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.altria.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Revenues from Contracts with Customers",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomers",
     "shortName": "Revenues from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Investments in Equity Securities",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecurities",
     "shortName": "Investments in Equity Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - Financial Instruments",
     "role": "http://www.altria.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121105 - Disclosure - Benefit Plans",
     "role": "http://www.altria.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125106 - Disclosure - Earnings per Share",
     "role": "http://www.altria.com/role/EarningsperShare",
     "shortName": "Earnings per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - Other Comprehensive Earnings/Losses",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLosses",
     "shortName": "Other Comprehensive Earnings/Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132108 - Disclosure - Segment Reporting",
     "role": "http://www.altria.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Debt",
     "role": "http://www.altria.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - Income Taxes",
     "role": "http://www.altria.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143111 - Disclosure - Contingencies",
     "role": "http://www.altria.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:InventoryRawMaterialsPlantMaterialNetofReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163112 - Disclosure - New Accounting Guidance Not Yet Adopted",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted",
     "shortName": "New Accounting Guidance Not Yet Adopted",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Background and Basis of Presentation (Policies)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies",
     "shortName": "Background and Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Background and Basis of Presentation (Tables)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationTables",
     "shortName": "Background and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Investments in Equity Securities (Tables)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables",
     "shortName": "Investments in Equity Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.altria.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Benefit Plans (Tables)",
     "role": "http://www.altria.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Earnings per Share (Tables)",
     "role": "http://www.altria.com/role/EarningsperShareTables",
     "shortName": "Earnings per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - Other Comprehensive Earnings/Losses (Tables)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables",
     "shortName": "Other Comprehensive Earnings/Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.altria.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:SummaryOfIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Income Taxes update (Tables)",
     "role": "http://www.altria.com/role/IncomeTaxesupdateTables",
     "shortName": "Income Taxes update (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mo:SummaryOfIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Contingencies (Tables)",
     "role": "http://www.altria.com/role/ContingenciesTables",
     "shortName": "Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364310 - Disclosure - New Accounting Guidance Not Yet Adopted (Tables)",
     "role": "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables",
     "shortName": "New Accounting Guidance Not Yet Adopted (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Background and Basis of Presentation (Narrative) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
     "shortName": "Background and Basis of Presentation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ic2bf43f38c1b4da4b2508c1a4e0c14c1_I20211028",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
     "shortName": "Background and Basis of Presentation (Share Repurchase Table) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i456a551753af43a3a51e3142885b59a0_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
     "shortName": "Revenues from Contracts with Customers (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails",
     "shortName": "Investments in Equity Securities (Summary of Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i7eb076cfe6f641f2a07a06b53c206a16_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:EquityInvestmentFairValueOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
     "shortName": "Investments in Equity Securities (Earnings in Equity Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i9c85ce8790e54af78ef8a2b11e4fb9f9_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ifac8a899318948c599bdf090d2fa77ba_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ifac8a899318948c599bdf090d2fa77ba_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion",
      "reportCount": 1,
      "unitRef": "director",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i4c8c372e468e4f52a45366c632127ce7_D20181201-20181231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i591aee96bde948f381ffaaf7af7d4bdd_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
     "shortName": "Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ied72379ce65f44d1b138e007119e5e27_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Earnings",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
     "shortName": "Condensed Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "if488a491d85b439783705940ff379d59_I20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquityMethodInvestments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i80a9923020f3440a85a8e77c1756d28c_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
     "shortName": "Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i2dc2fabe77454f58917baa8655d3871f_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails",
     "shortName": "Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i2495225aefaf4ca5a81af27c16a5d6c8_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Benefit Plans (Narrative) (Details)",
     "role": "http://www.altria.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i638d9bed5d8e4db8882e0a3f989a87da_D20220101-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Earnings per Share (Basic and Diluted Earnings Per Share) (Details)",
     "role": "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails",
     "shortName": "Earnings per Share (Basic and Diluted Earnings Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "iea1d15baae55479686b0438960a20553_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i46947c74848d4152a49d1bb99f803439_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ic32394b7c33e4adaa729d30f5b7f8492_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails",
     "shortName": "Segment Reporting (Segment Data Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "icc496503d8eb423a9c0790379753eb4a_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Earnings",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
     "shortName": "Condensed Consolidated Statements of Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Segment Reporting (Narrative) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0c63006a91f04aa0a97e0e25d1afb998_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
     "shortName": "Segment Reporting (Schedule of Tobacco and Health and Certain Other Litigation Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ia9269c502f174ba7b95d543c1fe32410_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Debt (Narrative) (Details)",
     "role": "http://www.altria.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShortTermBorrowings",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i964ab02efa4447bb862d040ab72bdce7_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - Income Taxes - Summary of Income Taxes (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails",
     "shortName": "Income Taxes - Summary of Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:SummaryOfIncomeTaxesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i964ab02efa4447bb862d040ab72bdce7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - Income Taxes (Details)",
     "role": "http://www.altria.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i964ab02efa4447bb862d040ab72bdce7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - Contingencies (General Information) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGeneralInformationDetails",
     "shortName": "Contingencies (General Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "iea1d15baae55479686b0438960a20553_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446425 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
     "shortName": "Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i15710cf918bb4ad0bfe9ff7a338e1fb1_D20220401-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447426 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
     "shortName": "Contingencies (Schedule of Pending Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0c6153fbe7224388926901e9703fa838_I20210726",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "iac977efcc9484319b8cd4e82324c3fa3_I20210726",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448427 - Disclosure - Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
     "shortName": "Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "ibb6b8d3df195424ebe21e8eab674f407_D19990101-20220725",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsDecided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449428 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
     "shortName": "Contingencies (Non-Engle Progeny Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0c5245e6da544ef581a1619155446591_I20200229",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i5349a45275c54d33af6c9dba5397bc77_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i5f71e968f79944aea5e02c01739659a7_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "id41b8120810c4e6d829b0b1591449c2e_D20220201-20220228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450429 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
     "shortName": "Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i9240c78c98394f3cb2cc1b313917c5ad_I20000731",
      "decimals": "-9",
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
     "shortName": "Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i259df7aad9264b5a979579e9065bdd22_I20220430",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i494b0e99edea410eab5611b73ffe2f4b_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452431 - Disclosure - Contingencies (Florida Bond Statute) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
     "shortName": "Contingencies (Florida Bond Statute) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i494b0e99edea410eab5611b73ffe2f4b_I20090630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i44d3390cbcd0491bb2a57fa5618b6c6a_I20220725",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453432 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
     "shortName": "Contingencies (Other Smoking and Health Class Actions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i9a1eedb0c135405eb108bc5d0c630bdc_D19960501-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
     "shortName": "Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "id4f21fac489e4144bd9e820c3d8f7baf_D19981101-19981130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i9f5f2465cb9b42f78c6b70d2cf9a8649_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)",
     "role": "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
     "shortName": "Contingencies (NPM Adjustment Disputes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i87b1662c87ee4da4894098d4f121317e_D20220301-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456435 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "role": "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
     "shortName": "Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "iff41499bda0e43b9b0d28d1dbc5ad7e0_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i73a1bcfdbc704c5b910f93fbc5852433_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457436 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)",
     "role": "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
     "shortName": "Contingencies (Federal Government's Lawsuit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i346e658d67ab4443b81460637eece234_D20060801-20060831",
      "decimals": null,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i87bf8ff853e2425f96934e4e9ddef164_I20210726",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458437 - Disclosure - Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)",
     "role": "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
     "shortName": "Contingencies (E-vapor Product Litigation and IQOS Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i7ee7e14784294b1aa50a20edf7383985_I20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:NumberOfThirdPartyLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lawsuit",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "id54b8c1baf4c4086bb509612132c190e_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459438 - Disclosure - Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "role": "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
     "shortName": "Contingencies (Antitrust Litigation and Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "id54b8c1baf4c4086bb509612132c190e_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i49fc4815acd44dd095f74bae91742f69_I20220725",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460439 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)",
     "role": "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
     "shortName": "Contingencies (Lights/Ultra Lights Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i49fc4815acd44dd095f74bae91742f69_I20220725",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i453bba98eb8743d79202cf42541d0607_I20220725",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461440 - Disclosure - Contingencies (UST Litigations Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
     "shortName": "Contingencies (UST Litigations Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i453bba98eb8743d79202cf42541d0607_I20220725",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462441 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "role": "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
     "shortName": "Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i0ad5f8c024af410fa48d33f23c6f16f4_I20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i91be2da432a948cfbc579ace82b48610_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Background and Basis of Presentation",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentation",
     "shortName": "Background and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i1eb3c1286be44dae85543d5c7aa2224c_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i964ab02efa4447bb862d040ab72bdce7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - mo-20220630.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - mo-20220630.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20220630.htm",
      "contextRef": "i964ab02efa4447bb862d040ab72bdce7_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 171,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "Puerto Rico [Member]"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mo_ABInBevMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AB InBev [Member]",
        "label": "AB InBev [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "ABInBevMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AccruedSettlementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Settlement Liability, Current",
        "label": "Accrued Settlement Liability, Current",
        "terseLabel": "Settlement charges"
       }
      }
     },
     "localname": "AccruedSettlementLiabilityCurrent",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "label": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "AccumulatedEquityMethodInvestmentsAttributableToParentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net",
        "terseLabel": "Stock award activity"
       }
      }
     },
     "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Group",
        "label": "Altria Group [Member]",
        "terseLabel": "Altria Group [Member]"
       }
      }
     },
     "localname": "AltriaGroupMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AmountAwardedtoOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount Awarded to Other Party",
        "label": "Amount Awarded to Other Party",
        "terseLabel": "Amount awarded to other party"
       }
      }
     },
     "localname": "AmountAwardedtoOtherParty",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ArbitrationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period",
        "label": "Arbitration Period [Axis]",
        "terseLabel": "Arbitration Period [Axis]"
       }
      }
     },
     "localname": "ArbitrationPeriodAxis",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ArbitrationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period [Domain]",
        "label": "Arbitration Period [Domain]",
        "terseLabel": "Arbitration Period [Domain]"
       }
      }
     },
     "localname": "ArbitrationPeriodDomain",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_BritishColumbiaSaskatchewanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Columbia, Saskatchewan [Member]",
        "label": "British Columbia, Saskatchewan [Member]",
        "terseLabel": "British Columbia and Saskatchewan [Member]"
       }
      }
     },
     "localname": "BritishColumbiaSaskatchewanMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CanadianTobaccoManufacturersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Tobacco Manufacturers [Member]",
        "label": "Canadian Tobacco Manufacturers [Member]",
        "terseLabel": "Canadian Tobacco Manufacturers [Member]"
       }
      }
     },
     "localname": "CanadianTobaccoManufacturersMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Discounts",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Action Lawsuit [Member]",
        "label": "Class Action Lawsuit [Member]",
        "terseLabel": "Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock0.3313ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 0.33 1/3 Par Value [Member]",
        "label": "Common Stock, 0.33 1/3 Par Value [Member]",
        "terseLabel": "Common Stock, $0.33 1/3 par value [Member]"
       }
      }
     },
     "localname": "CommonStock0.3313ParValueMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.000NotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "label": "Common Stock, 1.000% Notes Due 2023 [Member]",
        "terseLabel": "1.000% Notes due 2023 [Member]"
       }
      }
     },
     "localname": "CommonStock1.000NotesDue2023Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.700NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "label": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "terseLabel": "1.700% Notes due 2025 [Member]"
       }
      }
     },
     "localname": "CommonStock1.700NotesDue2025Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock2.200NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "label": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "terseLabel": "2.200% Notes due 2027 [Member]"
       }
      }
     },
     "localname": "CommonStock2.200NotesDue2027Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock3.125NotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "label": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "terseLabel": "3.125% Notes due 2031 [Member]"
       }
      }
     },
     "localname": "CommonStock3.125NotesDue2031Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group Inc. [Member]",
        "label": "Cronos Group Inc. [Member]",
        "verboseLabel": "Cronos [Member]"
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "label": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "terseLabel": "Debt instrument, consolidated EBITDA to interest expense ratio"
       }
      }
     },
     "localname": "DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Term",
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Debt instrument, extension term"
       }
      }
     },
     "localname": "DebtInstrumentExtensionTerm",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_ETSSmokingandHealthCaseFlightAttendantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "label": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "terseLabel": "ETS Smoking and Health Case, Flight Attendants [Member]"
       }
      }
     },
     "localname": "ETSSmokingandHealthCaseFlightAttendantsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesChadwellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Chadwell [Member] [Member]",
        "label": "Engle Progeny Cases, Chadwell [Member]",
        "terseLabel": "Engle Progeny Cases, Chadwell [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesChadwellMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCooperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cooper [Member]",
        "label": "Engle Progeny Cases, Cooper [Member]",
        "terseLabel": "Engle Progeny Cases, Cooper [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCooperMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCuddiheeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cuddihee",
        "label": "Engle Progeny Cases, Cuddihee [Member]",
        "terseLabel": "Engle Progeny Cases, Cuddihee [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCuddiheeMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesD.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, D. Brown [Member]",
        "label": "Engle Progeny Cases, D. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, D. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesD.BrownMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesDuignanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Duignan [Member]",
        "label": "Engle Progeny Cases, Duignan [Member]",
        "terseLabel": "Engle Progeny Cases, Duignan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesDuignanMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFederalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Federal [Member]",
        "label": "Engle Progeny Cases, Federal [Member]",
        "terseLabel": "Engle Progeny Cases, Federal [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFederalMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFreemanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Freeman [Member]",
        "label": "Engle Progeny Cases, Freeman [Member]",
        "terseLabel": "Engle Progeny Cases, Freeman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFreemanMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGarciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Garcia",
        "label": "Engle Progeny Cases, Garcia [Member]",
        "terseLabel": "Engle Progeny Cases, Garcia [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGarciaMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerRintoulandDuignamMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "label": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerRintoulandDuignamMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHollimanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Holliman [Member]",
        "label": "Engle Progeny Cases, Holliman [Member]",
        "terseLabel": "Engle Progeny Cases, Holliman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHollimanMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanAndSommersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases Kaplan And Sommers",
        "label": "Engle Progeny Cases Kaplan And Sommers [Member]",
        "terseLabel": "Engle Progeny Cases Kaplan And Sommers [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanAndSommersMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanMcLauighlinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Kaplan [Member]",
        "label": "Engle Progeny Cases, Kaplan (McLauighlin) [Member]",
        "terseLabel": "Engle Progeny Cases, Kaplan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanMcLauighlinMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLippMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Lipp",
        "label": "Engle Progeny Cases, Lipp [Member]",
        "terseLabel": "Engle Progeny Cases, Lipp [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLippMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMcCallMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, McCall [Member]",
        "label": "Engle Progeny Cases, McCall [Member]",
        "terseLabel": "Engle Progeny Cases, McCall [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMcCallMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases [Member]",
        "label": "Engle Progeny Cases [Member]",
        "terseLabel": "Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPearsonDCohenCollarChaconMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "label": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]",
        "terseLabel": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPearsonDCohenCollarChaconMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPollariMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pollari [Member]",
        "label": "Engle Progeny Cases, Pollari [Member]",
        "terseLabel": "Engle Progeny Cases, Pollari [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPollariMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesR.DouglasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, R. Douglas [Member]",
        "label": "Engle Progeny Cases, R. Douglas [Member]",
        "terseLabel": "Engle Progeny Cases, R. Douglas [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesR.DouglasMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesReiderandBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Reider and Banks [Member]",
        "label": "Engle Progeny Cases, Reider and Banks [Member]",
        "terseLabel": "Engle Progeny Cases, Reider and Banks [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesReiderandBanksMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSchertzerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Schertzer",
        "label": "Engle Progeny Cases, Schertzer [Member]",
        "terseLabel": "Engle Progeny Cases, Schertzer [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSchertzerMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, State [Member]",
        "label": "Engle Progeny Cases, State [Member]",
        "terseLabel": "Engle Progeny Cases, State [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesStateMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesWeingartandHancockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "label": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "terseLabel": "Engle Progeny Cases, Weingart and Hancock [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesWeingartandHancockMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractPreemptiveRIghtsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Preemptive RIghts [Member]",
        "label": "Equity Contract, Preemptive RIghts [Member]",
        "terseLabel": "Fixed-price Preemptive Rights [Member]",
        "verboseLabel": "Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractPreemptiveRIghtsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantAndEquityContractPreemptiveRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Warrant And Equity Contract, Preemptive Rights",
        "label": "Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]",
        "terseLabel": "Equity Contract, Warrant And Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantAndEquityContractPreemptiveRightsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Warrant [Member]",
        "label": "Equity Contract, Warrant [Member]",
        "terseLabel": "Equity Contract, Warrant [Member]",
        "verboseLabel": "Cronos Warrant [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityInvestmentFairValueOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investment, Fair Value Option",
        "label": "Equity Investment, Fair Value Option",
        "terseLabel": "Fair value equity investment"
       }
      }
     },
     "localname": "EquityInvestmentFairValueOption",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityInvestmentsFairValueOptionVotingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investments, Fair Value Option, Voting Shares",
        "label": "Equity Investments, Fair Value Option, Voting Shares",
        "terseLabel": "Equity investments, fair value option, voting shares (in shares)"
       }
      }
     },
     "localname": "EquityInvestmentsFairValueOptionVotingShares",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentAggregateExercisePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Aggregate Exercise Price",
        "label": "Equity Method Investment, Aggregate Exercise Price",
        "terseLabel": "Equity method investment, aggregate exercise price"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateExercisePrice",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value, percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountandFairValuePercentage",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, number of shares eligible for purchase (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedCommon": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Common",
        "label": "Equity Method Investment, Number of Shares Owned, Common",
        "terseLabel": "Number of ordinary shares owned (in shares)",
        "verboseLabel": "Number of ordinary shares owned (approximately) (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedCommon",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedRestricted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Restricted",
        "label": "Equity Method Investment, Number of Shares Owned, Restricted",
        "terseLabel": "Number of restricted shares owned (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedRestricted",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, percentage of shares eligible for purchase (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentPercentageofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentPricePerShareIfExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Price Per Share If Exercised",
        "label": "Equity Method Investment, Price Per Share If Exercised",
        "terseLabel": "Equity method investment, shares purchased, (CAD per share)"
       }
      }
     },
     "localname": "EquityMethodInvestmentPricePerShareIfExercised",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_EquityMethodInvestmentWarrantExercisedOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "label": "Equity Method Investment, Warrant Exercised, Ownership Percentage",
        "terseLabel": "Equity method investment, warrant exercised, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentWarrantExercisedOwnershipPercentage",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentsFairValueOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Fair Value Option",
        "label": "Equity Method Investments, Fair Value Option [Member]",
        "terseLabel": "Equity Method Investments, Fair Value Option [Member]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueOptionMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights",
        "label": "Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights",
        "terseLabel": "Cronos"
       }
      }
     },
     "localname": "EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "terseLabel": "Equity securities without readily determinable fair value, non-compete release trigger percentage of investment carrying value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembers",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investee Stockholders Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investee stockholders upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvesteeStockholdersUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Appointed By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members appointed by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersAppointedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Board Members Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of board members upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfBoardMembersUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Independent Board Members Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of independent board members upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfIndependentBoardMembersUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Investor Nominating Committee Designees Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of investor nominating committee designees upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestorNominatingCommitteeDesigneesUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Nominating Committee Directors Designated By Investee Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of nominating committee directors designated by investee upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfNominatingCommitteeDirectorsDesignatedByInvesteeUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Chair Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee chair directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeChairDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion",
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Oversight Committee Directors Designated By Investor Upon Share Conversion",
        "terseLabel": "Equity securities without readily determinable fair value, number of oversight committee directors designated by investor upon share conversion"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfOversightCommitteeDirectorsDesignatedByInvestorUponShareConversion",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "terseLabel": "Equity securities, ownership percentage"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "label": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "terseLabel": "Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Service Agreement Term",
        "label": "Equity Securities Without Readily Determinable Fair Value, Service Agreement Term",
        "terseLabel": "Equity securities without readily determinable fair value, service agreement term"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueServiceAgreementTerm",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_EvaporLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-vapor Litigation [Member]",
        "label": "E-vapor Litigation [Member]",
        "terseLabel": "E-vapor Litigation [Member]"
       }
      }
     },
     "localname": "EvaporLitigationMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalGovernmentsLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Government's Lawsuit [Member]",
        "label": "Federal Governments Lawsuit [Member]",
        "terseLabel": "Federal Governments Lawsuit [Member]"
       }
      }
     },
     "localname": "FederalGovernmentsLawsuitMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalTradeCommissionDisclosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Trade Commission, Disclosure Period",
        "label": "Federal Trade Commission, Disclosure Period",
        "terseLabel": "Disclosure period"
       }
      }
     },
     "localname": "FederalTradeCommissionDisclosurePeriod",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt",
        "label": "Foreign Currency Denominated Debt [Abstract]",
        "terseLabel": "Foreign currency denominated debt included in long-term debt above:"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtAbstract",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt [Member]",
        "label": "Foreign Currency Denominated Debt [Member]",
        "terseLabel": "Foreign Currency Denominated Debt [Member]",
        "verboseLabel": "Foreign currency denominated debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2004NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment",
        "label": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions20052007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2005NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2006NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2008NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2009NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2010NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2011NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2012NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2013NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2014NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2015NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2017NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2018NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2019NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2020 NPM Adjustments",
        "label": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2020NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2021 NPM Adjustments",
        "label": "Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2021NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions [Member]",
        "label": "Health Care Cost Recovery Actions [Member]",
        "terseLabel": "Health Care Cost Recovery Actions [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2018 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042020Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2021",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042021Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20192021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2019-2021",
        "label": "Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20192021Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IQOSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IQOS",
        "label": "IQOS [Member]",
        "terseLabel": "IQOS [Member]"
       }
      }
     },
     "localname": "IQOSMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ImplementationofCorrectiveCommunicationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Implementation of Corrective Communications [Member]",
        "label": "Implementation of Corrective Communications [Member]",
        "terseLabel": "Implementation of Corrective Communications [Member]"
       }
      }
     },
     "localname": "ImplementationofCorrectiveCommunicationsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IncomeLossFromEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Investments",
        "label": "Income (Loss) from Equity Investments",
        "negatedTerseLabel": "(Income) losses from equity investments",
        "negatedTotalLabel": "(Income) losses from equity investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityInvestments",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IncomeLossFromEquityInvestmentsFairValueOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Investments, Fair Value Option",
        "label": "Income (Loss) from Equity Investments, Fair Value Option",
        "negatedTerseLabel": "JUUL",
        "verboseLabel": "Income (loss) from equity investments, fair value option"
       }
      }
     },
     "localname": "IncomeLossFromEquityInvestmentsFairValueOption",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IncreaseDecreaseInSettlementPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the period in Settlement payable.",
        "label": "Increase (Decrease) In Settlement Payable",
        "terseLabel": "Accrued settlement charges"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayable",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndividualSmokingAndHealthCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Smoking and Health Cases [Member]",
        "label": "Individual Smoking And Health Cases [Member]",
        "terseLabel": "Individual Smoking and Health Cases [Member]"
       }
      }
     },
     "localname": "IndividualSmokingAndHealthCasesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestAndOtherDebtExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest And Other Debt Expense, Net [Member]",
        "label": "Interest And Other Debt Expense, Net [Member]",
        "terseLabel": "Interest and other debt expense, net [Member]"
       }
      }
     },
     "localname": "InterestAndOtherDebtExpenseNetMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestExpenseRelatedToLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense Related To Litigation [Member]",
        "label": "Interest Expense Related To Litigation [Member]",
        "terseLabel": "Related Interest Costs [Member]"
       }
      }
     },
     "localname": "InterestExpenseRelatedToLitigationMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InventoryRawMaterialsPlantMaterialNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods",
        "label": "Inventory, Raw Materials, Plant Material, Net of Reserves",
        "terseLabel": "Leaf tobacco"
       }
      }
     },
     "localname": "InventoryRawMaterialsPlantMaterialNetofReserves",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Investments [Table]",
        "label": "Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments [Table]",
        "label": "Investments [Table]",
        "terseLabel": "Investments [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_JUULMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JUUL [Member]",
        "label": "JUUL [Member]",
        "terseLabel": "JUUL [Member]"
       }
      }
     },
     "localname": "JUULMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_January2021ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 Share Repurchase Program",
        "label": "January 2021 Share Repurchase Program [Member]",
        "terseLabel": "January 2021 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "January2021ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lights [Member]",
        "label": "Lights [Member]",
        "terseLabel": "Lights [Member]"
       }
      }
     },
     "localname": "LightsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationCasesResultsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Cases Results [Member]",
        "label": "Litigation Cases Results [Member]",
        "terseLabel": "Tobacco and Health and Certain Other Litigation [Member]"
       }
      }
     },
     "localname": "LitigationCasesResultsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationEscrowDeposit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Escrow Deposit",
        "label": "Litigation Escrow Deposit",
        "terseLabel": "Security posted for appeal of judgments"
       }
      }
     },
     "localname": "LitigationEscrowDeposit",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Expected To Be Awarded from Other Party",
        "label": "Litigation Settlement, Amount Expected To Be Awarded from Other Party",
        "terseLabel": "Litigation settlement, amount expected to be awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountExpectedToBeAwardedFromOtherParty",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualLegalFeesPayableMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "label": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "terseLabel": "State settlement agreements attorney fees annual cap"
       }
      }
     },
     "localname": "LitigationSettlementAnnualLegalFeesPayableMaximum",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualPaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Payment Amount",
        "label": "Litigation Settlement, Annual Payment Amount",
        "terseLabel": "State settlement agreements annual payments"
       }
      }
     },
     "localname": "LitigationSettlementAnnualPaymentAmount",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementEstimateofPossibleGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Estimate of Possible Gain",
        "label": "Litigation Settlement, Estimate of Possible Gain",
        "terseLabel": "Estimate of possible gain"
       }
      }
     },
     "localname": "LitigationSettlementEstimateofPossibleGain",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyClaimsDecided": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided",
        "label": "Loss Contingency, Claims Decided",
        "terseLabel": "Number of verdicts returned"
       }
      }
     },
     "localname": "LossContingencyClaimsDecided",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedFavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Favorable, Number",
        "label": "Loss Contingency, Claims Decided Favorable, Number",
        "terseLabel": "Number of favorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedFavorableNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedUnfavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Unfavorable, Number",
        "label": "Loss Contingency, Claims Decided Unfavorable, Number",
        "terseLabel": "Number of unfavorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedUnfavorableNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Not Certified, Number",
        "label": "Loss Contingency, Claims Not Certified, Number",
        "terseLabel": "Claims not certified, number"
       }
      }
     },
     "localname": "LossContingencyClaimsNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsResolvedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Resolved, Number",
        "label": "Loss Contingency, Claims Resolved, Number",
        "terseLabel": "Number of claims resolved"
       }
      }
     },
     "localname": "LossContingencyClaimsResolvedNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassActionLawsuit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action Lawsuit",
        "label": "Loss Contingency, Class Action Lawsuit",
        "terseLabel": "Loss contingency, class action lawsuit"
       }
      }
     },
     "localname": "LossContingencyClassActionLawsuit",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Not Certified, Number",
        "label": "Loss Contingency, Class Not Certified, Number",
        "terseLabel": "Class not certified"
       }
      }
     },
     "localname": "LossContingencyClassNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Value",
        "label": "Loss Contingency, Compensatory Damages Awarded, Value",
        "terseLabel": "Compensatory damages awarded"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyDamagesRecoverableValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Recoverable, Value",
        "label": "Loss Contingency, Damages Recoverable, Value",
        "terseLabel": "Loss contingency, damages recoverable, value"
       }
      }
     },
     "localname": "LossContingencyDamagesRecoverableValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases",
        "label": "Loss Contingency, Number Of Cases",
        "verboseLabel": "Number of cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfCases",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesWithSetTrialDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases With Set Trial Dates",
        "label": "Loss Contingency, Number of Cases With Set Trial Dates",
        "terseLabel": "Loss contingency, number of cases with set trial dates"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesWithSetTrialDates",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Complaints",
        "label": "Loss Contingency, Number Of Complaints",
        "terseLabel": "Loss contingency, number of complaints"
       }
      }
     },
     "localname": "LossContingencyNumberOfComplaints",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Cases",
        "label": "Loss Contingency, Number Of Inactive Cases",
        "terseLabel": "Loss contingency, number of inactive cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveCases",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of inactive class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveClassActionLawsuits",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfPendingCasesConsolidated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Pending Cases Consolidated",
        "label": "Loss Contingency, Number Of Pending Cases Consolidated",
        "terseLabel": "Loss contingency, number of pending cases consolidated"
       }
      }
     },
     "localname": "LossContingencyNumberOfPendingCasesConsolidated",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing derivative lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingDerivativeLawsuits",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states not in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled",
        "label": "Loss Contingency, Number Of States Not Settled",
        "terseLabel": "Loss contingency, number of states not settled"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettled",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled, Arbitration Period",
        "label": "Loss Contingency, Number Of States Not Settled, Arbitration Period",
        "terseLabel": "Loss contingency, number of states not settled, arbitration period"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettledArbitrationPeriod",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyNumberOfStatesWithConcludedHearings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States With Concluded Hearings",
        "label": "Loss Contingency, Number Of States With Concluded Hearings",
        "terseLabel": "Loss contingency, number of states with concluded hearings"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesWithConcludedHearings",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "label": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "terseLabel": "Loss contingency, number of additional states extended with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofCasesSetforTrial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Set for Trial",
        "label": "Loss Contingency, Number of Cases Set for Trial",
        "terseLabel": "Number of cases set for trial"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSetforTrial",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "label": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "terseLabel": "Number of states that cap bond or require no bond"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesThatCapBondorRequireNoBond",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGeneralInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation",
        "label": "Loss Contingency, Number of States with Settled Litigation",
        "terseLabel": "Number of states with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigation",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "label": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "terseLabel": "Loss contingency, number of states with settled litigation including New York, subsequent expansion"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigationSettlementOne",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "label": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "terseLabel": "Number of pending claims, consolidated for pre-trial purposes"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "label": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "terseLabel": "Loss contingency, period for decertified class members to file individual actions against defendants"
       }
      }
     },
     "localname": "LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyPunitiveDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Awarded, Value",
        "label": "Loss Contingency, Punitive Damages Awarded, Value",
        "terseLabel": "Punitive damages awarded"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyReductionToCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Reduction To Cost Of Sales",
        "label": "Loss Contingency, Reduction To Cost Of Sales",
        "terseLabel": "Loss contingency, reduction to cost of sales"
       }
      }
     },
     "localname": "LossContingencyReductionToCostOfSales",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyStateCourtsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, State Courts, Number",
        "label": "Loss Contingency, State Courts, Number",
        "terseLabel": "Number of state courts"
       }
      }
     },
     "localname": "LossContingencyStateCourtsNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyUnfavorableVerdictsPendingReversed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "label": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "terseLabel": "Number of claims with unfavorable verdicts pending/reversed"
       }
      }
     },
     "localname": "LossContingencyUnfavorableVerdictsPendingReversed",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictReversedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdict Reversed, Number",
        "label": "Loss Contingency, Verdict Reversed, Number",
        "terseLabel": "Number of verdicts reversed"
       }
      }
     },
     "localname": "LossContingencyVerdictReversedNumber",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictsUpheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdicts Upheld",
        "label": "Loss Contingency, Verdicts Upheld",
        "terseLabel": "Number of verdicts upheld"
       }
      }
     },
     "localname": "LossContingencyVerdictsUpheld",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdictModified": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdict Modified",
        "label": "Loss Contingency, Zero Damages Verdict Modified",
        "terseLabel": "Zero damages verdict modified"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdictModified",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdicts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdicts",
        "label": "Loss Contingency, Zero Damages Verdicts",
        "terseLabel": "Zero damages verdicts"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdicts",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_MarketingAdministrationandResearchCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.",
        "label": "Marketing, Administration and Research Costs",
        "terseLabel": "Marketing, administration and research costs"
       }
      }
     },
     "localname": "MarketingAdministrationandResearchCosts",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MaximumBondForAllDefendants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Bond For All Defendants",
        "label": "Maximum Bond For All Defendants",
        "terseLabel": "Maximum bond for all defendants"
       }
      }
     },
     "localname": "MaximumBondForAllDefendants",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_NonEngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Engle Progeny Cases [Member]",
        "label": "Non Engle Progeny Cases [Member]",
        "terseLabel": "Non Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "NonEngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCasePrincipeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Principe",
        "label": "Non-Engle Progeny Smoking And Health Case, Principe [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Principe [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCasePrincipeMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGreeneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Greene [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGreeneMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseLaramieMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Laramie [Member] [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Laramie [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseLaramieMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonParticipatingManufacturerArbitrationPanelDecisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "label": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "terseLabel": "Non-Participating Manufacturer Arbitration Panel Decision [Member]"
       }
      }
     },
     "localname": "NonParticipatingManufacturerArbitrationPanelDecisionMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NpmAdjustmentToCostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NPM Adjustment to Cost Of Sales [Member]",
        "label": "NPM Adjustment to Cost Of Sales [Member]",
        "terseLabel": "NPM Adjustment to Cost Of Sales [Member]"
       }
      }
     },
     "localname": "NpmAdjustmentToCostOfSalesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NumberOfThirdPartyLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Third Party Lawsuits",
        "label": "Number Of Third Party Lawsuits",
        "terseLabel": "Number of third party lawsuits"
       }
      }
     },
     "localname": "NumberOfThirdPartyLawsuits",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "label": "Operating Income (Loss) Before General Corporate Expenses and Amortization Of Intangibles",
        "terseLabel": "OCI"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeGeneralCorporateExpensesandAmortizationOfIntangibles",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OralTobaccoSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Tobacco Segment [Member]",
        "label": "Oral Tobacco Segment [Member]",
        "terseLabel": "Oral Tobacco Segment [Member]",
        "verboseLabel": "Oral Tobacco Segment [Member]"
       }
      }
     },
     "localname": "OralTobaccoSegmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherDisputesUndertheStateSettlementAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Disputes Under the State Settlement Agreements [Member]",
        "label": "Other Disputes Under the State Settlement Agreements [Member]",
        "terseLabel": "Other Disputes Under the State Settlement Agreements [Member]"
       }
      }
     },
     "localname": "OtherDisputesUndertheStateSettlementAgreementsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherInventoryRawMaterialsNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Inventory, Raw Materials, Net of Reserves",
        "label": "Other Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Other raw materials"
       }
      }
     },
     "localname": "OtherInventoryRawMaterialsNetofReserves",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherTabaccoRelatedCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Tabacco-Related Cases [Member]",
        "label": "Other Tabacco-Related Cases [Member]",
        "terseLabel": "Other Tabacco-Related Cases [Member]"
       }
      }
     },
     "localname": "OtherTabaccoRelatedCasesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "negatedLabel": "Less: Distributed and undistributed earnings attributable to share-based awards"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "label": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "terseLabel": "Payments to acquire equity securities without readily determinable fair value"
       }
      }
     },
     "localname": "PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PendingClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Class Action Lawsuit",
        "label": "Pending Class Action Lawsuit [Member]",
        "terseLabel": "Pending Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "PendingClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingIndividualLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Individual Lawsuits [Member]",
        "label": "Pending Individual Lawsuits [Member]",
        "terseLabel": "Pending Individual Lawsuits [Member]"
       }
      }
     },
     "localname": "PendingIndividualLawsuitsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "label": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "terseLabel": "Pending Lawsuits Filed By State Or Local Governments [Member]"
       }
      }
     },
     "localname": "PendingLawsuitsFiledByStateOrLocalGovernmentsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period One",
        "label": "Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "PeriodOneMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Two",
        "label": "Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "PeriodTwoMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA [Member]",
        "label": "Philip Morris USA [Member]",
        "terseLabel": "PM USA [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAandAltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA and Altria Group [Member]",
        "label": "Philip Morris USA and Altria Group [Member]",
        "terseLabel": "Philip Morris USA and Altria Group [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAandAltriaGroupMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_RestrictedSharesLockupPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Shares, Lock-up Period",
        "label": "Restricted Shares, Lock-up Period",
        "terseLabel": "Restricted shares, lock-up period"
       }
      }
     },
     "localname": "RestrictedSharesLockupPeriod",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_RevolvingCreditFacilityDueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility Due August 2024 [Member]",
        "label": "Revolving Credit Facility Due August 2024 [Member]",
        "terseLabel": "Revolving Credit Facility Due August 2024 [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDueAugust2024Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table Text Block]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges"
       }
      }
     },
     "localname": "ScheduleOfPreTaxTobaccoAndHealthLitigationChargesTableTextBlock",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTable",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_SmokeableProductsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smokeable Products Segment [Member]",
        "label": "Smokeable Products Segment [Member]",
        "terseLabel": "Smokeable Products Segment [Member]"
       }
      }
     },
     "localname": "SmokeableProductsSegmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SmokingAndHealthClassActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]",
        "label": "Smoking And Health Class Actions [Member]",
        "terseLabel": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]"
       }
      }
     },
     "localname": "SmokingAndHealthClassActionsMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SummaryOfIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Income Taxes",
        "label": "Summary of Income Taxes [Table Text Block]",
        "terseLabel": "Summary of Income Taxes"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxesTableTextBlock",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesupdateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_TobaccoandHealthJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Judgment [Member]",
        "label": "Tobacco and Health Judgment [Member]",
        "terseLabel": "Tobacco and Health Judgment [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthJudgmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TobaccoandHealthLitigationCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Litigation Cases [Member]",
        "label": "Tobacco and Health Litigation Cases [Member]",
        "terseLabel": "Tobacco and Health Litigation Cases [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthLitigationCasesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes3490PercentDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 3.490 Percent, Due 2022",
        "label": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]",
        "terseLabel": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes3490PercentDue2022Member",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes [Member]",
        "label": "USD Denominated Notes [Member]",
        "terseLabel": "USD Denominated Notes [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UST Litigation [Member]",
        "label": "UST Litigation [Member]",
        "terseLabel": "UST Litigation [Member]"
       }
      }
     },
     "localname": "USTLitigationMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetDecreaseInAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Decrease In Amount",
        "negatedTerseLabel": "Reductions to valuation allowance credited to income tax benefit"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetDecreaseInAmount",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetIncreaseInAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase In Amount",
        "terseLabel": "Additions to valuation allowance charged to income tax expense"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseInAmount",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "label": "Valuation Allowance, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ValuationAllowanceForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceRollforwardRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance Rollforward [Roll Forward]",
        "label": "Valuation Allowance Rollforward [Roll Forward]",
        "terseLabel": "Valuation Allowance Rollforward [Roll Forward]"
       }
      }
     },
     "localname": "ValuationAllowanceRollforwardRollForward",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_WineSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wine Segment [Member]",
        "label": "Wine Segment [Member]",
        "terseLabel": "Wine Segment [Member]"
       }
      }
     },
     "localname": "WineSegmentMember",
     "nsuri": "http://www.altria.com/20220630",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r113",
      "r167",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r187",
      "r191",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r281",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r113",
      "r167",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r187",
      "r191",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r281",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]",
        "verboseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r261",
      "r263",
      "r264",
      "r265",
      "r289",
      "r325",
      "r445",
      "r450",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r601",
      "r649",
      "r651",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r254",
      "r261",
      "r263",
      "r264",
      "r265",
      "r289",
      "r325",
      "r389",
      "r445",
      "r450",
      "r452",
      "r453",
      "r454",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r601",
      "r649",
      "r651",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r254",
      "r261",
      "r263",
      "r264",
      "r265",
      "r289",
      "r325",
      "r389",
      "r445",
      "r450",
      "r452",
      "r453",
      "r454",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r601",
      "r649",
      "r651",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r358",
      "r361",
      "r650",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r358",
      "r361",
      "r650",
      "r661",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "stpr_AK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ALASKA",
        "terseLabel": "Alaska [Member]"
       }
      }
     },
     "localname": "AK",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_AR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "Arkansas [Member]"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONNECTICUT",
        "terseLabel": "Connecticut [Member]"
       }
      }
     },
     "localname": "CT",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DISTRICT OF COLUMBIA",
        "terseLabel": "District of Columbia [Member]"
       }
      }
     },
     "localname": "DC",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DELAWARE",
        "terseLabel": "Delaware [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FLORIDA",
        "terseLabel": "Florida [Member]"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IOWA",
        "terseLabel": "Iowa [Member]"
       }
      }
     },
     "localname": "IA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILLINOIS",
        "terseLabel": "Illinois [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KANSAS",
        "terseLabel": "Kansas [Member]"
       }
      }
     },
     "localname": "KS",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_LA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOUISIANA",
        "terseLabel": "Louisiana [Member]"
       }
      }
     },
     "localname": "LA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "verboseLabel": "Massachusetts [Member]"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MARYLAND",
        "terseLabel": "Maryland [Member]"
       }
      }
     },
     "localname": "MD",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MICHIGAN",
        "terseLabel": "Michigan [Member]"
       }
      }
     },
     "localname": "MI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINNESOTA",
        "terseLabel": "Minnesota [Member]"
       }
      }
     },
     "localname": "MN",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSOURI",
        "terseLabel": "Missouri [Member]"
       }
      }
     },
     "localname": "MO",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSISSIPPI",
        "terseLabel": "Mississippi [Member]"
       }
      }
     },
     "localname": "MS",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MONTANA",
        "terseLabel": "MONTANA [Member]"
       }
      }
     },
     "localname": "MT",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW HAMPSHIRE",
        "terseLabel": "New Hampshire [Member]"
       }
      }
     },
     "localname": "NH",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NJ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW JERSEY",
        "terseLabel": "New Jersey [Member]"
       }
      }
     },
     "localname": "NJ",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "New Mexico [Member]"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEVADA",
        "terseLabel": "Nevada [Member]"
       }
      }
     },
     "localname": "NV",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "New York [Member]"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OHIO",
        "terseLabel": "Ohio [Member]"
       }
      }
     },
     "localname": "OH",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OKLAHOMA",
        "terseLabel": "Oklahoma [Member]"
       }
      }
     },
     "localname": "OK",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OREGON",
        "terseLabel": "Oregon [Member]"
       }
      }
     },
     "localname": "OR",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_PA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PENNSYLVANIA",
        "terseLabel": "Pennsylvania [Member]"
       }
      }
     },
     "localname": "PA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_RI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RHODE ISLAND",
        "terseLabel": "Rhode Island [Member]"
       }
      }
     },
     "localname": "RI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_SC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SOUTH CAROLINA",
        "terseLabel": "South Carolina [Member]"
       }
      }
     },
     "localname": "SC",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TENNESSEE",
        "terseLabel": "Tennessee [Member]"
       }
      }
     },
     "localname": "TN",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas [Member]"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WISCONSIN",
        "terseLabel": "Wisconsin [Member]"
       }
      }
     },
     "localname": "WI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEST VIRGINIA",
        "terseLabel": "West Virginia [Member]"
       }
      }
     },
     "localname": "WV",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued liabilities:"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r51",
      "r58",
      "r67",
      "r68",
      "r69",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit Plans [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r53",
      "r58",
      "r67",
      "r68",
      "r69",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior service cost/credit [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r50",
      "r58",
      "r67",
      "r68",
      "r69",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Net loss [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r13",
      "r250"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r55",
      "r57",
      "r58",
      "r630",
      "r656",
      "r659"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive losses"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r67",
      "r68",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r54",
      "r58",
      "r67",
      "r68",
      "r69",
      "r114",
      "r115",
      "r116",
      "r498",
      "r565",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Losses [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r48",
      "r58",
      "r67",
      "r68",
      "r69",
      "r498",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Currency Translation Adjustments and Other [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r455",
      "r456",
      "r457",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to operating cash flows:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r163",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All Other [Member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "auth_ref": [
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "terseLabel": "Allowance for doubtful accounts, receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r100",
      "r246",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r16",
      "r108",
      "r175",
      "r182",
      "r189",
      "r217",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r493",
      "r499",
      "r545",
      "r567",
      "r569",
      "r608",
      "r627"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r33",
      "r108",
      "r217",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r493",
      "r499",
      "r545",
      "r567",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r511",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business combination, acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r10",
      "r102"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r96",
      "r102",
      "r103"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r96",
      "r549"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease)"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r106",
      "r108",
      "r138",
      "r139",
      "r144",
      "r147",
      "r149",
      "r160",
      "r161",
      "r162",
      "r217",
      "r271",
      "r276",
      "r277",
      "r278",
      "r284",
      "r285",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r545",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r613",
      "r635"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends declared (usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.33 1/3\u00a0per share (2,805,961,317 shares issued)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r77",
      "r620",
      "r643"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings attributable to Altria"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r76",
      "r491",
      "r492",
      "r503",
      "r619",
      "r642"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r64",
      "r75",
      "r490",
      "r503",
      "r618",
      "r641"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r74",
      "r84",
      "r617",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Earnings/Losses"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r339",
      "r340",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "netLabel": "General corporate expenses [Member]",
        "verboseLabel": "General corporate [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r80",
      "r602"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r303",
      "r310",
      "r311",
      "r313",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r107",
      "r113",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r315",
      "r316",
      "r317",
      "r318",
      "r560",
      "r609",
      "r610",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r286",
      "r315",
      "r316",
      "r559",
      "r560",
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r301",
      "r315",
      "r316",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r107",
      "r113",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r315",
      "r316",
      "r317",
      "r318",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r107",
      "r113",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r312",
      "r315",
      "r316",
      "r317",
      "r318",
      "r330",
      "r331",
      "r332",
      "r333",
      "r558",
      "r559",
      "r560",
      "r561",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument, term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r100",
      "r109",
      "r470",
      "r479",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r460",
      "r461"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r21",
      "r365",
      "r366",
      "r388"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r367",
      "r405",
      "r429",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r367",
      "r406",
      "r430",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r382",
      "r390",
      "r392",
      "r433",
      "r435",
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Defined benefit plan, plan assets, contributions by employer"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": {
     "auth_ref": [
      "r433",
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year",
        "terseLabel": "Anticipated additional employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r367",
      "r404",
      "r428",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r367",
      "r371",
      "r403",
      "r427",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r401",
      "r425",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit (income) cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r369",
      "r402",
      "r426",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r100",
      "r170"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedTerseLabel": "(Gain) loss on Cronos-related financial instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r46",
      "r512",
      "r514",
      "r518",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r530",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r509",
      "r512",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r509",
      "r512",
      "r518",
      "r522",
      "r523",
      "r527",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r509",
      "r510",
      "r516",
      "r518",
      "r524",
      "r526",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r505",
      "r506",
      "r509",
      "r510",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives, Policy"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r78",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r135",
      "r138",
      "r147",
      "r148",
      "r149",
      "r153",
      "r154",
      "r533",
      "r534",
      "r621",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r78",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r138",
      "r147",
      "r148",
      "r149",
      "r153",
      "r154",
      "r533",
      "r534",
      "r621",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r67",
      "r68",
      "r69",
      "r114",
      "r115",
      "r116",
      "r120",
      "r129",
      "r131",
      "r159",
      "r221",
      "r329",
      "r334",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r532",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r565",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r72",
      "r95",
      "r100",
      "r638"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends from ABI"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage",
        "verboseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r11",
      "r176",
      "r213"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r95",
      "r215",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities without readily determinable fair value, amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Impairment of JUUL equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.",
        "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]",
        "terseLabel": "Equity Securities Without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r541",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r539",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r301",
      "r315",
      "r316",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r435",
      "r540",
      "r574",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r301",
      "r390",
      "r392",
      "r397",
      "r435",
      "r540",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Unrealized gains (losses) included in (income) losses from equity investments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r301",
      "r315",
      "r316",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r435",
      "r574",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r312",
      "r328",
      "r530",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r46",
      "r390",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency contracts [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Gain (loss) related to litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r100",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt",
        "negatedTotalLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r319",
      "r320"
     ],
     "calculation": {
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Loss on extinguishment of debt, premiums and fees"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "General corporate expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r14",
      "r234",
      "r235",
      "r242",
      "r244",
      "r569",
      "r607"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r79",
      "r108",
      "r175",
      "r181",
      "r185",
      "r188",
      "r191",
      "r217",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r545"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r269"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Contingent liability related to performance surety bonds"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r175",
      "r181",
      "r185",
      "r188",
      "r191",
      "r606",
      "r615",
      "r623",
      "r646"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before income taxes",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r72",
      "r100",
      "r172",
      "r213",
      "r614",
      "r638"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "(Income) losses from investments under equity method of accounting",
        "negatedTerseLabel": "(Income) losses from equity investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r464",
      "r465",
      "r469",
      "r477",
      "r482",
      "r484",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r111",
      "r130",
      "r131",
      "r173",
      "r462",
      "r478",
      "r483",
      "r647"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/IncomeTaxesSummaryofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r66",
      "r458",
      "r459",
      "r465",
      "r466",
      "r468",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Cash effects of changes:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Accrued liabilities and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits",
        "negatedTerseLabel": "Decrease in obligation, pension and other postretirement benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInPensionAndPostretirementObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r245",
      "r247"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTerseLabel": "Interest and other debt expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r612",
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest on long-term debt"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r233"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished product"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r31",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r30",
      "r233"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r215",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r205",
      "r210",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Investment [Table Text Block]",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r205",
      "r210",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r636"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Investments",
        "verboseLabel": "Investments in equity securities ($451 million and $1,720 million at June 30, 2022 and December 31, 2021, respectively, measured at fair value)"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, fair value disclosure"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r108",
      "r183",
      "r217",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r494",
      "r499",
      "r500",
      "r545",
      "r567",
      "r568"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "verboseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r108",
      "r217",
      "r545",
      "r569",
      "r611",
      "r632"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r39",
      "r108",
      "r217",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r494",
      "r499",
      "r500",
      "r545",
      "r567",
      "r568",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit line available under the agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Loss contingency, credits to offset payments",
        "verboseLabel": "Amount ordered to be paid from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.",
        "label": "Litigation Settlement Interest",
        "netLabel": "Litigation settlement interest expense (income)"
       }
      }
     },
     "localname": "LitigationSettlementInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r20",
      "r300",
      "r314",
      "r315",
      "r316",
      "r610",
      "r629"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Carrying value",
        "verboseLabel": "Carrying value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r41",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r258",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Accrued liability for tobacco and health litigation items at end of period",
        "periodStartLabel": "Accrued liability for tobacco and health litigation items at beginning of period",
        "terseLabel": "Pre-tax charge"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Loss contingency accrual, provision"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Loss Contingency Accrual [Roll Forward]",
        "terseLabel": "Loss Contingency Accrual [Roll Forward]"
       }
      }
     },
     "localname": "LossContingencyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [
      "r260",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Loss contingency, claims settled, number"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r258",
      "r260",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded, value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r258",
      "r260",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Judgments paid (approximately)"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r258",
      "r260",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r258",
      "r260",
      "r261",
      "r262",
      "r263",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r260",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r260",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "verboseLabel": "Number of cases pending"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items [Member]"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r96",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r60",
      "r63",
      "r69",
      "r73",
      "r101",
      "r108",
      "r119",
      "r124",
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r145",
      "r175",
      "r181",
      "r185",
      "r188",
      "r191",
      "r217",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r534",
      "r545",
      "r616",
      "r639"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Altria",
        "verboseLabel": "Net earnings attributable to Altria"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r63",
      "r69",
      "r130",
      "r131",
      "r496",
      "r502"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net (earnings) losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r135",
      "r136",
      "r146",
      "r149",
      "r175",
      "r181",
      "r185",
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Earnings (losses) for basic EPS"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r137",
      "r140",
      "r141",
      "r142",
      "r143",
      "r146",
      "r149"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings (losses) for diluted EPS"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r322",
      "r496",
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "terseLabel": "Net periodic benefit income, excluding service cost"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r117",
      "r118",
      "r121",
      "r122",
      "r132",
      "r133",
      "r134",
      "r201",
      "r202",
      "r222",
      "r223",
      "r474",
      "r475",
      "r476",
      "r531",
      "r535",
      "r536",
      "r537",
      "r546",
      "r547",
      "r548",
      "r562",
      "r563",
      "r564",
      "r566",
      "r603",
      "r604",
      "r605",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdopted"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r334",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OciEquityMethodInvestmentAfterTax": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.",
        "label": "OCI, Equity Method Investment, after Tax",
        "terseLabel": "ABI"
       }
      }
     },
     "localname": "OciEquityMethodInvestmentAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r175",
      "r181",
      "r185",
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]",
        "terseLabel": "Operating Income (Loss) [Member]"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Background and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r32",
      "r569"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r550",
      "r552",
      "r556"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other comprehensive earnings (losses) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r70",
      "r550",
      "r552",
      "r556"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r56",
      "r67"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r49",
      "r55",
      "r517",
      "r520",
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "(Gain) Loss Recognized in Net Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "(Gain) Loss Recognized in Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r61",
      "r64",
      "r67",
      "r68",
      "r70",
      "r74",
      "r329",
      "r550",
      "r555",
      "r556",
      "r617",
      "r640"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses), net of deferred income taxes",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r52",
      "r55"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Other Cost of Operating Revenue",
        "terseLabel": "Excise taxes on products"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r418",
      "r422",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Postretirement [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r21",
      "r365",
      "r366",
      "r388"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.",
        "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent",
        "terseLabel": "Accrued postretirement health care costs"
       }
      }
     },
     "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for Legal Settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r85",
      "r87"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Premiums and fees related to early extinguishment of debt"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation [Member]"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitContributions": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.",
        "label": "Payment for Pension and Other Postretirement Benefits",
        "negatedLabel": "Pension plan contributions"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitContributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r389",
      "r391",
      "r397",
      "r414",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r435",
      "r437",
      "r438",
      "r439",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Pension provisions and postretirement, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r363",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r418",
      "r422",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r440",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension [Member]",
        "verboseLabel": "Pension [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Long-term debt issued"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r89",
      "r93"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r60",
      "r63",
      "r69",
      "r94",
      "r108",
      "r119",
      "r130",
      "r131",
      "r175",
      "r181",
      "r185",
      "r188",
      "r191",
      "r217",
      "r271",
      "r272",
      "r273",
      "r276",
      "r277",
      "r278",
      "r280",
      "r282",
      "r284",
      "r285",
      "r490",
      "r495",
      "r497",
      "r502",
      "r503",
      "r534",
      "r545",
      "r623"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r12",
      "r249"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r251",
      "r569",
      "r624",
      "r634"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r569",
      "r633",
      "r660"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r550",
      "r554",
      "r556"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified to net earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r70",
      "r550",
      "r554",
      "r556"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTotalLabel": "Amounts reclassified to net earnings, net of deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r56",
      "r59",
      "r67"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Long-term debt repaid",
        "terseLabel": "Long-term debt repaid"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r10",
      "r103"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r15",
      "r103",
      "r662"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r334",
      "r569",
      "r631",
      "r655",
      "r659"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Earnings reinvested in the business"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r114",
      "r115",
      "r116",
      "r120",
      "r129",
      "r131",
      "r221",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r532",
      "r652",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Earnings Reinvested in the Business [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r418",
      "r422",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r418",
      "r422",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r166",
      "r167",
      "r180",
      "r186",
      "r187",
      "r194",
      "r195",
      "r198",
      "r357",
      "r358",
      "r602"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r360",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Expected period for satisfaction of performance obligation"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r58",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansScheduleOfComponentsOfNetPeriodicBenefitCostIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r512",
      "r518",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Pre-tax Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r4",
      "r108",
      "r216",
      "r217",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsinEquitySecuritiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r258",
      "r261",
      "r263",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Contingencies"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Periodic Benefit (Income) Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r123",
      "r126",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Recent Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/NewAccountingGuidanceNotYetAdoptedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r175",
      "r178",
      "r184",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r175",
      "r178",
      "r184",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchase Activity"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r163",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r198",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r256",
      "r257",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Reporting Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r175",
      "r179",
      "r185",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails",
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r17",
      "r569",
      "r609",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r163",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r198",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r253",
      "r256",
      "r257",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofTobaccoandHealthandCertainOtherLitigationItemsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r106",
      "r108",
      "r138",
      "r139",
      "r144",
      "r147",
      "r149",
      "r160",
      "r161",
      "r162",
      "r217",
      "r271",
      "r276",
      "r277",
      "r278",
      "r284",
      "r285",
      "r323",
      "r324",
      "r326",
      "r327",
      "r329",
      "r545",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r45",
      "r67",
      "r68",
      "r69",
      "r114",
      "r115",
      "r116",
      "r120",
      "r129",
      "r131",
      "r159",
      "r221",
      "r329",
      "r334",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r532",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r556",
      "r565",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r159",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Planned share repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r68",
      "r108",
      "r114",
      "r115",
      "r116",
      "r120",
      "r129",
      "r217",
      "r221",
      "r334",
      "r455",
      "r456",
      "r457",
      "r472",
      "r473",
      "r488",
      "r489",
      "r501",
      "r532",
      "r545",
      "r550",
      "r551",
      "r556",
      "r565",
      "r653",
      "r654"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r557",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationandShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporProductLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofAltriaandorPMUSATobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesupdateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ThreatenedLitigationMember": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.",
        "label": "Threatened Litigation [Member]",
        "terseLabel": "Threatened Litigation [Member]"
       }
      }
     },
     "localname": "ThreatenedLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r203",
      "r204",
      "r206",
      "r207",
      "r208",
      "r312",
      "r328",
      "r530",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "verboseLabel": "Average price per share of shares repurchased (usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r44",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Cost of Repurchased Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r24",
      "r329",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "verboseLabel": "Total number of shares repurchased (shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r44",
      "r335",
      "r338"
     ],
     "calculation": {
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Cost of repurchased stock (1,003,717,832 shares at June 30, 2022 and 982,785,699 shares at December 31, 2021)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r329",
      "r334",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchases of common stock",
        "terseLabel": "Aggregate cost of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationShareRepurchaseTableDetails",
      "http://www.altria.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r137",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares for diluted EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r135",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares for basic EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.altria.com/role/DebtNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GainsLossesOnExtinguishmentOfDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write-off of amortized debt discounts and issuance costs, debt extinguishment"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 17
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e639-108305"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32472-111569"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r675": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r676": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r677": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r678": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r679": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r680": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r681": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r682": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r683": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r684": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r685": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r686": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0000764180-22-000091-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000764180-22-000091-xbrl.zip
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M /1RX/F!DHAM_-YAH%$#X$= #ZB9V@J*\C'FD0;-2!LV 3".E0CH@GY?@RI
M$<WD3(D,!ET@T*I"K0H)*P4R#[L+)>B]B?D>8\$$-*<(PE..@IZOF=4VDZA&
M<<.Z$]+'ZQ(9#R]\#9;3(ZX"U0Y]:5ZCO)FO3(PV?#/H!MK8SF,1GG\Q^\LJ
M,#_0,5.8*[ & 0H&7NWP/MP'O6Q>^K^].C[Y$+(;:!CV2X0%&MGCOJ7+Z$TD
M FKU&Z@R5&A3>O@>]2W4\)ZXBT)/!J0C'=9 RV,B'68;&7WQ%?0C)8M?HVF!
M'AA +5WFL*%5</C,*NT#?19X100=DYZF@6OI"1H:^^DDO(2JZT_03X1)#;P(
M54\7-#QP!"H\IAIL 6HX>'2J;<S/J)O7Z9AQ.5)BA*"Q_1$%\L]T!1;X>@1<
MXN@>2AH&("%_0-MT%I2& %4$!HUI'S@2US,V7['^7#!"MOS0F$3]9=X&X)<*
M;>><.BH^V^O+FJ^8[@*WFS=?ZM<7I'(-45^MTNA<SGG#&:I]NN>6Q@,4_H)'
M-J?25IL20\8,C!+\GW;/''=GCE%,J8A'<#\J7V) ?X6E%N;8%BL6Y'W(K7D7
MR+Z,]GK@6J S5<!Z (^O M!8AV\+-A0&VK<9RY@/7U_HGE6+Y39=^2X#+EA;
M0"T=$,7O%B@(KTHE=>GS._O+MO.##:#!("AMH7\?@,NK\:Z]3Y^%39Y4P+!)
M%_0X&!0?+!W>EO%6A=W9@$D6H=VEX*N$O]DD@>W*X(6 F,JGIR>1OK9=#<6<
MK8YQIL'7 X\>6B&*9%1,1#95<*W!2D(-,+Z)[]MFSRE$7N*8+CAHO9!.-*;3
MS/URZ8#V6>C:+OK$?(7'Q>2(:Q5[>W%\@-V3%? !-8;[!@Q=T:F[D4&I;E7!
MA9H+>@'8"C9OVL#C"[VJ63 "T9LTU#I^D;# SPM\]+)L)H'9X'D 7J$:3!\;
M!A"5H)<9/1*9G2BW$*E6<(^=P)AI% J,%E,UDV?M>1X''U6+<R6T$%EHT#.9
M6L/8;%[_M(I7\(--)(3PAG2BSE=54^53(%6N': 07(0PMD!J@HV@JWK@AD#
MBAFMZ(8".<>H VZS8<)G:".X6@5+29<TZ82 RP(J^ABXL\V^ KS-EOK8*AI/
M]F!K2%^'5L"CF"&,(J,W<9XM8]K8<GRKF&)^A\E)UI3?,W'\ SIR?UY7H!]6
M&4#Q#I5SJ@)=ELF\NAAQ0<YM'M"9:HT;+1C4#O/=W'@%TE !-QS<ZE@_7*N1
M-?&D?&BUQ,G?-;2.PNEJI54CU9MVA[1JU9N[6NN/O$?8])$,7Y3@61TC3V/B
M782[M@AW,4GVE'!^()>5(0>-#:GVX[3L58#.&K-BR4*CGLDM[%R+HVC0IDCQ
M+L>,$"DJ'"+ I-9,"R\^G]3&T\]0<%6)8-#E4T7<9D,_U,2'H28^W2:OOS?.
M0"_E[VHQXA&"^L5EIVTSAE\;G5:%Q!?",8%JI5U;GJ"0K2Z\.C6;& 7!-J:-
M>SR:<4U/J\;CTDN)59MO-:D6)PLP/E-I-)72;'5F*5U+)$*[)M7&PT'8.(:[
MAZB7W'%L<YJ"*)\@7J5R'O&"5KE,(E#+<SQ6 G1) 4;GX7%\ $4(E0[?66R.
MUJV4$K/0ABJ<AO?>#K'S$5N:EQ8_&+VG-'N$=@WH?G_U(R\_(2M=5HGI:?,_
M/1U79DC[;!_'*Q_V:0_J^IZ*,9V8O<W-X\N*?:@V*NTVJ53M3+5&Y;[]M=YI
MD_KUW4WC#@?Q:OMWE=N;%KEMW9Q_K7;R:206!HJG6<V0]>'<B*718COFCN[N
MSE#,)WR8:0^X[\W;BJNO7QND ?H@H?X>]R*;W'4%6W F$TF_RE!S0<H6K?)I
M'M&Z970T(:_![QS8^7CM,:-V:I9\DPI@TH \CN"UTL@MN8!A1= N'2PD3H_*
M^46P5:P5UP!56P7+4*7:WTK0QVDLY:/\8M8LGJ\#LU1Z-3E$3O!W..1)Q'+<
M3V_ '_5P2%%O"K<JU 340+HC?)A?Y"Z5XZT-N1HU?A(XK/D?2C_$L-TXOK*@
MY1>SVH"[DY]'"]57$JT.DY(9PU@2KAQ3K EW]-4 <XUQY 1!TD38N5$_C>*"
M<IL6F^!:CLGV!5W7:<1)C0>??277@%P:_^9?D,#P7_G%L,K]";:N!<K.-OKE
MK,1T8"O'\%VQ7L_.Y8EX2-J.I]1LE&]3_EV*KW+.G!#.'#LK#>9V<8KYQEB8
M""&FF.793ZD9A^(XQ>8HF IE(J*=0?DNOU "##U<KY& $  HDJ/#4H'<0IWI
MF$*]^6Q"SY=V86YF&:Y]D6 <)#D+5Z'<P-\P4=+FT IJHV7N!V'&&:42!&*6
M9%BODOU;B"42QYFBV@VU'[QW?V%2U4L9K1F>I_G%$].(24S/M!KCKSM ?P#0
MSYJY. K]L(/O1^"K0YE\S0'/C6;]F:L^A0F5>%YAJBHUW)QKU&%_41/C=45E
M !$CL:0Z+.41K9MH07J+<;#)+]<C8^C"-&L^L;N@W2X8@PWEO;XPZ0?.PR1&
M[#/K:@O983F_D-TRA4-GMT$7[H^LJ]D\VW 0)$Q/YQ.VI0Q8 L$":9ZG\6]#
M5C3/#*Q(NVO& YJ(A>CC$AIV3G&%$G[5+MX6$<.Y>*7RW?'*IL.5:(I(:'9R
M.7VFXM(!N6+R@4OSPS G!'A>;.!JE!?!_JCT%/:_XD2;PU]^HLUS?54/",V8
M)"WN>&R2HI':Z)UWBG]D71F%4PSRJ8S:'IT(2BH.\WE*CFIAIY1H,H^9PFQ6
MP;Q1M4-R"#,4#^B!!Z.Y_PUM[+J0+NZH/)TM@T-M/CF?++LWW(3*Y,Q.#ED;
M]B]L5K,+_96BDM2"+I4/9HWX[I1U<K%\X#!RP<$G C(OH(H+.>S5+\6+5(H_
MAOH.]B>&<"5_H  -[CRVH_<&?1$.'N&$-!4N"5RD-[B#[C1 _5)L%ZOK5.0[
M223FS5!L)UPFYQ!3B;4Z+#NLDZMIG ?.R"W3.BT(BM,RI'&[$\(&5;PQN$3T
MEH,8V!J!_NW5V],/"^ND=OBG3>NACH8(%+/CPF&/9B>_V.SDKB=L-"UC2(</
MA^OL"#N<$QJ'2@;._#T7'A,[K_+E@%[R*R%L*MH$^MK5_EHE$2T(RZ\@.DI.
M*,I!<#HP^_=4I ]$V4Q-LWA?+/R4"';=8#$[!EARTH#KNPS-2XWMI2<AFT7<
M.2[K8QHYSD;NAKFS((6:QC,Z AR3S>[DY_R3O>U1*4%]?^%2V@E9.Z@W-\KA
M27*IP']),Z$[F-<$\[T2O3Z-MA=O!]^ WXS\A[,^DQZ%'XO.2GA8C1WZN"S^
MIYAQUR;'8H$X"CR8+PQQ38NA"J0*;LU]YG,SN]E+*<(]VLU>>NY,>\&@6#0'
MDC^D#I#,#(+*@$'(=5#E<EQ 6Q$^3Y\\DRW;FV.H=Y/RLB"%:P!?"6K(G>HS
ML6JF1ZUXEV5C.UW?DDL1W()23RR7KBH]+)(F\[4:*@$ER:55P#>X"427&F^Z
MRF^AC_SVZNC=AXSTDBB=_"Y#N[$]=?3 $UO9XD%CX7%F^=W,=B5+T[<OK/]^
M,]V2<+-"27]_QO9=?VY*O%*'3H3[NO:Y@YY<=$CI_"*LN5U.JX+C)MEM/(K2
MG@S8:%1_9I';TN9KMD?F>#UE-3HO,#[?X)*%&TQ6M,\=$>T(B8<>*&G/\.W@
M8;JJE\1N<7_XC@X7\0\&W/;UOPU:EW93>0XN5=532"BPF9)&!V2&MF9I*^+X
M^-Z?6B)XP11@LKRR[3A#6.Y,P>.*MW+=J7=:7]N=?&O@NB2:/;J+],K-_,\8
MGF1K-T#_C%LK/*DJ<KQNL\68PU(LTG<@]E/>X4E^(3L3:O#?@!M_"[#E>5T_
M!,]@L]FW;<"6)0/T3-C.&77'$[&X]\8+X19N6))/W!J@RC7?!F@Y-@>?!0Z)
MZ<DV8,NQ2;BGPG@OBADFP=[E%[ 6<WN<"??%,<OS=B55JH59W&+V13#+LT([
MLXG1*FDQGW*Q,@&S.0"O LFBC8[SB6!;]?B?R+H==,\>;%%*DS/*^SOP?H1W
M$(X;P.06XH8)H&%/TMH2CCDVM5?4>7AIJV%!.\RQJ6TZ%QY[V;R(/<(HQ_VU
MKL=<NE0P\CE@PH+!8[/Q@@#^,.EV![PE)7J<KYE;^4BOMR\KK=KE3>.\UB+P
MKWY7Z=3O:M,#XK)0_^<::BK=B9G7E;@0:VX'SW6E"<+SD*(TP5:/O\VAE!I*
M.W1>2!>\!_AN2$AY3N94E<?DHW1>.'_4CA->,@F8J.G<G$=.9\UQ*OJ""]P'
M*X5%:YRKL' 053YQNL37^$IN%*=XJ^?(S<[E5#A<.:K$T-LH4/,G_^83IC--
M PD-Y8\QZOE*R>9#<PQ+0PW9MSE$JD@&)G\"D3#8_U=^(6DRK;GOFV>A4@&M
M/L#)V8_@ J%5GE<8G=.$/KXODDLN7-;5H()\T@YT7X+1^7'JQ*=UGN07I*93
M54($@[4JF=@AS%*GVDT!>V+N[W6GUKJV,[\J#5*MM&N9B$N??SHY"ND[SQE?
M.%\<#"U. >-]2?X,-#<NMR><9_>T\<=/HJ>2NC0+U7RF0HI/43E74C(A,.XH
MIAP)$K:O0!J^.Y=3O)$^'AT__05T_! J!N*.?,>%"4)9R"H04ML?T2'4T!'4
M -DLZ>#RTRJ)AV3/!!>?G3X2(QH.[J0<^+)"N+\'K,N<Q"FS\"K-J%@AZ-"W
MBX]:)&2;HOXEY>RSH<>D215S<D#@#+Q8;M<Z@3_216\BY '*5K,!6Q1M\NSJ
MG7!?/.,!Z#?IGPP>L_.FH7]"R,%QL2?<%![QMRA1%']]@!T5IU='RSH:?,#M
M:MJ8!PEQ+]/BCDI'!2-X?8OU41E,9O8@D2>QB;=2><OL"-=F@* U.)$*W!'-
M'#7"(XAV3 F9@E=OM1IQZ;#XI/HS'4@SQC,.@38MY7M0LR6E$08E\(0M,_(=
M##ECTO&6"[H*P*M#\LW;D/@L17O0]B*/PC12. &[]&['HNW&\TIC,VQZ X3$
MZ6QI6!/Z>P]0"#33)B*!C4X=+KZ?*Q6;Z0;AI]*D2D6?+JL:!!: [JK C]P-
MZU:63K?L5K8'ZH%'N]YX$7-^(>/49H.A8#]!E@4K9#6)&H$KXBA_YIFLYL"[
MD -;UAB_. >^!! %;E!?0"D<G%"@P3V7D@]9?Z8YJ@P#DQ2B0"T"^2#56!*7
M O!@!<.94SN5L66ZX&:;9E-T0;3:U#Q0W_'8F,I"DBKX(+JS\@GM@O.=2COM
MLGVZ/.W4QDFH.?<UX;TN9BW"-*/Q>>@#3Y-9J^DPFV)PE U._.H^ZAG($;I
M>J0;I3,>#WC3XF8<88'P!#/8JR+>)1<D3%672SLEL=WAM7.F!]S=\6''!^MC
M0(VT9!-RP:3=9"!,4?3 EW %8H+_&K2KJ0M-?]1P)**358442$>'H>R(A[L8
M+!)E>A:Z#5G*Y2W[H"]C0'[%F=UO\S6S.YM]-1R#>JXV3_AX\4#6=/ J3C,M
MI;%1<8?]\O"7Z)?9)<.\MS_OXT<YPZ<6NVPD];BC1R;IL1 ,XH<I6>*$T>*
M!I  MZ,-=W.\9&Z?):W]^A-1. TTW-*T?+@+&;-)G2EMYO-&ZZ;.DSFI\ :U
M[#@JN:" =BS*#(N2:B<YN'JK[6\U=TRU2^K&Q@Q/\2IIT98BD+12Y[@RMQJF
ME O&;+ANSY1O<:M8_3I]YSNG)\S& K'C_$AW61A.G&G4>.**[2)O,]Y%_NY*
M%;=1@*O/'A-*SD==G>='HVH0P2)Y>W1R>HQS%6^>SON'&;V33.C1K6;T=@OX
MD^+XU^HTST%7N1/XS_,'XM/_ U!+ P04    " !\.?Q433[WQ04$   )'@
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MA7CMQO6;?Y7A_^']_<6;,E\<S>;ON^S9@^F?:O57UWWK$M^^_>D_-, 0")U
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M[OFX>_J&?G!U4]IL+O5[F>L/NSDDDFL-&7,D&["%3(J=L=AJZNTA1K4L>[#
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M:ZA K8E(P-8@>Y\PQ^*9<\8\KG(S$Y.'P>2M#-BF;+TF0+W?>,7:"V9QI$I
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ML4OJ^.N/^NIZO.;C8:W]E=4:!Q?Q61?Q&E0_6KGM$8<;C58SVIHLQ5#LK:[
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M<9JY2Q74B0JEG"<\_M=1:XGT3%&DJ5-,2F--YBY35I>+"=Q%&@U3S5(0'-6
MPOC#J$  0Y@PPIA4H>0N8HR[W'W^YNUPER>*<.8N#Y7?,>[B!84:1;A7B!!
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MV09G0E$E8XUG-O'*V(1:6%X[.VR:9@X$?C74(,ZIP-E.FPM8W8JOUX/3GL_
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MAP/Q4"$#"&4>4*PE,(938+'#SG(6OX(1J<@\<[A?P-2L.-Q;08?*D)Z,#E-
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MEM$BFK 3/D<$Y*$) Y[# Y,A:"[H3(:@Z4+0&*G1R,HHM ((Z3F@5CF@H Y
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M"%@SZ!:6"5\4]!7E0IS.:O,\J1(SQL] >MXXQE?&@,@8/WV,'S,G!/7$"(@
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MW$AS>X9N\G(]/$.7S\Z] 9IT#?RRJ3<U/#R:D&0+$F<X0PB00")I<@P"HU4
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M(?5" TU,M(ZD\3K^A8)C$1X7E<QA.7GS:PXXVO0/665(FBDDC7EHD/,<2JJ
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M(P%D0";]+U)<NK#,Z7BD75;@JBAP%3PBF1"\B#[CV_H<9T=3:BUP@?M42(T
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M4! @%RQ:/<I:M;!,1=;T*FKZT]?TV05Y9$VOAE?C,C:$1N(6%'' ."039S=
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M^':_WNVD5O:ZK5:9U'N8O"IOX$T/!K?'G27*8Z4P(\ @%^T>SFPD3\%$XT=
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MIZS$G.DHP90^'E-:/QPM4F9.ECHD59*(:^V1E90AQI2-,@9-J5M:)1!]NF
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MA#/A73!J:94N9[686[UL &H :@#J6P0[,8<#Y4%;@[DA7,L4+);&ZAB-"1B
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MUOE'4FS+<=EO5#A*E.9TDS.6Y4__=(/DG'4^C63>M:O(&@X) HVKKV[T 8V
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M#S@L(Q$IHT31F&I8-RLR]N)UNI'P96[TE%M;K#4M@JTP+LR1*ETX4S:#7F^
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M6< WT%-AD</U,\WLT5Z!6SV,O?K/=!![DS%L3]U >WX_=*+[R20-QOI]=^M
M6>6M3CQ!+R#AGCHBL>R?YCI**>-9A/6B1J$7CE5G2\9E=3Z/XH'NI5H5GM=&
M\D(!1&7I*HK4'P G";P/%@U,.3<ZQ? &U:M82J7$*_ZTJ)4K2E1?B.S2_6<,
M(P)RB=\Z[%<]=LN)$E][TO)AAKB%R7D,Y3TSB%TW>C.&&>^/6@1?O:_^2';
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MZ=7#_P9-,T:++Q_,TWQX1?/2CHM3V$"EZ_]LU.S'N^\[6P=18A+'J"4PY6
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M)IY?I?G?L*4^UD]_ OEMCR <YNQ \"1A:0*@FS!-N(PS(J-($<=5EG##'<N
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M4^ 0KVUPLL[G]:^]Z%9?E9G"'%]*[:C;.+@#XT+4&X5@U&1L*4* Q SWY;0
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M7/=S:^:F;CY,FA%;,'7S?:=]T,Y!XU[_K_&K%'-COLA_Q*WO^U(%&IG%2(H
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MF84D\W2>Q'Y%C9_Y:]W9Q6VOCG2$DF-MK A<8:K;(W#/WZF ,T]8A9TPGN[
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MBTI*0QR/4JYMT"<,^BX+.U>R6?<#.YX\:9'DJG/@WU!DN@ <!JZ)=II[','
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M87!]HFY[U1<"E"^Q<6R_Q<I\N!AU8]AK]$[[C9/8'>2E/(']OOKC\# V8 E
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M=]IFCE.7CRR]0\XKAF3D5@F% Z5R;4.;%>K.62!V)2&V&)H/A5@1K)?)*D;
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M2G*74X8T)?2W5U Y]P+>5X&:._O)^21B<-XS(CAAV% ?M>24,TN82_B9H:9
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MV- X2YR0""<15 C1,RO#VF;[9*N"20639:1#519TT&# 1&"2.["1>6]M-E2
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MI*7$2<F)SIE:*82EQ2_A3DC)-9"CB[!QDQD+*VQ<$C9:FJ["_6HH:76R0>S
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M;;/F[K[#!ITA22%5L);B3L. 0YXJ&7"A#(([T]6@.VS0+<U0TIR4XT"2Y(J
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MUB6GUVJ['50\+Y% JUKQ):VX)6D*QF14UI-,F29 I2+.!4:42,%F6O8<I?:
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MW1% *=<3B!5@J .I 'S# 53[Z*)R@(HJ'5%9*@>X)L X$UWS]9T38&DTEN2
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MR>2I"J#W6!?2<:6%U2Q:Q:1(*<Z$PS>.B5@![KT"+KX N(>;>\)SRSC6*,;
M4YDWCY24!BF.&94\8"GYLY?\SODD;KHD'AOW?C[0>VB*N;2@=V>6&0/CVF-!
MG)-<%X4AA&N:SJZ3".3%W_@DTPKT[A7TZ$66N;\7I,(8+ $4I98H31DRL0#0
MBXZ0@A@C;?'L)?N!4@XL/^#^E)B[(IJWQ=P0?(R1F52(EDNG+;"80D9BA118
M1';CPS\KS+U7S.47B>;^GF#.,F(]\CA5'@Q4((V50<E#P[D)QE'R[.4\Y"XI
M[-U3OO>EQJ%WH1OZI@W]ZQ_W^F806J$NTKG*YOZ@?))@J;$O,(&EPKF/FD8@
M)B$$*:CUV*^\EH^);6<3K^76Z\]L:V=SCUG)G17 )T-A$7<^\4D3D3$%QR$=
M$W%A43+F)T0G5QE=EY<+"6*L 2M&84TX#4(S:XG5G$5:*-F<3+M7I]OT$:18
M?@T>G8=^;X4C-\,1/,&1(P9CL,>Y=E8R@2@M".!(P0%'A$(2E "SVDD9BK1R
M%24IEG]I,KRN5O0],P"C::&=P#02R:V15@LO.',D!C!W;I$;9\4 [G7ETFD&
MD#Q*L@!;IF >P3\R9; )2$F/43#2"TV*R(1;,8 57CP4 T@;;EQ)HKC@E#+#
M3/J[<-%SI<T#>$-6#. ^<(3/,@";YI%(B8PH&.*%,TA381% B.?&4BHC6T8&
M<-O8MZ?D#AGE\LD'ANJ#0C[8P<@ILM;JACO%NOWP-53O3(L"F#1"@CT=-. :
MQ29X"\:VCK[@D5&Z<HPLC6/D#?QQ>V"'"J^)1588C3A3,E6I M.F !++N!78
M\6<OR5.F1:N:R\M+B[SS-&*C'4 $)\PJ4A3*:BZ*0E)3Z)5C9#EQ!%_ D?.-
MO4B*X+"T", D((XM1MIBBT(0CJ=$3,3[>Z-%JQ6]O Q <1ZLEIARIWA0A94I
MP) 7A?:!4V]6CI&E<8S RMU9W\.&!*&-0#!3L'(-K&$E@T+>%E06L*1ALE8,
M8(47#U4I@GGB"H =RP 4L#*8%(HX[B2G E.[<HPL)X[PBSBROQ>5BAZ,/$2(
MPHC+J),EX9!ABCM#?$K MXP,X+9Q(C]%\;N=WL"T[Q)+\OW2D]_GM"Q;%.)=
M([_O=6R61?7<F:I2%8-U.%)16*X#-403*F'T"( +0-G*6?6(*F;KU05GU=G6
MX?X>CTIH)SB2AC/$G0850P*%GV :+;4F4/GLI7C24>'WK%V^Q^[?"N.7(=+\
MA\3X.YL7.BBKBR)0+PC74BH<C,0V:H\=MT2NCCL^+L9/.Q+/ME^[/1,<EY0$
M9&( C*=@4&A3<*0H#M1Z9@4Q]W'<<86S/RG.KKCT@^3QP%8' %!FN4@E/XT5
M4?@ QCZ3T6.V<OL^+L[2"SB[L[[GC0E6&HN8(A)QJP2R41BDF W!6^-=H0%G
MYVMRKKCT"N.7'>-77/HAN+0!#NV,U)&ZP!6Q5L%_AIA@M%,VWKR<VPKC[Q7C
M^46,W]@S3$E!1$ <-#'BTE&DF;-($4:"H)9S$>_A1.<RP.P57OQ1XFWH9?@V
M,J^^>=MOKJ;@T;]YL>S@3"[[E\M;_&2FX%++= !?4G[*@]YI-Y4$2A_6*?:-
M[9V$21&H2W-:IKN@>T<A:9>UEO&=LEM6@[I,: X0[H<JF+X[R#6=;EW+*26,
MCL-^'6Q<5FY8)=6U!LT(J[(\5S1DIBK/O,!.B6IS(T_U$8Y[59F^\"*7C2A/
MPJ0L0F(T4W<UDHTGMQB;RU==?LM<3MM'6A-3N6OKT9GZ^Z _:LVQV0_(]H,Y
M0B9"8U^8]JDYJY[]=G&=PR*?'L#9OE_:PQ@?K(>U@O=IV>?9?I&+D:5O09O,
MTK2E==!/Y/=_2F4LB84U"ON"4U<8ZWCR&RN3F*XA>P0_>YG+^B2$^-=OYNGV
M(@%$@KK<B05">)L:*IP)(KG7U!/"7336$_@/!RN#UM'%[^_B6NJR6^ONO\.R
MABS45)O,U>>6L(JKF6KJJ(Y/K5)O6+\U..>I+R+WGO!HF,8@G29&C(4E.(8;
M[]7\,:R@"\G&[-BRFX5Q:ER;8<VCNJK9N;!FY^'N:2K<2@S6(A"4<F@@'IQ
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MML4F4MX:'B>#*YEB^W#C?LI,"G9;UY7'8-K5WOV;>@>8#"EG.XZ.>BZ,LC0
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M(:DF(@U!I Q:VBO)O!*^@(: UEY-]OU/=FK#^9Z0'/@:94A*Q1%W%".+(T;
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M?HDE+%0HHM$MFSXV4GO]N:QGZ&7LN:I_J6,O,@#;"&SEDN6HK84:^NU+['>
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M/*R)T>R% I.QL326<<WESD7+)O#)X?_(I$@1#\DB[9U'46BGG4]."++$TB@
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MPFJ#^LS"*Q/:.(6=/LH;\;';B?# Z0@>>&YM"]@RP:/M1[D<L8K0CJN1)[U
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M<T;G;!!_&O_P<V@/0/A<_-3NEL64+_U\G3Z^9+!V<"7JAY3G5;^>@C._Q!5
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M5+$0'4>*6(8X9@*9P"@27F"6,B%0_N+5]>&PC\A<SX:S")V-L@SJ_%VQAJZ
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MGM,N_1E]KQL:_PN,!]YWCNGFC-]FVQZPML)X15TJ_1Z&<VVLL4)$)V/"1.%
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M'O:X*:R!M+R,.!C0R]%ZBK@('CFN'+)@*%&L&5A-BX-!+QN-/^.Z-6'GX[5
M=U5+6@UKA3YD7S6&QN_@AQY6=O-3]J)58^(*;-)X>%P]_C(C3U#\\^_YX@)#
M0<G/I16D_L7'SK!O&_._GFL3J]JO\C=.8RB-4:<]X+A>@2Q9<.6X3WF,*57U
ME*Q_^]3KTOWUVZAST:!BJX;XJ!MB\MN_[N3!DHU<19\E0LB-89.!AH.MANUD
MY*L"M%+!B7H@C'X<#F-N-!LEV*11OS3PW=ANE?O0KL;!1.ZC ;$%AA 'R].
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MIX:/ERTPWRG+L[2Y$KFC(6JDG:?(&>ZDB4'BG+^E9D&UXQ5J6#$6&9A+WLH
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MF>>1A">0"1NHV,4TL]\\;UEE*+=&(2)LS&7\>8"0$DAZ;2)-0L=$7KSJ=1<
MQ9;3GQ_HF(<-[X#CV^V!7W?< P.ITC^+K9VM*6C3'964+A3J,M3X^%N5/=0M
ME%'@(\:W7*(FP?I:B9ZU<D1*ZK6*$=0;UX9CHP-/A!)&U#BIP\:!F?M,"MR(
MN+N0Z^5;WDHZRGP *"8*Y$J<1M8EBUBBSI@8N-4Y?J^N46L&RIZ.$)U8Y27Z
MTH\^YMZUOX"1!(]V5@FAA>#<$L? D&.66E"WU!I["Y%\$Y"([S"*!__X\Y;F
MTAJ6]2 Q I0A4PB44@[S!LU\\-EL>?%*WUY^7C<\_K!2#;K!VFN=T0XUST-%
M:0I26ANCB(JDV\3'AC(>C3(.>4O!60#'2A2DR<J/:>2\9HA;'%TBPG"::\IN
MH(P)('H%^3$!A,@IH8I:ZD;=8=]V*W2%QD6T_5D T9W2G]RMAY36:*0E+CJ)
MN!8*'"O6B?":H">MU"(#'IJF@:ID%'<J.2:PE]CAC%JHKI?!;PCRVQ#D[O[;
MRQ;( 4LEI8C2X!'7+&0 0XJT%(91BS'CZ6919:\!G\SC:M4S-5*[#Y_6V(95
MK(K2C. [Z@]&>;1'3<?+#+>: JO13D5[KD:%*E#B/9/6:<8Y Q]22F_!20B2
MF>1N37>IE:GPUW[O=(.K= <Z/&Z*%H_2:1P2TC;#PR9&D&'1(YS #.;@%BB<
MQPB]7)09GP7:JE R!U7VZB\;67^19FY+D5;D\K8&]MSO_1+_ NE\ER+LV(L6
M<0YK\.\1%B:!",MX 5Q2Y"G8.)(:\"A)KJFX089EH56&A13"Z:4$DN=JCG$.
MSFGJ(3+Y9)FH!\TD/(>,%)=Y>_+3#GK]DYET%.B1)Q[+D"MYEV5>!O',]K,^
M6YI#KVRPR8O=)[!^[0YGL7\6AZ/V\&**DW]O[4DX"#SJDQ,N<:V4,5;"*P?.
M.=%$%*>"B'&,35R-L6ULN$<2@'O[[R];3K$4=,+(1>- =X(U9RQF2#!%3*#9
M]<M#'6XJ&CF[8H5-"&F&1I>IUQK&O):?%113F!D%'^=%9Q@5?*7)$PY[98Q?
MKY_/?86:B8TL?0!9VH2OV:Y=E\Q^<4US.=M?%:7C][JW)!W?8$;1XU)1U1[,
M/JP*[E5PPG8R_]A=C)^W(K"_-,Y+$X7BQG%.C55$.RE\9#BW$J1B<.*QP8DW
M8O;;B%G<O'Q+6D8;.!IB$77,5ST_!E.'HO'$,YN$QP;$[%(A^YSKP:H4PBA+
MZB6U8!7;U!-_]C/DV[_R3,C=WK 6+F$M:H8V-OHWT2LY=GV%4AZ[;.OF.JDR
M-&F*N[MBU4$4+B0O@E)2<>!S"U:PCRE2)217G-P2"+A#2FZO3LE] BZ"7Q;@
MY_"O:'/B<3-[=)E<WMW>8:T,FN"%XTB5$";S>0*UA9/@5HM(G#.<OGC5;2_-
M*->@RY-AMW<Q$LITLJJDN9.'4KOVL%_!A"[[QCBE4YD*LV'.R;=!1S0:KQNY
M</JH6MK63 R^#%F?0I)61D<9<C#]?C79]]8\>*.@$E_],MR\&SN-]F PRC?/
MMCJ0\*!40H<X\/VVFZ"(-QICXBPOMA(WN0QMH,&V82)RK 3<%?P4E6'N=0J*
MWV+E;+CIL;CI\B-O::Z"\S8@9S5!/$J?.YL#4M@G3A++>!3+N.D^!5W?CAC
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M+.?P .5,)&ACX')CJO;\ &2$2<UI16 @.C&.C/B,M\HP">9F7C'*N*)Z$;P
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M^K@Y:.R,!=<MS_%_.^RT'39].Y>5E>02)UQ0JP$&U5T=WYX>-:T<,71?$\"
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MNX6'8+<CJST\L/[(\AS_^?;MVP'Q6^$DMHZF+"//%5+IT13,?>NU<F!;[T6
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MG$$0V*A)ID/?YZ,AIF4-Q\D$+HH_B<83_]F/8"OT>$T-+\M4>%F(D)NFC;(
M2YE+:/W*[@AT!8;5<H$XR()K%V<EFQ%K!BN^$ C'";#N''M!9V#?J'?)3$E9
MV!=Q;8FVK$=5PM8R)%NH,EDK:,76;J@JVY&7TX3-V*&+NJ6_Y^/):8\W\%X<
M8??J>L)]D+X>D15)#M.6.\+P=8CZ1*(2T:.@0U;J<>,JZ, LYBQ9-<R]56RJ
M,I,,'49X#923H..G,/PNJOVN<GS SPJ:+\&T4[^WU4  [;$*?>1@)@%OY/"9
MB+SJEPR4#ZK'ZX$ML\[FE&$:U_!#EN6(H0@W[I*5\'WCH<K(*Y&8GJHDR1J
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M>08*"4,"BZC-T#322WVBMIM_7N@8NP#2Q'_/V#F*S04JLD;" OX8^!3"-U.
M AZ92\6!@B!MVNM]Z<[?_3^XB/TDG&H7:,DBTJD;X?2LU3RB(LHSK43.1;\D
MO-K4>3Y!C3'#$!J?2ZV00 NDAZ($1H_$1UH10PO*TJV65A;&#9$O8$> $WI6
M%+J+AUF"H4L,R%4$N9C-F^1]V6U'=(3!AFXS&0>T!)X,-D]I@/U$EJ&<&&9C
MHF*"RA=<)'$Y*+]D;5XRXZ^J5:?LS9NDNG##'<0" H[9J"CH,+)VR:GW$5%S
MC90HV97H*=2@JA2+;&Y4)L#1,Z$,#IIV#,8[;DBB7>C$A:@=5TLR%R%O:-F"
MHJFIVR?9U4(G9J(]<W-U8'I,[.>4)4);E/LK;J-@Y*BO(O"Z$@2ZY8SH9XND
M)>HQ8)OFY(TU4Z+@-:"IBE1;8 =J:>I.MZ>3:@@P%?,A.F'5U$KSXG*G;FV_
MJO'SDE$17COQ1.;-'F.;IG(GL!NOJTRN1:M5!/18D=^C(F4@6E;PZZHB)%(R
M9"0^$(&6)'PVQTAATPR\,8OK:58F.G%+7B2X&H*@99>N7+L@4-[5E S]C[\Y
M8_NE9RL#!5Z,8$) L5M!.03I)(FX$WI1$/A@FC!O,O*2<>1'46JGHU1:*..-
M13@-X,Z<OT^/2KA\]1L6D]P^9I^SV7+V4U&6U&WIB"W@FSW>SD:#Y:_C/_]C
M?TI<'CKAQ!U&# V6%/$^F!\-@S!(1N-T-)J,W6<_^N/-F Z4'TB!ZIS3W2)3
MFLZF@:3-KB7G!OQ)]:\1!BBZ]5 YRX4,/FLNMZ'H4M8*:(&H[.!ID^7=L.YM
MB-1FR2@-8MOU6>H[=LK\(/&\U/7B<>J,4[^?2-=A1C07>M^H ))&7W\&U@IW
M;4^:FTCSW:OCRT^N$XZB<> /&;J]P7 &JIR +1W%C$<L'$V2B??L1R?<3)HI
M-5<I.1:!%YB"I-&+KA:8$<M)2ZBFG$MH/55$.Y!MO('74ZXN_"_Q0VKV9B$?
M-^D?LY2;WDX*/DHG< %_GDEG5$L#0 UNDPJ OC\*G&),= 8\3DO_//O?$LP0
M,%1V7KI])..D2?BCJ$"KUV.3R]S33.;#\5OK.3XM3;Y7YI.'ZLG&_E/!9)$V
M7E''2E2)E+:(L!Q6!1KDL$A3]6'7N%OA:P?:4$01:MKLTBNC&U*JS&66H]$O
ME7UI$C;]?D@:JUZ31N?+$IVNL$H:I9'JK3V@I#XD<7-*9F?-[I2,\1,L&,(7
M*-<ETE'K>QP8?T"_PU<-S-=VYH4__+*9B#<0OEG2NY]7SK*%HBYT(OW^QK*_
MS>VW6)\*A$1$5@BFE5Y@6V*I7U5Z4U1J WUD7%IYL*CU2[T-YPR;1'5>W:?[
M^E;N6\ZWTJ07K*8N6UIO)=_9DI)26%0 +0A7R.YMFQ'N&]QKR,VX=F3DUB+A
M)L7 KF#"Y)@6I9-$DK>"2?F9%R!^V.Z+)\GD\([*]NI=M=/ KC5=/(+2Z--E
MK0IF0$V,:@.@80#*B#12S">V DVTXV#B<8<'0>+SF#&0=&/?=9( 2]S"\3U:
M4N'34U?M=W_%]B=@Y<$H"M,A=[$%.X^C8>3Y;)BD;IS"0;G,!775.^B!QXND
MOBK.H=%@A#(H?8(F1354@VYP;!!"JL1"!' Q70/$S!ML,;JD>ZA8(G$:$#1P
M/VMNA7!]=XLKPD4YV"*I>8U?O#2RC]$!"KJ)9"$__C,J?_AQ(^=Y>NG1H\WI
MT3A=NL/79[LZ[K-]4O6.IR,_C:3J*]F"_*0N%B_&7T&K<&[DER:>Z[@'*JWC
M'2;<8-=64[([//)BQPW&$??]A/%@-/*]9!1/&'-=UX^[<+<DXMLR':9[*+!4
M051\*(LY_#,6 +>'\^2(8CS5V[GY&UDJ7)W"/'X">_7\OH7XZ5LEQ/_\[ZOS
MT7__^/W\_:O?9N]>'=O_/<W/__/G6^\_?QWZQZ_>9,<__V=U[/XZ^N])5XB_
M.W]_FN>@!/CO?H;W_?5;_OZ/W[+C/Y,_CU^=71[_\?;ROW^^_>N_K_+\__OK
MM7=\]LGW6.RFW!V./=<9^DDR'D:@5PV3. +9SB<CE\?=+H-)$(]=;GL!]V,?
M%;* C]P1HB<S)^4I>X;XMB"9@?672V C2$S-UEL_+\'J1&L3J,/Z#]B;ATFQ
M "M4*0F22#HDWUM!<.U,?OS*A'>"A>C+'!3*/0G>A@3]][]^2D9AF(S<:,@2
M+Q[ZL<.'P<@/A@%S@0)=SAPV[I+4E=+RJVH1I]3/(L_)3K!$NIZ,F%?4)[J*
MRTRGT4E;BC74?Z:HGRT6H"$R$4X>Z 2_%3I@Q(6P(@3-JUY<9SPBC^]H@EK1
MZKTVXS!*7#^,\>8#X;L!&T5\% >A-X%;$X?PG%B85OH0 F<(6YRS1<5?J'^\
M!!U[D;/5BXP:<P[IH9?KL@@[!&+RI)P<S5-\W:A ![90@^H2_B]1;Y9?']!7
M/]1)SW?C@U&X^6O[P-G\Z!7#>NX!<)(['];U#YS0O?MAW0,W]&XT[ ^TP6*3
MX1R1LO[OF?>L4603-+=>N(O/EM-'4]W#%.=XU_I%>-U=)&(Y0>.0E4D3VY:K
M?^@+>]5PD<>VM->4OH%I<*\P98:\V<L(.*'U&F-%J\>Y7O2_-YWF3IHF4:WE
M7G,W(Q:?GY6("S>4DX]CSL&2D?P9Y0#LAT5^?0M7]O**K<IYNLZ9B\57D:TW
MVZK#DX^$I3:T@Z_BHPFW=]'0O*R?5,#^J)A%<(K"\_G\M%@ V0;VZ/L7IGZ+
M)'VD0C>'#9JM_NP7(V1$H57UC013.%I60*YK*3M7W(AO11GW0!2H;VF=:;G
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M?OGE2._7QY.3TZ/V<:C=.LOA.00"S2IYC6DT=6/TCI^<:L5W_:C^!7?R,Y#
MO+B0MI#Y=OK6/*F2+;($B/=,U">U!J3J701$FF=Q 7HX[L,RGG()<42N;SZ?
MBH!<9\,$W1H;)U!BL#B.H*H$9>B"F^POH;^6!#6\N]69^FC_Q86Y=[("NV!V
MKRHFGOIN[=0Q&%E148I=.JFS^/Q>E7 )!*"#2=G\@E>U0D+'SIC6+RRJ!FW&
MJ7IQDI:R\PRK!:L@)</:<BEEY' ^Y6#OED/0=^,IK/DG?F&='/[P[G>]],.?
MWK8YU&51YHGVTN2(I0<L*BKYI6([1YB87@D/5WL?Q3=]TN&(S>$?#$';YG,6
M9?,B2Z3Q_0 D/\:=J!M/P^1T!U;%LC>XA4@GV,TK>[_W=+?VY"<"LR4'(B@_
M>;+?FV8^1T#:(/K/^#="UWX8NW)R7K!\KPRTIE3,_Y_[W!'TX6*O.A ;Y]*V
M1#3^&,T<_,2 5I%1&@H+(.!T$ZQK G/HJ9 I:\#;$>(T[71\ZP: \ GR+Y,&
M# ]ADQ?,_-PA"=?O%#N%74C$GKT2.)<S436Z,_.^)L D@S^MH(^LWK?0R"E*
MF9$D,,PI_8 G+7\$^N%E%A%&YG0FHJ:(+J35I?!FL4O\+Z)720SVNMG,Q-A,
MU?-NF5-#086UGU,?"1GH8V=G)<+G\\$U*1,-G&$;:E.CZN"/UK5"C5O<!@+-
MOGJ$>4M.LH$>[S4.;I)66@!EJ1RV!F]X#Y2@@1+&^SYR.S"7/>3!=I ']W1;
M1#R^ZC)WB;='B:D$GTA!8;S7V%=#9X>44EIE\S27L%@J:22;+_%I/;X0;T?O
M?W_[:NB$%BP5U*4LEH#TF(^!:._S"U;)>,_'\Q*A2&4"GGAUTY^5]6:N[N &
M_Z&W0X"SBP9,$LFWR"^$/S0N"R"_>0$[0@L^X\6BP/H>T7X )!+6CX/0_!<,
M+=(F6OO>8!RHHZEPO,3ZG\@ PQ\+*."D!+Y/X3<0WP@#;CB%,3WB;"7;+"<R
MB1DD3D&M *GQL$#F)\17%=WGGQGH'Y& XE/I#5+S,94$2E.0G7Y!4\:\IIF$
M[JNP-7"$X)_3 C09$XW["M)0VV%0WQ3_/@-U2LT7J%5TI4) 203TQZT;]-.B
M?B='T/Q4MP4^PQ8 A#IN(5;Z,E]60IG2FI%Y<R)J)T/B%1M<T2^:P-E:9$IU
M+\)B]*(B-BAS>FCO15A3]FNF5CH<U+.L*%L= -)\B:G=PA6?"4 ]RDU7+G*1
MH9,2@+R.T^$+CD].FQBNVC<@'@K6H1K8/VL$D-< AQG0@"+>6.5-2?_]1MJ7
MA:4J&R19S>'VQ0)T?\,[Y?' ZWKVHT5J!;5PR+M1Z@YR^BS[K,%*%R50P'(F
MJ%/MGO2\R6;9E<QD*G0BRZ88&MTK@=C=W%"*9$C56G27EN,)8/BVDGW,*KRU
M)W!0(K/'P!AK0C1-QIGL=&"T>S!>@1H__4&0]RW"::9G-I%@M6(.!!(-A$QK
M$0Q$7Y+/M8&L;\B1_N/K.S/@ PO2MF'P-J[J&5 *^B_I.):E;E]/31?4W+"1
M M\U'^=[[8U528/ $'0)[@D7S5&'.L9S L?.X6_]$Z._RKT:'2*:+BYS)P$,
M.ZXHV25-3BEUU*D#R2VK6O8-:VKL*H7!J+DE:1<-L6EZW'W!_COET:D&<PEP
M;! .4GI+<2J8HF0<P%7*Y4*S:)+1AD0T$9'AGF2BP]#-9'I'65,=;'ID,&&Z
MSX>B*:0ZDTVZV0UE\!_3+!>QV;Y(1,M>-0*_PDLF:[#6LHGZ>AR)EH#(0&'3
M@2TJ%L<E.CO2EI@I_5).L.FZ@"ROS(3/34EHDV_I_B?$EB]8ENL.0XV'I627
M1G<GU0BEF.-M118F$J%P,PR)T)&#ET5Y3O)0H,GRCBFOY]8^GXI?IR>:,K23
M[E)/J;'G ,$I43Z2B-!MZ6&JH@TG:#YG,EU:>!)EIT[1_D_/D.@V4R)9DR[1
M&CFQ&L<)R8<<]FLNUD1-CT@;K%$5.Z/4\QSF-,1R W4C=/GY@!C-4K%_<GVR
ME&-G1-D<$F>PWC:KP!HIE&,$#"YP4M5%7)0@67!F*'CQ0JN1&SSVO6"Y-\%B
M\$5B@X9*T^%7U]P&@RBZ%V+WA<NIUIX4'^WTK(O@RB:"^)4D-JUC;%T'EZO*
M9>?+DLTXLAW3%7Q#/Z_,Y@8K;[;(^:!!DGZ#=B'Y2<OEF768S+)Y1K<:3U+7
M%KUJE%2$9Z;*.E'1DI&S1.J>HAT#!CP*V<-8V"T*(PE7QTJ1WP9/30O*=.\8
M,]B #[WK9?87"<,<^\]7^H=:K,PY*Y5I166ZF*&QG/.FG:?U4Y9@"X/VHA8(
M]5--<7Y@M@I6KRPTS1S7G11BSU5('D>7NT*)#F(H[(@JN":<R,9MD"VVZ/1
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MDIR.L",Y6U3\A?K'2^4LRN:T+GKHY;I1TG$WT@O%UPU5']B"LJ5G2KY9?GU
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M,@SPI?;XHPP#;+K_P4/J0/1@0A#7(TQ\@[KV+<OQ^F!%E(DO(A)D];>#$NV
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MF*\$.@ P/ECT884P"G1E!XB8DA1BK\KB(DN AF$J)7R]* 3,"M'"3%  ;L8
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M?K+&BFN2/W@,1\.>5^-S8'B-4PJOO->E4/9FP(..P5&V"S'K"MZD 4-VW%D
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M<OS]#^2U99#.U*U^)T;9?L?BF=>KIEO'Z7&Y_EZ66:W;RJ$TB$A-^<T[-TR
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MYK)WG\O&=A\!Z!ZAYS[@:0@92S3"3G1PA&7/YW NR/8GN .6^=;T7VQ%%NM
M$-^[J"K8KTENE(LQALW$3=74L,1FGVKI^W\0HX0:T7DGV!6L?\;\&&>8U-%%
M2GE=F++/_XHPG:F/"67XJR*:MM$54V,-KOIIWE(C+R)3^2Y<UY=/WRY=\)%'
MJ&!)X[X'-0,.*3:TU"^^?J]? @^_?N^\_R'D=#%5*(^VN%X\%](LL;,=!5H(
M^8R 3_C.0H5N0GJY>D#!PU!]V52!!J:PHC&5,!II+PZP$%=-S3U3U8YLW+K
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M^9WF?3)-#NWH\1+*\P PN&- GL&-]RN3L&2254P*"965\Q5YP4QFB4HPS[)
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M*(?Z.-9'9%G.9<#Q?4.G&"MC=:$;AN:2.&S1/IHS2O^,$SA=;@KJ_)[<@#G
MDXCUP7S BKJ[.$'C(**9'#S(N;1;YQ4>KO3)/UQ]N](%?12@)TV"KAQF6FA<
MLQ@E6!;.P(=!OW_2I"2]<X_E!'?MQ_YN@E$'^,;W2S#5!1#OCXBNH+3A*95J
MM">F5#*L"FW!&;8JKH2J"(Y!X1+.I"G$!OR(RH^#M!2H\.GY]^KIOLK,NVII
M^B_%-+'LL$%2D>0@.B!3'EYI!'K8)U;0%%@%KH!L/@*)! 4F+#8(S)@E*<V&
MYC 9FQCZHDDMA?9%-R$<(\U$B29^H?;2 ,SH9#SH!(+$$)X&1 PU'@<B!KK_
MN?KU,A4R%XD5W(S"Q18@R@G%3<EE)H([B4Q2YQ5G!C6Z&D<XH#R'8U<5K*^-
M(U+Y1.I[@D*E(1"F9K,H9[ <<N76A6T2/(T75C9S-VU %;$RW;XZ!U<"<]A5
MH !,/"FQ>8JW!OXBU08& KF4-E=KY2*&;%;H[NOFT];<8D40#<_Q.?-2$ZWZ
MJ&^8[F;)8X"P82*])5YF8[D^K>;DQB762ZD6[E5 =\;/5VHR!PT]T/Q=%[DN
MP"^PY3F#+\@OEFEA2;JB%"'10[YV43PP@>$)JK\:QAOB.[D5M<PY.8#&*W4(
MO(2B*B?ZV\2\]5IS!92I16MO<!A3!6EBC^@S6-&.Y^GY4][%Q1F=" ;2W.HD
M7PK1.!-L,YZ!F&X:[%O0E!07;::9]MI2_6G>I)L4WSA8\/"<XDMP5 UV8#(O
MM1]%&']0N"QE-VZ"Q],11E>A%^B/>&/==<!Z'\V<F'X898)T&!ZMR]P@#P-E
MO.;EQ0\2;-4WE$EMOIW]X$(']"5WD>?>A_!$V>45I,'P9R6)2(/_!0CN+_&#
MW_Q1S& ^+(D<ZS==*6?K"\75/L(^..1^"9+WCP3\(/V55"<\KKY\//I#6U=&
MC(Z"O0C&S/LEYMUW,,B$6$_$H&E+ZYT8JQ%Q*LE4NWG5I26)?P3H/<'.SWXN
M^OZH2<$LH<4AP,TW\@/\7'F("KY69#FX7SR0N>RC6;")!IL<6[!)"]9BP28M
M YO4WY8\S%#4&NK>E_L5XGPY+?J*V&$_1VQ,C)YD>9)I$LM9\@R^(#!"@EB,
M.)*Z,9=]9;FG@<GT82[W\A7S3F"]?U/R]$Y4T<WS&,S0BAULE'_IS6FC?9S$
MP!H1F*MC,#UN@R2.& ,IT8DJ)-,%U^A##>Z\2(H'S ,DRQ(LFE2(=M4,.(=?
M-("+DB;UPU8:YV,6H0\&4X26$7KTA5H C@T7W=05%K$RQC0ZUT3?Y@8N&#^S
M8!3D".8Z3YA+V()4C;@U1H]/R]U?5[0R5),5I'.8B.+;*=":36(9198A8&>4
M4'HH7X*;BYFID98AVNF;/@7"8JYQ0673K\0/;+>B\P)'<03&G@1T!R)]O=D!
MU=%(@G!XM1$F.5%0IN!/S((%D\;XS!R45![":5 DDK,X<0\THTEG/.3K<,1G
MC%:M:K%;"=X_)""4_:]+_<D-H#G'*.]Q[EU&.6\0VPM,5>A1:53U+,-EYGS@
M(E.\=72?"(.9L<8C(08,X]&(\G 8++BETWCK<',/-K#9I<KGU>6A_7P08;5O
M 4=OJ?.BN;30O^.*8#VE2U74\00YW>:E]$0=5(N-8+(\L4:6T!%)HKF,WR0B
M9]3"P]JOC3YBB."672L."?QQ??WMJL;!+_>M=3[Y*58+U;%@(<1^_>T3SQ<F
M+U!':'W8>1*)^]2Y$1'YZD!-%?<T4J_%H!6\,4'K03(U'!&."&0$$<UCY+&)
M%%P>4X(8:QH3$<Q'RR3EQ8VE\T[18&1Z.8&7=JZD!BXZ+RMAHM!(MGB18W5R
MH5F29P7>@4?R[V58G 155:::HIYPN^#',>EQ+6UBI?JP&4][*J2<7*=Q4O?7
M8H#PKQH6(DMDOB3!+?[BDD7(?1NV?S"E8YL>T=[Z1-<3=J^&X#^J(LJ X!3P
M(&S),!JVDO!19><5+5,V(0SHO(E;:*I!QWS &JWB&8GRVM6-?BL+Q,D RG1)
MC?YITWK8=5VK(6.$N7J-7)O+(P7JGU]Y-BF-^I$#^9/5](*2\=HX\9.6 &LP
M.LZ2R2!+ 7$A4I$4B@H%&.@TNQ*Q)ESDJBPS0@#S;:*AUQ$C,^13[B040PY4
MN'VMCYX'<XJ$G.AT(01L")\L.:2I14UA\K#L)+0B;_6M!'-&)28+.T0R3Y7G
MF=TO:I_@JF:'D\!LE<GQ=SJ#0@$*YH\40%JM6E\).G-5_LQVO$J/LB8W=YD4
M#.A*^\O:_&(0W8)=0%>F?E"%'E!##U[AX:SB/6,&,AJ>$K>J]T-VZ!PLJ".B
M!N7!T4**CC1/FGY4[1!;-7RB ?"7"!.-7P:@853>&#1AMD2OGBXY>L$/]:97
M5_"2*<XS\%TT]5)_/%MB!@>^BI+T[PBNN0=S,?-G_)?_'Y$7^!0%R7R]!G1N
MX:<,' ?^,5:/6+Q"!E6!#]5E5R_D!11>BR6\8@Y6FA)')B97ANWUL%^,,,B<
MCP^^& BK_R@1F(\BP5GCL-)L=N??M\D.:P;+%''H3GZ6R!-%83M' WDSB5L9
M\N(2F\MF!IK-Z:J&87Q'2%34B<II(G (/8UX%%9XN;P!GQ"YON_JY%V"NV _
MQ-C!;4QM07",]X12W%/X!KB4<VW(EPHZY/PN/=QAX$DI W(_!3ED2)"5;T2#
MG,= 4.<]OF/L*N+SU!1DAB7D,QO-LY#CR$ FLCO.$A%M7S#[HSQ'%8D?&?/\
M'3JTRD,"$<6%YR-LQY(5)F>I8CG,F/*B L.W8W&RC$C&^=R*')6-?H5^-*/K
MD;;"3\) R!R<PA*X*EC)/E\.IZD6T5!#5H'>>A: 48\Y'H>)J;9IG%T\'H.#
MUO[;51"%2GR9&Q_[BX4J:LG;=)@S36M@S1)X7*:@*D"B3"1&OSA)S\*P_;3Z
M6K)6'D"?&P8$QN7R&A>\U$&V+)O4!6!9V ')_$_9?D$'N2;U_5^J0; 55:W%
M\CAFD)N"-STN-U_0&.Q =9?0L"8%:7+-G+A?P*NY)KA']9:H>V5>(6<X1%IR
M"#FH<#7@N9@<>\ZV%/F;MXX;AOM.9@Q3R>@1UP(D=2MNT8$$6AHC*[\5[?2/
M9O4N? ;?N+PA=OHB2QLJPQ?WV^'G4NKRAPJ2\M%9A &LK9(IE"[3#&^RY!A4
MJ;9?%W%8-1R/>F<9F"'OHJD*K4Z%&R57VUT4_!J,3U99:'4UN7W'WH/55APD
M-0JNBI5(_EU:WD9(C%7>1,7RIS7BPD+T;6]FCHEKDY"H)HI4'H;E(5*T*]E6
M$NEFK0SAT7/XHC^"4Y)A!@NNTN"J$PNN:L%:++BJ+>"J#5$J?ZC<\>5XK$S)
M/SC#?26M[;*R=?>I:Q%#I2K"$S^H:*5ZL5X;HF?U4VR4PW$_LD\8,(;F_92"
M 1A1!@D=QM$-C4=4DW:#3#;LHQGA\#B=CC=J:JP=N3T[4A:]O2<3GNR%"H>B
M#2G-CO?2[&B'J?B52E_32M<GPJ/SOD2^+W1T*(.?][>@>C%X(>/ZYXBWH$G,
MIJ6E\O&)?)DL(.+JM&5R(\#8^"O'T#@8J"W"1/# SV)9&KA-0<H@ _ PQ[(*
M"<B*9Z-@(^&2(C/_6B:JL'TB_&RF*Y@386Q#01+X:2G=9#9Q,'V@2YUS%&02
MI-]3',89CQFE0 2\^OT?']\=>1>R;;+T"^F-L#JA9FP7P*)<#D?;R\./-TLP
M/W4+Y#G6N]T(G0.J(QP#8XIDXH@YF?IW6)Y)D41LDL'#M$'ED$]9H**!=-K$
M>&Z%/%D=&<1 .G)#.E$QKZ9F8RH)H=-BBN\#Q? <PI7P.\R$E'_!S%CY@4J<
M% _J)HF7"_E6&=R=8@Z6^8;O3G'EA6X:1M#-Y00"AK+EDB7OR<4HM!^OAMRP
MA41R^(ALS'&/6#Q) ]4QF('7EK-U03A)1+16F9T9[XEXL&\Z#O F36'KV#?+
M3SB3JO*:]-WI$B$VM5_5:"=)-[Z$!J>*'PM.#JO,5H[:E>,YU4NCFLY5*FK6
M"EX^$-W(J*/?BA63!3311UGV>[OOD9,?BT@!2A#(ZU9R>EW=UECW$ _R7<A8
MGA*FBC=UI5JN=8P+C*EB;EEDM.,KF8)D *K+68GN&%'G@JPH9^3AMYA>!0M1
MZFGS(F!]N8SI9R39:YLX\OOBQ&S=*%M9RDYK5<NV: .49RFQ]C+Z;NB!WV^-
M*G.$OJI"]3%LQP=O/Y43!6C00:GYR$(Q7!FD"@N[2?RY0B\0*M6 <4R7;$VC
M15,(G%? K@: 5@G_U5 9HR:=YQ<5(:MY?Y5UGL!SJ; UXW]P!1HNL?+WNMC.
MJ-2@[O1L^AC@84)3!VI>9E0J_S10O(3J0,=D?#]6,[/XAE!EODHKP]>R(]T6
M!@=%YW/,02%11:L>M?56PZ2ISU4&QRW1[\U@$.,WN17#S*H?DLH.9EA9B$T%
MDGOFDDR,9Q&UGV*PLFH56#E6=P6LM(K-EV2HPGVN2Y *BL45NQ4BJ2BQQERI
MB:KS3Z3HU<5"(R*:Z 0#/HX,\GO9, ))C1[U=!F6 >L!FY7:>@7A.Q%SUKQH
M9:;5Q%9^+3B*B!#>\L N9892O?Y49*5)"ZI#:%X=5$R.Y-5,6:'?4"9P]@AB
M!0PHF+H2^</D$"JCY*"219,&> 7@JXZ6R9T_0%].XT\RYT0]#\UT$L8$,#V/
M'8I6?JZR1OH/.GM6^0U/W$([+<+OU76X-,B?']&1QKI5:%>M0&F%];-:4:\T
M/>_@3(FEP15U37H\*D=*R=_F%"GV&:&7Y3ECUUDN9B*<O"XJID)W"VYJ(1"Q
MXN8BK]#RHE!]HR;C-CIFRH@NVQH2F1+>VPSR<V:0VW"%#L2!*/D*YLB-/4^H
MIQ;,P9RY(L#TV)TH-W<O7)J@-# $C7CPKKDIJIH@QFVL3)/]#4&]J?4+%:FD
M2T*Y78'E6: (W*]W8D[H9=7@X>,[7=B38=@7]6O(*.$E>R@!F9Q@921+*L2Y
M#7#$=N,M2(60@9 <<JT+RUP9]I(VSXSGKN"3P%;6R<E$<-\E"4PKW"!\*!DX
M@3 ;K\?3:3 6B5:_LX!4].B>%R7+O&33(I(!_)S+$+2:+\OG,*!B/!+("\2-
M[X5P7L&N5-FHFCM%4\@6)GKN W<BXXJX"8;W0<(RV6FRDT\02PEQ7*9:>[]^
MRUCZ/' ':TAR>^+]#] =R 17&+OGFF-U@-?O\^YGW-MJ3-GZ(BL5% T9#F.&
M3I+LRR'S_#Y4$ CYBVX>N#T[3'GMN49$NF_L2\51))2NE[5OQ%4Y][^5)0'J
M%#6:FG$COQ-W*C:YE'5SA;@L6==P?G%TQS8Q?+F(5%S]$%?7-6#O4RD"<#@J
M(A"1YT'D+&)0PJF\Y^J>JJ%,:85'BI=;EV>JDG>@["W.<\>O(SD0<:!-*5P$
MTZC:*JS(F>:TA4I""WO%C0-1&<  7,_ "D1_*_)]P*Y7QF_+Y8E*<))?59*T
MV'>69B^-P6R@1@MD\&#;<PK>^HN%'*C&"Q%%J93[>PO$6P<4.>4Z\"6UHT4'
M5I98R,]E=WE\)!41RTER0GEY?OJ=N^K(H@U, ?/AQP3C*"R?C%L.4IARUPC:
M-TCK.*D<>Z&._/,2N!#X^+??KEH=T*^W6%0)XC4)=UV):+:45#FV%NVEJ?FZ
M"7+'N) HIM!T@T90%@$:O61/4\=<!J86HT:-DS=(-Z</_+H& ?T5;@ORHA'U
MD;_5F"RZ.%*7D6#5E>Q@P//$%O?!Z3*N?I)NR@L>6.[1<V0GRF-H.@)KA+,:
M''T*<^!?)>.DS#B^8AQN]IER!0[FRE+P*7UL?=G:&<'[\&%>'J3KU$*Z6K 6
M"^EJ"Z1K=5/K$ $AF?.-@I4U<*W6*V.U@TSMH#J;R8]6=-:O*(%:"8M*JO B
M?"B5AQ&(!NV\BF6L%+39[;Z:!'DH?53%.^@)6EBS$TU4DTYZQC+#=*0T5+%Y
M]GWQ#?"GVL[\^7PA;F@@N  1/ +9RE0@4H&#H#RWP+^-@XE\4:CJW="8P<#X
MF*?.XF0)]L> <8#N;'N@<<MSII!29OJS@0;E79(+1.N"8[E:05V7)Y7I\N:D
MT'J5MK>,OD?Q'9(Y2":Z=3B\81E)<P6+]W)K)2V]4FZK.;508$.C)D76D#2,
M8<"F<DF $02)]B+S9!%$ZEWL>U#'I"ISUMT"60:&Q>FA?W?DC[C&6H_M251R
M0=JS2!QP6<'ZDOP\Q]?"3Z?+4 +-=?>@.=X1YK/"O$-MT]Q)S,U<K@[CUQGU
M%"UVBT:#-!(A[N@3V'4Q1;R#!_=FC!1J+.XR<V A#W3AP6*W(EH*GC>1JN&,
MQ@=T;C3NA[U&\SDTE^2[T%ZSKT8AFPUR==V .3_&S<?*F$,*XP),P4S N=R&
M.A42VQ/Z 9RDBF 5D[UUMPBSBU3 D?<F8#DF*:[KV(P>!%4>2HSSDI4H8!:"
MIT!-9G4+<:-2X86;WVW1DO^DN.=\&0781X1%2CZQ*[_XDBL4J^1MR!Z^A/@0
M;&U^Q\IQ)L(%IOEN.>(E2_08?^&J'N:KUJ!A'Q3N0J\TT,I/=O9?:U&8IQ8H
M>FD007+OJE)-F8B,,U7+1X_!F$LWXBEC4&F7/.*=41](J/]9^J&<"O=-M;)A
M6-=7_\[Y)&\C89QO, >K82Q7.$@UPL/Z DJP_7;?-0XRXJ!P$B]2YY4"I[!F
MG(#B$A32U,U.C78K&@J2(F39)_HL**<381L?HZ*MT#Z%>SO*[#R-G\O'TLL@
M7P&QY.8O9Q:%#6L5,:<JA,DRQRJ %IE.27N80S[XER!VD^5"JQ?==?U&Q'@W
M,IS$1[7=DAE 2H:L8+E<L( >HK"/A%GGSW6DQ(,='I&BQB&@/N@4^ E\C3K4
M,7ZD4&9(3>%(<2$"C:V );5)AS_^F]F1P[VY7M*8/.#)><Z3@<&3V ))LR3:
M98@%8M/3T':%>4\8]@9CW+1!\@@7L8?L8)]C5F0I8+&05Y>/5T$F>416_,"F
M[MPA5*O80J%Q/E-+=N"$G8M%9M[6M90D$P\>,@T*/]:^2>OOZJ4T8OG0_9L$
M8_',6*B5XHG4"KGX)N%68!ZZLJ:T:YP6+0/Q<.;EJUWTT%!,D&%'OU37A3G&
ME:=M-DLNR8]@/O)#&E/#[$4LSY4+<U([9GY5,IZ$=U*W* 5(4INF3H9RA^SD
M4)=/6!W<<1 GBQG1J XHQ*)(Y86:I5&MI' *N,EJ@U6V?U!6D2_%_RM?MH%P
MU..:G#*XC+'?F3Y9OZRVY%'+SEK+J/ %Q-)$Q<LCL\AY7D?2]-Y<6BC\::[W
M5TD.*1#P^@;)"G&P_N6O#M:K$P)E;)\<"$T_8#;2LI:C^02G/*+FO07#:R+,
M;V$IV1(6. K-7@9D]?(<O3*1=&].HV&P@CFJ1\NS83&ON+PP.XH>Q?A"$PRH
M?F%<D>+Q3O,9*>I1/D$D[U#A4.B %+'L?(WQ X96HN)O@B'FU3^HH&2JM?VB
M\DKB(E:*GB:E;[8WG &'QHD<T(O#2DRK00XOH;FZ$>8HP3_V4VW2A#2X))W!
M5?=O5.%\GGTJ=E>O E%5YN<K-F5G_(.O4M5_?$]PO/EK.7"4X;UYO9-ICC!?
MASA^E.#JQ#V<4://C#Y_?#,U+W![9)]K4G'<FGF1#*-EZJZR0.0["B;(JT)
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M+'<ZJL9:7:S<T?J[ZC)/Z^\Z[".MO[7^OCS]_43P0,$6(<;4>@KK.^MYIV:
M"[]3,\"%WZD9X,+OK!& \]<\@F/(H\2+(\+?S*$\XJ61%7&'!3YSK-ABXS"8
ML@]?/[SZ9/G6/2?8YSO;Y;[-V6T4!;9KQ8C!*? T+1:'8"XBF"0,]<&%F^*)
M%;,DPI>SR)K./ +<C.(@E-BY-AAYENNSQTG@\<A"0$B)+QTAQ.8L#/[@=LR
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M-'6$5<L^+?OV+OM:Y[-$9RS[S/W$5S5^[+/3TL\,Q*NTQVR=FHB?&#^LKLF
ME00OJ^D^*L&N[>_: ^L\>;E6(*7'TJ?UL4/,13ND,FMUL7*G5'_7J3/*6<L\
MK;_KL(]*]?>.37#/DY>U_JZY_FZNB"/4!&%V-S"_D$>)!S=)Z-C=D&,;C'U=
M]=)Q4#8FO&MD1=Q!H%;'BBTV#H,I^_#U _O@CX,[@D*U6!P"9R*X(%#FP;4Y
MBR=6S)((:&>QR)K.!'ID% ?P281'A0_\P6T<6?B=QW(XB.KJ\)EKJQ]BF(-#
M8+ 3-\K>'0KD5\O+H%G'0> 8S F3>P2BC2(VY:$]@1>Z\%1D()SM _==[MM
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M:4;;Z4OHVF@3W=ITIEUY??_[W=VWMXS_X':"MD]<Z/$XDY.QQ&3 _@KQG^1
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M&/:HTN*M+IK^5:#(T$F(PB6HT*!+#I1$AURRU]T0K+N<.8EMWXN6VZ,TWW,
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MLCQ#N![T6B_ \ O_8;L@+F&0.#P0?A&7LB.[@IZXS_CU@S4CF8?N,J*VN'8
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MZ!(*?,%CBC'@(3?,&0EK63H7^54G>@SHD:###DZ2/,=U7#Q>&B7$3JD]<N6
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M8C:CKD9]'"P876#F$\S3>Y9$,&-X\GEO3CNQ:OZGBY[WH1]Q@PSZU?4F?CX
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M*51FC9HK:,=@B[AX R.,X^ARV!,M:Q&7AS<O\QECY $3D</E.6?(^Z[3LN6
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M$(DH@#2_!E)'IM=@)LE7E(H/S_/:?M A1DDU+>)8$OG(=>FK$ =84YA,O?.
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M&TKQ 570K:\*/)9O<EA.Q>7 @B=]%<& *6= 2:EI(IH"W(I(*U^PR;:.[C;
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MFX%9ZVIC0P8^)PY"66&"$9*SUIY4"]Q;$?(KVR$_NKZ;]CW=.Z-MHA.&@CP
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MOO9/D\9%ZY@P!5NG=+0AV-%6R6$9UEA%6ZY[%Z_7+S$L\6]_^7]02P,$%
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M\Q3._P^&V2_TG?DH"R>T)0,PT3D!*I!+%U7.X .FJ 1*BX==\3\P\+.GMH5
M-Y!\4+CK+J95ON\*%3H>O"P"K&>%5"\:\$4C%.6"DLPDGDM#FF\-?6)$[RO4
M#52WB'X1KEDX?SW)^.?_B]5<\+ED2V"4LG6.9/47F< X#-(R,@]Y"[]X;=AG
M3_'APMQ [T&!KJO R\WF<IVV;P2B$S$!.I8(%,$+/"!$IQ0J;J5C[K#[W@=&
M?O8D-Q'I!IX/#VZ-<?X^Q',<88G"1:M!^6KM>T0R\4H"9V(TA@7&;(/TG.OA
M&C)ZZ_'Q,(MU+Y%M>J3TW>HEZ3^G\^D<\U^^7\PN\>:;T\D"_US\?([U /C+
M]W,\N[@7Z]V=\,LYG(7P<;1,':H?]/(\S.=ORM+J?_'G>#[R(F24VH*6,H,R
M]:ZLT+YCO M<9)69>RR$7<(\+OFY&FFE!7B^F%]_YT8=MH)IJ!Z/O /?H"[[
M<3OM0\8-G[5= [N-Y]5R(]P)T6CM-7HC]N^C:;G//_24_H;TQG1->Y'U,%H0
M12Z2]!VR+Y(<!Q_!&Z%!Q,*"DRQH]5C&R%-F_TYA@B.2WT7$#4F_F(YNA7?8
M#U)R^3;,_B.<7^)?<96[)'T)GO8V(0SM=TX$""(%\BR*S5$(,D7\7?+7*Q!L
M'V0X"ZX5!=->Y-?P/?I=9/P'QMAOTP7.7UTBD2.OP,5BI'+U]*L//)15&EQ.
MFKP)@<*@*BFK+N0^,,Z)\-M"BKTM7OZ#O0-.7^M?=H@VD GKG2-3)5F:-M*T
M0V#"Y&PPQVX4;QSG9"@^7(H-WZ3?!2=^$'? V2MP03&CI*IHL@"5R7/Q(1E(
MS"4NHO79NRX4/S#.B5#<0HH-WZ/?!2=_X$+?@)/\"ISG: O*0@<((W"8#43'
M/5@E&7FID0<ANU#\P#@G0G$+*3[X1OU??EP3SJ_TUWW+.DTR6:*8Z8OY]'R<
M:]&\+S;G?+H2RX?I.8T___F_+L>+SZ]HV#3>H?37_3I0>X_5H'!4FWFN59I"
ME;GA218NI,H"?2J*OD=;=$I*1S8Z8-Q&<92;H)(T4EJ3$\2(D;2:C,&@/9F%
M3):H'!T@_K'[R8,"*%]0'.H<OIZD&88YOL+5_U]/[DOPW?3\_)?I[(\PRR,7
MC4.9&7AO64WB$A"#,6!+]C1A9L*Z?7GPI#M"''['.U WUIW)/BEIZ(_<S'X=
M'$W@_+(F$[RMR;PD^05M'O%R40-M[Z>_32<UUDD"ID\\6R:!XGPQRHDG1Z<R
M1,7K"PP6P-$V ($QX1DKZ+1MOII:(!]>WWI5D'NQS<'9[2$$]ALN:B&,"_QU
M.I]OG< ,,^)%_>L#L_$I!^.U@%*B665*!9<C"#2"8PB6Z\=J1^VCJVUG<-HZ
M>T2V&WJ*U[-YL_B LYJC-\,/-<CY"6\F1S-]4]Z'/T<YEQ2<XY C6Q9ZX. 8
M20^MY.@<NE >NZK=1R-WP77:>M:<F;9.Z(O\GY?SQ=(N7DQ?Y+R4?#A_&\:T
M'%Z&C^-%.%_F_]4:T;G.@R815O7<2$[S\0)_Q]FG<<)5(LH[3-.S%7]ADE=3
MI1G^7 JF!<UWI$/TRCH#.B8+RM ?#F.!@+IXG;E$N3UJ,33JTU31ITY_PWIQ
MUV)]-?XT)M\PSV^%#5Z&^8>15.0Z%E4 HR^T FN!E* 8V(B98[%,N\?RT?;9
M&Q_"<IK*UI2!AN7FKG&]KS._G'U> EK>Y+Q(-/%9U?KYXJ^X^##-(T4;LE99
M0@DF@&))@E.)M->'S*P62NK'TLOWT9)=<)VVQC1GIF&1NH<]H.6Y/^)*9I.T
MABR]J@=[!%\S1I(3GL=BC5F_1NW!85U".6T=:2'_AE7L&CO&EN=LG26]SHF<
M"Z\MS8))0,]E-%B]YL?2\)Y*V.. @.HJ_XH8R^19F7K9ZD E$H;#K$D.Y&L5
MGUG4K0_INPCZSE#L*5AX@!B?7(KB2AFK)3J=5+-UF99C=$)6<RPBJ_>TFLX!
M5S.CF1<H64)M5>M8RZ. ADY5;$'T0SISL,!["-6M8;JZ0=P%5$]IBQL!'3ES
M\7#BIGU)?3"5D$*B33H#P_I0T19R*A(78)C21HI09&Q]83"@*NR:QCB0)G01
M=A\IK#<.Y=7%O_!D(3%M(!13LS6M!:?)I0Q).!&CM<6VSEZ_!V)XN[L!.>N9
MJP=)MH?KQ+N1JM?7D:KK?(\B?1&,0:XQ5!4R!\^L QY8\DX6B^ZQ$J/[T/XH
MH%-0@782[V'EO\,%S0_SSV$V(>]C?H6*,RL1N84DBP=5:OEC(3D(J=!G)4U4
MK=VFS4A.00$:R+B'>Z\7*5U>7)[7!)^'+EJN@#)-YUV6&;)6]7(YU;XS=-PY
M9[E%X0K'UI; SN!.03_Z8:+A9=?&<.(5I(P2LS&$9OE&7C(+$4, $PTYW4$7
MUV]<]W34X%#I]G#GLSDT=86M>*<X<@]:9IIKLA)\J"B%(JM&F%S"8P_4]\K2
M> 3/*:A ,WD_>,O3,!?WIY#^<3:;7DYRF.2?PGP\GY:WA)=$L>J&$F:U+<XG
M?%7/O_-Y]PS<SB,<G'=[V)S6LVU9\)Y))E (1;NSEUE*:1Q3V1N%;M1YM"9^
M_BI__,YN<RM6*E4RFB&XB(6,$J<A!JSQ?\L<<\44\5A?Q@.\_L=@-;E,>(<?
M+V?I0YCCV]GT;!8N7EPN/DQGX__&_.*B-FWB(]I/4[&B0$PJT!(+CAQ[FZ ^
M4.;2*[3])$ENAW:TW:V9MFR\=VK,25_IM_=@OL,J0]JC;_#>_,XU<F=,X:(P
M2"ER(*,^04"24^1*^H L1MG:--H?[=>B8,V9Z^]%^1V9K*XEO%19<L< /=+)
MSSF#(#!!D6A<H<,FX6.E& ]X6'X?S% W>GWK21MI/YG;OIIR=G];K6'KE*WW
M$CEP(Y<&)$(P3M;2@YHKC4:FUF?[PVB.=<_7B.WUO::-U'O82S8CN_)5=L'6
MT[7?8[B.=/O7B,.=5.,  H96$B>4PR0-E$2K07FN(2A90'#'8Q*<X+7V\X=7
MCFWW@4?0C2YR;ULDX7^&R668?29:^&:$5Q$)]-(J)0/(Y8ZIDZAW%QH*64@Z
M!N6#W5X,8\?!CO#LL!DYTUXE^Z#3,V"L9VTRRP.UM[#/8X/U'@':>:9KP2##
MHY4I>Z\R5XJ5(*6CG4-:4Y)URF\-!CTV</]QH>0,E]E:L"&0ODL;(412^EQ$
MD%JQ5&3K;-P!XD)W/G55J_LZ07J$JN3,+=E_Q!+Y@+6=1@P<$N9$*[UPG7N]
MV+@+YVFZYUVTXM'KC@-DWT/,9Z>T><YSX:6FD2I3LTI10)!%@9116^E9-J%U
MK/!I/F@85%%:L-&# 7T'XS6\%Y]P%LZPHGR+LZ6*CTH(V7";(7OR5Y5($D)M
M\J$Y*3P9#\+8UC[XKMA.7'-:L=)#*L8C,8F8B[-,@"BN9@?5&*0F.9B8,*9@
M^;UR<U]'O.\0K6@C[6<0[T-)3DKRK);FHCW1.0V>*U+M$(0+W'BIO^IX7Q>V
M=X_W=9'ZT*&<7;!]B_=UY+!+3&<? H96$EXD&4PR@_8YT]Z: CBG(AC&$S)T
M2NJO.=[7FVYTD?N1XGTH<VWS#,PD.G53C."BSV"]U9&5FIRXYO*<3+RO$SE[
MQ/LZ2':(>-_KR2>\*FXQGJP,LJNFT6.<_WYY<4&3FI9;O[5WL&_OD0Z.]+69
MXUJ83WG%M-8B\EA()TP05G!9,_:\E#S$T=ZC[KVZ;WW6+0.:=K&B/6U@1IOZ
M)E9"S($LJIQ\#CY&M5[0:,-2WO3);1ZCK;SZ6Y\_XBX:'YP%<L9J2$@6\)Y+
MD%%QG[0.1;0NJ?\ E.%VIA;D;7Y_=IA\VU9=OWXC?XWEES!>U8-_\[&*=52T
M*RJ[>M:*^F"*U:>XG-'^B]YKYFR*;*NJ;AGD>7+:6'AMC8H'%.U++82_U^36
M^J)RDG\9_XGY[:R60IHA7GRL*:_OQF<?2"T16;"ROHH)1M7LOT3XDP->V^])
M%HQS84?R#X3RS%5D2")Z")'=WJJ0,1O1:T#M0KT<I:U*Z0Q)TW]&\ZQBZ\=I
M)[/][RO'MJ7S;J%8Q6*4R<AT+?H83*JY5P0E. /)\UA?/$7G2Q=S9)" 9>-U
M>I!0GDHX\I?Q)$S2N+9>G--X]2-73^830U6KDQG#.<FD*/!H#&22D:IOY@-O
M?7_\ )2A Y$',SMM+^%>;L#"9%YP5H^155U#.EK>E UHY^_I(^>;?W1=&&.'
MN?04IVPYC^/$-9LHR+V;M".S^]0U-@JT//($.M4FARC)SBXH %,2,EC,1<NO
M3E.W!%F?O*)V(760JBRHO(P2,_B(9%G$:H3SVI.%F_K^H42.K:NX/8&J+,?C
M=&LQERZ$-(R:S&>+T>_I ^;+<WQ3-CMX][^+^%NXP.42L]PZY%*!JP:_BH5#
ML$Z!3;E@$=9DL=,[(@)R2XGH;S<*="C&YVJG#<I-0T^[XGX(U]7:V059%[-L
MB_8\CF98XVI85J>]4M+PJ-H!H7+H3<@9;*X;;LP.0J(CW9@H@@LA"[M3@<DG
MJ"P/V#=/55>Z,-$V%OSBI]>3G_#3=04TFYQ)KD IO+:KDQJB80GH +;*6"[C
M>FVY37T,;G_D<#9):S%/&\BH[77,__S;WWZ];O!H:YF*9(#Q6J$JR@C., LE
M120Z),]Y^\W+S>>= DM[2J=Q$]O9=#*=_]ML>OGQ]23]<*TRIFCCR&,2N110
M5DOPDFQ18TB9.&T;B#OTG=[TT:= W.$R>]#6&BKOXKI^W/V?])-]L7V\?G,P
M.LYW+1,CI1"BY\QYGY5/Q1?I7/(Q!*3CM:C',S&VCWU@!MX6^^#V=4)$JZP7
M8-&3-8!10:SUI4C]I70E2Z%:9S[LCJY!?\RKCDZ_T";P8'(",\%HG8#,'T8B
MX @1E:7]%I$7S2V+K3.9=P)VA"2U?O1F0X_,QK2T-5(VX;N%;#T+ FTT4D4#
M3I,-I91&\$8[$$*Q+).RW&PW9+J->7*JT:_4VQI(6X".)!T#,1<)6@6R(60@
M5\M:#S$4Q*2Y#':[J;1ED*]0 3K)M8<DD:T"6$7UBLK&Z%K8R=:2RX('<#4B
M;)(DMSLHR9N?)KLA&ZQ'RC"'2 ]T'#O-X?#03LR9A$9'9K0(BC,//N0 R9=@
MK(MH<*>Z^B<4>.]379K%Y#O0-FQX=1=DWV+R#5CM$)/?@Y)AE:9HH3G+%G1B
M=0TQ"\&B B^*%=E@CK[%]=])Q>3[T94N3/09DR]>2)NT)S,]UC_(GW.Q9-"6
M:\<$3[QLS[-^NC'Y3F)^*";?149MW=W-P<MDC+?2&4#,!A1A@.BM!8SH,&6:
M;SZ%@.^>W!TNL\:/+&_=',C(4BWL58D E0E.,":#5R70C (FL<,[RJ=YK[(G
M6WM*Y^@Q^9L?CB>T6QQ>\_Z@T?J-QW>:ZUHT7K,H1+(L2F&5"B+R4FP0'FO_
MS53DX]'X;2,/%HLO GVQ*(&[ZH$DX4DWHX7(R!76@9GBW"Z&TY.,Q6_^_#=_
M3' V_S#^^)9<N5J,[@Q'*@I35&" EF%-HF/@I39D$3%>#T-I;.L\Q)W!/>FX
M6Q?]V>WEYJ'T]/&6<QWC;Y=5@-.RJO)6$>=W]*/9."TPCUP),8NL0'E%?V F
MF61/YC7W9%-%HYV56T_#/08^.4490/Y#/!'=@':5>#MBF"59:1&,T9)\,!G
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MPI]P\0?BY+KR]JJ@[(M)ONFG(E"Y%#/Y;8XK4,(X\,Q*L)9K[UT)%G=M1W(
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M@M5FZ)ZVX.A" &.Y+4ZJH%+K#G7/*\.H-^WH(ODC9!BI%!DY+![(8ZW9,*R
MESR EB;$Z'PV:M<"*<\JPZ@3+1TSC+K(=, ,(V;05PV/ 6MJOXD0.,U8.IM"
M,LDK?4H91DT(WE^"#R[EA@&:3:GV7XJR?'FH&";YNCCAJCSNOG&:PX8[.%S3
M<+;K49NH(A>2_)"<E8^<%FM&I"/ >H4YN4VO93H,W>I8O_&EA+(IU^);KNA
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MIX:/]]39/OO2LYP;V[Y:/7]_]^VW=+'\<';1TN^_C$MTUBY%$WF]RQR#8I3
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MTI-C<=O2"I\#AQM6V]DH' -9WXN0M^_/SL\^_KR\O#R[^ON[5_?G]]I9Z8H
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M4,_VS^ZKPS/B.1[(["BG==!*U9BD\2DA"6FC5R%@FPC48L0XLZGHH&D9O5F
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M+DFIF(6&%%;=0%333TNK?L9H1424;G<!S3%IM>])<7\T^V:';5 @%@X54C9
MU;5;"-$4%*2"*D/1SFK41>Z>?9^S8O.^D^]TO#HF?&U70"%;BJ=8P:-R_(BI
M]0#2CK_56&0(@LR#ANTGK0*U[^%&'X /I@(UQ*B7I@(UBJA!6D#[H'PP%2A9
MBHO.&@B6:JLH,I 0'9!)RF)RRM=!RL_/B_J]5*#Z,S\&W(Z,Y^7-Q?7EGXMO
M7BT25>NB]:!54&!\1$B6G\YIY*#1VLH_'W#Y=_>)MPS???.9X,_C/1=9E%'
M+R>AUEL4ZM7?%C+KXK2)8'ACW7;8CA<>CCQ2\0*SKD+E;3VP!TG8O/K;,7.U
M#U*]1:'83WAV,$YF HJ>P%A1>63V&/+%^9*$DP^K8<83==POU3Y(]1:%^N;7
MA434GKR$:%33I J>(WC44!"KRS9J:[8=Z@\CZM?C)VH<4CWOXNXTJ1PYWA%Q
MN%T#[XN,%!QSMQ[T)@M^JN2R\-OV(4>FWK4W42.1ZKFA:,/_]&KA:Y!2:X),
MB.V%%A"]%6R-Y2DY^5C-MKAQ$%$_'?_4-Q*IGOO].SF^H N;ZCEX"3'Q.DD1
MHA,1T ;4,K:N<=NTTXY,N'!OHD8BU;$PZW;X=POO<X@J6@BD-+_&,0,/&_A;
MKS@,U8H#F\E$O3M^HL8A]9@H/XVH-PM2B9*U[92][0XBKXXH.>BTO%%(I+,O
M8CI1;XZ?J'%(/28J3!/7_>M"VQB\:]NXF-KPQ4",(@,)-%:KFJV:'$R\_NO1
M$S42J<=$Q6E$_1>_T(GCEYRA5FW!$%N-QF1H"LRE%BSEH;K$'D3]U_$3-0ZI
M-1O>B7K5_UI4PYL $Q4(TY3<<N;M093\1@ORINJD=!J23+Z=J7\=/U/CD%K#
MU+2SB3=_74A3K H^ 8_<U'T-03+9@2!EI?)4I!]R\K>5J3?'/_F-1&H-4],.
M)]Z^6HB*%7V*X%U@VTFR[9$=I_"J:31:HP<5:&QEZNWQ1^@CD5K#U+33B5]^
M7"B?7-):@<JIE? 5A$A2@! F(QD7)$Y^IW[Y\>B9&HG4&J:F'4_\^GKAG:!2
M=  M2?)>KDB(61>H3@91.-1Q=IN<Q2"F?GU]]$R-1&H-4]/.)_[YCX70*42O
M'%C^L^F?%=YUJQ;@"-YPBZ2MGGS9\<]_'#U3(Y%:PY2;5T;W08+:Y[27/B*Y
M.S^^KP3NN*=Y('"+*)EGS6M5-,:G@$*EFHS6+A#I*A?CAII-OE9KLDKY#"X6
M=JC4CE"RJA"EC50CI6!["[GTEZ]=([.U_/"1+J[:W__S6_R O]'5JS^0WX+R
M#SR_H450E$40J=WS\QZJA@PI"82JLM-2*($/[\0'*)AM'_-9B5N-H7V+F%E'
ME&>5JGU[T[#^G=89F6WF>-)EL+Z)KS71/9Z#-=2@99(N"3M$VWWP>"?H!KW0
MG4&:Y(&EZRRT09*0R/XI6Z\BP@A!5 <^L*O:4J2M,PM:GZ*7S$1 Q[R #1:^
MROGR!L]Y)?[]K"62+8RDZAUYH-22K3E&@U X9C/1**O81E6V!:<=_..A2:?J
M').@[YB(L",QF(1O[0(%E#:1&4V\JHG"]LD87,G9))WG#IF>BTQB/_;W@O>I
M91(W%,_&))+D^0WRJGB6:H#DB2<X_I<AIE(H]>BG_.SU 491N5T?8 RDARH3
M'V+32]$'&,7/D'KQ?< ]%/'%N5!2:/W;6U!KO 8L0@%J9WR3&K)JD%#NLR)\
MG#Y =[['8-JWI/C!X<NZPKNWEV<\K7VDN_(MY6QL_3&!5B?;E"VDG 2PY0IC
MT3:%!R'A[BK5W<,^DTJX441M+%[MC'+?TX/UMN*7MOYP271Q;VEVB4A4-M('
MR5&0XS@5^:L6N^9J4E$R[ND/&P<]16_H@_ A9H>O+/T)+_'#V;VIUE,)CN=#
M-)A;D^H"*?!75+7WRKJ(<O=YTMA13]X;]L>XLT;F0[%!RJXVT7X0A7@'5(N&
M4 G;-DC9A,IE&G)W=:RJI_N$^%-AG%/U=(@=)ZAZ.@K^39*9^V WJ^JIX=7!
M"@-8=0 3BH.D+:\<2I8@=70R#TG5.!+5TRX4CH'L$*JG-O)F(H4"JFB>7D*3
M'!(^@H]$J*6NQ8U6S7QZG<PQ(.]2/1V#T,8H>:Z$@-6J_H5^%(?[7R[TJ[:&
M=VV"^Z0([#%@WZ2!J4_\((T@H,]>.L\AC3;D4FI-'GWK$!4L%7K0)W>/P6=+
M+"C1&ND3!^NDB*>C%J+)%@HF4VT-.I*<MY_Z/(D%V^XZ:Q!$(:X*)1%,FXLQ
M<0AL6SMTU$:F 2HX1WJ3/(;N_6Z2QZ [;S(!79XM2UU>?DN9+J_/ZAF5U4MW
M.R-?72^_/SNGSTI.=])YKWYCB*^NOZ7*+SA>7%\M0@C>.]'RP4WBV-GRBI!4
MDP+B=W[5"S*,;J/7R[A3=*ZGX&W^G(9U/:*=*:H*&\'R1A@,AP@0/ D@YW/.
MRB'6WKU7CJQ)]SXN-1,!\^<TW!KUIKYE$_F'M?)N(<A$2B,X7RT8YXC#QF!!
MH[*"D*2*,WO(8Z-.U4$FPM]7KW%[(^H:4_15@XJJ@L$VJ17>F6B3"^6<JA/3
M6CP?/<4]$>PKS3BNP;"3A%BB@AQ:)ZI<#(28"TCV/)>]J4GN%EH]WB;.,U _
M#>..J@^/[?S"M+M^M%=WB]9]7]I%U4K[I&33M_)@4B0( AD:C870"M1Q=(_?
MW<.>H$]TQKJCR,3(=O3>B%BKMU"IJ0 11[E1E 2AR!"KBB+*:6O!]R]K?IB"
M;T<%BZ$MJG4PID6QT.KTP%@5(5F.8*L+F2/;XJ)W8^E__DV_^_ ^'=&.2AB/
MS?M_Z')Y=\)R/T4M"I;6V,-#*TSG#8ODM2HH#=[Y$JI*PI31\<":<4Z0[*EH
M=M32&)%T7W)KX<![#ZTP-77C !AX(4H^Y.QJ#OEAOX275O70<0,XE8">*AY#
M'/CG95F=CBUTU3JF[$&+[%I]1H7@DP?KI3 6Q6-9@GUFA?OACI[^V;#M*0ZR
M*Z'#8D;>F@!E+YN<:H+HD?<P:$P)R21IYBUW>4;5#?VF@+W@?>KJAEW-S)V3
MCG314&H[Y*2@(&HCP.9<:]+!^S*H8<"T+N_/,2EJ#,F[N[R/!GN&2X?-/<V'
M&#:F"F*:-SQ%0E57ZG:[PP3<#^H89(Q0"1%2LKS?J5+S A<3M-SM6(0):'NO
M) =VB W964_C#V/@GM\/[K*3"'/21FM S[&MR9)GPHQ-#4B8=H<:9!G46F)_
M'SATME=GHK;3OP?*/7L5K"\-JDI14K9 %LKS\_'V)OB<V1IJ@D(EJ[@M[?)T
MJA_WB (Z0-I3.G];KO\0FUY*]>,H?H94P^T#[J&J'QVO4TZA!Q>$ 6.IM(UK
MA>@*R2*2%[A-3?QY$CZN^K$[WV,P[9MWO;&C9)144S20K>*51(<*2=16=J4P
M9^M#-+O/_Y]W&\Y1H ]HJ#H"L;X)BH\L6C6XNC,+L[$E!@.E74 ;KQT@6K8R
MN52#<<4-N,?;-L+AV.P%_A8N]T5NYI?R>^+/Q//[RMCJ=;9(X&1)K?R-.+*@
M"%[$J%Q05<4]WLVOQC@I4O='KV,PM<ZPMX275\N+;[]9OJ>+;Y;GYWCYS7O,
MG_J$HBI!IZ AZ[A*$S,0JFX9)*84F4(2:7>A^=A13VQV[HGQS&_Y+W36'/6B
M_ 4O_GW_$N@D*#:K1*[^3O*S&H(@@]$QYA3B'CZP;J@3(WXRFC.__/^D5N1\
M>=WJG/$B+_._[]L[<P")J C8\UH5=>O$D-C:+&RF+'.1>7<NUN#A3HSU+JCV
M3;E]/"6M9J&S^],;(=FPRC/.ZLP&"0'Y2]"E)E$441F@1;I]C!/C>'_\^J;<
M/C+LAW/^^O(7QFQY<\X>^.W-V6\7^.&^Z[?/M5!BYRN46]=OA"1EA*IUX=VD
M\!Q4CB=ZZY@G1GP_?/OFVSZ.."^)/N#%IT4G2=_ZM#0Q2S#*\7I33$L'8K\5
M[>I_@"3(]C%.C.C]\>N;,/O(L+_A1W:\5Q?EW?+#![J\#RL<VR2;A5XD#::Z
MR'N*Q#M'42P'F$V_,HUG>/U@)T9U!T0[IL>N4U8(J>5_8 7TDC>,4;?[NEI!
M6J,BA1QH:Y[#T4N\['&/,17&C@'8(_F%(7:<H,3+*/@WZ8/L@]V<$B^I:D^\
M/( U+8O2K(2@:@2.!%+1/!/9.*0%[9%(O'2A< QDAY!XT0YY^Z54>XK X7L5
M@*%$-LI62KXUR]B]VWUN$B^C0-XE\3(&H:>1>/ER/?]29>2N\HDC=?XW^?RF
M4.FH\[+'J#.(O4Q]]@>*+\ZK6*+6R4?DO6P*GK<UI"5F;4E36*/XLH<%\\F^
M"%4#50M4<DM%P0RA!@7*8A,]BH'RO'7E3]1/Q@1%Q1(DT<X@:LT099&0O:/"
M#QZ]WZT >L3]9,;0/J&?S B4YY6 V:)3XZNM)67-T5E9'4=Y:.5\8,F2RKH&
M1#_6%8Y&!:B+&_1"=W[ME4<=*[3,2B$'9UH'-J\8"3R1>R O#!DK3-BJ!GKJ
MS4+V\8\YH)]?<F6=[RKAK2H.^9FQB1CG#+RJMVXW.6-,(;J<YG6.4YP_9B*@
MXPG$CO.59# JIUQ3T=>WI48Q-[%S0S$;9RH;/7?(]&PJKKHYP%[P/G7%U89T
M0\>N6JH6$%5[CL);_E 20C522A>]H(>GRZ>943V*RNT9U6,@/5AB[0";7DI&
M]2A^!F78[@'NH8C/NA@7K 4.7R,84R.D2 ZL\KY(T3II]:^8>%X9U=WY'H/I
MS&E=[_)[NKS^_^CR/F$AR(0J"' B*S">MR_!Z5;_KZ3'H(U6#Q;\01FY7X_R
M3&X)1]&P+2]W H8S)UO_=/;QXYU5U6M*U6<H$@48&PPD<HGW("FDDHPU%L<S
M^WF $R-U3^1F?EU_X$\^PSN[8DVAR0N#421;=ZO (8>3$&)1TJ3(Y.T^V-LZ
MQ(EQNC=Z,V=;WJ8*W6>49)&M%H87F<"["Q-YYDBN1)"^R4AK42GMEE[>/L:)
M\;H_?C,G4_Z<O^'=YOVR4+P(0EK(,JYV^!*2(&PG02JVB@U4NP]?MPYQ8K3N
MC=[,F91_79Z?GWW. "O>Z*2+!&L$/VZR"F)<U=\9(6*,TM;=\F0[!CDQ9B<@
M.'-RY#?OL?Q!G[Q.NJ1KM0DD:>('MIZ7?LDK!2D1G<G6RSW"X:\'.3%N)R!X
MD/S(G_-/R.O%>_X7=R8FU+HZ3V!U6JE=(D19V?UBK4%H4LGO4<6R8;038[L'
MIGT51!_7VOS'M\N;W\[Q/GL3O1&D4P4*PH,1ACW2R,P.2M9;+Y+2>Z2Z/QCE
MQ&B>@F%?O=#'\\UR^?'3UML%[6RI&826KI7%VB9<FR$J'4TH-20J>\S77PQQ
M8L3NC=YC5O>6!ET;TO_'7RZ7?]S/)B&&$BU**-'DUI6,GU:[MG5KLL3>9^?V
MV.E^-<:)\;H_?FM.,+H>27US4\K9>[HO9!=%>=*.([ZF,\0SB>;0(%I0Y+S)
MIFH,>]2+?SW(B7$[ <$UY$[/._GTO$V@X.9J=6:N2[(\EPC(Q3:58<\[M980
M8Q"U2Y(RA4%MZ,=<'*^QXP0N";O!/$=BR0.;[AQ]B%4SR2ZNM^AI-!>G,[;#
M!2; /4?^V7KKBJL>0W*00E,4U-FQST<-F=U=)*\SB4&23,_4"7;H+![*!\:@
M/ /W=^G<GXV[/XLU;;-7)/B ;)8/$H)0&J3S*L?($Z!UG<G?8,H3Y))U8&K9
M'^:.-XZ?E!_I^OJ<RB.S;)1.Q8J\2_0*3"M\CY5CE"S)V815Q=*[S^H&4TZ"
M_1XP=RYX>UP%%@7I( !;QS@3-3NB1;8G)N,$BIK=MLG^V,M1]XGOIL(X;SGJ
M;CM.LAQU!/R;RU''8S=G.2K9G'A0;!M/]DW4[;X[5@C56HLU1&^GO9K/K!RU
M X5C(#M$.6I-R"NZB1 H5Y[HM8(D><KW(IH0M0E>[CX&>V[EJ*- WE6..@:A
M@Y>C?G^^O#PK^)?E15G%!-?4I^!T\^?V+2D=:/_#HE$=M:VB94DE4R@F1Y3X
M08S258M0%@/'F*TL5$H34F7?JU6TW5C0[#/(F[-@BO*6#?9'41;Z,_ZOLP\W
M'QITWR\O7YV??]$6/"KIG5 6E&EGA(:GPQ0]_T$QZBR,5'GW/?:6 9Y5I<X8
M0K^847KA-\,&:T.XZ5!:U?*;D.-],%FT8WV..6WE?442H2;3>W_U;*MS]B&]
M([S/H3IGI0_</N0'6OYVB1_?GV4\7T5#TCF90S1@5!.IHBS8<QD<FZQS,7IR
M-0]QE!U)_!L->&;;M%'$+GL#W+ERX]VMXWQITEUD-<2HCC4[&PTY?-%.)Z*6
M<Z%\,!?0DB.NEGSC@^5XV.8,R2M>MTHE7R2VVL7CHWY+^<XAF1\#;D_&KS]>
M+K[_:>%%\ 5;SW9?6J,'Z8 70-[KM&8]);!I#R4[UV[HV\?=<MN^^H+7VV$.
M>W?>">SE_DAUC-XVE)-9?A(M2DMO32V6M H"MG(2$W5T.:!X*,)QFA6S^Z["
M$R'M> V^-=MCB$TOI6)V%#]#*BCW ?=@I=*.2LZA@"B>P)26^NJ2 Y>%CE6I
M;-.@OG+/BO!Q%;/=^1Z#Z=P5LU]T8:F(,<35FN)SZ[6D '7T4$S.)=12#.U3
M+?L4_6OZP3^P@\T8[ Y^5/OF^CU=OONP_/>M1MU?B?_V^V_.\>KJ56[#7/4Y
MN1T\3-^#W/V>[L&Y;O&^>JHAQ*A-C18%I:#0E+ *JL1BOR%G.^85U;KJ;8):
M3;ML<!XB50F28B0.0W3MWN[S(.I_#</7R^MOZ/)ZU;S]]<UMO9Q7GI+*4)B=
MVS9PR7D)#HU*NK([TGC5O_5C/:O#WS$T;U'[ZX#J[.? ?]ZE [&Q9Q^N[BST
MT50=K0<7O6O9P+S-];* XW [R2BPB-X95[NM.GH/F8F OJ'* ^-N[5G6G_'B
MIF*^OKFDRZM%BJVG$ =D.5K1$I B1%TL\'2NH@VF\K9K[+RP=J2CYWP.1/L*
M"3PP[Q]T6<[R]=7?/[ZG\[*P-F9AJP(2KK634HKG*M* &&+&Z*JJN\L:MPYQ
M@A1/P+"OEL"K#\N;B^L[B<#KY2I^>HN7UW\N(@D.G9,'"DZ"R10 A1"\URI)
MI2B3\;OU(39^_"EPV@>[CBH".T["O$(E$Z\66J>6K,1[YJ1,A"*=D8%$1)IW
MS7Y&][C]5N>]X'W>][A!6$6B(-206M?7R.Y;T(,(*'3BJ,-U.5HZEGO<4<0.
MNL<= _#!+O&&&/72[G%'$37H-F\?E _F F@36L_11S9-0-H4CC&ML^!\5MIJ
MC$2#<M2>%_5[W>/V9WX,N+WO<5_]LM"HI:F\3712\_Z! Q0(#BMH(77(-4DJ
M90NW@^YQ7_WR7.YQ1X&]W!^IGO>X;?AO7BVT2DX95\&GR*&)-!I2(0&MGYPN
MOF0L>BI1W[PZ>J)&(M7[C?KVNT6U2@B.#"!@;E.$#QP7R-P*HKP-.?$OM\V6
M@XCZ]KNC)VHD4CTOSE?#?[/(+4J3P0)OIQ.8HA/$5!RT>P1*.9+:FGH]C*AO
MCI^H<4AU/(CXE$%C<ZR:-'C;&FJV[F&I8-.(\<KY&B2&R6O4\\DUVINHD4AU
M/&%8#?_C3XMDHK:I$F3;M(=EM>TPT@,2UN)E$44/Z0>ZE:@?CY^HD4AU%!V\
M'?[50I2@B8P%65J_J"#83] 5?K_Y+9?&.9WD9**./Y@8B51'!<'5\'][M] )
MC<.LP267P21R@(;722-4TL$[GH:W*=D,(NIO[XZ>J)%(==3\6PW_TZN%JC)Z
M-A""T1%,5;6UHC1M>"%<K5)N;6$TB*B?CO^-&HE41_6^U? _?[O04B2*V4)M
ME9JF8N9)USNP*0>2O*NO8G(P\?.W1T_42*0Z"O+=#O_C0G)<&2Q97AV;.DVJ
MO(UCFT%IQP%HJH$GX\E$_7C\1(U#JJ? WNWXKQ<J&'1MPQVC:"T*<NN#+A4D
M3RB-]23L=*9>'S]3XY#JJ9:W&O_U/Q:53(J1-P0AVR:,RYL$]-(#[PQJ,KQ>
MRH>5N..9>OV/HV=J)%)KF)IV./'ZOQ;1LF,(GX"0J(FY2(@F"<;:5-XMF)K#
M$,&,[4S]U_$S-0ZI-4Q-.YUX_:\%J>QU.PWV"=MQHV_+)&\3*$932O&9:'*(
M_OI?Q\_4.*36,#7M>.+-7Q?*!R=4K&QL9-N=-) 2QZ"9?VAUXG"F3GZGWOSU
MZ)D:B=0:IJ:=3[SYVT)9'[Q(&E3R/+XV MI)([#5%JM'3'I;R?@PIOYV_$R-
M0VH-4],.*-[\LHCD'"^&&G(FT01T>%_GK 0A@LH<D]9LIK]3QW]_.!*I-4Q-
M.Z%X^VH1JRI2N0)25!Z?5T5(P47@/7?A75Z(.FWKI3B(J;?'?T(Q$JDU3.U]
M1)%;XN#EGXNWORP0I62?T& =!YTFAL"OM6#?B0%5E%$Z'%)>??>)MWS=??.9
MLL_C'3-K>Z*VAKAI1Q;OOED8(WRQP4,40?)DS$:$7 @H69."EA15G?J*O3O^
M&\612*VY^IUV9/'K_VR:M3+PG,O&^M@\Q0.J+$%JD8PAQPXT^>[WU_]Y]$R-
M1&H-4]..+/[YXR(D3=5GA&#B2J9/ 09;0%4DS<NIX;W?5*;^>?S'@".16L/4
MWD<6]Q/P-Z\62E)+H*Y09-/)X&T=!&0[0@S5.^FR=D-N088M6\>=K;0G:FN(
MFU+H\9=+!NSJ_3?+\YL/Z0S?X=6_\3J_IS\^M<?3WEF;0BLA(_8JWQI\E*K!
M1V/9ZA*BVEW(LW.88V:R.XQK.-[[[&.=/*T51@95 Q1A6P4\SQ'1B@S6JL)S
M155YT*7RL>ID[Y.X/Q7&CNEKCS1LA]AQ@CK9H^#?)+*\#W:SZF17ITUR!-DG
MCK:$D!!U]="T#IRGA,4-2<PY$IWL+A2.@>P0.MDI%IVK69T9.%Y"#(=A5 U8
M+1/'8U:DM'O!?'8ZV6- WJ63/0:ACIGTC^W!B_)J)57RP^7RYN-]0XN,5K4J
M34,M!/"20P 7F]Q,]-ZX;+T8K7.^;J"C9W,R>GW?QF_P LL97ORZ3)CS\JLR
M^7OCO O!D@2=FNB;1L&.MU+U,R1$S9GQV$GM[G&.C]G.V/45&GCL9%J:Y&/E
MA2*19EN\AY12 %U2;;GHEG=,.WD\@1=R&C(],_77*[$9JSWY8D"ZFMB:6"&J
M5?LAHWPEH\K#SJFG*3:Y;ZGP1$AG)?@+@;8A-KT4L<E1_ P1']P'W$.)328I
M><(1"F1%7O&=TX"*#+B8,KNVMTENJTE\GH2/$YOLSO<83/L&4'<">:_6">3=
M=_NM&=%H#<6L&AM9"<F8UNS-%4V!4-;=^DV[QWDFPI.CJ%C.A>,,2F[O;M(5
M_?<-75Q_]SO_T1YYY<RH*^5DFS:UX>BAB-;!JDJP/FI^<&]=Z2T%L\&4$UC
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M9,N4I1I<>'B"^ QS0#:<%-Y)D7USCF<?KE[?W&GI&QM+4S4DUSKB.G[W/%E
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MR2+QO4SW7-4!4DU%==@KT0^B.HS6V!$3& 'W?,8@'15G%1PD4QOD1(,0;;3
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M%Y@SKAS7"3=,YW"V0ZV79=84#SLIP2-.&<@SE<!!B@M*):]AHH;S8.OYMBT
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MH6T (?+B1"0Q)#3Q(!(^A4G@NS 6C(C821R*=//5:'2W-/KJ+9MBN5R-E=)
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M4*E_Y+S=Y[)L- *_*YT,SWF/&DL]IIMKA";FP&D'QY@@;:!JB3I'B3(KJ=H
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M<G7T]OFWDLL)^/,C+[ 22@5\/=6I+%>.&T8D]A@D<2RG0$*8.A2+H:O.(/!
M^>')JLHKO-9;J>AW;33A[028<,*31BQ5L42/K>R /(,WF[)><_P$\JT& .]4
M,%M^&(R*WC)C&JPGGL(4S'7(UFT7YM^V,.^$!]?],!NO),P1L[1B,.AXUI6!
M.2"O5P #6K!;'>E37GWE5;7F;.4Y/&0,AQ#3A$+DNQ%,1.A#C[N)_"&AU-4*
M!]/O<FE6NT;=HRRO5'8G);V=FCJ= 3 UQFW .KO)?5 =1\H-ODZ$J)V21,.0
MO71:)S.$K54:.@1K6%FA3CN+J"%TJ)=NP: C=]KB\*UM7)>M[IC&*^&&H8]\
M#!'S//D/=2&)@@BZGN]%"8L"YL7CN/Q4UW\D3M_Y9NHCX%W/S%@F.CDP0SG>
M!MP7Y/K=FKU&^F8.I,=ROPW$%S '#$#>PES0!Y[IG'"RO0O/#7UZ]L\1O2T8
MSQ4JYK-^X*[7Z_R[*E/W)5^O15ZHW5[U\4/S41K\D8,#Q" )'3E31(D'<<0H
MC#R$?!(*0;0/+.OVN;3982<WV D..I*#W]4?H!5>/]9->PAZIX,I@)UX'K@T
MIMK$/P6V,S&^)8Q-F-X4K9,4K]W07-QNJEF'U(UO'>R2;O:!4_J.BS3C["W/
MY(>J?/]#&K$E_\*?)%OB]6?1?O'^!UUOU,3RE1=/*:U/+*N=YCR3#^<J3 *"
M$ FA$X4!1%X4P#AQ7(B< 'L\]MW8T2I;,9%\2YLEE-?UL=4/D$:S-I3F"O"M
M)J!L5)$+B?)T[;-9QE?; WZI49O!3;Y5#;2Z@:URH%4&O-GJI]:"[9<_78&=
MDJ#5LLG6L-/3JD-]B@&PYW6W*MW<KODIH#WBOY^DFX')(N@]9YLUEYT=K1I1
M_B(E_%CQAW+%19BX/L+026)5X8XD$">(0!KX">>$^5'L&*6.T.YZ:>2^E;PF
M@1/%54KPNY(?U J8)I;0'Q0]VIX&ZHD9V2+*YDDHC &SE9)"O^-Y$U08 W*0
MKL*\A:&5#+JL>BN?*<6C5(5_;*I-P=\_/*[S9Q5%F55%2C9U+IXO_ &G&5/N
ME0]I2?'Z?W-<K%CH> [U LA4=#E2U9JQ<I$'GL.$+T*.N9:[P[YH2Z/$ZZQ*
M:?I8!U1AQE(EN;22>*M0[4[?:61:-L':>.JQY65&:6(V?672 J76%=@J!AK-
MP%8U\$*W*[#33I%QHQ]0"MHLYF ;=&NE'ZP)-G.A"-N 'I:5L-Z#>3W.[&[-
M;XO\CF?/M4/\W9_?%OGW;)<P'3'N>!2&<4@A8I$ZWQ[XT'=QQ'Q!PD2$NL4V
MS_:T-#ZNI06MN,U.SA5X]V=0BVQ^$KL'YEZ?M#WP)J;)>7'3+TMI#;^Y:DZ.
MP]&HG*06-J=K19Z_?;9"D%I:=*L\ZMU@JX1C$YCR[1Y7-_CQ;9ZQO/C"I2%?
M\$^Y^G.5D-#SXMB%@8A4!A<W@,2-!"2(A(S&(L""CBOIV"?"TCCXT^M(P$J*
M#BA^!$1*JY*A%8WX(,OKK\;6*.P=HV&A)':1OU1(2;X+;E-Z2$IZ!&_;86AU
M 9_R^JO)AV%LZ4B;PW'I>!,+PV*AO*0NHJ;E)GO;O7#Y25V]^\M1:K=D/"%]
M_'\^?VWM)5]0DL2N@,AQY1P3N0DDG#DPB'G@.RS&Q-'-$K9O=6G3AI+,W-+L
MH-3+\L-TGYBX1ZNMS:K#U)^)*)5P5ICN4,N3Y-6Y="X^.I2N0S%'?C3/8_P+
MO\/K-B&J*K :D<B/!68PH")624HI)$Z U5D5QW-#Y$6Q5N;S(VTOC4%J\4";
M@M>D4NTQW,ZSR4@TIC8&#8 PRCM\0N5!J89?MS5;=N$32G03"I^Z9-C.S"]Y
M=O>-%P\J@=HG*5^=6JU:!8$(D, Q#!.'0A2*!,8TDE-[R!,4A$2$&)NE[SG>
MD<F#.4]*'B4GE(SP4">:--L6.0&FWA;'>( F7\9)9)2$=8K#;H1-DY"O K_B
M:E-8/JYZ'A9+&PHG.IEU<^"\HJ\=_3U7VW(Q7>_V#9O%Q/L?%<\89]_3ZKX]
M#K6O%K@B-'2X+R=P3ID'$?$3F/B. R59T-A-F"]"-L[?9"3/XFR ,X>8.ANT
MK6>*MZH!I=OVM"I8[[0;ZQ(Q&]JA;JK)!NR"/JN]3EL_R?L78]7JU2E_.^]8
MC?5E339F"W!L61P["SZN04B;.KS,.KFP]VL0(OVNL&'-#C2I4TS2]3:UC!\G
MCO @Q:HX3T@Q)+$CC6F'!0P'08(<QR2U3*=MH]EMAMPQWU0?<G[:"6AH.W=0
MTS28AV$Q]<2A 8"Y$7RHJBW+M]/RO.;NH4H'-NZ12X:]DJ\3+W[,;E6FQCR[
MSMAM7E8%K]*B*=Q%UBT+E"N$2. C[$-!10!1[/DP=CT$@RB,111$<D7LKS*Y
M'*\X^Z8?<3A(&*TG/&F>\ .1IGO:MSJ - /Y3MHK=29?:02PVC9J\H:_T&Q[
M_L:0)(:-HQZ=3#<L,SGK6_G!FZT&/ZE1^=P9E=O.J+0YMU^.RMN^43%FKE&H
M6N*X83+,RH:C8'K-F^,:,V/8LJCV50__RO.[ C_>IQ2O:T>UF[A)P$D$ QI1
MB)S(42<4'8AHZ"6.&X91K)5<]FPO2UOF=^4S<O6?Q_(\BUE#:&*6,@%'FVRT
ME#]')K*!#I'(O_8D<K[M64A"2[TM">A=;#6G9G-@Y$6>NUVR>,+D$C4,8^A$
M7-I0;L0@CAT$12P\!Q/J$L3,-A+,A5C>)L.9Y(\[/722/]H:)3T+:5KD)R:>
MGIR;QV"?))'_<!"G3<-Y3H EI./4 $@S+:=.2^,//?P-/\KG[U?Z"]ZD=_?R
MIC8D)HHB1Y*?#Z.811!Y)(:)&W$8>Z[ZORA*8MW\G+I]+LU .AJ(WLAN(9S_
M%/"].QA3P#DQJ9U#\DU'\)\FQ'7X@0D+^%[RZ(3N$SOJX$0/1OI'*$XU=+'#
M%#V:G3M6T7?K,.OV"Z=K7):ID-:R>IP^;ZK/XIK*!VRS5OZT4W5>OF&RYM_X
MC^JM5/6?*QJYG&*2P,!W54X&SX&)$V*(>4R$RTD8A48Y&>R(M;0YX+56(-_4
M]9,ZBH'359?,#&)+ ZMG),\_7!//,>-&"OQ>*P:49J!6S:(M;1=K2_:U):%F
MM;GM OG:#K?<NGG<<1,M*7MXR+.OE6SKZSV6KXB4HZQPG;ASY;EAPEPO@HX;
M<(@8<F'BQ2&,!0M0%(1^%"'=4.3^[I;&QFTX;B,RJ&6^ HW4H",V>)-FH*R_
M_DD_>ED#_?/4:A_3R<UR+3CMQ#WK(S,H%%JC^=FBH_55[09,&]PUS'#\@--"
MI9#DOW)<;IJ=E7+WY;^EO)!-WC^_RU6:A95/(I*XW(-$^ %$#F<P=D0$&7.8
MYPN$F$A,[$.CWI=&/$I.4 L*=I+6VY.?KO\.?F]D-LS4938:>D;=9!A/3$3C
MX#6VQP;!9,GL,NM[5NMJ$"ROC:AAC0Q="3_EZR>5S[S@+*T^8*K"<)ZW'DSB
MJB4NAT&"78@2QJ6I%"72:(IQ$)*0X%C+5-+J;6F$M1,6--*"K;B&'C8]J'67
MG)8 G'PE.1B[ 4M##4RLK?C.]37S0DY#[</UF<Y-@ZF$9QO^04I:YYS"M/I'
M6MW?;,I*KO"*VWR=TN>]CP4%(O8I1=")U3*,1J'D%KDJBT+L^:'KQ8YGZ#PS
MZ7Z!9*.D!VJ<P5;^)DY]JX$QVYB,AC;]3(3Q]'S4!R_XO1%_*O_5$.3LL99)
MYW/3V !@CO#:D%:&QL9\OZ8TW]1'#VZ+/),?:6.E76?LYEX^>+S\F'6O23.:
M/JX[81B4!R1!B0_=$$OV(US .)!D*-P@(3SF"?*TSL]9E&EIE+B759W?R1@N
M6 E^>U3%=NJ%3:.4"GSM7+E32R>B8[+1U6/3F<=L8HJ=?K@&!.!8 ]A:1,YX
MB68.T;$&X6',CKVFS3<*WK7A!-_DK:N((8Q<$<# \>7JEB<<8N%3&$><)'$2
M)3C62E3ZNN&E4>I6-J"$TW?KO\"JWX$_%(&)"4I/>2.'_#%-![G>7S0TFY/]
MF/A==_K1WVVEA>]4XFB_594U=E,H=UR"HY# ,%'%K8,8P=@G!'(/!4@@'H>1
MUGF"H0(L[=6]?LB+*OW/>E?U+V-3N/=@KV>^3(GHU%1P-!W[BR)$VY_J4D)O
M&G?)3Y-8*4-QG"S#>D_W%\ZCK@=.?[9TS7:,PX-/N-C>;?CUYDZN1^4 H&U^
M=(?& 8L$I$Z"(/+D^B\)G!#&#%&?!1R%B6Z L'ZO2R.VTZYB*3QHI =*?//
M5H.A.$]YDP%\,3?\G-AJAPU/@_%,@<,6L38)(S;'[&0@L4%3<X42FVO7"28>
M<//XPR#U@;SVP7=5D0M"!20^9A )5_([\0(8!UPP'[EA1'43YI[K9VF,?C2$
MOI;7PMF$+KZ]I&T+M8EI>C; AA_@& C<)0]M: (XZLS&$5CTSVET;[[8V8PC
M&IP[CW'L<EL9"'_%V49(VWM32)):N1'FH8==2!,BR=.-$TBP'T O\*1]+!D4
MN5K[PYK]+8U$]WG,'KIBCDTO]Q+C7@*UC=S$1'HN'=ROT\$X-@O?8#@7D&5/
M#U8+"?2.@F2:(.]E(Q=.@'=4H_X$=\=O&^J6)=6[M*3K7 4:[L-!?!HAAS@(
M^J[@$$ET(8EY AD2PO&#@!/DF7E?C_:S--)]9YP'^A2 NB[4T;!,[BDE%=B+
M"'Z?)#JF!P=KGL[CO<SLT#RKZJ'?\OSE ^N.;[/&O-V4:<;+\BN_:S9>5?HA
M1%V7A-+HBEDH7WY?(!B'D8!!XG'?"X3 H=:R5:NWI5' 5C:C=$YZN.IQ@C6T
M)F8&7:#,JW_K &"KX/?9ON:M\:VC]D%9;ZV;AI%$>U:SK#Z+SX^\P,H.:>/L
M5I0B'D8NAEZ8R,59E'B2+(2 # =A+,VP*'2,[(,S?2V-(-[_H&G)085_\!+D
M&7@L<K:AINDMSX&KQQ.6()N8);;'Q<OZ(/E.4-!*:H\U-."PQ!GG>IJ5,314
M?LT7.K<8NW,:]_KU7<%K*FI]C8DG ASY'$:$*O]-XDN*8 X4KL<C%@5!F+B:
M_INC'2R-%]I=GYV4YJ[;XSCV^FA&HS,Q!4P%C+;7931 ,[E9S($R<:N<1>&D
M'^7X77,Y3L[*W/&4G+]N:!:)K_=\O5;)*G#VO(HX0S2B#L0NC2%B/H:8"LEI
MCBL27RZ/'$\K5N-X\TLCLS:M02TB:&4T30/Q K[S+#8>E,EWZ SP&)#3X9C:
M(W(XO&ANYIP-QU0YS-%P]*JA&?]5DL=FU;.-8 Q9'#/" D@BJ@X7^BY, C>$
MP@D)=RAW'!*;K$^.]+&T5[8CXN"S+\>@U%N-C 1HXM?7$)L!J>]/:F\ML?UA
M#S.GK3^IXF%2^M.7#HX>YT6A,KHVR:)^O/^ARD[P-G!SQ5E$<.*J,W0>@0A[
M,<0!=:%'0R<(0\_!PBA/04]_2WOUM^*"M$G$5N$?RBWQE-8E(-ZT!3@T\SCI
M8JZ[PV$-R<EW.EH0VVQV4E;0"@O>O.V#<$C4MPXP]H*\S_8V=TRWCNI'0KBU
M;C/W7^SS1?E_=KW@4U[Q\MV&>X[OMFM-(GR/LT1 GG"5"(5@&+LD@APC*J1E
MX8:^U@$QK=Z61B^UF/\GJ 4%;,.!$G7 *KX?YGY?AU7PIG9\O$@*]P+%=U.B
MJ.\8L8KF7%X2&Z@:.4ZT43KM1>EO8C:7BK8V7?^*_DT#\^JE&<YHBM<?,VDP
MUH]1O64J:, \I!)0L43RKG P)$Q@2*DO$BH?D, QVHH^T<_2&'<G)MC+.6A#
M^A2N>L:;!;0FIM@A0)GGNCL/@ZVL=B=ZF3=_W7E5#S+5]5QN+\FFRN;R6Y:3
MDA=/*E?PQ^QQ4Y5?N-(K7:?UG"/_VA1%FMV]Q65:7I<EK_Z*TTR%T4F;<;UA
MRG9\CXM,7E*Z*S]P(Q?'(118<8OCQC )@Q@2'H9.C$44F86YS"/VTJCJMZS@
M>)W^IUPXW4FI2_!F+07GI:I(V BO4GZ\:5:F/X'FQR8/$_^/C7*JIGMWP?CT
MGQ,\)YI<N;C1GYIZ=PE'KT!'YR:I5E=KT*@-7NI]!7::@UKU*U K?P64^N"-
M D#5:MH_0UL0IDUB.MV839C]= *A+YXV=;J!T,FW.F'OQOZ)?Y,$6]W?X(*K
MR TEPQ,OGE5)JSPK/<=-/MW^>LW^?=.2:+L*C //X?5>94+D/SZCD#@X@9SP
M*(QCY--$:+HL!@FPM(FJ40(H+9IXI*T>H%7D"BA5@-0%=)0Q7Z$/&ZY>U\?D
M@S#Q?+%P_+6=)I./PTQ^E,G&P\2W,@K,D^Z68:W.Y8$9I7/'*3.N'?/:SS>R
MV7R=LOJY_%CQA[)-K)_X ::N7$@Q)X@@PD2%QA & X0$]Q/$71;HEGX^U<G2
M9I,7<H):4,,B!F<A/3\;V )J<O_W (R,*D'W@3"B$/3)IF>K ]VG7+<,=.^U
M \\);:0!_!\;21_OGSJ!E[%'@\"1IF1M7H91 #&*'>@B@K"/2>PZ6I&]9WM9
MV@N_%Q+44@XL G <43T7PVB<)G[?S2$R/QMT#@);9X*.]C'O6:!S:AZ< 3I[
M\?#,J$UVM/<9>X<KOO+E!,\YPY!RN9)$'%$8"\R@YZ$D"7PGI$3+6WJRAZ6]
M\+MTH8V40(H)E)SF:5-? GG^7;<"S\3ON3$R@W*J'M5^5'+5ERW.GF7UJ$+'
MTJT>O]"VV\ASCJ^#$R_AS'?E>^ZZ$'DN@Q@[,71BSZ$HB$*&J1VWT7$!ED8#
M6LMDSYG<;7%BN,:ZC<8/PA+<1I?#WY;;:/PX+,EM=#@><WB+SF,XU%MTHM6%
M>(O.ZZSO+>IIQWCR^9^__?9+^XJ$(G&XCU6!]$!:CB'CD 2,P2"AB(8^0KYV
MEMM]JTN;)I1DYIS30:F7R(?I/C$[CU9;FS^'J3\3*>K!8$)UA^J>Y*_.I7.1
MTJ%T':8Y\N/8#($WJJCXI[RZX465BI2S)A?62D@L0B<0,/!9J-)4,4@(#6!$
MW"1&Q,&1H^5YUNYQ:;13BPFRO )T*^C0U':G,.XE)OO(34Q:A^GL&ABET& G
M]3;'G6TXA^8*M #KQ;(%#H%W1,; 'JAT<P:>:N9"60-[M#J=-[#OQH%; _2>
ML\V:?Q;75#Y6FS6N.&O3BSP\%OR>9V7ZQ)O#.DJB;RJ,IIMAT U"=8">2MM3
MFH81@[$G[4,/NXP*1)AO5M]EI#Q+(_:M.BIK3D<AL,VGTU%I>V"M"9DSW(X8
M.8J:&Q?SC<W46QQ#AP7\7NLT37%12_C:VC\9*<V\.RUVH#O8D['4[-#CTD7Z
M)&=YU<$V+K_<AB:^??XWSN[JO$_KVA(H[]/'M\^-*+M\<K^HAT[^^/;Y6&-?
MTO*?M<0K'OD1#UT&(QISB!Q/P#A&0GXB7A!'#D>>UL'(^45?&N/OA>V<92E?
MAD,W)&*XY3SCTZ W'2QSC*?>-+,PO ,.F<^-M+7SZK,)/O/1][D'Y/ 4_>P2
M#)O$ZGCZ<A5XF+G"\V! < 21)U<,./0)]%R7(.11QL-D5>457NM-,$VS1N2_
M:WPZ=OBF^F@.P!@>@FIATF-><^4G9L4>C8T)[Z6"ELBH;716HGBIR.N7^-6O
M-G+_[_(].0QCETMC3DJ-E!WG0(*P"U%(6<(X%1$SBNX[WLWRK*]7>>X'9M Z
M :JN8306JLF-&&.41M8"F*SHZ=%.+E@)H+^ Z=FKAU' ]G#:+2^^WN/.\\HB
M)R(N#R5R D.$> 03&A(8A(Z7< =A@;2*+_5UM#0:D/*!4@D(&*ZP89WEDVCJ
MO?TV,)KX_=^*J"+_0"WD)!30AX0E$CC9S:PTT*?L:R+HO7X8%?R25NE=;=9_
MY56UK@W]ZX=\(__]CF4[[(.4O/9@W>*B>EXE@1"A$[G0B;@'$4E"F+@,0^P$
M88RB"(5F%8(,^U\:<=2;7K2[Z47KG,0EJ'*0"R'M-?"(GP=D.3 =&$YYY"7(
M@V'@AQ E 8.8.P$4G"9QS(5(1+1ZX@7)%S T73DF7&74PC:O V=J1 B7HY&R
M)@]%7COO'Y7LTPZ-WCPP(=Q3;ZSO) =[T:] "W\K?8-YLV%R>Q9SXWEC('*6
MIA/3WF>=909"\WKR&=K,T,S.1_U.=08K7P0AQYX+N9_$$+F! [$?RF6JBY$7
M)6X<"*.-AS-]+6VN:3<6=[*"K;"#4H2= UF/L"Q!-S$Y#49M0#;H7CRL984^
MW=/,V:%[53[,$MU_BWDJ5YQAEN+L6TXPI?F+4IEMQ"F/O3#D?@!=ER.(/.Q!
MXL8Q#'SA4X<E7NPQW52NO;TMC3JV$H-6Y)?E6P=D(^W'^SR'6$=Q8A:Y (#Z
MZ5RM CE7.M>1@!IE<M4&Z'0FU_XF9LODJJU--Y.K_DV#4_6G&6=M4NY;.=8J
M%+%(R:;>3WS[_/[A<9T_R^<:,R<B*$90A(%<J+I1 &.'^##R PDZ"W@8&D4
M:O>\-%)N!0=MGG[P*'^]JO\%N-[HN:H]"SM- 'D&O-7%.*>_YN#H;EA, /GD
M>Q@-VJW0X+9&6_W;[K]>@9O7:+_O0WM(^G\SY.P5 M#L=^Z2 &9P'"D.8-B
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MN$FM$6C*<H-*Z33DV- T ^QQCGPOPI!@-X HH"$D44 @QX1RJ9@;Z66,7]H
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MFI<[?@!1XF*8.#Z%C/HN#7RY!D;C3O7UBK T(C]]IB_;Y;\J:V4 ;[4!(B_
M-I$%>(,?'XO\1_J *[Y^_@F\2;/V!LT8PA'#V6]J3S](4QOA)T^4[?.3-7J
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M,^SQ9H8]4<D,BE+HJZIHF6MU@"[<[>C!*YH#D\5QJL):7/"M!O+?6X'L40[
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ME44J34*84*8WAUF"(,XD@@I)%BHIDQA9'9&^:75J\]MLQ$W$*Z=S\+>25^N
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MLEM"^R@_\/3IU-MY"3Q4TM,RMVMVU*7L4)G#Y>KH[WV6I)M9@E0BPQ!!Q'
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MEC$IL0P)5 %/]53!F=[580JU645%3,(TQE;&U>GFIS9S#NH-@C^-D+93Z#2
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MXY46V)'[JK1 Y\?GZF!?!5\S+;WOEU?+:J6V*)F+:A;C5-GI>0 S%NNZ'(3
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M *$#38H6"K!66(!*@Z%S]EHT!JV/Y_YQ]?K+)OO)#*W:G5$-;UL-H$8 M!"
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ML2D-HR#35'KJI&X*A+?,SB/3C)RT>9K9_7S,GN===)/[68CB3&WS!"8Y5J9
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MO*QJ9Y^&XG@U["/OC5;?^C3=W8K5/4^ZJ40Z[.]ZH52L^BOX7"S$]4H\5;.
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M:W*3">QF![UG, ?>Q!MJ04NNOX/; @=/I[7)C*,>T180O#V7;5YU.8PO9UE
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M<([P;"$>R$KP>QM'=<_$1OLF;_;-WO3#[:&?-+D_*T- WTXO0-,$&)9BK@D
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M%U',82;C *(XH#!/10031J* 4BZ0L.J6<WJZJ0F(;^*AOICM4-OT0734('K
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M)*%9)#C.\LBR$I8#%3:;9IP"$3="MUFH&;%V(=DO@JF#:5!@!W<_U=0#O8O
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M\XRKDU>=&G;7.A^$7.HC@^E,UD(6K*:F_?$]^3&34H:!2'/=5%R)=<13J+1
M!#,6R)0'/,6Q4=<P'\1,3>"WUS&O>F#L79(#6I.OVPB_9LOAXL9U$2VN>$98
MFE$N@PYV)MG<E+=+LL?.]C>*(\_71V?BZO.BR964\:^DS@3MX.75N6,Z5I>K
MZ]W6]0)NY7U99V:^U$7L/A<+4:=BS1))LY@0!'&8*E&;YAFD,<]AP$0>1RB-
M$TZL*LWUSSDUB=J0?-'6N= ];EJRVQ9H?VC*F]Q 2V/<9 ',Q*1G6(?VD_I
MU+X,G3E&ODK2&<PX;GDZ<PCV2M59O&K?_N338J5&O^1<?695^Q\];C@C.,0H
M%0%,$J1O:)3"E[,P@FFJ0R)1++!90,W)628G<FI"04OBQ>8OH-X7MPN+)BC'
M@3TM6+S!-?B5BR-25JU0>I%PZH5R?-31FJ'T,M;MAM+_L&,[E&^Z%$2=8/1[
ML7I<ZN(/A!?SEX]";;:G8J$#^+9U)#;1W3=+_1M]A:RK[Q:KE1 ?"V70J%6L
M/HJJ>%CHQ,0/+TTE?R%^>U86K?9%7BW53\I*^U#2,$XPE2',2)Y")'$*<1)G
M, O3,$\C'J6(6S58>2].)B? FA87U1:.N@.LPD.9G#4@@'<0 5(7L?G>%+'9
MI2\MMKAH>[8!!O -,FJ$#32 OK1M8=0#:X5.6Q28;?&Q;%CR;A]D_Y7XO\UG
M-HH."79(@!8*T&(!NF" ;IFD7<K/#A*PQ01L00$[5,"'%[#!!6A@VH;)5_]V
M7YAEDYU_AR]MW+8]T__B[)L"O?<J][09>C?RQFU<]-ZKL-<*Z=T)<O-KW95+
M)@2O?E$0MW<6U2_+LO:T_:)H6S!=+Y.MBN\U;S.9)40*+F$:99$NA8YACD0(
M4<(IY8&,J9D6Z#C_U'2WFDZ'^N>VL)MYM@8$<V -94,YT%L=_+0A7K?@^;EM
M5;YE .PX\.?P<H3.D_/+=O91'6&.T+QUBKD.XR;7=,1T2=A*"^.K=;5:/HER
M4YSC99;)((]I'D)&=>99GC-(@E! (>,<DR3*:6+4+-1HMJG)K(]"BE*7/"W%
M=[%8&SK(S( UDU/>X!I8*FWHK URL*'T FQI]2=_C"#Q)&U.SS6J;#%B^ZTD
M,7O)46XT3OO:6?]Q^42*Q2R)=*\\+*$,T@0BC@G$"2%0B#!B68[BE%DUD-J?
M8FH28GO7U%XQ-51:7M@=0-)0.IR%S] BP1(:>T%PE'M?NW]_@G&W_%$&]_;Y
M\2?=-K<Z^8J%LJ?$0OUE=:<65E?F8\K$^BI6ZW)QN] _:[)C9RSBNE*6@"PC
MJ;)TU-_R- E@+L,0*V5!)B&:+9K6#68;WV9ZHT\^;S[Y+A$#NG1:6I7:H(G5
M!=.?U0-.6>Q6"V$F-;R#.XX\:<D&+=U $WD!ME@WM&^Z92K(]>_;1'E_,L<%
M.T_2R&KJ4>64"RAO)9C3&*ZR;5.NZ7I1K<K:R5O5C4[XPRO#ZF-1L?E2%Y:_
MI%6M1\VBD!#"E1$42X$ABB6'!#$&4Q%3EHN(9+&5.70&+5-3A3I%S3J\M"U]
M:FXZ[@BPXP?\L>'(4FTZ9QU-)>4HJS.XX!QN81P$Z-F0>I.G[I2,+%[/AFQ?
MVIX_Y#G1H5_$ZG')&U]]/??=<EZPEQFA*4>A[D"<Y%*+5P1QJL2KR"C'2%F/
M06+E,S\YV]0$:'L3V% +.N2ZA'\>0]A,\'G#;9SK^GW(P!\-K>!>_%B!#VH[
M_>D]YK,''J_1GL?F>H<XSQZV#T=X]KWDZ((J!2]6OQ!6^[/J=&,9!U*9G1G,
M TDARFFJS- <02)SR>(\XP)C*Q?4WA13$QL-A6!#HE/^]@$@#3U09\$SM ?*
M#AE[!]11YGTYH/8G&-<!=93!/0?4\2?=MK:R^HJRSA+4=M^]&J3^*AF6*<.4
M0)S''"*IO4P!BB!.<(2"D.;2KA#BX6FFML5W5#9>#4VGTSX_@JK97C\?JX'W
MNPM,UIO^- J>-OZ124;=_*<9?2L >IYV/-])]:C_7^L0W\E<ZPU?E0)1%MHO
MI'^A3);7/^@\N;7UI8RS5&8!#.(D@B@2"-*$!C#!04#".&$1LU,)?% U-1&C
MR;P 3/T)Q([:VDE0;GFI?_^?EJJ%ES4TU$;&7IFA%9AZ4?2?H$.H+D^U79'F
M$;U,;W[8?6,03XY7L'TI3%YH&E?'\@GCGEKF=?!S/#[;G4RS.*8!Y3"BNM]6
M3B3,0RXAX5A2' @>2BL/^NOAIR966P>%JXO[#78VSIL)BC-S,!P],@-)E3>#
MOX//I6^?'WG*-6/VGORXYDH$;(L#-%'8,Q$D6/"8P2"13&E2$8.Y#O=! 18I
MY9%:]LPN:_;(3)/;QDT^J*(6O":WS<&PS9P]!O#I#>X5MJ'WNBMB#AFT/6B<
MD45[;.21,VE[&-S/INU[P:']\:9ZB Y*;L1-QYL["V)"4EWBF/&$0T1I!"E1
MIWI,LS"B0<A9P#8A0/>&S8]/SN@0]7,_@J#XJ2'[9]"41&J"]$5S[A6V-SH&
MN(?*FLWB3,*,9@(BS&.84R1A*J,LYW&0RS3>XM[?Q'08W$?H:3HV[J<%M2<8
MQVHTW2D8U0#7*FK65Y &P%ETE?8&X&C-I,\!TJZ%M!$V)SI'GWY_O(;11GR\
MZA-M]H9CR8AMO#PI2[)8M370LP"G-& $QI&^=,@C"DFD[R!8&&5(8$1CXW+^
MQZ>9G,[;?+L;6B] 2ZU#I?D3V&(IDYSE*4P9C2&2H82$LASR0!U>D5"G&L]G
MWT5)E^.AVYUNR-O)Y6)9#8-J[_'D":EQ' 8#?X*6M0O.!FW<P@(.X-EG^I_$
MI"<-__"[X^;(GZ1_+X']]--V1T^U>BYGOU_/<,K3C*$8$AZD$$6401H%"11,
MHA!G69)RH\BW=KRI'2:_%Y5:BZI86&[=#3RG!9H#TP-+KM^OOUW=WGR[OCE_
MD[UA[H0W0S_9N#/TWW;^C,T(H^RI-^1N-L_;'Y_;0D_7-A6+2F/VTC9YNOR+
MJ*%X739B)F2F-#9*81RD!*(@8A"3)(<T()&(912%Q"@5T7KFJ>V\+KG;IGJD
M(=BUZ5L?^+WJQW"0#KRO]]N]O<)WT_:MI?ZBJ=0S%,RN#?8\POUN7?;.@?V,
M7GN&T)DVW.L;[IVZ[AER>;SUGND UJ? ;]\^?A1M!3_!;Y8K4<4H#^Z$^M 6
MJX]KH0%O]7K*,\)"%D&4('4$9'D$\TP9\$S$N60!HH)3PR/ 8MJIR7]%.NC0
M#FKB+T#\'XI^T#)P 10+0/-@;UG9K$CON3 0S@,?"E."V/A,& CJD0X$.\B]
MG 0.@!T]!FS&&NL,<."O<P"XO'VV#3 GQ5/U4;!"'2R_+23YOBQU\;A-M$)*
MXC3ARH:."(8(RQ3F2O1#&9(TB# )A5FLN.W$4SL!;K:E;]<[4C=]M2WZ<UF!
M;VT">(-T? N@)AVTM(,.\1=6X2'6&#OK_]ZP?C_UWQWS<[1_(^",E?_3H[V7
M[F_$XPG5W^Q]UZR@N@Z;OOL[5-IJ&RA),L(CC#%,(IU'C)7J3^,L47]34C]@
M$4HBJ[:NAO-.3?*W9#=WT8=+M#F'IIHNQ>F#8$" !SX'/&'KD']DA92WA"2S
M64?.4+*"8C]ER>YU:W7U"_E1/*V?/BP7_)=E>3F?ZWJ2"TYT'$R4X)3&#$$6
MZ'MOA!'$B$J8\DRR$..88*,.6*>GF9I :DD%5-&J*]8",I\#OB776$\ZA6RO
MYND)KX'ERP8J3290= )%*/CH%RIC!=(39".IBZ[0V6B&!H@<U0-/O3N6UF=
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M2C3-,,M3 3GC"41$A#"/L80X83S/2"IEF-KL_@-S3&WG-R3J2\>62*=Z58?
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M]V=4;'P[XLB5&H\PM%^A\=B#'G*BJJH1&I_)7]6Z6,TR'+$X2SF,J<Z#(DD
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M!!PBK!TBHTC   DN&9,\IE;,P1=[FENLV:P3&RI'G^O9W9 Z+NK[ #6R:W+
MR'])W:7_T&OCHWY^SB*W2]W.U6KG"WZNX ]:YF:E:XK%U#_7C'(DJ2 0,U.C
M#$41I"B+8""5HA$CB$@KGN&N#N9F^!OYFC)0/J9_!*&=Q?<!9F1#=\+$V=2[
M%!_(PH^:G]2PNY0[M.?.YWHP"NZPC?VNI6V9[VA 640P@P$69F434DA)E$$A
M@U1_'V:*.%T(Z>YJ;J;=D.0MWT3U8!0\C:F=A0^#U,BVWH"TQR#X)N? )()G
ML1B20/!T1].3!YY5^"1QX/DWW.L*Z)::$ND?*RW^?V_ETZK*UPN>8AGB-((B
M,41-%'&82<(A8TE  T)Q;)U3[NAB;L[@WJ3MS<D*+9TI&ZE6):!/3Y(NS?;?
MWVWZR=)%G$'V8B)Y +Q&=@EO$H)&1-#*V!L<^\H _4&:JAZ ,UA.)0#.X]!-
M_-_QWF1T_^?EWB7YO_"D7SSTN>"K1VDHISYIL9K3.;_)]7=3-O-%-KQXU2(*
M$Q2F&,,X%4RO=50""2$!U-_)(&-Q1JG:L&78!4=6_5K]BO?I,D9VCN\:N=^#
MI99<5L",)<C?) ;/A<8>R.9LVF.MD'&;)H7_7'-WN856=L/#591@FA*8$E/&
M2J0AU!\P#&FH%"=Z])CP(#,9:XRFH#0Y.5#ML.R,UQBC81?S#@?N-'-=(R]X
M9R1^W\#9GL!LI :?+5!UCH:=4!HH,+;K<](8V0F&PW#9[>4A6$]?:U9ONKRC
MKXU)A%0F(1$I%)&H:0532%B0P(AGA#$F5))@#P=UOM>9>J:->'U838\ MO,Y
M ^#UD]A+6U&OP$7T>C*8=H$R"FOI46<_D:FT2_'S[*2=;_FYD4TS#ZMKKOU4
M*>_*U9,LUZ]W^N>QOBZ$\5Y/YI&%HBRFVG- *J(,(D61(6A 4 4)3M,,*4*Y
MATNQEV"F[N4#?<K7>JU>,[B)W/#&.KH:AT&P<SL#8SJ-"]H(#=8KT(H--G)K
M-V0DOZH//6V%'\XEN0,VD'MRZ'A25^4.R*';\FC!\\H<_R[%\U)^41]I:>Y
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M;K[:\;J>C-QV=/1VF7#'[ZPKWMC]J?U'?_KUE\TW^A]&*_GK+_\'4$L#!!0
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M,.A!6&GKR2Q5&# )U$5-6/,H_C@I]Y MO)&'N)'U-@3K'),!A[HVZPCKM&D
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M"JPNMD[U^I>K,'M7+KYQE:"XB"WK45ZKE1?S^EH\)14#*P6T,R0%4>N22T)
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M6BG<\.PCA)(<.;'!U([]#+3#4G0RR3=/:N]!7F^/L9X/?PW4U:GOMJYOK^7
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M$!C:\RGU85KJ\ZKI:4MP?''W 6L\BXU[E@+O7?'JE-'!*@L%<QU!&^I[?*?
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M;2&C74/A&^U T2II+8,D"L7)'!&\KF\O*"Q/-F"RLG4V8PL9X[KVQVK\X9;
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MA_%*MA#S8@I[GM'=.%9G?PB4_OWS8KX.@E\O2!W+U;K).?'*D"2O6+TE,<5
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M"5 2ID \9!O5D^?H"VCDM)=RMC9RVD=28V=2MZ0$B7QG932 HL[49-Y!]"Z
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M0K-W-@25D_0'W5#N4?F=02=6^C$J6[207P?NR&'WKNBY$DX(B@*,)[,7%(3
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M]*T/M6<":?/.PM\M2+;S"YH%??'S58.N,Q(@N<"A0.+5-2E:@U-T))5@&,J
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MC[><Y"U&QQT#;X.D.$,E0%X8:&=35I8Y&>3>8Z7G6\Y!"MIWRSE$6EWEVV\
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MZ*$#C_RI=T]R]>BT904*V6UR_U(A\QM),IB==LP;:=LW,ST^J^"Y*5 &:?G
MK((A(N\3.=N'3QU<MLHF8)EQ4%@9:I,WM1-7HA/,2%Y:YTV^L*R"0:H^.*M@
MB-S[ ]!5\6R2LIA0PPN50*5$;B0/'H01TD?-G(^M$[M?5%;!("4?E%4P1.)=
M<3"MMY((7F87!) Y1E!>RDU9&R-S[#!KSM.$U%S/S9AQS+G40+!=P>+69BE&
M,:N]!YXKS[ RK/8^DJ"M%CP;^M]A!"L_ S77('T>0LTU1+A39UZGV?=9NL3S
M3U\7_Z M\^J*6.HVJU"VI;!:7^>3( %E9L%GRT"RHE3R0@:UGU3WH*%ZP<6Q
MRER,*-F)^;K^_+1="-Y>R&_GL\]?+EY=U.L,G%_7'BB=Z>QE!M89HBI$0>O2
M")YY0:<F*_F EIR#AIRL:>((BEX\@]2G1=/54I;Y]6)U\3''Q?>\_/$J5GVM
MKHOQ8RC<T$X+C$YL%>L])TH0CIPO7EP*=G^QQP$#=<@*=Z3-:2W5B2W.=_RV
M6#XH3E&NN$A*IM/:&5#<$+Y+<*!B-DPJ&Z2+^TW+H]^>YE%S#"0TD-VTRG]_
M\24OR7.O9)?;0J7;YA2]2C(*#TE'2;&>M^!2U*!S\JX$&TW8?[[L'F.:YZ0Q
MP-!0EET3R1;G='0T\\(]KS&[AI!=!'0VH39!V/LQS3A$LLWKU\< 14-9=G!C
M]BBUE)8RYA@\S5S3&ACG$*PIX&W2Q2)#CLWS_UX*4]LIU_0G"[M#P%QM)IH]
M.AG) I9,'C0&\%[0>DK0@M;!Y'T2E?\]3&V#-'P84]L0<7< FJ=HPW2,GBE6
M(++:(DQ1A!>"%&!8<(S[Z MO7>_WDIC:!FGY0*:V(2*?F*UILX*;:X*W^,_5
MY>PZ:"])HT 1(&,E0*R$#2&%!,:PB!3#.^'V7Z[M&63B&_EVL&@LSRZ0<37_
MWV;G.?WR8]U+Z_WR+?W-\[_4 'Z^SMFXXJTJLFCM:G_ -36#9( 8%8BDI.?,
M<R/V7XH<,?#$3LP8"!I-[A._^:P74N?^E[SXO,1O7V:THO4);C#K$#-)293:
M%I>$YB.+D(H4R17I3&SQZ//D!#K+T#SM8;"-F*?&2OY\?PG;O:6$0_0%P2A'
M!VQ0 LBH<M!)UC16SZ,YR*?9AY6G)C#=2U CQ2Y:2WE*J%Q\6Y[]_O8LH3.)
M:P-D=OWFK@&+4"0/*8NSF8* 7;EO5_RB]7,;4-2?;@%B,\R$JF^CJ,7Q4IM:
MR>_^. NQ2!ZS >;LNF&G!F0\0^:<D\_-H[[_VCM<R>_^F.[5900E#Y3:U$K^
MX]59RBZ7( 2(@@*48P@.?82HC?6)(P7V)ROYCU?3/:B,H.2!4CM:R>1ZAD4+
M-?_V]LR)*)VR%N*Z+LES259'TXEEN!)6<6[TKIS!@]3\VV$&>Y2GDA'4/%!J
M'5Q+#6$@M2X(F0P4'VL:0BT@JUV@M9:*H5#9\G&)6U\<.?!)%^7C**8[R-UC
MIPS>FY@E2*4E24QJH!B=UF.\,SEPDV5SFIB?@1QX" *&D ,/4$?/Y,#6BB),
M JLI %/920@F>Q*/SR2>FN&TOR_D"R4''J+!0\F!!XBS.WMSI[H656UM&1F8
MP$IM_I KF2 %6YDB*Q,H8-=N["/M[2#"O.<F>FUZA!TG^.X@]..J1/<<9U]7
M[RXW]1Y:R<AD!NXC"<JD *@UIU\=%MHM7MXG(&]]<CTRJY[LTO'ZWWU@G:J,
M26.M:FKO6>_U"NB(KW;W+,NBBHNUJ91-H.JCI5,N0O"L.&W0DL7=?W+M&*&S
M>IO3$-)2FIW!@N"]6FVR<;=O3V?")AZS)VB;:&@UOI[JIC(I)Y_1H1#)#L7&
MPV$ZRT!J#9 3Y3JQT_LXV'^?(RWH>]Z GAF7DO 6"AH.J@8(Z[ZI)I2@;9!6
MI/V9C8>,U-D+W5BFY'CI]@V6!QMA=59$R$DILI>QWH,I"C!#%@(,1A$3R^R0
M3.GAXW9VES,ZD$Z4?'_^\1,T5"45IKRT@,*05^8+HU@T<] L.Q<PH&,C7^Z<
M0!#V?('7*%YR Y5TB[-K=CURX"@<90)L\)7C& 4XFQR=W!0!9$3K2H=,A\_'
M@3\FLHY20N\4AS>4H-8&C"PH, YKVXGH@999(,AD.4].</8\Y(;#"%K=SX&M
MH]3P OCKWE.P^'V6_[DHK];_&<[38OGAC[]]>K4ML=F67-U<Q[XC\XW5:VA#
M<M=@ JV9\%K+9!*Z/*^%\R8KX)I<-\6$ :=- *NCUUG**)IW\>F!+J]ZK2Z4
M!)E+!8H'3:%S"!"$S<&YB,XV+X%Y\71Y0[!R(%W>$#UTX-8]1>A5DN-*"P76
MUUZ%@E: )!"()1OIN$3=_$[])='E#=+R@71Y0T3>)W*V#Y\<A8[%*XJ;ZUVO
MK_09+"I [D4LPBLI1NZC-C5C45-5'TR7-T3N_0%H^\+-2LC.5I]5KRO$ H)S
M*8$3QJFDM6-B9)[.'O(*&BGY(+J\(1*?$#8IS\[>4NQY_BM9XXM-\HV-T=M0
M-*10.RMQ%RK3'\E&T;X*Z%ERA^1)TJ<W.*$?;N#QR("=/=D=?Q:=*LR)<;"9
M]54YF4LRB5K>H5,M<-:<@EZ120@I6,N%=GQ7O^#](+@]VC1FX61U+1K(;N*J
M2Y+,[-L?B^5RMJ* =&N[C#699P*[$17[D=/4T2@H@7,1.$-^/]A[K*[RL4]/
MI^CC%;1H**VNM(WSM+F1^,MR<?GMJK;3,D-N5&WC(CVH(A!02@ZLD%!"*/P!
MZ<-^W3\VT#1&?R0DG"S)KIA1UX80&4=;B\:9T R4$Q9\%!*04!XQ(@OVH'Z$
MXQ#F/C=#S#'>0 /!=@6+6^ZRY $ETJ1S(K]6)<X!!2_@"P9RF"6RPYI5_@R$
MN8/T>0AA[A#A]D]<R50Q9/4D!56&K* H)!E:") C)5Q(27,A]YXGK8@KGY<L
M=Y BAQ%7#I'JM!AYP -[DQQRS=0:<B[<(GA;W]=D+0E&9DEBF-%P887?[V[N
M'Z=#:M,C$=)8IA,SF\X_G^</RP6=MS]N,S$Z&02+Y#X9)ZI=K9V]N'+ N>$Y
M*1^RWY_F]\3'.^0V/1(*+:0WK?[?+>9/+B+PI"PCESR)RLN:&+@@-9C"(L7B
M2=NX/UWOZ>]W2&IZ) H:R? ET.^G((2/3$)PZS8DHA+OA75N,VKF$;G97_K6
MCG[_>>E-CX1'>\EV28;-# K,44$NIEZYLTHMP@443D&^T1)EXOM/C./)L)MG
M5(YR8)PNNZEIFIZD),HZ)9M] 8O"D$A";7HD#?TJ,7'G6%8']73\J2B]CKVZ
M:"/FJ;'R)"4&3\EXHQ4XG<E!YE9!0#2051 :@Q&V',2'_#-1>@U2[$&47D.D
M/"%4XN)R?K'\<?;ZU5G(11NO+4CA!"CK$8(F:1B)Y$AI7>C/#WCWVGYQ XWM
M+S?(N!FO1WJO04I;G"3!J<F?7OW'&8\R&:D\* J0:Z1LR#32B1J291AE82+N
M2H0^B!7HU7_TR/!UC)Z/D=K42B9,DA53AL<,V=L,2K-",R5T9IN,38$9+G>1
M?1ZDY ,W\S,S?!VMY(%2FUS)?YYQ1&FSY>"5J(1DKE8!H82$6$S47FJUZU7B
M,"7_V2._U_%*'B:UJ97\V]LSDPU%)^3$%D<QBN*,/-E:,*$B(RD$$YG=Y>.W
M)'$;)?8?0<D#I3:UDM^^.K/%<2YEAI@1J^%AX*UF-'M-QTZPOJA=SOE!2GY[
MF+D>):@?0<D#I3:UDO]X=>9DHJ59<@R=#^1'9 _>, ^H'4KN:S/ 7?1[+5DW
MFU<LCJ3D@5*;GG7SCT]GUD;GA=?@LI!D<'P$FJBC7ZV@ $$*<AM/5O.G:8H'
MQU+S,*E-OI??GV41<M"ZOBW4F,^3_X"<P@%-X5_(,MK$3E?R^X.4[%^*DH=)
M;6HEO_OKF=3>65,#>Q_J=),"[UF$S%!I*4K4XF37Z]U?#[L182]$RP/%-KF6
M_[U6))-[&".4(C6H3*M$I2)4=O94$J943F9)?O?OAVGY!5Q\'2.VR;7\7V=%
M46RGO "F*N5EC!3U>8Z5)\.J(H.0X9#T_MU:_J_#M/Q2KKT&BFUJ+;__ZQE7
M20MG ]!$*W>WRA!4-,"RT%S8G+@]Y#)[IY;?'VBQ7\J]UT"Q3:WE#Z_.6,&"
M-GBPQM%2,Z>E>L)H(K="2=1*'E2JLU/+'PY\J7@I%U\#Q3:UEC_^?B9L,$%*
M 2*&6J*8$'SF#!A3$;,RCN/)>_GC[X=I^:7<? T4V]1:_O/=F34LIR0=2)XY
MA?>)@X\R03'<L41NI-&[""<.TO*?[P[3\DNY^AHHMJFU_/?_/&,R.&^% 4W_
M!*4)F=Z(ZCLR5A0+4LN3WQS__I^':?FEW'T-%%L'I?@[**6\*5HH'R 811X&
MR@@AIDJUF7+QUCG&1N>5>3N(I_VY6XV<P@722/#=0>A1:G#)/'DMR8,/(M0-
M9<E9S1%<-,YE);*^7SWQOYFG?9#^A_.T#U%&9X3<FQ4L-LSBG_)%62S_7,[P
M_,PHF744"G0M9E4^NMH=(P!*@8))G>F'NP [E#3WX6"=44&<AIN19-P5Z_(&
M_6]RG*6<SH3,1?(B@(#/Z@$M:]6)!4L^F##,&&_U4*C<&:&SXN#6^#A>FOV"
MXC?\OEC6(WUK(H/QBH(OI(/=:J ?:]YZ04 72(*\*'G_?GD@1NX-V%E2]JB0
M.476_2+H;_-R;UW2DCUTD8(\ES,HI0TXGBG<DX5IS@SMF\$M '8/V9F//"J*
M3I-WASCZF%>+\^\Y;5=C$TVY. 0C%=E50T&&DQ@@4?S)38J9L2-/J;L#=4O#
MWA(S)\BV*Z3\9UZF6;SXF+_7CU\MQX7 /6,6=&7\5L5G0,,*9&L$2BS,NS@4
M*H^.U"VQ>ANLG"[=%T!^?:\*]Z;&K@VU]=[/MR:N'K:>26BI+0IO,53VB_I2
M9Y0"GPH#FZ,4WC'DY2 BFA=&2YV9-8EK!LG4[#"9:5.RE$!Q[\C(1A5D;+SL
MET]+/00K!])2#]%#5UQ.ZW(_'UC@M&,AKIF+<G$0;*8X@?ZF\R&E''85Q8Q,
M\?7<Y-.#=+F;XFN(8+N"Q:WR\F2,2\$I.I:K(Z<L[9O$!* D/Z!28FIQT O%
MST#Q-4B?AU!\#1%N5^PLC_%'?%C.:!M]RULF 6&TYTI8R.L']QPU.8R! :U4
MH$]2![>_P^?@87O!R[%*?I++I;'$>T03WE[;7Y8YSZ]6%DW(F5$,J:SCH(+1
MX)!^LB;;6%1(@OLCL?3DH!W2A#5%4AMI=X^CM[C$K[.KI6F;DS-DMU%AI/6Q
M!,'13[E(:X4V'OE^UJ"AHW;(,C8>DHZ7=V?L]SF:4J\?@*4L2$Y)@BL9P44A
M=$!AXOT.U3\A^_TQSO"IPNR*_5Z1S=-,4:PH'2A7VY5*3?90\.2X](;'0Y(M
M7QK[_2!U/<E^/T!V7?&A7]DN3SY]< E$DH1]5TDTF?5@?<XHN2S)#&9 [XO]
M?HB"]K'?#Y%6=PE5=VZZI<Q:"!O!^$3@#[7:,HH"GFN?B\_!Z7&;K0[.R7MN
M%O1C3H7&@N_JS>CUXNNW/%_5__['&_R*G_/JU3^1=),VS8B=R)$Y%BJ?EB9S
MZDA>@2$4$8WD3#"\SR5UP$/C[C$[NUH[4LE/OSDVE'A74/IP.9^M.WX^LJBH
M(]I@(FA;G?;Z#A_J!BQ.\L!-8-H-AM&.\3IS2%M#J)6DNSO,'MT0VO',.-)>
MX"AJ6:H'QXH!ZVA;Z$36O(R<'7PLPJ;(XCL&82,IHS]X/>A=K7@N]6X(<JB$
MP8$LKDM6U8))H06M2:0>6XA/D>O7$%@GJ>$%9%&L+YIN=31X-4^W[Y[6^=(?
M\^J2<-(FK^*( 5MG6IRZYDER+Z3S41M48$NI?<]"KG>)]*LMDFG4@MO620A=
MY%YHC*A*@!PMK\R7 3QYFT!_J)(+M+?5N%;O)>9>#,'*H;D7 _30P6'Z5--B
M8[C),DE(A0X%E9T 7U,G=8RE!.FL30=QEO^D+<$':?G EN!#1-XG<K87>5DI
M)@(BQ;@:*=KE$ISU >JCKZ?MY5"W-D4OK"7X(%4?W!)\B-S[ ]#VXC9C#%))
M"6A]KFU+:6=%K!0)3%EKF./I( +\G[4E^" E']02?(C$NTH+6V^E(D2FV")!
M9,*2/#"0/&(M5LR592%%X7<]B8V<+?CL#Z1'G$L-!-L5+&YM%D,&U0BT8!QY
M=4KG1&L(%-^:E'EBP3+<Q>7Z4V4+#M+G(=F"0X0[<6.FIYJ0>9Y+\ JB%F3O
MI"L06*GI10)CU-9Y=>]IK7$OO^?-_!NDL -Z^0V07F?Z7_>:V2X#H]+).P4I
M)I**E080-:TJF%"<,LGP_86_NT:8!@FM%+<#!\=*L3,P_)9) WA^E;5:K(P:
M,QB>0DT1RW2"9@^6>2^,$T7X(VS"G3&F\1R> 1#'2[(S2'S(N%PMYF]>+[[D
M^>O%^3DN7W_!>-V6#D5R,C@)47H-RA@%KL@$G*N4>'"!A?W)Y$-'[3 #N-6)
MTE+>G4'I8Y[533%/O^#\'U<;3@:6?5T%B\5N&<.*RN"X4]+[&)P_ C^/#=5A
MLF\KT)PLV<Z0\O=<DY>7%S5_&>=Q$?]QU0&5G'-$D8%07K.C*U-WH-5%IF..
M/"8>]U=['SQ<A^V'6R&FB80[0\V'M;6<7=WE,$X+*609US<XF!&0?@292F!)
MY)P.2.W:/4:'_8>;'4-'R[(S4/SEG'Y>?IS-+Q:7YX3V-Y>SSW/\>M54U\:2
M<B"@IQQK4UV$P+F'(F4*0C-+#OMPD.P<L\-&Q:U TT[6G8'HMV7.7W%^?; &
M;FO[@)H/!$H8.E.3DF -[1&F.)8#2I5VCS%=3Z3107*\+#L#Q7_@-P+YJWGZ
MM/CZE4;8KLC0&GA=D65!@BK&4ZP7%"26-#GO-04H#$?'XX--UU-I=)@TD&YG
M96LNJ"PR%D#+ R@OZTMG*<"U$CZ[Z/+./()QRM:>O4#AB%>94X794]E:*-)F
M,GJ@%89Z"-:RR^*!SL:0).T1[0_IF_C2RM8&J>NILK4ALNNQ;$T:I A*B+IJ
M1UYT88 N>5J$+CG0T@K?'[SV7+8V2$'[RM:&2*N#%(X=J<7):\5M('-'>X#.
MK"H67DNZ@RJZ..DS5SOV_ 1E:\^7@'UZ#EDCP;^86J/B6,[.K]L_(WG,M25A
ML)+V7+8<I>(A\;U6I'&MT13E:H.4>U2MT1!)]P6?O)PM4EDLW^28EQ>S,LMI
MG;N^,:VKB\5OL_/\^SS-OL_2)9YO4MI7KSZ3$5]=O*'ISQ/.+^C8=JZF/=7N
M:8H,NM2*)"#($!?:IVOB8C>8A[75Y#I+.FH.S"ETV-TY^F@+!Z.2*$Q[T%A3
M1KWS%&)F!MG8&*.H-P>[6ME.V$]CBHJY8^ XDC(F[:?QQ)HVRWA?/M"BZ ]+
M69UEQT,6$L'8LGYBS>"9TR!1:)8Q<^%'QM?#277FMHT"KQ-5T=41?*]/1/'!
MVR)!>%$HEJGF-VE:AHHIQQB*8:=U5.B6_+[-87B\-/L%Q4,.?\,S8O(4]CB;
M0-7L,>=C3>T0WD1+\1$O)Z'DN)X)4_#?CP";T^3=%8YN+65+V[[:'LU7].UG
M10II@^!@)%I0P6=P#$F4$E-&S5#ZP;3X^X?MEB._#9X:R[TK3.WL4F,5\Z58
M#26+2HM ,81G*8!+W/DB//,') :W[@C4_%UK&KMTBJR[0M#C'22D4ZK&"%#[
M^(+2PD/0%!\4XR+%#<EXNS^)N%E_#O]B,7.Z=+L"R_^7EXOMG=N5*3U+F(2,
M9#;IZ)442G(ZCYVHN0 VN2("4VFP__/(.(?=:+(7BY131=O?)=!CE[,IAIP+
M!852U+<F'AR@H],V6!>C*=%%?U!KA.>G3>(OY;9\)&UT;H?^6*3U9>N9+%+Z
M$"U(%DTEA"HUDZ6V0N),:61*\L$/+4\/=QAT7NY]=B-!OQ1ZI-NI3+?)@;;Q
M JX)6>+Y)>V@AAQ)1XPZ"E'2J:N?A"W)ERATL0Q\K@S[#A&\B QT#D6&I"SJ
MGY$M*2CTP@A3NZ;(S1[WL3:H4-E'<BXI%!F7?_ ELB4-P<J!;$E#]- 5R<"&
MQD6%F(HD@8BZA%3(AJ> 4!3GG*(0EN]GO?[,G:H&Z7(W]\00P78%BULYP5$F
M99S64!QZ4*I0E.JS 2UL[49:^17;$Y-TRCTQ2)^'<$\,$>ZD#["/ULW'+WEY
M\3]Y>55HY'A X1@8%@4H*SPX(VLP(;A%)Y448J_/O6^47O!PK!)W\1"<(,_.
MRBO>SKY]VZZB6$GGJHV0.#)0VBD(V03(-KB0@M(4)0Q'Q<T '9:3MP+$D5+L
M# M_H9G,<+L.7X*K^7>@1.:UPY^CP]5P<#X)KH(GQ>]O.;9SB XKQ5OAX6A)
M=H:(36GA51599%%+IN@H=4[4\@('P20/W-8<3<E*#OOS%'>/T6$M>"M,'"_+
MSD#Q1WR-YU><*SE9YAC7$+FOO?)JIP"6$8+UPE<6'A1V."9N#]%A^7<K2!PM
MR<X0\=?%^?GLIMHT626#3!RT8B2>H 5XO^:!4XQY[[F^WXS\$$S<':3#^NY6
MJ#A!FIWAXO473/_,UPCG)LA2= ">928!:4NN$:?3, OFC8K:\B/"CKN#=%C2
MW0H7)TBS,UQLJH[_B&^1SL0O]#>V2PHH93$V@Y9AG92!X'DAJ/M2')-9!'L$
M2]$3HW58U=T**2WDVQED/O[;F\7EYW.\JE!'JUB6H<#_7]Z7-L>9&VE^WU^Q
ML=]S%O<1L;$1LOJPQMUJ34OM&7^J2%RM6E,L#0^U]>\W420EBBQ6O0>*+\BV
M(V@><@'(? !D)C*?S(Y94$P1^A6/M!FRMMJR(.0$2I$[HRR3[/(H$)DCS\Z@
M\7*S^?@E%&.<-#J5"$QR4VDA=<WKBN"%],JEXD).$^Z86T,LE-CR.%?,5%%V
M!HGO_NTO9YL_;HX]YUWR&CDDKV+M\TG2D:;ZXS7ES]IHS(10QC=C+)22\CB.
MZV1A=H:*EY<IK=_G&P99EH3-TI Y7>GLZ<B39#MY#2(;JZ(J$MT$XM5O!UDH
MW^1Q#HOIXNPA^>V+>"JK\.7Y]ME(IJ#IS&,0DZX)?);<;\QT'R)*$WB.V=W)
M%IG_2K]C'IT5W4Y_;6TF[ X!<[V;DBD673 07*W,E-&06+R$2!)AP<J8V2#&
M_QF0Z:'QS'P-'X#,!'%W )KK5*ROB[D)_ZKJ;R4.UB$MPSH.C@D)W%@1/;GP
MN7F/[0>FTA=LIFAYTU[D'2#G;;ZX.*%1[RY#>VZ$+TB.FB4?OO*#^D(7;N39
MZ(!%^-2:YN:!J2Q\2[5'3@N1=\>&Y\FM=PRPUG,K+PGTNJ;1^: ,0U:BV7<[
M/0\VO"F6RUQA]L2&EW4,-#FLMCZM'V5]@/8%7-%:8W'>ZGD@Z)4-;X2Z'F+#
M&R.['MGP2D"ZX)0'EV.ALTL*")Q.,<N\<EXJ9_GAV$?/;'BC%'2(#6^,M#JP
M$?:5DS!17"X:<HJUQQY&DH@3(#2:;+6G!1Z77:5[-KQ9_FP;P7=5H_5R\^%C
M/CVO_WYG\9E33N2D,P16V>E+B> YF=/1FIQH:=[:PR?)N#$[RSJ?J.2'"]0;
M2KPK*.VC^[-%EQ2B!/K-MLF!A5IO#SKK+*(L#O%PPE!C8L5%ZOV:0*B5I+N[
MS#Z_B/'L$D_>G&T^K<])72O)HQ#( TCI:#E)\9H:92%;IK+23+E\W'[S]Z;4
MF;,S#UO'4$-_J-JU3P2CFSX9)!GA-O$N D9)-B"+$7UPWL1!156/7^.^"!-=
M.VS-5<83J%+^X61SMD[XE\UIVH:I+G*;.N2'/[=UI?' %2Q22YRX#-'3"51L
MJOE,@8&+3D(HHA1OI':^=5%M#[7$!KD6-6,<??&T!5E]@B?W11<936"N!'5T
MIO,G5TL\!BL#:XG'Z&'AHM%MY]PJJA_SYO<S_/A^'?%D&R7CQO#HO (E:FN@
M'!F$C QTT,9X;[,I@^KQ#U2-/CB!SGR\"9K=M!;STEC)O]]=PG6L3?*4?<T:
MM4X74)HNYV %&8"I9)LX5AN@!58>FL!R):6-%+MI+>4EH7+Q\6SUPT\KRYQ-
M6 D];;*@"C=TIA8!%GV2R=%2[C;WV_FZ4#_N"A3UNUN N!IF0=6W4=1FNM2Z
M(AS8@E[3RB5+M0@EU!8T6H##6N2JO"0+W2&[&\1Y3!Z*Q\Z,FGI;S!1L5["X
MW9O.D&L870*6+'F(J589F&# 1"9]$2+JL*_YUK/BH1BESR$\%&.$VUGZ[?8.
MO7EH0_3.;T\^&^D+"D#I+2058W(E)96G,%!\':$7%$Q5W3[VB8ER["X:]TU<
MB7/EZ :44 JKN8+5-:L,"M&I)*SVP=C.'BP?.XUERC736/#+GB@_X[_6'RX_
MU%#4#YNS%R<GM_KO>,&M84*#4#7[7$DRP[RE+]E[&9GB(AX^4/8,T)F;.E%]
MF^:R? (QV%\NWN>SMQ\V_[SB1/QKIG_]?MODZ;J;4YN0[.!A6D=HIZUOD8"M
ME%SSS"UHD<AC*B) )<4!3S)-VB;M0NOZBAX"ME:@X,$:D#+43#0R!0/M+4C<
M*.XR\YA;9WL__8#M&*P,#-B.T</20;@' TZ.:9%90B@N*%#6DT&0T (C9T(&
MZ;5IXEX]K8#M*,T."MB.$?/26'DP0H4ZH+9"0%3UL5XE#S1Q#<9&(;5$G_,@
MH_HY!6Q'*790P':,E)<.V+[X=251<E44 \,E \40P1DL(!F7+I; <]K'Z3\H
M8/OBUQX#MJ,4M9DNM:65_/+%2HI@A#(%;/ (BBMR"U)FP()E,MD4,<FY2G[Y
M8CE*QR,H>:34EE;R=]^OBJ9/I7L/',9ZE%E'MQZ/M3#):A<#_7'?\3Y(R=]]
MOQQ/XQ&4/%)JBROYY2I6^X4[75M]D#>>))G (1EP E4.T6>Q-S V3,DOER->
M/(:2QTEM:277YT =?9%9@M6,,"FK_9JPLJY886QQ'-WL.WG@(^I1J!2/H.21
M4EM:R:]^6@7EI0XE0]25)IH7#9YN%<",)5F>6)+[7DT'*?G5,"4?A1GQ"$H>
M*;7%E?QBQ9*3.2L-/-6B#<<(DV@2G4-T&G%EC Q\MI*'&5Y'H3D\AI+'26UI
M)?_M[4H&5 :C!!-,!!6R 51D1R@F@G36T%6S+XXY2,E_>[L<0^$1E#Q2:DLK
M^:<7*U&XMUA;RRKI:P"R$!R3JM-ES)3"^=ZZ@$%*_FG83CX*Q^ 1E#Q2:DLK
M^>?O5I*SD'W44&K9KRH8Z6*Q!G2(+G,7:B.VN4K^^;L%.0./H.618EM<RZ]6
MG Q^I[,F\Z'2#X5"?CVM$80TY!F$XNC&F:WE5PN2 !Y#R^/$MKB67Z^$4VAJ
M],9[5EMO1/+Y+!<0;$:NM,U,S]?RZP4I_8ZAY7%B6UK+K_^^*ED%[\G+<U'7
M0@[R_-!R"^3NE:#(H.!W,SW&:_GUWX=I^:E$O4:*;7$M__O*:\(@LP$RYES9
M&3AX%1CI215R 56);@AGS7XM__LP+3^5L-=(L2VNY7^LLHA6UJ<4&[#&VVTU
M(\CWR]ZKE)*-.<_VHU[_8YB6GTK<:Z38EM;R+W]=">L,$[[0VCPMU7 %(9!S
M$.F76@8R%<OLO?S+7X=I^:D$OD:*;7$M_VTEM'66!0DB6)JN5 QJJ!UHD1J+
M10QR7R'A,"W_;9B6GTKD:Z38%M?RKRN?C2%;04*,F56Z+7+TC>; F!.17(42
MU?R]/#!YX*F$OD:*;6DMOWFQ\D4D+DP"S@I-EXP&",YX8*8D\OJ=EV%?*]E!
M6GXS+/3%GTKL:Z38%M1RW%R>7IQ]7KWY=87(.<%/@C;D"RCO')T^C&#J'0K/
M/3<XI'CS^A.O='W]PU=U?QUO6+[($XB#313ATEO[[<N54JSFSEKPS'&Z;VC.
M+J8,.6@5G.39BS)W:[\=EDX@GDHH;*38EM;RN_^J9-?<T;5":[.^@M("BLB!
M2Q:4RH:P.CMIY-U_#=/R4PF%C13;TEK^SU<K%V0N-B(XY;<$J +0Z02B8)9D
M;2C.9B<4_.>PL+9X*J&PD6+KX)I^^6(E>-:FV *)5Z8!\O+!(4W;>5>LX29*
M,^0I<M@U/32M\PF$Q2:*<-DRQ[^<K2_6Y^]?;DXN/X0UOL7S?^)%?)__^-(2
M5%JC=2 I&),)P+:VVDE%@O5*TR*3\^)PG\2#PPQ#P1,(FS67:6<D_YHI[D1Q
MD)BNE>!TE'G-(NA:.86YB#@H&Z4MR?]CDW!,J0":*\RN2/Z+D2J8#-$&,ET8
MX^!EL6!S<<;F@,D,R3M[:B3_H]3U(,G_"-GU2/(??)*QJ&VTP="AJ,B@R46!
MECR09:-9"(?O@ZY)_L<HZ!#)_QAI=:5M/$TOMH7@/YYM+C_>-*>)J(4/A/U<
M+T3+Z4(TOK**>&N5B=JRT0T>=@VTS*%_)"3,EN2RN'B)IYC6>/IN$S#&S<]X
M>EDP7ER>T8??+,8:YW3F($,E"Y'(".1;JC*5&2LQDOP.PN+P.,O4!K5"16,Y
M+@N*^X"67 7K"UV&(4N:N[400G @4RBU_D63SW,0 ],.@N:^82N5SY-25Y1K
M6_M':6FS30JX*8%F[PMXL6U_IH0M68ETM[?Q8S+Q/39%TE0:@)F"[0H6MQC'
M N>$;B: %Z1KS1@)*+("XT,DB5@=^+XBX&?%Q#=*GT.8^,8(=]F;X9H;Z,4N
M;J";YLTE(BHI(:EMKS3-(2A56QR:)+/+R(LZ>%4<'J<71$Q5X^98,NV F^_M
M93C/_WU)<OS^$WVI(MIN')0EQZ K-:VB^S&QVE"O<-#62Q*4U2:U)B]Z8"J=
M]<28?N6T%'F?R+DQTB0+N79C)2&1J^U, /12 U>R^!R8*:QU:Y4')[,L;U$3
M51^&SP2Y]P>@Z_,3!?J25 892XW3U-">IYWEA=(^TW^U;]WP:>=$N@/.%"7O
MA\X$B7< FSVLF*S4QSX=H!15GWB-!9]I6_'L:1G2R9(&N46/QR;;_!WMB/=6
M(\%WU;-P:\"]WER\S&<7Z[+.Z?7E=D]D*VP.(D*2JM(0(LG)6 X&E0BRD/F;
MQ[>]W#U69\QZ$Y7Z<+O+!A+N[M3Y_":?)OJ6%K?^<'Z](NM5D5Y;<B)H@RFF
M& 3+Z],R\L ]P\2.R_>Y:U:=O=K.0]>1E#$97I_R6=@T/Y.N5K IWP2F5\'[
MHC*9C-%K!DI&7PE1-"1KA==.E1(.^^I#1NHLQ-?Z/)HOW:XNL+_GL[2.%^>_
M?7R?3])*:Q^9+@(R(_$H+02=JED"HO,1O2FB''X3WCM$9^YX:WC,D.?"#T$?
M:M;;=5?-B\V6'OP-GEU\7OG,$.L+9W:&@XK9D;-)'F=D*8C@>2!_\_"#T$,?
MWYF9.QL/;>3X! CRKR.8).:7F_.+7W/<T'7V^6O$M T__M!16M/C3UK=0NU,
M.<9D&'!9LQ"*KRDJE<X.<^*6K!?=O!%Q#^SXK!*+)(%D_]>6OZYRR424H LK
MS&$I;B\MWI^3'7\,5@:RXX_10V\9L"64PDD:=/($NIR=!&\LH[M:A\QM-DKO
M<[B.DP'[V!SXH_2W+P-VA#![RH -1FKEZ4)VE2-2Z9(@:(V@?0HI%A[5W4RX
MYY$!.T9=#V7 CI%=][EOF:<<:#V W&>H021RX6P EJ*1*3L6[.&\IT:Y;\?/
MC1VENE&Y;V/DV$-@[HM)MVU4?[[='2)8:W(EMW*51$/1R8C6D(A4=CI($I=J
M_A"P8QZ=!=^F7QC-A-TA8&XVE/-"8M20MGQHV7IPUC/PQ2*=$"8PW$<PU@(R
M/;Q8S]?P <A,$'<'H'E'*D=R#FG@+^NYR20U22/=NH"N4I\JI$5X0V>RT-$8
M9+G<S;>=#9R'9],7>*;H>G,4P2_=J^GA1O(LA\B\!XM2U@8S"EQ.#AAM-RZ$
MKW3V#9(UY_7U>NR$WBE75#LQ+XV5!ZM@A95>H53D\U>;W^<"0:"#7'O4U#)8
M-JQ9[G/JZS5*L8/Z>HV1<A\\ >BTT[1<"+$2$"%:\)P<PA*9<3Y')?;V>SL*
M3\ CD[R,4MI]FH Q$NPJ[7^[!V11.G)1()?J"WI+BZ^\@5(+G9"1+S@L9>XX
MU2"/G9H[]?*8*=BN8'$K7Q"52\%I#R(72P>DS/4%TT"R458&8&GEGZ8:9)0^
MAU2#C!'NL@&TW>]AWY8N&"W(+G<,<B6Z4B8A>!8SH#8F6^$R,W>Z(NR(H T8
MJ!=,3%7DYFA2[;]B2/.04A% ]V5]@'(!G$=!9ZU4KL0B.>,'(=*H8N@H#&.M
M$=)8IAV$0O:D7,C@N+1:@=$104EIP%N3R>]W9)=9;:1L_93]Q/*O9P5?VPB^
M.PCMS-^,7I9@(EGDH;;K#$(">L[!&.&#*($\O7V\T@LFTRZ1JCU*_^.3:<<H
MXTDDT\IL$ZMO7)7FJX8.0_7W,D3N$W..<5[*P6NL63+M$NG74Q!S#.EVE4Q[
MLYQMN.G\C_7%^[?YXN+D=NQYQ2(R$74$^H8$9[R @'2,A\(#)J=H7[BIT-DS
M;F=QVF,!J97D%X;5UW>0[2IJT.K%Z>DEGKS!S]L?MDFF*T.>0<J,0\FI=N?)
M') %!)L#MR'Q8..!7,OA@W46JYD/H"/(N%?4;)-_?LCYG)96S<B?\5_K#Y<?
M5BD(GYE4($2MW!2TP-H=%Q3WZ*,LEBL[ S\/#-N987U$)+60>P_F]JX%WDYS
M?W<[S=V&[*V0$G+4DA:7(SBF.$C)14XI,1.;6]YC)KA,I^MC&^%'4]$3J$1X
M_>;G%^G_79YOTZ"_6Y]_O"0;H$WYP=Z/;EUS,'P=BQ0:&.<*YUQ +(Y.K2@(
MGX:^L$R@#1Q1\'V$P4^UT$!'&:)$#S;5TCZOD=Q8-&!=\A93E%[L:W;RYRPT
M&(.5@84&8_2P= K&@^D&69 \0A;@B_"@=%: JC@P'@L7C*>"+5[3YJ7K/'8)
MPBC-#DK7&2/FI;'R,&D]%A]]RB -F8K*.+(2+08@/T18ZX4W=RNVGW^ZSBC%
M#DK7&2/EI9NWO/['2HKDN4X2I'6U;H.DX%.J;#[2TDK(B@GS^Q@/['WZN"DZ
MHQ2UF2ZUI97\\[N5BG1%:K00DJR<TF2D!Q<04J1K4](7E68WQ?SYW7*/I$=0
M\DBI+:WD5S^MN"^^!*4@R=K"LQ0#3DH&9-8GSR*MQ@UIO;!7R:]^6B;N>R0E
MCY1:9^6F(FB?E8GD=8=*&5T4(95KB%8%5-E8YX:TQWS:#5>FV'ISA=E3N:DF
M0Z682J!F5*V[,PH<$GZ52:$V(U)VT/W]U,I-1ZGKH7+3,;+KJ@7'30L1RZ0Q
M6@,K)H-2/ ,Z=,!K,V>%UM(%=C#<WG/#E5$*.MAP982TNDJ>W0+>)C1%!0=%
MUM;-DM'LDQ9@A#7<28UI&(?M\V#8G^KASQ1L5["XE0M(,"XL^@R1_-7*F!K!
M&^?I1^4Q\)Q8'E0K^AQRJD?I<TA.]1CA]I]3K=%8[[D%D;:Y,*R KWGG/KFL
ME/$JXN%,HZ>94SU*D>-RJL=(M6.,T%CJFT>CFZM3D!.EN:F,S+2GBO3@<M2@
M->,B*F1A0%[(E)&70=$QE#X03RTTT#? ]*[EH<XN>^.!?/$:3S,<?*#KG4>=
M=$:#>D#^XY21E_%IEP78; WT#3"S:WF&*4M6HB=11EI>B+5*WWK HKF-)@MC
MQ&R [1IY&?-Y68#-UD#? +.[EN=29#9S!\SR*DJOKYB0=$B)H[9*%SD;8+M&
M7B:/<EF S=9 WP!SNY;'N2N2(]FL5F10C".02: @6ETRPVQ%.4PG-F7D9=(K
MEP78; WT#3"_\X 61@H6.=F4)=6G< ^AOJ+H4$**3B8A<3; =HV\3 +EL@";
MK8&N <;9KN4IEY+4%J$83?ZW4PA8N<NCJ)O'U<JMV2?8SI$' <P^*X#-UT#?
M .,[?9CBDY9,@Q6:]D^66+T9 R4XH;T.VK"9? $/C#P(8.YY 6RV!OH&F-AY
M0,>8164US3HZL@"LAMJ. 1B=S,9Y8:R9'0?;.?(@@/GG!;#9&N@;8'+7\D3A
M12B&Y+ELB\/\EI:#/&7E9"P24U*SXV [1QX6:&7/"V&S5= WPG8&DGU"Y]%$
MH .:3NC@MH\@)-1$(,K%*%$.EPM/&7D8PIY7+'^^"OI&V+>1Y!M9IN#0,^X!
MJR^CR'.A'50;W:#(F"JUG9@="ML]]#",/:]P?@,E] TRLVM]-]SPD6MG,H?B
M12&'1A@(4=7JP\IB904F$V9#;<\$A@'N>87WFRFD;]C9G=M*ZY2E"@6*3I7S
MH3HXS@8P3'-1V<A-.%SA/FGH85![7H'^!DKH&V1NY_J$\U[J$B ZE\D$#0E<
M3 &*2$7KH%#(^3;:SJ&'@>QY!?L;**%OD/F=Z[/9\RWM:(J5H5A*1R>U81 U
MR11S5%S.#Y;M''H8R)Y7P+^!$KH&F6 [UU=0<&F]A/IZ0<(4'#!X2\N5!H6C
MG^]V$Q@/LMU##P/9\PKZ-U!"WR#C.]<7-*?3V%@R![2I$1LR-[GS((I//"7N
MR+&>#;*=0P\#V?,*_#=00L<@>W>&I^?K^NT_,IYMTS'KOKJ)W!2=-9)3;9!L
M3L5-A,!9+3U2D2/SR;N92-L[_C"X/:=G@';JZ!AS-27SH:0F#%II6@G$("/Y
MTY;.[N0]:,:9=VBT'- _?>KHPY)CG]>C0!M5=(RVW5N*WV0(,!=,4 %X0 8J
M.@$D4TO^M>11.^WQ;DN?-B<<[Y9G_1A5(^UT\)2 QOVM15HKK Q* Z,M1YY/
MI<$TSH%0M'')$1)9^,9 NSW^<C0&RP)ML@[ZHHW\V@I2)1L132)LU)RY*$AJ
MF<=*XA!#X.B\N!/&6*ZSZF-W'II2)=M,V!T"YGJCD5F8I")A%%%KJ83DX**0
M$#RY+F1)BI2/W8RWV\ZJHS0\K+/J&'%W )I[/-\W413-Z:CT ?R6XS1A(:'P
M APU4]:(P)H?- ],I2_83-'RIKW(.T#.=:>*>\O0R<M@@P1K&"T#M05T))H8
MH_+<^Y3D/F*F*<AY8"H+,_BT1TX+D2]K0K\X"^N+L^W<W^2S]29MCV%F749&
MDJ"SV($JMC8G3@B8O0]>"8?L<*+ISH_NC"Q]NJ'21':=Z?YZ1RBEC-&F0+:5
MN#LE#H$;!5QF%[22*,WA+- '/GRQBOH&RMJC^0F26YC1:3OM7T[S3;Z6I3/+
M* &"IT""X+5;34@0%6)*H5AYE]]G%Y?3MQ_:CZZGJ&?31%8]:/G='YN;B+4N
MM,AH(!=']Y+1"IQ 16ZWB1GICX$=SNRX\Z&+41@<1<O39-6!]??J-&X^Y"],
MPS_5_T/503WE"G(A8F:0Y#;0HNF\XW3*29XX62H*'3>-+< ]T^FL8<7\6$4K
MT?>+HANB4Y$%UU)#-)Z\\V0D>(X6"A=:6^9D%(^$HQX"&,W4/@Q.$W30 :!J
M4/B7\A9/\LV[F0_"ZQ@],*5K&3NCG5:[O1:AT)N<D:;1&$3W)M$E<*8H>--2
MVAW 95\[(2;(>^8!I'.QGM ,7*5+9JYX55LHJN:'S\QFNLVSNXX9;V\C^/XZ
MQGU_?K'^0#MM4][0$M<DIQ_K+A-<^MKR#ERV!A1F"4XBK<S%9!@WN<3#14+#
MQ^NL3\E$Y>[O$== TD^M^^G7Q9-WN&(&N6+%DRQKHB/: DYS!C%S;E+* O.
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M7CO)=PRKUYN+:U-UE:W 8*4F8?'ZYB4R!)X\")5(>I%IEP<<6L,&6X:T;B$
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M87)T97(N:'1M4$L! A0#%     @ ?#G\5$@IN?(N!   )!$  !P
M     ( !.1$  &5X:&EB:70S,C%Q,C(P,C(M<75A<G1E<BYH=&U02P$"% ,4
M    " !\.?Q4"WBN)S,$  "U$0  '               @ &A%0  97AH:6)I
M=#,R,G$R,C R,BUQ=6%R=&5R+FAT;5!+ 0(4 Q0    ( 'PY_%1T4(OK;A4
M &76   <              "  0X:  !E>&AI8FET.3DQ<3(R,#(R+7%U87)T
M97(N:'1M4$L! A0#%     @ ?#G\5$T^]\4%!   "1X  !P
M ( !MB\  &5X:&EB:70Y.3)Q,C(P,C(M<75A<G1E<BYH=&U02P$"% ,4
M" !\.?Q4^&Q++-BY P#Q;BL #P              @ 'U,P  ;6\M,C R,C V
M,S N:'1M4$L! A0#%     @ ?#G\5.."(%1F'0  ;E,!  \
M ( !^NT# &UO+3(P,C(P-C,P+GAS9%!+ 0(4 Q0    ( 'PY_%3S^8I2*QX
M ',H 0 3              "  8T+! !M;RTR,#(R,#8S,%]C86PN>&UL4$L!
M A0#%     @ ?#G\5*OERK4+IP  24<' !,              ( !Z2D$ &UO
M+3(P,C(P-C,P7V1E9BYX;6Q02P$"% ,4    " !\.?Q4"V[9CR,B 0"G$PP
M$P              @ $ET00 ;6\M,C R,C V,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( 'PY_%1==1#F_]   (YD"0 3              "  7GS!0!M;RTR,#(R
B,#8S,%]P<F4N>&UL4$L%!@     ,  P .@,  *G$!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
